ss_sbclllr_frctn,ss_tst_tp,ss_tss,ss_cll_tp,ss_ctgr,cnfdnc_scr,vrnt_d,src_ss_d,rltnshp_tp,td,dc_d,src_d,ss_tx_d,ss_d,ss_strn,b_frmt,ss_rgnsm,tss_d,chmbl_d,ss_tp,cll_d,dscrptn,crtd_b
,In vivo,Kidney,,,1,,,N,50597,9866,1,10116.0,7524,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL618647,A,,Biodistribution in normal rat kidney in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Intermediate
,In vivo,Kidney,,,1,,,N,50597,9866,1,10116.0,7525,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL618648,A,,Biodistribution in normal rat kidney in the presence of 0.01 M Gd/0.05 M lig,Intermediate
,In vivo,Kidney,,,1,,,N,50597,9866,1,10116.0,7526,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL618649,A,,Biodistribution in normal rat kidney in the presence of NAC Gd 0.01 M lig at 2 hr,Intermediate
,In vivo,Liver,,,1,,,N,50597,9866,1,10116.0,7527,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL618650,A,,Biodistribution in normal rat liver in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Intermediate
,In vivo,Liver,,,1,,,N,50597,9866,1,10116.0,7528,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL618651,A,,Biodistribution in normal rat liver in the presence of 0.01 M Gd/0.05 M lig,Intermediate
,In vivo,Liver,,,1,,,N,50597,9866,1,10116.0,7529,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL876497,A,,Biodistribution in normal rat liver in the presence of NAC Gd 0.01 M lig at 2 hr,Intermediate
,In vivo,Lung,,,1,,,N,50597,9866,1,10116.0,7530,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL618652,A,,Biodistribution in normal rat lung in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Intermediate
,In vivo,Lung,,,1,,,N,50597,9866,1,10116.0,7531,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL618653,A,,Biodistribution in normal rat lung in the presence of 0.01 M Gd/0.05 M lig,Intermediate
,In vivo,Lung,,,1,,,N,50597,9866,1,10116.0,7532,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL618654,A,,Biodistribution in normal rat lung in the presence of NAC Gd 0.01 M lig at 2 hr,Intermediate
,,,,,1,,,N,50597,6351,1,10116.0,7533,,BAO_0000218,Rattus norvegicus,,CHEMBL618655,A,,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats; Not tested,Intermediate
,,,,,1,,,N,50597,1465,1,10116.0,7534,,BAO_0000218,Rattus norvegicus,,CHEMBL618656,A,,Compound was tested for solubility in water,Intermediate
,,,,,0,,,U,22229,5182,1,,7535,,BAO_0000100,,,CHEMBL618657,P,,Solubility in phosphate buffered saline (1% DMSO) at pH 6.5 (24 hr equilibration),Intermediate
,,,,,1,,,N,50597,17847,1,10116.0,7536,,BAO_0000218,Rattus norvegicus,,CHEMBL618658,A,,Solubility was determined,Intermediate
,,,,,1,,,N,50597,15339,1,10116.0,7537,,BAO_0000218,Rattus norvegicus,,CHEMBL618659,A,,solubility in water (ug/mL) at 37 degree C.,Intermediate
,,,,,1,,,N,50597,5202,1,10116.0,7538,,BAO_0000218,Rattus norvegicus,,CHEMBL618660,A,,First pass metabolism and metabolic bioavailability using rat hepatic microsomes,Intermediate
,,,,,1,,,N,50597,1088,1,10116.0,7539,,BAO_0000218,Rattus norvegicus,,CHEMBL618661,A,,In vitro stability relative to (+)-AJ76 in rat hepatocyte assay,Intermediate
,,,,,1,,,N,50597,3169,1,10116.0,7540,,BAO_0000218,Rattus norvegicus,,CHEMBL873807,A,,Half life in rats,Intermediate
,,,,,1,,,N,50597,5353,1,10116.0,7541,,BAO_0000218,Rattus norvegicus,,CHEMBL618662,A,,Half life in Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,2864,1,10116.0,7542,,BAO_0000218,Rattus norvegicus,,CHEMBL618663,A,,Half life period after 3 mg/kg iv administration,Intermediate
,In vivo,,,,1,,,N,50597,2864,1,10116.0,7543,,BAO_0000218,Rattus norvegicus,,CHEMBL618664,A,,Half life period after 3 mg/kg iv administration in rat,Intermediate
,In vivo,,,,1,,,N,50597,2864,1,10116.0,7544,,BAO_0000218,Rattus norvegicus,,CHEMBL618665,A,,Half life period after 3 mg/kg iv administration in the rat,Intermediate
,,,,,1,,,N,50597,6362,1,10116.0,7545,,BAO_0000218,Rattus norvegicus,,CHEMBL876498,A,,Half life period in female Sprague-Dawley rats,Intermediate
,,,,,1,,,N,50597,6249,1,10116.0,7546,,BAO_0000218,Rattus norvegicus,,CHEMBL618666,A,,Half life period in rat,Intermediate
,,,,,1,,,N,50597,3169,1,10116.0,7547,,BAO_0000218,Rattus norvegicus,,CHEMBL620440,A,,Half-life in rats was determined,Intermediate
,,,,,1,,,N,50597,3169,1,10116.0,7548,,BAO_0000218,Rattus norvegicus,,CHEMBL620441,A,,Half-life in rats with metabolic oxidation,Intermediate
,,,,,1,,,N,50597,3169,1,10116.0,7549,,BAO_0000218,Rattus norvegicus,,CHEMBL620442,A,,Half-life in rats,Intermediate
,In vivo,,,,1,,,N,50597,17260,1,10116.0,7550,,BAO_0000218,Rattus norvegicus,,CHEMBL620443,A,,T 1/2 at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,Intermediate
,In vivo,,,,1,,,N,50597,17260,1,10116.0,7551,,BAO_0000218,Rattus norvegicus,,CHEMBL620444,A,,T 1/2 at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,Intermediate
,In vivo,,,,1,,,N,50597,17260,1,10116.0,7552,,BAO_0000218,Rattus norvegicus,,CHEMBL620445,A,,T max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,Intermediate
,In vivo,,,,1,,,N,50597,17260,1,10116.0,7553,,BAO_0000218,Rattus norvegicus,,CHEMBL620446,A,,T max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,Intermediate
,,Plasma,,,1,,,N,50597,2879,1,10116.0,7554,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL620447,A,,Biological half-life measured in plasma of rat,Intermediate
,,Plasma,,,1,,,N,50597,2879,1,10116.0,7555,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL621129,A,,Biological half-life measured in plasma of rat; 22-25,Intermediate
,,Plasma,,,1,,,N,50597,2879,1,10116.0,7556,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL621130,A,,Biological half-life measured in plasma of rat; 9-16,Intermediate
,In vivo,,,,1,,,N,50597,3184,1,10116.0,7557,,BAO_0000218,Rattus norvegicus,,CHEMBL873808,A,,Compound was evaluated for its half life when administered intravenously in rat,Intermediate
,In vivo,,,,1,,,N,50597,4891,1,10116.0,7558,,BAO_0000218,Rattus norvegicus,,CHEMBL876598,A,,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 8 h,Intermediate
,In vivo,,,,1,,,N,50597,429,1,10116.0,7559,,BAO_0000218,Rattus norvegicus,,CHEMBL621131,A,,Evaluated for pharmacokinetic parameter half-life in rat at the dose 50 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,5656,1,10116.0,7560,,BAO_0000218,Rattus norvegicus,,CHEMBL621132,A,,Half life (T1/2) after oral administration in rat,Intermediate
,In vivo,,,,1,,,N,50597,4413,1,10116.0,7561,,BAO_0000218,Rattus norvegicus,,CHEMBL621133,A,,Half life of compound after iv administration of 20 mg/kg dose in rat,Intermediate
,In vivo,,,,1,,,N,50597,3598,1,10116.0,7562,,BAO_0000218,Rattus norvegicus,,CHEMBL621312,A,,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,Expert
,,,,,1,,,N,50597,17267,1,10116.0,7563,,BAO_0000218,Rattus norvegicus,,CHEMBL621313,A,,Half life of compound was determined in rat,Intermediate
,,Blood,,,1,,,N,50597,4727,1,10116.0,7564,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL621314,A,,Half life of compound was determined in rat blood,Intermediate
,In vivo,,,,1,,,N,50597,17651,1,10116.0,7565,,BAO_0000218,Rattus norvegicus,,CHEMBL621315,A,,Half life at 1 mg/kg was determined in rat,Intermediate
,In vivo,,,,1,,,N,50597,17651,1,10116.0,7566,,BAO_0000218,Rattus norvegicus,,CHEMBL621316,A,,Half life at 10 mg/kg was determined in rat,Intermediate
,,,,,1,,,N,50597,401,1,10116.0,7567,,BAO_0000218,Rattus norvegicus,,CHEMBL621317,A,,Half life in rats,Intermediate
,,,,,1,,,N,50597,4942,1,10116.0,7568,,BAO_0000218,Rattus norvegicus,,CHEMBL621318,A,,Half life in rats in hours,Intermediate
,In vivo,,,,1,,,N,50597,17735,1,10116.0,7569,,BAO_0000218,Rattus norvegicus,,CHEMBL621319,A,,Half life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,Intermediate
,In vivo,,,,1,,,N,50597,6056,1,10116.0,7570,,BAO_0000218,Rattus norvegicus,,CHEMBL621377,A,,Half life was calculated at a single intravenous administration of 20 mg/kg in rat,Intermediate
,,,,,1,,,N,50597,5213,1,10116.0,7571,,BAO_0000218,Rattus norvegicus,,CHEMBL621378,A,,Half life was determined,Intermediate
,In vivo,,,,1,,,N,50597,6616,1,10116.0,7572,,BAO_0000218,Rattus norvegicus,,CHEMBL876599,A,,Half life after i.v. administration,Intermediate
,In vivo,,,,1,,,N,50597,5937,1,10116.0,7573,,BAO_0000218,Rattus norvegicus,,CHEMBL621379,A,,Half life in rat after intravenous administration at a concentration 0.5 mg/kg,Intermediate
,,Plasma,,,1,,,N,50597,5819,1,10116.0,7574,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL621380,A,,Half life in rat plasma,Intermediate
,,Plasma,,,1,,,N,50597,5819,1,10116.0,7575,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL621381,A,,Half life in rat plasma; Not detected,Intermediate
,,,,,1,,,N,50597,6803,1,10116.0,7576,,BAO_0000218,Rattus norvegicus,,CHEMBL618515,A,,Half life in rats,Intermediate
,In vivo,,,,1,,,N,50597,17804,1,10116.0,7577,,BAO_0000218,Rattus norvegicus,,CHEMBL618516,A,,Half life period of compound was determined after peroral administration,Intermediate
,In vivo,,,,1,,,N,50597,17804,1,10116.0,7578,,BAO_0000218,Rattus norvegicus,,CHEMBL618517,A,,Half life period of compound was determined at a dose of 3 mg/kg by intravenous administration,Intermediate
,,,,,1,,,N,50597,5948,1,10116.0,7579,,BAO_0000218,Rattus norvegicus,,CHEMBL618518,A,,Half life period in rat,Intermediate
,In vivo,,,,1,,,N,50597,1916,1,10116.0,7580,,BAO_0000218,Rattus norvegicus,,CHEMBL618519,A,,Half life period was evaluated against Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,Intermediate
,In vivo,,,,1,,,N,50597,1916,1,10116.0,7581,,BAO_0000218,Rattus norvegicus,,CHEMBL618698,A,,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,Intermediate
,In vivo,,,,1,,,N,50597,1916,1,10116.0,7582,,BAO_0000218,Rattus norvegicus,,CHEMBL618862,A,,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration; Not available,Intermediate
,In vivo,,,,1,,,N,50597,4890,1,10116.0,7583,,BAO_0000218,Rattus norvegicus,,CHEMBL618863,A,,Half life period was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,Intermediate
,In vivo,,,,1,,,N,50597,17764,1,10116.0,7584,,BAO_0000218,Rattus norvegicus,,CHEMBL618864,A,,Half life period was determined for compound after intravenous administration in rats at 24 uM/kg,Intermediate
,In vivo,,,,1,,,N,50597,4727,1,10116.0,7585,,BAO_0000218,Rattus norvegicus,,CHEMBL618865,A,,Half life time in rat the dose of 2 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,17509,1,10116.0,7586,,BAO_0000218,Rattus norvegicus,,CHEMBL618866,A,,Half-life 24 hr after 10 mg/kg iv administration in rats,Intermediate
,In vivo,,,,1,,,N,50597,17509,1,10116.0,7587,,BAO_0000218,Rattus norvegicus,,CHEMBL618867,A,,Half-life 24 hr after 2 mg/kg iv administration in rats,Intermediate
,,,,,1,,,N,50597,6597,1,10116.0,7588,,BAO_0000218,Rattus norvegicus,,CHEMBL875828,A,,Half-life consistent with the observed metabolic steady state in rats,Intermediate
,In vivo,,,,1,,,N,50597,17735,1,10116.0,7589,,BAO_0000218,Rattus norvegicus,,CHEMBL618868,A,,Half-life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,Intermediate
,,,,,1,,,N,50597,6597,1,10116.0,7590,,BAO_0000218,Rattus norvegicus,,CHEMBL618869,A,,Half-life for oxidative metabolic stability was determined using male human,Intermediate
,In vivo,,,,1,,,N,50597,17670,1,10116.0,7591,,BAO_0000218,Rattus norvegicus,,CHEMBL618870,A,,"Half-life in fischer rats at 5 mg/kg dose, administered intravenously",Intermediate
,,Plasma,,,1,,,N,50597,1696,1,10116.0,7592,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL618871,A,,Half-life in rat plasma,Intermediate
,,Plasma,,,1,,,N,50597,1742,1,10116.0,7593,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL618872,A,,Half-life in rat plasma was determined,Intermediate
,,,,,1,,,N,50597,17800,1,10116.0,7594,,BAO_0000218,Rattus norvegicus,,CHEMBL873816,A,,Half-life in rats was determined,Intermediate
,,,,,0,,,U,22224,12923,1,,7595,,BAO_0000218,,,CHEMBL618873,A,,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by gavage method in dog,Autocuration
,,,,,0,,,U,22224,11954,1,,7596,,BAO_0000019,,,CHEMBL621602,A,,Area under curve after oral dose of 0.1 mg//kg,Autocuration
,,,,,0,,,U,22224,11954,1,,7597,,BAO_0000218,,,CHEMBL621603,A,,Area under curve after oral dose of 0.3 mg/kg,Autocuration
,,,,,0,,,U,22224,11954,1,,7598,,BAO_0000218,,,CHEMBL621604,A,,Area under curve after oral dose of 1 mg/kg,Autocuration
,,,,,0,,,U,22224,11954,1,,7599,,BAO_0000218,,,CHEMBL621605,A,,Area under curve after oral dose of 10 mg/kg,Autocuration
,,,,,0,,,U,22224,11954,1,,7600,,BAO_0000218,,,CHEMBL621606,A,,Area under curve after oral dose of 23.4 mg/kg,Autocuration
,,,,,0,,,U,22224,11954,1,,7601,,BAO_0000218,,,CHEMBL621607,A,,Area under curve after oral dose of 3 mg/kg,Autocuration
,,,,,0,,,U,22224,11954,1,,7602,,BAO_0000218,,,CHEMBL621608,A,,Area under curve after oral dose of 3.87 mg/kg,Autocuration
,,,,,0,,,U,22224,5237,1,,7603,,BAO_0000019,,,CHEMBL621609,A,,Area under curve was determined,Autocuration
,,,,,0,,,U,22224,4026,1,,7604,,BAO_0000218,,,CHEMBL621610,A,,Area under curve at a dose of 10 mg/kg,Autocuration
,,,,,1,,,N,50597,5237,1,10116.0,7605,,BAO_0000218,Rattus norvegicus,,CHEMBL621611,A,,Area under curve was determined; ND=No data,Intermediate
,,,,,1,,,N,50597,14793,1,10116.0,7606,,BAO_0000218,Rattus norvegicus,,CHEMBL621612,A,,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,Intermediate
,,,,,1,,,N,50597,14793,1,10116.0,7607,,BAO_0000218,Rattus norvegicus,,CHEMBL622308,A,,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,Intermediate
,,,,,1,,,N,50597,14793,1,10116.0,7608,,BAO_0000218,Rattus norvegicus,,CHEMBL622309,A,,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,Intermediate
,,,,,1,,,N,50597,14793,1,10116.0,7609,,BAO_0000218,Rattus norvegicus,,CHEMBL622310,A,,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for infinite hours,Intermediate
,,,,,1,,,N,50597,14793,1,10116.0,7610,,BAO_0000218,Rattus norvegicus,,CHEMBL622311,A,,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,Intermediate
,,,,,1,,,N,50597,14793,1,10116.0,7611,,BAO_0000218,Rattus norvegicus,,CHEMBL622312,A,,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for infinite hours; Not calculated,Intermediate
,,,,,1,,,N,50597,14793,1,10116.0,7612,,BAO_0000218,Rattus norvegicus,,CHEMBL622931,A,,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,Intermediate
,,,,,1,,,N,50597,14793,1,10116.0,7613,,BAO_0000218,Rattus norvegicus,,CHEMBL622932,A,,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for infinite hours; Not calculated,Intermediate
,,Plasma,,,1,,,N,50597,14793,1,10116.0,7614,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622736,A,,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,Intermediate
,,Plasma,,,1,,,N,50597,14793,1,10116.0,7615,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622737,A,,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,Intermediate
,,Plasma,,,1,,,N,50597,14793,1,10116.0,7616,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622738,A,,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,Intermediate
,,Plasma,,,1,,,N,50597,14793,1,10116.0,7617,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622739,A,,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for infinite hours,Intermediate
,,Plasma,,,1,,,N,50597,14793,1,10116.0,7618,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622740,A,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,Intermediate
,,Plasma,,,1,,,N,50597,14793,1,10116.0,7619,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622741,A,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for infinite hours,Intermediate
,,Plasma,,,1,,,N,50597,14793,1,10116.0,7620,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622742,A,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,Intermediate
,,Plasma,,,1,,,N,50597,14793,1,10116.0,7621,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622743,A,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for infinite hours,Intermediate
,,Plasma,,,1,,,N,50594,11637,1,10090.0,7622,,BAO_0000218,Mus musculus,1969.0,CHEMBL622744,A,,AUC in mice,Intermediate
,,,,,0,,,U,22224,11149,1,,7623,,BAO_0000019,,,CHEMBL624134,A,,Area under curve was measured from the graph obtained from concentration Vs time,Autocuration
,,,,,0,,,U,22224,10016,1,,7624,,BAO_0000019,,,CHEMBL624135,A,,Area under curve value of compound per hour after oral administration,Autocuration
,,,,,1,,,N,50597,17796,1,10116.0,7625,,BAO_0000218,Rattus norvegicus,,CHEMBL624136,A,,Area under curve was determined after oral administration in rats,Intermediate
,,,,,1,,,N,50597,17796,1,10116.0,7626,,BAO_0000218,Rattus norvegicus,,CHEMBL624137,A,,Area under curve was determined after oral administration in rats; No data,Intermediate
,,,,,1,,,N,50597,17796,1,10116.0,7627,,BAO_0000218,Rattus norvegicus,,CHEMBL624320,A,,Area under curve was determined after oral administration in rats;No data,Intermediate
,,,,,1,,,N,50588,12923,1,9615.0,7628,,BAO_0000218,Canis lupus familiaris,,CHEMBL624321,A,,Area under curve was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,Intermediate
,,,,,1,,,N,50597,15372,1,10116.0,7629,,BAO_0000218,Rattus norvegicus,,CHEMBL624322,A,,Area under curve was determined for the compound after iv dose of 4.74 mg/kg in rats,Intermediate
,,,,,1,,,N,50597,15372,1,10116.0,7630,,BAO_0000218,Rattus norvegicus,,CHEMBL624323,A,,Area under curve was determined for the compound after iv dose of 5.06 in rats,Intermediate
,,,,,1,,,N,50597,15372,1,10116.0,7631,,BAO_0000218,Rattus norvegicus,,CHEMBL624324,A,,Area under curve was determined for the compound after iv dose of 5.10 mg/kg in rats,Intermediate
,,,,,1,,,N,50597,15372,1,10116.0,7632,,BAO_0000218,Rattus norvegicus,,CHEMBL624325,A,,Area under curve was determined for the compound after po dose of 5.01 mg/kg in rats,Intermediate
,,,,,1,,,N,50597,15372,1,10116.0,7633,,BAO_0000218,Rattus norvegicus,,CHEMBL624326,A,,Area under curve was determined for the compound after po dose of 5.03 mg/kg in rats,Intermediate
,,,,,1,,,N,50597,15372,1,10116.0,7634,,BAO_0000218,Rattus norvegicus,,CHEMBL624327,A,,Area under curve was determined for the compound after po dose of 5.22 mg/kg in rats,Intermediate
,,,,,1,,,N,50597,15372,1,10116.0,7635,,BAO_0000218,Rattus norvegicus,,CHEMBL624328,A,,Area under curve was determined for the compound after po dose of 5.46 mg/kg in rats,Intermediate
,,,,,1,,,N,50588,14169,1,9615.0,7636,,BAO_0000218,Canis lupus familiaris,,CHEMBL627848,A,,Area under curve was determined in Dogs after peroral administration,Intermediate
,,,,,1,,,N,50597,14169,1,10116.0,7637,,BAO_0000218,Rattus norvegicus,,CHEMBL627849,A,,Area under curve was determined in Rats after peroral administration,Intermediate
,,,,,1,,,N,50597,14258,1,10116.0,7638,,BAO_0000218,Rattus norvegicus,,CHEMBL627850,A,,Area under curve was determined in carotid blood of rat when administered intradermally,Intermediate
,,,,,1,,,N,50597,14258,1,10116.0,7639,,BAO_0000218,Rattus norvegicus,,CHEMBL627851,A,,Area under curve was determined in portal blood of rat when administered intradermally,Intermediate
,,,,,1,,,N,50594,15011,1,10090.0,7640,,BAO_0000218,Mus musculus,,CHEMBL627852,A,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,Intermediate
,,,,,1,,,N,50594,15011,1,10090.0,7641,,BAO_0000218,Mus musculus,,CHEMBL627853,A,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,Intermediate
,,,,,1,,,N,50594,15011,1,10090.0,7642,,BAO_0000218,Mus musculus,,CHEMBL627854,A,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),Intermediate
,,,,,1,,,N,50594,15011,1,10090.0,7643,,BAO_0000218,Mus musculus,,CHEMBL627855,A,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,Intermediate
,,,,,1,,,N,50594,15011,1,10090.0,7644,,BAO_0000218,Mus musculus,,CHEMBL627856,A,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg (run time 7 hr),Intermediate
,,,,,1,,,N,50594,15011,1,10090.0,7645,,BAO_0000218,Mus musculus,,CHEMBL875339,A,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,Intermediate
,,,,,1,,,N,50594,15011,1,10090.0,7646,,BAO_0000218,Mus musculus,,CHEMBL627857,A,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (Run time = 7 hr),Intermediate
,In vivo,Spleen,,,1,,,N,50597,11195,1,10116.0,7647,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL627858,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 65 mins after i.v. administration,Intermediate
,,Blood,,,1,,,N,50597,10130,1,10116.0,7648,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL627859,A,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in blood; Expressed as percent dose/organ,Intermediate
,,Brain,,,1,,,N,50597,10130,1,10116.0,7649,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL627860,A,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in brain; Expressed as percent dose/organ,Intermediate
,,Heart,,,1,,,N,50597,10130,1,10116.0,7650,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL627019,A,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in heart; Expressed as percent dose/organ,Intermediate
,,Liver,,,1,,,N,50597,10130,1,10116.0,7651,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL627020,A,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in liver; Expressed as percent dose/organ,Intermediate
,,Lung,,,1,,,N,50597,10130,1,10116.0,7652,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL627021,A,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in lung; Expressed as percent dose/organ,Intermediate
,,Muscle tissue,,,1,,,N,50597,10130,1,10116.0,7653,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL627022,A,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in muscle; Expressed as percent dose/organ,Intermediate
,,,,,1,,,N,50597,10130,1,10116.0,7654,,BAO_0000218,Rattus norvegicus,,CHEMBL627023,A,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in skin; Expressed as percent dose/organ,Intermediate
,,Spleen,,,1,,,N,50597,10130,1,10116.0,7655,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL627024,A,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in spleen; Expressed as percent dose/organ,Intermediate
,,Thyroid gland,,,1,,,N,50597,10130,1,10116.0,7656,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL627025,A,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in thyroid; Expressed as percent dose/organ,Intermediate
,,Kidney,,,1,,,N,50597,10130,1,10116.0,7657,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL627026,A,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in kidney; Expressed as percent dose/organ,Intermediate
,,Blood,,,1,,,N,50597,10130,1,10116.0,7658,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL627027,A,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in blood; Expressed as percent dose/organ,Intermediate
,,Brain,,,1,,,N,50597,10130,1,10116.0,7659,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL627028,A,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in brain; Expressed as percent dose/organ,Intermediate
,,Heart,,,1,,,N,50597,10130,1,10116.0,7660,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL627029,A,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in heart; Expressed as percent dose/organ,Intermediate
,,Kidney,,,1,,,N,50597,10130,1,10116.0,7661,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL627030,A,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in kidney; Expressed as percent dose/organ,Intermediate
,,Liver,,,1,,,N,50597,10130,1,10116.0,7662,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL627031,A,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in liver; Expressed as percent dose/organ,Intermediate
,,Lung,,,1,,,N,50597,10130,1,10116.0,7663,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL627032,A,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in lung; Expressed as percent dose/organ,Intermediate
,,Muscle tissue,,,1,,,N,50597,10130,1,10116.0,7664,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL627033,A,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in muscle; Expressed as percent dose/organ,Intermediate
,,,,,1,,,N,50597,10130,1,10116.0,7665,,BAO_0000218,Rattus norvegicus,,CHEMBL627034,A,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in skin; Expressed as percent dose/organ,Intermediate
,,Spleen,,,1,,,N,50597,10130,1,10116.0,7666,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL627035,A,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in spleen; Expressed as percent dose/organ,Intermediate
,,Thyroid gland,,,1,,,N,50597,10130,1,10116.0,7667,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL627036,A,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in thyroid; Expressed as percent dose/organ,Intermediate
,,Blood,,,1,,,N,50597,10130,1,10116.0,7668,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL875340,A,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in blood; Expressed as percent dose/organ,Intermediate
,,Heart,,,1,,,N,50597,10130,1,10116.0,7669,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL627037,A,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in heart; Expressed as percent dose/organ,Intermediate
,,Kidney,,,1,,,N,50597,10130,1,10116.0,7670,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL627038,A,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in kidney; Expressed as percent dose/organ,Intermediate
,,Liver,,,1,,,N,50597,10130,1,10116.0,7671,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL627039,A,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in liver; Expressed as percent dose/organ,Intermediate
,,Muscle tissue,,,1,,,N,50597,10130,1,10116.0,7672,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL627040,A,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in muscle; Expressed as percent dose/organ,Intermediate
,,Spleen,,,1,,,N,50597,10130,1,10116.0,7673,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL624663,A,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in spleen; Expressed as percent dose/organ,Intermediate
,,Thyroid gland,,,1,,,N,50597,10130,1,10116.0,7674,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL625963,A,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in thyroid; Expressed as percent dose/organ,Intermediate
,,Brain,,,1,,,N,50597,10130,1,10116.0,7675,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL876799,A,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in brain; Expressed as percent dose/organ,Intermediate
,,Lung,,,1,,,N,50597,10130,1,10116.0,7676,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL626133,A,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in lung; Expressed as percent dose/organ,Intermediate
,,,,,1,,,N,50597,10130,1,10116.0,7677,,BAO_0000218,Rattus norvegicus,,CHEMBL626134,A,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in skin; Expressed as percent dose/organ,Intermediate
,,,,,1,,,N,50597,6295,1,10116.0,7678,,BAO_0000218,Rattus norvegicus,,CHEMBL626135,A,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,Intermediate
,,,,,1,,,N,50597,6296,1,10116.0,7679,,BAO_0000218,Rattus norvegicus,,CHEMBL626136,A,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,Intermediate
,,,,,1,,,N,50597,6296,1,10116.0,7680,,BAO_0000218,Rattus norvegicus,,CHEMBL626137,A,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg; Below detection limit,Intermediate
,,,,,1,,,N,50597,6295,1,10116.0,7681,,BAO_0000218,Rattus norvegicus,,CHEMBL626138,A,,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,Intermediate
,,,,,1,,,N,50597,6296,1,10116.0,7682,,BAO_0000218,Rattus norvegicus,,CHEMBL626139,A,,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,17260,1,10116.0,7683,,BAO_0000218,Rattus norvegicus,,CHEMBL626140,A,,C max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,Intermediate
,In vivo,,,,1,,,N,50597,17260,1,10116.0,7684,,BAO_0000218,Rattus norvegicus,,CHEMBL626141,A,,C max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,Intermediate
,,,,,1,,,N,50597,17686,1,10116.0,7685,,BAO_0000218,Rattus norvegicus,,CHEMBL626142,A,,C24h in rat p.o. at 20 mg/kg concentration,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,9866,1,10116.0,7686,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL627930,A,,Biodistribution in normal rat muscle in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,9866,1,10116.0,7687,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL627931,A,,Biodistribution in normal rat muscle in the presence of 0.01 M Gd/0.05 M lig,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,9866,1,10116.0,7688,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL627932,A,,Biodistribution in normal rat muscle in the presence of NAC Gd 0.01 M lig at 2 hr,Intermediate
,In vivo,Spleen,,,1,,,N,50597,9866,1,10116.0,7689,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL627933,A,,Biodistribution in normal rat spleen in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Intermediate
,In vivo,Spleen,,,1,,,N,50597,9866,1,10116.0,7690,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL627934,A,,Biodistribution in normal rat spleen in the presence of 0.01 M Gd/0.05 M lig,Intermediate
,In vivo,Spleen,,,1,,,N,50597,9866,1,10116.0,7691,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL627935,A,,Biodistribution in normal rat spleen in the presence of NAC Gd 0.01 M lig at 2 hr,Intermediate
,In vivo,Blood,,,1,,,N,50597,9866,1,10116.0,7692,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL627936,A,,Biodistribution in rat blood in the presence of 0.001 M/0.008 M GdDTPA-AEP,Intermediate
,In vivo,Blood,,,1,,,N,50597,9866,1,10116.0,7693,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL627937,A,,Biodistribution in rat blood in the presence of 0.01 M GdDTPA-BDP,Intermediate
,In vivo,Blood,,,1,,,N,50597,9866,1,10116.0,7694,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL627938,A,,Biodistribution in rat blood in the presence of 0.01 M/0.01 M GdDTPA-AEP,Intermediate
,In vivo,Blood,,,1,,,N,50597,9866,1,10116.0,7695,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL627939,A,,Biodistribution in rat blood in the presence of 0.05 M Gd/0.15 M lig,Intermediate
,In vivo,Blood,,,1,,,N,50597,9866,1,10116.0,7696,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL627940,A,,Biodistribution in rat blood in the presence of 0.05 M GdDTPA-BDP,Intermediate
,In vivo,Blood,,,1,,,N,50597,9866,1,10116.0,7697,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL627941,A,,Biodistribution in rat blood in the presence of 0.05 M/0.05 M GdDTPA-AEP,Intermediate
,In vivo,Blood,,,1,,,N,50597,9866,1,10116.0,7698,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL876800,A,,Biodistribution in rat blood in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Intermediate
,In vivo,Blood,,,1,,,N,50597,9866,1,10116.0,7699,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL627942,A,,Biodistribution in rat blood in the presence of 0.10 M GdDTPA-BDP,Intermediate
,In vivo,Blood,,,1,,,N,50597,9866,1,10116.0,7700,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL627943,A,,Biodistribution in rat blood in the presence of 0.10 M/0.11 M GdDTPA-AEP,Intermediate
,In vivo,Blood,,,1,,,N,50597,9866,1,10116.0,7701,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL627944,A,,Biodistribution in rat blood in the presence of 50 Gd/kg at 15 min,Intermediate
,In vivo,Blood,,,1,,,N,50597,9866,1,10116.0,7702,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL627945,A,,Biodistribution in rat blood in the presence of 50 Gd/kg at 2 hr,Intermediate
,In vivo,Blood,,,1,,,N,50597,9866,1,10116.0,7703,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL628584,A,,Biodistribution in rat blood in the presence of 50 Gd/kg at 6 hr,Intermediate
,In vivo,Blood,,,1,,,N,50597,9866,1,10116.0,7704,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL628585,A,,Biodistribution in rat blood in the presence of GdDTPA at 15 min,Intermediate
,In vivo,Blood,,,1,,,N,50597,9866,1,10116.0,7705,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL628586,A,,Biodistribution in rat blood in the presence of GdDTPA at 1 hr,Intermediate
,In vivo,Blood,,,1,,,N,50597,9866,1,10116.0,7706,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL628587,A,,Biodistribution in rat blood in the presence of GdDTPA at 30 min,Intermediate
,In vivo,Blood,,,1,,,N,50597,9866,1,10116.0,7707,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL628588,A,,Biodistribution in rat blood in the presence of GdDTPA at 4 hr,Intermediate
,In vivo,Blood,,,1,,,N,50597,9866,1,10116.0,7708,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL628589,A,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 15 min,Intermediate
,In vivo,Blood,,,1,,,N,50597,9866,1,10116.0,7709,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL625304,A,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 30 min,Intermediate
,In vivo,Blood,,,1,,,N,50597,9866,1,10116.0,7710,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL625305,A,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 4 hr,Intermediate
,In vivo,Blood,,,1,,,N,50597,9866,1,10116.0,7711,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL625306,A,,Biodistribution in rat blood in the presence of GdDTPA-BDPat 1 hr,Intermediate
,In vivo,Blood,,,1,,,N,50597,9866,1,10116.0,7712,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL625307,A,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 15 min,Intermediate
,In vivo,Blood,,,1,,,N,50597,9866,1,10116.0,7713,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL625308,A,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 30 min,Intermediate
,In vivo,Blood,,,1,,,N,50597,9866,1,10116.0,7714,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL627740,A,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 4 hr,Intermediate
,In vivo,Blood,,,1,,,N,50597,9866,1,10116.0,7715,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL627741,A,,Biodistribution in rat blood in the presence of GdDTPA-HPDPat 1 hr,Intermediate
,In vivo,Blood,,,1,,,N,50597,9866,1,10116.0,7716,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL627742,A,,Biodistribution in rat blood in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Intermediate
,In vivo,Blood,,,1,,,N,50597,9866,1,10116.0,7717,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL627743,A,,Biodistribution in rat blood in the presence of NCA Gd/0.01 M lip,Intermediate
,In vivo,Blood,,,1,,,N,50597,9866,1,10116.0,7718,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL627744,A,,Biodistribution in rat blood in the presence of NCAGd/0.01 M lig,Intermediate
,In vivo,Bone,,,1,,,N,50597,9866,1,10116.0,7719,,BAO_0000218,Rattus norvegicus,10000001.0,CHEMBL627745,A,,Biodistribution in rat bone in the presence of 0.01 M GdDTPA-BDP,Intermediate
,In vivo,Bone,,,1,,,N,50597,9866,1,10116.0,7720,,BAO_0000218,Rattus norvegicus,10000001.0,CHEMBL627746,A,,Biodistribution in rat bone in the presence of 0.01 M/0.01 M GdDTPA-AEP,Intermediate
,In vivo,Bone,,,1,,,N,50597,9866,1,10116.0,7721,,BAO_0000218,Rattus norvegicus,10000001.0,CHEMBL627747,A,,Biodistribution in rat bone in the presence of 0.01 M/0.08 M GdDTPA-AEP,Intermediate
,In vivo,Bone,,,1,,,N,50597,9866,1,10116.0,7722,,BAO_0000218,Rattus norvegicus,10000001.0,CHEMBL876810,A,,Biodistribution in rat bone in the presence of 0.05 M Gd/0.15 M lig,Intermediate
,In vivo,Bone,,,1,,,N,50597,9866,1,10116.0,7723,,BAO_0000218,Rattus norvegicus,10000001.0,CHEMBL627748,A,,Biodistribution in rat bone in the presence of 0.05 M GdDTPA-BDP,Intermediate
,In vivo,Bone,,,1,,,N,50597,9866,1,10116.0,7724,,BAO_0000218,Rattus norvegicus,10000001.0,CHEMBL627749,A,,Biodistribution in rat bone in the presence of 0.05 M/0.05 M GdDTPA-AEP,Intermediate
,In vivo,Bone,,,1,,,N,50597,9866,1,10116.0,7725,,BAO_0000218,Rattus norvegicus,10000001.0,CHEMBL627750,A,,Biodistribution in rat bone in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Intermediate
,In vivo,Bone,,,1,,,N,50597,9866,1,10116.0,7726,,BAO_0000218,Rattus norvegicus,10000001.0,CHEMBL618728,A,,Biodistribution in rat bone in the presence of 0.10 M GdDTPA-BDP,Intermediate
,In vivo,Bone,,,1,,,N,50597,9866,1,10116.0,7727,,BAO_0000218,Rattus norvegicus,10000001.0,CHEMBL618729,A,,Biodistribution in rat bone in the presence of 0.10 M/0.11 M GdDTPA-AEP,Intermediate
,In vivo,Bone,,,1,,,N,50597,9866,1,10116.0,7728,,BAO_0000218,Rattus norvegicus,10000001.0,CHEMBL618730,A,,Biodistribution in rat bone in the presence of GdDTPA at 15 min,Intermediate
,In vivo,Bone,,,1,,,N,50597,9866,1,10116.0,7729,,BAO_0000218,Rattus norvegicus,10000001.0,CHEMBL618731,A,,Biodistribution in rat bone in the presence of GdDTPA at 1 hr,Intermediate
,In vivo,Bone,,,1,,,N,50597,9866,1,10116.0,7730,,BAO_0000218,Rattus norvegicus,10000001.0,CHEMBL618732,A,,Biodistribution in rat bone in the presence of GdDTPA at 30 min,Intermediate
,In vivo,Bone,,,1,,,N,50597,9866,1,10116.0,7731,,BAO_0000218,Rattus norvegicus,10000001.0,CHEMBL618733,A,,Biodistribution in rat bone in the presence of GdDTPA at 4 hr,Intermediate
,In vivo,Bone,,,1,,,N,50597,9866,1,10116.0,7732,,BAO_0000218,Rattus norvegicus,10000001.0,CHEMBL618734,A,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 15 min,Intermediate
,In vivo,Bone,,,1,,,N,50597,9866,1,10116.0,7733,,BAO_0000218,Rattus norvegicus,10000001.0,CHEMBL618735,A,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 1 hr,Intermediate
,In vivo,Bone,,,1,,,N,50597,9866,1,10116.0,7734,,BAO_0000218,Rattus norvegicus,10000001.0,CHEMBL876602,A,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 30 min,Intermediate
,In vivo,Bone,,,1,,,N,50597,9866,1,10116.0,7735,,BAO_0000218,Rattus norvegicus,10000001.0,CHEMBL618736,A,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 4 hr,Intermediate
,In vivo,Bone,,,1,,,N,50597,9866,1,10116.0,7736,,BAO_0000218,Rattus norvegicus,10000001.0,CHEMBL618737,A,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 15 min,Intermediate
,In vivo,Bone,,,1,,,N,50597,9866,1,10116.0,7737,,BAO_0000218,Rattus norvegicus,10000001.0,CHEMBL618738,A,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 1 hr,Intermediate
,In vivo,Bone,,,1,,,N,50597,9866,1,10116.0,7738,,BAO_0000218,Rattus norvegicus,10000001.0,CHEMBL618739,A,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 30 min,Intermediate
,In vivo,Bone,,,1,,,N,50597,9866,1,10116.0,7739,,BAO_0000218,Rattus norvegicus,10000001.0,CHEMBL618740,A,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 4 hr,Intermediate
,In vivo,Bone,,,1,,,N,50597,9866,1,10116.0,7740,,BAO_0000218,Rattus norvegicus,10000001.0,CHEMBL618741,A,,Biodistribution in rat bone in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Intermediate
,In vivo,Bone,,,1,,,N,50597,9866,1,10116.0,7741,,BAO_0000218,Rattus norvegicus,10000001.0,CHEMBL618742,A,,Biodistribution in rat bone in the presence of NCA Gd/0.01 M lip,Intermediate
,In vivo,Bone,,,1,,,N,50597,9866,1,10116.0,7742,,BAO_0000218,Rattus norvegicus,10000001.0,CHEMBL618743,A,,Biodistribution in rat bone in the presence of NCAGd/0.01 M lig,Intermediate
,In vivo,Plasma,,,1,,,N,50597,17752,1,10116.0,7743,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL618744,A,,Half-life from rat plasma at a single oral dose of 25 mg/kg,Intermediate
,,,,,1,,,N,50597,5610,1,10116.0,7744,,BAO_0000218,Rattus norvegicus,,CHEMBL618745,A,,Half-life in male rat,Intermediate
,In vivo,,,,1,,,N,50597,5939,1,10116.0,7745,,BAO_0000218,Rattus norvegicus,,CHEMBL620479,A,,Half-life in rat after peroral administration at 10 mg/kg concentration,Intermediate
,In vivo,,,,1,,,N,50597,5939,1,10116.0,7746,,BAO_0000218,Rattus norvegicus,,CHEMBL620480,A,,Half-life in rat after peroral administration at 5 mg/kg concentration,Intermediate
,In vivo,,,,1,,,N,50597,17771,1,10116.0,7747,,BAO_0000218,Rattus norvegicus,,CHEMBL620481,A,,Half-life in rat at a dose of 3 mg/kg,Intermediate
,,,,,1,,,N,50597,1974,1,10116.0,7748,,BAO_0000218,Rattus norvegicus,,CHEMBL620482,A,,Half-life was evaluated in rats,Intermediate
,,,,,1,,,N,50597,4239,1,10116.0,7749,,BAO_0000218,Rattus norvegicus,,CHEMBL876603,A,,Half-life was measured in rat,Intermediate
,In vivo,,,,1,,,N,50597,6681,1,10116.0,7750,,BAO_0000218,Rattus norvegicus,,CHEMBL620483,A,,Half-life period for the compound was determined in rats at 50 mg/kg dose,Intermediate
,In vivo,,,,1,,,N,50597,17752,1,10116.0,7751,,BAO_0000218,Rattus norvegicus,,CHEMBL620484,A,,Half-life period in rats after intravenous administration at 5 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,6046,1,10116.0,7752,,BAO_0000218,Rattus norvegicus,,CHEMBL620485,A,,Half-life period in rat at 10 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,6685,1,10116.0,7753,,BAO_0000218,Rattus norvegicus,,CHEMBL620486,A,,"Half-life period was determined in rats at 10 mg/kg, p.o. dose",Intermediate
,In vivo,,,,1,,,N,50597,6685,1,10116.0,7754,,BAO_0000218,Rattus norvegicus,,CHEMBL620487,A,,"Half-life period was determined in rats at 20 mg/kg, i.p. dose",Intermediate
,In vivo,,,,1,,,N,50597,6685,1,10116.0,7755,,BAO_0000218,Rattus norvegicus,,CHEMBL620488,A,,"Half-life period was determined in rats at 2 mg/kg, i.v. dose",Intermediate
,In vivo,,,,1,,,N,50597,4727,1,10116.0,7756,,BAO_0000218,Rattus norvegicus,,CHEMBL620489,A,,Half-life time in rat the dose of 2 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,1088,1,10116.0,7757,,BAO_0000218,Rattus norvegicus,,CHEMBL620490,A,,Half-life was estimated from the elimination phase of the oral [C] vs time curves in 4 rats,Intermediate
,In vivo,,,,1,,,N,50597,5610,1,10116.0,7758,,BAO_0000218,Rattus norvegicus,,CHEMBL620491,A,,In vivo activity against Staphylococcus aureus when administered orally for 1 hr in rat at a dose of 15 mg/kg,Intermediate
,In vivo,Plasma,,,1,,,N,50597,3032,1,10116.0,7759,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL876604,A,,"In vivo half life of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",Intermediate
,In vivo,,,,1,,,N,50597,5199,1,10116.0,7760,,BAO_0000218,Rattus norvegicus,,CHEMBL620492,A,,Oral half life was determined,Intermediate
,In vivo,,,,1,,,N,50597,14941,1,10116.0,7761,,BAO_0000218,Rattus norvegicus,,CHEMBL620493,A,,"Pharmacokinetic Parameter, half life period measured in Female Wistar Rats at 100 mg/kg by po administration",Intermediate
,In vivo,,,,1,,,N,50597,4408,1,10116.0,7762,,BAO_0000218,Rattus norvegicus,,CHEMBL620494,A,,Pharmacokinetic property (t1/2) in rat,Intermediate
,,Plasma,,,1,,,N,50597,2552,1,10116.0,7763,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL620495,A,,Plasma elimination half-life was determined,Intermediate
,In vivo,Plasma,,,1,,,N,50597,5199,1,10116.0,7764,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL620496,A,,Plasma elimination half-life was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,Intermediate
,In vivo,Plasma,,,1,,,N,50597,15662,1,10116.0,7765,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL620497,A,,Plasma half life was observed after intravenous administration in rat,Intermediate
,,Plasma,,,1,,,N,50597,1465,1,10116.0,7766,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL620498,A,,Plasma half-life was determined,Intermediate
,In vivo,Plasma,,,1,,,N,50597,1446,1,10116.0,7767,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL620499,A,,Plasma half-life following oral administration in Fisher rats,Intermediate
,,Plasma,,,1,,,N,50597,6824,1,10116.0,7768,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL620500,A,,Plasma half-life in rat,Intermediate
,In vivo,Plasma,,,1,,,N,50597,17533,1,10116.0,7769,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL873809,A,,Plasmatic Half-life after intravenous administration to rat,Intermediate
,In vivo,,,,1,,,N,50597,5979,1,10116.0,7770,,BAO_0000218,Rattus norvegicus,,CHEMBL620501,A,,T1/2 (half life) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,Intermediate
,In vivo,,,,1,,,N,50597,4689,1,10116.0,7771,,BAO_0000218,Rattus norvegicus,,CHEMBL620502,A,,Terminal half life after intravenous administration (1 mg/kg) in rat,Intermediate
,In vivo,,,,1,,,N,50597,4689,1,10116.0,7772,,BAO_0000218,Rattus norvegicus,,CHEMBL620503,A,,Terminal half life in Rat at a oral dose of 5 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,2463,1,10116.0,7773,,BAO_0000218,Rattus norvegicus,,CHEMBL620504,A,,Terminal phase half-life was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,Intermediate
,In vivo,,,,1,,,N,50597,4883,1,10116.0,7774,,BAO_0000218,Rattus norvegicus,,CHEMBL876605,A,,Tested for half life value after intravenous administration at dose of 0.2 mg/kg in rat,Intermediate
,In vivo,,,,1,,,N,50597,4883,1,10116.0,7775,,BAO_0000218,Rattus norvegicus,,CHEMBL620505,A,,Tested for half life value after oral administration at dosage of 4 mg/kg in rat,Intermediate
,In vivo,Plasma,,,1,,,N,50597,15662,1,10116.0,7776,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL873811,A,,plasma half life was observed after intravenous administration in rat,Intermediate
,In vivo,,,,1,,,N,50597,3598,1,10116.0,7777,,BAO_0000218,Rattus norvegicus,,CHEMBL624016,A,,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,Expert
,,,,,1,,,N,50597,4576,1,10116.0,7778,,BAO_0000218,Rattus norvegicus,,CHEMBL624017,A,,Half life of compound determined in rat,Intermediate
,,,,,1,,,N,50597,4576,1,10116.0,7779,,BAO_0000218,Rattus norvegicus,,CHEMBL624018,A,,Mean residence time determined in rat,Intermediate
,,,,,1,,,N,50597,4576,1,10116.0,7780,,BAO_0000218,Rattus norvegicus,,CHEMBL624019,A,,Plasma half life determined in rat,Intermediate
,In vivo,Brain,,,1,,,N,50597,4910,1,10116.0,7781,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL624020,A,,Compound was evaluated for Tmax in brain after intravenous administration in male rats,Intermediate
,In vivo,,,,1,,,N,50597,4891,1,10116.0,7782,,BAO_0000218,Rattus norvegicus,,CHEMBL624201,A,,Compound was evaluated for pharmacokinetic parameter maximum time period,Intermediate
,In vivo,,,,1,,,N,50597,429,1,10116.0,7783,,BAO_0000218,Rattus norvegicus,,CHEMBL872528,A,,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,5974,1,10116.0,7784,,BAO_0000218,Rattus norvegicus,,CHEMBL624202,A,,In vivo Tmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,5974,1,10116.0,7785,,BAO_0000218,Rattus norvegicus,,CHEMBL624203,A,,In vivo Tmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,5974,1,10116.0,7786,,BAO_0000218,Rattus norvegicus,,CHEMBL624350,A,,In vivo Tmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,5974,1,10116.0,7787,,BAO_0000218,Rattus norvegicus,,CHEMBL621320,A,,In vivo Tmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,17582,1,10116.0,7788,,BAO_0000218,Rattus norvegicus,,CHEMBL621321,A,,In vivo maximum time required for clearance of compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,Intermediate
,,,,,1,,,N,50597,4026,1,10116.0,7789,,BAO_0000218,Rattus norvegicus,,CHEMBL621322,A,,Maximum time (Tmax) required to reach Cmax in rats,Intermediate
,In vivo,,,,1,,,N,50597,4890,1,10116.0,7790,,BAO_0000218,Rattus norvegicus,,CHEMBL621323,A,,Maximum time constant was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,Intermediate
,In vivo,,,,1,,,N,50597,6571,1,10116.0,7791,,BAO_0000218,Rattus norvegicus,,CHEMBL621324,A,,Maximum time of clearance of compound in rats after peroral administration,Intermediate
,,,,,1,,,N,50597,4727,1,10116.0,7792,,BAO_0000218,Rattus norvegicus,,CHEMBL621325,A,,Maximum time at the dose of 2 mg/kg in rat,Intermediate
,In vivo,Plasma,,,1,,,N,50597,17651,1,10116.0,7793,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL875837,A,,Maximum time to achieve peak plasma concentration was determined in rat at 1 mg/kg,Intermediate
,In vivo,Plasma,,,1,,,N,50597,17651,1,10116.0,7794,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL621326,A,,Maximum time to achieve peak plasma concentration was determined in rat at 10 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,14465,1,10116.0,7795,,BAO_0000218,Rattus norvegicus,,CHEMBL621327,A,,Tmax in Guinea pig (PO dose),Intermediate
,In vivo,,,,1,,,N,50597,14941,1,10116.0,7796,,BAO_0000218,Rattus norvegicus,,CHEMBL621328,A,,"Pharmacokinetic Parameter, Tmax is the time at which maximum concentration (Cmax) is reached in Female Wistar Rats at 100 mg/kg by po administration",Intermediate
,In vivo,,,,1,,,N,50597,5960,1,10116.0,7797,,BAO_0000218,Rattus norvegicus,,CHEMBL621329,A,,Pharmacokinetic parameter (Tmax) in rat,Intermediate
,In vivo,,,,1,,,N,50597,5022,1,10116.0,7798,,BAO_0000218,Rattus norvegicus,,CHEMBL621330,A,,Pharmacokinetic parameter (Tmax) was estimated,Intermediate
,In vivo,,,,1,,,N,50597,4408,1,10116.0,7799,,BAO_0000218,Rattus norvegicus,,CHEMBL621331,A,,Pharmacokinetic property (Tmax) in rat,Intermediate
,In vivo,,,,1,,,N,50597,5983,1,10116.0,7800,,BAO_0000218,Rattus norvegicus,,CHEMBL621332,A,,Pharmacokinetic property (Tmax) was measured in rat at the dose of 0.32 mg/kg p.o.,Intermediate
,In vivo,,,,1,,,N,50597,4689,1,10116.0,7801,,BAO_0000218,Rattus norvegicus,,CHEMBL621333,A,,T max in Rat at a oral dose of 5 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,2792,1,10116.0,7802,,BAO_0000218,Rattus norvegicus,,CHEMBL621334,A,,T max was determined at 10 mg/kg po dose in rats,Intermediate
,,,,,1,,,N,50594,15011,1,10090.0,7803,,BAO_0000218,Mus musculus,,CHEMBL621335,A,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (run time 7 hr),Intermediate
,,,,,1,,,N,50588,14180,1,9615.0,7804,,BAO_0000218,Canis lupus familiaris,,CHEMBL621336,A,,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in dogs,Intermediate
,,,,,1,,,N,50597,14180,1,10116.0,7805,,BAO_0000218,Rattus norvegicus,,CHEMBL621337,A,,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in rats,Intermediate
,,,,,1,,,N,50588,14599,1,9615.0,7806,,BAO_0000218,Canis lupus familiaris,,CHEMBL621338,A,,Area under curve was measured after i.v. administration into Beagle dog.,Intermediate
,,,,,1,,,N,50588,14599,1,9615.0,7807,,BAO_0000218,Canis lupus familiaris,,CHEMBL875838,A,,Area under curve was measured after iv administration into Beagle dog,Intermediate
,,,,,1,,,N,50588,14599,1,9615.0,7808,,BAO_0000218,Canis lupus familiaris,,CHEMBL621339,A,,Area under curve was measured after po administration into Beagle dog,Intermediate
,,,,,1,,,N,50588,14599,1,9615.0,7809,,BAO_0000218,Canis lupus familiaris,,CHEMBL621340,A,,Area under curve was measured after po administration into Beagle dog.,Intermediate
,,,,,0,,,U,22224,15675,1,,7810,,BAO_0000218,,,CHEMBL621341,A,,Area under curve was measured at peroral dose of 3 mg/kg,Autocuration
,,,,,0,,,U,22224,12706,1,,7811,,BAO_0000019,,,CHEMBL621342,A,,Area under curve was measured by using concentration Vs time,Autocuration
,,,,,0,,,U,22224,12706,1,,7812,,BAO_0000019,,,CHEMBL621343,A,,Area under curve was measured by using concentration Vs time; not tested,Autocuration
,,,,,1,,,N,50594,9750,1,10090.0,7813,,BAO_0000218,Mus musculus,,CHEMBL621344,A,,Area under curve(AUC) was measured in mice after oral administration (50 mg/kg),Intermediate
,,,,,1,,,N,50594,9750,1,10090.0,7814,,BAO_0000218,Mus musculus,,CHEMBL621345,A,,Area under curve(AUC) was measured in mice after oral administration.,Intermediate
,,,,,0,,,U,22224,14691,1,,7815,,BAO_0000019,,,CHEMBL621346,A,,Area under curve(AUC) value of the compound,Autocuration
,,,,,0,,,U,22224,14691,1,,7816,,BAO_0000218,,,CHEMBL621347,A,,Area under curve(AUC) value of the compound in dogs at 0.5 mg/kg dose upon oral administration,Autocuration
,,,,,1,,,N,50588,14691,1,9615.0,7817,,BAO_0000218,Canis lupus familiaris,,CHEMBL621348,A,,Area under curve(AUC) value of the compound in dogs at 1 mg/kg dose upon oral administration,Intermediate
,,Blood,,,0,,,U,22224,2939,1,,7818,,BAO_0000019,,178.0,CHEMBL621349,A,,Area under curve(carotid artery) was determined by the availability in blood,Autocuration
,,Blood,,,0,,,U,22224,2939,1,,7819,,BAO_0000019,,178.0,CHEMBL621350,A,,Area under curve(carotid artery) was determined by the availability in blood; ND means no data,Autocuration
,,Blood,,,0,,,U,22224,2939,1,,7820,,BAO_0000019,,178.0,CHEMBL875839,A,,Area under curve(carotid artery) was determined by the availability in blood; No data,Autocuration
,,Blood,,,0,,,U,22224,2939,1,,7821,,BAO_0000019,,178.0,CHEMBL620211,A,,Area under curve(portal vein) was determined by the availability in blood,Autocuration
,,Blood,,,0,,,U,22224,2939,1,,7822,,BAO_0000019,,178.0,CHEMBL620212,A,,Area under curve(portal vein) was determined by the availability in blood; ND means no data,Autocuration
,,Blood,,,0,,,U,22224,2939,1,,7823,,BAO_0000019,,178.0,CHEMBL620213,A,,Area under curve(portal vein) was determined by the availability in blood; No data,Autocuration
,,Plasma,,,1,,,N,50797,9552,1,9544.0,7824,,BAO_0000218,Macaca mulatta,1969.0,CHEMBL620214,A,,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",Intermediate
,,Plasma,,,1,,,N,50797,9552,1,9544.0,7825,,BAO_0000218,Macaca mulatta,1969.0,CHEMBL620215,A,,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",Intermediate
,,Plasma,,,1,,,N,50797,9552,1,9544.0,7826,,BAO_0000218,Macaca mulatta,1969.0,CHEMBL620216,A,,Area under plasma concentration vs time curve observed in Rhesus monkeys after oral administration of single 30 mg/kg dose,Intermediate
,,Plasma,,,1,,,N,50588,9552,1,9615.0,7827,,BAO_0000218,Canis lupus familiaris,1969.0,CHEMBL620888,A,,"Area under plasma concentration vs time curve observed in female mongrel dogs after, iv administration of single 15 mg/kg dose",Intermediate
,,Plasma,,,1,,,N,50588,9552,1,9615.0,7828,,BAO_0000218,Canis lupus familiaris,1969.0,CHEMBL620889,A,,"Area under plasma concentration vs time curve observed in female mongrel dogs after, oral administration of single 15 mg/kg dose",Intermediate
,,Plasma,,,0,,,U,22224,9552,1,,7829,,BAO_0000019,,1969.0,CHEMBL620890,A,,Area under plasma concentration vs time curve observed in rats for 0-3 h,Autocuration
,,Plasma,,,1,,,N,50597,11911,1,10116.0,7830,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL620891,A,,Area under plasma time curve determined in male rat,Intermediate
,,,,,0,,,U,22224,16618,1,,7831,,BAO_0000019,,,CHEMBL620892,A,,Area under the MAP curve measured over 5 min.,Autocuration
,,,,,1,,,N,50594,14387,1,10090.0,7832,,BAO_0000218,Mus musculus,,CHEMBL621079,A,,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through iv route in mice,Intermediate
,,,,,1,,,N,50594,14387,1,10090.0,7833,,BAO_0000218,Mus musculus,,CHEMBL621080,A,,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through oral route in mice,Intermediate
,,,,,1,,,N,50588,12836,1,9615.0,7834,,BAO_0000218,Canis lupus familiaris,,CHEMBL621081,A,,Area under the concentration vs time curve in dog at 10 mg/kg oral dose,Intermediate
,,,,,1,,,N,100712,12836,1,10026.0,7835,,BAO_0000218,Cricetinae,,CHEMBL621082,A,,Area under the concentration vs time curve in hamster at 10 mg/kg oral dose,Intermediate
,,,,,1,,,N,50597,12836,1,10116.0,7836,,BAO_0000218,Rattus norvegicus,,CHEMBL621083,A,,Area under the concentration vs time curve in rat at 10 mg/kg oral dose,Intermediate
,,,,,1,,,N,50588,14339,1,9615.0,7837,,BAO_0000218,Canis lupus familiaris,,CHEMBL621084,A,,Area under the concentration-time curve from time zero to infinity after intravenous administration of 2.5 mg/kg in dogs,Intermediate
,,,,,1,,,N,50588,14339,1,9615.0,7838,,BAO_0000218,Canis lupus familiaris,,CHEMBL621085,A,,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fasted dogs,Intermediate
,,,,,1,,,N,50588,14339,1,9615.0,7839,,BAO_0000218,Canis lupus familiaris,,CHEMBL621086,A,,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fed dogs,Intermediate
,,,,,1,,,N,50588,10524,1,9615.0,7840,,BAO_0000218,Canis lupus familiaris,,CHEMBL621087,A,,Area under the concentration/ time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),Intermediate
,,,,,1,,,N,50588,9994,1,9615.0,7841,,BAO_0000218,Canis lupus familiaris,,CHEMBL622607,A,,Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg),Intermediate
,,,,,1,,,N,50588,11325,1,9615.0,7842,,BAO_0000218,Canis lupus familiaris,,CHEMBL622608,A,,Serum AUC in marmosets (IV dose),Intermediate
,,,,,0,,,U,22224,12536,1,,7843,,BAO_0000019,,,CHEMBL624481,A,,Area under the curve after intravenous administration at a dose of 10 umol/kg,Autocuration
,,,,,0,,,U,22224,12536,1,,7844,,BAO_0000019,,,CHEMBL624482,A,,Area under the curve after intravenous administration at a dose of 2 umol/kg,Autocuration
,,,,,0,,,U,22224,12536,1,,7845,,BAO_0000019,,,CHEMBL624483,A,,Area under the curve after intravenous administration at a dose of 4 umol/kg,Autocuration
,,,,,0,,,U,22224,12536,1,,7846,,BAO_0000019,,,CHEMBL624484,A,,Area under the curve after intravenous administration at a dose of 40 umol/kg,Autocuration
,,,,,0,,,U,22224,12536,1,,7847,,BAO_0000019,,,CHEMBL624485,A,,Area under the curve after intravenous administration at a dose of 5 umol/kg,Autocuration
,,,,,1,,,N,50597,15556,1,10116.0,7848,,BAO_0000218,Rattus norvegicus,,CHEMBL624486,A,,Area under the curve for fumarate salt was evaluated in F344 Rats.,Intermediate
,,,,,0,,,U,22224,2809,1,,7849,,BAO_0000019,,,CHEMBL624487,A,,Area under the curve for the compound was calculated.,Autocuration
,,,,,0,,,U,22224,9511,1,,7850,,BAO_0000019,,,CHEMBL624488,A,,Area under the curve in concentration/ time,Autocuration
,,,,,1,,,N,50597,12818,1,10116.0,7851,,BAO_0000218,Rattus norvegicus,,CHEMBL624489,A,,Area under the curve administered intraintestinal in rats.,Intermediate
,,,,,1,,,N,50597,12818,1,10116.0,7852,,BAO_0000218,Rattus norvegicus,,CHEMBL625184,A,,Area under the curve administered intravenously in rats.,Intermediate
,,,,,0,,,U,22224,15118,1,,7853,,BAO_0000019,,,CHEMBL625185,A,,Area under the curve during intravenous administration,Autocuration
,,,,,0,,,U,22224,15118,1,,7854,,BAO_0000019,,,CHEMBL875954,A,,Area under the curve during intravenous administration; Not determined,Autocuration
,,,,,0,,,U,22224,15118,1,,7855,,BAO_0000019,,,CHEMBL625186,A,,Area under the curve during systemic administration,Autocuration
,,,,,0,,,U,22224,15118,1,,7856,,BAO_0000019,,,CHEMBL625187,A,,Area under the curve during systemic administration; Not determined,Autocuration
,,,,,0,,,U,22224,2632,1,,7857,,BAO_0000019,,,CHEMBL625188,A,,Area under the curve was calculated for the compound.,Autocuration
,,,,,1,,,N,50588,14346,1,9615.0,7858,,BAO_0000218,Canis lupus familiaris,,CHEMBL625189,A,,Area under the curve was determined after intravenous administration of 1.8 mg/kg in male Beagle dogs,Intermediate
,,,,,1,,,N,50588,14346,1,9615.0,7859,,BAO_0000218,Canis lupus familiaris,,CHEMBL625190,A,,Area under the curve was determined after intravenous administration of 10 mg/kg in male Beagle dogs,Intermediate
,,,,,1,,,N,50597,14346,1,10116.0,7860,,BAO_0000218,Rattus norvegicus,,CHEMBL621733,A,,Area under the curve was determined after intravenous administration of 2.5 mg/kg in male Dawley rats,Intermediate
,,,,,1,,,N,50597,14346,1,10116.0,7861,,BAO_0000218,Rattus norvegicus,,CHEMBL621734,A,,Area under the curve was determined after intravenous administration of 2.6 mg/kg in male Dawley rats,Intermediate
,,,,,1,,,N,50597,11149,1,10116.0,7862,,BAO_0000218,Rattus norvegicus,,CHEMBL621735,A,,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate after oral administration to male F344 rats,Intermediate
,,Plasma,,,1,,,N,50597,17796,1,10116.0,7863,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL621736,A,,Clearance of the drug was measured in the plasma of rat; No data,Intermediate
,,Plasma,,,1,,,N,50597,5247,1,10116.0,7864,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL621737,A,,The pharmacokinetic parameter plasma clearance in vivo in rats,Intermediate
,,,,,1,,,N,50597,4727,1,10116.0,7865,,BAO_0000218,Rattus norvegicus,,CHEMBL621738,A,,Plasma clearance at the dose of 2 mg/kg in rat,Intermediate
,In vivo,,,,1,,,N,50597,5654,1,10116.0,7866,,BAO_0000218,Rattus norvegicus,,CHEMBL622806,A,,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,Intermediate
,In vivo,,,,1,,,N,50597,5654,1,10116.0,7867,,BAO_0000218,Rattus norvegicus,,CHEMBL623519,A,,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,Intermediate
,In vivo,,,,1,,,N,50597,17260,1,10116.0,7868,,BAO_0000218,Rattus norvegicus,,CHEMBL623520,A,,CL at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,Intermediate
,In vivo,,,,1,,,N,50597,17065,1,10116.0,7869,,BAO_0000218,Rattus norvegicus,,CHEMBL623521,A,,Clearance measured after intravenous bolus administration of 50 mg/kg of compound to rats,Intermediate
,In vivo,,,,1,,,N,50597,17671,1,10116.0,7870,,BAO_0000218,Rattus norvegicus,,CHEMBL623522,A,,Clearance in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,6672,1,10116.0,7871,,BAO_0000218,Rattus norvegicus,,CHEMBL623523,A,,Clearance rate in rat,Intermediate
,In vivo,,,,1,,,N,50597,6673,1,10116.0,7872,,BAO_0000218,Rattus norvegicus,,CHEMBL623690,A,,Clearance rate in rat,Intermediate
,In vivo,,,,1,,,N,50597,5978,1,10116.0,7873,,BAO_0000218,Rattus norvegicus,,CHEMBL623691,A,,Clearance (Cl) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,5978,1,10116.0,7874,,BAO_0000218,Rattus norvegicus,,CHEMBL623692,A,,Clearance (Cl) of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,5978,1,10116.0,7875,,BAO_0000218,Rattus norvegicus,,CHEMBL623693,A,,Clearance (Cl) of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,5978,1,10116.0,7876,,BAO_0000218,Rattus norvegicus,,CHEMBL623694,A,,Clearance (Cl) of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,4413,1,10116.0,7877,,BAO_0000218,Rattus norvegicus,,CHEMBL623695,A,,Clearance of compound after iv administration of 20 mg/kg dose in rat,Intermediate
,In vivo,,,,1,,,N,50597,2661,1,10116.0,7878,,BAO_0000218,Rattus norvegicus,,CHEMBL623696,A,,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female wistar rats,Intermediate
,In vivo,,,,1,,,N,50597,2661,1,10116.0,7879,,BAO_0000218,Rattus norvegicus,,CHEMBL623697,A,,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to male wistar rats,Intermediate
,In vivo,Plasma,,,0,,,U,22224,5005,1,9544.0,7880,,BAO_0000218,Macaca mulatta,1969.0,CHEMBL623698,A,,Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,Intermediate
,In vivo,Plasma,,,0,,,U,22224,5005,1,10116.0,7881,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623699,A,,Compound was tested for its plasma clearance rate in Sprague Dawley rats,Intermediate
,In vivo,,,,1,,,N,50597,15765,1,10116.0,7882,,BAO_0000218,Rattus norvegicus,,CHEMBL623700,A,,Mean (%CV) PK parameters for CL(mL/min/kg).,Intermediate
,In vivo,,,,1,,,N,50597,3747,1,10116.0,7883,,BAO_0000218,Rattus norvegicus,,CHEMBL623701,A,,Pharmacokinetic studies were carried out to determine the clearance after administration at 20 mg/kg intravenously in rat,Intermediate
,In vivo,Plasma,,,1,,,N,50597,16366,1,10116.0,7884,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623702,A,,Pharmacokinetic parameter plasma clearance was determined at when a dose of 1 mg/kg is administered,Intermediate
,In vivo,,,,1,,,N,50597,4199,1,10116.0,7885,,BAO_0000218,Rattus norvegicus,,CHEMBL623703,A,,Plasma Clearance measured at steady-state following iv infusion at 0.6 mg/kg/h in rats,Intermediate
,In vivo,,,,1,,,N,50597,17267,1,10116.0,7886,,BAO_0000218,Rattus norvegicus,,CHEMBL623704,A,,Plasma clearance in rat was determined,Intermediate
,In vivo,,,,1,,,N,50597,6535,1,10116.0,7887,,BAO_0000218,Rattus norvegicus,,CHEMBL623705,A,,Plasma clearance in rat after administration of 2 mg/kg iv,Intermediate
,In vivo,,,,1,,,N,50597,6535,1,10116.0,7888,,BAO_0000218,Rattus norvegicus,,CHEMBL623706,A,,Plasma clearance in rat after administration of 2 mg/kg iv,Intermediate
,In vivo,,,,1,,,N,50597,5041,1,10116.0,7889,,BAO_0000218,Rattus norvegicus,,CHEMBL623707,A,,Plasma clearance was determined,Intermediate
,In vivo,,,,1,,,N,50597,5960,1,10116.0,7890,,BAO_0000218,Rattus norvegicus,,CHEMBL623708,A,,Plasma clearance in rat,Intermediate
,In vivo,,,,1,,,N,50597,5937,1,10116.0,7891,,BAO_0000218,Rattus norvegicus,,CHEMBL623709,A,,Plasma clearance in rat after intravenous administration at a concentration 0.5 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,5871,1,10116.0,7892,,BAO_0000218,Rattus norvegicus,,CHEMBL623710,A,,Plasma clearance in rat by iv administration,Intermediate
,In vivo,,,,1,,,N,50597,5874,1,10116.0,7893,,BAO_0000218,Rattus norvegicus,,CHEMBL623711,A,,Plasma clearance in rat by iv administration at a dose of 3 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,6504,1,10116.0,7894,,BAO_0000218,Rattus norvegicus,,CHEMBL623712,A,,Plasma clearance in rat p.o.,Intermediate
,In vivo,,,,1,,,N,50597,6803,1,10116.0,7895,,BAO_0000218,Rattus norvegicus,,CHEMBL623713,A,,Plasma clearance in rats,Intermediate
,In vivo,,,,1,,,N,50597,5041,1,10116.0,7896,,BAO_0000218,Rattus norvegicus,,CHEMBL623714,A,,Plasma clearance was determined; ND denotes no data,Intermediate
,In vivo,,,,1,,,N,50597,5041,1,10116.0,7897,,BAO_0000218,Rattus norvegicus,,CHEMBL623715,A,,Plasma clearance was determined; ND denotes not determined,Intermediate
,In vivo,,,,1,,,N,50597,1916,1,10116.0,7898,,BAO_0000218,Rattus norvegicus,,CHEMBL623716,A,,Plasma clearance was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,Intermediate
,In vivo,,,,1,,,N,50597,5199,1,10116.0,7899,,BAO_0000218,Rattus norvegicus,,CHEMBL622980,A,,Plasma clearance was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,Intermediate
,In vivo,,,,1,,,N,50597,16367,1,10116.0,7900,,BAO_0000218,Rattus norvegicus,,CHEMBL622981,A,,Plasma administration to rats,Intermediate
,In vivo,,,,1,,,N,50597,6362,1,10116.0,7901,,BAO_0000218,Rattus norvegicus,,CHEMBL622982,A,,Plasma clearance of the compound in female Sprague-Dawley rats,Intermediate
,In vivo,,,,1,,,N,50597,15662,1,10116.0,7902,,BAO_0000218,Rattus norvegicus,,CHEMBL622983,A,,Plasma clearance was observed after intravenous administration in rat,Intermediate
,In vivo,,,,1,,,N,50597,6215,1,10116.0,7903,,BAO_0000218,Rattus norvegicus,,CHEMBL622984,A,,Systemic clearance after intravenous administration (5.0 mg/kg) was determined in rat,Intermediate
,In vivo,,,,1,,,N,50597,1466,1,10116.0,7904,,BAO_0000218,Rattus norvegicus,,CHEMBL622985,A,,Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in rat,Intermediate
,In vivo,Plasma,,,1,,,N,50597,15662,1,10116.0,7905,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623631,A,,plasma clearance was observed after intravenous administration in rat,Intermediate
,In vivo,,,,1,,,N,50597,4723,1,10116.0,7906,,BAO_0000218,Rattus norvegicus,,CHEMBL623632,A,,In vivo CL/F determined,Intermediate
,In vivo,Plasma,,,1,,,N,50597,2792,1,10116.0,7907,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623633,A,,Pharmacokinetic parameter plasma clearance was determined at 2 mg/kg i.v. dose in rats,Intermediate
,In vivo,Plasma,,,1,,,N,50597,2792,1,10116.0,7908,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623634,A,,Pharmacokinetic parameter plasma clearance was determined at 5 mg/kg i.v. dose in rats,Intermediate
,In vivo,,,,1,,,N,50597,5213,1,10116.0,7909,,BAO_0000218,Rattus norvegicus,,CHEMBL623635,A,,Compound was tested for the lower blood clearance in rat,Intermediate
,In vivo,,,,1,,,N,50597,4687,1,10116.0,7910,,BAO_0000218,Rattus norvegicus,,CHEMBL621195,A,,Evaluated for the low clearance in rat (in vivo),Intermediate
,In vivo,,,,1,,,N,50597,3371,1,10116.0,7911,,BAO_0000218,Rattus norvegicus,,CHEMBL621196,A,,Pharmacokinetic property (CLb)of the compound was determined in rat,Intermediate
,In vivo,,,,1,,,N,50597,4690,1,10116.0,7912,,BAO_0000218,Rattus norvegicus,,CHEMBL875287,A,,Rapid clearance after intravenous administration in rat was determined,Intermediate
,In vivo,,,,1,,,N,50597,5702,1,10116.0,7913,,BAO_0000218,Rattus norvegicus,,CHEMBL621197,A,,Clearance measured in rat,Intermediate
,In vivo,Plasma,,,1,,,N,50597,740,1,10116.0,7914,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL621198,A,,Compound was evaluated for plasma clearance in rat,Intermediate
,In vivo,Plasma,,,1,,,N,50597,4853,1,10116.0,7915,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL621199,A,,Low plasma clearance was calculated in rat,Intermediate
,In vivo,,,,1,,,N,50597,5789,1,10116.0,7916,,BAO_0000218,Rattus norvegicus,,CHEMBL621200,A,,Pharmacokinetic property (Clp) in rat,Intermediate
,In vivo,,,,1,,,N,50597,4527,1,10116.0,7917,,BAO_0000218,Rattus norvegicus,,CHEMBL621201,A,,Plasma clearance in dog at a dose of 1 uM/kg in rat was determined,Intermediate
,In vivo,,,,1,,,N,50597,4527,1,10116.0,7918,,BAO_0000218,Rattus norvegicus,,CHEMBL621202,A,,Plasma clearance in rat at a dose of 10 uM/kg in rat was determined,Intermediate
,In vivo,,,,1,,,N,50597,6518,1,10116.0,7919,,BAO_0000218,Rattus norvegicus,,CHEMBL621203,A,,Plasma clearance after IV dosing at 0.5 mg/kg in rat,Intermediate
,In vivo,,,,1,,,N,50597,6518,1,10116.0,7920,,BAO_0000218,Rattus norvegicus,,CHEMBL621204,A,,Plasma clearance after IV dosing at 1 mg/kg in rat,Intermediate
,In vivo,Heart,,,1,,,N,50597,9866,1,10116.0,7921,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL621205,A,,Biodistribution in rat heart in the presence of 0.01 M Gd/0.01 M GdDTPA-AEP,Intermediate
,In vivo,Heart,,,1,,,N,50597,9866,1,10116.0,7922,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL621206,A,,Biodistribution in rat heart in the presence of 0.01 M GdDTPA-BDP,Intermediate
,In vivo,Heart,,,1,,,N,50597,9866,1,10116.0,7923,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL621207,A,,Biodistribution in rat heart in the presence of 0.01 M/0.08 M GdDTPA-AEP,Intermediate
,In vivo,Heart,,,1,,,N,50597,9866,1,10116.0,7924,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL621208,A,,Biodistribution in rat heart in the presence of 0.05 M /0.05 M GdDTPA-AEP,Intermediate
,In vivo,Heart,,,1,,,N,50597,9866,1,10116.0,7925,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL621209,A,,Biodistribution in rat heart in the presence of 0.05 M Gd/0.15 M lig,Intermediate
,In vivo,Heart,,,1,,,N,50597,9866,1,10116.0,7926,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL876484,A,,Biodistribution in rat heart in the presence of 0.05 M GdDTPA-BDP,Intermediate
,In vivo,Heart,,,1,,,N,50597,9866,1,10116.0,7927,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL621210,A,,Biodistribution in rat heart in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Intermediate
,In vivo,Heart,,,1,,,N,50597,9866,1,10116.0,7928,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL621211,A,,Biodistribution in rat heart in the presence of 0.10 M GdDTPA-BDP,Intermediate
,In vivo,Heart,,,1,,,N,50597,9866,1,10116.0,7929,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL621212,A,,Biodistribution in rat heart in the presence of 0.10 M/0.11 M GdDTPA-AEP,Intermediate
,In vivo,Heart,,,1,,,N,50597,9866,1,10116.0,7930,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL621213,A,,Biodistribution in rat heart in the presence of GdDTPA at 15 min,Intermediate
,In vivo,Heart,,,1,,,N,50597,9866,1,10116.0,7931,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL621214,A,,Biodistribution in rat heart in the presence of GdDTPA at 1 hr,Intermediate
,In vivo,Heart,,,1,,,N,50597,9866,1,10116.0,7932,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL621215,A,,Biodistribution in rat heart in the presence of GdDTPA at 30 min,Intermediate
,In vivo,Heart,,,1,,,N,50597,9866,1,10116.0,7933,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL621216,A,,Biodistribution in rat heart in the presence of GdDTPA at 4 hr,Intermediate
,In vivo,Heart,,,1,,,N,50597,9866,1,10116.0,7934,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL621217,A,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 1 hr,Intermediate
,In vivo,Heart,,,1,,,N,50597,9866,1,10116.0,7935,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL621218,A,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 30 min,Intermediate
,In vivo,Heart,,,1,,,N,50597,9866,1,10116.0,7936,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL621219,A,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 4 hr,Intermediate
,In vivo,Heart,,,1,,,N,50597,9866,1,10116.0,7937,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL621220,A,,Biodistribution in rat heart in the presence of GdDTPA-BDPat 15 min,Intermediate
,In vivo,Heart,,,1,,,N,50597,9866,1,10116.0,7938,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL621221,A,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 1 hr,Intermediate
,In vivo,Heart,,,1,,,N,50597,9866,1,10116.0,7939,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL621222,A,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 30 min,Intermediate
,In vivo,Heart,,,1,,,N,50597,9866,1,10116.0,7940,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL621223,A,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 4 hr,Intermediate
,In vivo,Heart,,,1,,,N,50597,9866,1,10116.0,7941,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL876485,A,,Biodistribution in rat heart in the presence of GdDTPA-HPDPat 15 min,Intermediate
,In vivo,Heart,,,1,,,N,50597,9866,1,10116.0,7942,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL621224,A,,Biodistribution in rat heart in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Intermediate
,In vivo,Heart,,,1,,,N,50597,9866,1,10116.0,7943,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL621225,A,,Biodistribution in rat heart in the presence of NCA Gd/0.01 M lip,Intermediate
,In vivo,Heart,,,1,,,N,50597,9866,1,10116.0,7944,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL621226,A,,Biodistribution in rat heart in the presence of NCAGd/0.01 M lig,Intermediate
,In vivo,Kidney,,,1,,,N,50597,9866,1,10116.0,7945,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL621227,A,,Biodistribution in rat kidney in the presence of 0.01 M GdDTPA-BDP,Intermediate
,In vivo,Kidney,,,1,,,N,50597,9866,1,10116.0,7946,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL621228,A,,Biodistribution in rat kidney in the presence of 0.01 M/0.01 M GdDTPA-AEP,Intermediate
,In vivo,Kidney,,,1,,,N,50597,9866,1,10116.0,7947,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL621229,A,,Biodistribution in rat kidney in the presence of 0.01 M/0.08 M GdDTPA-AEP,Intermediate
,In vivo,Kidney,,,1,,,N,50597,9866,1,10116.0,7948,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL621230,A,,Biodistribution in rat kidney in the presence of 0.05 M Gd/0.15 M lig,Intermediate
,In vivo,Kidney,,,1,,,N,50597,9866,1,10116.0,7949,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL621231,A,,Biodistribution in rat kidney in the presence of 0.05 M GdDTPA-BDP; ND=No data,Intermediate
,In vivo,Kidney,,,1,,,N,50597,9866,1,10116.0,7950,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL621232,A,,Biodistribution in rat kidney in the presence of 0.05 M/0.05 M GdDTPA-AEP,Intermediate
,In vivo,Kidney,,,1,,,N,50597,9866,1,10116.0,7951,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL621233,A,,Biodistribution in rat kidney in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Intermediate
,In vivo,Kidney,,,1,,,N,50597,9866,1,10116.0,7952,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL621234,A,,Biodistribution in rat kidney in the presence of 0.10 M GdDTPA-BDP,Intermediate
,In vivo,Kidney,,,1,,,N,50597,9866,1,10116.0,7953,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL621235,A,,Biodistribution in rat kidney in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,Intermediate
,In vivo,Kidney,,,1,,,N,50597,9866,1,10116.0,7954,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL621236,A,,Biodistribution in rat kidney in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Intermediate
,In vivo,Kidney,,,1,,,N,50597,9866,1,10116.0,7955,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL621237,A,,Biodistribution in rat kidney in the presence of NCA Gd/0.01 M lip,Intermediate
,In vivo,Kidney,,,1,,,N,50597,9866,1,10116.0,7956,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL876486,A,,Biodistribution in rat kidney in the presence of NCAGd/0.01 M lig,Intermediate
,In vivo,Intestine,,,1,,,N,50597,9866,1,10116.0,7957,,BAO_0000218,Rattus norvegicus,160.0,CHEMBL622436,A,,Biodistribution in rat l. intestine in the presence of 0.01 M carrier at 1 hr,Intermediate
,In vivo,Intestine,,,1,,,N,50597,9866,1,10116.0,7958,,BAO_0000218,Rattus norvegicus,160.0,CHEMBL622437,A,,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 2 hr,Intermediate
,In vivo,Intestine,,,1,,,N,50597,9866,1,10116.0,7959,,BAO_0000218,Rattus norvegicus,160.0,CHEMBL622438,A,,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 6 hr,Intermediate
,In vivo,Liver,,,1,,,N,50597,9866,1,10116.0,7960,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL622439,A,,Biodistribution in rat liver by in the presence 50 Gd/kg at 15 min,Intermediate
,In vivo,Liver,,,1,,,N,50597,9866,1,10116.0,7961,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL622440,A,,Biodistribution in rat liver by in the presence of 0.05 M Gd/0.15 M lig,Intermediate
,In vivo,Liver,,,1,,,N,50597,9866,1,10116.0,7962,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL622441,A,,Biodistribution in rat liver by in the presence of NCAGd/0.01 M lig,Intermediate
,In vivo,Liver,,,1,,,N,50597,9866,1,10116.0,7963,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL622442,A,,Biodistribution in rat liver in the presence of 0.001 M/0.008 M GdDTPA-AEP,Intermediate
,In vivo,Liver,,,1,,,N,50597,9866,1,10116.0,7964,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL622443,A,,Biodistribution in rat liver in the presence of 0.01 M GdDTPA-BDP,Intermediate
,In vivo,Liver,,,1,,,N,50597,9866,1,10116.0,7965,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL622444,A,,Biodistribution in rat liver in the presence of 0.01 M/0.01 M GdDTPA-AEP,Intermediate
,In vivo,Liver,,,1,,,N,50597,9866,1,10116.0,7966,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL622445,A,,Biodistribution in rat liver in the presence of 0.05 M GdDTPA-BDP,Intermediate
,In vivo,Liver,,,1,,,N,50597,9866,1,10116.0,7967,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL622446,A,,Biodistribution in rat liver in the presence of 0.05 M/0.05 M GdDTPA-AEP,Intermediate
,In vivo,Liver,,,1,,,N,50597,9866,1,10116.0,7968,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL622447,A,,Biodistribution in rat liver in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Intermediate
,In vivo,Liver,,,1,,,N,50597,9866,1,10116.0,7969,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL622448,A,,Biodistribution in rat liver in the presence of 0.10 M GdDTPA-BDP,Intermediate
,In vivo,Liver,,,1,,,N,50597,9866,1,10116.0,7970,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL622449,A,,Biodistribution in rat liver in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,Intermediate
,In vivo,Liver,,,1,,,N,50597,9866,1,10116.0,7971,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL622450,A,,Biodistribution in rat liver in the presence of 50 Gd/kg at 2 hr,Intermediate
,In vivo,Liver,,,1,,,N,50597,9866,1,10116.0,7972,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL622451,A,,Biodistribution in rat liver in the presence of 50 Gd/kg at at 6 hr,Intermediate
,In vivo,Liver,,,1,,,N,50597,9866,1,10116.0,7973,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL622452,A,,Biodistribution in rat liver in the presence of GdDTPA at 15 min,Intermediate
,In vivo,Liver,,,1,,,N,50597,9866,1,10116.0,7974,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL622453,A,,Biodistribution in rat liver in the presence of GdDTPA at 1 hr,Intermediate
,In vivo,Liver,,,1,,,N,50597,9866,1,10116.0,7975,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL622454,A,,Biodistribution in rat liver in the presence of GdDTPA at 30 min,Intermediate
,In vivo,Liver,,,1,,,N,50597,9866,1,10116.0,7976,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL622455,A,,Biodistribution in rat liver in the presence of GdDTPA at 4 hr,Intermediate
,In vivo,Liver,,,1,,,N,50597,9866,1,10116.0,7977,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL876024,A,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 15 min,Intermediate
,In vivo,,,,1,,,N,50597,2792,1,10116.0,7978,,BAO_0000218,Rattus norvegicus,,CHEMBL622456,A,,T max was determined at 3 mg/kg po dose in rats,Intermediate
,In vivo,,,,1,,,N,50597,15078,1,10116.0,7979,,BAO_0000218,Rattus norvegicus,,CHEMBL622457,A,,"The Tmax value in female wistar rat at 100 mg/kg, p.o. dose",Intermediate
,In vivo,,,,1,,,N,50597,15078,1,10116.0,7980,,BAO_0000218,Rattus norvegicus,,CHEMBL622458,A,,"The Tmax value in male wistar rat at 100 mg/kg, p.o. dose",Intermediate
,,,,,1,,,N,50597,15022,1,10116.0,7981,,BAO_0000218,Rattus norvegicus,,CHEMBL622459,A,,The time to reach maximum concentration of compound was measured at the dose of 100 umol/kg,Intermediate
,,,,,1,,,N,50597,15022,1,10116.0,7982,,BAO_0000218,Rattus norvegicus,,CHEMBL873343,A,,The time to reach maximum concentration of compound was measured at the dose of 300 umol/kg,Intermediate
,,,,,1,,,N,50597,15022,1,10116.0,7983,,BAO_0000218,Rattus norvegicus,,CHEMBL622460,A,,The time to reach maximum concentration of compound was measured at the dose of 30 umol/kg,Intermediate
,,Plasma,,,1,,,N,50597,4576,1,10116.0,7984,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622461,A,,Time for maximum plasma concentration determined in rat,Intermediate
,In vivo,Plasma,,,1,,,N,50597,6681,1,10116.0,7985,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622462,A,,Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,Intermediate
,In vivo,,,,1,,,N,50597,16365,1,10116.0,7986,,BAO_0000218,Rattus norvegicus,,CHEMBL622463,A,,Time of maximum concentration of the drug when administered orally a dose of 10 mg/kg to a fasting rat,Intermediate
,In vivo,,,,1,,,N,50597,16365,1,10116.0,7987,,BAO_0000218,Rattus norvegicus,,CHEMBL622464,A,,Time of maximum concentration of the drug when administered orally a dose of 1 mg/kg to a fasting rat,Intermediate
,In vivo,,,,1,,,N,50597,16365,1,10116.0,7988,,BAO_0000218,Rattus norvegicus,,CHEMBL622465,A,,Time of maximum concentration of the drug when administered orally a dose of 30 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,16365,1,10116.0,7989,,BAO_0000218,Rattus norvegicus,,CHEMBL622466,A,,Time of maximum concentration of the drug when administered orally a dose of 3 mg/kg to a fasting rat,Intermediate
,In vivo,,,,1,,,N,50597,16365,1,10116.0,7990,,BAO_0000218,Rattus norvegicus,,CHEMBL622467,A,,Time of maximum concentration of the drug when administered orally at dose of 3 mg/kg,Intermediate
,,Plasma,,,1,,,N,50597,6824,1,10116.0,7991,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622468,A,,Time of maximum plasma concentration in rat,Intermediate
,,Plasma,,,1,,,N,50597,6685,1,10116.0,7992,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL876025,A,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 10 mg/kg, p.o. dose",Intermediate
,,Plasma,,,1,,,N,50597,6685,1,10116.0,7993,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622469,A,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 20 mg/kg, i.p. dose",Intermediate
,,Plasma,,,1,,,N,50597,6685,1,10116.0,7994,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622470,A,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",Intermediate
,In vivo,,,,1,,,N,50597,15662,1,10116.0,7995,,BAO_0000218,Rattus norvegicus,,CHEMBL622471,A,,Time required to reach maximum concentration (Cmax) after oral administration in rat,Intermediate
,,Plasma,,,1,,,N,50597,1742,1,10116.0,7996,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622472,A,,Time required to reach maximum concentration in rat plasma,Intermediate
,In vivo,Plasma,,,1,,,N,50597,2774,1,10116.0,7997,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622473,A,,Time taken by the compound to achieve maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,Intermediate
,In vivo,Plasma,,,1,,,N,50597,5199,1,10116.0,7998,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL624282,A,,Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,Intermediate
,In vivo,Plasma,,,1,,,N,50597,12873,1,10116.0,7999,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL624283,A,,Time taken for maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,Intermediate
,In vivo,Plasma,,,1,,,N,50597,12873,1,10116.0,8000,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL624284,A,,Time taken for maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,Intermediate
,In vivo,Plasma,,,1,,,N,50597,1916,1,10116.0,8001,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL624285,A,,Time taken to reach maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,Intermediate
,In vivo,,,,1,,,N,50597,16367,1,10116.0,8002,,BAO_0000218,Rattus norvegicus,,CHEMBL624286,A,,Time to reach Cmax after oral administration to rats,Intermediate
,In vivo,,,,1,,,N,50597,16366,1,10116.0,8003,,BAO_0000218,Rattus norvegicus,,CHEMBL624287,A,,Time to reach Cmax when a dose of 1 mg/kg is administered orally,Intermediate
,,,,,1,,,N,50597,216,1,10116.0,8004,,BAO_0000218,Rattus norvegicus,,CHEMBL624288,A,,Time to reach maximum concentration following oral administration of 200 mg/kg in rat; value ranges from 2-4,Intermediate
,In vivo,Plasma,,,1,,,N,50597,6410,1,10116.0,8005,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL624289,A,,Time to reach maximum plasma concentration was evaluated at an intravenous dose of 3 mg/kg; Not applicable,Intermediate
,In vivo,Plasma,,,1,,,N,50597,6410,1,10116.0,8006,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL873344,A,,Time to reach maximum plasma concentration was evaluated at an oral dose of 30 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,6215,1,10116.0,8007,,BAO_0000218,Rattus norvegicus,,CHEMBL619623,A,,Tmax after peroral administration (10 mg/kg) was determined in rat,Intermediate
,In vivo,,,,1,,,N,50597,3598,1,10116.0,8008,,BAO_0000218,Rattus norvegicus,,CHEMBL621399,A,,Tmax of compound determined in rat after iv administration at a dose of 10 mg/kg,Expert
,In vivo,,,,1,,,N,50597,4527,1,10116.0,8009,,BAO_0000218,Rattus norvegicus,,CHEMBL621400,A,,Tmax by oral administration at a dose of 100 uM/kg in rat was determined,Intermediate
,In vivo,,,,1,,,N,50597,17670,1,10116.0,8010,,BAO_0000218,Rattus norvegicus,,CHEMBL621401,A,,"Tmax in fischer rats at 5 mg/kg dose, administered intravenously",Intermediate
,,,,,1,,,N,50597,1465,1,10116.0,8011,,BAO_0000218,Rattus norvegicus,,CHEMBL621402,A,,Tmax was determined,Intermediate
,,,,,1,,,N,50597,2552,1,10116.0,8012,,BAO_0000218,Rattus norvegicus,,CHEMBL621403,A,,Tmax was determined,Intermediate
,In vivo,,,,1,,,N,50597,5656,1,10116.0,8013,,BAO_0000218,Rattus norvegicus,,CHEMBL621121,A,,Tmax after oral administration in rat,Intermediate
,In vivo,,,,1,,,N,50597,17764,1,10116.0,8014,,BAO_0000218,Rattus norvegicus,,CHEMBL872525,A,,Tmax after peroral administration in rats at 2.4 uM/kg,Intermediate
,,,,,1,,,N,50597,5610,1,10116.0,8015,,BAO_0000218,Rattus norvegicus,,CHEMBL621122,A,,Tmax in male rat,Intermediate
,In vivo,,,,1,,,N,50597,6046,1,10116.0,8016,,BAO_0000218,Rattus norvegicus,,CHEMBL621123,A,,Tmax in rat at 10 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,5874,1,10116.0,8017,,BAO_0000218,Rattus norvegicus,,CHEMBL621124,A,,Tmax in rat by po administration at a dose of 40 mg/kg,Intermediate
,,,,,1,,,N,50597,17596,1,10116.0,8018,,BAO_0000218,Rattus norvegicus,,CHEMBL621125,A,,Tmax in rats,Intermediate
,In vivo,,,,1,,,N,50597,17804,1,10116.0,8019,,BAO_0000218,Rattus norvegicus,,CHEMBL621126,A,,Tmax was measured in rats after peroral administration at 5 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,1908,1,10116.0,8020,,BAO_0000218,Rattus norvegicus,,CHEMBL621127,A,,Tmax value after oral dose at a dose of 10 mg/kg in rats.,Intermediate
,In vivo,,,,1,,,N,50597,2959,1,10116.0,8021,,BAO_0000218,Rattus norvegicus,,CHEMBL621128,A,,Tmax value after administration of 20 mg/Kg oral dose in rat,Intermediate
,In vivo,,,,1,,,N,50597,6757,1,10116.0,8022,,BAO_0000218,Rattus norvegicus,,CHEMBL618263,A,,Tmax value at a dose of 10 mg/kg in male SD rats,Intermediate
,In vivo,,,,1,,,N,50597,6757,1,10116.0,8023,,BAO_0000218,Rattus norvegicus,,CHEMBL618264,A,,Tmax value at a dose of 100 mg/kg in male SD rats,Intermediate
,In vivo,,,,1,,,N,50597,6757,1,10116.0,8024,,BAO_0000218,Rattus norvegicus,,CHEMBL618265,A,,Tmax value at a dose of 50 mg/kg in male SD rats,Intermediate
,In vivo,Plasma,,,1,,,N,50597,4186,1,10116.0,8025,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL618266,A,,Total concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,Intermediate
,In vivo,,,,1,,,N,50597,15662,1,10116.0,8026,,BAO_0000218,Rattus norvegicus,,CHEMBL618267,A,,time required to reach maximum concentration (Cmax) after oral administration in rat,Intermediate
,,Urine,,,1,,,N,50597,429,1,10116.0,8027,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL618450,A,,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg ( 0-24 hr ),Intermediate
,,Urine,,,1,,,N,50597,429,1,10116.0,8028,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL618451,A,,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg (0-24 hr),Intermediate
,,,,,1,,,N,50597,5546,1,10116.0,8029,,BAO_0000218,Rattus norvegicus,,CHEMBL618452,A,,Unbound plasma was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,Intermediate
,,Urine,,,1,,,N,50597,3173,1,10116.0,8030,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL618453,A,,Amount of urine output was measured in rat at a dose of 1 mg/kg/po,Intermediate
,,Urine,,,1,,,N,50597,3173,1,10116.0,8031,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL618454,A,,Amount of urine output was measured in rat at a dose of 10 mg/kg/po,Intermediate
,,Urine,,,1,,,N,50597,3173,1,10116.0,8032,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL618455,A,,Amount of urine output was measured in rat at a dose of 10 mg/kg/po; NT-Not tested,Intermediate
,In vivo,,,,1,,,N,50597,4257,1,10116.0,8033,,BAO_0000218,Rattus norvegicus,,CHEMBL618456,A,,Volume of distribution was determined in rat after a 3 mg/kg of iv dose,Intermediate
,In vivo,,,,1,,,N,50597,6011,1,10116.0,8034,,BAO_0000218,Rattus norvegicus,,CHEMBL618457,A,,Compound distribution in rat tissues was determined,Intermediate
,In vivo,,,,1,,,N,50597,5472,1,10116.0,8035,,BAO_0000218,Rattus norvegicus,,CHEMBL618458,A,,Volume of distribution was evaluated in rat,Intermediate
,,,,,1,,,N,50597,14346,1,10116.0,8036,,BAO_0000218,Rattus norvegicus,,CHEMBL618459,A,,Area under the curve was determined after intravenous administration of 2.7 mg/kg in male Dawley rats,Intermediate
,,,,,1,,,N,50597,14346,1,10116.0,8037,,BAO_0000218,Rattus norvegicus,,CHEMBL876733,A,,Area under the curve was determined after intravenous administration of 2.8 mg/kg in male Dawley rats,Intermediate
,,,,,1,,,N,50588,14346,1,9615.0,8038,,BAO_0000218,Canis lupus familiaris,,CHEMBL618460,A,,Area under the curve was determined after intravenous administration of 4.9 mg/kg in male Beagle dogs,Intermediate
,,,,,1,,,N,50597,14346,1,10116.0,8039,,BAO_0000218,Rattus norvegicus,,CHEMBL618461,A,,Area under the curve was determined after intravenous administration of 5.1 mg/kg in male Dawley rats,Intermediate
,,,,,0,,,U,22224,15469,1,,8040,,BAO_0000019,,,CHEMBL618462,A,,Area under the curve was determined after oral administration (300 uM/Kg),Autocuration
,,,,,1,,,N,50597,14346,1,10116.0,8041,,BAO_0000218,Rattus norvegicus,,CHEMBL618463,A,,Area under the curve was determined after peroral administration of 5.0 mg/kg in male Dawley rats,Intermediate
,,,,,1,,,N,50597,14346,1,10116.0,8042,,BAO_0000218,Rattus norvegicus,,CHEMBL618464,A,,Area under the curve was determined after peroral administration of 5.1 mg/kg in mal Dawley rats,Intermediate
,,,,,1,,,N,50597,14346,1,10116.0,8043,,BAO_0000218,Rattus norvegicus,,CHEMBL618465,A,,Area under the curve was determined after peroral administration of 5.1 mg/kg in male Dawley rats,Intermediate
,,,,,1,,,N,50597,14346,1,10116.0,8044,,BAO_0000218,Rattus norvegicus,,CHEMBL618466,A,,Area under the curve was determined after peroral administration of 5.2 mg/kg in mal Dawley rats,Intermediate
,,,,,1,,,N,50597,14346,1,10116.0,8045,,BAO_0000218,Rattus norvegicus,,CHEMBL618467,A,,Area under the curve was determined after peroral administration of 5.2 mg/kg in male Dawley rats,Intermediate
,,,,,1,,,N,50597,15372,1,10116.0,8046,,BAO_0000218,Rattus norvegicus,,CHEMBL618468,A,,Area under the curve was determined for the compound after iv dose of 4.97 mg/kg in rats,Intermediate
,,Plasma,,,1,,,N,50588,12935,1,9615.0,8047,,BAO_0000218,Canis lupus familiaris,1969.0,CHEMBL618469,A,,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 100 mg/kg,Intermediate
,,Plasma,,,1,,,N,50588,12935,1,9615.0,8048,,BAO_0000218,Canis lupus familiaris,1969.0,CHEMBL618470,A,,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 20 mg/kg,Intermediate
,,,,,0,,,U,22224,14813,1,,8049,,BAO_0000218,,,CHEMBL618471,A,,Plasma drug AUC in rat (PO dose),Autocuration
,,,,,1,,,N,50594,15792,1,10090.0,8050,,BAO_0000218,Mus musculus,,CHEMBL618472,A,,Area under the tumor growth curve (AUC) in the B-6 Melanoma Model in C57/b1 mice at the dose of 1 mg/kg.,Intermediate
,,,,,0,,,U,22224,3579,1,,8051,,BAO_0000218,,,CHEMBL618473,A,,Area under was determined at a dose of 30 mg/kg,Autocuration
,,,,,1,,,N,50506,12487,1,9669.0,8052,,BAO_0000218,Mustela putorius furo,,CHEMBL621699,A,,Average area under curve for compound at 1 mg/kg dose intravenous administration to Ferret,Intermediate
,,,,,1,,,N,50597,12487,1,10116.0,8053,,BAO_0000218,Rattus norvegicus,,CHEMBL621700,A,,Average area under curve for the compound at 10 mg/kg dose after intraduodenal administration to rat,Intermediate
,,,,,1,,,N,50597,12487,1,10116.0,8054,,BAO_0000218,Rattus norvegicus,,CHEMBL621701,A,,Average area under curve for the compound at 1 mg/kg dose after intravenous administration to rat,Intermediate
,,,,,1,,,N,50506,12487,1,9669.0,8055,,BAO_0000218,Mustela putorius furo,,CHEMBL621702,A,,Average area under curve at 10 mg/kg dose after intraduodenal administration to Ferret,Intermediate
,,,,,1,,,N,50588,12487,1,9615.0,8056,,BAO_0000218,Canis lupus familiaris,,CHEMBL621703,A,,Average area under curve at 10 mg/kg intraduodenal administration to salt depleted dog,Intermediate
,,,,,1,,,N,50588,12487,1,9615.0,8057,,BAO_0000218,Canis lupus familiaris,,CHEMBL621704,A,,Average area under curve at 1 mg/kg intravenous administration to salt depleted dog,Intermediate
,,,,,1,,,N,50597,12902,1,10116.0,8058,,BAO_0000218,Rattus norvegicus,,CHEMBL624259,A,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 1.0(pmol/g/h)",Intermediate
,,,,,1,,,N,50597,12902,1,10116.0,8059,,BAO_0000218,Rattus norvegicus,,CHEMBL624260,A,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 2.0(pmol/g/h)",Intermediate
,,,,,1,,,N,50597,12902,1,10116.0,8060,,BAO_0000218,Rattus norvegicus,,CHEMBL624430,A,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 4.0(pmol/g/h)",Intermediate
,,,,,1,,,N,50597,12902,1,10116.0,8061,,BAO_0000218,Rattus norvegicus,,CHEMBL624431,A,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 5.0(pmol/g/h)",Intermediate
,,,,,1,,,N,50597,12902,1,10116.0,8062,,BAO_0000218,Rattus norvegicus,,CHEMBL624432,A,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 54.0(pmol/g/h)",Intermediate
,,,,,1,,,N,50597,12902,1,10116.0,8063,,BAO_0000218,Rattus norvegicus,,CHEMBL624433,A,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 10.0(pmol/g/h)",Intermediate
,,,,,1,,,N,50597,12902,1,10116.0,8064,,BAO_0000218,Rattus norvegicus,,CHEMBL624434,A,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 20.0(pmol/g/h)",Intermediate
,,,,,1,,,N,50597,12902,1,10116.0,8065,,BAO_0000218,Rattus norvegicus,,CHEMBL624435,A,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 40.0(pmol/g/h)",Intermediate
,,,,,1,,,N,50594,12745,1,10090.0,8066,,BAO_0000218,Mus musculus,,CHEMBL618570,A,,Bioavailability in mouse brain after intravenous administration of 105.1 mg/kg of dose,Intermediate
,,,,,1,,,N,50594,12745,1,10090.0,8067,,BAO_0000218,Mus musculus,,CHEMBL618571,A,,Bioavailability in mouse brain after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),Intermediate
,,,,,1,,,N,50594,12745,1,10090.0,8068,,BAO_0000218,Mus musculus,,CHEMBL618572,A,,Bioavailability in mouse brain after oral administration of 100 mg/kg of dose,Intermediate
,,,,,1,,,N,50594,12745,1,10090.0,8069,,BAO_0000218,Mus musculus,,CHEMBL618573,A,,Bioavailability in mouse brain after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),Intermediate
,,,,,1,,,N,50594,12745,1,10090.0,8070,,BAO_0000218,Mus musculus,,CHEMBL619267,A,,Bioavailability in mouse serum after intravenous administration of 105.1 mg/kg of dose,Intermediate
,,,,,1,,,N,50594,12745,1,10090.0,8071,,BAO_0000218,Mus musculus,,CHEMBL619431,A,,Bioavailability in mouse serum after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),Intermediate
,,,,,1,,,N,50594,12745,1,10090.0,8072,,BAO_0000218,Mus musculus,,CHEMBL619432,A,,Bioavailability in mouse serum after oral administration of 100 mg/kg of dose,Intermediate
,,,,,1,,,N,50594,12745,1,10090.0,8073,,BAO_0000218,Mus musculus,,CHEMBL619433,A,,Bioavailability in mouse serum after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),Intermediate
,,Plasma,,,0,,,U,22224,13298,1,,8074,,BAO_0000218,,1969.0,CHEMBL619434,A,,AUC in mice after oral dose (50 mg/kg),Autocuration
,,Serum,,,1,,,N,50594,12226,1,10090.0,8075,,BAO_0000218,Mus musculus,1977.0,CHEMBL619435,A,,Blood level after oral administration in mice (50 mg/kg) was determined by bioassay procedure and represent total activity present in the serum,Intermediate
,,Plasma,,,0,,,U,22224,12634,1,,8076,,BAO_0000019,,1969.0,CHEMBL619436,A,,AUC (0-4 hr) ug/ml/h,Autocuration
,,,,,1,,,N,50597,14810,1,10116.0,8077,,BAO_0000218,Rattus norvegicus,,CHEMBL619437,A,,Compound at a dose of 10 mg/kg was orally administered to rats and Area under curve was reported,Intermediate
,,,,,0,,,U,22224,13889,1,,8078,,BAO_0000218,,,CHEMBL619438,A,,Compound evaluated for AUC = Area under the nucleoside serum or brain concentration versus time curve after iv administration,Autocuration
,,,,,1,,,N,50594,10018,1,10090.0,8079,,BAO_0000218,Mus musculus,,CHEMBL619439,A,,Compound was evaluated for Area under curve in mice,Intermediate
,,,,,1,,,N,50597,8758,1,10116.0,8080,,BAO_0000218,Rattus norvegicus,,CHEMBL619440,A,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,Intermediate
,,,,,0,,,U,22224,8758,1,,8081,,BAO_0000218,,,CHEMBL619441,F,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,Autocuration
,,,,,1,,,N,50597,8758,1,10116.0,8082,,BAO_0000218,Rattus norvegicus,,CHEMBL619442,A,,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,Intermediate
,,,,,0,,,U,22224,2249,1,,8083,,BAO_0000019,,,CHEMBL875156,A,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 1,Autocuration
,,,,,0,,,U,22224,2249,1,,8084,,BAO_0000019,,,CHEMBL619443,A,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 4,Autocuration
,,,,,0,,,U,22224,2249,1,,8085,,BAO_0000019,,,CHEMBL619444,A,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 1,Autocuration
,,,,,0,,,U,22224,2249,1,,8086,,BAO_0000019,,,CHEMBL623464,A,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 4,Autocuration
,,,,,1,,,N,50594,15115,1,10090.0,8087,,BAO_0000218,Mus musculus,,CHEMBL623465,A,,Compound was evaluated for area under curve when administered through oral route in mouse,Intermediate
,In vivo,,,,1,,,N,50597,6518,1,10116.0,8088,,BAO_0000218,Rattus norvegicus,,CHEMBL623466,A,,Plasma clearance after oral administration at a dose of 2 mg/kg in rat; no data,Intermediate
,In vivo,,,,1,,,N,50597,6518,1,10116.0,8089,,BAO_0000218,Rattus norvegicus,,CHEMBL623467,A,,Plasma clearance after oral administration at a dose of 4 mg/kg in rat; no data,Intermediate
,In vivo,,,,1,,,N,50597,6249,1,10116.0,8090,,BAO_0000218,Rattus norvegicus,,CHEMBL623468,A,,Plasma clearance in rat,Intermediate
,In vivo,,,,1,,,N,50597,2463,1,10116.0,8091,,BAO_0000218,Rattus norvegicus,,CHEMBL622660,A,,Plasma clearance was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,Intermediate
,In vivo,,,,1,,,N,50597,4969,1,10116.0,8092,,BAO_0000218,Rattus norvegicus,,CHEMBL622661,A,,Plasma clearance rate in Sprague-Dawley rats,Intermediate
,In vivo,,,,1,,,N,50597,17720,1,10116.0,8093,,BAO_0000218,Rattus norvegicus,,CHEMBL622662,F,,CLtot at a dose of 4 mg/kg in Rat Plasma after iv administration,Intermediate
,In vivo,,,,1,,,N,50597,3457,1,10116.0,8094,,BAO_0000218,Rattus norvegicus,,CHEMBL622663,A,,Pharmacokinetic property (total body clearance) in rat,Intermediate
,In vivo,,,,1,,,N,50597,5983,1,10116.0,8095,,BAO_0000218,Rattus norvegicus,,CHEMBL622664,A,,Pharmacokinetic property (CLtot)of the compound was measured in rat at the dose of 0.32 mg/kg i.v.,Intermediate
,,,,,1,,,N,50597,6295,1,10116.0,8096,,BAO_0000218,Rattus norvegicus,,CHEMBL622665,A,,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,Intermediate
,,,,,1,,,N,50597,6296,1,10116.0,8097,,BAO_0000218,Rattus norvegicus,,CHEMBL622666,A,,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,17686,1,10116.0,8098,,BAO_0000218,Rattus norvegicus,,CHEMBL621615,A,,Cl in rat i.v. at 2 mg/kg concentration,Intermediate
,In vivo,,,,1,,,N,50597,17764,1,10116.0,8099,,BAO_0000218,Rattus norvegicus,,CHEMBL621616,A,,Clearance of compound after intravenous administration in rats at 24 uM/kg,Intermediate
,In vivo,,,,1,,,N,50597,5503,1,10116.0,8100,,BAO_0000218,Rattus norvegicus,,CHEMBL621617,A,,Clearance was determined,Intermediate
,In vivo,,,,1,,,N,50597,4368,1,10116.0,8101,,BAO_0000218,Rattus norvegicus,,CHEMBL621618,A,,Clearance by intravenous administration of 3.4 mg/kg in rat,Intermediate
,In vivo,,,,1,,,N,50597,6005,1,10116.0,8102,,BAO_0000218,Rattus norvegicus,,CHEMBL621619,A,,Clearance was evaluated after i.v. administration in rat at a dose of 1 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,5031,1,10116.0,8103,,BAO_0000218,Rattus norvegicus,,CHEMBL621620,A,,Clearance rate after i.v. administration in rats,Intermediate
,In vivo,,,,1,,,N,50597,4890,1,10116.0,8104,,BAO_0000218,Rattus norvegicus,,CHEMBL621786,A,,Clearance was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,Intermediate
,In vivo,,,,1,,,N,50597,5182,1,10116.0,8105,,BAO_0000218,Rattus norvegicus,,CHEMBL621787,A,,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,Intermediate
,In vivo,,,,1,,,N,50597,5979,1,10116.0,8106,,BAO_0000218,Rattus norvegicus,,CHEMBL621788,A,,Clearance (Cl) of compound after 2 h iv infusion of 8.4 mg/kg in three rat,Intermediate
,In vivo,,,,1,,,N,50597,5656,1,10116.0,8107,,BAO_0000218,Rattus norvegicus,,CHEMBL621789,A,,Clearance (Cl) after oral administration in rat,Intermediate
,In vivo,,,,1,,,N,50597,17804,1,10116.0,8108,,BAO_0000218,Rattus norvegicus,,CHEMBL621790,A,,Compound clearance in rats was measured after intravenous administration at 3 mg/kg,Intermediate
,In vivo,Plasma,,,1,,,N,50597,4839,1,10116.0,8109,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL621791,A,,Compound was tested for plasma clearance in rat,Intermediate
Microsomes,In vitro,,,,1,,,N,50597,5041,1,10116.0,8110,,BAO_0000218,Rattus norvegicus,,CHEMBL621792,A,,In vitro microsome metabolism clearance in rat was determined,Intermediate
Microsomes,In vitro,,,,1,,,N,50597,5041,1,10116.0,8111,,BAO_0000218,Rattus norvegicus,,CHEMBL621793,A,,In vitro microsome metabolism clearance in rat was determined; ND denotes no data,Intermediate
,In vivo,,,,1,,,N,50597,5974,1,10116.0,8112,,BAO_0000218,Rattus norvegicus,,CHEMBL621794,A,,In vivo Clearance (Cl) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Intermediate
,In vivo,Plasma,,,1,,,N,50597,5496,1,10116.0,8113,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL621795,A,,In vivo plasma clearance was determined,Intermediate
,In vivo,,,,1,,,N,50597,5739,1,10116.0,8114,,BAO_0000218,Rattus norvegicus,,CHEMBL621796,A,,Pharmacokinetic property (Clearance) for the compound (5 mg/kg iv) was determined in rats,Intermediate
,In vivo,Liver,Hepatocyte,,1,,,N,50597,5676,1,10116.0,8115,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL621797,A,401.0,Pharmacokinetic property (Clearance) in rat hepatocyte i.v.,Intermediate
,In vivo,,,,1,,,N,50597,4239,1,10116.0,8116,,BAO_0000218,Rattus norvegicus,,CHEMBL621798,A,,Pharmacokinetic property (Plasma clearance) was measured in rat,Intermediate
,In vivo,,,,1,,,N,50597,5676,1,10116.0,8117,,BAO_0000218,Rattus norvegicus,,CHEMBL621799,A,,Pharmacokinetic property (clearance) in rat i.v.,Intermediate
,In vivo,,,,1,,,N,50597,1918,1,10116.0,8118,,BAO_0000218,Rattus norvegicus,,CHEMBL621800,A,,"Plasma Clearance was evaluated in rats, iv",Intermediate
,In vivo,,,,1,,,N,50597,17800,1,10116.0,8119,,BAO_0000218,Rattus norvegicus,,CHEMBL621801,A,,Plasma clearance (in vivo) in rats was determined,Intermediate
,In vivo,,,,1,,,N,50597,6056,1,10116.0,8120,,BAO_0000218,Rattus norvegicus,,CHEMBL621802,A,,Plasma clearance for the compound was calculated at a single intravenous administration of 20 mg/kg in rat,Intermediate
,In vivo,,,,1,,,N,50597,5496,1,10116.0,8121,,BAO_0000218,Rattus norvegicus,,CHEMBL618596,A,,Plasma clearance was determined,Intermediate
,In vivo,,,,1,,,N,50597,5939,1,10116.0,8122,,BAO_0000218,Rattus norvegicus,,CHEMBL618597,A,,Plasma clearance in rat after peroral administration at 10 mg/kg concentration,Intermediate
,In vivo,,,,1,,,N,50597,5939,1,10116.0,8123,,BAO_0000218,Rattus norvegicus,,CHEMBL618598,A,,Plasma clearance in rat after peroral administration at 5 mg/kg concentration,Intermediate
,In vivo,,,,1,,,N,50597,17752,1,10116.0,8124,,BAO_0000218,Rattus norvegicus,,CHEMBL618599,A,,Plasma clearance in rats,Intermediate
,In vivo,,,,1,,,N,50597,4576,1,10116.0,8125,,BAO_0000218,Rattus norvegicus,,CHEMBL618600,A,,Plasma clearance rate determined in rat,Intermediate
,In vivo,,,,1,,,N,50597,6011,1,10116.0,8126,,BAO_0000218,Rattus norvegicus,,CHEMBL618601,A,,Plasma clearance was determined in rat,Intermediate
,In vivo,,,,1,,,N,50597,5510,1,10116.0,8127,,BAO_0000218,Rattus norvegicus,,CHEMBL618602,A,,Plasma clearance was determined,Intermediate
,In vivo,,,,1,,,N,50597,5948,1,10116.0,8128,,BAO_0000218,Rattus norvegicus,,CHEMBL618603,A,,Plasma clearance value in rat,Intermediate
,Ex vivo,Liver,,,1,,,N,50597,6125,1,10116.0,8129,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL618604,A,,Clearance rate constant using isolated perfused rat liver (IPRL) assay,Intermediate
,In vivo,,,,1,,,N,50597,4839,1,10116.0,8130,,BAO_0000218,Rattus norvegicus,,CHEMBL618605,A,,Clearance in rat,Intermediate
,In vivo,,,,1,,,N,50597,17686,1,10116.0,8131,,BAO_0000218,Rattus norvegicus,,CHEMBL618606,A,,Total body clearance in rat i.v. at 2 mg/kg concentration,Intermediate
,In vivo,,,,1,,,N,50597,6571,1,10116.0,8132,,BAO_0000218,Rattus norvegicus,,CHEMBL618607,A,,Clearance of compound in rats after intravenous administration,Intermediate
,In vivo,,,,1,,,N,50597,3364,1,10116.0,8133,,BAO_0000218,Rattus norvegicus,,CHEMBL618608,A,,Clearance after iv administration to rats,Intermediate
,In vivo,,,,1,,,N,50597,13569,1,10116.0,8134,,BAO_0000218,Rattus norvegicus,,CHEMBL618609,A,,Clearance at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,Intermediate
,In vivo,,,,1,,,N,50597,13569,1,10116.0,8135,,BAO_0000218,Rattus norvegicus,,CHEMBL618610,A,,Clearance at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,Intermediate
,In vivo,,,,1,,,N,50597,13569,1,10116.0,8136,,BAO_0000218,Rattus norvegicus,,CHEMBL618611,A,,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,Intermediate
,In vivo,,,,1,,,N,50597,13569,1,10116.0,8137,,BAO_0000218,Rattus norvegicus,,CHEMBL618612,A,,Clearance at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,Intermediate
,In vivo,,,,1,,,N,50597,13569,1,10116.0,8138,,BAO_0000218,Rattus norvegicus,,CHEMBL618613,A,,Clearance at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,Intermediate
,In vivo,,,,1,,,N,50597,13569,1,10116.0,8139,,BAO_0000218,Rattus norvegicus,,CHEMBL621076,A,,Clearance at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,Intermediate
,In vivo,,,,1,,,N,50597,13569,1,10116.0,8140,,BAO_0000218,Rattus norvegicus,,CHEMBL621077,A,,Clearance at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,Intermediate
,In vivo,,,,1,,,N,50597,17670,1,10116.0,8141,,BAO_0000218,Rattus norvegicus,,CHEMBL621078,A,,"Clearance in fischer rats at 5 mg/kg dose, administered intravenously",Intermediate
,In vivo,,,,1,,,N,50597,5970,1,10116.0,8142,,BAO_0000218,Rattus norvegicus,,CHEMBL621251,A,,Clearance in rat,Intermediate
,In vivo,,,,1,,,N,50597,6495,1,10116.0,8143,,BAO_0000218,Rattus norvegicus,,CHEMBL621252,A,,Clearance in rat after oral administration at 10 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,4590,1,10116.0,8144,,BAO_0000218,Rattus norvegicus,,CHEMBL621253,A,,Clearance in rat.,Intermediate
,In vivo,,,,1,,,N,50597,6193,1,10116.0,8145,,BAO_0000218,Rattus norvegicus,,CHEMBL621254,A,,Clearance rate following an oral dose of 20 mg/kg in rats,Intermediate
,In vivo,,,,1,,,N,50597,2832,1,10116.0,8146,,BAO_0000218,Rattus norvegicus,,CHEMBL621255,A,,Compound was evaluated for the rate of clearance in rat upon intravenous administration.,Intermediate
,In vivo,Plasma,,,1,,,N,50597,1052,1,10116.0,8147,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL621256,A,,Compound was tested for plasma clearance in rats after 5 mg/kg of intravenous dosing,Intermediate
,In vivo,Liver,,,1,,,N,50597,9866,1,10116.0,8148,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL621257,A,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 1 hr,Intermediate
,In vivo,Liver,,,1,,,N,50597,9866,1,10116.0,8149,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL621258,A,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 30 min,Intermediate
,In vivo,Liver,,,1,,,N,50597,9866,1,10116.0,8150,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL621259,A,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 4 hr,Intermediate
,In vivo,Liver,,,1,,,N,50597,9866,1,10116.0,8151,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL621260,A,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 15 min,Intermediate
,In vivo,Liver,,,1,,,N,50597,9866,1,10116.0,8152,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL876494,A,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 1 hr,Intermediate
,In vivo,Liver,,,1,,,N,50597,9866,1,10116.0,8153,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL621261,A,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 30 min,Intermediate
,In vivo,Liver,,,1,,,N,50597,9866,1,10116.0,8154,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL621262,A,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 4 hr,Intermediate
,In vivo,Liver,,,1,,,N,50597,9866,1,10116.0,8155,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL621263,A,,Biodistribution in rat liver in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Intermediate
,In vivo,Liver,,,1,,,N,50597,9866,1,10116.0,8156,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL621264,A,,Biodistribution in rat liver in the presence of NCA Gd/0.01 M lip,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,9866,1,10116.0,8157,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL621265,A,,Biodistribution in rat muscle in the presence of 0.01 M GdDTPA-BDP,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,9866,1,10116.0,8158,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL621266,A,,Biodistribution in rat muscle in the presence of 0.05 M Gd/0.15 M lig,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,9866,1,10116.0,8159,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL621267,A,,Biodistribution in rat muscle in the presence of 0.05 M GdDTPA-BDP,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,9866,1,10116.0,8160,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL621268,A,,Biodistribution in rat muscle in the presence of 0.10 M GdDTPA-BDP,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,9866,1,10116.0,8161,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL621269,A,,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 1 hr,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,9866,1,10116.0,8162,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL621270,A,,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 4 hr,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,9866,1,10116.0,8163,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL621271,A,,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 15 min,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,9866,1,10116.0,8164,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL621272,A,,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 30 min,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,9866,1,10116.0,8165,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL621273,A,,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 1 hr,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,9866,1,10116.0,8166,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL621274,A,,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 4 hr,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,9866,1,10116.0,8167,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL876495,A,,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 15 min,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,9866,1,10116.0,8168,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL621275,A,,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 30 min,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,9866,1,10116.0,8169,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL621276,A,,Biodistribution in rat muscle in the presence of NCA Gd/0.01 M lip,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,9866,1,10116.0,8170,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL621277,A,,Biodistribution in rat muscle in the presence of NCAGd/0.01 M lig,Intermediate
,In vivo,Intestine,,,1,,,N,50597,9866,1,10116.0,8171,,BAO_0000218,Rattus norvegicus,160.0,CHEMBL621278,A,,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 2 hr,Intermediate
,In vivo,Intestine,,,1,,,N,50597,9866,1,10116.0,8172,,BAO_0000218,Rattus norvegicus,160.0,CHEMBL621279,A,,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 6 hr,Intermediate
,In vivo,Intestine,,,1,,,N,50597,9866,1,10116.0,8173,,BAO_0000218,Rattus norvegicus,160.0,CHEMBL621280,A,,Biodistribution in rat s. intestine in the presence of NCA (No carrier added),Intermediate
,In vivo,Spleen,,,1,,,N,50597,9866,1,10116.0,8174,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL621281,A,,Biodistribution in rat spleen in the presence of 0.01 M GdDTPA-BDP,Intermediate
,In vivo,Spleen,,,1,,,N,50597,9866,1,10116.0,8175,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL621282,A,,Biodistribution in rat spleen in the presence of 0.05 M Gd/0.15 M lig; ND=No data,Intermediate
,In vivo,Spleen,,,1,,,N,50597,9866,1,10116.0,8176,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL621283,A,,Biodistribution in rat spleen in the presence of 0.05 M GdDTPA-BDP; ND=No data,Intermediate
,In vivo,Spleen,,,1,,,N,50597,9866,1,10116.0,8177,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL621284,A,,Biodistribution in rat spleen in the presence of 0.10 M GdDTPA-BDP,Intermediate
,In vivo,Spleen,,,1,,,N,50597,9866,1,10116.0,8178,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL621285,A,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 15 min,Intermediate
,In vivo,Spleen,,,1,,,N,50597,9866,1,10116.0,8179,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL621286,A,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 2 hr,Intermediate
,In vivo,Spleen,,,1,,,N,50597,9866,1,10116.0,8180,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL623220,A,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 6 hr,Intermediate
,In vivo,Spleen,,,1,,,N,50597,9866,1,10116.0,8181,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL623221,A,,Biodistribution in rat spleen in the presence of NCA Gd/0.01 M lip,Intermediate
,In vivo,Spleen,,,1,,,N,50597,9866,1,10116.0,8182,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL876029,A,,Biodistribution in rat spleen in the presence of NCAGd/0.01 M lig,Intermediate
,In vivo,Stomach,,,1,,,N,50597,9866,1,10116.0,8183,,BAO_0000218,Rattus norvegicus,945.0,CHEMBL623222,A,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 15 min,Intermediate
,In vivo,Stomach,,,1,,,N,50597,9866,1,10116.0,8184,,BAO_0000218,Rattus norvegicus,945.0,CHEMBL623223,A,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 2 hr,Intermediate
,In vivo,Stomach,,,1,,,N,50597,9866,1,10116.0,8185,,BAO_0000218,Rattus norvegicus,945.0,CHEMBL621445,A,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 6 h; ND=No data,Intermediate
,In vivo,Blood,,,1,,,N,50597,13950,1,10116.0,8186,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL621446,A,,Biodistribution of [123I]-label in rat blood was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Intermediate
,In vivo,Blood,,,1,,,N,50597,13950,1,10116.0,8187,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL621447,A,,Biodistribution of [123I]-label in rat blood was reported at 1 hr post injection. Value shown is %ID/g of tissue,Intermediate
,In vivo,Blood,,,1,,,N,50597,13950,1,10116.0,8188,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL619681,A,,Biodistribution of [123I]-label in rat blood was reported at 2 hr post injection. Value shown is %ID/g of tissue,Intermediate
,In vivo,Blood,,,1,,,N,50597,13950,1,10116.0,8189,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL619682,A,,Biodistribution of [123I]-label in rat blood was reported at 24 hr post injection. Value shown is %ID/g of tissue,Intermediate
,In vivo,Blood,,,1,,,N,50597,13950,1,10116.0,8190,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL619683,A,,Biodistribution of [123I]-label in rat blood was reported at 4 hr post injection. Value shown is %ID/g of tissue,Intermediate
,In vivo,Brain,,,1,,,N,50597,13950,1,10116.0,8191,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL619684,A,,Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Intermediate
,In vivo,Brain,,,1,,,N,50597,13950,1,10116.0,8192,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL619685,A,,Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/g of tissue,Intermediate
,In vivo,Brain,,,1,,,N,50597,13950,1,10116.0,8193,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL619686,A,,Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/g of tissue,Intermediate
,In vivo,Brain,,,1,,,N,50597,13950,1,10116.0,8194,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL619687,A,,Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/g of tissue,Intermediate
,In vivo,Brain,,,1,,,N,50597,13950,1,10116.0,8195,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL619688,A,,Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/g of tissue,Intermediate
,In vivo,Heart,,,1,,,N,50597,13950,1,10116.0,8196,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL619689,A,,Biodistribution of [123I]-label in rat heart was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Intermediate
,In vivo,Heart,,,1,,,N,50597,13950,1,10116.0,8197,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL619690,A,,Biodistribution of [123I]-label in rat heart was reported at 1 hr post injection. Value shown is %ID/g of tissue,Intermediate
,In vivo,Heart,,,1,,,N,50597,13950,1,10116.0,8198,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL619691,A,,Biodistribution of [123I]-label in rat heart was reported at 2 hr post injection. Value shown is %ID/g of tissue,Intermediate
,In vivo,,,,1,,,N,50597,6062,1,10116.0,8199,,BAO_0000218,Rattus norvegicus,,CHEMBL619692,A,,Terminal phase volume of distribution was measured in rat after an iv dose of 1 mg/kg,Intermediate
,,,,,1,,,N,50597,3598,1,10116.0,8200,,BAO_0000218,Rattus norvegicus,,CHEMBL619693,A,,Apparent volume of the central plasma compartment (Vc) of compound determined in rat after iv administration at a dose of 10 mg/kg,Expert
,In vivo,,,,1,,,N,50597,1908,1,10116.0,8201,,BAO_0000218,Rattus norvegicus,,CHEMBL619694,A,,Vc value after IV dose at a dose of 5 mg/kg in rats.,Intermediate
,In vivo,,,,1,,,N,50597,17596,1,10116.0,8202,,BAO_0000218,Rattus norvegicus,,CHEMBL619695,A,,Apparent volume of distribution at 10 mg/kg in rat upon intravenous administration,Intermediate
,In vivo,,,,1,,,N,50597,4891,1,10116.0,8203,,BAO_0000218,Rattus norvegicus,,CHEMBL619696,A,,Compound was evaluated for pharmacokinetic parameter volume of distribution,Intermediate
,In vivo,,,,1,,,N,50597,740,1,10116.0,8204,,BAO_0000218,Rattus norvegicus,,CHEMBL619697,A,,Compound was evaluated for volume of distribution in rat,Intermediate
,In vivo,,,,1,,,N,50597,16366,1,10116.0,8205,,BAO_0000218,Rattus norvegicus,,CHEMBL619698,A,,Steady state volume distribution was determined; steady state(ss),Intermediate
,In vivo,,,,1,,,N,50597,3364,1,10116.0,8206,,BAO_0000218,Rattus norvegicus,,CHEMBL619699,A,,Steady state volume of distribution after iv administration to rats,Intermediate
,In vivo,,,,1,,,N,50597,2552,1,10116.0,8207,,BAO_0000218,Rattus norvegicus,,CHEMBL619700,A,,Steady state volume of distribution dosing at 3 mg/kg iv,Intermediate
,In vivo,,,,1,,,N,50597,406,1,10116.0,8208,,BAO_0000218,Rattus norvegicus,,CHEMBL619701,A,,The compound was evaluated for volume of distribution in rat,Intermediate
,In vivo,,,,1,,,N,50597,12500,1,10116.0,8209,,BAO_0000218,Rattus norvegicus,,CHEMBL619702,A,,The compound was tested for volume of distribution in rat,Intermediate
,In vivo,,,,1,,,N,50597,12500,1,10116.0,8210,,BAO_0000218,Rattus norvegicus,,CHEMBL620335,A,,The compound was tested for volume of distribution in rat at dose of 3-10 mgkg,Intermediate
,In vivo,,,,1,,,N,50597,5656,1,10116.0,8211,,BAO_0000218,Rattus norvegicus,,CHEMBL620336,A,,Volume distribution (VD) after oral administration in rat,Intermediate
,In vivo,,,,1,,,N,50597,17671,1,10116.0,8212,,BAO_0000218,Rattus norvegicus,,CHEMBL620337,A,,Volume distribution of compound in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,1094,1,10116.0,8213,,BAO_0000218,Rattus norvegicus,,CHEMBL620520,A,,Volume distribution in rat,Intermediate
,In vivo,,,,1,,,N,50597,5833,1,10116.0,8214,,BAO_0000218,Rattus norvegicus,,CHEMBL620521,A,,Volume distribution in rat,Intermediate
,In vivo,,,,1,,,N,50597,5939,1,10116.0,8215,,BAO_0000218,Rattus norvegicus,,CHEMBL875825,A,,Volume distribution in rat after peroral administration at 10 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,5939,1,10116.0,8216,,BAO_0000218,Rattus norvegicus,,CHEMBL620522,A,,Volume distribution in rat after peroral administration at 5 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,6005,1,10116.0,8217,,BAO_0000218,Rattus norvegicus,,CHEMBL620523,A,,Volume distribution was evaluated after i.v. administration in rat at a dose of 1 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,1696,1,10116.0,8218,,BAO_0000218,Rattus norvegicus,,CHEMBL620524,A,,Volume of distribution in rat.,Intermediate
,In vivo,,,,1,,,N,50597,6672,1,10116.0,8219,,BAO_0000218,Rattus norvegicus,,CHEMBL620525,A,,Volume of distribution in rat,Intermediate
,In vivo,,,,1,,,N,50597,6673,1,10116.0,8220,,BAO_0000218,Rattus norvegicus,,CHEMBL620526,A,,Volume of distribution in rat,Intermediate
,In vivo,,,,1,,,N,50597,5871,1,10116.0,8221,,BAO_0000218,Rattus norvegicus,,CHEMBL620527,A,,Volume of distribution in rat by iv administration,Intermediate
,In vivo,,,,1,,,N,50597,6803,1,10116.0,8222,,BAO_0000218,Rattus norvegicus,,CHEMBL620528,A,,Volume of distribution in rats,Intermediate
,In vivo,,,,1,,,N,50597,5199,1,10116.0,8223,,BAO_0000218,Rattus norvegicus,,CHEMBL620529,A,,Volume of distribution was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,Intermediate
,,,,,1,,,N,50597,4727,1,10116.0,8224,,BAO_0000218,Rattus norvegicus,,CHEMBL620530,A,,Volume distribution at the dose of 2 mg/kg in rat,Intermediate
,In vivo,,,,1,,,N,50597,16367,1,10116.0,8225,,BAO_0000218,Rattus norvegicus,,CHEMBL620531,A,,Steady state volume of distribution was determined,Intermediate
,In vivo,,,,0,,,U,22224,5005,1,9544.0,8226,,BAO_0000218,Macaca mulatta,,CHEMBL620532,A,,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,Intermediate
,In vivo,,,,0,,,U,22224,5005,1,10116.0,8227,,BAO_0000218,Rattus norvegicus,,CHEMBL620533,A,,Compound was tested for its plasma volume distribution in Sprague Dawley rats,Intermediate
,In vivo,,,,0,,,U,22224,5005,1,10116.0,8228,,BAO_0000218,Rattus norvegicus,,CHEMBL620534,A,,Compound was tested for its plasma volume distribution in Sprague Dawley rats; ND is not determined,Intermediate
,In vivo,,,,1,,,N,50597,15765,1,10116.0,8229,,BAO_0000218,Rattus norvegicus,,CHEMBL620535,A,,Mean (%CV) PK parameters for Vdss(mL/kg).,Intermediate
,In vivo,,,,1,,,N,50597,2792,1,10116.0,8230,,BAO_0000218,Rattus norvegicus,,CHEMBL875826,A,,Pharmacokinetic parameter Vdss was determined at 2 mg/kg i.v. dose in rats,Intermediate
,In vivo,,,,1,,,N,50597,2792,1,10116.0,8231,,BAO_0000218,Rattus norvegicus,,CHEMBL620536,A,,Pharmacokinetic parameter Vdss was determined at 5 mg/kg i.v. dose in rats,Intermediate
,In vivo,,,,1,,,N,50597,5334,1,10116.0,8232,,BAO_0000218,Rattus norvegicus,,CHEMBL620537,A,,Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,5334,1,10116.0,8233,,BAO_0000218,Rattus norvegicus,,CHEMBL618526,A,,Pharmacokinetic parameter volume of distribution was reported in Sprague-Dawley rat; ND=Not determined,Intermediate
,In vivo,,,,1,,,N,50597,5739,1,10116.0,8234,,BAO_0000218,Rattus norvegicus,,CHEMBL618527,A,,Pharmacokinetic property (Vdss) for the compound (5 mg/kg iv) was determined in rats,Intermediate
,In vivo,,,,1,,,N,50597,5789,1,10116.0,8235,,BAO_0000218,Rattus norvegicus,,CHEMBL618528,A,,Pharmacokinetic property (Vdss) in rat,Intermediate
,In vivo,,,,1,,,N,50597,4239,1,10116.0,8236,,BAO_0000218,Rattus norvegicus,,CHEMBL618529,A,,Pharmacokinetic property (vdss) was measured in rat,Intermediate
,In vivo,,,,1,,,N,50597,4709,1,10116.0,8237,,BAO_0000218,Rattus norvegicus,,CHEMBL618530,A,,Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in rat,Intermediate
,In vivo,,,,1,,,N,50597,6642,1,10116.0,8238,,BAO_0000218,Rattus norvegicus,,CHEMBL618531,A,,Volume of distribution in rat,Intermediate
,In vivo,,,,1,,,N,50597,5247,1,10116.0,8239,,BAO_0000218,Rattus norvegicus,,CHEMBL618532,A,,The pharmacokinetic parameter volume of distribution in vivo in rats,Intermediate
,In vivo,,,,1,,,N,50597,17720,1,10116.0,8240,,BAO_0000218,Rattus norvegicus,,CHEMBL618533,F,,Vdss at a dose of 4 mg/kg in Rat Plasma after iv administration,Intermediate
,In vivo,,,,1,,,N,50597,17686,1,10116.0,8241,,BAO_0000218,Rattus norvegicus,,CHEMBL618534,A,,Vdss in rat i.v. at 2 mg/kg concentration,Intermediate
,In vivo,,,,1,,,N,50597,4689,1,10116.0,8242,,BAO_0000218,Rattus norvegicus,,CHEMBL618535,A,,Volume distribution after intravenous administration (1 mg/kg) in rat,Intermediate
,In vivo,,,,1,,,N,50597,5654,1,10116.0,8243,,BAO_0000218,Rattus norvegicus,,CHEMBL618536,A,,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,Intermediate
,In vivo,,,,1,,,N,50597,5654,1,10116.0,8244,,BAO_0000218,Rattus norvegicus,,CHEMBL618537,A,,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,Intermediate
,In vivo,,,,1,,,N,50597,4527,1,10116.0,8245,,BAO_0000218,Rattus norvegicus,,CHEMBL618538,A,,Volume distribution at a dose of 10 uM/kg in rat was determined,Intermediate
,In vivo,,,,1,,,N,50597,4521,1,10116.0,8246,,BAO_0000218,Rattus norvegicus,,CHEMBL618539,A,,Volume distribution in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,Intermediate
,In vivo,,,,1,,,N,50597,6057,1,10116.0,8247,,BAO_0000218,Rattus norvegicus,,CHEMBL618540,A,,Volume distribution was calculated in rat,Intermediate
,In vivo,,,,1,,,N,50597,5510,1,10116.0,8248,,BAO_0000218,Rattus norvegicus,,CHEMBL618541,A,,Volume distribution was determined,Intermediate
,In vivo,,,,1,,,N,50597,2938,1,10116.0,8249,,BAO_0000218,Rattus norvegicus,,CHEMBL618542,A,,Volume of distribution after intravenous administration was evaluated in rat,Intermediate
,In vivo,,,,1,,,N,50597,6679,1,10116.0,8250,,BAO_0000218,Rattus norvegicus,,CHEMBL622544,A,,Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,Intermediate
,In vivo,,,,1,,,N,50597,6685,1,10116.0,8251,,BAO_0000218,Rattus norvegicus,,CHEMBL622545,A,,"Volume of distribution at steady state was determined in rats at 10 mg/kg, p.o. dose; n/a: not applicable",Intermediate
,In vivo,,,,1,,,N,50597,6685,1,10116.0,8252,,BAO_0000218,Rattus norvegicus,,CHEMBL622546,A,,"Volume of distribution at steady state was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",Intermediate
,In vivo,,,,1,,,N,50597,6685,1,10116.0,8253,,BAO_0000218,Rattus norvegicus,,CHEMBL622547,A,,"Volume of distribution at steady state was determined in rats at 2 mg/kg, i.v. dose",Intermediate
,In vivo,,,,1,,,N,50597,5145,1,10116.0,8254,,BAO_0000218,Rattus norvegicus,,CHEMBL622548,A,,Volume of distribution in steady state was determined in rat,Intermediate
,In vivo,,,,1,,,N,50597,6467,1,10116.0,8255,,BAO_0000218,Rattus norvegicus,,CHEMBL622549,A,,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration,Intermediate
,In vivo,,,,1,,,N,50597,6467,1,10116.0,8256,,BAO_0000218,Rattus norvegicus,,CHEMBL622550,A,,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,Intermediate
,,,,,1,,,N,50594,15115,1,10090.0,8257,,BAO_0000218,Mus musculus,,CHEMBL622551,A,,Compound was evaluated for area under curve when administered through oral route to mouse,Intermediate
,,,,,1,,,N,50597,8758,1,10116.0,8258,,BAO_0000218,Rattus norvegicus,,CHEMBL622552,A,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,Intermediate
,,,,,1,,,N,50597,8758,1,10116.0,8259,,BAO_0000218,Rattus norvegicus,,CHEMBL622553,A,,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,Intermediate
,In vivo,,,,0,,,U,22224,8267,1,,8260,,BAO_0000218,,,CHEMBL622554,F,,Compound was evaluated for its bioavailability after oral administration (100 mg) to Beagle dogs,Autocuration
,,,,,1,,,N,50588,8267,1,9615.0,8261,,BAO_0000218,Canis lupus familiaris,,CHEMBL622555,A,,Compound was evaluated for its bioavailability after oral administration (200 mg) to Beagle dogs,Intermediate
,,,,,1,,,N,50594,14239,1,10090.0,8262,,BAO_0000218,Mus musculus,,CHEMBL622556,A,,Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,Intermediate
,,,,,1,,,N,50594,14239,1,10090.0,8263,,BAO_0000218,Mus musculus,,CHEMBL622557,A,,Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,Intermediate
,,Blood,,,1,,,N,50594,10754,1,10090.0,8264,,BAO_0000218,Mus musculus,178.0,CHEMBL622558,A,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg intramuscular administration to mice,Intermediate
,,Blood,,,1,,,N,50594,10754,1,10090.0,8265,,BAO_0000218,Mus musculus,178.0,CHEMBL622559,A,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to mice,Intermediate
,,,,,1,,,N,50588,10754,1,9615.0,8266,,BAO_0000218,Canis lupus familiaris,,CHEMBL622560,A,,Compound was evaluated in vivo in for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to dogs.,Intermediate
,,,,,1,,,N,50597,14681,1,10116.0,8267,,BAO_0000218,Rattus norvegicus,,CHEMBL622561,A,,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose,Intermediate
,,,,,1,,,N,50597,14681,1,10116.0,8268,,BAO_0000218,Rattus norvegicus,,CHEMBL622562,A,,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose. ,Intermediate
,,,,,1,,,N,50597,14681,1,10116.0,8269,,BAO_0000218,Rattus norvegicus,,CHEMBL622563,A,,Compound was tested for area under concentration -time curve from time 0 to time of last detectable concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,Intermediate
,,,,,0,,,U,22224,13118,1,,8270,,BAO_0000019,,,CHEMBL622564,A,,Concentration of compound in Central nervous system,Autocuration
,,,,,0,,,U,22224,13118,1,,8271,,BAO_0000019,,,CHEMBL622565,A,,Concentration of compound in Central nervous system; Not detectable,Autocuration
,,,,,1,,,N,50594,13318,1,10090.0,8272,,BAO_0000218,Mus musculus,,CHEMBL622566,A,,"Concentration of diester in the blood, following oral administration in mice",Intermediate
,,,,,1,,,N,50594,13318,1,10090.0,8273,,BAO_0000218,Mus musculus,,CHEMBL624515,A,,"Concentration of monoester in the blood, following oral administration in mice",Intermediate
,,,,,1,,,N,50594,13318,1,10090.0,8274,,BAO_0000218,Mus musculus,,CHEMBL624516,A,,Concentration of the 9-[2-(Phosphonomethoxy)ethoxy]adenine in the blood following oral administration in mice,Intermediate
,,,,,0,,,U,22224,15692,1,,8275,,BAO_0000019,,,CHEMBL624517,A,,Evaluated for Pharmacokinetic property: Area under the curve,Autocuration
,,,,,1,,,N,50594,14839,1,10090.0,8276,,BAO_0000218,Mus musculus,,CHEMBL624518,A,,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after a peroral dose of 25 mg/kg in nude mice,Intermediate
,,,,,1,,,N,100710,14839,1,9541.0,8277,,BAO_0000218,Macaca fascicularis,,CHEMBL624519,A,,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after iv dose of 25 mg/kg in nude mice,Intermediate
,,,,,1,,,N,100710,14839,1,9541.0,8278,,BAO_0000218,Macaca fascicularis,,CHEMBL624520,A,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after iv dose of 5 mg/kg expressed as Area under the curve,Intermediate
,,,,,1,,,N,100710,14839,1,9541.0,8279,,BAO_0000218,Macaca fascicularis,,CHEMBL624521,A,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 10 mg/kg expressed as Area under the curve,Intermediate
,,,,,1,,,N,100710,14839,1,9541.0,8280,,BAO_0000218,Macaca fascicularis,,CHEMBL624522,A,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 5 mg/kg expressed as Area under the curve,Intermediate
,,,,,1,,,N,100710,14839,1,9541.0,8281,,BAO_0000218,Macaca fascicularis,,CHEMBL624523,A,,In vivo antitumor efficacy in cynomolgus monkeys 0-8 hours after peroral dose of 25 mg/kg expressed as Area under the curve,Intermediate
,,,,,1,,,N,100710,14839,1,9541.0,8282,,BAO_0000218,Macaca fascicularis,,CHEMBL624409,A,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",Intermediate
,,,,,1,,,N,100710,14839,1,9541.0,8283,,BAO_0000218,Macaca fascicularis,,CHEMBL624410,A,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-8 hr)",Intermediate
,,,,,1,,,N,100710,14839,1,9541.0,8284,,BAO_0000218,Macaca fascicularis,,CHEMBL624411,A,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",Intermediate
,,,,,1,,,N,100710,14839,1,9541.0,8285,,BAO_0000218,Macaca fascicularis,,CHEMBL623531,A,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, iv and the total drug exposure was determined. (0-8 hr)",Intermediate
,,,,,1,,,N,100710,14839,1,9541.0,8286,,BAO_0000218,Macaca fascicularis,,CHEMBL623532,A,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, perorally and the total drug exposure was determined (0-8 hr)",Intermediate
,,,,,1,,,N,100710,14839,1,9541.0,8287,,BAO_0000218,Macaca fascicularis,,CHEMBL623533,A,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, intravenously and the total drug exposure was determined (0-8 hr)",Intermediate
,,,,,1,,,N,100710,14839,1,9541.0,8288,,BAO_0000218,Macaca fascicularis,,CHEMBL623534,A,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",Intermediate
,,,,,1,,,N,50594,14839,1,10090.0,8289,,BAO_0000218,Mus musculus,,CHEMBL623535,A,,In vivo antitumor efficacy in nude mice 0-24 hr after intravenous dose of 25 mg/kg expressed as Area under the curve,Intermediate
,,,,,1,,,N,50594,14839,1,10090.0,8290,,BAO_0000218,Mus musculus,,CHEMBL623536,A,,In vivo antitumor efficacy in nude mice 0-24 hr after iperoral dose of 25 mg/kg expressed as Area under the curve,Intermediate
,,,,,1,,,N,50594,14839,1,10090.0,8291,,BAO_0000218,Mus musculus,,CHEMBL623537,A,,In vivo antitumor efficacy in nude mice 0-24 hr after iv dose of 25 mg/kg expressed as Area under the curve,Intermediate
,,,,,1,,,N,50594,14839,1,10090.0,8292,,BAO_0000218,Mus musculus,,CHEMBL623538,A,,In vivo antitumor efficacy in nude mice 0-24 hr after peroral dose of 25 mg/kg expressed as Area under the curve,Intermediate
,,,,,1,,,N,50594,14839,1,10090.0,8293,,BAO_0000218,Mus musculus,,CHEMBL623539,A,,In vivo antitumor efficacy in nude mice after peroral dose of 10 mg/kg expressed as Area under the curve,Intermediate
,,,,,1,,,N,50594,14839,1,10090.0,8294,,BAO_0000218,Mus musculus,,CHEMBL623540,A,,In vivo antitumor efficacy in nude mice after peroral dose of 25 mg/kg expressed as Area under the curve,Intermediate
,,,,,1,,,N,50594,14839,1,10090.0,8295,,BAO_0000218,Mus musculus,,CHEMBL623541,A,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined.",Intermediate
,,,,,1,,,N,50594,14839,1,10090.0,8296,,BAO_0000218,Mus musculus,,CHEMBL623542,A,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-24hr)",Intermediate
,,,,,1,,,N,50594,14839,1,10090.0,8297,,BAO_0000218,Mus musculus,,CHEMBL623543,A,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-4 hr)",Intermediate
,,,,,1,,,N,50594,14839,1,10090.0,8298,,BAO_0000218,Mus musculus,,CHEMBL623544,A,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined",Intermediate
,,,,,1,,,N,50594,14839,1,10090.0,8299,,BAO_0000218,Mus musculus,,CHEMBL623545,A,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-24hr)",Intermediate
,,,,,1,,,N,50594,14839,1,10090.0,8300,,BAO_0000218,Mus musculus,,CHEMBL623546,A,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-4 hr)",Intermediate
,In vivo,Plasma,,,1,,,N,50597,5408,1,10116.0,8301,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623547,A,,Evaluated for plasma clearance after iv administration of 5 mg/kg to male Sprague-Dawley rats,Intermediate
,In vivo,,,,1,,,N,50597,6827,1,10116.0,8302,,BAO_0000218,Rattus norvegicus,,CHEMBL623548,A,,High i.v. clearance in Dawley rats,Intermediate
Microsomes,In vitro,Liver,,,1,,,N,50597,17538,1,10116.0,8303,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL623549,A,,In vitro clearance in rat liver microsomes,Intermediate
Microsomes,In vitro,Liver,,,1,,,N,50597,6331,1,10116.0,8304,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL623550,A,,Intrinsic clearance in rat liver microsomes was determined,Intermediate
,In vitro,Liver,Hepatocyte,,1,,,N,50597,5948,1,10116.0,8305,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL875276,A,401.0,Intrinsic clearance in rat hepatocytes was determined,Intermediate
,In vivo,,,,1,,,N,50597,4026,1,10116.0,8306,,BAO_0000218,Rattus norvegicus,,CHEMBL621872,A,,Plasma Clearance was determined,Intermediate
,In vivo,,,,1,,,N,50597,6647,1,10116.0,8307,,BAO_0000218,Rattus norvegicus,,CHEMBL621873,A,,Plasma clearance after intravenous administration of 0.4 mg/kg of dose in rats was determined,Intermediate
,In vivo,,,,1,,,N,50597,1696,1,10116.0,8308,,BAO_0000218,Rattus norvegicus,,CHEMBL621874,A,,Plasma clearance in rat.,Intermediate
,In vivo,,,,1,,,N,50597,6597,1,10116.0,8309,,BAO_0000218,Rattus norvegicus,,CHEMBL621875,A,,Plasma clearance in rats,Intermediate
,In vivo,,,,1,,,N,50597,347,1,10116.0,8310,,BAO_0000218,Rattus norvegicus,,CHEMBL621876,A,,Plasma clearance was estimated from the AUC after 5 mg/kg intravenous dosing in rats,Intermediate
,In vivo,,,,1,,,N,50597,16423,1,10116.0,8311,,BAO_0000218,Rattus norvegicus,,CHEMBL621877,A,,Plasma clearance was evaluated after 10 uM/kg of intra arterial administration,Intermediate
,In vivo,,,,1,,,N,50597,2879,1,10116.0,8312,,BAO_0000218,Rattus norvegicus,,CHEMBL621878,A,,Plasma clearance was measured in rat,Intermediate
,In vivo,,,,1,,,N,50597,4883,1,10116.0,8313,,BAO_0000218,Rattus norvegicus,,CHEMBL621879,A,,Clearance after iv administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,Intermediate
,In vivo,Plasma,,,1,,,N,50597,5328,1,10116.0,8314,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL621880,A,,"Tested for the plasma clearance in Dawley rat at a dose of 1 mg/kg intravenous, 2 mg/kg orally",Intermediate
,In vivo,,,,1,,,N,50597,5160,1,10116.0,8315,,BAO_0000218,Rattus norvegicus,,CHEMBL621881,A,,The clearance rate in mature male rat at a intravenous dose of 3 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,17582,1,10116.0,8316,,BAO_0000218,Rattus norvegicus,,CHEMBL621882,A,,Total body clearance was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,Intermediate
,In vivo,,,,1,,,N,50597,17651,1,10116.0,8317,,BAO_0000218,Rattus norvegicus,,CHEMBL875283,A,,Total clearance at 1 mg/kg was determined in rat,Intermediate
,In vivo,,,,1,,,N,50597,17651,1,10116.0,8318,,BAO_0000218,Rattus norvegicus,,CHEMBL621883,A,,Total clearance at 10 mg/kg was determined in rat,Intermediate
,In vivo,,,,1,,,N,50597,6596,1,10116.0,8319,,BAO_0000218,Rattus norvegicus,,CHEMBL621884,A,,Clearance in rat,Intermediate
,In vivo,,,,1,,,N,50597,4796,1,10116.0,8320,,BAO_0000218,Rattus norvegicus,,CHEMBL621885,A,,Plasma clearance rate determined in rats,Intermediate
,In vivo,,,,1,,,N,50597,6850,1,10116.0,8321,,BAO_0000218,Rattus norvegicus,,CHEMBL621886,A,,Clearance of compound in rat was evaluated,Intermediate
,In vivo,Plasma,,,1,,,N,50597,5932,1,10116.0,8322,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL621887,A,,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,Intermediate
,In vivo,,,,1,,,N,50597,3371,1,10116.0,8323,,BAO_0000218,Rattus norvegicus,,CHEMBL621888,A,,Pharmacokinetic property (blood clearance) in rat,Intermediate
,In vivo,,,,1,,,N,50597,2083,1,10116.0,8324,,BAO_0000218,Rattus norvegicus,,CHEMBL621889,A,,Plasma clearance in rat,Intermediate
,In vivo,,,,1,,,N,50597,4942,1,10116.0,8325,,BAO_0000218,Rattus norvegicus,,CHEMBL621890,A,,Plasma clearance in rats,Intermediate
Microsomes,In vitro,Liver,,,1,,,N,50597,6838,1,10116.0,8326,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL621891,A,,Intrinsic clearance of compound against NADPH-fortified rat liver microsomes,Intermediate
,In vivo,,,,1,,,N,50597,5353,1,10116.0,8327,,BAO_0000218,Rattus norvegicus,,CHEMBL621892,A,,Clearance in Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,6641,1,10116.0,8328,,BAO_0000218,Rattus norvegicus,,CHEMBL621893,A,,Clearance rat,Intermediate
,In vivo,,,,1,,,N,50597,6641,1,10116.0,8329,,BAO_0000218,Rattus norvegicus,,CHEMBL621894,A,,Clearance rat (dosed at 0.5 mpk IV and 2.0 mpk po.),Intermediate
,In vivo,,,,1,,,N,50597,6641,1,10116.0,8330,,BAO_0000218,Rattus norvegicus,,CHEMBL621895,A,,Clearance rat; Not determined,Intermediate
,In vivo,,,,1,,,N,50597,6444,1,10116.0,8331,,BAO_0000218,Rattus norvegicus,,CHEMBL875284,A,,Clearance rate was determined in rat at a dose of 1 mpk i.v.,Intermediate
,In vivo,,,,1,,,N,50597,6444,1,10116.0,8332,,BAO_0000218,Rattus norvegicus,,CHEMBL618699,A,,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND means not determined,Intermediate
,In vivo,,,,1,,,N,50597,6444,1,10116.0,8333,,BAO_0000218,Rattus norvegicus,,CHEMBL618700,A,,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND=not determined,Intermediate
,In vivo,,,,1,,,N,50597,6211,1,10116.0,8334,,BAO_0000218,Rattus norvegicus,,CHEMBL618701,A,,Clearance was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,Intermediate
,In vivo,Plasma,,,1,,,N,50597,12873,1,10116.0,8335,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL876600,A,,"Clearance in plasma calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",Intermediate
,In vivo,,,,1,,,N,50597,6570,1,10116.0,8336,,BAO_0000218,Rattus norvegicus,,CHEMBL618702,A,,Clearance of compound in rat after 1 mg/kg i.v. administration,Intermediate
,In vivo,,,,1,,,N,50597,3341,1,10116.0,8337,,BAO_0000218,Rattus norvegicus,,CHEMBL618703,A,,Compound was evaluated for Hepatic clearance in rat,Intermediate
,In vivo,,,,1,,,N,50597,4891,1,10116.0,8338,,BAO_0000218,Rattus norvegicus,,CHEMBL618704,A,,In vivo clearance after 5 mg/kg dose,Intermediate
,In vivo,Plasma,,,1,,,N,50597,1094,1,10116.0,8339,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL618705,A,,Compound was tested for plasma clearance in rats,Intermediate
,In vivo,,,,1,,,N,50597,2938,1,10116.0,8340,,BAO_0000218,Rattus norvegicus,,CHEMBL618706,A,,Hepatic clearance after intravenous administration was evaluated in rat,Intermediate
,In vivo,,,,1,,,N,50597,17853,1,10116.0,8341,,BAO_0000218,Rattus norvegicus,,CHEMBL618707,A,,Lower clearance in rat (i.v.) at 0.5 mpk,Intermediate
,In vivo,Plasma,,,1,,,N,50597,6049,1,10116.0,8342,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL618708,A,,Pharmacokinetic parameter expressed as plasma clearance in rat,Intermediate
,In vivo,,,,1,,,N,50597,5789,1,10116.0,8343,,BAO_0000218,Rattus norvegicus,,CHEMBL618709,A,,Pharmacokinetic property (Clp) in rat,Intermediate
,In vivo,,,,1,,,N,50597,4514,1,10116.0,8344,,BAO_0000218,Rattus norvegicus,,CHEMBL618710,A,,Plasma clearance in Sprague-Dawley rats,Intermediate
,In vivo,,,,1,,,N,50597,6448,1,10116.0,8345,,BAO_0000218,Rattus norvegicus,,CHEMBL618711,A,,Plasma clearance (Clp) in rat,Intermediate
,In vivo,,,,1,,,N,50597,6062,1,10116.0,8346,,BAO_0000218,Rattus norvegicus,,CHEMBL618712,A,,Plasma clearance for the compound was measured in rat after an iv dose of 1 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,5710,1,10116.0,8347,,BAO_0000218,Rattus norvegicus,,CHEMBL618713,A,,Plasma clearance in fasted male Sprague dawely rats on administration of 0.5 mg/Kg i.v. of the compound,Intermediate
,In vivo,,,,1,,,N,50597,4709,1,10116.0,8348,,BAO_0000218,Rattus norvegicus,,CHEMBL618714,A,,Plasma clearance after intravenous administration of 1 mg/kg in rat,Intermediate
,In vivo,,,,1,,,N,50597,4521,1,10116.0,8349,,BAO_0000218,Rattus norvegicus,,CHEMBL618715,A,,Plasma clearance in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,Intermediate
,In vivo,,,,1,,,N,50597,1742,1,10116.0,8350,,BAO_0000218,Rattus norvegicus,,CHEMBL618716,A,,Plasma clearance in rat was determined,Intermediate
,In vivo,,,,1,,,N,50597,6057,1,10116.0,8351,,BAO_0000218,Rattus norvegicus,,CHEMBL876601,A,,Plasma clearance measured in rat,Intermediate
,In vivo,,,,1,,,N,50597,6057,1,10116.0,8352,,BAO_0000218,Rattus norvegicus,,CHEMBL618717,A,,Plasma clearance was calculated in rat,Intermediate
,In vivo,,,,1,,,N,50597,5145,1,10116.0,8353,,BAO_0000218,Rattus norvegicus,,CHEMBL618718,A,,Plasma clearance in rat,Intermediate
,In vivo,,,,1,,,N,50597,5833,1,10116.0,8354,,BAO_0000218,Rattus norvegicus,,CHEMBL618719,A,,Plasma clearance in rat,Intermediate
,In vivo,,,,1,,,N,50597,6453,1,10116.0,8355,,BAO_0000218,Rattus norvegicus,,CHEMBL618720,A,,Plasma clearance in rat,Intermediate
,In vivo,,,,1,,,N,50597,6640,1,10116.0,8356,,BAO_0000218,Rattus norvegicus,,CHEMBL618721,A,,Plasma clearance in rat,Intermediate
,In vivo,,,,1,,,N,50597,6305,1,10116.0,8357,,BAO_0000218,Rattus norvegicus,,CHEMBL621477,A,,Plasma clearance in rats,Intermediate
,In vivo,,,,1,,,N,50597,6642,1,10116.0,8358,,BAO_0000218,Rattus norvegicus,,CHEMBL621478,A,,Plasma clearance in rat,Intermediate
,In vivo,,,,1,,,N,50597,5472,1,10116.0,8359,,BAO_0000218,Rattus norvegicus,,CHEMBL621479,A,,Plasma clearance was evaluated in rat,Intermediate
,In vivo,,,,1,,,N,50597,5472,1,10116.0,8360,,BAO_0000218,Rattus norvegicus,,CHEMBL621480,A,,Plasma clearance was evaluated in rat; Not tested,Intermediate
,In vivo,,,,1,,,N,50597,5144,1,10116.0,8361,,BAO_0000218,Rattus norvegicus,,CHEMBL621481,A,,Plasma clearance rate was determined for the compound in rat,Intermediate
,In vivo,,,,1,,,N,50597,6685,1,10116.0,8362,,BAO_0000218,Rattus norvegicus,,CHEMBL621482,A,,"Plasma clearance rate was determined in rats at 10mg/kg, p.o. dose; n/a: not applicable",Intermediate
,In vivo,,,,1,,,N,50597,6685,1,10116.0,8363,,BAO_0000218,Rattus norvegicus,,CHEMBL621483,A,,"Plasma clearance rate was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",Intermediate
,In vivo,,,,1,,,N,50597,6685,1,10116.0,8364,,BAO_0000218,Rattus norvegicus,,CHEMBL621484,A,,"Plasma clearance rate was determined in rats at 2 mg/kg, i.v. dose",Intermediate
,In vivo,Heart,,,1,,,N,50597,13950,1,10116.0,8365,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL621485,A,,Biodistribution of [123I]-label in rat heart was reported at 24 hr post injection. Value shown is %ID/g of tissue,Intermediate
,In vivo,Heart,,,1,,,N,50597,13950,1,10116.0,8366,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL621486,A,,Biodistribution of [123I]-label in rat heart was reported at 4 hr post injection. Value shown is %ID/g of tissue,Intermediate
,In vivo,Intestine,,,1,,,N,50597,13950,1,10116.0,8367,,BAO_0000218,Rattus norvegicus,160.0,CHEMBL621487,A,,Biodistribution of [123I]-label in rat intestine was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Intermediate
,In vivo,Intestine,,,1,,,N,50597,13950,1,10116.0,8368,,BAO_0000218,Rattus norvegicus,160.0,CHEMBL621488,A,,Biodistribution of [123I]-label in rat intestine was reported at 1 hr post injection. Value shown is %ID/g of tissue,Intermediate
,In vivo,Intestine,,,1,,,N,50597,13950,1,10116.0,8369,,BAO_0000218,Rattus norvegicus,160.0,CHEMBL621489,A,,Biodistribution of [123I]-label in rat intestine was reported at 2 hr post injection. Value shown is %ID/g of tissue,Intermediate
,In vivo,Intestine,,,1,,,N,50597,13950,1,10116.0,8370,,BAO_0000218,Rattus norvegicus,160.0,CHEMBL621490,A,,Biodistribution of [123I]-label in rat intestine was reported at 24 hr post injection. Value shown is %ID/g of tissue,Intermediate
,In vivo,Intestine,,,1,,,N,50597,13950,1,10116.0,8371,,BAO_0000218,Rattus norvegicus,160.0,CHEMBL621491,A,,Biodistribution of [123I]-label in rat intestine was reported at 4 hr post injection. Value shown is %ID/g of tissue,Intermediate
,In vivo,Kidney,,,1,,,N,50597,13950,1,10116.0,8372,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL621492,A,,Biodistribution of [123I]-label in rat kidneys was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Intermediate
,In vivo,Kidney,,,1,,,N,50597,13950,1,10116.0,8373,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL621493,A,,Biodistribution of [123I]-label in rat kidneys was reported at 1 h post injection. Value shown is %ID/g of tissue,Intermediate
,In vivo,Kidney,,,1,,,N,50597,13950,1,10116.0,8374,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL621494,A,,Biodistribution of [123I]-label in rat kidneys was reported at 2 hr post injection. Value shown is %ID/g of tissue,Intermediate
,In vivo,Kidney,,,1,,,N,50597,13950,1,10116.0,8375,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL621495,A,,Biodistribution of [123I]-label in rat kidneys was reported at 24 hr post injection. Value shown is %ID/g of tissue,Intermediate
,In vivo,Kidney,,,1,,,N,50597,13950,1,10116.0,8376,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL621496,A,,Biodistribution of [123I]-label in rat kidneys was reported at 4 hr post injection. Value shown is %ID/g of tissue,Intermediate
,In vivo,Liver,,,1,,,N,50597,13950,1,10116.0,8377,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL621497,A,,Biodistribution of [123I]-label in rat liver was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Intermediate
,In vivo,Liver,,,1,,,N,50597,13950,1,10116.0,8378,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL621498,A,,Biodistribution of [123I]-label in rat liver was reported at 1 hr post injection. Value shown is %ID/g of tissue,Intermediate
,In vivo,Liver,,,1,,,N,50597,13950,1,10116.0,8379,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL621499,A,,Biodistribution of [123I]-label in rat liver was reported at 2 hr post injection. Value shown is %ID/g of tissue,Intermediate
,In vivo,Liver,,,1,,,N,50597,13950,1,10116.0,8380,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL618634,A,,Biodistribution of [123I]-label in rat liver was reported at 24 h post injection. Value shown is %ID/g of tissue,Intermediate
,In vivo,Liver,,,1,,,N,50597,13950,1,10116.0,8381,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL618635,A,,Biodistribution of [123I]-label in rat liver was reported at 4 hr post injection. Value shown is %ID/g of tissue,Intermediate
,In vivo,Lung,,,1,,,N,50597,13950,1,10116.0,8382,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL618636,A,,Biodistribution of [123I]-label in rat lung was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Intermediate
,In vivo,Lung,,,1,,,N,50597,13950,1,10116.0,8383,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL619737,A,,Biodistribution of [123I]-label in rat lung was reported at 1 hr post injection. Value shown is %ID/g of tissue,Intermediate
,In vivo,Lung,,,1,,,N,50597,13950,1,10116.0,8384,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL619738,A,,Biodistribution of [123I]-label in rat lung was reported at 2 hr post injection. Value shown is %ID/g of tissue,Intermediate
,In vivo,Lung,,,1,,,N,50597,13950,1,10116.0,8385,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL624329,A,,Biodistribution of [123I]-label in rat lung was reported at 24 hr post injection. Value shown is %ID/g of tissue,Intermediate
,In vivo,Lung,,,1,,,N,50597,13950,1,10116.0,8386,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL624330,A,,Biodistribution of [123I]-label in rat lung was reported at 4 hr post injection. Value shown is %ID/g of tissue,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,13950,1,10116.0,8387,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL624331,A,,Biodistribution of [123I]-label in rat muscle was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,13950,1,10116.0,8388,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL624332,A,,Biodistribution of [123I]-label in rat muscle was reported at 1 hr post injection. Value shown is %ID/g of tissue,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,13950,1,10116.0,8389,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL624333,A,,Biodistribution of [123I]-label in rat muscle was reported at 2 hr post injection. Value shown is %ID/g of tissue,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,13950,1,10116.0,8390,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL624334,A,,Biodistribution of [123I]-label in rat muscle was reported at 24 hr post injection. Value shown is %ID/g of tissue,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,13950,1,10116.0,8391,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL624335,A,,Biodistribution of [123I]-label in rat muscle was reported at 4 hr post injection. Value shown is %ID/g of tissue,Intermediate
,In vivo,Spleen,,,1,,,N,50597,13950,1,10116.0,8392,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL620016,A,,Biodistribution of [123I]-label in rat spleen was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Intermediate
,In vivo,Spleen,,,1,,,N,50597,13950,1,10116.0,8393,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL620169,A,,Biodistribution of [123I]-label in rat spleen was reported at 1 hr post injection. Value shown is %ID/g of tissue,Intermediate
,In vivo,Spleen,,,1,,,N,50597,13950,1,10116.0,8394,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL620170,A,,Biodistribution of [123I]-label in rat spleen was reported at 2 hr post injection. Value shown is %ID/g of tissue,Intermediate
,In vivo,Spleen,,,1,,,N,50597,13950,1,10116.0,8395,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL620171,A,,Biodistribution of [123I]-label in rat spleen was reported at 24 h post injection. Value shown is %ID/g of tissue,Intermediate
,In vivo,Spleen,,,1,,,N,50597,13950,1,10116.0,8396,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL620172,A,,Biodistribution of [123I]-label in rat spleen was reported at 4 hr post injection. Value shown is %ID/g of tissue,Intermediate
,In vivo,Stomach,,,1,,,N,50597,13950,1,10116.0,8397,,BAO_0000218,Rattus norvegicus,945.0,CHEMBL620173,A,,Biodistribution of [123I]-label in rat stomach was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Intermediate
,In vivo,Stomach,,,1,,,N,50597,13950,1,10116.0,8398,,BAO_0000218,Rattus norvegicus,945.0,CHEMBL620174,A,,Biodistribution of [123I]-label in rat stomach was reported at 1 h post injection. Value shown is %ID/g of tissue,Intermediate
,In vivo,Stomach,,,1,,,N,50597,13950,1,10116.0,8399,,BAO_0000218,Rattus norvegicus,945.0,CHEMBL620175,A,,Biodistribution of [123I]-label in rat stomach was reported at 2 hr post injection. Value shown is %ID/g of tissue,Intermediate
,In vivo,Stomach,,,1,,,N,50597,13950,1,10116.0,8400,,BAO_0000218,Rattus norvegicus,945.0,CHEMBL620176,A,,Biodistribution of [123I]-label in rat stomach was reported at 24 hr post injection. Value shown is %ID/g of tissue,Intermediate
,In vivo,Stomach,,,1,,,N,50597,13950,1,10116.0,8401,,BAO_0000218,Rattus norvegicus,945.0,CHEMBL620177,A,,Biodistribution of [123I]-label in rat stomach was reported at 4 hr post injection. Value shown is %ID/g of tissue,Intermediate
,,Cerebellum,,,1,,,N,50597,13950,1,10116.0,8402,,BAO_0000218,Rattus norvegicus,2037.0,CHEMBL620178,A,,Distribution of [123I]-label in rat brain (cerebellum) was reported at 20 min post injection. Value shown is %ID/g of tissue,Intermediate
,,Cerebellum,,,1,,,N,50597,13950,1,10116.0,8403,,BAO_0000218,Rattus norvegicus,2037.0,CHEMBL620179,A,,Distribution of [123I]-label in rat brain (cerebellum) was reported at 60 min post injection. Value shown is %ID/g of tissue,Intermediate
,,,,,1,,,N,50597,13950,1,10116.0,8404,,BAO_0000218,Rattus norvegicus,,CHEMBL620180,A,,Distribution of [123I]-label in rat brain (diencephalon) was reported at 20 min post injection. Value shown is %ID/g of tissue,Intermediate
,In vivo,,,,1,,,N,50597,6570,1,10116.0,8405,,BAO_0000218,Rattus norvegicus,,CHEMBL620181,A,,Volume of distribution of compound in rat after 1 mg/kg i.v. administration,Intermediate
,In vivo,,,,1,,,N,50597,6571,1,10116.0,8406,,BAO_0000218,Rattus norvegicus,,CHEMBL620182,A,,Volume of distribution of compound in rats after intravenous administration,Intermediate
,In vivo,,,,1,,,N,50597,6453,1,10116.0,8407,,BAO_0000218,Rattus norvegicus,,CHEMBL620183,A,,Volume of distribution in rat,Intermediate
,In vivo,,,,1,,,N,50597,6444,1,10116.0,8408,,BAO_0000218,Rattus norvegicus,,CHEMBL620184,A,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.,Intermediate
,In vivo,,,,1,,,N,50597,6444,1,10116.0,8409,,BAO_0000218,Rattus norvegicus,,CHEMBL620185,A,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND means not determined,Intermediate
,In vivo,,,,1,,,N,50597,6444,1,10116.0,8410,,BAO_0000218,Rattus norvegicus,,CHEMBL620186,A,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND=not determined,Intermediate
,In vivo,,,,1,,,N,50597,5353,1,10116.0,8411,,BAO_0000218,Rattus norvegicus,,CHEMBL620187,A,,Volume of distribution was determined in Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,5334,1,10116.0,8412,,BAO_0000218,Rattus norvegicus,,CHEMBL620188,A,,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,5334,1,10116.0,8413,,BAO_0000218,Rattus norvegicus,,CHEMBL620189,A,,Volume of distribution was reported in Sprague-Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,6641,1,10116.0,8414,,BAO_0000218,Rattus norvegicus,,CHEMBL620190,A,,Volumes of distribution in rat after peroral administration,Intermediate
,In vivo,,,,1,,,N,50597,6641,1,10116.0,8415,,BAO_0000218,Rattus norvegicus,,CHEMBL620191,A,,Volumes of distribution in rat after po administration,Intermediate
,In vivo,,,,1,,,N,50597,6641,1,10116.0,8416,,BAO_0000218,Rattus norvegicus,,CHEMBL620192,A,,Volumes of distribution in rat after po administration; Not determined,Intermediate
,In vivo,,,,1,,,N,50597,5676,1,10116.0,8417,,BAO_0000218,Rattus norvegicus,,CHEMBL620193,A,,Pharmacokinetic property (Volume) in rat i.v.,Intermediate
,In vivo,,,,1,,,N,50597,6410,1,10116.0,8418,,BAO_0000218,Rattus norvegicus,,CHEMBL620194,A,,Apparent volume of distribution when 3 mg/Kg dose was administered intravenously,Intermediate
,In vivo,,,,1,,,N,50597,17670,1,10116.0,8419,,BAO_0000218,Rattus norvegicus,,CHEMBL876730,A,,"Volume distribution in fischer rats at 5 mg/kg dose, administered intravenously",Intermediate
,In vivo,,,,1,,,N,50597,6495,1,10116.0,8420,,BAO_0000218,Rattus norvegicus,,CHEMBL620195,A,,Volume distribution in rat after oral administration at 10 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,5408,1,10116.0,8421,,BAO_0000218,Rattus norvegicus,,CHEMBL620196,A,,Evaluated for Volume of distribution after iv administration of 5 mg/kg to male Sprague-Dawley rats,Intermediate
,In vivo,,,,1,,,N,50597,4883,1,10116.0,8422,,BAO_0000218,Rattus norvegicus,,CHEMBL620197,A,,Tested for volume of distribution after intravenous administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,6647,1,10116.0,8423,,BAO_0000218,Rattus norvegicus,,CHEMBL620198,A,,Volume of distribution after oral administration of 6 mg/kg of dose in rats was determined,Intermediate
,In vivo,,,,1,,,N,50597,6495,1,10116.0,8424,,BAO_0000218,Rattus norvegicus,,CHEMBL620199,A,,Volume of distribution in rats,Intermediate
,In vivo,,,,1,,,N,50597,2661,1,10116.0,8425,,BAO_0000218,Rattus norvegicus,,CHEMBL620200,A,,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female wistar rats,Intermediate
,In vivo,,,,1,,,N,50597,2661,1,10116.0,8426,,BAO_0000218,Rattus norvegicus,,CHEMBL620201,A,,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to male wistar rats,Intermediate
,In vivo,,,,1,,,N,50597,5974,1,10116.0,8427,,BAO_0000218,Rattus norvegicus,,CHEMBL620202,A,,In vivo Volume distribution (Vss) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,5974,1,10116.0,8428,,BAO_0000218,Rattus norvegicus,,CHEMBL620203,A,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,5974,1,10116.0,8429,,BAO_0000218,Rattus norvegicus,,CHEMBL620204,A,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat;no value,Intermediate
,In vivo,,,,1,,,N,50597,5974,1,10116.0,8430,,BAO_0000218,Rattus norvegicus,,CHEMBL620205,A,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,5960,1,10116.0,8431,,BAO_0000218,Rattus norvegicus,,CHEMBL624664,A,,Pharmacokinetic parameter (Vss) in rat,Intermediate
,In vivo,,,,1,,,N,50597,5676,1,10116.0,8432,,BAO_0000218,Rattus norvegicus,,CHEMBL624665,A,,Pharmacokinetic property (Volume) in rat i.v.,Intermediate
,,,,,1,,,N,50597,5948,1,10116.0,8433,,BAO_0000218,Rattus norvegicus,,CHEMBL624666,A,,Pharmacokinetic property (Vss) in rat,Intermediate
,In vivo,,,,1,,,N,50597,5979,1,10116.0,8434,,BAO_0000218,Rattus norvegicus,,CHEMBL624667,A,,Steady state volume distribution (Vss) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,Intermediate
,In vivo,,,,1,,,N,50597,5978,1,10116.0,8435,,BAO_0000218,Rattus norvegicus,,CHEMBL624668,A,,Steady state volume distribution (Vss) of compound after iv administration was determined in Sprague-Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,5978,1,10116.0,8436,,BAO_0000218,Rattus norvegicus,,CHEMBL624669,A,,Steady state volume distribution (Vss) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,5978,1,10116.0,8437,,BAO_0000218,Rattus norvegicus,,CHEMBL624670,A,,Steady state volume distribution (Vss) of compound(9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,5978,1,10116.0,8438,,BAO_0000218,Rattus norvegicus,,CHEMBL624671,A,,Steady state volume distribution (Vss) of compound(9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,6448,1,10116.0,8439,,BAO_0000218,Rattus norvegicus,,CHEMBL624672,A,,Steady state volume distribution in rat,Intermediate
,In vivo,Plasma,,,1,,,N,50597,12873,1,10116.0,8440,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL624673,A,,"Steady state volume of distribution calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv.",Intermediate
,In vivo,,,,1,,,N,50597,4576,1,10116.0,8441,,BAO_0000218,Rattus norvegicus,,CHEMBL624674,A,,Steady state volume of distribution determined in rat,Intermediate
,In vivo,,,,1,,,N,50597,17582,1,10116.0,8442,,BAO_0000218,Rattus norvegicus,,CHEMBL624675,A,,Steady-state volume of distribution was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,Intermediate
,In vivo,,,,1,,,N,50597,1466,1,10116.0,8443,,BAO_0000218,Rattus norvegicus,,CHEMBL621728,A,,Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in rat,Intermediate
,,,,,1,,,N,50597,5182,1,10116.0,8444,,BAO_0000218,Rattus norvegicus,,CHEMBL621729,A,,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined,Intermediate
,,,,,1,,,N,50597,5182,1,10116.0,8445,,BAO_0000218,Rattus norvegicus,,CHEMBL621730,A,,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined; NC means not calculated,Intermediate
,In vivo,,,,1,,,N,50597,6535,1,10116.0,8446,,BAO_0000218,Rattus norvegicus,,CHEMBL621731,A,,Volume distribution in rat after administration of 2 mg/kg iv,Intermediate
,In vivo,,,,1,,,N,50597,6535,1,10116.0,8447,,BAO_0000218,Rattus norvegicus,,CHEMBL621732,A,,Volume distribution in rat after administration of 2 mg/kg iv,Intermediate
,In vivo,,,,1,,,N,50597,5041,1,10116.0,8448,,BAO_0000218,Rattus norvegicus,,CHEMBL621908,A,,Volume in steady state distribution value was determined,Intermediate
,In vivo,,,,1,,,N,50597,5041,1,10116.0,8449,,BAO_0000218,Rattus norvegicus,,CHEMBL875347,A,,Volume in steady state distribution value was determined; ND denotes no data,Intermediate
,In vivo,,,,1,,,N,50597,5041,1,10116.0,8450,,BAO_0000218,Rattus norvegicus,,CHEMBL621909,A,,Volume in steady state distribution value was determined; ND denotes not determined,Intermediate
,In vivo,,,,1,,,N,50597,17065,1,10116.0,8451,,BAO_0000218,Rattus norvegicus,,CHEMBL621910,A,,Volume of distribution at a steady state measured after intravenous bolus administration of 50 mg/kg of compound to rats,Intermediate
,In vivo,,,,1,,,N,50597,6597,1,10116.0,8452,,BAO_0000218,Rattus norvegicus,,CHEMBL621911,A,,Volume of distribution at steady state was evaluated in rats,Intermediate
,In vivo,,,,1,,,N,50597,15662,1,10116.0,8453,,BAO_0000218,Rattus norvegicus,,CHEMBL621912,A,,Volume of distribution at steady state was observed after intravenous administration in rat,Intermediate
,In vivo,,,,1,,,N,50597,6485,1,10116.0,8454,,BAO_0000218,Rattus norvegicus,,CHEMBL621913,A,,Volume of distribution in steady state was determined in rat,Intermediate
,In vivo,,,,1,,,N,50597,17655,1,10116.0,8455,,BAO_0000218,Rattus norvegicus,,CHEMBL621914,A,,Volume of distribution in steady state was determined in rat,Intermediate
,In vivo,,,,1,,,N,50597,6616,1,10116.0,8456,,BAO_0000218,Rattus norvegicus,,CHEMBL621915,A,,Volume of distribution after i.v. administration,Intermediate
,In vivo,,,,1,,,N,50597,1916,1,10116.0,8457,,BAO_0000218,Rattus norvegicus,,CHEMBL621916,A,,Volume of distribution was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,Intermediate
,In vivo,Liver,,,1,,,N,50594,16438,1,10090.0,8458,,BAO_0000218,Mus musculus,2107.0,CHEMBL621917,A,,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",Intermediate
,In vivo,Liver,,,1,,,N,50594,16438,1,10090.0,8459,,BAO_0000218,Mus musculus,2107.0,CHEMBL621918,A,,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",Intermediate
,In vivo,Spleen,,,1,,,N,50594,16438,1,10090.0,8460,,BAO_0000218,Mus musculus,2106.0,CHEMBL621919,A,,Biodistribution of compound (oxidized form) in spleen tissue,Intermediate
,In vivo,Spleen,,,1,,,N,50594,16438,1,10090.0,8461,,BAO_0000218,Mus musculus,2106.0,CHEMBL621920,A,,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",Intermediate
,In vivo,Spleen,,,1,,,N,50594,16438,1,10090.0,8462,,BAO_0000218,Mus musculus,2106.0,CHEMBL621921,A,,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",Intermediate
,In vivo,Spleen,,,1,,,N,50594,16438,1,10090.0,8463,,BAO_0000218,Mus musculus,2106.0,CHEMBL622401,A,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Intermediate
,In vivo,Spleen,,,1,,,N,50594,16438,1,10090.0,8464,,BAO_0000218,Mus musculus,2106.0,CHEMBL875348,A,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",Intermediate
,In vivo,Spleen,,,1,,,N,50594,16438,1,10090.0,8465,,BAO_0000218,Mus musculus,2106.0,CHEMBL622402,A,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",Intermediate
,In vivo,Blood,,,1,,,N,50594,16438,1,10090.0,8466,,BAO_0000218,Mus musculus,178.0,CHEMBL622403,A,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood,Intermediate
,In vivo,Blood,,,1,,,N,50594,16438,1,10090.0,8467,,BAO_0000218,Mus musculus,178.0,CHEMBL622404,A,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Intermediate
,In vivo,Brain,,,1,,,N,50594,16438,1,10090.0,8468,,BAO_0000218,Mus musculus,955.0,CHEMBL622405,A,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues,Intermediate
,In vivo,Brain,,,1,,,N,50594,16438,1,10090.0,8469,,BAO_0000218,Mus musculus,955.0,CHEMBL622406,A,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO",Intermediate
,In vivo,Brain,,,1,,,N,50594,16438,1,10090.0,8470,,BAO_0000218,Mus musculus,955.0,CHEMBL622407,A,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Intermediate
,In vivo,Heart,,,1,,,N,50594,16438,1,10090.0,8471,,BAO_0000218,Mus musculus,948.0,CHEMBL622408,A,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues,Intermediate
,In vivo,Heart,,,1,,,N,50594,16438,1,10090.0,8472,,BAO_0000218,Mus musculus,948.0,CHEMBL622409,A,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO",Intermediate
,In vivo,Heart,,,1,,,N,50594,16438,1,10090.0,8473,,BAO_0000218,Mus musculus,948.0,CHEMBL622410,A,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Intermediate
,In vivo,Kidney,,,1,,,N,50594,16438,1,10090.0,8474,,BAO_0000218,Mus musculus,2113.0,CHEMBL622411,A,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney,Intermediate
,In vivo,Kidney,,,1,,,N,50594,16438,1,10090.0,8475,,BAO_0000218,Mus musculus,2113.0,CHEMBL627864,A,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing in DMSO",Intermediate
,In vivo,Kidney,,,1,,,N,50594,16438,1,10090.0,8476,,BAO_0000218,Mus musculus,2113.0,CHEMBL627865,A,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Intermediate
,In vivo,Liver,,,1,,,N,50594,16438,1,10090.0,8477,,BAO_0000218,Mus musculus,2107.0,CHEMBL627866,A,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver,Intermediate
,In vivo,Liver,,,1,,,N,50594,16438,1,10090.0,8478,,BAO_0000218,Mus musculus,2107.0,CHEMBL627751,A,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Intermediate
,In vivo,Spleen,,,1,,,N,50594,16438,1,10090.0,8479,,BAO_0000218,Mus musculus,2106.0,CHEMBL627752,A,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen,Intermediate
,In vivo,Spleen,,,1,,,N,50594,16438,1,10090.0,8480,,BAO_0000218,Mus musculus,2106.0,CHEMBL627753,A,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing in DMSO",Intermediate
,In vivo,Spleen,,,1,,,N,50594,16438,1,10090.0,8481,,BAO_0000218,Mus musculus,2106.0,CHEMBL627754,A,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Intermediate
,,,,,1,,,N,50594,12467,1,10090.0,8482,,BAO_0000218,Mus musculus,,CHEMBL627755,A,,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK2 murine fibrosarcoma cells,Intermediate
,In vivo,Brain,,,1,,,N,50594,17208,1,10090.0,8483,,BAO_0000218,Mus musculus,955.0,CHEMBL627756,A,,Biodistribution of radioactivity in normal mice (ICR) brain after 1 hour of intravenous injection of [125I]-16(IMPY),Intermediate
,In vivo,Brain,,,1,,,N,50594,17208,1,10090.0,8484,,BAO_0000218,Mus musculus,955.0,CHEMBL627757,A,,Biodistribution of radioactivity in normal mice (ICR) brain after 2 hours of intravenous injection of [125I]-16(IMPY),Intermediate
,In vivo,Brain,,,1,,,N,50594,17208,1,10090.0,8485,,BAO_0000218,Mus musculus,955.0,CHEMBL627758,A,,Biodistribution of radioactivity in normal mice (ICR) brain after 2 minutes of intravenous injection of [125I]-16(IMPY),Intermediate
,In vivo,Brain,,,1,,,N,50594,17208,1,10090.0,8486,,BAO_0000218,Mus musculus,955.0,CHEMBL627759,A,,Biodistribution of radioactivity in normal mice (ICR) brain after 24 hours of intravenous injection of [125I]-16(IMPY),Intermediate
,In vivo,Brain,,,1,,,N,50594,17208,1,10090.0,8487,,BAO_0000218,Mus musculus,955.0,CHEMBL627760,A,,Biodistribution of radioactivity in normal mice (ICR) brain after 30 minutes of intravenous injection of [125I]-16(IMPY),Intermediate
,In vivo,Brain,,,1,,,N,50594,17208,1,10090.0,8488,,BAO_0000218,Mus musculus,955.0,CHEMBL627761,A,,Biodistribution of radioactivity in normal mice (ICR) brain after 6 hours of intravenous injection of [125I]-16(IMPY),Intermediate
,In vivo,Heart,,,1,,,N,50594,17208,1,10090.0,8489,,BAO_0000218,Mus musculus,948.0,CHEMBL876811,A,,Biodistribution of radioactivity in normal mice (ICR) heart after 1 hour of intravenous injection of [125I]-16(IMPY),Intermediate
,In vivo,Heart,,,1,,,N,50594,17208,1,10090.0,8490,,BAO_0000218,Mus musculus,948.0,CHEMBL627762,A,,Biodistribution of radioactivity in normal mice (ICR) heart after 2 hours of intravenous injection of [125I]-16(IMPY),Intermediate
,In vivo,Heart,,,1,,,N,50594,17208,1,10090.0,8491,,BAO_0000218,Mus musculus,948.0,CHEMBL627763,A,,Biodistribution of radioactivity in normal mice (ICR) heart after 2 minutes of intravenous injection of [125I]-16(IMPY),Intermediate
,In vivo,Heart,,,1,,,N,50594,17208,1,10090.0,8492,,BAO_0000218,Mus musculus,948.0,CHEMBL627764,A,,Biodistribution of radioactivity in normal mice (ICR) heart after 24 hours of intravenous injection of [125I]-16(IMPY),Intermediate
,In vivo,Heart,,,1,,,N,50594,17208,1,10090.0,8493,,BAO_0000218,Mus musculus,948.0,CHEMBL627765,A,,Biodistribution of radioactivity in normal mice (ICR) heart after 30 minutes of intravenous injection of [125I]-16(IMPY),Intermediate
,In vivo,Heart,,,1,,,N,50594,17208,1,10090.0,8494,,BAO_0000218,Mus musculus,948.0,CHEMBL627766,A,,Biodistribution of radioactivity in normal mice (ICR) heart after 6 hours of intravenous injection of [125I]-16(IMPY),Intermediate
,In vivo,Kidney,,,1,,,N,50594,17208,1,10090.0,8495,,BAO_0000218,Mus musculus,2113.0,CHEMBL627767,A,,Biodistribution of radioactivity in normal mice (ICR) kidney after 1 hour of intravenous injection of [125I]-16(IMPY),Intermediate
,In vivo,Kidney,,,1,,,N,50594,17208,1,10090.0,8496,,BAO_0000218,Mus musculus,2113.0,CHEMBL627768,A,,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 hours of intravenous injection of [125I]-16(IMPY),Intermediate
,In vivo,Kidney,,,1,,,N,50594,17208,1,10090.0,8497,,BAO_0000218,Mus musculus,2113.0,CHEMBL628422,A,,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 minutes of intravenous injection of [125I]-16(IMPY),Intermediate
,In vivo,Kidney,,,1,,,N,50594,17208,1,10090.0,8498,,BAO_0000218,Mus musculus,2113.0,CHEMBL628423,A,,Biodistribution of radioactivity in normal mice (ICR) kidney after 24 hours of intravenous injection of [125I]-16(IMPY),Intermediate
,In vivo,,,,1,,,N,50597,5089,1,10116.0,8499,,BAO_0000218,Rattus norvegicus,,CHEMBL628424,A,,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing) in Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,5089,1,10116.0,8500,,BAO_0000218,Rattus norvegicus,,CHEMBL628425,A,,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing)) in Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,4257,1,10116.0,8501,,BAO_0000218,Rattus norvegicus,,CHEMBL628426,A,,Plasma clearance value was determined in rat after a 3 mg/kg of iv dose,Intermediate
,In vivo,,,,1,,,N,50597,6679,1,10116.0,8502,,BAO_0000218,Rattus norvegicus,,CHEMBL628427,A,,Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,Intermediate
,In vivo,,,,1,,,N,50597,5546,1,10116.0,8503,,BAO_0000218,Rattus norvegicus,,CHEMBL626938,A,,Plasma clearance was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,Intermediate
,In vivo,,,,1,,,N,50597,6141,1,10116.0,8504,,BAO_0000218,Rattus norvegicus,,CHEMBL626939,A,,Plasma clearance was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,Intermediate
,In vivo,,,,1,,,N,50597,5334,1,10116.0,8505,,BAO_0000218,Rattus norvegicus,,CHEMBL626940,A,,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,5334,1,10116.0,8506,,BAO_0000218,Rattus norvegicus,,CHEMBL626941,A,,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,5334,1,10116.0,8507,,BAO_0000218,Rattus norvegicus,,CHEMBL626942,A,,Plasma clearance was reported in Sprague-Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,4689,1,10116.0,8508,,BAO_0000218,Rattus norvegicus,,CHEMBL876812,A,,Plasma clearance after intravenous administration (1 mg/kg) in rat,Intermediate
,In vivo,,,,1,,,N,50597,6848,1,10116.0,8509,,BAO_0000218,Rattus norvegicus,,CHEMBL626943,A,,Plasma clearance of compound in rats was evaluated,Intermediate
,In vivo,,,,1,,,N,50597,6848,1,10116.0,8510,,BAO_0000218,Rattus norvegicus,,CHEMBL626944,A,,Plasma clearance of compound in rats was evaluated; ND indicates not determined,Intermediate
,In vivo,,,,1,,,N,50597,6467,1,10116.0,8511,,BAO_0000218,Rattus norvegicus,,CHEMBL626945,A,,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration,Intermediate
,In vivo,,,,1,,,N,50597,6467,1,10116.0,8512,,BAO_0000218,Rattus norvegicus,,CHEMBL626946,A,,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,Intermediate
,In vivo,,,,1,,,N,50597,4956,1,10116.0,8513,,BAO_0000218,Rattus norvegicus,,CHEMBL626856,A,,Plasma clearance rate in Sprague-Dawley rats,Intermediate
,In vivo,,,,1,,,N,50597,5529,1,10116.0,8514,,BAO_0000218,Rattus norvegicus,,CHEMBL626857,A,,Plasma clearance was determined in rat after intravenous administration (0.5 mg/kg),Intermediate
,In vivo,Plasma,,,1,,,N,50597,406,1,10116.0,8515,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626858,A,,The compound was evaluated for plasma clearance in rat,Intermediate
,In vivo,Plasma,,,1,,,N,50597,17655,1,10116.0,8516,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL627018,A,,Total plasma clearance in rat,Intermediate
,In vivo,Blood,,,1,,,N,50597,3293,1,10116.0,8517,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL625331,A,,Absorption behavior was judged by the peak blood concentration determined after oral dose of 30 mg/kg in rats.,Intermediate
,In vivo,Blood,,,1,,,N,50597,4075,1,10116.0,8518,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL625332,A,,Blood level after a 10 mg/kg oral dose in rat expressed as Cmax was determined,Intermediate
,In vivo,,,,1,,,N,50597,2792,1,10116.0,8519,,BAO_0000218,Rattus norvegicus,,CHEMBL877590,A,,C max was determined at 10 mg/kg po dose in rats,Intermediate
,In vivo,,,,1,,,N,50597,2792,1,10116.0,8520,,BAO_0000218,Rattus norvegicus,,CHEMBL625333,A,,C max was determined at 3 mg/kg po dose in rats,Intermediate
,In vivo,,,,1,,,N,50597,17594,1,10116.0,8521,,BAO_0000218,Rattus norvegicus,,CHEMBL625334,A,,Cmax after repeated oral dose of compound at 1 mg/kg in rats,Intermediate
,In vivo,,,,1,,,N,50597,17594,1,10116.0,8522,,BAO_0000218,Rattus norvegicus,,CHEMBL625335,A,,Cmax after single intravenous bolus of 1 mg/kg in rats,Intermediate
,In vivo,,,,1,,,N,50597,4762,1,10116.0,8523,,BAO_0000218,Rattus norvegicus,,CHEMBL625336,A,,Cmax of compound at 5 mg/kg after po administration was determined in rat,Intermediate
,In vivo,,,,1,,,N,50597,17509,1,10116.0,8524,,BAO_0000218,Rattus norvegicus,,CHEMBL625337,A,,Cmax 24 hr after 10 mg/kg oral administration in rats,Intermediate
,In vivo,,,,1,,,N,50597,17509,1,10116.0,8525,,BAO_0000218,Rattus norvegicus,,CHEMBL625338,A,,Cmax 24 hr after 2 mg/kg oral administration in rats,Intermediate
,In vivo,Plasma,,,1,,,N,50597,1466,1,10116.0,8526,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL625339,A,,Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in rat,Intermediate
,In vivo,,,,1,,,N,50597,6535,1,10116.0,8527,,BAO_0000218,Rattus norvegicus,,CHEMBL625340,A,,Cmax in rat after administration of 2 mg/kg iv,Intermediate
,In vivo,,,,1,,,N,50597,6535,1,10116.0,8528,,BAO_0000218,Rattus norvegicus,,CHEMBL625341,A,,Cmax in rat after administration of 2 mg/kg iv,Intermediate
,In vivo,,,,1,,,N,50597,3169,1,10116.0,8529,,BAO_0000218,Rattus norvegicus,,CHEMBL622687,A,,Cmax in rats determined 6 hours after oral dosing of 20 mg/kg,Intermediate
,In vivo,Plasma,,,1,,,N,50597,6515,1,10116.0,8530,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622688,A,,Cmax wa determined in rat plasma at 30 mg/kg after po administration,Intermediate
,In vivo,Blood,,,1,,,N,50597,11149,1,10116.0,8531,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL622689,A,,Cmax was calculated as maximum concentration reached in the blood after oral administration to male F344 rats,Intermediate
,In vivo,Blood,,,1,,,N,50597,11149,1,10116.0,8532,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL620295,A,,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate after oral administration to male F344 rats,Intermediate
,In vivo,,,,1,,,N,50597,17858,1,10116.0,8533,,BAO_0000218,Rattus norvegicus,,CHEMBL620296,A,,Cmax after 10 mg/kg oral administration in rat,Intermediate
,In vivo,,,,1,,,N,50597,6518,1,10116.0,8534,,BAO_0000218,Rattus norvegicus,,CHEMBL620297,A,,Cmax after IV dosing at 0.5 mg/kg in rat; no data,Intermediate
,In vivo,,,,1,,,N,50597,6518,1,10116.0,8535,,BAO_0000218,Rattus norvegicus,,CHEMBL620298,A,,Cmax after IV dosing at 1 mg/kg in rat; no data,Intermediate
,In vivo,,,,1,,,N,50597,4426,1,10116.0,8536,,BAO_0000218,Rattus norvegicus,,CHEMBL620299,A,,Cmax after oral administration at 20 mpk in rats,Intermediate
,In vivo,,,,1,,,N,50597,4426,1,10116.0,8537,,BAO_0000218,Rattus norvegicus,,CHEMBL620300,A,,Cmax after oral administration at 20 mpk in rats; Not performed.,Intermediate
,In vivo,,,,1,,,N,50597,4426,1,10116.0,8538,,BAO_0000218,Rattus norvegicus,,CHEMBL620301,A,,Cmax after oral administration at 20 mpk in rats d; Not performed.,Intermediate
,In vivo,,,,1,,,N,50597,5656,1,10116.0,8539,,BAO_0000218,Rattus norvegicus,,CHEMBL620302,A,,Cmax after oral administration in rat,Intermediate
,In vivo,,,,1,,,N,50597,6518,1,10116.0,8540,,BAO_0000218,Rattus norvegicus,,CHEMBL620303,A,,Cmax after oral administration at a dose of 2 mg/kg in rat,Intermediate
,In vivo,,,,1,,,N,50597,6518,1,10116.0,8541,,BAO_0000218,Rattus norvegicus,,CHEMBL620304,A,,Cmax after oral administration at a dose of 4 mg/kg in rat,Intermediate
,In vivo,,,,1,,,N,50597,6113,1,10116.0,8542,,BAO_0000218,Rattus norvegicus,,CHEMBL620305,A,,Cmax in rats after 20 mg/kg oral dose,Intermediate
,In vivo,,,,1,,,N,50597,17764,1,10116.0,8543,,BAO_0000218,Rattus norvegicus,,CHEMBL620306,A,,Cmax after peroral administration in rats at 2.4 uM/kg,Intermediate
,In vivo,,,,1,,,N,50597,4756,1,10116.0,8544,,BAO_0000218,Rattus norvegicus,,CHEMBL620307,A,,Cmax at the dose of 2 mg/Kg administered perorally in rats,Intermediate
,In vivo,,,,1,,,N,50597,4756,1,10116.0,8545,,BAO_0000218,Rattus norvegicus,,CHEMBL620308,A,,Cmax at the dose of 5 mg/Kg administered perorally in rats,Intermediate
,In vivo,,,,1,,,N,50597,6402,1,10116.0,8546,,BAO_0000218,Rattus norvegicus,,CHEMBL620309,A,,Cmax by administering at 20 mg/kg p.o. in rats,Intermediate
,In vivo,,,,1,,,N,50597,5610,1,10116.0,8547,,BAO_0000218,Rattus norvegicus,,CHEMBL620310,A,,Cmax in male rat,Intermediate
,In vivo,,,,1,,,N,50597,5207,1,10116.0,8548,,BAO_0000218,Rattus norvegicus,,CHEMBL620311,A,,Cmax in rat,Intermediate
,In vivo,,,,1,,,N,50597,6011,1,10116.0,8549,,BAO_0000218,Rattus norvegicus,,CHEMBL620312,A,,Cmax in rat,Intermediate
,In vivo,,,,1,,,N,50597,6504,1,10116.0,8550,,BAO_0000218,Rattus norvegicus,,CHEMBL620313,A,,Cmax in rat,Intermediate
,In vivo,,,,1,,,N,50597,6046,1,10116.0,8551,,BAO_0000218,Rattus norvegicus,,CHEMBL620314,A,,Cmax in rat at 10 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,6504,1,10116.0,8552,,BAO_0000218,Rattus norvegicus,,CHEMBL620315,A,,Cmax in rat at the dose of 1 mg/kg i.v.,Intermediate
,In vivo,,,,1,,,N,50597,5874,1,10116.0,8553,,BAO_0000218,Rattus norvegicus,,CHEMBL620316,A,,Cmax in rat by po administration at a dose of 40 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,17686,1,10116.0,8554,,BAO_0000218,Rattus norvegicus,,CHEMBL620317,A,,Cmax in rat p.o. at 20 mg/kg concentration,Intermediate
,In vivo,,,,1,,,N,50597,5836,1,10116.0,8555,,BAO_0000218,Rattus norvegicus,,CHEMBL620318,A,,Cmax in rats,Intermediate
,In vivo,,,,1,,,N,50597,17596,1,10116.0,8556,,BAO_0000218,Rattus norvegicus,,CHEMBL620319,A,,Cmax in rats,Intermediate
,In vivo,,,,1,,,N,50597,16423,1,10116.0,8557,,BAO_0000218,Rattus norvegicus,,CHEMBL620320,A,,Cmax was evaluated after 20 uM/kg of peroral administration,Intermediate
,In vivo,,,,1,,,N,50597,17804,1,10116.0,8558,,BAO_0000218,Rattus norvegicus,,CHEMBL620321,A,,Cmax was measured in rats after peroral administration at 3 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,1908,1,10116.0,8559,,BAO_0000218,Rattus norvegicus,,CHEMBL620322,A,,Cmax value after oral dose at a dose of 10 mg/kg in rats.,Intermediate
,,,,,1,,,N,50597,13950,1,10116.0,8560,,BAO_0000218,Rattus norvegicus,,CHEMBL620323,A,,Distribution of [123I]-label in rat brain (diencephalon) was reported at 60 min post injection. Value shown is %ID/g of tissue,Intermediate
,,Frontal cortex,,,1,,,N,50597,13950,1,10116.0,8561,,BAO_0000218,Rattus norvegicus,1870.0,CHEMBL620324,A,,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,Intermediate
,,Frontal cortex,,,1,,,N,50597,13950,1,10116.0,8562,,BAO_0000218,Rattus norvegicus,1870.0,CHEMBL620325,A,,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,Intermediate
,,Hippocampus,,,1,,,N,50597,13950,1,10116.0,8563,,BAO_0000218,Rattus norvegicus,10000000.0,CHEMBL620326,A,,Distribution of [123I]-label in rat brain (hippocampus) was reported at 20 min post injection. Value shown is %ID/g of tissue,Intermediate
,,Hippocampus,,,1,,,N,50597,13950,1,10116.0,8564,,BAO_0000218,Rattus norvegicus,10000000.0,CHEMBL620327,A,,Distribution of [123I]-label in rat brain (hippocampus) was reported at 60 min post injection. Value shown is %ID/g of tissue,Intermediate
,,,,,1,,,N,50597,13950,1,10116.0,8565,,BAO_0000218,Rattus norvegicus,,CHEMBL620328,A,,Distribution of [123I]-label in rat brain (medulla pons) was reported at 20 min post injection. Value shown is %ID/g of tissue,Intermediate
,,,,,1,,,N,50597,13950,1,10116.0,8566,,BAO_0000218,Rattus norvegicus,,CHEMBL620329,A,,Distribution of [123I]-label in rat brain (medulla pons) was reported at 60 min post injection. Value shown is %ID/g of tissue,Intermediate
,,Midbrain,,,1,,,N,50597,13950,1,10116.0,8567,,BAO_0000218,Rattus norvegicus,1891.0,CHEMBL620330,A,,Distribution of [123I]-label in rat brain (midbrain) was reported at 20 min post injection. Value shown is %ID/g of tissue,Intermediate
,,Midbrain,,,1,,,N,50597,13950,1,10116.0,8568,,BAO_0000218,Rattus norvegicus,1891.0,CHEMBL875286,A,,Distribution of [123I]-label in rat brain (midbrain) was reported at 60 min post injection. Value shown is %ID/g of tissue,Intermediate
,,,,,1,,,N,50597,13950,1,10116.0,8569,,BAO_0000218,Rattus norvegicus,,CHEMBL620331,A,,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,Intermediate
,,,,,1,,,N,50597,13950,1,10116.0,8570,,BAO_0000218,Rattus norvegicus,,CHEMBL620332,A,,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,Intermediate
,,Striatum,,,1,,,N,50597,13950,1,10116.0,8571,,BAO_0000218,Rattus norvegicus,2435.0,CHEMBL620333,A,,Distribution of [123I]-label in rat brain (striatum) was reported at 20 min post injection. Value shown is %ID/g of tissue,Intermediate
,,Striatum,,,1,,,N,50597,13950,1,10116.0,8572,,BAO_0000218,Rattus norvegicus,2435.0,CHEMBL620334,A,,Distribution of [123I]-label in rat brain (striatum) was reported at 60 min post injection. Value shown is %ID/g of tissue,Intermediate
,,Blood,,,1,,,N,50597,16434,1,10116.0,8573,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL621015,A,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate
,,Blood,,,1,,,N,50597,16434,1,10116.0,8574,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL621016,A,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate
,,Blood,,,1,,,N,50597,16434,1,10116.0,8575,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL621191,A,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate
,,Blood,,,1,,,N,50597,16434,1,10116.0,8576,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL621192,A,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate
,,Blood,,,1,,,N,50597,16434,1,10116.0,8577,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL621193,A,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Intermediate
,,Blood,,,1,,,N,50597,16434,1,10116.0,8578,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL621194,A,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Intermediate
,,Blood,,,1,,,N,50597,16434,1,10116.0,8579,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL624204,A,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Intermediate
,,Blood,,,1,,,N,50597,16434,1,10116.0,8580,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL624205,A,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Intermediate
,,Blood,,,1,,,N,50597,16435,1,10116.0,8581,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL624206,A,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate
,,Blood,,,1,,,N,50597,16435,1,10116.0,8582,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL624207,A,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate
,,Blood,,,1,,,N,50597,16435,1,10116.0,8583,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL624208,A,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate
,,Blood,,,1,,,N,50597,16435,1,10116.0,8584,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL624209,A,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate
,,Blood,,,1,,,N,50597,16435,1,10116.0,8585,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL624210,A,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate
,,Blood,,,1,,,N,50597,16435,1,10116.0,8586,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL624211,A,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate
,,Blood,,,1,,,N,50597,16435,1,10116.0,8587,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL624212,A,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate
,,Blood,,,1,,,N,50597,16435,1,10116.0,8588,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL624213,A,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate
,,Blood,,,1,,,N,50597,16434,1,10116.0,8589,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL876611,A,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate
,,Blood,,,1,,,N,50597,16434,1,10116.0,8590,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL624214,A,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Intermediate
,,Blood,,,1,,,N,50597,16434,1,10116.0,8591,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL624215,A,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate
,,Blood,,,1,,,N,50597,16435,1,10116.0,8592,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL624216,A,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate
,,Blood,,,1,,,N,50597,16435,1,10116.0,8593,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL624217,A,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate
,,Blood,,,1,,,N,50597,16435,1,10116.0,8594,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL624218,A,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate
,,Blood,,,1,,,N,50597,16435,1,10116.0,8595,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL624219,A,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate
,,Blood,,,1,,,N,50597,16435,1,10116.0,8596,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL624220,A,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate
,,Blood,,,1,,,N,50597,16435,1,10116.0,8597,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL624221,A,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate
,,,,,1,,,N,50597,16434,1,10116.0,8598,,BAO_0000218,Rattus norvegicus,,CHEMBL624222,A,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate
,,,,,1,,,N,50597,16434,1,10116.0,8599,,BAO_0000218,Rattus norvegicus,,CHEMBL624223,A,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate
,,,,,1,,,N,50597,16434,1,10116.0,8600,,BAO_0000218,Rattus norvegicus,,CHEMBL624224,A,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate
,,,,,1,,,N,50597,16434,1,10116.0,8601,,BAO_0000218,Rattus norvegicus,,CHEMBL624225,A,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate
,In vivo,,,,1,,,N,50597,17764,1,10116.0,8602,,BAO_0000218,Rattus norvegicus,,CHEMBL622420,A,,Volume of solubility in solution after intravenous administration in rats at 24 uM/kg,Intermediate
,In vivo,,,,1,,,N,50597,5031,1,10116.0,8603,,BAO_0000218,Rattus norvegicus,,CHEMBL622421,A,,Volume of steady state distribution after i.v. administration in rats,Intermediate
,In vivo,,,,1,,,N,50597,6215,1,10116.0,8604,,BAO_0000218,Rattus norvegicus,,CHEMBL622422,A,,Vss after intravenous administration (5.0 mg/kg) was determined in rat,Intermediate
,In vivo,,,,1,,,N,50597,17671,1,10116.0,8605,,BAO_0000218,Rattus norvegicus,,CHEMBL622423,A,,Vss in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,17752,1,10116.0,8606,,BAO_0000218,Rattus norvegicus,,CHEMBL622424,A,,Vss was determined,Intermediate
,In vivo,,,,1,,,N,50597,6596,1,10116.0,8607,,BAO_0000218,Rattus norvegicus,,CHEMBL622425,A,,Vss in rat,Intermediate
,In vivo,,,,1,,,N,50597,16423,1,10116.0,8608,,BAO_0000218,Rattus norvegicus,,CHEMBL876612,A,,Vss was evaluated after 10 uM/kg of intra arterial administration,Intermediate
,In vivo,,,,1,,,N,50597,15662,1,10116.0,8609,,BAO_0000218,Rattus norvegicus,,CHEMBL622426,A,,volume of distribution at steady state was observed after intravenous administration in rat,Intermediate
,In vivo,,,,1,,,N,50597,6062,1,10116.0,8610,,BAO_0000218,Rattus norvegicus,,CHEMBL622427,A,,Volume of distribution was measured in rat after an iv dose of 1 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,5874,1,10116.0,8611,,BAO_0000218,Rattus norvegicus,,CHEMBL622428,A,,Pharmacokinetic (PK) parameter Vz in rat,Intermediate
,In vivo,,,,1,,,N,50597,4942,1,10116.0,8612,,BAO_0000218,Rattus norvegicus,,CHEMBL622429,A,,Volume distribution in rats,Intermediate
,In vivo,,,,1,,,N,50597,17796,1,10116.0,8613,,BAO_0000218,Rattus norvegicus,,CHEMBL622430,A,,Volume of distribution in rat; No data,Intermediate
,In vivo,,,,1,,,N,50597,4890,1,10116.0,8614,,BAO_0000218,Rattus norvegicus,,CHEMBL622431,A,,Volume of distribution was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,Intermediate
,,Ileum,,,1,,,N,50597,15765,1,10116.0,8615,,BAO_0000218,Rattus norvegicus,2116.0,CHEMBL622432,A,,% absorption predicted from in vitro rat ileum transport studies,Intermediate
,In vivo,,,,1,,,N,50597,13569,1,10116.0,8616,,BAO_0000218,Rattus norvegicus,,CHEMBL622433,A,,Bioavailability at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,Intermediate
,In vivo,,,,1,,,N,50597,13569,1,10116.0,8617,,BAO_0000218,Rattus norvegicus,,CHEMBL622434,A,,Bioavailability at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,Intermediate
,In vivo,,,,1,,,N,50597,13569,1,10116.0,8618,,BAO_0000218,Rattus norvegicus,,CHEMBL622435,A,,Bioavailability at an iv dose of 14 mg/Kg and po dose of 28 mg/Kg,Intermediate
,In vivo,,,,1,,,N,50597,13569,1,10116.0,8619,,BAO_0000218,Rattus norvegicus,,CHEMBL618748,A,,Bioavailability (dose 15 mg/kg i.v. and 30 mg/kg p.o.),Intermediate
,In vivo,,,,1,,,N,50597,13569,1,10116.0,8620,,BAO_0000218,Rattus norvegicus,,CHEMBL618749,A,,Bioavailability at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,Intermediate
,In vivo,,,,1,,,N,50597,13569,1,10116.0,8621,,BAO_0000218,Rattus norvegicus,,CHEMBL618750,A,,Bioavailability at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,Intermediate
,In vivo,,,,1,,,N,50597,13569,1,10116.0,8622,,BAO_0000218,Rattus norvegicus,,CHEMBL618751,A,,Bioavailability at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,Intermediate
,In vivo,,,,1,,,N,50597,13569,1,10116.0,8623,,BAO_0000218,Rattus norvegicus,,CHEMBL618752,A,,Bioavailability at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,Intermediate
,In vivo,,,,1,,,N,50597,4576,1,10116.0,8624,,BAO_0000218,Rattus norvegicus,,CHEMBL618753,A,,Oral bioavailability in rat,Intermediate
,In vivo,Plasma,,,1,,,N,50597,750,1,10116.0,8625,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL618754,A,,Oral bioavailability estimated by measurement of the circulating plasma levels of BMS-183920 after intravenous and oral dosing to rats for 4 determinations,Intermediate
,In vivo,,,,1,,,N,50597,750,1,10116.0,8626,,BAO_0000218,Rattus norvegicus,,CHEMBL618755,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,4590,1,10116.0,8627,,BAO_0000218,Rattus norvegicus,,CHEMBL618756,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,1716,1,10116.0,8628,,BAO_0000218,Rattus norvegicus,,CHEMBL618757,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,1974,1,10116.0,8629,,BAO_0000218,Rattus norvegicus,,CHEMBL618758,A,,Bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,4502,1,10116.0,8630,,BAO_0000218,Rattus norvegicus,,CHEMBL621088,A,,Oral bioavailability in rat (dose 30 mg/kg),Intermediate
,,,,,1,,,N,50597,3371,1,10116.0,8631,,BAO_0000218,Rattus norvegicus,,CHEMBL621089,A,,Pharmacokinetic property (cLogP) in rat,Intermediate
,,Blood,,,1,,,N,50597,9099,1,10116.0,8632,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL621090,F,,Hyperglycemic activity and change in blood glucose concentration was reported 2 hours after administration of 100 mg/Kg perorally,Intermediate
,,Blood,,,1,,,N,50597,9099,1,10116.0,8633,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL621091,F,,Hyperglycemic activity and change in blood glucose concentration was reported 4 hours after administration of 100 mg/Kg perorally,Intermediate
,In vivo,,,,1,,,N,50597,4590,1,10116.0,8634,,BAO_0000218,Rattus norvegicus,,CHEMBL876731,A,,Clearance in rat.,Intermediate
,In vivo,,,,1,,,N,50597,3184,1,10116.0,8635,,BAO_0000218,Rattus norvegicus,,CHEMBL621092,A,,Compound was evaluated for its clearance when administered intravenously in rat,Intermediate
,In vivo,,,,1,,,N,50597,16456,1,10116.0,8636,,BAO_0000218,Rattus norvegicus,,CHEMBL621093,A,,Plasma clearance in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,Intermediate
,,,,,1,,,N,50597,4199,1,10116.0,8637,,BAO_0000218,Rattus norvegicus,,CHEMBL621094,A,,Blood: Brain distribution ratio is determined in rat,Intermediate
,,,,,1,,,N,50597,4199,1,10116.0,8638,,BAO_0000218,Rattus norvegicus,,CHEMBL621095,A,,Blood: Brain distribution ratio is determined in rat; NQ: non quantifable,Intermediate
,,,,,1,,,N,50597,4199,1,10116.0,8639,,BAO_0000218,Rattus norvegicus,,CHEMBL621096,A,,Blood: Brain distribution ratio is determined in rat; NQ:non quantifable,Intermediate
,In vivo,Kidney,,,1,,,N,50597,8677,1,10116.0,8640,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL621097,A,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate
,,,,,1,,,N,50597,7449,1,10116.0,8641,,BAO_0000218,Rattus norvegicus,,CHEMBL621098,F,,Percent dose excreted in 0-48 hours administered ip to male rat,Intermediate
,,Cerebellum,,,1,,,N,50597,11977,1,10116.0,8642,,BAO_0000218,Rattus norvegicus,2037.0,CHEMBL621099,A,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,,Cerebellum,,,1,,,N,50597,11977,1,10116.0,8643,,BAO_0000218,Rattus norvegicus,2037.0,CHEMBL621100,A,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,,Cerebellum,,,1,,,N,50597,11977,1,10116.0,8644,,BAO_0000218,Rattus norvegicus,2037.0,CHEMBL621101,A,,Uptake of radioligand [125I]-FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate
,,Cerebellum,,,1,,,N,50597,11977,1,10116.0,8645,,BAO_0000218,Rattus norvegicus,2037.0,CHEMBL621102,A,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,,Cerebellum,,,1,,,N,50597,11977,1,10116.0,8646,,BAO_0000218,Rattus norvegicus,2037.0,CHEMBL876732,A,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,,,,,1,,,N,50597,11977,1,10116.0,8647,,BAO_0000218,Rattus norvegicus,,CHEMBL621103,A,,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,,,,,1,,,N,50597,11977,1,10116.0,8648,,BAO_0000218,Rattus norvegicus,,CHEMBL621104,A,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,,,,,1,,,N,50597,11977,1,10116.0,8649,,BAO_0000218,Rattus norvegicus,,CHEMBL621105,A,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate
,,,,,1,,,N,50597,11977,1,10116.0,8650,,BAO_0000218,Rattus norvegicus,,CHEMBL621106,A,,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,,,,,1,,,N,50597,11977,1,10116.0,8651,,BAO_0000218,Rattus norvegicus,,CHEMBL621107,A,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,,,,,1,,,N,50597,11977,1,10116.0,8652,,BAO_0000218,Rattus norvegicus,,CHEMBL621108,A,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,,,,,1,,,N,50597,11977,1,10116.0,8653,,BAO_0000218,Rattus norvegicus,,CHEMBL621109,A,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,In vivo,Kidney,,,1,,,N,50594,17208,1,10090.0,8654,,BAO_0000218,Mus musculus,2113.0,CHEMBL621110,A,,Biodistribution of radioactivity in normal mice (ICR) kidney after 30 minutes of intravenous injection of [125I]-16(IMPY),Intermediate
,In vivo,Kidney,,,1,,,N,50594,17208,1,10090.0,8655,,BAO_0000218,Mus musculus,2113.0,CHEMBL621111,A,,Biodistribution of radioactivity in normal mice (ICR) kidney after 6 hours of intravenous injection of [125I]-16(IMPY),Intermediate
,In vivo,Liver,,,1,,,N,50594,17208,1,10090.0,8656,,BAO_0000218,Mus musculus,2107.0,CHEMBL622541,A,,Biodistribution of radioactivity in normal mice (ICR) liver after 1 hour of intravenous injection of [125I]-16(IMPY),Intermediate
,In vivo,Liver,,,1,,,N,50594,17208,1,10090.0,8657,,BAO_0000218,Mus musculus,2107.0,CHEMBL622542,A,,Biodistribution of radioactivity in normal mice (ICR) liver after 2 hours of intravenous injection of [125I]-16(IMPY),Intermediate
,In vivo,Liver,,,1,,,N,50594,17208,1,10090.0,8658,,BAO_0000218,Mus musculus,2107.0,CHEMBL622543,A,,Biodistribution of radioactivity in normal mice (ICR) liver after 2 minutes of intravenous injection of [125I]-16(IMPY),Intermediate
,In vivo,Liver,,,1,,,N,50594,17208,1,10090.0,8659,,BAO_0000218,Mus musculus,2107.0,CHEMBL624412,A,,Biodistribution of radioactivity in normal mice (ICR) liver after 24 hours of intravenous injection of [125I]-16(IMPY),Intermediate
,In vivo,Liver,,,1,,,N,50594,17208,1,10090.0,8660,,BAO_0000218,Mus musculus,2107.0,CHEMBL624413,A,,Biodistribution of radioactivity in normal mice (ICR) liver after 30 minutes of intravenous injection of [125I]-16(IMPY),Intermediate
,In vivo,Liver,,,1,,,N,50594,17208,1,10090.0,8661,,BAO_0000218,Mus musculus,2107.0,CHEMBL624414,A,,Biodistribution of radioactivity in normal mice (ICR) liver after 6 hours of intravenous injection of [125I]-16(IMPY),Intermediate
,In vivo,Lung,,,1,,,N,50594,17208,1,10090.0,8662,,BAO_0000218,Mus musculus,2048.0,CHEMBL624415,A,,Biodistribution of radioactivity in normal mice (ICR) lung after 1 hour of intravenous injection of [125I]-16(IMPY),Intermediate
,In vivo,Lung,,,1,,,N,50594,17208,1,10090.0,8663,,BAO_0000218,Mus musculus,2048.0,CHEMBL624416,A,,Biodistribution of radioactivity in normal mice (ICR) lung after 2 hours of intravenous injection of [125I]-16(IMPY),Intermediate
,In vivo,Lung,,,1,,,N,50594,17208,1,10090.0,8664,,BAO_0000218,Mus musculus,2048.0,CHEMBL624417,A,,Biodistribution of radioactivity in normal mice (ICR) lung after 2 minutes of intravenous injection of [125I]-16(IMPY),Intermediate
,In vivo,Lung,,,1,,,N,50594,17208,1,10090.0,8665,,BAO_0000218,Mus musculus,2048.0,CHEMBL624418,A,,Biodistribution of radioactivity in normal mice (ICR) lung after 24 hours of intravenous injection of [125I]-16(IMPY),Intermediate
,In vivo,Lung,,,1,,,N,50594,17208,1,10090.0,8666,,BAO_0000218,Mus musculus,2048.0,CHEMBL624419,A,,Biodistribution of radioactivity in normal mice (ICR) lung after 30 minutes of intravenous injection of [125I]-16(IMPY),Intermediate
,In vivo,Lung,,,1,,,N,50594,17208,1,10090.0,8667,,BAO_0000218,Mus musculus,2048.0,CHEMBL624420,A,,Biodistribution of radioactivity in normal mice (ICR) lung after 6 hours of intravenous injection of [125I]-16(IMPY),Intermediate
,In vivo,Muscle tissue,,,1,,,N,50594,17208,1,10090.0,8668,,BAO_0000218,Mus musculus,2385.0,CHEMBL624421,A,,Biodistribution of radioactivity in normal mice (ICR) muscle after 1 hr of intravenous injection of [125I]-16(IMPY),Intermediate
,In vivo,Muscle tissue,,,1,,,N,50594,17208,1,10090.0,8669,,BAO_0000218,Mus musculus,2385.0,CHEMBL624422,A,,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 hours of intravenous injection of [125I]-16(IMPY),Intermediate
,In vivo,Muscle tissue,,,1,,,N,50594,17208,1,10090.0,8670,,BAO_0000218,Mus musculus,2385.0,CHEMBL624423,A,,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 minutes of intravenous injection of [125I]-16(IMPY),Intermediate
,In vivo,Muscle tissue,,,1,,,N,50594,17208,1,10090.0,8671,,BAO_0000218,Mus musculus,2385.0,CHEMBL625123,A,,Biodistribution of radioactivity in normal mice (ICR) muscle after 24 hours of intravenous injection of [125I]-16(IMPY),Intermediate
,In vivo,Muscle tissue,,,1,,,N,50594,17208,1,10090.0,8672,,BAO_0000218,Mus musculus,2385.0,CHEMBL625124,A,,Biodistribution of radioactivity in normal mice (ICR) muscle after 30 minutes of intravenous injection of [125I]-16(IMPY),Intermediate
,In vivo,Muscle tissue,,,1,,,N,50594,17208,1,10090.0,8673,,BAO_0000218,Mus musculus,2385.0,CHEMBL625125,A,,Biodistribution of radioactivity in normal mice (ICR) muscle after 6 hours of intravenous injection of [125I]-16(IMPY),Intermediate
,In vivo,Zone of skin,,,1,,,N,50594,17208,1,10090.0,8674,,BAO_0000218,Mus musculus,14.0,CHEMBL625126,A,,Biodistribution of radioactivity in normal mice (ICR) skin after 1 hour of intravenous injection of [125I]-16(IMPY),Intermediate
,In vivo,Zone of skin,,,1,,,N,50594,17208,1,10090.0,8675,,BAO_0000218,Mus musculus,14.0,CHEMBL626947,A,,Biodistribution of radioactivity in normal mice (ICR) skin after 2 hours of intravenous injection of [125I]-16(IMPY),Intermediate
,In vivo,Zone of skin,,,1,,,N,50594,17208,1,10090.0,8676,,BAO_0000218,Mus musculus,14.0,CHEMBL626948,A,,Biodistribution of radioactivity in normal mice (ICR) skin after 2 minutes of intravenous injection of [125I]-16(IMPY),Intermediate
,In vivo,Zone of skin,,,1,,,N,50594,17208,1,10090.0,8677,,BAO_0000218,Mus musculus,14.0,CHEMBL626949,A,,Biodistribution of radioactivity in normal mice (ICR) skin after 24 hours of intravenous injection of [125I]-16(IMPY),Intermediate
,In vivo,Zone of skin,,,1,,,N,50594,17208,1,10090.0,8678,,BAO_0000218,Mus musculus,14.0,CHEMBL626950,A,,Biodistribution of radioactivity in normal mice (ICR) skin after 30 minutes of intravenous injection of [125I]-16(IMPY),Intermediate
,In vivo,Zone of skin,,,1,,,N,50594,17208,1,10090.0,8679,,BAO_0000218,Mus musculus,14.0,CHEMBL626951,A,,Biodistribution of radioactivity in normal mice (ICR) skin after 6 hours of intravenous injection of [125I]-16(IMPY),Intermediate
,In vivo,Spleen,,,1,,,N,50594,17208,1,10090.0,8680,,BAO_0000218,Mus musculus,2106.0,CHEMBL626952,A,,Biodistribution of radioactivity in normal mice (ICR) spleen after 1 hour of intravenous injection of [125I]-16(IMPY),Intermediate
,In vivo,Spleen,,,1,,,N,50594,17208,1,10090.0,8681,,BAO_0000218,Mus musculus,2106.0,CHEMBL626953,A,,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 hours of intravenous injection of [125I]-16(IMPY),Intermediate
,In vivo,Spleen,,,1,,,N,50594,17208,1,10090.0,8682,,BAO_0000218,Mus musculus,2106.0,CHEMBL626954,A,,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 minutes of intravenous injection of [125I]-16(IMPY),Intermediate
,In vivo,Spleen,,,1,,,N,50594,17208,1,10090.0,8683,,BAO_0000218,Mus musculus,2106.0,CHEMBL626955,A,,Biodistribution of radioactivity in normal mice (ICR) spleen after 24 hours of intravenous injection of [125I]-16(IMPY),Intermediate
,In vivo,Spleen,,,1,,,N,50594,17208,1,10090.0,8684,,BAO_0000218,Mus musculus,2106.0,CHEMBL626956,A,,Biodistribution of radioactivity in normal mice (ICR) spleen after 30 minutes of intravenous injection of [125I]-16(IMPY),Intermediate
,In vivo,Spleen,,,1,,,N,50594,17208,1,10090.0,8685,,BAO_0000218,Mus musculus,2106.0,CHEMBL626957,A,,Biodistribution of radioactivity in normal mice (ICR) spleen after 6 hours of intravenous injection of [125I]-16(IMPY),Intermediate
,In vivo,Blood,,,1,,,N,50594,17208,1,10090.0,8686,,BAO_0000218,Mus musculus,178.0,CHEMBL626958,A,,Biodistribution of radioactivity in normal mice blood after 1 hour of intravenous injection of [125I]-16(IMPY),Intermediate
,In vivo,Blood,,,1,,,N,50594,17208,1,10090.0,8687,,BAO_0000218,Mus musculus,178.0,CHEMBL626959,A,,Biodistribution of radioactivity in normal mice blood after 2 hours of intravenous injection of [125I]-16(IMPY),Intermediate
,In vivo,Blood,,,1,,,N,50594,17208,1,10090.0,8688,,BAO_0000218,Mus musculus,178.0,CHEMBL626960,A,,Biodistribution of radioactivity in normal mice blood after 2 minutes of intravenous injection of [125I]-16(IMPY),Intermediate
,In vivo,Blood,,,1,,,N,50594,17208,1,10090.0,8689,,BAO_0000218,Mus musculus,178.0,CHEMBL626961,A,,Biodistribution of radioactivity in normal mice blood after 24 hours of intravenous injection of [125I]-16(IMPY),Intermediate
,In vivo,Blood,,,1,,,N,50594,17208,1,10090.0,8690,,BAO_0000218,Mus musculus,178.0,CHEMBL627589,A,,Biodistribution of radioactivity in normal mice blood after 30 minutes of intravenous injection of [125I]-16(IMPY),Intermediate
,In vivo,Blood,,,1,,,N,50594,17208,1,10090.0,8691,,BAO_0000218,Mus musculus,178.0,CHEMBL627590,A,,Biodistribution of radioactivity in normal mice blood after 6 hours of intravenous injection of [125I]-16(IMPY),Intermediate
,,,,,1,,,N,50594,3132,1,10090.0,8692,,BAO_0000218,Mus musculus,,CHEMBL627591,A,,Time taken for EC90 was determined when tested in mouse,Intermediate
,,,,,1,,,N,50594,3132,1,10090.0,8693,,BAO_0000218,Mus musculus,,CHEMBL627592,A,,Time taken for EC90 was determined when tested in mouse at dose 25 mg/kg,Intermediate
,In vivo,,,,1,,,N,50594,16597,1,10090.0,8694,,BAO_0000218,Mus musculus,,CHEMBL627593,A,,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),Intermediate
,,,,,1,,,N,50594,5727,1,10090.0,8695,,BAO_0000218,Mus musculus,,CHEMBL627594,A,,Half life in mice,Intermediate
,In vivo,,,,1,,,N,50594,5302,1,10090.0,8696,,BAO_0000218,Mus musculus,,CHEMBL876813,A,,Half life period in mouse after 10 mg/Kg dose,Intermediate
,In vivo,,,,1,,,N,50594,5302,1,10090.0,8697,,BAO_0000218,Mus musculus,,CHEMBL627595,A,,Half life period in mouse after 10 mg/kg dose,Intermediate
,In vivo,,,,1,,,N,50594,6348,1,10090.0,8698,,BAO_0000218,Mus musculus,,CHEMBL627596,A,,Half life was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,Intermediate
,In vivo,,,,1,,,N,50597,5964,1,10116.0,8699,,BAO_0000218,Rattus norvegicus,,CHEMBL627597,A,,Cmax value at 5 mg/kg po was determined in rat,Intermediate
,In vivo,,,,1,,,N,50597,6078,1,10116.0,8700,,BAO_0000218,Rattus norvegicus,,CHEMBL627598,A,,Cmax value evaluated in rat,Intermediate
,In vivo,Brain,,,1,,,N,50597,5206,1,10116.0,8701,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL627599,A,,Cmax value was calculated by applying at a dose of 10 mg/Kg ip in rat brain,Intermediate
,In vivo,,,,1,,,N,50597,2959,1,10116.0,8702,,BAO_0000218,Rattus norvegicus,,CHEMBL627600,A,,Cmax value after administration of 20 mg/Kg oral dose in rat,Intermediate
,In vivo,,,,1,,,N,50597,5964,1,10116.0,8703,,BAO_0000218,Rattus norvegicus,,CHEMBL627601,A,,Cmax value at 1 mg/kg po in rat,Intermediate
,In vivo,,,,1,,,N,50597,5964,1,10116.0,8704,,BAO_0000218,Rattus norvegicus,,CHEMBL627776,A,,Cmax value at 5 mg/kg po in rat,Intermediate
,In vivo,,,,1,,,N,50597,6757,1,10116.0,8705,,BAO_0000218,Rattus norvegicus,,CHEMBL627777,A,,Cmax value at a dose of 10 mg/kg in male SD rats,Intermediate
,In vivo,,,,1,,,N,50597,6757,1,10116.0,8706,,BAO_0000218,Rattus norvegicus,,CHEMBL627778,A,,Cmax value at a dose of 100 mg/kg in male SD rats,Intermediate
,In vivo,,,,1,,,N,50597,6757,1,10116.0,8707,,BAO_0000218,Rattus norvegicus,,CHEMBL627779,A,,Cmax value at a dose of 50 mg/kg in male SD rats,Intermediate
,In vivo,,,,1,,,N,50597,17617,1,10116.0,8708,,BAO_0000218,Rattus norvegicus,,CHEMBL876814,A,,Cmax value in rats at 10 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,1445,1,10116.0,8709,,BAO_0000218,Rattus norvegicus,,CHEMBL627780,A,,Cmax value was evaluated in rats at a dose of 20 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,6082,1,10116.0,8710,,BAO_0000218,Rattus norvegicus,,CHEMBL627781,A,,Cmax value was determined after peroral administration of 20 mg/kg in rat,Intermediate
,In vivo,,,,1,,,N,50597,1446,1,10116.0,8711,,BAO_0000218,Rattus norvegicus,,CHEMBL627782,A,,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,Intermediate
,In vivo,Plasma,,,1,,,N,50597,5407,1,10116.0,8712,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL627783,A,,Compound was evaluated for its pharmacokinetic parameter maximum plasma concentration (Cmax) after oral administration to rats,Intermediate
,In vivo,Plasma,,,1,,,N,50597,2690,1,10116.0,8713,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL627784,A,,Compound was evaluated for maximal plasma concentration in rat upon 5 mg/kg upon oral administration,Intermediate
,In vivo,,,,1,,,N,50597,2661,1,10116.0,8714,,BAO_0000218,Rattus norvegicus,,CHEMBL627785,A,,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female wistar rats,Intermediate
,In vivo,,,,1,,,N,50597,2661,1,10116.0,8715,,BAO_0000218,Rattus norvegicus,,CHEMBL627786,A,,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to male wistar rats,Intermediate
,In vivo,Plasma,,,1,,,N,50597,4891,1,10116.0,8716,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL627787,A,,Compound was evaluated for pharmacokinetic parameter maximum plasma concentration,Intermediate
,In vivo,Plasma,,,1,,,N,50597,2807,1,10116.0,8717,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL627788,A,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 0.5 hr,Intermediate
,In vivo,Plasma,,,1,,,N,50597,2807,1,10116.0,8718,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626579,A,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 1 hr,Intermediate
,In vivo,Plasma,,,1,,,N,50597,2807,1,10116.0,8719,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626580,A,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 2 hr,Intermediate
,In vivo,,,,1,,,N,50597,3634,1,10116.0,8720,,BAO_0000218,Rattus norvegicus,,CHEMBL876815,A,,Compound was evaluated for the pharmacokinetic property in rats after an oral dose of 10 mg/kg,Intermediate
,In vivo,Plasma,,,1,,,N,50597,1881,1,10116.0,8721,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626581,A,,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 1 hr,Intermediate
,In vivo,Plasma,,,1,,,N,50597,1881,1,10116.0,8722,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626582,A,,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 2 hr,Intermediate
,In vivo,,,,1,,,N,50597,429,1,10116.0,8723,,BAO_0000218,Rattus norvegicus,,CHEMBL626583,A,,Evaluated for pharmacokinetic parameter Cmax in rat at the dose 50 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,5974,1,10116.0,8724,,BAO_0000218,Rattus norvegicus,,CHEMBL626205,A,,In vivo Cmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,5974,1,10116.0,8725,,BAO_0000218,Rattus norvegicus,,CHEMBL626206,A,,In vivo Cmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,5974,1,10116.0,8726,,BAO_0000218,Rattus norvegicus,,CHEMBL626207,A,,In vivo Cmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,5974,1,10116.0,8727,,BAO_0000218,Rattus norvegicus,,CHEMBL623882,A,,In vivo Cmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,17582,1,10116.0,8728,,BAO_0000218,Rattus norvegicus,,CHEMBL623883,A,,Maximal concentration in male Sprague-Dawley rats after 5 mg/kg intravenous dose,Intermediate
,In vivo,,,,1,,,N,50597,17582,1,10116.0,8729,,BAO_0000218,Rattus norvegicus,,CHEMBL623884,A,,Maximal concentration in male Sprague-Dawley rats after 10 mg/kg oral dose,Intermediate
,In vivo,Plasma,,,1,,,N,50597,3032,1,10116.0,8730,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623885,A,,"In vivo maximum concentration of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",Intermediate
,In vivo,Plasma,,,1,,,N,50597,6295,1,10116.0,8731,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623886,A,,In vivo maximum concentration in rat plasma exposure after oral administration 50 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,6619,1,10116.0,8732,,BAO_0000218,Rattus norvegicus,,CHEMBL623887,A,,Maximal concentration in rat was determined,Intermediate
,In vivo,,,,1,,,N,50597,6616,1,10116.0,8733,,BAO_0000218,Rattus norvegicus,,CHEMBL623888,A,,Maximal concentration after i.v. administration,Intermediate
,In vivo,Plasma,,,1,,,N,50597,3249,1,10116.0,8734,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623889,A,,Maximal concentration (Cmax) in the rat plasma at a dose of 10 mg/kg,Intermediate
,In vivo,Plasma,,,1,,,N,50597,17791,1,10116.0,8735,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623890,A,,Maximal plasma concentration in rat after oral administration at 50 mg/kg,Intermediate
,In vivo,Plasma,,,1,,,N,50597,17791,1,10116.0,8736,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623891,A,,Cmax in rat plasma after oral dose (50 mg/Kg),Intermediate
,In vivo,Plasma,,,1,,,N,50597,1360,1,10116.0,8737,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623892,A,,Maximal plasma concentration was determined.,Intermediate
,In vivo,Plasma,,,1,,,N,50597,2552,1,10116.0,8738,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623893,A,,Maximal plasma drug concentration was determined,Intermediate
,In vivo,,,,1,,,N,50597,6571,1,10116.0,8739,,BAO_0000218,Rattus norvegicus,,CHEMBL877616,A,,Maximal concentration in rats after peroral administration,Intermediate
,In vivo,,,,1,,,N,50597,6570,1,10116.0,8740,,BAO_0000218,Rattus norvegicus,,CHEMBL623894,A,,Maximum concentration in rat after 2 mg/kg peroral administration,Intermediate
,In vivo,Plasma,,,1,,,N,50597,6567,1,10116.0,8741,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623895,A,,Maximum concentration in rat plasma after 5 mg/kg oral gavage,Intermediate
,In vivo,,,,1,,,N,50597,3031,1,10116.0,8742,,BAO_0000218,Rattus norvegicus,,CHEMBL623896,A,,Maximum concentration of compound in rat was evaluated.,Intermediate
,In vivo,,,,1,,,N,50597,3436,1,10116.0,8743,,BAO_0000218,Rattus norvegicus,,CHEMBL623897,A,,Maximum concentration at 0.5 hr by peroral administration at a dose of 20 mg/kg in rats,Intermediate
,In vivo,,,,1,,,N,50597,3436,1,10116.0,8744,,BAO_0000218,Rattus norvegicus,,CHEMBL623898,A,,Maximum concentration at 2 hr by peroral administration at a dose of 20 mg/kg in rats,Intermediate
,In vivo,,,,1,,,N,50597,2083,1,10116.0,8745,,BAO_0000218,Rattus norvegicus,,CHEMBL623899,A,,Maximum concentration at 4 hr after administration of 5 mg/kg dose peroral in rat,Intermediate
,In vivo,,,,1,,,N,50597,3436,1,10116.0,8746,,BAO_0000218,Rattus norvegicus,,CHEMBL623900,A,,Maximum concentration at 4 hr by peroral administration at a dose of 20 mg/kg in rats,Intermediate
,In vivo,,,,1,,,N,50597,4527,1,10116.0,8747,,BAO_0000218,Rattus norvegicus,,CHEMBL623901,A,,Maximum concentration by oral administration at a dose of 100 uM/kg in rat was determined,Intermediate
,In vivo,,,,1,,,N,50597,1974,1,10116.0,8748,,BAO_0000218,Rattus norvegicus,,CHEMBL623902,A,,Maximum concentration was evaluated in rats,Intermediate
,In vivo,Cerebrospinal fluid,,,1,,,N,50597,3307,1,10116.0,8749,,BAO_0000218,Rattus norvegicus,1359.0,CHEMBL623903,A,,Maximum concentration in CSF at 30 min following 24 mg/kg subcutaneous dose in rats,Intermediate
,In vivo,Plasma,,,1,,,N,50597,3307,1,10116.0,8750,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623904,A,,Maximum concentration in plasma at 30 min following 24 mg/kg subcutaneous dose in rats,Intermediate
,In vivo,Plasma,,,1,,,N,50597,1916,1,10116.0,8751,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL877617,A,,Maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,Intermediate
,In vivo,,,,1,,,N,50597,1500,1,10116.0,8752,,BAO_0000218,Rattus norvegicus,,CHEMBL623905,A,,Maximum concentration in portal vein was determined at a concentration of 10 mg/kg in rats,Intermediate
,In vivo,,,,1,,,N,50597,1500,1,10116.0,8753,,BAO_0000218,Rattus norvegicus,,CHEMBL623906,A,,Maximum concentration in portal vein was determined at a concentration of 20 mg/kg in rats,Intermediate
,In vivo,Plasma,,,1,,,N,50597,4186,1,10116.0,8754,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623907,A,,Maximum concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,Intermediate
,,,,,1,,,N,50597,16434,1,10116.0,8755,,BAO_0000218,Rattus norvegicus,,CHEMBL623908,A,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Intermediate
,,,,,1,,,N,50597,16434,1,10116.0,8756,,BAO_0000218,Rattus norvegicus,,CHEMBL623909,A,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 30 min.,Intermediate
,,,,,1,,,N,50597,16434,1,10116.0,8757,,BAO_0000218,Rattus norvegicus,,CHEMBL623910,A,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Intermediate
,,,,,1,,,N,50597,16434,1,10116.0,8758,,BAO_0000218,Rattus norvegicus,,CHEMBL623911,A,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Intermediate
,,,,,1,,,N,50597,16435,1,10116.0,8759,,BAO_0000218,Rattus norvegicus,,CHEMBL623912,A,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate
,,,,,1,,,N,50597,16435,1,10116.0,8760,,BAO_0000218,Rattus norvegicus,,CHEMBL624616,A,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate
,,,,,1,,,N,50597,16435,1,10116.0,8761,,BAO_0000218,Rattus norvegicus,,CHEMBL624617,A,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate
,,,,,1,,,N,50597,16435,1,10116.0,8762,,BAO_0000218,Rattus norvegicus,,CHEMBL624618,A,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate
,,,,,1,,,N,50597,16435,1,10116.0,8763,,BAO_0000218,Rattus norvegicus,,CHEMBL624619,A,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate
,,,,,1,,,N,50597,16435,1,10116.0,8764,,BAO_0000218,Rattus norvegicus,,CHEMBL624794,A,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate
,,,,,1,,,N,50597,16435,1,10116.0,8765,,BAO_0000218,Rattus norvegicus,,CHEMBL624795,A,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate
,,,,,1,,,N,50597,16435,1,10116.0,8766,,BAO_0000218,Rattus norvegicus,,CHEMBL623921,A,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate
,,,,,1,,,N,50597,16434,1,10116.0,8767,,BAO_0000218,Rattus norvegicus,,CHEMBL623922,A,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate
,,,,,1,,,N,50597,16434,1,10116.0,8768,,BAO_0000218,Rattus norvegicus,,CHEMBL623923,A,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Intermediate
,,,,,1,,,N,50597,16434,1,10116.0,8769,,BAO_0000218,Rattus norvegicus,,CHEMBL623924,A,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate
,,,,,1,,,N,50597,16435,1,10116.0,8770,,BAO_0000218,Rattus norvegicus,,CHEMBL623925,A,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate
,,,,,1,,,N,50597,16435,1,10116.0,8771,,BAO_0000218,Rattus norvegicus,,CHEMBL623926,A,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate
,,,,,1,,,N,50597,16435,1,10116.0,8772,,BAO_0000218,Rattus norvegicus,,CHEMBL623927,A,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate
,,,,,1,,,N,50597,16435,1,10116.0,8773,,BAO_0000218,Rattus norvegicus,,CHEMBL623928,A,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate
,,,,,1,,,N,50597,16435,1,10116.0,8774,,BAO_0000218,Rattus norvegicus,,CHEMBL623929,A,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate
,,,,,1,,,N,50597,16435,1,10116.0,8775,,BAO_0000218,Rattus norvegicus,,CHEMBL623930,A,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate
,,Brain,,,1,,,N,50597,16434,1,10116.0,8776,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL623931,A,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate
,,Brain,,,1,,,N,50597,16434,1,10116.0,8777,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL622165,A,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate
,,Brain,,,1,,,N,50597,16434,1,10116.0,8778,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL621249,A,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate
,,Brain,,,1,,,N,50597,16434,1,10116.0,8779,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL621250,A,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate
,,Brain,,,1,,,N,50597,16434,1,10116.0,8780,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL621448,A,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Intermediate
,,Brain,,,1,,,N,50597,16434,1,10116.0,8781,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL621449,A,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Intermediate
,,Brain,,,1,,,N,50597,16434,1,10116.0,8782,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL621450,A,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Intermediate
,,Brain,,,1,,,N,50597,16434,1,10116.0,8783,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL621451,A,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Intermediate
,,Brain,,,1,,,N,50597,16435,1,10116.0,8784,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL621452,A,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate
,,Brain,,,1,,,N,50597,16435,1,10116.0,8785,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL621453,A,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate
,,Brain,,,1,,,N,50597,16435,1,10116.0,8786,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL621454,A,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate
,,Brain,,,1,,,N,50597,16435,1,10116.0,8787,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL621455,A,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate
,,Brain,,,1,,,N,50597,16435,1,10116.0,8788,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL621456,A,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate
,,Brain,,,1,,,N,50597,16435,1,10116.0,8789,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL625145,A,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate
,,Brain,,,1,,,N,50597,16435,1,10116.0,8790,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL875847,A,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate
,,Brain,,,1,,,N,50597,16435,1,10116.0,8791,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL625146,A,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate
,,Brain,,,1,,,N,50597,16434,1,10116.0,8792,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL625147,A,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate
,,Brain,,,1,,,N,50597,16434,1,10116.0,8793,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL625148,A,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Intermediate
,,Brain,,,1,,,N,50597,16434,1,10116.0,8794,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL625149,A,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate
,,Brain,,,1,,,N,50597,16435,1,10116.0,8795,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL625150,A,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate
,,Brain,,,1,,,N,50597,16435,1,10116.0,8796,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL625151,A,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate
,,Brain,,,1,,,N,50597,16435,1,10116.0,8797,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL625152,A,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate
,,Brain,,,1,,,N,50597,16435,1,10116.0,8798,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL625153,A,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate
,,Brain,,,1,,,N,50597,16435,1,10116.0,8799,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL625154,A,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate
,,Brain,,,1,,,N,50597,16435,1,10116.0,8800,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL625155,A,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate
,,,,,1,,,N,50597,11977,1,10116.0,8801,,BAO_0000218,Rattus norvegicus,,CHEMBL625156,A,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate
,,,,,1,,,N,50597,11977,1,10116.0,8802,,BAO_0000218,Rattus norvegicus,,CHEMBL624354,A,,Uptake of radioligand [125I]-FIDA1 by hippo-campus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,,Hippocampus,,,1,,,N,50597,11977,1,10116.0,8803,,BAO_0000218,Rattus norvegicus,10000000.0,CHEMBL624355,A,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,,Hippocampus,,,1,,,N,50597,11977,1,10116.0,8804,,BAO_0000218,Rattus norvegicus,10000000.0,CHEMBL624356,A,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,,Hippocampus,,,1,,,N,50597,11977,1,10116.0,8805,,BAO_0000218,Rattus norvegicus,10000000.0,CHEMBL624357,A,,Uptake of radioligand [125I]-FIDA1 by hippocampus in rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,,Hippocampus,,,1,,,N,50597,11977,1,10116.0,8806,,BAO_0000218,Rattus norvegicus,10000000.0,CHEMBL624358,A,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,,Striatum,,,1,,,N,50597,11977,1,10116.0,8807,,BAO_0000218,Rattus norvegicus,2435.0,CHEMBL624359,A,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,,Striatum,,,1,,,N,50597,11977,1,10116.0,8808,,BAO_0000218,Rattus norvegicus,2435.0,CHEMBL624360,A,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,,Striatum,,,1,,,N,50597,11977,1,10116.0,8809,,BAO_0000218,Rattus norvegicus,2435.0,CHEMBL624361,A,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate
,,Striatum,,,1,,,N,50597,11977,1,10116.0,8810,,BAO_0000218,Rattus norvegicus,2435.0,CHEMBL624362,A,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,,Striatum,,,1,,,N,50597,11977,1,10116.0,8811,,BAO_0000218,Rattus norvegicus,2435.0,CHEMBL624363,A,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,In vivo,Blood,,,1,,,N,50597,11977,1,10116.0,8812,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL624364,A,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,In vivo,Blood,,,1,,,N,50597,11977,1,10116.0,8813,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL624365,A,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,In vivo,Blood,,,1,,,N,50597,11977,1,10116.0,8814,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL624366,A,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,In vivo,Blood,,,1,,,N,50597,11977,1,10116.0,8815,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL624367,A,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,In vivo,Brain,,,1,,,N,50597,11977,1,10116.0,8816,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL624368,A,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,In vivo,Brain,,,1,,,N,50597,11977,1,10116.0,8817,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL624369,A,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,In vivo,Brain,,,1,,,N,50597,11977,1,10116.0,8818,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL624370,A,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate
,In vivo,Brain,,,1,,,N,50597,11977,1,10116.0,8819,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL625069,A,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,In vivo,Brain,,,1,,,N,50597,11977,1,10116.0,8820,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL625070,A,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,In vivo,Heart,,,1,,,N,50597,11977,1,10116.0,8821,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL626051,A,,Biodistribution of radioligand [125I]-FIDA1 in heart of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,In vivo,Heart,,,1,,,N,50597,11977,1,10116.0,8822,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL626052,A,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,In vivo,Heart,,,1,,,N,50597,11977,1,10116.0,8823,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL626053,A,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate
,In vivo,Heart,,,1,,,N,50597,11977,1,10116.0,8824,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL626054,A,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,In vivo,Heart,,,1,,,N,50597,11977,1,10116.0,8825,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL626055,A,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,In vivo,Kidney,,,1,,,N,50597,11977,1,10116.0,8826,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL626056,A,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,In vivo,Kidney,,,1,,,N,50597,11977,1,10116.0,8827,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL626057,A,,Biodistribution of radioligand [125I]-FIDA1 in kidney of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,In vivo,Kidney,,,1,,,N,50597,11977,1,10116.0,8828,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL625193,A,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,In vivo,Kidney,,,1,,,N,50597,11977,1,10116.0,8829,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL625194,A,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,In vivo,Liver,,,1,,,N,50597,11977,1,10116.0,8830,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL625195,A,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,In vivo,Liver,,,1,,,N,50597,11977,1,10116.0,8831,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL625196,A,,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,In vivo,Liver,,,1,,,N,50597,11977,1,10116.0,8832,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL625197,A,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate
,In vivo,Liver,,,1,,,N,50597,11977,1,10116.0,8833,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL625198,A,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,In vivo,Liver,,,1,,,N,50597,11977,1,10116.0,8834,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL627929,A,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,In vivo,Lung,,,1,,,N,50597,11977,1,10116.0,8835,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL627074,A,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,In vivo,Lung,,,1,,,N,50597,11977,1,10116.0,8836,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL627075,A,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,In vivo,Lung,,,1,,,N,50597,11977,1,10116.0,8837,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL627076,A,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate
,In vivo,Lung,,,1,,,N,50597,11977,1,10116.0,8838,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL627077,A,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,In vivo,Lung,,,1,,,N,50597,11977,1,10116.0,8839,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL627078,A,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,11977,1,10116.0,8840,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL627079,A,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 2 rats),Intermediate
,In vivo,,,,1,,,N,50594,4573,1,10090.0,8841,,BAO_0000218,Mus musculus,,CHEMBL873824,A,,Half life (t1/2) determined at a dose 10 mg/kg administered intraperitoneally to mice,Intermediate
,In vivo,Plasma,,,1,,,N,50594,3132,1,10090.0,8842,,BAO_0000218,Mus musculus,1969.0,CHEMBL627080,A,,Half life in mouse plasma was determined at dose 25 mg/kg,Intermediate
,,,,,1,,,N,50594,17718,1,10090.0,8843,,BAO_0000218,Mus musculus,,CHEMBL627081,A,,Half life was determined,Intermediate
,In vivo,,,,1,,,N,50594,17728,1,10090.0,8844,,BAO_0000218,Mus musculus,,CHEMBL627082,A,,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,Intermediate
,In vivo,,,,1,,,N,50594,5961,1,10090.0,8845,,BAO_0000218,Mus musculus,,CHEMBL627083,A,,Half-life in male mice after 1 mg/kg intravenous dose,Intermediate
,,Plasma,,,1,,,N,50594,17731,1,10090.0,8847,,BAO_0000218,Mus musculus,1969.0,CHEMBL627085,A,,Half life in mice plasma,Intermediate
,,,,,1,,,N,50594,17592,1,10090.0,8848,,BAO_0000218,Mus musculus,,CHEMBL627086,A,,Half life in mouse,Intermediate
,In vivo,Plasma,,,1,,,N,50594,3132,1,10090.0,8849,,BAO_0000218,Mus musculus,1969.0,CHEMBL627087,A,,Half life in mouse plasma at dose 25 mg/kg,Intermediate
,In vivo,,,,1,,,N,50594,17729,1,10090.0,8850,,BAO_0000218,Mus musculus,,CHEMBL627088,A,,Half life when injected i.p. in mice at a dose of 50 mg/kg was determined,Intermediate
,In vivo,,,,1,,,N,50594,17729,1,10090.0,8851,,BAO_0000218,Mus musculus,,CHEMBL627089,A,,Half life when injected intravenously in mice at a dose of 20 mg/kg was determined,Intermediate
,In vivo,,,,1,,,N,50594,17729,1,10090.0,8852,,BAO_0000218,Mus musculus,,CHEMBL627090,A,,Half life when injected perorally in mice at a dose of 50 mg/kg was determined,Intermediate
,In vivo,,,,1,,,N,50594,3277,1,10090.0,8853,,BAO_0000218,Mus musculus,,CHEMBL627091,A,,Half life was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),Intermediate
,In vivo,,,,1,,,N,50594,3760,1,10090.0,8854,,BAO_0000218,Mus musculus,,CHEMBL627092,A,,"Half life was evaluated at 5 mg/kg of compound dose, administered perorally in mice",Intermediate
,In vivo,,,,1,,,N,50594,3760,1,10090.0,8855,,BAO_0000218,Mus musculus,,CHEMBL876785,A,,"Half life was evaluated at 50 mg/kg of compound dose, administered perorally in mice",Intermediate
,In vivo,,,,1,,,N,50594,2862,1,10090.0,8856,,BAO_0000218,Mus musculus,,CHEMBL627093,A,,Half-life by iv administration in mouse,Intermediate
,In vivo,,,,1,,,N,50594,2862,1,10090.0,8857,,BAO_0000218,Mus musculus,,CHEMBL627094,A,,Half-life by oral administration in mouse,Intermediate
,,,,,1,,,N,50594,5980,1,10090.0,8858,,BAO_0000218,Mus musculus,,CHEMBL627095,A,,Half-life in mice,Intermediate
,,Brain,,,1,,,N,50594,6159,1,10090.0,8859,,BAO_0000218,Mus musculus,955.0,CHEMBL627096,A,,Half-life using mouse brain homogenate,Intermediate
,,,,,1,,,N,50594,6254,1,10090.0,8860,,BAO_0000218,Mus musculus,,CHEMBL627097,A,,Half-life was measured in mice,Intermediate
,In vivo,,,,1,,,N,50594,6062,1,10090.0,8861,,BAO_0000218,Mus musculus,,CHEMBL627098,A,,Half-life was measured in mouse after an iv dose of 1 mg/kg,Intermediate
,,Blood,,,1,,,N,50594,1574,1,10090.0,8862,,BAO_0000218,Mus musculus,178.0,CHEMBL627099,A,,Half-life period was determined in mouse blood,Intermediate
,,Brain,,,1,,,N,50594,56,1,10090.0,8863,,BAO_0000218,Mus musculus,955.0,CHEMBL627100,A,,"Half-times of inhibition of PEP in in an ex vivo enzyme studies, using mice brain",Intermediate
,,Plasma,,,1,,,N,50594,993,1,10090.0,8864,,BAO_0000218,Mus musculus,1969.0,CHEMBL627101,A,,Plasma half life in mouse,Intermediate
,,,,,1,,,N,50594,6652,1,10090.0,8865,,BAO_0000218,Mus musculus,,CHEMBL627102,A,,Stability of the peptide in the presence of mouse serum,Intermediate
,,,,,1,,,N,50594,17852,1,10090.0,8866,,BAO_0000218,Mus musculus,,CHEMBL627103,A,,Terminal half life of compound was determined in mouse,Intermediate
,In vivo,,,,1,,,N,50594,2675,1,10090.0,8867,,BAO_0000218,Mus musculus,,CHEMBL627104,A,,Terminal half life was evaluated in mice after intravenous administration,Intermediate
,In vivo,,,,1,,,N,50594,2675,1,10090.0,8868,,BAO_0000218,Mus musculus,,CHEMBL627105,A,,Terminal half life was evaluated in mice after oral administration,Intermediate
,,,,,1,,,N,50594,499,1,10090.0,8869,,BAO_0000218,Mus musculus,,CHEMBL876786,A,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 5.,Intermediate
,,,,,1,,,N,50594,499,1,10090.0,8870,,BAO_0000218,Mus musculus,,CHEMBL873825,A,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7.,Intermediate
,,,,,1,,,N,50594,499,1,10090.0,8871,,BAO_0000218,Mus musculus,,CHEMBL627106,A,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7; ND means no data,Intermediate
,In vivo,,,,1,,,N,50594,14239,1,10090.0,8872,,BAO_0000218,Mus musculus,,CHEMBL626336,A,,half life period is evaluated by administering intravenously at 25 mg/kg in mice,Intermediate
,In vivo,,,,1,,,N,50594,5506,1,10090.0,8873,,BAO_0000218,Mus musculus,,CHEMBL877462,A,,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice",Intermediate
,In vivo,,,,1,,,N,50594,5506,1,10090.0,8874,,BAO_0000218,Mus musculus,,CHEMBL626337,A,,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice; NC: not calculable",Intermediate
,,,,,1,,,N,50594,17734,1,10090.0,8875,,BAO_0000218,Mus musculus,,CHEMBL626338,A,,Half life after intraperitoneal administration of 100 mg/kg in mice,Intermediate
,In vivo,,,,1,,,N,50594,17728,1,10090.0,8876,,BAO_0000218,Mus musculus,,CHEMBL626339,A,,Half life in BALB/C mice at the dose of 20 mg/kg by i.p. administration,Intermediate
,In vivo,,,,1,,,N,50594,17728,1,10090.0,8877,,BAO_0000218,Mus musculus,,CHEMBL626340,A,,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,Intermediate
,In vivo,,,,1,,,N,50594,17728,1,10090.0,8878,,BAO_0000218,Mus musculus,,CHEMBL625377,A,,Half life in BALB/C mice at the dose of 20 mg/kg by p.o. administration,Intermediate
,In vivo,,,,1,,,N,50594,17728,1,10090.0,8879,,BAO_0000218,Mus musculus,,CHEMBL625378,A,,Half life in BALB/C mice at the dose of 50 mg/kg by i.p. administration,Intermediate
,In vivo,,,,1,,,N,50594,17728,1,10090.0,8880,,BAO_0000218,Mus musculus,,CHEMBL625379,A,,Half life in BALB/C mice at the dose of 50 mg/kg by p.o. administration,Intermediate
Microsomes,,,,,0,,,U,22224,14294,1,9823.0,8881,,BAO_0000251,Sus scrofa,,CHEMBL625380,A,,Metabolism of compound in mini pig S9 microsomes ('+''indicates <20% largest observed peak),Autocuration
Microsomes,,,,,0,,,U,22224,14294,1,9823.0,8882,,BAO_0000251,Sus scrofa,,CHEMBL625381,A,,Metabolism of compound in mini pig S9 microsomes ('++++' indicates largest observed peak),Autocuration
,,,,,0,,,U,22224,6056,1,9823.0,8883,,BAO_0000019,Sus scrofa,,CHEMBL625382,A,,Stability to porcine renal DHP-I,Autocuration
,In vivo,,,,0,,,U,22224,1317,1,9823.0,8884,,BAO_0000218,Sus scrofa,,CHEMBL873828,A,,Compound was tested for its half-life period at an intravenous dose of 30 ug/kg,Autocuration
,In vivo,,,,0,,,U,22224,1317,1,9823.0,8885,,BAO_0000218,Sus scrofa,,CHEMBL625383,A,,Compound was tested for its half-life period at an intravenous dose of 3 ug/kg,Autocuration
,,,,,0,,,U,22224,5229,1,9823.0,8886,,BAO_0000019,Sus scrofa,,CHEMBL625384,A,,Half-life of the parent prodrug in porcine esterase solution,Autocuration
,,,,,0,,,U,22224,4231,1,9823.0,8887,,BAO_0000019,Sus scrofa,,CHEMBL625385,A,,"First order rate constant, k was determined in in pig liver Esterase",Autocuration
,,Liver,,,0,,,U,22224,4231,1,9823.0,8888,,BAO_0000221,Sus scrofa,2107.0,CHEMBL625386,A,,Half life of the in pig liver Esterase,Autocuration
,,Liver,,,0,,,U,22224,5318,1,9823.0,8889,,BAO_0000221,Sus scrofa,2107.0,CHEMBL623571,A,,Tested for half life period at 37 degree Celsius in PBS buffer at 11.8 pH containing porcine liver esterase,Autocuration
,,Liver,,,0,,,U,22224,5318,1,9823.0,8890,,BAO_0000221,Sus scrofa,2107.0,CHEMBL623572,A,,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH containing porcine liver esterase,Autocuration
,,Liver,,,0,,,U,22224,5318,1,9823.0,8891,,BAO_0000221,Sus scrofa,2107.0,CHEMBL623573,A,,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH in containing porcine liver esterase,Autocuration
,,Liver,,,0,,,U,22224,3305,1,9823.0,8892,,BAO_0000221,Sus scrofa,2107.0,CHEMBL623574,A,,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay,Autocuration
,,Liver,,,0,,,U,22224,3305,1,9823.0,8893,,BAO_0000221,Sus scrofa,2107.0,CHEMBL623575,A,,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay; ND is not determined,Autocuration
,,Liver,,,0,,,U,22224,2842,1,9823.0,8894,,BAO_0000221,Sus scrofa,2107.0,CHEMBL623749,A,,Half-life in the presence of pig liver esterase(PLE) was evaluated.,Autocuration
,,Liver,,,0,,,U,22224,2842,1,9823.0,8895,,BAO_0000221,Sus scrofa,2107.0,CHEMBL623750,A,,Half-life in the presence of pig liver esterase(PLE) was evaluated; Stable,Autocuration
,In vitro,Liver,,,0,,,U,22224,889,1,9823.0,8896,,BAO_0000221,Sus scrofa,2107.0,CHEMBL623751,A,,Half-life in vitro in pig liver,Autocuration
,,Liver,,,0,,,U,22224,1904,1,9823.0,8897,,BAO_0000221,Sus scrofa,2107.0,CHEMBL623752,A,,Half-life time was determined for esterase-catalyzed hydrolysis of the phenol ester bond in porcine liver esterase,Autocuration
,In vivo,Plasma,,,1,,,N,50597,4186,1,10116.0,8898,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623753,A,,Maximum concentration in rat plasma after administration of 50 mg/kg dose through subcutaneous route,Intermediate
,In vivo,Plasma,,,1,,,N,50597,2774,1,10116.0,8899,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623754,A,,Maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,Intermediate
,In vivo,Plasma,,,1,,,N,50597,1742,1,10116.0,8900,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623755,A,,Maximum concentration in rat plasma was determined,Intermediate
,In vivo,,,,1,,,N,50597,3169,1,10116.0,8901,,BAO_0000218,Rattus norvegicus,,CHEMBL623756,A,,Maximum concentration in rats,Intermediate
,In vivo,,,,1,,,N,50597,3169,1,10116.0,8902,,BAO_0000218,Rattus norvegicus,,CHEMBL623757,A,,Maximum concentration in rats at 1-2 hours,Intermediate
,In vivo,,,,1,,,N,50597,2081,1,10116.0,8903,,BAO_0000218,Rattus norvegicus,,CHEMBL623758,A,,Maximum concentration in rats at 1 hr was determined when dosed at 20 mg/Kg perorally,Intermediate
,In vivo,Brain,,,1,,,N,50597,3307,1,10116.0,8904,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL623759,A,,Maximum concentration in whole brain at 30 min following 24 mg/kg subcutaneous dose in rats,Intermediate
,In vivo,,,,1,,,N,50597,4727,1,10116.0,8905,,BAO_0000218,Rattus norvegicus,,CHEMBL623760,A,,Maximum concentration at the dose of 2 mg/kg in rat,Intermediate
,In vivo,,,,1,,,N,50597,6597,1,10116.0,8906,,BAO_0000218,Rattus norvegicus,,CHEMBL623761,A,,Maximum concentration was evaluated in rats,Intermediate
,In vivo,Plasma,,,1,,,N,50597,16365,1,10116.0,8907,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623762,A,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 10 mg/kg to a fasting rat,Intermediate
,In vivo,Plasma,,,1,,,N,50597,16365,1,10116.0,8908,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL877594,A,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 1 mg/kg to a fasting rat,Intermediate
,In vivo,Plasma,,,1,,,N,50597,16365,1,10116.0,8909,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623763,A,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 30 mg/kg,Intermediate
,In vivo,Plasma,,,1,,,N,50597,16365,1,10116.0,8910,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623764,A,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg,Intermediate
,In vivo,Plasma,,,1,,,N,50597,16365,1,10116.0,8911,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623765,A,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg to a fasting rat,Intermediate
,In vivo,Blood,,,1,,,N,50597,2591,1,10116.0,8912,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL623766,A,,Maximum concentration value was evaluated for high sustained blood levels in rat after 1 hr of administration,Intermediate
,In vivo,Blood,,,1,,,N,50597,2591,1,10116.0,8913,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL623767,A,,Maximum concentration value was evaluated for high sustained blood levels in rat after 2 hr of administration,Intermediate
,In vivo,Blood,,,1,,,N,50597,2591,1,10116.0,8914,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL623768,A,,Maximum concentration value was evaluated for high sustained blood levels in rat after 30 min of administration,Intermediate
,In vivo,Plasma,,,1,,,N,50597,5978,1,10116.0,8915,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623769,A,,Maximum plasma concentration (Cmax) of compound (19.2 mg/kg) after po administration was determined Sprague-Dawley rat,Intermediate
,In vivo,Plasma,,,1,,,N,50597,5978,1,10116.0,8916,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623770,A,,Maximum plasma concentration (Cmax) of compound (19.76 mg/kg) after po administration was determined Sprague-Dawley rat,Intermediate
,In vivo,Plasma,,,1,,,N,50597,5978,1,10116.0,8917,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623771,A,,Maximum plasma concentration (Cmax) of compound (20.73 mg/kg) after po administration was determined Sprague-Dawley rat,Intermediate
,In vivo,Plasma,,,1,,,N,50597,5978,1,10116.0,8918,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623772,A,,Maximum plasma concentration (Cmax) of compound (25 mg/kg) after po administration was determined Sprague-Dawley rat,Intermediate
,In vivo,Plasma,,,1,,,N,50597,5978,1,10116.0,8919,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623773,A,,Maximum plasma concentration (Cmax) of compound (9.83 mg/kg) after iv administration was determined Sprague-Dawley rat,Intermediate
,In vivo,Plasma,,,1,,,N,50597,5978,1,10116.0,8920,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623774,A,,Maximum plasma concentration (Cmax) of compound (9.84 mg/kg) after iv administration was determined Sprague-Dawley rat,Intermediate
,In vivo,Plasma,,,1,,,N,50597,5978,1,10116.0,8921,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623775,A,,Maximum plasma concentration (Cmax) of compound (9.92 mg/kg) after iv administration was determined Sprague-Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,14465,1,10116.0,8922,,BAO_0000218,Rattus norvegicus,,CHEMBL623776,A,,Cmax in rat (PO dose),Intermediate
,In vivo,Plasma,,,1,,,N,50597,4723,1,10116.0,8923,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622191,A,,Maximum plasma concentration determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Intermediate
,In vivo,Plasma,,,1,,,N,50597,4723,1,10116.0,8924,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622192,A,,Maximum plasma concentration determined after 3 mg/kg oral administration in potassium oxonate treated rats,Intermediate
,In vivo,Plasma,,,1,,,N,50597,4576,1,10116.0,8925,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622193,A,,Maximum plasma concentration determined in rat,Intermediate
,In vivo,Plasma,,,1,,,N,50597,12873,1,10116.0,8926,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622194,A,,Maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,Intermediate
,In vivo,Plasma,,,1,,,N,50597,12873,1,10116.0,8927,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622195,A,,Maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,Intermediate
,In vivo,Plasma,,,1,,,N,50597,6824,1,10116.0,8928,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622196,A,,Maximum plasma concentration in rat,Intermediate
,In vivo,Plasma,,,1,,,N,50597,17065,1,10116.0,8929,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622197,A,,Maximum plasma concentration measured after intravenous bolus administration of 50 mg/kg of compound to rats,Intermediate
,In vivo,Plasma,,,1,,,N,50597,2932,1,10116.0,8930,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622198,A,,Maximum plasma concentration of compound present in rats at the dose of 37 mg/kg in 15 min,Intermediate
,In vivo,Plasma,,,1,,,N,50597,2932,1,10116.0,8931,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622199,A,,Maximum plasma concentration of compound present in rats at the dose of 38 mg/kg in 15 min,Intermediate
,In vivo,Plasma,,,1,,,N,50597,2879,1,10116.0,8932,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622200,A,,Maximum plasma concentration of compound was measured in rat,Intermediate
,In vivo,Plasma,,,1,,,N,50597,2864,1,10116.0,8933,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622201,A,,Maximum plasma concentration after 20 mg/kg oral administration in rat,Intermediate
,In vivo,Plasma,,,1,,,N,50597,16367,1,10116.0,8934,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623990,A,,Maximum plasma concentration after oral administration to rats,Intermediate
,In vivo,Plasma,,,1,,,N,50597,17717,1,10116.0,8935,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623991,A,,Maximum plasma concentration at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,Intermediate
,In vivo,Plasma,,,1,,,N,50597,17717,1,10116.0,8936,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623992,A,,"Maximum plasma concentration at a concentration of 3 mg/kg in rats, intravenously",Intermediate
,In vivo,Plasma,,,1,,,N,50597,17717,1,10116.0,8937,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623993,A,,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,Intermediate
,In vivo,Plasma,,,1,,,N,50597,17717,1,10116.0,8938,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623994,A,,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with control,Intermediate
,In vivo,Plasma,,,1,,,N,50597,17720,1,10116.0,8939,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623995,F,,Maximum plasma concentration at a dose of 100 mg/kg in Rat Plasma after iv administration,Intermediate
,In vivo,Plasma,,,1,,,N,50597,17720,1,10116.0,8940,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623996,F,,Maximum plasma concentration at a dose of 4 mg/kg in Rat Plasma after iv administration,Intermediate
,In vivo,Plasma,,,1,,,N,50597,17720,1,10116.0,8941,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623997,F,,Maximum plasma concentration at a dose of 50 mg/kg in Rat Plasma after iv administration,Intermediate
,In vivo,Plasma,,,1,,,N,50597,4516,1,10116.0,8942,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623998,A,,Maximum plasma concentration dosed orally in rats,Intermediate
,In vivo,Plasma,,,1,,,N,50597,4516,1,10116.0,8943,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623999,A,,Maximum plasma concentration dosed orally in rats after 6 hours,Intermediate
,In vivo,Plasma,,,1,,,N,50597,4516,1,10116.0,8944,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL624000,A,,Maximum plasma concentration dosed orally in rats after 6 hours; ND is not detected,Intermediate
,In vivo,Plasma,,,1,,,N,50597,5199,1,10116.0,8945,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL624001,A,,Maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,Intermediate
,In vivo,Plasma,,,1,,,N,50597,17538,1,10116.0,8946,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL624002,A,,Maximum plasma concentration in rat after po administration,Intermediate
,In vivo,Plasma,,,1,,,N,50597,6685,1,10116.0,8947,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL624003,A,,"Maximum plasma concentration in rats at 10 mg/kg, p.o. dose",Intermediate
,In vivo,Plasma,,,1,,,N,50597,6685,1,10116.0,8948,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL624004,A,,"Maximum plasma concentration in rats at 20mg/kg, i.p. dose",Intermediate
,,Heart,,,1,,,N,50597,16434,1,10116.0,8949,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL624005,A,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate
,,Heart,,,1,,,N,50597,16434,1,10116.0,8950,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL624006,A,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate
,,Heart,,,1,,,N,50597,16434,1,10116.0,8951,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL624007,A,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate
,,Heart,,,1,,,N,50597,16434,1,10116.0,8952,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL624008,A,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate
,,Heart,,,1,,,N,50597,16434,1,10116.0,8953,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL624009,A,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Intermediate
,,Heart,,,1,,,N,50597,16434,1,10116.0,8954,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL874387,A,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Intermediate
,,Heart,,,1,,,N,50597,16434,1,10116.0,8955,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL624010,A,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Intermediate
,,Heart,,,1,,,N,50597,16434,1,10116.0,8956,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL624011,A,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,Intermediate
,,Heart,,,1,,,N,50597,16435,1,10116.0,8957,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL624012,A,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate
,,Heart,,,1,,,N,50597,16435,1,10116.0,8958,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL624013,A,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate
,,Heart,,,1,,,N,50597,16435,1,10116.0,8959,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL624736,A,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate
,,Heart,,,1,,,N,50597,16435,1,10116.0,8960,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL624737,A,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate
,,Heart,,,1,,,N,50597,16434,1,10116.0,8961,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL624738,A,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate
,,Heart,,,1,,,N,50597,16434,1,10116.0,8962,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL624739,A,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Intermediate
,,Heart,,,1,,,N,50597,16434,1,10116.0,8963,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL624740,A,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate
,,Heart,,,1,,,N,50597,16435,1,10116.0,8964,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL624896,A,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate
,,Heart,,,1,,,N,50597,16435,1,10116.0,8965,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL624897,A,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate
,,Heart,,,1,,,N,50597,16435,1,10116.0,8966,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL624108,A,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate
,,Heart,,,1,,,N,50597,16435,1,10116.0,8967,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL624109,A,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate
,,Heart,,,1,,,N,50597,16435,1,10116.0,8968,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL624110,A,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate
,,Heart,,,1,,,N,50597,16435,1,10116.0,8969,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL624111,A,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate
,,Heart,,,1,,,N,50597,16435,1,10116.0,8970,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL624112,A,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate
,,Heart,,,1,,,N,50597,16435,1,10116.0,8971,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL624113,A,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate
,,Heart,,,1,,,N,50597,16435,1,10116.0,8972,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL619709,A,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate
,,Heart,,,1,,,N,50597,16435,1,10116.0,8973,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL619710,A,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate
,,Kidney,,,1,,,N,50597,16434,1,10116.0,8974,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL619711,A,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate
,,Kidney,,,1,,,N,50597,16434,1,10116.0,8975,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL619712,A,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate
,,Kidney,,,1,,,N,50597,16434,1,10116.0,8976,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL619713,A,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate
,,Kidney,,,1,,,N,50597,16434,1,10116.0,8977,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL619714,A,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate
,,Kidney,,,1,,,N,50597,16434,1,10116.0,8978,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL619715,A,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Intermediate
,,Kidney,,,1,,,N,50597,16434,1,10116.0,8979,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL619716,A,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Intermediate
,,Kidney,,,1,,,N,50597,16434,1,10116.0,8980,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL619717,A,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Intermediate
,,Kidney,,,1,,,N,50597,16434,1,10116.0,8981,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL619718,A,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Intermediate
,,Kidney,,,1,,,N,50597,16435,1,10116.0,8982,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL619719,A,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate
,,Kidney,,,1,,,N,50597,16435,1,10116.0,8983,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL875329,A,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate
,,Kidney,,,1,,,N,50597,16435,1,10116.0,8984,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL619720,A,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate
,,Kidney,,,1,,,N,50597,16435,1,10116.0,8985,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL619721,A,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate
,,Kidney,,,1,,,N,50597,16435,1,10116.0,8986,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL619722,A,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate
,,Kidney,,,1,,,N,50597,16435,1,10116.0,8987,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL619723,A,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate
,,Kidney,,,1,,,N,50597,16435,1,10116.0,8988,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL619724,A,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate
,,Kidney,,,1,,,N,50597,16435,1,10116.0,8989,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL619725,A,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate
,,Kidney,,,1,,,N,50597,16434,1,10116.0,8990,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL619726,A,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate
,,Kidney,,,1,,,N,50597,16434,1,10116.0,8991,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL619727,A,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Intermediate
,,Kidney,,,1,,,N,50597,16434,1,10116.0,8992,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL619728,A,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate
,,Kidney,,,1,,,N,50597,16435,1,10116.0,8993,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL619729,A,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,11977,1,10116.0,8994,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL619730,A,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,11977,1,10116.0,8995,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL619731,A,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,11977,1,10116.0,8996,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL619732,A,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,11977,1,10116.0,8997,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL619733,A,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,11977,1,10116.0,8998,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL619734,A,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,In vivo,Zone of skin,,,1,,,N,50597,11977,1,10116.0,8999,,BAO_0000218,Rattus norvegicus,14.0,CHEMBL619735,A,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,In vivo,Zone of skin,,,1,,,N,50597,11977,1,10116.0,9000,,BAO_0000218,Rattus norvegicus,14.0,CHEMBL875330,A,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,In vivo,Zone of skin,,,1,,,N,50597,11977,1,10116.0,9001,,BAO_0000218,Rattus norvegicus,14.0,CHEMBL628465,A,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate
,In vivo,Zone of skin,,,1,,,N,50597,11977,1,10116.0,9002,,BAO_0000218,Rattus norvegicus,14.0,CHEMBL628466,A,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,In vivo,Zone of skin,,,1,,,N,50597,11977,1,10116.0,9003,,BAO_0000218,Rattus norvegicus,14.0,CHEMBL628467,A,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,In vivo,Spleen,,,1,,,N,50597,11977,1,10116.0,9004,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL628468,A,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,In vivo,Spleen,,,1,,,N,50597,11977,1,10116.0,9005,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL628469,A,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,In vivo,Spleen,,,1,,,N,50597,11977,1,10116.0,9006,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL628470,A,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate
,In vivo,Spleen,,,1,,,N,50597,11977,1,10116.0,9007,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL628471,A,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,In vivo,Spleen,,,1,,,N,50597,11977,1,10116.0,9008,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL628472,A,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,In vivo,Thyroid gland,,,1,,,N,50597,11977,1,10116.0,9009,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL625191,A,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,In vivo,Thyroid gland,,,1,,,N,50597,11977,1,10116.0,9010,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL625192,A,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,In vivo,Thyroid gland,,,1,,,N,50597,11977,1,10116.0,9011,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL875337,A,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate
,In vivo,Thyroid gland,,,1,,,N,50597,11977,1,10116.0,9012,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL626341,A,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,In vivo,Thyroid gland,,,1,,,N,50597,11977,1,10116.0,9013,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL626342,A,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,In vivo,Liver,,,1,,,N,50597,11977,1,10116.0,9014,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL621943,A,,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate
,,,,,1,,,N,50597,3748,1,10116.0,9015,,BAO_0000218,Rattus norvegicus,,CHEMBL621944,A,,Half life in rats,Intermediate
,,,,,1,,,N,50597,15765,1,10116.0,9016,,BAO_0000218,Rattus norvegicus,,CHEMBL621945,A,,Mean percent inhibition of joint damage reduction in fasted rats at 35 mg/kg administered orally twice daily,Intermediate
,,,,,1,,,N,50597,4871,1,10116.0,9017,,BAO_0000218,Rattus norvegicus,,CHEMBL621946,A,,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver),Intermediate
,,,,,1,,,N,50597,4871,1,10116.0,9018,,BAO_0000218,Rattus norvegicus,,CHEMBL621947,A,,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver); ND=Not determined,Intermediate
,,,,,1,,,N,50597,4872,1,10116.0,9019,,BAO_0000218,Rattus norvegicus,,CHEMBL621948,A,,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver),Intermediate
,,,,,1,,,N,50597,4872,1,10116.0,9020,,BAO_0000218,Rattus norvegicus,,CHEMBL621949,A,,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver); ND=Not determined,Intermediate
,,,,,1,,,N,50597,5413,1,10116.0,9021,,BAO_0000218,Rattus norvegicus,,CHEMBL621950,A,,Rate constant (k) of clearance from isolated perfused rat liver (IPRL),Intermediate
,,,,,1,,,N,50597,5413,1,10116.0,9022,,BAO_0000218,Rattus norvegicus,,CHEMBL621951,A,,Tested for rate of clearance from isolated perfused rat liver (IPRL) and expressed in terms of rate constant (k); not determined,Intermediate
,In vivo,Blood,,,1,,,N,50597,15272,1,10116.0,9023,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL621952,A,,Maximal blood concentration after oral administration of a 30 uM/kg dose of compound,Intermediate
,,Liver,,,1,,,N,50597,4689,1,10116.0,9024,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL621953,A,,Stability (%) in rat liver microsomes,Intermediate
,,,,,1,,,N,50597,6057,1,10116.0,9025,,BAO_0000218,Rattus norvegicus,,CHEMBL621954,A,,Area under curve was calculated after intravenous administration,Intermediate
,,,,,1,,,N,50597,6057,1,10116.0,9026,,BAO_0000218,Rattus norvegicus,,CHEMBL621955,A,,Area under the curve was calculated after iv administration in rat,Intermediate
,,,,,1,,,N,50597,6057,1,10116.0,9027,,BAO_0000218,Rattus norvegicus,,CHEMBL621956,A,,Area under the curve was calculated in rat after peroral administration,Intermediate
,,,,,1,,,N,50597,6211,1,10116.0,9028,,BAO_0000218,Rattus norvegicus,,CHEMBL621957,A,,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,Intermediate
,,,,,1,,,N,50597,5710,1,10116.0,9029,,BAO_0000218,Rattus norvegicus,,CHEMBL621958,A,,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral dose of 2 mg/Kg,Intermediate
,,,,,1,,,N,50597,5710,1,10116.0,9030,,BAO_0000218,Rattus norvegicus,,CHEMBL621959,A,,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral of 2 mg/Kg,Intermediate
,,,,,1,,,N,50597,17853,1,10116.0,9031,,BAO_0000218,Rattus norvegicus,,CHEMBL621960,A,,Dose-normalized area under curve in rat (i.v.) at 0.5 mpk,Intermediate
,,,,,1,,,N,50597,17853,1,10116.0,9032,,BAO_0000218,Rattus norvegicus,,CHEMBL621961,A,,Dose-normalized area under curve in rat (p.o.) at 2.0 mpk,Intermediate
,,,,,1,,,N,50597,15765,1,10116.0,9033,,BAO_0000218,Rattus norvegicus,,CHEMBL621962,A,,p value of the compound,Intermediate
,,,,,1,,,N,50597,15765,1,10116.0,9034,,BAO_0000218,Rattus norvegicus,,CHEMBL876787,F,,p value of the compound,Intermediate
,,,,,1,,,N,50597,15765,1,10116.0,9035,,BAO_0000218,Rattus norvegicus,,CHEMBL621963,A,,p value of the compound,Intermediate
,,Stomach,,,1,,,N,50597,6175,1,10116.0,9036,,BAO_0000218,Rattus norvegicus,945.0,CHEMBL622637,A,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Intermediate
,,Stomach,,,1,,,N,50597,6175,1,10116.0,9037,,BAO_0000218,Rattus norvegicus,945.0,CHEMBL622638,A,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (20 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Intermediate
,,Stomach,,,1,,,N,50597,6175,1,10116.0,9038,,BAO_0000218,Rattus norvegicus,945.0,CHEMBL626561,A,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Intermediate
,,,,,0,,,U,22224,7991,1,9986.0,9039,,BAO_0000019,Oryctolagus cuniculus,,CHEMBL626562,F,,Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic),Autocuration
,,,,,0,,,U,22224,429,1,9986.0,9040,,BAO_0000218,Oryctolagus cuniculus,,CHEMBL626563,A,,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg ( 0-4 hr ),Autocuration
,,,,,0,,,U,22224,429,1,9986.0,9041,,BAO_0000218,Oryctolagus cuniculus,,CHEMBL626564,A,,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg (0-4 hr ),Autocuration
,In vivo,,,,0,,,U,22224,6253,1,9986.0,9042,,BAO_0000218,Oryctolagus cuniculus,,CHEMBL626565,A,,Clearance was measured at the concentration of 1.11 mg/kg in rabbit blood sample,Autocuration
,In vivo,,,,0,,,U,22224,6253,1,9986.0,9043,,BAO_0000218,Oryctolagus cuniculus,,CHEMBL626566,A,,Clearance was measured at the concentration of 2.0 mg/kg in rabbit blood sample,Autocuration
,In vivo,,,,0,,,U,22224,3615,1,9986.0,9044,,BAO_0000218,Oryctolagus cuniculus,,CHEMBL626567,A,,Clearance rate in rabbits,Autocuration
,In vivo,,,,0,,,U,22224,4059,1,9986.0,9045,,BAO_0000218,Oryctolagus cuniculus,,CHEMBL626568,A,,Plasma clearance was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,Autocuration
,In vivo,,,,0,,,U,22224,5124,1,9986.0,9046,,BAO_0000218,Oryctolagus cuniculus,,CHEMBL626569,A,,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,Autocuration
,In vivo,,,,0,,,U,22224,5124,1,9986.0,9047,,BAO_0000218,Oryctolagus cuniculus,,CHEMBL626570,A,,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,Autocuration
,In vivo,,,,0,,,U,22224,5124,1,9986.0,9048,,BAO_0000218,Oryctolagus cuniculus,,CHEMBL626571,A,,Clearance in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,Autocuration
,In vivo,,,,0,,,U,22224,429,1,9986.0,9049,,BAO_0000218,Oryctolagus cuniculus,,CHEMBL626572,A,,Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg,Autocuration
,In vivo,Plasma,,,0,,,U,22224,4059,1,9986.0,9050,,BAO_0000218,Oryctolagus cuniculus,1969.0,CHEMBL626573,A,,Maximum plasma concentration was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,Autocuration
Microsomes,,Liver,,,0,,,U,22224,9659,1,9986.0,9051,,BAO_0000251,Oryctolagus cuniculus,2107.0,CHEMBL626574,A,,Oxidation by dutch rabbit liver microsomes in presence of NADPH/O2,Autocuration
Microsomes,,Liver,,,0,,,U,22224,9659,1,9986.0,9052,,BAO_0000251,Oryctolagus cuniculus,2107.0,CHEMBL626575,A,,Oxidation by dutch rabbit liver microsomes in presence of cumene hydroperoxide,Autocuration
,,,,,0,,,U,22224,3639,1,9986.0,9053,,BAO_0000218,Oryctolagus cuniculus,,CHEMBL626576,A,,Dose at which bioavailability of intravenously administered compound was tested in rabbit,Autocuration
,,,,,0,,,U,22224,3639,1,9986.0,9054,,BAO_0000218,Oryctolagus cuniculus,,CHEMBL626577,A,,Dose at which bioavailability of perorally administered compound was tested in rabbit,Autocuration
,In vivo,,,,0,,,U,22224,3639,1,9986.0,9055,,BAO_0000218,Oryctolagus cuniculus,,CHEMBL626578,A,,The compound was tested for its bioavailability in rabbit (by oral dosage).,Autocuration
,In vivo,,,,0,,,U,22224,5124,1,9986.0,9056,,BAO_0000218,Oryctolagus cuniculus,,CHEMBL625263,A,,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,Autocuration
,In vivo,,,,0,,,U,22224,5124,1,9986.0,9057,,BAO_0000218,Oryctolagus cuniculus,,CHEMBL625264,A,,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,Autocuration
,In vivo,,,,0,,,U,22224,5124,1,9986.0,9058,,BAO_0000218,Oryctolagus cuniculus,,CHEMBL625265,A,,Mean retention time in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,Autocuration
Microsomes,,,,,0,,,U,22224,14294,1,9986.0,9059,,BAO_0000251,Oryctolagus cuniculus,,CHEMBL625266,A,,Metabolism of compound in rabbit S9 microsomes ('+''indicates <20% largest observed peak),Autocuration
Microsomes,,,,,0,,,U,22224,14294,1,9986.0,9060,,BAO_0000251,Oryctolagus cuniculus,,CHEMBL876796,A,,Metabolism of compound in rabbit S9 microsomes ('++++' indicates largest observed peak),Autocuration
,In vivo,,,,0,,,U,22224,429,1,9986.0,9061,,BAO_0000218,Oryctolagus cuniculus,,CHEMBL625267,A,,Evaluated for pharmacokinetic parameter half-life in rabbit at the dose 20 mg/kg,Autocuration
,In vivo,Plasma,,,0,,,U,22224,5124,1,9986.0,9062,,BAO_0000218,Oryctolagus cuniculus,1969.0,CHEMBL625268,A,,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,Autocuration
,In vivo,Plasma,,,0,,,U,22224,5124,1,9986.0,9063,,BAO_0000218,Oryctolagus cuniculus,1969.0,CHEMBL625269,A,,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,Autocuration
,In vivo,Plasma,,,0,,,U,22224,5124,1,9986.0,9064,,BAO_0000218,Oryctolagus cuniculus,1969.0,CHEMBL624689,A,,Plasma half-life in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,Autocuration
,In vivo,,,,0,,,U,22224,429,1,9986.0,9065,,BAO_0000218,Oryctolagus cuniculus,,CHEMBL624690,A,,Evaluated for pharmacokinetic parameter tmax in rabbit at the dose 20 mg/kg,Autocuration
,,Urine,,,0,,,U,22224,429,1,9986.0,9066,,BAO_0000218,Oryctolagus cuniculus,1088.0,CHEMBL624691,A,,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg ( 0-24 hr ),Autocuration
,,Urine,,,0,,,U,22224,429,1,9986.0,9067,,BAO_0000218,Oryctolagus cuniculus,1088.0,CHEMBL624692,A,,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg (0-24 hr),Autocuration
,In vivo,,,,0,,,U,22224,4059,1,9986.0,9068,,BAO_0000218,Oryctolagus cuniculus,,CHEMBL624693,A,,The compound was evaluated for volume of distribution in rabbit at a dose of 5 mg/kg/h administered i.v.,Autocuration
,In vivo,,,,0,,,U,22224,4137,1,9986.0,9069,,BAO_0000218,Oryctolagus cuniculus,,CHEMBL624694,A,,Volume of distribution after intravenous administration of 1 mg/kg/h in dog,Autocuration
,In vitro,,,,0,,,U,22224,11672,1,9986.0,9070,,BAO_0000221,Oryctolagus cuniculus,,CHEMBL877596,A,,In vitro Biological half-life in crude homogenate of rabbit renal cortex,Autocuration
,,,,,0,,,U,22224,12886,1,9986.0,9071,,BAO_0000019,Oryctolagus cuniculus,,CHEMBL624695,A,,Time within which only 10% of the drug was degraded,Autocuration
,,Liver,,,0,,,U,22224,3853,1,9986.0,9072,,BAO_0000221,Oryctolagus cuniculus,2107.0,CHEMBL624696,A,,Half life period in rabbit liver homogenate,Autocuration
,,,,,0,,,U,22224,3615,1,9986.0,9073,,BAO_0000019,Oryctolagus cuniculus,,CHEMBL624697,A,,Half life value in rabbits,Autocuration
,In vivo,Blood,,,0,,,U,22224,6253,1,9986.0,9074,,BAO_0000218,Oryctolagus cuniculus,178.0,CHEMBL624698,A,,Half-life was measured at the concentration of 1.11 mg/kg in rabbit blood sample,Autocuration
,In vivo,Blood,,,0,,,U,22224,6253,1,9986.0,9075,,BAO_0000218,Oryctolagus cuniculus,178.0,CHEMBL624699,A,,Half-life was measured at the concentration of 2.0 mg/kg in rabbit blood sample,Autocuration
,In vivo,,,,0,,,U,22224,6077,1,9986.0,9076,,BAO_0000218,Oryctolagus cuniculus,,CHEMBL624700,A,,Half-life period in rabbits following intravenous administration at 2 mg/kg,Autocuration
,,Plasma,,,1,,,N,50597,17617,1,10116.0,9077,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622903,A,,AUC 0-8 hr value in rats at 10 mg/kg,Intermediate
,,Plasma,,,1,,,N,50597,17594,1,10116.0,9078,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622904,A,,AUC after administration at 2000 mg/kg/day in rats,Intermediate
,,Plasma,,,1,,,N,50597,6149,1,10116.0,9079,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622905,A,,AUC of compound for a 2 mpk po dose of the sodium salt in rats.,Intermediate
,,Plasma,,,1,,,N,50597,17260,1,10116.0,9080,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622906,A,,AUC at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,Intermediate
,,Plasma,,,1,,,N,50597,17260,1,10116.0,9081,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622907,A,,AUC at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,Intermediate
,,Plasma,,,1,,,N,50597,6644,1,10116.0,9082,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622908,A,,AUC in rat after oral administration at 10.5 mg/kg dose,Intermediate
,,Plasma,,,1,,,N,50597,6644,1,10116.0,9083,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622909,A,,AUC in rat after oral administration at 11.2 mg/kg dose,Intermediate
,,Plasma,,,1,,,N,50597,6644,1,10116.0,9084,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622910,A,,AUC in rat after oral administration at 9.7 mg/kg dose,Intermediate
,,Brain,,,1,,,N,50597,6495,1,10116.0,9085,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL622911,A,,AUC in rat brain after oral administration at 10 mg/kg,Intermediate
,,Plasma,,,1,,,N,50597,6504,1,10116.0,9086,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622912,A,,AUC in rat p.o.,Intermediate
,,Plasma,,,1,,,N,50597,17686,1,10116.0,9087,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622913,A,,AUC in rat p.o. at 20 mg/kg concentration,Intermediate
,,Plasma,,,1,,,N,50597,6495,1,10116.0,9088,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622914,A,,AUC in rat plasma after oral administration at 10 mg/kg,Intermediate
,,Plasma,,,1,,,N,50597,216,1,10116.0,9089,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622915,A,,AUC in rats,Intermediate
,,Plasma,,,1,,,N,50597,1908,1,10116.0,9090,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622916,A,,AUC value after IV dose at a dose of 5 mg/kg in rats.,Intermediate
,,Plasma,,,1,,,N,50597,1908,1,10116.0,9091,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622917,A,,AUC value after oral dose at a dose of 10 mg/kg in rats.,Intermediate
,In vivo,Plasma,,,1,,,N,50597,6685,1,10116.0,9092,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622918,A,,"Maximum plasma concentration in rats at 2 mg/kg, i.v. dose; n/a: not applicable",Intermediate
,In vivo,Plasma,,,1,,,N,50597,216,1,10116.0,9093,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622919,A,,Maximum plasma concentration in rats when a oral dose of 200 mg/kg was given,Intermediate
,In vivo,Plasma,,,1,,,N,50597,6049,1,10116.0,9094,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622920,A,,Maximum plasma concentration was evaluated in rat,Intermediate
,In vivo,Plasma,,,1,,,N,50597,2463,1,10116.0,9095,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622921,A,,Maximum plasma concentration was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,Intermediate
,In vivo,Plasma,,,1,,,N,50597,6679,1,10116.0,9096,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622922,A,,Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,Intermediate
,In vivo,Plasma,,,1,,,N,50597,6681,1,10116.0,9097,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622923,A,,Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,Intermediate
,In vivo,Plasma,,,1,,,N,50597,4890,1,10116.0,9098,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL877604,A,,Maximum plasma concentration was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,Intermediate
,In vivo,Plasma,,,1,,,N,50597,6410,1,10116.0,9099,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622924,A,,Maximum plasma concentration was evaluated in rats at an intravenous dose of 3 mg/kg,Intermediate
,In vivo,Plasma,,,1,,,N,50597,6410,1,10116.0,9100,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622925,A,,Maximum plasma concentration was evaluated in rats at an oral dose of 30 mg/kg,Intermediate
,In vivo,Plasma,,,1,,,N,50597,16366,1,10116.0,9101,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622926,A,,Maximum plasma concentration was measured when a dose of 1 mg/kg is administered orally,Intermediate
,In vivo,Plasma,,,1,,,N,50597,6227,1,10116.0,9102,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623625,A,,Maximum plasma concentration (Cmax) in rat (in vivo) at a dose of 10 mg/kg,Intermediate
,In vivo,Plasma,,,1,,,N,50597,3598,1,10116.0,9103,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623626,A,,Maximum plasma drug concentration of compound determined in rat after iv administration at a dose of 10 mg/kg,Expert
,In vivo,Plasma,,,1,,,N,50597,1465,1,10116.0,9104,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623627,A,,Maximum plasma drug concentration was determined,Intermediate
,In vivo,,,,1,,,N,50597,4368,1,10116.0,9105,,BAO_0000218,Rattus norvegicus,,CHEMBL623628,A,,Maximum concentration by intravenous administration of 3.4 mg/kg in rat,Intermediate
,In vivo,Plasma,,,1,,,N,50597,15662,1,10116.0,9106,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623629,A,,Mean peak plasma concentration was observed after intravenous administration in rat,Intermediate
,In vivo,Plasma,,,1,,,N,50597,15662,1,10116.0,9107,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623630,A,,Mean peak plasma concentration was observed after oral administration in rat,Intermediate
,In vivo,,,,1,,,N,50597,5355,1,10116.0,9108,,BAO_0000218,Rattus norvegicus,,CHEMBL623804,A,,Peak concentration (Cmax) at a dose of 10 mg/kg in rats,Intermediate
,In vivo,,,,1,,,N,50597,5355,1,10116.0,9109,,BAO_0000218,Rattus norvegicus,,CHEMBL623805,A,,Peak concentration (Cmax) at a dose of 20 mg/kg in rats,Intermediate
,In vivo,Plasma,,,1,,,N,50597,1567,1,10116.0,9110,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623806,A,,Peak oral plasma concentration was determined in rats by oral administration,Intermediate
,In vivo,Plasma,,,1,,,N,50597,4026,1,10116.0,9111,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623807,A,,Peak plasma concentration (Cmax) was determined,Intermediate
,In vivo,Plasma,,,1,,,N,50597,6193,1,10116.0,9112,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623808,A,,Peak plasma concentration (Cmax) following an oral dose of 20 mg/kg in rats,Intermediate
,In vivo,Plasma,,,1,,,N,50597,4026,1,10116.0,9113,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623809,A,,Peak plasma concentration (Cmax) in rats,Intermediate
,In vivo,Plasma,,,1,,,N,50597,6485,1,10116.0,9114,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623810,A,,Peak plasma concentration at 1 mg/kg peroral administration,Intermediate
,In vivo,Plasma,,,1,,,N,50597,17655,1,10116.0,9115,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623811,A,,Peak plasma concentration in rat,Intermediate
,In vivo,Plasma,,,1,,,N,50597,14941,1,10116.0,9116,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623812,A,,"Pharmacokinetic Parameter, Cmax is observed maximum plasma concentration in Female Wistar Rats at 100 mg/kg by po administration",Intermediate
,In vivo,,,,1,,,N,50597,5394,1,10116.0,9117,,BAO_0000218,Rattus norvegicus,,CHEMBL877605,A,,Pharmacokinetic parameter Cmax was measured after administration into rat at 10 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,4408,1,10116.0,9118,,BAO_0000218,Rattus norvegicus,,CHEMBL623813,A,,Pharmacokinetic property (Cmax) in rat,Intermediate
,In vivo,,,,1,,,N,50597,5983,1,10116.0,9119,,BAO_0000218,Rattus norvegicus,,CHEMBL623814,A,,Pharmacokinetic property (Cmax) was measured in rat at the dose of 0.32 mg/kg p.o.,Intermediate
,In vivo,,,,1,,,N,50597,4878,1,10116.0,9120,,BAO_0000218,Rattus norvegicus,,CHEMBL623815,A,,Cmax in rat after 3mg/kg oral dose,Intermediate
,In vivo,,,,1,,,N,50597,5862,1,10116.0,9121,Sprague-Dawley,BAO_0000218,Rattus norvegicus,,CHEMBL623816,A,,Clearance in Sprague-Dawley rats after 2mg/kg oral dose,Intermediate
,In vivo,,,,1,,,N,50597,4517,1,10116.0,9122,,BAO_0000218,Rattus norvegicus,,CHEMBL623145,A,,Cmax in rats after 20 mg/kg oral dose,Intermediate
,In vivo,Plasma,,,1,,,N,50597,5932,1,10116.0,9123,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623146,A,,Cmax in rat plasma after 30mg/kg oral dose,Intermediate
,In vivo,Plasma,,,1,,,N,50597,5436,1,10116.0,9124,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623147,A,,Plasma concentration after oral administration of 100 mg/kg to rats,Intermediate
,In vivo,Brain,,,1,,,N,50597,4910,1,10116.0,9125,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL623042,A,,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,Intermediate
,In vivo,,,,1,,,N,50597,4950,1,10116.0,9126,,BAO_0000218,Rattus norvegicus,,CHEMBL623043,A,,Tested for the Cmax in rat at 10 mg/kg per orally,Intermediate
,In vivo,,,,1,,,N,50597,15078,1,10116.0,9127,,BAO_0000218,Rattus norvegicus,,CHEMBL623044,A,,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",Intermediate
,In vivo,,,,1,,,N,50597,15078,1,10116.0,9128,,BAO_0000218,Rattus norvegicus,,CHEMBL623045,A,,"The Cmax value in male wistar rat at 100 mg/kg, p.o. dose",Intermediate
,In vivo,,,,1,,,N,50597,3360,1,10116.0,9129,,BAO_0000218,Rattus norvegicus,,CHEMBL623046,A,,Bioavailability as oral Cmax in rats at 30 mins,Intermediate
,In vivo,,,,1,,,N,50597,3360,1,10116.0,9130,,BAO_0000218,Rattus norvegicus,,CHEMBL623226,A,,Bioavailability as oral Cmax in rats at 6hr,Intermediate
,In vivo,,,,1,,,N,50597,15022,1,10116.0,9131,,BAO_0000218,Rattus norvegicus,,CHEMBL623227,A,,The maximum concentration of compound was measured at the dose of 100 umol/kg,Intermediate
,In vivo,,,,1,,,N,50597,15022,1,10116.0,9132,,BAO_0000218,Rattus norvegicus,,CHEMBL623228,A,,The maximum concentration of compound was measured at the dose of 300 umol/kg,Intermediate
,In vivo,,,,1,,,N,50597,15022,1,10116.0,9133,,BAO_0000218,Rattus norvegicus,,CHEMBL623229,A,,The maximum concentration of compound was measured at the dose of 30 umol/kg,Intermediate
,In vivo,Plasma,,,1,,,N,50597,5160,1,10116.0,9134,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623230,A,,The maximum plasma levels for the compounds were determined by LC-MS.,Intermediate
,In vivo,Plasma,,,1,,,N,50597,15662,1,10116.0,9135,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623231,A,,mean peak plasma concentration was observed after intravenous administration in rat,Intermediate
,In vivo,Plasma,,,1,,,N,50597,15662,1,10116.0,9136,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623232,A,,mean peak plasma concentration was observed after oral administration in rat,Intermediate
,,,,,1,,,N,50597,4709,1,10116.0,9137,,BAO_0000218,Rattus norvegicus,,CHEMBL623233,A,,Concentration in the plasma after intravenous administration of 1 mg/kg in rat,Intermediate
,,,,,1,,,N,50597,3535,1,10116.0,9138,,BAO_0000218,Rattus norvegicus,,CHEMBL623234,A,,Concentration in plasma (portal) following oral dose in rats at 0.25 hr,Intermediate
,,,,,1,,,N,50597,3535,1,10116.0,9139,,BAO_0000218,Rattus norvegicus,,CHEMBL623235,A,,Concentration in plasma (portal) following oral dose in rats at 1 hr,Intermediate
,,,,,1,,,N,50597,3535,1,10116.0,9140,,BAO_0000218,Rattus norvegicus,,CHEMBL623236,A,,Concentration in plasma (portal) following oral dose in rats at 2 hr,Intermediate
,,,,,1,,,N,50597,3535,1,10116.0,9141,,BAO_0000218,Rattus norvegicus,,CHEMBL623237,A,,Concentration in plasma (systemic) following oral dose in rats at 0.25 hr,Intermediate
,,,,,1,,,N,50597,3535,1,10116.0,9142,,BAO_0000218,Rattus norvegicus,,CHEMBL623238,A,,Concentration in plasma (systemic) following oral dose in rats at 1 hr,Intermediate
,,,,,1,,,N,50597,3535,1,10116.0,9143,,BAO_0000218,Rattus norvegicus,,CHEMBL623239,A,,Concentration in plasma (systemic) following oral dose in rats at 2 hr,Intermediate
,In vivo,Plasma,,,0,,,U,22224,5005,1,10116.0,9144,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623240,A,,Compound was evaluated for the plasma concentration in rats versus time curves (AUC) in vivo,Intermediate
,,Hypothalamus,,,1,,,N,50597,6326,1,10116.0,9145,,BAO_0000218,Rattus norvegicus,1898.0,CHEMBL623241,A,,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 2 hours",Intermediate
,,Hypothalamus,,,1,,,N,50597,6326,1,10116.0,9146,,BAO_0000218,Rattus norvegicus,1898.0,CHEMBL623242,A,,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 6 hours",Intermediate
,,,,,1,,,N,50597,6326,1,10116.0,9147,,BAO_0000218,Rattus norvegicus,,CHEMBL874394,A,,"Concentration (30 mg/kg, p.o.) in rat plasma after 2 hours",Intermediate
,,,,,1,,,N,50597,6326,1,10116.0,9148,,BAO_0000218,Rattus norvegicus,,CHEMBL623243,A,,"Concentration (30 mg/kg, p.o.) in rat plasma after 6 hours",Intermediate
,,,,,1,,,N,50597,17411,1,10116.0,9149,,BAO_0000218,Rattus norvegicus,,CHEMBL623244,A,,Kidney concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate
,,Kidney,,,1,,,N,50597,16435,1,10116.0,9150,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL623245,A,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate
,,Kidney,,,1,,,N,50597,16435,1,10116.0,9151,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL623246,A,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate
,,Kidney,,,1,,,N,50597,16435,1,10116.0,9152,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL623247,A,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate
,,Kidney,,,1,,,N,50597,16435,1,10116.0,9153,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL623248,A,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate
,,Kidney,,,1,,,N,50597,16435,1,10116.0,9154,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL623249,A,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate
,,Liver,,,1,,,N,50597,16434,1,10116.0,9155,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL625072,A,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate
,,Liver,,,1,,,N,50597,16434,1,10116.0,9156,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL625073,A,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate
,,Liver,,,1,,,N,50597,16434,1,10116.0,9157,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL625074,A,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate
,,Liver,,,1,,,N,50597,16434,1,10116.0,9158,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL625075,A,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate
,,Liver,,,1,,,N,50597,16434,1,10116.0,9159,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL625076,A,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min.,Intermediate
,,Liver,,,1,,,N,50597,16434,1,10116.0,9160,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL625077,A,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Intermediate
,,Liver,,,1,,,N,50597,16434,1,10116.0,9161,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL625078,A,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Intermediate
,,Liver,,,1,,,N,50597,16434,1,10116.0,9162,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL874395,A,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Intermediate
,,Liver,,,1,,,N,50597,16435,1,10116.0,9163,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL625079,A,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate
,,Liver,,,1,,,N,50597,16435,1,10116.0,9164,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL625080,A,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate
,,Liver,,,1,,,N,50597,16435,1,10116.0,9165,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL625081,A,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate
,,Liver,,,1,,,N,50597,16435,1,10116.0,9166,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL625082,A,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate
,,Liver,,,1,,,N,50597,16435,1,10116.0,9167,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL625083,A,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate
,,Liver,,,1,,,N,50597,16435,1,10116.0,9168,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL625084,A,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate
,,Liver,,,1,,,N,50597,16435,1,10116.0,9169,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL625085,A,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate
,,Liver,,,1,,,N,50597,16435,1,10116.0,9170,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL625086,A,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate
,,Liver,,,1,,,N,50597,16434,1,10116.0,9171,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL625087,A,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate
,,Liver,,,1,,,N,50597,16434,1,10116.0,9172,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL625088,A,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Intermediate
,,Liver,,,1,,,N,50597,16434,1,10116.0,9173,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL622205,A,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate
,,Liver,,,1,,,N,50597,16435,1,10116.0,9174,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL622206,A,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate
,,Liver,,,1,,,N,50597,16435,1,10116.0,9175,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL622207,A,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate
,,Liver,,,1,,,N,50597,16435,1,10116.0,9176,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL622366,A,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate
,,Liver,,,1,,,N,50597,16435,1,10116.0,9177,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL622367,A,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate
,,Liver,,,1,,,N,50597,16435,1,10116.0,9178,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL875331,A,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate
,,Liver,,,1,,,N,50597,16435,1,10116.0,9179,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL622368,A,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate
,,Lung,,,1,,,N,50597,16434,1,10116.0,9180,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL622369,A,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate
,,Lung,,,1,,,N,50597,16434,1,10116.0,9181,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL622370,A,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate
,,Lung,,,1,,,N,50597,16434,1,10116.0,9182,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL622371,A,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate
,,Lung,,,1,,,N,50597,16434,1,10116.0,9183,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL622372,A,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate
,,Lung,,,1,,,N,50597,16434,1,10116.0,9184,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL622373,A,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Intermediate
,,Lung,,,1,,,N,50597,16434,1,10116.0,9185,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL622374,A,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Intermediate
,,Lung,,,1,,,N,50597,16434,1,10116.0,9186,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL622375,A,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Intermediate
,,Lung,,,1,,,N,50597,16434,1,10116.0,9187,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL622376,A,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,Intermediate
,,Lung,,,1,,,N,50597,16435,1,10116.0,9188,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL622377,A,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate
,,Lung,,,1,,,N,50597,16435,1,10116.0,9189,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL622378,A,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate
,,Lung,,,1,,,N,50597,16435,1,10116.0,9190,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL622379,A,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate
,,Lung,,,1,,,N,50597,16435,1,10116.0,9191,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL622380,A,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate
,,Lung,,,1,,,N,50597,16435,1,10116.0,9192,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL622381,A,,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate
,,Lung,,,1,,,N,50597,16435,1,10116.0,9193,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL622382,A,,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate
,,Lung,,,1,,,N,50597,16434,1,10116.0,9194,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL622383,A,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min,Intermediate
,,Stomach,,,1,,,N,50597,6175,1,10116.0,9195,,BAO_0000218,Rattus norvegicus,945.0,CHEMBL875332,A,,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured ( 5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Intermediate
,,Stomach,,,1,,,N,50597,6175,1,10116.0,9196,,BAO_0000218,Rattus norvegicus,945.0,CHEMBL622384,A,,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Intermediate
,,Stomach,,,1,,,N,50597,6175,1,10116.0,9197,,BAO_0000218,Rattus norvegicus,945.0,CHEMBL622385,A,,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (2.5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Intermediate
,,Stomach,,,1,,,N,50597,6175,1,10116.0,9198,,BAO_0000218,Rattus norvegicus,945.0,CHEMBL622386,A,,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Intermediate
,,,,,1,,,N,50597,10839,1,10116.0,9199,,BAO_0000218,Rattus norvegicus,,CHEMBL622387,A,,The compound was tested for the plasma binding in rat,Intermediate
,,,,,1,,,N,50597,16459,1,10116.0,9200,,BAO_0000218,Rattus norvegicus,,CHEMBL622388,A,,"Plasma concentration after intravenous aministration at 1hr, (1 mg/kg, n=3)",Intermediate
,,,,,1,,,N,50597,16459,1,10116.0,9201,,BAO_0000218,Rattus norvegicus,,CHEMBL622389,A,,"Plasma concentration after intravenous aministration at 30 min. (1 mg/kg, n=3)",Intermediate
,,,,,1,,,N,50597,16459,1,10116.0,9202,,BAO_0000218,Rattus norvegicus,,CHEMBL622390,A,,"Plasma concentration after intravenous aministration at 60 min. (1 mg/kg, n=3)",Intermediate
,,,,,1,,,N,50597,16459,1,10116.0,9203,,BAO_0000218,Rattus norvegicus,,CHEMBL622391,A,,Plasma concentration after oral aministration at 1 hr. (10 mg/kg),Intermediate
,,,,,1,,,N,50597,16459,1,10116.0,9204,,BAO_0000218,Rattus norvegicus,,CHEMBL622392,A,,Plasma concentration after oral aministration at 2 hr. (10 mg/kg),Intermediate
,,,,,1,,,N,50597,16459,1,10116.0,9205,,BAO_0000218,Rattus norvegicus,,CHEMBL622393,A,,Plasma concentration after oral aministration at 4 hr. (10 mg/kg),Intermediate
,,,,,1,,,N,50597,3278,1,10116.0,9206,,BAO_0000218,Rattus norvegicus,,CHEMBL622394,A,,Plasma level at 2 hr after administration of the compound,Intermediate
,,,,,1,,,N,50597,3278,1,10116.0,9207,,BAO_0000218,Rattus norvegicus,,CHEMBL622395,A,,plasma level at 2 hr after administration of the compound,Intermediate
,,Serum,,,1,,,N,50597,4684,1,10116.0,9208,,BAO_0000218,Rattus norvegicus,1977.0,CHEMBL622396,A,,Stability in rat serum measured as % recovery at 1 min,Intermediate
,,Serum,,,1,,,N,50597,4684,1,10116.0,9209,,BAO_0000218,Rattus norvegicus,1977.0,CHEMBL624894,A,,Stability in rat serum measured as % recovery at 10 min,Intermediate
,,Serum,,,1,,,N,50597,4684,1,10116.0,9210,,BAO_0000218,Rattus norvegicus,1977.0,CHEMBL624895,A,,Stability in rat serum measured as % recovery at 10 mins,Intermediate
,,Serum,,,1,,,N,50597,4684,1,10116.0,9211,,BAO_0000218,Rattus norvegicus,1977.0,CHEMBL624058,A,,Stability in rat serum measured as % recovery at 2 hr,Intermediate
,,Serum,,,1,,,N,50597,4684,1,10116.0,9212,,BAO_0000218,Rattus norvegicus,1977.0,CHEMBL624059,A,,Stability in rat serum measured as % recovery at 3 min,Intermediate
,,Serum,,,1,,,N,50597,4684,1,10116.0,9213,,BAO_0000218,Rattus norvegicus,1977.0,CHEMBL624060,A,,Stability in rat serum measured as % recovery at 3 mins,Intermediate
,,Serum,,,1,,,N,50597,4684,1,10116.0,9214,,BAO_0000218,Rattus norvegicus,1977.0,CHEMBL624061,A,,Stability in rat serum measured as % recovery at 5 min,Intermediate
,,Serum,,,1,,,N,50597,4684,1,10116.0,9215,,BAO_0000218,Rattus norvegicus,1977.0,CHEMBL624062,A,,Stability in rat serum measured as % recovery at 5 mins,Intermediate
,In vivo,,,,1,,,N,50597,16456,1,10116.0,9216,,BAO_0000218,Rattus norvegicus,,CHEMBL624063,A,,Alpha-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,16456,1,10116.0,9217,,BAO_0000218,Rattus norvegicus,,CHEMBL624064,A,,Beta-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,Intermediate
,,Plasma,,,1,,,N,50597,723,1,10116.0,9218,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL624065,A,,Half life in plasma was determined against ovariectomized rats; t 1/2 (h) is short in plasma,Intermediate
,,Plasma,,,1,,,N,50597,723,1,10116.0,9219,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL624066,A,,Half life in plasma was determined against ovariectomized rats; t1/2 is longer in plasma.,Intermediate
,In vivo,,,,1,,,N,50597,5160,1,10116.0,9220,,BAO_0000218,Rattus norvegicus,,CHEMBL877490,A,,Half life tested in mature male rat at a dose of 30 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,4709,1,10116.0,9221,,BAO_0000218,Rattus norvegicus,,CHEMBL874442,A,,Half life after intravenous administration of 1 mg/kg in rat,Intermediate
,In vivo,,,,1,,,N,50597,5633,1,10116.0,9222,,BAO_0000218,Rattus norvegicus,,CHEMBL626890,A,,Half life period after administration (30 mg/kg) in rat,Intermediate
,In vivo,,,,1,,,N,50597,5302,1,10116.0,9223,,BAO_0000218,Rattus norvegicus,,CHEMBL626891,A,,Half life period in rat after 5 mg/Kg dose,Intermediate
,In vivo,,,,1,,,N,50597,5302,1,10116.0,9224,,BAO_0000218,Rattus norvegicus,,CHEMBL626892,A,,Half life period in rat after 5 mg/kg dose,Intermediate
,,,,,1,,,N,50597,17791,1,10116.0,9225,,BAO_0000218,Rattus norvegicus,,CHEMBL626893,A,,Half life period was determined,Intermediate
,,,,,1,,,N,50597,17791,1,10116.0,9226,,BAO_0000218,Rattus norvegicus,,CHEMBL626894,A,,Half life period was evaluated in rat,Intermediate
,,,,,1,,,N,50597,17791,1,10116.0,9227,,BAO_0000218,Rattus norvegicus,,CHEMBL626895,A,,Half life period was evaluated in rat; 0.5-1.0,Intermediate
,,,,,1,,,N,50597,17791,1,10116.0,9228,,BAO_0000218,Rattus norvegicus,,CHEMBL626896,A,,Half life period was evaluated in rat; 5.9-7.5,Intermediate
,,Plasma,,,1,,,N,50597,14512,1,10116.0,9229,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626897,A,,Half-life in rat plasma,Intermediate
,,,,,1,,,N,50597,6230,1,10116.0,9230,,BAO_0000218,Rattus norvegicus,,CHEMBL626898,A,,Half-life time in rat was determined,Intermediate
,In vivo,,,,1,,,N,50597,3364,1,10116.0,9231,,BAO_0000218,Rattus norvegicus,,CHEMBL626899,A,,Terminal half-life after iv administration to rats,Intermediate
,In vivo,,,,1,,,N,50597,6874,1,10116.0,9232,,BAO_0000218,Rattus norvegicus,,CHEMBL626900,A,,Tested for iv terminal half-life dosed as a solution in male Han Wistar rats,Intermediate
,,,,,1,,,N,50597,857,1,10116.0,9233,,BAO_0000218,Rattus norvegicus,,CHEMBL626901,A,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg,Intermediate
,In vivo,,,,1,,,N,50597,858,1,10116.0,9234,,BAO_0000218,Rattus norvegicus,,CHEMBL626902,A,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg (iv),Intermediate
,In vivo,,,,1,,,N,50597,858,1,10116.0,9235,,BAO_0000218,Rattus norvegicus,,CHEMBL626903,A,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 5 umol/kg (iv),Intermediate
,In vivo,,,,1,,,N,50597,5355,1,10116.0,9236,,BAO_0000218,Rattus norvegicus,,CHEMBL874443,A,,Time for peak concentration (tmax) at a dose of 10 mg/kg in rats,Intermediate
,In vivo,,,,1,,,N,50597,5355,1,10116.0,9237,,BAO_0000218,Rattus norvegicus,,CHEMBL626904,A,,Time for peak concentration (tmax) at a dose of 20 mg/kg in rats,Intermediate
,,,,,1,,,N,50597,6305,1,10116.0,9238,,BAO_0000218,Rattus norvegicus,,CHEMBL626905,A,,Half life in rats,Intermediate
,In vivo,Plasma,,,1,,,N,50597,13501,1,10116.0,9239,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL873830,A,,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 4 mg/kg to rat,Intermediate
,In vivo,,,,1,,,N,50597,17594,1,10116.0,9240,,BAO_0000218,Rattus norvegicus,,CHEMBL626906,A,,Apparent half-life after single intravenous bolus of 1 mg/kg in rats,Intermediate
,In vivo,Plasma,,,1,,,N,50597,4186,1,10116.0,9241,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL631076,A,,Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,Intermediate
,,Plasma,,,1,,,N,50597,2932,1,10116.0,9242,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL631077,A,,Biological half-life was measured in plasma of rats,Intermediate
,In vivo,,,,1,,,N,50597,17065,1,10116.0,9243,,BAO_0000218,Rattus norvegicus,,CHEMBL631078,A,,Circulatory half life measured after intravenous bolus administration of 50 mg/kg of compound to rats,Intermediate
,In vivo,,,,1,,,N,50597,15765,1,10116.0,9244,,BAO_0000218,Rattus norvegicus,,CHEMBL631079,A,,Compound demonstarted an oral bioavailability of 6% with the half-life time as given in rats.,Intermediate
,In vivo,,,,1,,,N,50597,2713,1,10116.0,9245,,BAO_0000218,Rattus norvegicus,,CHEMBL631080,A,,Compound was evaluated for half life (t1/2) upon intravenous administration of 1 mg/Kg in rats,Intermediate
,In vivo,,,,1,,,N,50597,2661,1,10116.0,9246,,BAO_0000218,Rattus norvegicus,,CHEMBL631081,A,,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to female wistar rats,Intermediate
,In vivo,,,,1,,,N,50597,2661,1,10116.0,9247,,BAO_0000218,Rattus norvegicus,,CHEMBL631239,A,,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to male wistar rats,Intermediate
,,Plasma,,,1,,,N,50597,740,1,10116.0,9248,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL631240,A,,Compound was evaluated for plasma half life in rat,Intermediate
,,Plasma,,,1,,,N,50597,6597,1,10116.0,9249,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL631241,A,,AUC value at a dose of 5 mg/kg (p.o.) in rats,Intermediate
,,Plasma,,,1,,,N,50597,2959,1,10116.0,9250,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL631242,A,,AUC value after administration of 20 mg/Kg oral dose in rat,Intermediate
,,Plasma,,,1,,,N,50597,17594,1,10116.0,9251,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL631243,A,,AUC0-24 after repeated oral dose of compound at 1 mg/kg in rats,Intermediate
,,Plasma,,,1,,,N,50597,17596,1,10116.0,9252,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL874444,A,,AUC0-96 after administration at 50 mg/kg,Intermediate
,,Plasma,,,1,,,N,50597,17594,1,10116.0,9253,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL631244,A,,AUC0-infinity after single intravenous bolus of 1 mg/kg in rats,Intermediate
,,,,,1,,,N,50597,3293,1,10116.0,9254,,BAO_0000218,Rattus norvegicus,,CHEMBL631245,A,,"Absorption behavior was judged by the area under the curve, determined after oral dose of 30 mg/kg in rats.",Intermediate
,,,,,1,,,N,50597,6757,1,10116.0,9255,,BAO_0000218,Rattus norvegicus,,CHEMBL627162,A,,Area under curve (0-24 hr) at a dose of 10 mg/kg in male SD rats,Intermediate
,,,,,1,,,N,50597,6757,1,10116.0,9256,,BAO_0000218,Rattus norvegicus,,CHEMBL627163,A,,Area under curve (0-24 hr) at a dose of 100 mg/kg in male SD rats,Intermediate
,,,,,1,,,N,50597,6757,1,10116.0,9257,,BAO_0000218,Rattus norvegicus,,CHEMBL627164,A,,Area under curve (0-24 hr) at a dose of 50 mg/kg in male SD rats,Intermediate
,,Kidney,,,1,,,N,50597,5979,1,10116.0,9258,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL627165,A,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat kidney,Intermediate
,,,,,1,,,N,50597,5979,1,10116.0,9259,,BAO_0000218,Rattus norvegicus,,CHEMBL627166,A,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat liver,Intermediate
,,,,,1,,,N,50597,5979,1,10116.0,9260,,BAO_0000218,Rattus norvegicus,,CHEMBL627167,A,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat lung,Intermediate
,,,,,1,,,N,50597,4026,1,10116.0,9261,,BAO_0000218,Rattus norvegicus,,CHEMBL627822,A,,Area under curve (AUC) at a dose of 30 mg/kg in rats,Intermediate
,,,,,1,,,N,50597,5355,1,10116.0,9262,,BAO_0000218,Rattus norvegicus,,CHEMBL627823,A,,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,Intermediate
,,,,,1,,,N,50597,5355,1,10116.0,9263,,BAO_0000218,Rattus norvegicus,,CHEMBL627824,A,,Area under curve (AUC) was calculated using trapezoidal rule. at a dose of 10 mg/kg in rats,Intermediate
,,,,,1,,,N,50597,5355,1,10116.0,9264,,BAO_0000218,Rattus norvegicus,,CHEMBL627825,A,,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,Intermediate
,,,,,1,,,N,50597,5633,1,10116.0,9265,,BAO_0000218,Rattus norvegicus,,CHEMBL627826,A,,Area under curve (AUC0-24 h) after administration (30 mg/kg) in rat,Intermediate
,,,,,1,,,N,50597,1716,1,10116.0,9266,,BAO_0000218,Rattus norvegicus,,CHEMBL627827,A,,Area under curve (Pharmacokinetic property) was determined,Intermediate
,,,,,1,,,N,50597,1716,1,10116.0,9267,,BAO_0000218,Rattus norvegicus,,CHEMBL627828,A,,Area under curve (Pharmacokinetic property) of the compound; Not determined,Intermediate
,,,,,1,,,N,50597,4689,1,10116.0,9268,,BAO_0000218,Rattus norvegicus,,CHEMBL627829,A,,Area under curve after intravenous administration (1 mg/kg) in rat,Intermediate
,,,,,1,,,N,50597,4527,1,10116.0,9269,,BAO_0000218,Rattus norvegicus,,CHEMBL627830,A,,Area under curve by intravenous administration at a dose of 10 uM/kg in rat was determined,Intermediate
,,,,,1,,,N,50597,4527,1,10116.0,9270,,BAO_0000218,Rattus norvegicus,,CHEMBL627831,A,,Area under curve by oral administration at a dose of 100 uM/kg in rat was determined,Intermediate
,,,,,1,,,N,50597,15662,1,10116.0,9271,,BAO_0000218,Rattus norvegicus,,CHEMBL627832,A,,Area under curve in male SD rats was observed after oral administration in rat,Intermediate
,,,,,1,,,N,50597,4413,1,10116.0,9272,,BAO_0000218,Rattus norvegicus,,CHEMBL627833,A,,Area under curve of compound after iv administration of 20 mg/kg dose in rat,Intermediate
,,,,,1,,,N,50597,3598,1,10116.0,9273,,BAO_0000218,Rattus norvegicus,,CHEMBL627834,A,,Area under curve of compound determined in rat after iv administration at a dose of 10 mg/kg,Expert
,,,,,1,,,N,50597,3598,1,10116.0,9274,,BAO_0000218,Rattus norvegicus,,CHEMBL628004,A,,Area under curve of compound from zero time to infinity determined in rat after iv administration at a dose of 10 mg/kg,Expert
,,,,,1,,,N,50597,5964,1,10116.0,9275,,BAO_0000218,Rattus norvegicus,,CHEMBL628005,A,,Area under curve at 5 mg/kg po was determined in rat,Intermediate
,,,,,1,,,N,50597,4689,1,10116.0,9276,,BAO_0000218,Rattus norvegicus,,CHEMBL628006,A,,Area under curve in Rat at a oral dose of 5 mg/kg,Intermediate
,,,,,1,,,N,50597,4186,1,10116.0,9277,,BAO_0000218,Rattus norvegicus,,CHEMBL628007,A,,Area under curve in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,Intermediate
,,,,,1,,,N,50597,5510,1,10116.0,9278,,BAO_0000218,Rattus norvegicus,,CHEMBL625676,A,,Area under curve was determined,Intermediate
,,,,,1,,,N,50597,17858,1,10116.0,9279,,BAO_0000218,Rattus norvegicus,,CHEMBL631309,A,,Area under curve after 10 mg/kg oral administration in rat at 0-24 hr,Intermediate
,,,,,1,,,N,50597,17804,1,10116.0,9280,,BAO_0000218,Rattus norvegicus,,CHEMBL631310,A,,Area under curve after intravenous administration at 3 mg/kg,Intermediate
,,,,,1,,,N,50597,6106,1,10116.0,9281,,BAO_0000218,Rattus norvegicus,,CHEMBL631311,A,,Area under curve after peroral administration at 10 mg/kg in rat for 0-6 h,Intermediate
,,,,,1,,,N,50597,5964,1,10116.0,9282,,BAO_0000218,Rattus norvegicus,,CHEMBL631312,A,,Area under curve at 4 hr in rat,Intermediate
,,,,,1,,,N,50597,4026,1,10116.0,9283,,BAO_0000218,Rattus norvegicus,,CHEMBL631313,A,,Area under curve at a dose of 30 mg/kg,Intermediate
,,,,,1,,,N,50597,4756,1,10116.0,9284,,BAO_0000218,Rattus norvegicus,,CHEMBL631314,A,,Area under curve at the dose of 2 mg/Kg administered perorally in rats,Intermediate
,,,,,1,,,N,50597,4756,1,10116.0,9285,,BAO_0000218,Rattus norvegicus,,CHEMBL631315,A,,Area under curve at the dose of 5 mg/Kg administered perorally in rats,Intermediate
,,,,,1,,,N,50597,5862,1,10116.0,9286,,BAO_0000218,Rattus norvegicus,,CHEMBL631316,A,,Area under curve for a 2-mpk po dose in SD rats,Intermediate
,,,,,1,,,N,50597,5862,1,10116.0,9287,,BAO_0000218,Rattus norvegicus,,CHEMBL631317,A,,Area under curve in SD rats,Intermediate
,,,,,1,,,N,50597,6644,1,10116.0,9288,,BAO_0000218,Rattus norvegicus,,CHEMBL874471,A,,Area under curve in rat after oral administration at 13 mg/kg dose,Intermediate
,,,,,1,,,N,50597,5871,1,10116.0,9289,,BAO_0000218,Rattus norvegicus,,CHEMBL631318,A,,Area under curve in rat by po administration at 0-24 hr,Intermediate
,,Plasma,,,1,,,N,50597,5919,1,10116.0,9290,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL631319,A,,Area under curve in rat plasma,Intermediate
,,,,,1,,,N,50597,5939,1,10116.0,9291,,BAO_0000218,Rattus norvegicus,,CHEMBL631320,A,,Area under curve in rat plasma for 0-4 hr after peroral administration at 10 mg/kg,Intermediate
,,,,,1,,,N,50597,5939,1,10116.0,9292,,BAO_0000218,Rattus norvegicus,,CHEMBL631321,A,,Area under curve in rat plasma for 0-4 hr after peroral administration at 5 mg/kg,Intermediate
,,,,,1,,,N,50597,10,1,10116.0,9293,,BAO_0000218,Rattus norvegicus,,CHEMBL631322,A,,Area under curve was evaluated in rat at 3 mg/kg dose administered intravenously,Intermediate
,,,,,1,,,N,50597,11149,1,10116.0,9294,,BAO_0000218,Rattus norvegicus,,CHEMBL631323,A,,Area under curve was measured from the graph obtained from concentration Vs time after oral administration to male F344 rats,Intermediate
,,,,,1,,,N,50597,5302,1,10116.0,9295,,BAO_0000218,Rattus norvegicus,,CHEMBL631324,A,,Area under curve value in rat at a dose of 5 mg/kg,Intermediate
,,,,,1,,,N,50597,17796,1,10116.0,9296,,BAO_0000218,Rattus norvegicus,,CHEMBL631325,A,,Area under curve was determined after oral administration in rats,Intermediate
,,,,,1,,,N,50597,4890,1,10116.0,9297,,BAO_0000218,Rattus norvegicus,,CHEMBL631326,A,,Area under curve was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,Intermediate
,,,,,1,,,N,50597,6011,1,10116.0,9298,,BAO_0000218,Rattus norvegicus,,CHEMBL631327,A,,Area under curve was determined after peroral administration in rat,Intermediate
,,,,,1,,,N,50597,5375,1,10116.0,9299,,BAO_0000218,Rattus norvegicus,,CHEMBL631328,A,,Area under curve was determined at a dose 30 mpk administered orally.,Intermediate
,,,,,1,,,N,50597,17764,1,10116.0,9300,,BAO_0000218,Rattus norvegicus,,CHEMBL631329,A,,Area under curve was determined for compound after intravenous administration in rats at 24 uM/kg,Intermediate
,,,,,1,,,N,50597,4368,1,10116.0,9301,,BAO_0000218,Rattus norvegicus,,CHEMBL627217,A,,Area under curve was determined for the compound by intravenous administration of 3.4 mg/kg in rat,Intermediate
,,,,,1,,,N,50597,5610,1,10116.0,9302,,BAO_0000218,Rattus norvegicus,,CHEMBL626352,A,,Area under curve was determined in male rat,Intermediate
,,,,,1,,,N,50597,5833,1,10116.0,9303,,BAO_0000218,Rattus norvegicus,,CHEMBL626353,A,,Area under curve was determined in rat after PO administration,Intermediate
,,,,,1,,,N,50597,4257,1,10116.0,9304,,BAO_0000218,Rattus norvegicus,,CHEMBL626354,A,,Area under curve was determined in rat after a 3 mg/kg of oral dose,Intermediate
,,,,,1,,,N,50597,5937,1,10116.0,9305,,BAO_0000218,Rattus norvegicus,,CHEMBL626355,A,,Area under curve was determined in rat after oral administration at a concentration 1 mg/kg,Intermediate
,,,,,1,,,N,50597,5932,1,10116.0,9306,,BAO_0000218,Rattus norvegicus,,CHEMBL626356,A,,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg,Intermediate
,,,,,1,,,N,50597,5932,1,10116.0,9307,,BAO_0000218,Rattus norvegicus,,CHEMBL626357,A,,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg; NA= Not active,Intermediate
,,,,,1,,,N,50597,17411,1,10116.0,9308,,BAO_0000218,Rattus norvegicus,,CHEMBL626358,A,,Liver concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate
,,,,,1,,,N,50597,17411,1,10116.0,9309,,BAO_0000218,Rattus norvegicus,,CHEMBL626359,A,,Lung concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate
,,Plasma,,,1,,,N,50597,17771,1,10116.0,9310,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626360,A,,Peak plasma concentration in rat at a dose of 3 mg/kg,Intermediate
,,,,,1,,,N,50597,1628,1,10116.0,9311,,BAO_0000218,Rattus norvegicus,,CHEMBL626361,A,,Plasma concentration at 2 hr in rats was evaluated.,Intermediate
,,,,,1,,,N,50597,1628,1,10116.0,9312,,BAO_0000218,Rattus norvegicus,,CHEMBL626362,A,,Plasma concentration at 2 hr in rats was evaluated; Not available,Intermediate
,,,,,1,,,N,50597,17411,1,10116.0,9313,,BAO_0000218,Rattus norvegicus,,CHEMBL626363,A,,Serum concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate
,,,,,1,,,N,50597,4910,1,10116.0,9314,,BAO_0000218,Rattus norvegicus,,CHEMBL626970,A,,Tested for concentration in brain after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,Intermediate
,,,,,1,,,N,50597,4910,1,10116.0,9315,,BAO_0000218,Rattus norvegicus,,CHEMBL626971,A,,Tested for concentration in brain after 2 hrs of intravenous administration (5 mg/kg) to male rats,Intermediate
,,Plasma,,,1,,,N,50597,4910,1,10116.0,9316,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626972,A,,Tested for plasma concentration after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,Intermediate
,,Plasma,,,1,,,N,50597,4910,1,10116.0,9317,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626973,A,,Tested for plasma concentration after 2 hrs of intravenous administration (5 mg/kg) to male rats,Intermediate
,,Plasma,,,1,,,N,50597,4910,1,10116.0,9318,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626974,A,,Tested for plasma concentration in the after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,Intermediate
,,Plasma,,,1,,,N,50597,4910,1,10116.0,9319,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL874592,A,,Tested for plasma concentration in the after 2 hrs of intravenous administration (5 mg/kg) to male rats,Intermediate
,,,,,1,,,N,50597,5510,1,10116.0,9320,,BAO_0000218,Rattus norvegicus,,CHEMBL626975,A,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C,Intermediate
,,,,,1,,,N,50597,5510,1,10116.0,9321,,BAO_0000218,Rattus norvegicus,,CHEMBL626976,A,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Converted to an unknown compound,Intermediate
,,,,,1,,,N,50597,5510,1,10116.0,9322,,BAO_0000218,Rattus norvegicus,,CHEMBL626977,A,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not determined,Intermediate
,,,,,1,,,N,50597,5510,1,10116.0,9323,,BAO_0000218,Rattus norvegicus,,CHEMBL626978,A,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not tested,Intermediate
,,,,,1,,,N,50597,16427,1,10116.0,9324,,BAO_0000218,Rattus norvegicus,,CHEMBL626979,A,,PK study was carried to determine the relative absorption ranking in rat.,Intermediate
,In vivo,Plasma,,,1,,,N,50597,4689,1,10116.0,9325,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626980,A,,Maximum plasma concentration in Rat at a oral dose of 5 mg/kg,Intermediate
,,Blood,,,1,,,N,50597,11450,1,10116.0,9326,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL626981,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.57-0.75 % dose/g",Intermediate
,,Blood,,,1,,,N,50597,11450,1,10116.0,9327,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL626982,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.63 % dose/g",Intermediate
,,Blood,,,1,,,N,50597,11450,1,10116.0,9328,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL626983,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.40-0.55 % dose/g",Intermediate
,,Blood,,,1,,,N,50597,11450,1,10116.0,9329,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL622522,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.28-0.37% dose/g",Intermediate
,,Blood,,,1,,,N,50597,11450,1,10116.0,9330,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL622523,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.56-0.74 % dose/g",Intermediate
,,Blood,,,1,,,N,50597,11450,1,10116.0,9331,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL622524,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from % dose/g",Intermediate
,,Brain,,,1,,,N,50597,11450,1,10116.0,9332,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL622525,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.20-2.85 % dose/g",Intermediate
,,Brain,,,1,,,N,50597,11450,1,10116.0,9333,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL622526,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.16-1.76 % dose/g",Intermediate
,,Brain,,,1,,,N,50597,11450,1,10116.0,9334,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL619849,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.96-3.72 % dose/g",Intermediate
,,Brain,,,1,,,N,50597,11450,1,10116.0,9335,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL619850,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.57-3.59 % dose/g",Intermediate
,,Brain,,,1,,,N,50597,11450,1,10116.0,9336,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL623864,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.36-1.53 % dose/g",Intermediate
,,Brain,,,1,,,N,50597,11450,1,10116.0,9337,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL623865,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.81-1.08 % dose/g",Intermediate
,,Heart,,,1,,,N,50597,11450,1,10116.0,9338,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL623866,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.84-0.98 % dose/g",Intermediate
,,Heart,,,1,,,N,50597,11450,1,10116.0,9339,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL623867,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.53 % dose/g",Intermediate
,,Heart,,,1,,,N,50597,11450,1,10116.0,9340,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL877615,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.22-1.48 % dose/g",Intermediate
,,Heart,,,1,,,N,50597,11450,1,10116.0,9341,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL623868,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.85-1.13 % dose/g",Intermediate
,,Heart,,,1,,,N,50597,11450,1,10116.0,9342,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL623869,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.55-0.63 % dose/g",Intermediate
,,Heart,,,1,,,N,50597,11450,1,10116.0,9343,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL623870,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.33-0.42 % dose/g",Intermediate
,,Lung,,,1,,,N,50597,16434,1,10116.0,9344,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL623871,A,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,Intermediate
,,Lung,,,1,,,N,50597,16434,1,10116.0,9345,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL623872,A,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate
,,Lung,,,1,,,N,50597,16435,1,10116.0,9346,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL622129,A,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate
,,Lung,,,1,,,N,50597,16435,1,10116.0,9347,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL622130,A,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate
,,Lung,,,1,,,N,50597,16435,1,10116.0,9348,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL622131,A,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate
,,Lung,,,1,,,N,50597,16435,1,10116.0,9349,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL622132,A,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate
,,Lung,,,1,,,N,50597,16435,1,10116.0,9350,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL622133,A,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate
,,Lung,,,1,,,N,50597,16435,1,10116.0,9351,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL622134,A,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate
,,Lung,,,1,,,N,50597,16435,1,10116.0,9352,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL622135,A,,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate
,,Lung,,,1,,,N,50597,16435,1,10116.0,9353,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL622136,A,,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate
,,Muscle tissue,,,1,,,N,50597,16434,1,10116.0,9354,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL622137,A,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate
,,Muscle tissue,,,1,,,N,50597,16434,1,10116.0,9355,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL622138,A,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate
,,Muscle tissue,,,1,,,N,50597,16434,1,10116.0,9356,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL623017,A,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate
,,Muscle tissue,,,1,,,N,50597,16434,1,10116.0,9357,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL623018,A,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate
,,Muscle tissue,,,1,,,N,50597,16434,1,10116.0,9358,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL623019,A,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Intermediate
,,Muscle tissue,,,1,,,N,50597,16434,1,10116.0,9359,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL623020,A,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Intermediate
,,Muscle tissue,,,1,,,N,50597,16434,1,10116.0,9360,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL623021,A,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min.,Intermediate
,,Muscle tissue,,,1,,,N,50597,16434,1,10116.0,9361,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL623022,A,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,Intermediate
,,Muscle tissue,,,1,,,N,50597,16435,1,10116.0,9362,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL623023,A,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate
,,Muscle tissue,,,1,,,N,50597,16435,1,10116.0,9363,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL623024,A,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate
,,Muscle tissue,,,1,,,N,50597,16435,1,10116.0,9364,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL623025,A,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate
,,Muscle tissue,,,1,,,N,50597,16435,1,10116.0,9365,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL620545,A,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate
,,Muscle tissue,,,1,,,N,50597,16435,1,10116.0,9366,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL620546,A,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate
,,Muscle tissue,,,1,,,N,50597,16435,1,10116.0,9367,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL620547,A,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate
,,Muscle tissue,,,1,,,N,50597,16435,1,10116.0,9368,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL620548,A,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate
,,Muscle tissue,,,1,,,N,50597,16435,1,10116.0,9369,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL620549,A,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate
,,Muscle tissue,,,1,,,N,50597,16434,1,10116.0,9370,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL620550,A,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate
,,Muscle tissue,,,1,,,N,50597,16434,1,10116.0,9371,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL620551,A,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,Intermediate
,,Muscle tissue,,,1,,,N,50597,16434,1,10116.0,9372,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL620552,A,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate
,,Muscle tissue,,,1,,,N,50597,16435,1,10116.0,9373,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL620553,A,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate
,,Muscle tissue,,,1,,,N,50597,16435,1,10116.0,9374,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL620554,A,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate
,,Muscle tissue,,,1,,,N,50597,16435,1,10116.0,9375,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL875845,A,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate
,,Muscle tissue,,,1,,,N,50597,16435,1,10116.0,9376,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL620555,A,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate
,,Muscle tissue,,,1,,,N,50597,16435,1,10116.0,9377,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL620556,A,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate
,,Muscle tissue,,,1,,,N,50597,16435,1,10116.0,9378,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL620557,A,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate
,,,,,1,,,N,50597,16434,1,10116.0,9379,,BAO_0000218,Rattus norvegicus,,CHEMBL620558,A,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate
,,,,,1,,,N,50597,16434,1,10116.0,9380,,BAO_0000218,Rattus norvegicus,,CHEMBL620559,A,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate
,,,,,1,,,N,50597,16434,1,10116.0,9381,,BAO_0000218,Rattus norvegicus,,CHEMBL622939,A,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate
,,,,,1,,,N,50597,16434,1,10116.0,9382,,BAO_0000218,Rattus norvegicus,,CHEMBL622940,A,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate
,,,,,1,,,N,50597,16434,1,10116.0,9383,,BAO_0000218,Rattus norvegicus,,CHEMBL622941,A,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Intermediate
,,,,,1,,,N,50597,16434,1,10116.0,9384,,BAO_0000218,Rattus norvegicus,,CHEMBL622942,A,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Intermediate
,,,,,1,,,N,50597,16434,1,10116.0,9385,,BAO_0000218,Rattus norvegicus,,CHEMBL622943,A,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Intermediate
,,,,,1,,,N,50597,16434,1,10116.0,9386,,BAO_0000218,Rattus norvegicus,,CHEMBL622944,A,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Intermediate
,,,,,1,,,N,50597,16435,1,10116.0,9387,,BAO_0000218,Rattus norvegicus,,CHEMBL622945,A,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate
,,,,,1,,,N,50597,16435,1,10116.0,9388,,BAO_0000218,Rattus norvegicus,,CHEMBL622946,A,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate
,,,,,1,,,N,50597,3341,1,10116.0,9389,,BAO_0000218,Rattus norvegicus,,CHEMBL622947,A,,Compound was evaluated for terminal half life in rat,Intermediate
,In vivo,Plasma,,,1,,,N,50597,3634,1,10116.0,9390,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622948,A,,Compound was evaluated in vivo in rat for the plasma half-life at a iv dose of 3 mg/kg and oral dose of 10 mg/kg and experiment by using concentration vs time curve,Intermediate
,In vivo,Plasma,,,1,,,N,50597,3634,1,10116.0,9391,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622949,A,,Compound was evaluated in vivo in rat for the plasma half-life at a oral dose of 20 mg/kg experiment by using concentration vs time curve,Intermediate
,,,,,1,,,N,50597,4839,1,10116.0,9392,,BAO_0000218,Rattus norvegicus,,CHEMBL622950,A,,Compound was tested for its half life in rat,Intermediate
,In vivo,Plasma,,,0,,,U,22224,5005,1,9544.0,9393,,BAO_0000218,Macaca mulatta,1969.0,CHEMBL622951,A,,Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,Intermediate
,,Plasma,,,0,,,U,22224,5005,1,10116.0,9394,,BAO_0000366,Rattus norvegicus,1969.0,CHEMBL622952,A,,Compound was tested for its plasma half life in Sprague Dawley rats,Intermediate
,,Plasma,,,0,,,U,22224,5005,1,10116.0,9395,,BAO_0000366,Rattus norvegicus,1969.0,CHEMBL622953,A,,Compound was tested for its plasma half life in Sprague Dawley rats; ND is not determined,Intermediate
,,Plasma,,,1,,,N,50597,1094,1,10116.0,9396,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL873818,A,,Compound was tested for plasma half-life period in rat,Intermediate
,In vivo,,,,1,,,N,50597,5031,1,10116.0,9397,,BAO_0000218,Rattus norvegicus,,CHEMBL622954,A,,Elimination half life after i.v. administration of compound in rats,Intermediate
,In vivo,,,,1,,,N,50597,6518,1,10116.0,9398,,BAO_0000218,Rattus norvegicus,,CHEMBL622955,A,,Elimination half-life after IV dosing at 0.5 mg/kg in rat,Intermediate
,In vivo,,,,1,,,N,50597,6518,1,10116.0,9399,,BAO_0000218,Rattus norvegicus,,CHEMBL875229,A,,Elimination half-life after IV dosing at 1 mg/kg in rat,Intermediate
,In vivo,,,,1,,,N,50597,6518,1,10116.0,9400,,BAO_0000218,Rattus norvegicus,,CHEMBL622956,A,,Elimination half-life after oral administration at a dose of 2 mg/kg in rat,Intermediate
,In vivo,,,,1,,,N,50597,6518,1,10116.0,9401,,BAO_0000218,Rattus norvegicus,,CHEMBL622957,A,,Elimination half-life after oral administration at a dose of 4 mg/kg in rat,Intermediate
,In vivo,Brain,,,1,,,N,50597,5408,1,10116.0,9402,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL622958,A,,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,Intermediate
,In vivo,Plasma,,,1,,,N,50597,5408,1,10116.0,9403,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622959,A,,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,Intermediate
,In vivo,Brain,,,1,,,N,50597,5408,1,10116.0,9404,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL622960,A,,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,Intermediate
,In vivo,Plasma,,,1,,,N,50597,5408,1,10116.0,9405,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622961,A,,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,Intermediate
,In vivo,,,,1,,,N,50597,4687,1,10116.0,9406,,BAO_0000218,Rattus norvegicus,,CHEMBL622962,A,,Evaluated for the half life in rat (in vivo),Intermediate
,,,,,1,,,N,50597,6640,1,10116.0,9407,,BAO_0000218,Rattus norvegicus,,CHEMBL622963,A,,Hafl life in rat,Intermediate
,,,,,1,,,N,50597,6640,1,10116.0,9408,,BAO_0000218,Rattus norvegicus,,CHEMBL622964,A,,Hafl life rat,Intermediate
,,,,,1,,,N,50597,6641,1,10116.0,9409,,BAO_0000218,Rattus norvegicus,,CHEMBL622965,A,,Hafl life rat,Intermediate
,,,,,1,,,N,50597,6640,1,10116.0,9410,,BAO_0000218,Rattus norvegicus,,CHEMBL622966,A,,Hafl life rat; Not determined,Intermediate
,,,,,1,,,N,50597,6641,1,10116.0,9411,,BAO_0000218,Rattus norvegicus,,CHEMBL622967,A,,Hafl life rat; Not determined,Intermediate
,In vivo,Kidney,,,1,,,N,50597,17411,1,10116.0,9412,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL622968,A,,Half life in kidney was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate
,In vivo,Liver,,,1,,,N,50597,17411,1,10116.0,9413,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL622969,A,,Half life in liver was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate
,In vivo,Lung,,,1,,,N,50597,17411,1,10116.0,9414,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL875327,A,,Half life in lung was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,6570,1,10116.0,9415,,BAO_0000218,Rattus norvegicus,,CHEMBL628638,A,,Half life in rat after 1 mg/kg i.v. administration,Intermediate
,In vivo,,,,1,,,N,50597,6570,1,10116.0,9416,,BAO_0000218,Rattus norvegicus,,CHEMBL628639,A,,Half life in rat after 2 mg/kg peroral administration,Intermediate
,In vivo,,,,1,,,N,50597,17411,1,10116.0,9417,,BAO_0000218,Rattus norvegicus,,CHEMBL625840,A,,Half life in serum was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,4722,1,10116.0,9418,,BAO_0000218,Rattus norvegicus,,CHEMBL625841,A,,Half life of 10 mg/kg oral dose determined in rats,Intermediate
,In vivo,,,,1,,,N,50597,5978,1,10116.0,9419,,BAO_0000218,Rattus norvegicus,,CHEMBL625842,A,,Half life of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,5978,1,10116.0,9420,,BAO_0000218,Rattus norvegicus,,CHEMBL625843,A,,Half life of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,5978,1,10116.0,9421,,BAO_0000218,Rattus norvegicus,,CHEMBL625844,A,,Half life of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,5978,1,10116.0,9422,,BAO_0000218,Rattus norvegicus,,CHEMBL873822,A,,Half life of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,5978,1,10116.0,9423,,BAO_0000218,Rattus norvegicus,,CHEMBL625845,A,,Half life of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,5978,1,10116.0,9424,,BAO_0000218,Rattus norvegicus,,CHEMBL627059,A,,Half life of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,5978,1,10116.0,9425,,BAO_0000218,Rattus norvegicus,,CHEMBL627060,A,,Half life of compound (9.84 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,5978,1,10116.0,9426,,BAO_0000218,Rattus norvegicus,,CHEMBL627061,A,,Half life of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,4762,1,10116.0,9427,,BAO_0000218,Rattus norvegicus,,CHEMBL627709,A,,Half life of compound at 5 mg/kg after po administration was determined in rat,Intermediate
,In vivo,,,,1,,,N,50597,5327,1,10116.0,9428,,BAO_0000218,Rattus norvegicus,,CHEMBL627710,A,,Half life of compound determined after intravenous administration to rat,Intermediate
,,,,,1,,,N,50597,4847,1,10116.0,9429,,BAO_0000218,Rattus norvegicus,,CHEMBL627711,A,,Half life of compound was determined in rat,Intermediate
,In vivo,Plasma,,,1,,,N,50597,17720,1,10116.0,9430,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL627712,A,,Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,Intermediate
,In vivo,,,,1,,,N,50597,4723,1,10116.0,9431,,BAO_0000218,Rattus norvegicus,,CHEMBL627713,A,,Half life determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Intermediate
,In vivo,,,,1,,,N,50597,4723,1,10116.0,9432,,BAO_0000218,Rattus norvegicus,,CHEMBL627714,A,,Half life determined after 3 mg/kg oral administration in potassium oxonate treated rats,Intermediate
,In vivo,,,,0,,,U,22224,4256,1,9541.0,9433,,BAO_0000218,Macaca fascicularis,,CHEMBL627889,A,,Half life determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,Intermediate
,In vivo,,,,0,,,U,22224,4256,1,10116.0,9434,,BAO_0000218,Rattus norvegicus,,CHEMBL627890,A,,Half life determined in rat by intravenous administration,Intermediate
,In vivo,,,,1,,,N,50597,4722,1,10116.0,9435,,BAO_0000218,Rattus norvegicus,,CHEMBL627891,A,,Half life determined in rats after iv administration,Intermediate
,In vivo,Plasma,,,1,,,N,50597,6535,1,10116.0,9436,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL627892,A,,Half life in rat plasma after administration of 2 mg/kg iv,Intermediate
,In vivo,Plasma,,,1,,,N,50597,6535,1,10116.0,9437,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL627893,A,,Half life in rat plasma after administration of 2 mg/kg iv,Intermediate
,,Plasma,,,1,,,N,50597,1435,1,10116.0,9438,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL627894,A,,Half life in rat plasma was determined,Intermediate
,,Plasma,,,1,,,N,50597,1435,1,10116.0,9439,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL627895,A,,Half life in rat plasma was determined; NA means not applicable,Intermediate
,,,,,1,,,N,50597,5206,1,10116.0,9440,,BAO_0000218,Rattus norvegicus,,CHEMBL627896,A,,Half life in rat was tested,Intermediate
,,Plasma,,,1,,,N,50597,6080,1,10116.0,9441,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL627897,A,,Half life measured in rat plasma,Intermediate
,,,,,1,,,N,50597,4449,1,10116.0,9442,,BAO_0000218,Rattus norvegicus,,CHEMBL627898,A,,Half life recorded in rats,Intermediate
,,,,,1,,,N,50597,6057,1,10116.0,9443,,BAO_0000218,Rattus norvegicus,,CHEMBL627899,A,,Half life was calculated,Intermediate
,,,,,1,,,N,50597,6057,1,10116.0,9444,,BAO_0000218,Rattus norvegicus,,CHEMBL873823,A,,Half life was calculated in rat,Intermediate
,,,,,1,,,N,50597,3747,1,10116.0,9445,,BAO_0000218,Rattus norvegicus,,CHEMBL627900,A,,Half life was determined,Intermediate
,In vivo,,,,1,,,N,50597,17858,1,10116.0,9446,,BAO_0000218,Rattus norvegicus,,CHEMBL627901,A,,Half life after 10 mg/kg oral administration in rat,Intermediate
,In vivo,,,,1,,,N,50597,16365,1,10116.0,9447,,BAO_0000218,Rattus norvegicus,,CHEMBL627902,A,,Half life after administering orally a dose of 10 mg/kg to a fasting rat,Intermediate
,In vivo,,,,1,,,N,50597,16365,1,10116.0,9448,,BAO_0000218,Rattus norvegicus,,CHEMBL627903,A,,Half life after administering orally a dose of 30 mg/kg,Intermediate
,,,,,1,,,N,50597,5031,1,10116.0,9449,,BAO_0000218,Rattus norvegicus,,CHEMBL627904,A,,Area under the curve (Concentration) was determined for the compound as AUC with limits 0-8 after i.v. administration in rats,Intermediate
,,,,,1,,,N,50597,4722,1,10116.0,9450,,BAO_0000218,Rattus norvegicus,,CHEMBL627905,A,,Area under the curve determined under pharmacokinetic behavior of the 10 mg/kg oral dose of compound for 0-6 hours,Intermediate
,,,,,1,,,N,50597,6078,1,10116.0,9451,,BAO_0000218,Rattus norvegicus,,CHEMBL627906,A,,Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in rat,Intermediate
,,,,,1,,,N,50597,6078,1,10116.0,9452,,BAO_0000218,Rattus norvegicus,,CHEMBL627907,A,,Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in rat,Intermediate
,,,,,1,,,N,50597,6078,1,10116.0,9453,,BAO_0000218,Rattus norvegicus,,CHEMBL876783,A,,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg,Intermediate
,,,,,1,,,N,50597,6078,1,10116.0,9454,,BAO_0000218,Rattus norvegicus,,CHEMBL627908,A,,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg; activity was not determined,Intermediate
,,,,,1,,,N,50597,17065,1,10116.0,9455,,BAO_0000218,Rattus norvegicus,,CHEMBL627909,A,,Area under the curve measured after intravenous bolus administration of 50 mg/kg of compound to rats,Intermediate
,,,,,1,,,N,50597,1353,1,10116.0,9456,,BAO_0000218,Rattus norvegicus,,CHEMBL627910,A,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats,Intermediate
,,,,,1,,,N,50597,1353,1,10116.0,9457,,BAO_0000218,Rattus norvegicus,,CHEMBL627911,A,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-1),Intermediate
,,,,,1,,,N,50597,1353,1,10116.0,9458,,BAO_0000218,Rattus norvegicus,,CHEMBL627912,A,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-2),Intermediate
,,,,,1,,,N,50597,1353,1,10116.0,9459,,BAO_0000218,Rattus norvegicus,,CHEMBL627913,A,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-5),Intermediate
,,,,,1,,,N,50597,1353,1,10116.0,9460,,BAO_0000218,Rattus norvegicus,,CHEMBL627914,A,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(5-10),Intermediate
,,,,,1,,,N,50597,16423,1,10116.0,9461,,BAO_0000218,Rattus norvegicus,,CHEMBL627915,A,,Area under the curve was evaluated after 10 uM/kg of intra arterial administration,Intermediate
,,,,,1,,,N,50597,16423,1,10116.0,9462,,BAO_0000218,Rattus norvegicus,,CHEMBL627916,A,,Area under the curve was evaluated after 20 uM/kg of peroral administration,Intermediate
,,,,,1,,,N,50597,6062,1,10116.0,9463,,BAO_0000218,Rattus norvegicus,,CHEMBL627917,A,,Area under the curve was measured in rat after an iv dose of 1 mg/kg,Intermediate
,,,,,1,,,N,50597,6056,1,10116.0,9464,,BAO_0000218,Rattus norvegicus,,CHEMBL627918,A,,Area under the curve was calculated for the compound at a single intravenous administration of 20 mg/kg in rat,Intermediate
,,,,,1,,,N,50597,5182,1,10116.0,9465,,BAO_0000218,Rattus norvegicus,,CHEMBL627919,A,,Area under the curve was determined by administering the compound at a dose of 1 mg/kg intravenously in male wistar rat,Intermediate
,,,,,1,,,N,50597,6410,1,10116.0,9466,,BAO_0000218,Rattus norvegicus,,CHEMBL627920,A,,Area under the curve was evaluated at an intravenous dose of 3 mg/kg,Intermediate
,,,,,1,,,N,50597,6410,1,10116.0,9467,,BAO_0000218,Rattus norvegicus,,CHEMBL627921,A,,Area under the curve was evaluated at an oral dose of 30 mg/kg,Intermediate
,,,,,1,,,N,50597,4723,1,10116.0,9468,,BAO_0000218,Rattus norvegicus,,CHEMBL627922,A,,Area under the effect time curves from time 0-24 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Intermediate
,,,,,1,,,N,50597,4723,1,10116.0,9469,,BAO_0000218,Rattus norvegicus,,CHEMBL876784,A,,Area under the effect time curves from time 0-24 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,Intermediate
,,,,,1,,,N,50597,4723,1,10116.0,9470,,BAO_0000218,Rattus norvegicus,,CHEMBL627923,A,,Area under the effect time curves from time 0-6 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Intermediate
,,,,,1,,,N,50597,4723,1,10116.0,9471,,BAO_0000218,Rattus norvegicus,,CHEMBL626208,A,,Area under the effect time curves from time 0-6 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,Intermediate
,,,,,1,,,N,50597,4723,1,10116.0,9472,,BAO_0000218,Rattus norvegicus,,CHEMBL626209,A,,Area under the effect time curves from time 0-infinity hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Intermediate
,,,,,1,,,N,50597,4723,1,10116.0,9473,,BAO_0000218,Rattus norvegicus,,CHEMBL626210,A,,Area under the effect time curves from time 0-infinity hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,Intermediate
,,Plasma,,,1,,,N,50597,2463,1,10116.0,9474,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL627994,A,,Area under the plasma concentration curve was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,Intermediate
,,,,,1,,,N,50597,4709,1,10116.0,9475,,BAO_0000218,Rattus norvegicus,,CHEMBL627995,A,,Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in rat,Intermediate
,,,,,1,,,N,50597,4075,1,10116.0,9476,,BAO_0000218,Rattus norvegicus,,CHEMBL627996,A,,Blood level after a 10 mg/kg oral dose in rat expressed as AUC was determined,Intermediate
,,,,,1,,,N,50597,5394,1,10116.0,9477,,BAO_0000218,Rattus norvegicus,,CHEMBL627997,A,,Compound at a dose 10 mg/kg was administered orally to rat and the pharmacokinetic parameter area under curve (AUC) was measured,Intermediate
,,,,,1,,,N,50597,2661,1,10116.0,9478,,BAO_0000218,Rattus norvegicus,,CHEMBL627998,A,,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female wistar rats,Intermediate
,,,,,1,,,N,50597,2661,1,10116.0,9479,,BAO_0000218,Rattus norvegicus,,CHEMBL628640,A,,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to male wistar rats,Intermediate
,,,,,1,,,N,50597,2661,1,10116.0,9480,,BAO_0000218,Rattus norvegicus,,CHEMBL628641,A,,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female wistar rats,Intermediate
,,,,,1,,,N,50597,2661,1,10116.0,9481,,BAO_0000218,Rattus norvegicus,,CHEMBL628642,A,,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to male wistar rats,Intermediate
,,,,,1,,,N,50597,17791,1,10116.0,9482,,BAO_0000218,Rattus norvegicus,,CHEMBL628643,A,,Compound was evaluated for area under the curve expressed as (h*ug/ml),Intermediate
,,,,,1,,,N,50597,2591,1,10116.0,9483,,BAO_0000218,Rattus norvegicus,,CHEMBL628644,A,,Compound was tested for area under curve in rat,Intermediate
,,,,,1,,,N,50597,6567,1,10116.0,9484,,BAO_0000218,Rattus norvegicus,,CHEMBL628645,A,,Concentration in rat plasma after 5 mg/kg oral gavage for 8 hours,Intermediate
,,,,,1,,,N,50597,6211,1,10116.0,9485,,BAO_0000218,Rattus norvegicus,,CHEMBL628646,A,,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,Intermediate
,,,,,1,,,N,50597,5529,1,10116.0,9486,,BAO_0000218,Rattus norvegicus,,CHEMBL628647,A,,Dose-normalized AUC was determined in rat after peroral administration (2 mg/kg),Intermediate
,,,,,1,,,N,50597,5408,1,10116.0,9487,,BAO_0000218,Rattus norvegicus,,CHEMBL628648,A,,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,Intermediate
,,,,,1,,,N,50597,5408,1,10116.0,9488,,BAO_0000218,Rattus norvegicus,,CHEMBL625358,A,,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,Intermediate
,,,,,1,,,N,50597,5408,1,10116.0,9489,,BAO_0000218,Rattus norvegicus,,CHEMBL625359,A,,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,Intermediate
,,,,,1,,,N,50597,5408,1,10116.0,9490,,BAO_0000218,Rattus norvegicus,,CHEMBL625360,A,,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,Intermediate
,,,,,1,,,N,50597,429,1,10116.0,9491,,BAO_0000218,Rattus norvegicus,,CHEMBL625361,A,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg ( 0-8 hr ),Intermediate
,,,,,1,,,N,50597,429,1,10116.0,9492,,BAO_0000218,Rattus norvegicus,,CHEMBL625362,A,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr ),Intermediate
,,,,,1,,,N,50597,429,1,10116.0,9493,,BAO_0000218,Rattus norvegicus,,CHEMBL625363,A,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr),Intermediate
,,,,,1,,,N,50597,4796,1,10116.0,9494,,BAO_0000218,Rattus norvegicus,,CHEMBL625364,A,,Hepatic portal AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,Intermediate
,,,,,1,,,N,50597,5974,1,10116.0,9495,,BAO_0000218,Rattus norvegicus,,CHEMBL625365,A,,In vivo Area under curve (AUC) was determined after intravenous administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Intermediate
,,,,,1,,,N,50597,5974,1,10116.0,9496,,BAO_0000218,Rattus norvegicus,,CHEMBL625366,A,,In vivo Area under curve (AUC) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Intermediate
,,,,,1,,,N,50597,5974,1,10116.0,9497,,BAO_0000218,Rattus norvegicus,,CHEMBL625367,A,,In vivo Area under curve (AUC) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,Intermediate
,,Kidney,,,1,,,N,50597,11450,1,10116.0,9498,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL625368,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.98-2.56 % dose/g",Intermediate
,,Kidney,,,1,,,N,50597,11450,1,10116.0,9499,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL625369,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.15-1.43 % dose/g",Intermediate
,,Kidney,,,1,,,N,50597,11450,1,10116.0,9500,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL625370,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.43-4.52 % dose/g",Intermediate
,,Kidney,,,1,,,N,50597,11450,1,10116.0,9501,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL625371,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.12-3.14 % dose/g",Intermediate
,,Kidney,,,1,,,N,50597,11450,1,10116.0,9502,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL625372,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.40-1.60 % dose/g",Intermediate
,,Kidney,,,1,,,N,50597,11450,1,10116.0,9503,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL625373,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.74-0.85 % dose/g",Intermediate
,,Liver,,,1,,,N,50597,11450,1,10116.0,9504,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL625374,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.31-1.45 % dose/g",Intermediate
,,Liver,,,1,,,N,50597,11450,1,10116.0,9505,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL877593,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.90 % dose/g",Intermediate
,,Liver,,,1,,,N,50597,11450,1,10116.0,9506,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL625375,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.02-2.78 % dose/g",Intermediate
,,Liver,,,1,,,N,50597,11450,1,10116.0,9507,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL625376,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.64-2.38 % dose/g",Intermediate
,,Liver,,,1,,,N,50597,11450,1,10116.0,9508,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL621973,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.95-1.07 % dose/g",Intermediate
,,Liver,,,1,,,N,50597,11450,1,10116.0,9509,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL621974,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.61-0.81 % dose/g",Intermediate
,,Lung,,,1,,,N,50597,11450,1,10116.0,9510,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL621975,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 5.01-7.13 % dose/g",Intermediate
,,Lung,,,1,,,N,50597,11450,1,10116.0,9511,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL622166,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.51-3.71 % dose/g",Intermediate
,,Lung,,,1,,,N,50597,11450,1,10116.0,9512,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL622167,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 10.84-13.77 % dose/g",Intermediate
,,Lung,,,1,,,N,50597,11450,1,10116.0,9513,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL622168,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.92-8.51% dose/g",Intermediate
,,Lung,,,1,,,N,50597,11450,1,10116.0,9514,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL622169,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.37-3.94 % dose/g",Intermediate
,,Lung,,,1,,,N,50597,11450,1,10116.0,9515,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL622170,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.87-2.12 % dose/g",Intermediate
,,Thyroid gland,,,1,,,N,50597,11450,1,10116.0,9516,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL622171,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 37.97-75.23 % dose/g",Intermediate
,,Thyroid gland,,,1,,,N,50597,11450,1,10116.0,9517,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL622172,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.03-36.88 % dose/g",Intermediate
,,Thyroid gland,,,1,,,N,50597,11450,1,10116.0,9518,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL622173,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 13.20-17.31 % dose/g",Intermediate
,,Thyroid gland,,,1,,,N,50597,11450,1,10116.0,9519,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL622174,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 7.87-16.51 % dose/g",Intermediate
,,Thyroid gland,,,1,,,N,50597,11450,1,10116.0,9520,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL622175,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 81.37-166.09 % dose/g",Intermediate
,,Thyroid gland,,,1,,,N,50597,11450,1,10116.0,9521,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL622176,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 31.90-39.98 % dose/g",Intermediate
,,Thyroid gland,,,1,,,N,50597,11450,1,10116.0,9522,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL622177,A,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.41-0.83 % dose/g",Intermediate
,,Thyroid gland,,,1,,,N,50597,11450,1,10116.0,9523,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL622178,A,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.05-0.38 % dose/g",Intermediate
,,Thyroid gland,,,1,,,N,50597,11450,1,10116.0,9524,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL622179,A,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.16-0.20 % dose/g",Intermediate
,,Thyroid gland,,,1,,,N,50597,11450,1,10116.0,9525,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL622180,A,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.17 % dose/g",Intermediate
,,,,,1,,,N,50597,16435,1,10116.0,9526,,BAO_0000218,Rattus norvegicus,,CHEMBL622181,A,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate
,,,,,1,,,N,50597,16435,1,10116.0,9527,,BAO_0000218,Rattus norvegicus,,CHEMBL622182,A,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate
,,,,,1,,,N,50597,16435,1,10116.0,9528,,BAO_0000218,Rattus norvegicus,,CHEMBL622183,A,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate
,,,,,1,,,N,50597,16435,1,10116.0,9529,,BAO_0000218,Rattus norvegicus,,CHEMBL622184,A,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate
,,,,,1,,,N,50597,16435,1,10116.0,9530,,BAO_0000218,Rattus norvegicus,,CHEMBL622185,A,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate
,,,,,1,,,N,50597,16435,1,10116.0,9531,,BAO_0000218,Rattus norvegicus,,CHEMBL622186,A,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate
,,,,,1,,,N,50597,16434,1,10116.0,9532,,BAO_0000218,Rattus norvegicus,,CHEMBL622187,A,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate
,,,,,1,,,N,50597,16434,1,10116.0,9533,,BAO_0000218,Rattus norvegicus,,CHEMBL625002,A,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,Intermediate
,,,,,1,,,N,50597,16434,1,10116.0,9534,,BAO_0000218,Rattus norvegicus,,CHEMBL622090,A,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min,Intermediate
,,,,,1,,,N,50597,16435,1,10116.0,9535,,BAO_0000218,Rattus norvegicus,,CHEMBL622091,A,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate
,,,,,1,,,N,50597,16435,1,10116.0,9536,,BAO_0000218,Rattus norvegicus,,CHEMBL622092,A,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate
,,,,,1,,,N,50597,16435,1,10116.0,9537,,BAO_0000218,Rattus norvegicus,,CHEMBL622093,A,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate
,,,,,1,,,N,50597,16435,1,10116.0,9538,,BAO_0000218,Rattus norvegicus,,CHEMBL622094,A,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate
,,,,,1,,,N,50597,16435,1,10116.0,9539,,BAO_0000218,Rattus norvegicus,,CHEMBL622095,A,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate
,,,,,1,,,N,50597,16435,1,10116.0,9540,,BAO_0000218,Rattus norvegicus,,CHEMBL622264,A,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate
,,Spleen,,,1,,,N,50597,16434,1,10116.0,9541,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL622265,A,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate
,,Spleen,,,1,,,N,50597,16434,1,10116.0,9542,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL622266,A,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate
,,Spleen,,,1,,,N,50597,16434,1,10116.0,9543,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL622267,A,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate
,,Spleen,,,1,,,N,50597,16434,1,10116.0,9544,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL622268,A,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate
,,Spleen,,,1,,,N,50597,16434,1,10116.0,9545,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL622269,A,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Intermediate
,,Spleen,,,1,,,N,50597,16434,1,10116.0,9546,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL625071,A,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Intermediate
,,Spleen,,,1,,,N,50597,16434,1,10116.0,9547,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL621621,A,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Intermediate
,,Spleen,,,1,,,N,50597,16434,1,10116.0,9548,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL621622,A,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Intermediate
,,Spleen,,,1,,,N,50597,16435,1,10116.0,9549,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL621623,A,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate
,,Spleen,,,1,,,N,50597,16435,1,10116.0,9550,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL621624,A,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate
,,Spleen,,,1,,,N,50597,16435,1,10116.0,9551,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL621625,A,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate
,,Spleen,,,1,,,N,50597,16435,1,10116.0,9552,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL621626,A,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate
,,Spleen,,,1,,,N,50597,16435,1,10116.0,9553,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL621627,A,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate
,,Spleen,,,1,,,N,50597,16435,1,10116.0,9554,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL621628,A,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate
,,Spleen,,,1,,,N,50597,16435,1,10116.0,9555,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL875328,A,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate
,,Spleen,,,1,,,N,50597,16435,1,10116.0,9556,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL621629,A,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate
,,Spleen,,,1,,,N,50597,16434,1,10116.0,9557,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL621630,A,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate
,,Spleen,,,1,,,N,50597,16434,1,10116.0,9558,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL621631,A,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Intermediate
,,Spleen,,,1,,,N,50597,16434,1,10116.0,9559,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL621632,A,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate
,,Spleen,,,1,,,N,50597,16435,1,10116.0,9560,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL621633,A,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate
,,Spleen,,,1,,,N,50597,16435,1,10116.0,9561,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL621634,A,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate
,,Spleen,,,1,,,N,50597,16435,1,10116.0,9562,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL621635,A,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate
,,Spleen,,,1,,,N,50597,16435,1,10116.0,9563,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL621636,A,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate
,,Spleen,,,1,,,N,50597,16435,1,10116.0,9564,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL621637,A,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate
,,Spleen,,,1,,,N,50597,16435,1,10116.0,9565,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL621638,A,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate
,,,,,1,,,N,50597,16434,1,10116.0,9566,,BAO_0000218,Rattus norvegicus,,CHEMBL618883,A,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate
,,,,,1,,,N,50597,16434,1,10116.0,9567,,BAO_0000218,Rattus norvegicus,,CHEMBL618884,A,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate
,,,,,1,,,N,50597,16434,1,10116.0,9568,,BAO_0000218,Rattus norvegicus,,CHEMBL628627,A,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate
,,,,,1,,,N,50597,16434,1,10116.0,9569,,BAO_0000218,Rattus norvegicus,,CHEMBL628628,A,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate
,,,,,1,,,N,50597,16434,1,10116.0,9570,,BAO_0000218,Rattus norvegicus,,CHEMBL628629,A,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Intermediate
,In vivo,,,,1,,,N,50597,16365,1,10116.0,9571,,BAO_0000218,Rattus norvegicus,,CHEMBL628630,A,,Half life after administering orally a dose of 3 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,16365,1,10116.0,9572,,BAO_0000218,Rattus norvegicus,,CHEMBL628631,A,,Half life after administering orally a dose of 3 mg/kg to a fasting rat,Intermediate
,In vivo,,,,1,,,N,50597,16365,1,10116.0,9573,,BAO_0000218,Rattus norvegicus,,CHEMBL628632,A,,Half life after administering intravenously a dose of 1 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,526,1,10116.0,9574,,BAO_0000218,Rattus norvegicus,,CHEMBL628633,A,,Half life after oral dosing in rats,Intermediate
,In vivo,,,,1,,,N,50597,16365,1,10116.0,9575,,BAO_0000218,Rattus norvegicus,,CHEMBL628634,A,,Half life after the administered orally a dose of 1 mg/kg to a fasting rat,Intermediate
,In vivo,,,,1,,,N,50597,4368,1,10116.0,9576,,BAO_0000218,Rattus norvegicus,,CHEMBL627789,A,,Half life by intravenous administration of 3.4 mg/kg in rat,Intermediate
,,,,,1,,,N,50597,3371,1,10116.0,9577,,BAO_0000218,Rattus norvegicus,,CHEMBL627790,A,,Half life in rat,Intermediate
,,,,,1,,,N,50597,6448,1,10116.0,9578,,BAO_0000218,Rattus norvegicus,,CHEMBL627791,A,,Half life in rat,Intermediate
,,,,,1,,,N,50597,6453,1,10116.0,9579,,BAO_0000218,Rattus norvegicus,,CHEMBL627792,A,,Half life in rat,Intermediate
,In vivo,,,,1,,,N,50597,4353,1,10116.0,9580,,BAO_0000218,Rattus norvegicus,,CHEMBL627793,A,,Half life in rat after intravenous administration of the compound,Intermediate
,In vivo,Plasma,,,1,,,N,50597,4353,1,10116.0,9581,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL627794,A,,Half life in rat after intravenous administration of the compound; nf:unable to estimate plasma elimination half life,Intermediate
,In vivo,,,,1,,,N,50597,4353,1,10116.0,9582,,BAO_0000218,Rattus norvegicus,,CHEMBL627795,A,,Half life in rat after po administration of the compound,Intermediate
,In vivo,,,,1,,,N,50597,4353,1,10116.0,9583,,BAO_0000218,Rattus norvegicus,,CHEMBL627796,A,,Half life in rat after po administration of the compound; ND means Not determined,Intermediate
,In vivo,Plasma,,,1,,,N,50597,4353,1,10116.0,9584,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL875335,A,,Half life in rat after po administration of the compound; nf: unable to estimate plasma elimination half life,Intermediate
,In vivo,Plasma,,,1,,,N,50597,4353,1,10116.0,9585,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL627797,A,,Half life in rat after po administration of the compound; nf:unable to estimate plasma elimination half life,Intermediate
,In vivo,,,,1,,,N,50597,5789,1,10116.0,9586,,BAO_0000218,Rattus norvegicus,,CHEMBL627798,A,,Half life in rat i.v.,Intermediate
,In vivo,,,,1,,,N,50597,17686,1,10116.0,9587,,BAO_0000218,Rattus norvegicus,,CHEMBL627799,A,,Half life in rat i.v. at 2 mg/kg concentration,Intermediate
,,,,,1,,,N,50597,6495,1,10116.0,9588,,BAO_0000218,Rattus norvegicus,,CHEMBL627800,A,,Half life in rats,Intermediate
,In vivo,,,,1,,,N,50597,484,1,10116.0,9589,,BAO_0000218,Rattus norvegicus,,CHEMBL627801,A,,Half life in rats after intravenous administration,Intermediate
,In vivo,,,,1,,,N,50597,6467,1,10116.0,9590,,BAO_0000218,Rattus norvegicus,,CHEMBL627802,A,,Half life in rats at the dose of 1.0 mpk by i.v. administration,Intermediate
,,,,,1,,,N,50597,6642,1,10116.0,9591,,BAO_0000218,Rattus norvegicus,,CHEMBL627803,A,,Half life in rat,Expert
,In vivo,,,,1,,,N,50597,16367,1,10116.0,9592,,BAO_0000218,Rattus norvegicus,,CHEMBL873820,A,,Half life was evaluated after intravenous administration to rats,Intermediate
,,,,,1,,,N,50597,1369,1,10116.0,9593,,BAO_0000218,Rattus norvegicus,,CHEMBL627804,A,,Half life was evaluated by addition of 2 mM of 2-mercaptoethanol for inactivation of semicarbazide-sensitive amine oxidase (SSAO),Intermediate
,,,,,1,,,N,50597,5472,1,10116.0,9594,,BAO_0000218,Rattus norvegicus,,CHEMBL627805,A,,Half life was evaluated in rat,Intermediate
,,,,,1,,,N,50597,6049,1,10116.0,9595,,BAO_0000218,Rattus norvegicus,,CHEMBL627806,A,,Half life was evaluated in rat,Intermediate
,,,,,1,,,N,50597,5472,1,10116.0,9596,,BAO_0000218,Rattus norvegicus,,CHEMBL627107,A,,Half life was evaluated in rat; Not tested,Intermediate
,In vivo,,,,1,,,N,50597,16366,1,10116.0,9597,,BAO_0000218,Rattus norvegicus,,CHEMBL627108,A,,Half life was evaluated when a dose of 1 mg/kg was administered intravenously to rats,Intermediate
,In vivo,,,,1,,,N,50597,11149,1,10116.0,9598,,BAO_0000218,Rattus norvegicus,,CHEMBL627109,A,,Half life was measured as time taken to reach the half of the initial dose in air pouch exudate after oral administration to male F344 rats,Intermediate
,In vivo,Blood,,,1,,,N,50597,11149,1,10116.0,9599,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL627110,A,,Half life was measured as time taken to reach the half of the initial dose in the blood after oral administration to male F344 rats,Intermediate
,In vivo,,,,0,,,U,22224,2891,1,9443.0,9600,,BAO_0000218,Primates,,CHEMBL627111,A,,Half life was measured in monkey at dose of 10 mg/kg by po administration,Intermediate
,In vivo,,,,0,,,U,22224,2891,1,9443.0,9601,,BAO_0000218,Primates,,CHEMBL627112,A,,Half life was measured in monkey at dose of 10 mg/kg by po administration,Intermediate
,In vivo,,,,0,,,U,22224,2891,1,10116.0,9602,,BAO_0000218,Rattus norvegicus,,CHEMBL627113,A,,Half life was measured in rat at dose of 30 mg/kg by iv administration,Intermediate
,In vivo,,,,0,,,U,22224,2891,1,10116.0,9603,,BAO_0000218,Rattus norvegicus,,CHEMBL627114,A,,Half life was measured in rat at dose of 30 mg/kg by po administration,Intermediate
,,,,,1,,,N,50597,4026,1,10116.0,9604,,BAO_0000218,Rattus norvegicus,,CHEMBL627115,A,,Half life (t1/2) was determined,Intermediate
,,,,,1,,,N,50597,4527,1,10116.0,9605,,BAO_0000218,Rattus norvegicus,,CHEMBL627116,A,,Half life period at a dose of 10 uM/kg in rat was determined,Intermediate
,In vivo,,,,1,,,N,50597,4527,1,10116.0,9606,,BAO_0000218,Rattus norvegicus,,CHEMBL627117,A,,Half life period by oral administration at a dose of 100 uM/kg in rat was determined; ND is not determined,Intermediate
,,,,,1,,,N,50597,5503,1,10116.0,9607,,BAO_0000218,Rattus norvegicus,,CHEMBL627118,A,,Half life period was determined,Intermediate
,In vivo,,,,1,,,N,50597,4426,1,10116.0,9608,,BAO_0000218,Rattus norvegicus,,CHEMBL627119,A,,Half life period after intravenous administration at 20 mpk in rats,Intermediate
,In vivo,,,,1,,,N,50597,4426,1,10116.0,9609,,BAO_0000218,Rattus norvegicus,,CHEMBL627120,A,,Half life period after intravenous administration at 20 mpk in rats; Not performed.,Intermediate
,In vivo,,,,1,,,N,50597,6109,1,10116.0,9610,,BAO_0000218,Rattus norvegicus,,CHEMBL626922,A,,Half life period after intravenous administration in rat,Intermediate
,In vivo,,,,1,,,N,50597,5654,1,10116.0,9611,,BAO_0000218,Rattus norvegicus,,CHEMBL626923,A,,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,Intermediate
,In vivo,,,,1,,,N,50597,5654,1,10116.0,9612,,BAO_0000218,Rattus norvegicus,,CHEMBL626924,A,,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,Intermediate
,,Plasma,,,1,,,N,50597,4755,1,10116.0,9613,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626925,A,,Half life period in 80% rat plasma at 37 degree Centigrade,Intermediate
,,,,,1,,,N,50597,5862,1,10116.0,9614,,BAO_0000218,Rattus norvegicus,,CHEMBL626926,A,,Half life period in SD rats,Intermediate
,,Plasma,,,1,,,N,50597,1515,1,10116.0,9615,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626927,A,,Half life period in human plasma at 25 degree Celsius temperature (pH 7.4),Intermediate
,,Plasma,,,1,,,N,50597,1515,1,10116.0,9616,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626928,A,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4),Intermediate
,,Plasma,,,1,,,N,50597,1515,1,10116.0,9617,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626929,A,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,Intermediate
,,Plasma,,,1,,,N,50597,1515,1,10116.0,9618,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626930,A,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,Intermediate
,,,,,1,,,N,50597,5960,1,10116.0,9619,,BAO_0000218,Rattus norvegicus,,CHEMBL626931,A,,Half life period in rat,Intermediate
,,,,,1,,,N,50597,6103,1,10116.0,9620,,BAO_0000218,Rattus norvegicus,,CHEMBL626932,A,,Half life period in rat,Intermediate
,,,,,1,,,N,50597,6317,1,10116.0,9621,,BAO_0000218,Rattus norvegicus,,CHEMBL626933,A,,Half life period in rat,Intermediate
,In vivo,,,,1,,,N,50597,6644,1,10116.0,9622,,BAO_0000218,Rattus norvegicus,,CHEMBL873826,A,,Half life period in rat after oral administration at 10.5 mg/kg dose,Intermediate
,In vivo,,,,1,,,N,50597,6644,1,10116.0,9623,,BAO_0000218,Rattus norvegicus,,CHEMBL626934,A,,Half life period in rat after oral administration at 11.2 mg/kg dose,Intermediate
,In vivo,,,,1,,,N,50597,6644,1,10116.0,9624,,BAO_0000218,Rattus norvegicus,,CHEMBL626935,A,,Half life period in rat after oral administration at 13 mg/kg dose,Intermediate
,In vivo,,,,1,,,N,50597,6644,1,10116.0,9625,,BAO_0000218,Rattus norvegicus,,CHEMBL626936,A,,Half life period in rat after oral administration at 9.7 mg/kg dose,Intermediate
,,,,,1,,,N,50597,5974,1,10116.0,9626,,BAO_0000218,Rattus norvegicus,,CHEMBL626937,A,,In vivo Area under curve (AUC) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Intermediate
,,,,,1,,,N,50597,6295,1,10116.0,9627,,BAO_0000218,Rattus norvegicus,,CHEMBL625906,A,,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,Intermediate
,,,,,1,,,N,50597,6296,1,10116.0,9628,,BAO_0000218,Rattus norvegicus,,CHEMBL625907,A,,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,Intermediate
,,,,,1,,,N,50597,16427,1,10116.0,9629,,BAO_0000218,Rattus norvegicus,,CHEMBL625908,A,,PK study was carried to determine AUC (area under curve) value in rat,Intermediate
,,,,,1,,,N,50597,16367,1,10116.0,9630,,BAO_0000218,Rattus norvegicus,,CHEMBL625909,A,,Pharmacokinetic parameter AUC after intravenous administration to rats,Intermediate
,,,,,1,,,N,50597,16367,1,10116.0,9631,,BAO_0000218,Rattus norvegicus,,CHEMBL625910,A,,Pharmacokinetic parameter AUC after oral administration to rats,Intermediate
,,,,,1,,,N,50597,16365,1,10116.0,9632,,BAO_0000218,Rattus norvegicus,,CHEMBL625911,A,,Pharmacokinetic parameter AUC was evaluated intravenous administration of 3 mg/kg,Intermediate
,,,,,1,,,N,50597,16365,1,10116.0,9633,,BAO_0000218,Rattus norvegicus,,CHEMBL625912,A,,Pharmacokinetic parameter AUC was evaluated when a dose of 10 mg/kg is administered orally to a fasting rat,Intermediate
,,,,,1,,,N,50597,16365,1,10116.0,9634,,BAO_0000218,Rattus norvegicus,,CHEMBL626538,A,,Pharmacokinetic parameter AUC was evaluated when a dose of 1 mg/kg is administered orally to a fasting rat,Intermediate
,,,,,1,,,N,50597,16365,1,10116.0,9635,,BAO_0000218,Rattus norvegicus,,CHEMBL876794,A,,Pharmacokinetic parameter AUC was evaluated when a dose of 30 mg/kg is administered orally,Intermediate
,,,,,1,,,N,50597,16365,1,10116.0,9636,,BAO_0000218,Rattus norvegicus,,CHEMBL626539,A,,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally,Intermediate
,,,,,1,,,N,50597,16365,1,10116.0,9637,,BAO_0000218,Rattus norvegicus,,CHEMBL626540,A,,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally to a fasting rat,Intermediate
,,,,,1,,,N,50597,5394,1,10116.0,9638,,BAO_0000218,Rattus norvegicus,,CHEMBL626541,A,,Pharmacokinetic parameter area under curve (AUC) was measured after administration into monkey at 3 mg/kg,Intermediate
,,,,,1,,,N,50597,5394,1,10116.0,9639,,BAO_0000218,Rattus norvegicus,,CHEMBL626542,A,,Pharmacokinetic parameter area under curve (AUC) was measured after administration into rat at 10 mg/kg,Intermediate
,,,,,1,,,N,50597,2792,1,10116.0,9640,,BAO_0000218,Rattus norvegicus,,CHEMBL626543,A,,Pharmacokinetic parameter area under curve was determined at 10 mg/kg po dose in rats,Intermediate
,,,,,1,,,N,50597,2792,1,10116.0,9641,,BAO_0000218,Rattus norvegicus,,CHEMBL626544,A,,Pharmacokinetic parameter area under curve was determined at 2 mg/kg i.v. dose in rats,Intermediate
,,,,,1,,,N,50597,2792,1,10116.0,9642,,BAO_0000218,Rattus norvegicus,,CHEMBL626545,A,,Pharmacokinetic parameter area under curve was determined at 3 mg/kg po dose in rats,Intermediate
,,,,,1,,,N,50597,2792,1,10116.0,9643,,BAO_0000218,Rattus norvegicus,,CHEMBL626546,A,,Pharmacokinetic parameter area under curve was determined at 5 mg/kg i.v. dose in rats,Intermediate
,,,,,1,,,N,50597,5334,1,10116.0,9644,,BAO_0000218,Rattus norvegicus,,CHEMBL626547,A,,Pharmacokinetic parameter area under curve was reported,Intermediate
,,,,,1,,,N,50597,4408,1,10116.0,9645,,BAO_0000218,Rattus norvegicus,,CHEMBL626548,A,,Pharmacokinetic property (AUC) in rat,Intermediate
,,,,,1,,,N,50597,5983,1,10116.0,9646,,BAO_0000218,Rattus norvegicus,,CHEMBL626549,A,,Pharmacokinetic property (AUC) was measured in rat at the dose of 0.32 mg/kg p.o.,Intermediate
,,,,,1,,,N,50597,4397,1,10116.0,9647,,BAO_0000218,Rattus norvegicus,,CHEMBL626550,A,,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.,Intermediate
,,,,,1,,,N,50597,4397,1,10116.0,9648,,BAO_0000218,Rattus norvegicus,,CHEMBL626551,A,,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.; Not tested,Intermediate
,,,,,1,,,N,50597,5491,1,10116.0,9649,,BAO_0000218,Rattus norvegicus,,CHEMBL623777,A,,Pharmacokinetic property was determined,Intermediate
,,,,,1,,,N,50597,5491,1,10116.0,9650,,BAO_0000218,Rattus norvegicus,,CHEMBL623778,A,,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg,Intermediate
,,,,,1,,,N,50597,5491,1,10116.0,9651,,BAO_0000218,Rattus norvegicus,,CHEMBL623779,A,,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg; Not tested,Intermediate
,,Plasma,,,1,,,N,50597,4199,1,10116.0,9652,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623780,A,,Pharmacokinetic property( plasma concentration) was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,Intermediate
,,Plasma,,,1,,,N,50597,4199,1,10116.0,9653,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622015,A,,Pharmacokinetic property( plasma concentration) was determined upon 2 mg/kg in 1% methylcellulose peroral administration in rats,Intermediate
,,Plasma,,,1,,,N,50597,4199,1,10116.0,9654,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622016,A,,Pharmacokinetic property( plasma concentration) was determined upon 3 mg/kg in 1% methylcellulose peroral administration in rats,Intermediate
,,,,,1,,,N,50597,5173,1,10116.0,9655,,BAO_0000218,Rattus norvegicus,,CHEMBL622017,A,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.25 h",Intermediate
,,,,,1,,,N,50597,5173,1,10116.0,9656,,BAO_0000218,Rattus norvegicus,,CHEMBL622018,A,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.5 h",Intermediate
,,,,,1,,,N,50597,5173,1,10116.0,9657,,BAO_0000218,Rattus norvegicus,,CHEMBL622019,A,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 1 h",Intermediate
,,,,,1,,,N,50597,5173,1,10116.0,9658,,BAO_0000218,Rattus norvegicus,,CHEMBL622020,A,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 2 h",Intermediate
,,,,,1,,,N,50597,16366,1,10116.0,9659,,BAO_0000218,Rattus norvegicus,,CHEMBL622021,A,,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered intravenously,Intermediate
,,,,,1,,,N,50597,16366,1,10116.0,9660,,BAO_0000218,Rattus norvegicus,,CHEMBL622022,A,,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered orally,Intermediate
,,,,,1,,,N,50597,5327,1,10116.0,9661,,BAO_0000218,Rattus norvegicus,,CHEMBL622023,A,,Plasma concentration expressed as area under curve after intravenous administration was determined in rat,Intermediate
,,,,,1,,,N,50597,6681,1,10116.0,9662,,BAO_0000218,Rattus norvegicus,,CHEMBL622024,A,,Plasma concentration for the compound was determined in rats at 50 mg/kg dose,Intermediate
,,,,,1,,,N,50597,12873,1,10116.0,9663,,BAO_0000218,Rattus norvegicus,,CHEMBL622693,A,,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of solution (formulation of compound),Intermediate
,,,,,1,,,N,50597,12873,1,10116.0,9664,,BAO_0000218,Rattus norvegicus,,CHEMBL622694,A,,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of suspension (formulation of compound),Intermediate
,,,,,1,,,N,50597,6685,1,10116.0,9665,,BAO_0000218,Rattus norvegicus,,CHEMBL622695,A,,"Plasma concentration was determined in rats at 10 mg/kg, p.o. dose",Intermediate
,,,,,1,,,N,50597,6685,1,10116.0,9666,,BAO_0000218,Rattus norvegicus,,CHEMBL622696,A,,"Plasma concentration was determined in rats at 20 mg/kg, i.p. dose",Intermediate
,,,,,1,,,N,50597,6685,1,10116.0,9667,,BAO_0000218,Rattus norvegicus,,CHEMBL622697,A,,"Plasma concentration was determined in rats at 2 mg/kg, i.v. dose",Intermediate
,,,,,1,,,N,50597,6619,1,10116.0,9668,,BAO_0000218,Rattus norvegicus,,CHEMBL622874,A,,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (20 mg/kg, 30 min pre-treatment)",Intermediate
,,,,,1,,,N,50597,6619,1,10116.0,9669,,BAO_0000218,Rattus norvegicus,,CHEMBL622875,A,,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (30 mg/kg, 30 min pre-treatment)",Intermediate
,,,,,1,,,N,50597,10363,1,10116.0,9670,,BAO_0000218,Rattus norvegicus,,CHEMBL622876,A,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,Intermediate
,,,,,1,,,N,50597,4796,1,10116.0,9671,,BAO_0000218,Rattus norvegicus,,CHEMBL622877,A,,Systemic AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,Intermediate
,,,,,1,,,N,50597,4910,1,10116.0,9672,,BAO_0000218,Rattus norvegicus,,CHEMBL622878,A,,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,Intermediate
,,Plasma,,,1,,,N,50597,4910,1,10116.0,9673,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622879,A,,Tested for plasma concentration after intravenous administration (4.7 mg/kg) to male rats,Intermediate
,,,,,1,,,N,50597,4839,1,10116.0,9674,,BAO_0000218,Rattus norvegicus,,CHEMBL877602,A,,Tested for the pharmacokinetic parameter in rat and expressed as area under curve,Intermediate
,,,,,1,,,N,50597,15078,1,10116.0,9675,,BAO_0000218,Rattus norvegicus,,CHEMBL622880,A,,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",Intermediate
,,,,,1,,,N,50597,15078,1,10116.0,9676,,BAO_0000218,Rattus norvegicus,,CHEMBL622881,A,,"The AUC(0-infinitive) value in male wistar rat at 100 mg/kg, p.o. dose",Intermediate
,,,,,1,,,N,50597,15078,1,10116.0,9677,,BAO_0000218,Rattus norvegicus,,CHEMBL622882,A,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",Intermediate
,,,,,1,,,N,50597,15078,1,10116.0,9678,,BAO_0000218,Rattus norvegicus,,CHEMBL622883,A,,"The AUC(0-t)value in male wistar rat at 100 mg/kg, p.o. dose",Intermediate
,,Thyroid gland,,,1,,,N,50597,11450,1,10116.0,9679,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL622884,A,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.16-2.39% dose/g",Intermediate
,,Thyroid gland,,,1,,,N,50597,11450,1,10116.0,9680,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL622885,A,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.99-1.40 % dose/g",Intermediate
,,,,,1,,,N,50597,8151,1,10116.0,9681,,BAO_0000218,Rattus norvegicus,,CHEMBL622886,A,,Antidiuretic activity expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,Intermediate
,,,,,1,,,N,50597,8151,1,10116.0,9682,,BAO_0000218,Rattus norvegicus,,CHEMBL622887,A,,Antidiuretic activity expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,Intermediate
,,Urine,,,1,,,N,50597,8151,1,10116.0,9683,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL622888,A,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,Intermediate
,In vivo,Blood,,,1,,,N,50597,8677,1,10116.0,9684,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL622889,A,,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate
,In vivo,Blood,,,1,,,N,50597,8677,1,10116.0,9685,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL622890,A,,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate
,In vivo,Blood,,,1,,,N,50597,8677,1,10116.0,9686,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL622891,A,,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate
,In vivo,Blood,,,1,,,N,50597,8677,1,10116.0,9687,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL877603,A,,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate
,In vivo,Brain,,,1,,,N,50597,8677,1,10116.0,9688,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL622892,A,,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate
,In vivo,Brain,,,1,,,N,50597,8677,1,10116.0,9689,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL622893,A,,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate
,In vivo,Brain,,,1,,,N,50597,8677,1,10116.0,9690,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL622894,A,,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate
,In vivo,Brain,,,1,,,N,50597,8677,1,10116.0,9691,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL622895,A,,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate
,In vivo,Brain,,,1,,,N,50597,8677,1,10116.0,9692,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL622896,A,,Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration.,Intermediate
,In vivo,Heart,,,1,,,N,50597,8677,1,10116.0,9693,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL622897,A,,"Biodistribution in Sprague-Dawley rat heart 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate
,In vivo,Heart,,,1,,,N,50597,8677,1,10116.0,9694,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL622898,A,,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate
,In vivo,Heart,,,1,,,N,50597,8677,1,10116.0,9695,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL622899,A,,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate
,In vivo,Kidney,,,1,,,N,50597,8677,1,10116.0,9696,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL622900,A,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate
,In vivo,Kidney,,,1,,,N,50597,8677,1,10116.0,9697,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL624114,A,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate
,In vivo,Kidney,,,1,,,N,50597,8677,1,10116.0,9698,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL624115,A,,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate
,In vivo,Kidney,,,1,,,N,50597,8677,1,10116.0,9699,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL624116,A,,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate
,In vivo,Liver,,,1,,,N,50597,8677,1,10116.0,9700,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL624117,A,,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate
,In vivo,Liver,,,1,,,N,50597,8677,1,10116.0,9701,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL624118,A,,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate
,In vivo,Liver,,,1,,,N,50597,8677,1,10116.0,9702,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL624119,A,,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate
,In vivo,Liver,,,1,,,N,50597,8677,1,10116.0,9703,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL624120,A,,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate
,In vivo,Lung,,,1,,,N,50597,8677,1,10116.0,9704,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL624121,A,,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate
,In vivo,Lung,,,1,,,N,50597,8677,1,10116.0,9705,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL624122,A,,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate
,In vivo,Lung,,,1,,,N,50597,8677,1,10116.0,9706,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL624123,A,,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate
,In vivo,Lung,,,1,,,N,50597,8677,1,10116.0,9707,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL624124,A,,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,8677,1,10116.0,9708,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL624125,A,,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,8677,1,10116.0,9709,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL624126,A,,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,8677,1,10116.0,9710,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL624127,A,,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,8677,1,10116.0,9711,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL624128,A,,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate
,In vivo,Zone of skin,,,1,,,N,50597,8677,1,10116.0,9712,,BAO_0000218,Rattus norvegicus,14.0,CHEMBL624129,A,,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate
,In vivo,Zone of skin,,,1,,,N,50597,8677,1,10116.0,9713,,BAO_0000218,Rattus norvegicus,14.0,CHEMBL624130,A,,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate
,In vivo,Zone of skin,,,1,,,N,50597,8677,1,10116.0,9714,,BAO_0000218,Rattus norvegicus,14.0,CHEMBL622340,A,,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate
,In vivo,Zone of skin,,,1,,,N,50597,8677,1,10116.0,9715,,BAO_0000218,Rattus norvegicus,14.0,CHEMBL622341,A,,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate
,In vivo,Intestine,,,1,,,N,50597,8677,1,10116.0,9716,,BAO_0000218,Rattus norvegicus,160.0,CHEMBL622342,A,,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate
,In vivo,Intestine,,,1,,,N,50597,8677,1,10116.0,9717,,BAO_0000218,Rattus norvegicus,160.0,CHEMBL622343,A,,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate
,In vivo,Intestine,,,1,,,N,50597,8677,1,10116.0,9718,,BAO_0000218,Rattus norvegicus,160.0,CHEMBL622344,A,,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate
,In vivo,Intestine,,,1,,,N,50597,8677,1,10116.0,9719,,BAO_0000218,Rattus norvegicus,160.0,CHEMBL622345,A,,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate
,In vivo,Spleen,,,1,,,N,50597,8677,1,10116.0,9720,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL622346,A,,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate
,In vivo,Spleen,,,1,,,N,50597,8677,1,10116.0,9721,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL622347,A,,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate
,In vivo,Spleen,,,1,,,N,50597,8677,1,10116.0,9722,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL622348,A,,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate
,In vivo,Spleen,,,1,,,N,50597,8677,1,10116.0,9723,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL622349,A,,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate
,,,,,1,,,N,50597,16434,1,10116.0,9724,,BAO_0000218,Rattus norvegicus,,CHEMBL622350,A,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Intermediate
,,,,,1,,,N,50597,16434,1,10116.0,9725,,BAO_0000218,Rattus norvegicus,,CHEMBL622351,A,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Intermediate
,,,,,1,,,N,50597,16434,1,10116.0,9726,,BAO_0000218,Rattus norvegicus,,CHEMBL622352,A,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Intermediate
,,,,,1,,,N,50597,16435,1,10116.0,9727,,BAO_0000218,Rattus norvegicus,,CHEMBL622353,A,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate
,,,,,1,,,N,50597,16435,1,10116.0,9728,,BAO_0000218,Rattus norvegicus,,CHEMBL622354,A,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate
,,,,,1,,,N,50597,16435,1,10116.0,9729,,BAO_0000218,Rattus norvegicus,,CHEMBL622355,A,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate
,,,,,1,,,N,50597,16435,1,10116.0,9730,,BAO_0000218,Rattus norvegicus,,CHEMBL622356,A,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate
,,,,,1,,,N,50597,16435,1,10116.0,9731,,BAO_0000218,Rattus norvegicus,,CHEMBL622357,A,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate
,,,,,1,,,N,50597,16435,1,10116.0,9732,,BAO_0000218,Rattus norvegicus,,CHEMBL622358,A,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate
,,,,,1,,,N,50597,16435,1,10116.0,9733,,BAO_0000218,Rattus norvegicus,,CHEMBL622359,A,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate
,,,,,1,,,N,50597,16435,1,10116.0,9734,,BAO_0000218,Rattus norvegicus,,CHEMBL874393,A,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate
,,,,,1,,,N,50597,16434,1,10116.0,9735,,BAO_0000218,Rattus norvegicus,,CHEMBL622872,A,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate
,,,,,1,,,N,50597,16434,1,10116.0,9736,,BAO_0000218,Rattus norvegicus,,CHEMBL622873,A,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Intermediate
,,,,,1,,,N,50597,16434,1,10116.0,9737,,BAO_0000218,Rattus norvegicus,,CHEMBL623047,A,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate
,,,,,1,,,N,50597,16435,1,10116.0,9738,,BAO_0000218,Rattus norvegicus,,CHEMBL623048,A,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate
,,,,,1,,,N,50597,16435,1,10116.0,9739,,BAO_0000218,Rattus norvegicus,,CHEMBL623049,A,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate
,,,,,1,,,N,50597,16435,1,10116.0,9740,,BAO_0000218,Rattus norvegicus,,CHEMBL623050,A,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate
,,,,,1,,,N,50597,16435,1,10116.0,9741,,BAO_0000218,Rattus norvegicus,,CHEMBL623051,A,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate
,,,,,1,,,N,50597,16435,1,10116.0,9742,,BAO_0000218,Rattus norvegicus,,CHEMBL623052,A,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate
,,,,,1,,,N,50597,16435,1,10116.0,9743,,BAO_0000218,Rattus norvegicus,,CHEMBL626343,A,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate
,,,,,1,,,N,50597,16434,1,10116.0,9744,,BAO_0000218,Rattus norvegicus,,CHEMBL626344,A,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate
,,,,,1,,,N,50597,16434,1,10116.0,9745,,BAO_0000218,Rattus norvegicus,,CHEMBL626345,A,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate
,,,,,1,,,N,50597,16434,1,10116.0,9746,,BAO_0000218,Rattus norvegicus,,CHEMBL626346,A,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate
,,,,,1,,,N,50597,16434,1,10116.0,9747,,BAO_0000218,Rattus norvegicus,,CHEMBL626347,A,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate
,,,,,1,,,N,50597,16434,1,10116.0,9748,,BAO_0000218,Rattus norvegicus,,CHEMBL626348,A,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Intermediate
,,,,,1,,,N,50597,16434,1,10116.0,9749,,BAO_0000218,Rattus norvegicus,,CHEMBL626349,A,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate
,,,,,1,,,N,50597,16435,1,10116.0,9750,,BAO_0000218,Rattus norvegicus,,CHEMBL626350,F,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate
,,,,,1,,,N,50597,16435,1,10116.0,9751,,BAO_0000218,Rattus norvegicus,,CHEMBL626351,A,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate
,,,,,1,,,N,50597,16435,1,10116.0,9752,,BAO_0000218,Rattus norvegicus,,CHEMBL627650,A,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate
,,,,,1,,,N,50597,16435,1,10116.0,9753,,BAO_0000218,Rattus norvegicus,,CHEMBL627651,F,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate
,,,,,1,,,N,50597,16435,1,10116.0,9754,,BAO_0000218,Rattus norvegicus,,CHEMBL627652,A,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate
,,,,,1,,,N,50597,16435,1,10116.0,9755,,BAO_0000218,Rattus norvegicus,,CHEMBL627653,A,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate
,,,,,1,,,N,50597,13091,1,10116.0,9756,,BAO_0000218,Rattus norvegicus,,CHEMBL627654,A,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr blocked time interval,Intermediate
,,,,,1,,,N,50597,13091,1,10116.0,9757,,BAO_0000218,Rattus norvegicus,,CHEMBL627835,A,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr low time interval,Intermediate
,,,,,1,,,N,50597,13091,1,10116.0,9758,,BAO_0000218,Rattus norvegicus,,CHEMBL627836,A,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr time interval,Intermediate
,,,,,1,,,N,50597,13091,1,10116.0,9759,,BAO_0000218,Rattus norvegicus,,CHEMBL627837,A,,Tissue biodistribution into estrogen-primed immature female rat blood at 3 hr time interval,Intermediate
,,,,,1,,,N,50597,13091,1,10116.0,9760,,BAO_0000218,Rattus norvegicus,,CHEMBL627838,A,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr blocked time interval,Intermediate
,,,,,1,,,N,50597,13091,1,10116.0,9761,,BAO_0000218,Rattus norvegicus,,CHEMBL875338,A,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr low time interval,Intermediate
,,,,,1,,,N,50597,13091,1,10116.0,9762,,BAO_0000218,Rattus norvegicus,,CHEMBL627839,A,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr time interval,Intermediate
,,,,,1,,,N,50597,13091,1,10116.0,9763,,BAO_0000218,Rattus norvegicus,,CHEMBL627840,A,,Tissue biodistribution into estrogen-primed immature female rat bone at 3 hr time interval,Intermediate
,,,,,1,,,N,50597,13091,1,10116.0,9764,,BAO_0000218,Rattus norvegicus,,CHEMBL627841,A,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr blocked time interval,Intermediate
,,,,,1,,,N,50597,13091,1,10116.0,9765,,BAO_0000218,Rattus norvegicus,,CHEMBL627842,A,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr low time interval,Intermediate
,,,,,1,,,N,50597,13091,1,10116.0,9766,,BAO_0000218,Rattus norvegicus,,CHEMBL627843,A,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr time interval,Intermediate
,,,,,1,,,N,50597,13091,1,10116.0,9767,,BAO_0000218,Rattus norvegicus,,CHEMBL627844,A,,Tissue biodistribution into estrogen-primed immature female rat brain at 3 hr time interval,Intermediate
,,,,,1,,,N,50597,13091,1,10116.0,9768,,BAO_0000218,Rattus norvegicus,,CHEMBL627845,A,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr blocked time interval,Intermediate
,In vivo,,,,1,,,N,50597,5874,1,10116.0,9769,,BAO_0000218,Rattus norvegicus,,CHEMBL627846,A,,Half life period in rat by iv administration at a dose of 3 mg/kg,Intermediate
,,Plasma,,,1,,,N,50597,1515,1,10116.0,9770,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL627847,A,,Half life period in rat plasma at 25 degree Centigrade temperature (pH 7.4),Intermediate
,,Plasma,,,1,,,N,50597,1515,1,10116.0,9771,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL873821,A,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4),Intermediate
,,Plasma,,,1,,,N,50597,1515,1,10116.0,9772,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626079,A,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,Intermediate
,,Plasma,,,1,,,N,50597,1515,1,10116.0,9773,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626080,A,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,Intermediate
,,Plasma,,,1,,,N,50597,5491,1,10116.0,9774,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626081,A,,Half life period was evaluated in rat plasma,Intermediate
,,Plasma,,,1,,,N,50597,5491,1,10116.0,9775,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL875344,A,,Half life period was evaluated in rat plasma; Not tested,Intermediate
,,,,,1,,,N,50597,1918,1,10116.0,9776,,BAO_0000218,Rattus norvegicus,,CHEMBL626082,A,,Half life period was evaluated in rats,Intermediate
,In vivo,,,,1,,,N,50597,1918,1,10116.0,9777,,BAO_0000218,Rattus norvegicus,,CHEMBL626250,A,,"Half life period was evaluated in rats, iv",Intermediate
,In vivo,,,,1,,,N,50597,6113,1,10116.0,9778,,BAO_0000218,Rattus norvegicus,,CHEMBL626251,A,,Half life period after intravenous administration at 5 mg/kg in rat,Intermediate
,In vivo,,,,1,,,N,50597,5546,1,10116.0,9779,,BAO_0000218,Rattus norvegicus,,CHEMBL626252,A,,Half life period was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,Intermediate
,In vivo,,,,1,,,N,50597,5553,1,10116.0,9780,,BAO_0000218,Rattus norvegicus,,CHEMBL626253,A,,Half life period was determined in rat after iv administration at a dose of 5 mg/kg,Intermediate
,,Plasma,,,1,,,N,50597,4188,1,10116.0,9781,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626254,A,,Half life stability of compound was evaluated in rat plasma,Intermediate
,In vivo,,,,1,,,N,50597,6215,1,10116.0,9782,,BAO_0000218,Rattus norvegicus,,CHEMBL626255,A,,Half life time after intravenous administration (5.0 mg/kg) was determined in rat,Intermediate
,In vivo,,,,1,,,N,50597,6141,1,10116.0,9783,,BAO_0000218,Rattus norvegicus,,CHEMBL626256,A,,Half life time was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,Intermediate
,In vivo,,,,1,,,N,50597,5182,1,10116.0,9784,,BAO_0000218,Rattus norvegicus,,CHEMBL626257,A,,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,Intermediate
,In vivo,,,,1,,,N,50597,5182,1,10116.0,9785,,BAO_0000218,Rattus norvegicus,,CHEMBL626258,A,,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat; NC means not calculated,Intermediate
,In vivo,,,,1,,,N,50597,5710,1,10116.0,9786,,BAO_0000218,Rattus norvegicus,,CHEMBL626259,A,,Half life was measured in fasted male administration of compound 0.5 mg/Kg i.v.,Intermediate
,In vivo,,,,1,,,N,50597,5789,1,10116.0,9787,,BAO_0000218,Rattus norvegicus,,CHEMBL626260,A,,Half in rat i.v.,Intermediate
,In vivo,,,,1,,,N,50597,6011,1,10116.0,9788,,BAO_0000218,Rattus norvegicus,,CHEMBL875345,A,,Half period in rat after intravenous administration,Intermediate
,In vivo,,,,1,,,N,50597,17594,1,10116.0,9789,,BAO_0000218,Rattus norvegicus,,CHEMBL626261,A,,Half-life after repeated oral dose of compound at 1 mg/kg in rats,Intermediate
,In vitro,Liver,,,1,,,N,50597,12357,1,10116.0,9790,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL626262,A,,Half-life measured in in vitro Cathepsin B assay in rat liver,Intermediate
,,,,,1,,,N,50597,5210,1,10116.0,9791,,BAO_0000218,Rattus norvegicus,,CHEMBL626263,A,,Half-life of compound was determined in rats,Intermediate
,In vivo,,,,1,,,N,50597,17596,1,10116.0,9792,,BAO_0000218,Rattus norvegicus,,CHEMBL625270,A,,Half-life at 10 mg/kg in rat upon intravenous administration,Intermediate
,,,,,1,,,N,50597,6672,1,10116.0,9793,,BAO_0000218,Rattus norvegicus,,CHEMBL625271,A,,Half-life determined in rat,Intermediate
,,,,,1,,,N,50597,6673,1,10116.0,9794,,BAO_0000218,Rattus norvegicus,,CHEMBL625272,A,,Half-life determined in rat,Intermediate
,In vivo,Brain,,,1,,,N,50597,4910,1,10116.0,9795,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL625273,A,,Half-life in brain after intravenous administration (4.7 mg/kg) to male rats,Intermediate
,,Plasma,,,1,,,N,50597,3741,1,10116.0,9796,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL625274,A,,"Half-life in chemical and enzymatic hydrolysis, in 80% rat plasma",Intermediate
,In vivo,,,,1,,,N,50597,17671,1,10116.0,9797,,BAO_0000218,Rattus norvegicus,,CHEMBL625275,A,,Half-life in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,Intermediate
,In vivo,Plasma,,,1,,,N,50597,4910,1,10116.0,9798,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL625276,A,,Half-life in plasma after intravenous administration (4.7 mg/kg) to male rats,Intermediate
,,Plasma,,,1,,,N,50597,17537,1,10116.0,9799,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL625277,A,,Half-life in rat plasma,Intermediate
,,Plasma,,,1,,,N,50597,4965,1,10116.0,9800,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL625278,A,,Half-life in rat plasma was determined,Intermediate
,,Plasma,,,1,,,N,50597,17537,1,10116.0,9801,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL625279,A,,Half-life in rat plasma; Not tested,Intermediate
,,Serum,,,1,,,N,50597,6124,1,10116.0,9802,,BAO_0000218,Rattus norvegicus,1977.0,CHEMBL625280,A,,Half-life in rat serum,Intermediate
,,Serum,,,1,,,N,50597,6124,1,10116.0,9803,,BAO_0000218,Rattus norvegicus,1977.0,CHEMBL876797,A,,Half-life in rat serum; na is not available,Intermediate
,,,,,1,,,N,50597,6078,1,10116.0,9804,,BAO_0000218,Rattus norvegicus,,CHEMBL625281,A,,Half-life was calculated in rat,Intermediate
,,Plasma,,,1,,,N,50597,17668,1,10116.0,9805,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL873827,A,,Half-life was calculated in rat plasma,Intermediate
,,,,,1,,,N,50597,3185,1,10116.0,9806,,BAO_0000218,Rattus norvegicus,,CHEMBL625282,A,,Half-life was determined,Intermediate
,,,,,1,,,N,50597,4883,1,10116.0,9807,,BAO_0000218,Rattus norvegicus,,CHEMBL625283,A,,Half-life was determined,Intermediate
,In vivo,,,,1,,,N,50597,2959,1,10116.0,9808,,BAO_0000218,Rattus norvegicus,,CHEMBL625284,A,,Half-life after administration of 20 mg/Kg oral dose in rat,Intermediate
,In vivo,,,,1,,,N,50597,4029,1,10116.0,9809,,BAO_0000218,Rattus norvegicus,,CHEMBL625285,A,,Half-life after administration of 3.2 mg/kg intravenously in male rat,Intermediate
,In vivo,,,,1,,,N,50597,4029,1,10116.0,9810,,BAO_0000218,Rattus norvegicus,,CHEMBL625286,A,,Half-life after intravenous administration in female rat,Intermediate
,In vivo,,,,1,,,N,50597,4029,1,10116.0,9811,,BAO_0000218,Rattus norvegicus,,CHEMBL625287,A,,Half-life after intravenous administration in male rat,Intermediate
,In vivo,,,,1,,,N,50597,6180,1,10116.0,9812,,BAO_0000218,Rattus norvegicus,,CHEMBL625288,A,,Half-life after intravenous dose in rat,Intermediate
,,Liver,,,1,,,N,50597,1557,1,10116.0,9813,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL625289,A,,Half-life in a rat liver homogenate preparation,Intermediate
,,Plasma,,,1,,,N,50597,12500,1,10116.0,9814,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL625290,A,,Half-life in plasma of rat,Intermediate
,,Plasma,,,1,,,N,50597,12500,1,10116.0,9815,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL876798,A,,Half-life in plasma of rat at dose of 3-10 mgkg,Intermediate
,,,,,1,,,N,50597,5064,1,10116.0,9816,,BAO_0000218,Rattus norvegicus,,CHEMBL625291,A,,Half-life in rat,Intermediate
,,,,,1,,,N,50597,5145,1,10116.0,9817,,BAO_0000218,Rattus norvegicus,,CHEMBL625292,A,,Half-life in rat,Intermediate
,,,,,1,,,N,50597,5147,1,10116.0,9818,,BAO_0000218,Rattus norvegicus,,CHEMBL625293,A,,Half-life in rat,Intermediate
,,,,,1,,,N,50597,5833,1,10116.0,9819,,BAO_0000218,Rattus norvegicus,,CHEMBL622832,A,,Half-life in rat,Intermediate
,,,,,1,,,N,50597,6596,1,10116.0,9820,,BAO_0000218,Rattus norvegicus,,CHEMBL622833,A,,Half-life in rat,Intermediate
,,,,,1,,,N,50597,17655,1,10116.0,9821,,BAO_0000218,Rattus norvegicus,,CHEMBL622834,A,,Half-life in rat,Intermediate
,In vivo,,,,1,,,N,50597,6495,1,10116.0,9822,,BAO_0000218,Rattus norvegicus,,CHEMBL622835,A,,Half-life in rat after oral administration at 10 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,17538,1,10116.0,9823,,BAO_0000218,Rattus norvegicus,,CHEMBL622836,A,,Half-life in rat after po administration at a dose of 10 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,17538,1,10116.0,9824,,BAO_0000218,Rattus norvegicus,,CHEMBL622837,A,,Half-life in rat after po administration at a dose of 10 mg/kg; nd is not determined,Intermediate
,In vivo,,,,1,,,N,50597,10,1,10116.0,9825,,BAO_0000218,Rattus norvegicus,,CHEMBL622838,A,,Half-life in rat at 3 mg/kg dose administered intravenously,Intermediate
,,Brain,,,1,,,N,50597,17669,1,10116.0,9826,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL622839,A,,Half-life in rat brain homogenate,Intermediate
,,Plasma,,,1,,,N,50597,17065,1,10116.0,9827,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622840,A,,Half-life in rat plasma,Intermediate
,,,,,1,,,N,50597,4333,1,10116.0,9828,,BAO_0000218,Rattus norvegicus,,CHEMBL622841,A,,Half-life in rats,Intermediate
,,,,,1,,,N,50597,6827,1,10116.0,9829,,BAO_0000218,Rattus norvegicus,,CHEMBL622842,A,,Half-life in Dawley rats,Intermediate
,In vitro,Plasma,,,1,,,N,50597,889,1,10116.0,9830,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622843,A,,Half-life in vitro in rat plasma,Intermediate
,In vitro,Plasma,,,1,,,N,50597,889,1,10116.0,9831,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622844,A,,Half-life in vitro in rat plasma; No detectable degradation over 2 hr; no detectable degradation over 2 hours,Intermediate
,,,,,1,,,N,50597,3747,1,10116.0,9832,,BAO_0000218,Rattus norvegicus,,CHEMBL622845,A,,"The area under concentration-time curve(AUC) was determined at 20 mg/kg of compound dose, administered intravenously in rat",Intermediate
,,,,,1,,,N,50597,15022,1,10116.0,9833,,BAO_0000218,Rattus norvegicus,,CHEMBL622846,A,,The area under the curve of compound was measured at the dose of 100 umol/kg,Intermediate
,,,,,1,,,N,50597,15022,1,10116.0,9834,,BAO_0000218,Rattus norvegicus,,CHEMBL622847,A,,The area under the curve of compound was measured at the dose of 300 umol/kg,Intermediate
,,,,,1,,,N,50597,15022,1,10116.0,9835,,BAO_0000218,Rattus norvegicus,,CHEMBL622848,A,,The area under the curve of compound was measured at the dose of 30 umol/kg,Intermediate
,In vivo,,,,1,,,N,50597,3360,1,10116.0,9836,,BAO_0000218,Rattus norvegicus,,CHEMBL622849,A,,Bioavailability as oral AUC in rats,Intermediate
,,Plasma,,,1,,,N,50597,5334,1,10116.0,9837,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622850,A,,The plasma concentration versus time curve (AUC) was determined,Intermediate
,,,,,1,,,N,50597,17411,1,10116.0,9838,,BAO_0000218,Rattus norvegicus,,CHEMBL876807,A,,Total concentration in kidney was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate
,,,,,1,,,N,50597,17411,1,10116.0,9839,,BAO_0000218,Rattus norvegicus,,CHEMBL622851,A,,Total concentration in liver was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate
,,,,,1,,,N,50597,17411,1,10116.0,9840,,BAO_0000218,Rattus norvegicus,,CHEMBL622852,A,,Total concentration in lung was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate
,,,,,1,,,N,50597,6570,1,10116.0,9841,,BAO_0000218,Rattus norvegicus,,CHEMBL622853,A,,Total concentration in rat after 1 mg/kg i.v. administration in 24 hours,Intermediate
,,,,,1,,,N,50597,6570,1,10116.0,9842,,BAO_0000218,Rattus norvegicus,,CHEMBL622854,A,,Total concentration in rat after 2 mg/kg peroral administration in 24 hours,Intermediate
,,,,,1,,,N,50597,17411,1,10116.0,9843,,BAO_0000218,Rattus norvegicus,,CHEMBL622855,A,,Total concentration in serum was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate
,,Plasma,,,1,,,N,50597,14941,1,10116.0,9844,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622856,A,,"Pharmacokinetic Parameter, AUC (0-infinity) is the area under the plasma concentration versus time curve extrapolated to infinity in Female Wistar Rats at 100 mg/kg by po administration",Intermediate
,,Plasma,,,1,,,N,50597,14941,1,10116.0,9845,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622857,A,,"Pharmacokinetic Parameter, AUC (0-t) is the area under the plasma concentration versus time curve in Female Wistar Rats at 100 mg/kg by po administration",Intermediate
,,Plasma,,,1,,,N,50597,17538,1,10116.0,9846,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622858,A,,AUC in rat after po administration at a dose of 10 mg/kg,Intermediate
,,Plasma,,,1,,,N,50597,17752,1,10116.0,9847,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622859,A,,Area under the plasma concentration-time curve in rats after oral administration at 25 mg/kg,Intermediate
,,,,,1,,,N,50597,17509,1,10116.0,9848,,BAO_0000218,Rattus norvegicus,,CHEMBL622860,A,,Area under curve value 24 hr after 10 mg/kg iv administration in rats,Intermediate
,,,,,1,,,N,50597,17509,1,10116.0,9849,,BAO_0000218,Rattus norvegicus,,CHEMBL622861,A,,Area under curve value 24 hr after 10 mg/kg oral administration in rats,Intermediate
,,,,,1,,,N,50597,17509,1,10116.0,9850,,BAO_0000218,Rattus norvegicus,,CHEMBL622862,A,,Area under curve value 24 hr after 2 mg/kg iv administration in rats,Intermediate
,,,,,1,,,N,50597,17509,1,10116.0,9851,,BAO_0000218,Rattus norvegicus,,CHEMBL622863,A,,Area under curve value 24 hr after 2 mg/kg oral administration in rats,Intermediate
,,,,,1,,,N,50597,17509,1,10116.0,9852,,BAO_0000218,Rattus norvegicus,,CHEMBL623817,A,,Area under curve value 6 hr after po administration in rat,Intermediate
,,,,,1,,,N,50597,17717,1,10116.0,9853,,BAO_0000218,Rattus norvegicus,,CHEMBL623818,A,,Area under the curve at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,Intermediate
,,,,,1,,,N,50597,17717,1,10116.0,9854,,BAO_0000218,Rattus norvegicus,,CHEMBL623819,A,,"Area under the curve at a concentration of 3 mg/kg in rats, intravenously",Intermediate
,,,,,1,,,N,50597,17717,1,10116.0,9855,,BAO_0000218,Rattus norvegicus,,CHEMBL623820,A,,Area under the curve at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,Intermediate
,,,,,1,,,N,50597,17717,1,10116.0,9856,,BAO_0000218,Rattus norvegicus,,CHEMBL623821,A,,Area under the curve at a concentration of 60 mg/kg perorally in rats along with control,Intermediate
,,Plasma,,,1,,,N,50597,6642,1,10116.0,9857,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623822,A,,AUC normalized for dose (AUCN) in rat,Intermediate
,,,,,1,,,N,50597,6640,1,10116.0,9858,,BAO_0000218,Rattus norvegicus,,CHEMBL623823,A,,Area under curve in rat after p.o. administration,Intermediate
,,,,,1,,,N,50597,6641,1,10116.0,9859,,BAO_0000218,Rattus norvegicus,,CHEMBL623824,A,,Area under curve in rat after p.o. administration,Intermediate
,,,,,1,,,N,50597,6641,1,10116.0,9860,,BAO_0000218,Rattus norvegicus,,CHEMBL623825,A,,Area under curve in rat after p.o. administration; Not determined,Intermediate
,,,,,1,,,N,50597,6641,1,10116.0,9861,,BAO_0000218,Rattus norvegicus,,CHEMBL622070,A,,Area under curve in rat after peroral administration,Intermediate
,,,,,1,,,N,50597,3603,1,10116.0,9862,,BAO_0000218,Rattus norvegicus,,CHEMBL622071,A,,Area under curve (carotid artery) value of the compound,Intermediate
,,,,,1,,,N,50597,3550,1,10116.0,9863,,BAO_0000218,Rattus norvegicus,,CHEMBL622072,A,,Bioavailability expressed as the area under curve of rat carotid artery,Intermediate
,,,,,1,,,N,50597,15662,1,10116.0,9864,,BAO_0000218,Rattus norvegicus,,CHEMBL622073,A,,Area under curve in male SD rats was observed after intravenous administration in rat,Intermediate
,,,,,1,,,N,50597,17720,1,10116.0,9865,,BAO_0000218,Rattus norvegicus,,CHEMBL622074,A,,Area under curve of the compound was determined,Intermediate
,,,,,1,,,N,50597,5407,1,10116.0,9866,,BAO_0000218,Rattus norvegicus,,CHEMBL622075,A,,Compound was evaluated for its pharmacokinetic parameter maximum area under curve AUCmax,Intermediate
,,Plasma,,,1,,,N,50597,17752,1,10116.0,9867,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622076,A,,Area under the plasma concentration-time curve in rats after oral administration at 20 mg/kg,Intermediate
,,Plasma,,,1,,,N,50597,17752,1,10116.0,9868,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622077,A,,Area under the plasma concentration-time curve in rats following oral administration at 20 mg/kg,Intermediate
,,,,,1,,,N,50597,3603,1,10116.0,9869,,BAO_0000218,Rattus norvegicus,,CHEMBL622078,A,,Area under curve (portal vein) value of the compound,Intermediate
,,,,,1,,,N,50597,3550,1,10116.0,9870,,BAO_0000218,Rattus norvegicus,,CHEMBL622079,A,,Bioavailability expressed as the area under curve of rat portal vein,Intermediate
,,Plasma,,,1,,,N,50597,17655,1,10116.0,9871,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622080,A,,Area Under plasma concentration time curve in rat upon peroral administration,Intermediate
,,,,,1,,,N,50597,17582,1,10116.0,9872,,BAO_0000218,Rattus norvegicus,,CHEMBL877612,A,,In vivo area under curve was determined for the compound after i.v. administration at a dose of 5 mg/kg in rats,Intermediate
,,,,,1,,,N,50597,17582,1,10116.0,9873,,BAO_0000218,Rattus norvegicus,,CHEMBL622081,A,,In vivo area under curve was determined for the compound after oral (po) administration at a dose of 10 mg/kg in rats,Intermediate
,,,,,1,,,N,50597,17791,1,10116.0,9874,,BAO_0000218,Rattus norvegicus,,CHEMBL622082,A,,Compound was evaluated for oral bioavailability in rats,Intermediate
,,,,,1,,,N,50597,17791,1,10116.0,9875,,BAO_0000218,Rattus norvegicus,,CHEMBL622083,A,,Compound was evaluated for oral bioavailability in rats after iv administration,Intermediate
,,,,,1,,,N,50597,17791,1,10116.0,9876,,BAO_0000218,Rattus norvegicus,,CHEMBL622084,A,,Compound was evaluated for oral bioavailability in rats; 30-80,Intermediate
,,,,,1,,,N,50597,17791,1,10116.0,9877,,BAO_0000218,Rattus norvegicus,,CHEMBL622085,A,,Compound was evaluated for oral bioavailability in rats; 50-60,Intermediate
,,,,,1,,,N,50597,17791,1,10116.0,9878,,BAO_0000218,Rattus norvegicus,,CHEMBL622086,A,,Compound was evaluated for oral bioavailability in rats; no data,Intermediate
,,,,,1,,,N,50597,17791,1,10116.0,9879,,BAO_0000218,Rattus norvegicus,,CHEMBL622087,A,,Compound was evaluated for oral bioavailability in rats; peptide,Intermediate
,,Blood,,,1,,,N,50597,7768,1,10116.0,9880,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL622088,A,,"Distribution of radioactivity in blood of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.03",Intermediate
,,Blood,,,1,,,N,50597,7768,1,10116.0,9881,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL622089,A,,"Distribution of radioactivity in blood of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range-0.9-1.03",Intermediate
,,Blood,,,1,,,N,50597,7768,1,10116.0,9882,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL623685,A,,"Distribution of radioactivity in blood of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.88-1.15",Intermediate
,,Blood,,,1,,,N,50597,7768,1,10116.0,9883,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL623686,A,,"Distribution of radioactivity in blood of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range = 0.71-0.87",Intermediate
,In vivo,Stomach,,,1,,,N,50597,8677,1,10116.0,9884,,BAO_0000218,Rattus norvegicus,945.0,CHEMBL623687,A,,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate
,In vivo,Stomach,,,1,,,N,50597,8677,1,10116.0,9885,,BAO_0000218,Rattus norvegicus,945.0,CHEMBL623688,A,,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate
,In vivo,Stomach,,,1,,,N,50597,8677,1,10116.0,9886,,BAO_0000218,Rattus norvegicus,945.0,CHEMBL623689,A,,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate
,In vivo,Stomach,,,1,,,N,50597,8677,1,10116.0,9887,,BAO_0000218,Rattus norvegicus,945.0,CHEMBL622485,A,,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate
,In vivo,Thyroid gland,,,1,,,N,50597,8677,1,10116.0,9888,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL622486,A,,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate
,In vivo,Thyroid gland,,,1,,,N,50597,8677,1,10116.0,9889,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL877613,A,,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate
,In vivo,Thyroid gland,,,1,,,N,50597,8677,1,10116.0,9890,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL622487,A,,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate
,In vivo,Thyroid gland,,,1,,,N,50597,8677,1,10116.0,9891,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL622488,A,,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate
,In vivo,Heart,,,1,,,N,50597,8677,1,10116.0,9892,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL622489,A,,"Biodistribution in Sprague-Dawley rats heart 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate
,,Urine,,,1,,,N,50597,6899,1,10116.0,9893,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL622490,A,,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,Intermediate
,,Urine,,,1,,,N,50597,6899,1,10116.0,9894,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL622491,A,,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,Intermediate
,,Liver,,,1,,,N,50597,6899,1,10116.0,9895,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL622492,A,,Compound was evaluated for percent dose tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in liver,Intermediate
,,Urine,,,1,,,N,50597,6899,1,10116.0,9896,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL622493,A,,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,Intermediate
,,Urine,,,1,,,N,50597,6899,1,10116.0,9897,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL622494,A,,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,Intermediate
,,Muscle tissue,,,1,,,N,50597,8677,1,10116.0,9898,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL622495,A,,"Compound was evaluated for the biodistribution in Sprague-Dawley rats in muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate
,,,,,1,,,N,50597,6899,1,10116.0,9899,,BAO_0000218,Rattus norvegicus,,CHEMBL622496,A,,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in rat kidney,Intermediate
,,Urine,,,1,,,N,50597,6899,1,10116.0,9900,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL622497,A,,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,Intermediate
,,,,,1,,,N,50597,2189,1,10116.0,9901,,BAO_0000218,Rattus norvegicus,,CHEMBL622498,A,,Percent of radioactive dose in urine and faeces excreted in 0-24 hr by rats,Intermediate
,,Urine,,,1,,,N,50597,2189,1,10116.0,9902,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL624918,A,,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats,Intermediate
,,Urine,,,1,,,N,50597,2189,1,10116.0,9903,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL624919,A,,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats; NA is <10% inhibition at 1 uM for binding data,Intermediate
,In vivo,Blood,,,1,,,N,50597,10839,1,10116.0,9904,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL624920,A,,Biodistribution of compound in rat blood after 5 min of administration,Intermediate
,In vivo,Blood,,,1,,,N,50597,10839,1,10116.0,9905,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL624921,A,,Biodistribution of compound in rat blood after 5 min of administration.,Intermediate
,In vivo,Brain,,,1,,,N,50597,10839,1,10116.0,9906,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL624922,A,,Biodistribution of compound in rat brain after 5 min of administration,Intermediate
,In vivo,Heart,,,1,,,N,50597,10839,1,10116.0,9907,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL624923,A,,Biodistribution of compound in rat heart after 5 min of administration,Intermediate
,In vivo,Heart,,,1,,,N,50597,10839,1,10116.0,9908,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL624924,A,,Biodistribution of compound in rat heart after 5 min of administration.,Intermediate
,In vivo,Kidney,,,1,,,N,50597,10839,1,10116.0,9909,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL624925,A,,Biodistribution of compound in rat kidney after 5 min of administration,Intermediate
,In vivo,Kidney,,,1,,,N,50597,10839,1,10116.0,9910,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL624926,A,,Biodistribution of compound in rat kidney after 5 min of administration.,Intermediate
,In vivo,Liver,,,1,,,N,50597,10839,1,10116.0,9911,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL624927,A,,Biodistribution of compound in rat liver after 5 min of administration,Intermediate
,In vivo,Liver,,,1,,,N,50597,10839,1,10116.0,9912,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL874402,A,,Biodistribution of compound in rat liver after 5 min of administration.,Intermediate
,In vivo,Lung,,,1,,,N,50597,10839,1,10116.0,9913,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL624928,A,,Biodistribution of compound in rat lung after 5 min of administration,Intermediate
,In vivo,Lung,,,1,,,N,50597,10839,1,10116.0,9914,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL624929,A,,Biodistribution of compound in rat lung after 5 min of administration.,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,10839,1,10116.0,9915,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL624930,A,,Biodistribution of compound in rat muscle after 5 min of administration,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,10839,1,10116.0,9916,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL624931,A,,Biodistribution of compound in rat muscle after 5 min of administration.,Intermediate
,,Heart,,,1,,,N,50597,4043,1,10116.0,9917,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL624932,A,,In vivo heart distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Intermediate
,,Heart,,,1,,,N,50597,4043,1,10116.0,9918,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL624933,A,,In vivo heart distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Intermediate
,,Liver,,,1,,,N,50597,4043,1,10116.0,9919,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL624934,A,,In vivo liver distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Intermediate
,,Liver,,,1,,,N,50597,4043,1,10116.0,9920,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL624935,A,,In vivo liver distribution of total doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Intermediate
,,,,,1,,,N,50597,4043,1,10116.0,9921,,BAO_0000218,Rattus norvegicus,,CHEMBL624936,A,,In vivo plasma distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Intermediate
,,,,,1,,,N,50597,4043,1,10116.0,9922,,BAO_0000218,Rattus norvegicus,,CHEMBL624937,A,,In vivo plasma distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Intermediate
,,Spleen,,,1,,,N,50597,4043,1,10116.0,9923,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL624938,A,,In vivo spleen distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Intermediate
,,Spleen,,,1,,,N,50597,4043,1,10116.0,9924,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL624939,A,,In vivo spleen distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Intermediate
,,,,,1,,,N,50597,4043,1,10116.0,9925,,BAO_0000218,Rattus norvegicus,,CHEMBL624940,A,,In vivo tumor distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Intermediate
,,,,,1,,,N,50597,4043,1,10116.0,9926,,BAO_0000218,Rattus norvegicus,,CHEMBL874403,A,,In vivo tumor distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Intermediate
,,,,,1,,,N,50597,1446,1,10116.0,9927,,BAO_0000218,Rattus norvegicus,,CHEMBL624941,A,,Compound was tested for the duration that the plasma drug concentrations remained above the IC95,Intermediate
,,Urine,,,1,,,N,50597,9971,1,10116.0,9928,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL624942,A,,Dose required to lower urine osmolality to 300 mOsm/kg in rat,Intermediate
,,Urine,,,1,,,N,50597,9971,1,10116.0,9929,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL624943,A,,Dose required to lower urine osmolality to 300 mOsm/kg in rat; NT=Not tested,Intermediate
,In vivo,,,,1,,,N,50597,5765,1,10116.0,9930,,BAO_0000218,Rattus norvegicus,,CHEMBL624944,A,,% Bioavailability after 1 day of the drug administration in rats,Intermediate
,In vivo,,,,1,,,N,50597,5765,1,10116.0,9931,,BAO_0000218,Rattus norvegicus,,CHEMBL624945,A,,% Bioavailability after 4 day of the drug administration in rats,Intermediate
,In vivo,,,,1,,,N,50597,4257,1,10116.0,9932,,BAO_0000218,Rattus norvegicus,,CHEMBL624946,A,,Absolute bioavailability was evaluated in rat,Intermediate
,,,,,1,,,N,50597,13091,1,10116.0,9933,,BAO_0000218,Rattus norvegicus,,CHEMBL624947,A,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr low time interval,Intermediate
,,,,,1,,,N,50597,13091,1,10116.0,9934,,BAO_0000218,Rattus norvegicus,,CHEMBL624948,A,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr time interval,Intermediate
,,,,,1,,,N,50597,13091,1,10116.0,9935,,BAO_0000218,Rattus norvegicus,,CHEMBL624949,A,,Tissue biodistribution into estrogen-primed immature female rat fat at 3 hr time interval,Intermediate
,,Kidney,,,1,,,N,50597,13091,1,10116.0,9936,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL622025,A,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr blocked time interval,Intermediate
,,Kidney,,,1,,,N,50597,13091,1,10116.0,9937,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL622026,A,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr low time interval,Intermediate
,,Kidney,,,1,,,N,50597,13091,1,10116.0,9938,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL622027,A,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr time interval,Intermediate
,,Kidney,,,1,,,N,50597,13091,1,10116.0,9939,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL622028,A,,Tissue biodistribution into estrogen-primed immature female rat kidney at 3 hr time interval,Intermediate
,,Liver,,,1,,,N,50597,13091,1,10116.0,9940,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL622029,A,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr blocked time interval,Intermediate
,,Liver,,,1,,,N,50597,13091,1,10116.0,9941,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL622208,A,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr low time interval,Intermediate
,,Liver,,,1,,,N,50597,13091,1,10116.0,9942,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL622209,A,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr time interval,Intermediate
,,Liver,,,1,,,N,50597,13091,1,10116.0,9943,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL622210,A,,Tissue biodistribution into estrogen-primed immature female rat liver at 3 hr time interval,Intermediate
,,,,,1,,,N,50597,13091,1,10116.0,9944,,BAO_0000218,Rattus norvegicus,,CHEMBL622211,A,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr blocked time interval,Intermediate
,,,,,1,,,N,50597,13091,1,10116.0,9945,,BAO_0000218,Rattus norvegicus,,CHEMBL622212,A,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr low time interval,Intermediate
,,,,,1,,,N,50597,13091,1,10116.0,9946,,BAO_0000218,Rattus norvegicus,,CHEMBL622213,A,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr time interval,Intermediate
,,,,,1,,,N,50597,13091,1,10116.0,9947,,BAO_0000218,Rattus norvegicus,,CHEMBL874404,A,,Tissue biodistribution into estrogen-primed immature female rat lung at 3 hr time interval,Intermediate
,,Muscle tissue,,,1,,,N,50597,13091,1,10116.0,9948,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL620452,A,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr blocked time interval,Intermediate
,,Muscle tissue,,,1,,,N,50597,13091,1,10116.0,9949,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL620453,A,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr low time interval,Intermediate
,,Muscle tissue,,,1,,,N,50597,13091,1,10116.0,9950,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL620454,A,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr time interval,Intermediate
,,Muscle tissue,,,1,,,N,50597,13091,1,10116.0,9951,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL624067,A,,Tissue biodistribution into estrogen-primed immature female rat muscle at 3 hr time interval,Intermediate
,,,,,1,,,N,50597,13091,1,10116.0,9952,,BAO_0000218,Rattus norvegicus,,CHEMBL624068,A,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr blocked time interval,Intermediate
,,Female gonad,,,1,,,N,50597,13091,1,10116.0,9953,,BAO_0000218,Rattus norvegicus,992.0,CHEMBL624069,A,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr low time interval,Intermediate
,,Female gonad,,,1,,,N,50597,13091,1,10116.0,9954,,BAO_0000218,Rattus norvegicus,992.0,CHEMBL624070,A,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr time interval,Intermediate
,,Female gonad,,,1,,,N,50597,13091,1,10116.0,9955,,BAO_0000218,Rattus norvegicus,992.0,CHEMBL624071,A,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 3 hr time interval,Intermediate
,,Uterus,,,1,,,N,50597,13091,1,10116.0,9956,,BAO_0000218,Rattus norvegicus,995.0,CHEMBL624072,A,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr blocked time interval,Intermediate
,,Uterus,,,1,,,N,50597,13091,1,10116.0,9957,,BAO_0000218,Rattus norvegicus,995.0,CHEMBL624073,A,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr low time interval,Intermediate
,,Uterus,,,1,,,N,50597,13091,1,10116.0,9958,,BAO_0000218,Rattus norvegicus,995.0,CHEMBL624788,A,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr time interval,Intermediate
,,Uterus,,,1,,,N,50597,13091,1,10116.0,9959,,BAO_0000218,Rattus norvegicus,995.0,CHEMBL624789,A,,Tissue biodistribution into estrogen-primed immature female rat uterus at 3 hr time interval,Intermediate
,,,,,1,,,N,50597,13091,1,10116.0,9960,,BAO_0000218,Rattus norvegicus,,CHEMBL624790,A,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr blocked time interval,Intermediate
,,,,,1,,,N,50597,13091,1,10116.0,9961,,BAO_0000218,Rattus norvegicus,,CHEMBL624791,A,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr low time interval,Intermediate
,,,,,1,,,N,50597,13091,1,10116.0,9962,,BAO_0000218,Rattus norvegicus,,CHEMBL624792,A,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr time interval,Intermediate
,,,,,1,,,N,50597,13091,1,10116.0,9963,,BAO_0000218,Rattus norvegicus,,CHEMBL624793,A,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 3 hr time interval,Intermediate
,,Muscle tissue,,,1,,,N,50597,13091,1,10116.0,9964,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL877491,A,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr blocked time interval,Intermediate
,,Muscle tissue,,,1,,,N,50597,13091,1,10116.0,9965,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL624957,A,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr low time interval,Intermediate
,,Muscle tissue,,,1,,,N,50597,13091,1,10116.0,9966,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL624958,A,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr time interval,Intermediate
,,Muscle tissue,,,1,,,N,50597,13091,1,10116.0,9967,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL624959,A,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 3 hr time interval,Intermediate
,,,,,1,,,N,50597,11977,1,10116.0,9968,,BAO_0000218,Rattus norvegicus,,CHEMBL624960,A,,Dissociation constant was determined,Intermediate
,,,,,1,,,N,50597,14941,1,10116.0,9969,,BAO_0000218,Rattus norvegicus,,CHEMBL624961,A,,"Pharmacokinetic Parameter, Kel is elimination rate constant in Female Wistar Rats at 100 mg/kg by po administration",Intermediate
,,,,,1,,,N,50597,15078,1,10116.0,9970,,BAO_0000218,Rattus norvegicus,,CHEMBL624962,A,,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",Intermediate
,,,,,1,,,N,50597,15078,1,10116.0,9971,,BAO_0000218,Rattus norvegicus,,CHEMBL624963,A,,"The Kel value in male wistar rat at 100 mg/kg, p.o. dose",Intermediate
,,,,,1,,,N,50597,4755,1,10116.0,9972,,BAO_0000218,Rattus norvegicus,,CHEMBL624964,A,,Observed rate constant in 80% rat plasma at 37 degree Centigrade,Intermediate
,,,,,1,,,N,50597,589,1,10116.0,9973,,BAO_0000218,Rattus norvegicus,,CHEMBL624965,A,,LogP value was evaluated in the in situ rat gut perfusion assay,Intermediate
,In vivo,,,,1,,,N,50597,17582,1,10116.0,9974,,BAO_0000218,Rattus norvegicus,,CHEMBL624966,A,,In vivo retention time was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,Intermediate
,In vivo,,,,1,,,N,50597,5031,1,10116.0,9975,,BAO_0000218,Rattus norvegicus,,CHEMBL624967,A,,Mean residence time (Pharmacokinetic property) after i.v. administration in rats,Intermediate
,In vivo,,,,1,,,N,50597,17764,1,10116.0,9976,,BAO_0000218,Rattus norvegicus,,CHEMBL624968,A,,Mean-residence time of compound after intravenous administration in rats at 24 uM/kg,Intermediate
,,,,,1,,,N,50597,17720,1,10116.0,9977,,BAO_0000218,Rattus norvegicus,,CHEMBL624969,A,,Mean residence time at a dose of 4 mg/kg in Rat Plasma after iv administration,Intermediate
,,,,,1,,,N,50597,2862,1,10116.0,9978,,BAO_0000218,Rattus norvegicus,,CHEMBL624970,F,,Streptococcal cell wall-washed arthritis model in rats at 10.0 mg/kg peroral dose,Expert
,,,,,1,,,N,50597,16423,1,10116.0,9979,,BAO_0000218,Rattus norvegicus,,CHEMBL624971,A,,Half-life was evaluated after 10 uM/kg of intra arterial administration,Intermediate
,In vivo,,,,1,,,N,50597,16423,1,10116.0,9980,,BAO_0000218,Rattus norvegicus,,CHEMBL624972,A,,Half-life was evaluated after 20 uM/kg of peroral administration,Intermediate
,In vivo,,,,1,,,N,50597,6005,1,10116.0,9981,,BAO_0000218,Rattus norvegicus,,CHEMBL624973,A,,Half-life was evaluated after i.v. administration in rat at a dose of 1 mg/kg,Intermediate
,,Plasma,,,1,,,N,50597,2938,1,10116.0,9982,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL624974,A,,Half-life was evaluated in plasma of rat,Intermediate
,In vivo,,,,1,,,N,50597,6410,1,10116.0,9983,,BAO_0000218,Rattus norvegicus,,CHEMBL624975,A,,Half-life was evaluated in rats at an intravenous dose of 3 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,6410,1,10116.0,9984,,BAO_0000218,Rattus norvegicus,,CHEMBL877492,A,,Half-life was evaluated in rats at an oral dose of 30 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,6062,1,10116.0,9985,,BAO_0000218,Rattus norvegicus,,CHEMBL624976,A,,Half-life was measured in rat after an iv dose of 1 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,6571,1,10116.0,9986,,BAO_0000218,Rattus norvegicus,,CHEMBL624977,A,,Half-life period of compound in rats after peroral administration,Intermediate
,,Plasma,,,1,,,N,50597,3136,1,10116.0,9987,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626848,A,,Half-life period of compound was measured in rat plasma.,Intermediate
,,Plasma,,,1,,,N,50597,3136,1,10116.0,9988,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626849,A,,Half-life period of compound was measured in rat plasma; ND is not determined,Intermediate
,,Plasma,,,1,,,N,50597,3136,1,10116.0,9989,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626850,A,,Half-life period of compound was measured in rat plasma; not determined,Intermediate
,In vivo,,,,1,,,N,50597,4521,1,10116.0,9990,,BAO_0000218,Rattus norvegicus,,CHEMBL626851,A,,Half-life period in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,Intermediate
,In vivo,,,,1,,,N,50597,5871,1,10116.0,9991,,BAO_0000218,Rattus norvegicus,,CHEMBL626852,A,,Half-life period in rat by iv administration,Intermediate
,In vivo,,,,1,,,N,50597,6077,1,10116.0,9992,,BAO_0000218,Rattus norvegicus,,CHEMBL626853,A,,Half-life period in rats following intravenous administration at 2 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,6679,1,10116.0,9993,,BAO_0000218,Rattus norvegicus,,CHEMBL626854,A,,Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,Intermediate
,,,,,1,,,N,50597,5144,1,10116.0,9994,,BAO_0000218,Rattus norvegicus,,CHEMBL627486,A,,Half-life period was determined for the compound in rat,Intermediate
,In vivo,,,,1,,,N,50597,4498,1,10116.0,9995,,BAO_0000218,Rattus norvegicus,,CHEMBL627487,A,,"Half-life period was evaluated in rat, after administering 1 mg/kg intravenously",Intermediate
,In vivo,,,,1,,,N,50597,4498,1,10116.0,9996,,BAO_0000218,Rattus norvegicus,,CHEMBL627488,A,,"Half-life period was evaluated in rat, after administering 10 mg/kg orally",Intermediate
,In vivo,,,,1,,,N,50597,1908,1,10116.0,9997,,BAO_0000218,Rattus norvegicus,,CHEMBL627489,A,,Half-life value after IV dose at a dose of 5 mg/kg in rats.,Intermediate
,In vivo,,,,1,,,N,50597,6211,1,10116.0,9998,,BAO_0000218,Rattus norvegicus,,CHEMBL627490,A,,Half-life was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,Intermediate
,In vivo,,,,1,,,N,50597,5529,1,10116.0,9999,,BAO_0000218,Rattus norvegicus,,CHEMBL873829,A,,Half-life was determined in rat after intravenous administration (0.5 mg/kg),Intermediate
,In vivo,,,,1,,,N,50597,6444,1,10116.0,10000,,BAO_0000218,Rattus norvegicus,,CHEMBL627655,A,,Half-life was determined in rat at a dose of 1 mpk i.v.,Intermediate
,In vivo,,,,1,,,N,50597,6444,1,10116.0,10001,,BAO_0000218,Rattus norvegicus,,CHEMBL625994,A,,Half-life was determined in rat at a dose of 1 mpk i.v.; ND means not determined,Intermediate
,In vivo,,,,1,,,N,50597,6444,1,10116.0,10002,,BAO_0000218,Rattus norvegicus,,CHEMBL625995,A,,Half-life was determined in rat at a dose of 1 mpk i.v.; ND=not determined,Intermediate
,,,,,1,,,N,50597,5207,1,10116.0,10003,,BAO_0000218,Rattus norvegicus,,CHEMBL625996,A,,Half-life in rat,Intermediate
,In vitro,Plasma,,,1,,,N,50597,530,1,10116.0,10004,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL625850,A,,In vitro half life in rat plasma,Intermediate
,In vitro,Plasma,,,1,,,N,50597,1116,1,10116.0,10005,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL625851,A,,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in rat plasma",Intermediate
,In vitro,,,,1,,,N,50597,3219,1,10116.0,10006,,BAO_0000218,Rattus norvegicus,,CHEMBL625852,A,,In vitro half life in rat,Intermediate
,In vivo,,,,1,,,N,50597,6109,1,10116.0,10007,,BAO_0000218,Rattus norvegicus,,CHEMBL625853,A,,In vivo half life period after intravenous administration in rat,Intermediate
,In vivo,,,,1,,,N,50597,17582,1,10116.0,10008,,BAO_0000218,Rattus norvegicus,,CHEMBL625854,A,,In vivo half-life period for compound after i.v. administration at a dose of 5 mg/kg was measured in rats,Intermediate
,In vivo,,,,1,,,N,50597,17582,1,10116.0,10009,,BAO_0000218,Rattus norvegicus,,CHEMBL874450,A,,In vivo half-life period for compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,Intermediate
,In vivo,,,,1,,,N,50597,5974,1,10116.0,10010,,BAO_0000218,Rattus norvegicus,,CHEMBL625855,A,,In vivo t1/2 was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,5974,1,10116.0,10011,,BAO_0000218,Rattus norvegicus,,CHEMBL625856,A,,In vivo t1/2 was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,5974,1,10116.0,10012,,BAO_0000218,Rattus norvegicus,,CHEMBL625857,A,,In vivo t1/2 was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,5974,1,10116.0,10013,,BAO_0000218,Rattus norvegicus,,CHEMBL873831,A,,In vivo t1/2 was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,17853,1,10116.0,10014,,BAO_0000218,Rattus norvegicus,,CHEMBL625858,A,,Longer half-life in rat (i.v.) at 0.5 mpk,Intermediate
,In vivo,,,,1,,,N,50597,17853,1,10116.0,10015,,BAO_0000218,Rattus norvegicus,,CHEMBL625859,A,,Longer half-life in rat (p.o.) at 2.0 mpk,Intermediate
,,,,,1,,,N,50597,3457,1,10116.0,10016,,BAO_0000218,Rattus norvegicus,,CHEMBL625860,A,,Pharmacokinetic property (half life) in rat,Intermediate
,In vivo,,,,1,,,N,50597,2792,1,10116.0,10017,,BAO_0000218,Rattus norvegicus,,CHEMBL625861,A,,Pharmacokinetic parameter half-life was determined at 10 mg/kg po dose in rats,Intermediate
,In vivo,,,,1,,,N,50597,2792,1,10116.0,10018,,BAO_0000218,Rattus norvegicus,,CHEMBL625862,A,,Pharmacokinetic parameter half-life was determined at 2 mg/kg i.v. dose in rats,Intermediate
,In vivo,,,,1,,,N,50597,2792,1,10116.0,10019,,BAO_0000218,Rattus norvegicus,,CHEMBL625863,A,,Pharmacokinetic parameter half-life was determined at 3 mg/kg po dose in rats,Intermediate
,In vivo,,,,1,,,N,50597,2792,1,10116.0,10020,,BAO_0000218,Rattus norvegicus,,CHEMBL625864,A,,Pharmacokinetic parameter half-life was determined at 5 mg/kg i.v. dose in rats,Intermediate
,In vivo,,,,1,,,N,50597,5739,1,10116.0,10021,,BAO_0000218,Rattus norvegicus,,CHEMBL625865,A,,Pharmacokinetic property (t1/2) for the compound (5 mg/kg iv) was determined in rats,Intermediate
,In vivo,,,,1,,,N,50597,15765,1,10116.0,10022,,BAO_0000218,Rattus norvegicus,,CHEMBL625866,A,,Pharmacokinetic half time was determined intravenously in rats.,Intermediate
,In vivo,Plasma,,,1,,,N,50597,6567,1,10116.0,10023,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL625867,A,,Plasma half life in rat after 5 mg/kg oral gavage; 6-8 hours,Intermediate
,,Plasma,,,1,,,N,50597,2448,1,10116.0,10024,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL625868,A,,Plasma half life of hydrolysis of the compound,Intermediate
,In vivo,Plasma,,,1,,,N,50597,5423,1,10116.0,10025,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL625869,A,,Plasma half life was reported after a intravenous dose of 1 mg/kg in Dawley rat,Intermediate
,,Plasma,,,1,,,N,50597,4853,1,10116.0,10026,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL874451,A,,Plasma half life period was calculated in rat,Intermediate
,,Plasma,,,1,,,N,50597,4514,1,10116.0,10027,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL625870,A,,Plasma half-life in Sprague-Dawley rats,Intermediate
,,Plasma,,,1,,,N,50597,4514,1,10116.0,10028,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL625871,A,,Plasma half-life in Sprague-Dawley rats; Not determined,Intermediate
,,Plasma,,,1,,,N,50597,1500,1,10116.0,10029,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL625872,A,,Plasma half-life in rats,Intermediate
,,Plasma,,,1,,,N,50597,1500,1,10116.0,10030,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL625873,A,,Plasma half-life in rats; <MQL,Intermediate
,,Plasma,,,1,,,N,50597,5334,1,10116.0,10031,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL625874,A,,Plasma half-life period (0-8 h) was determined,Intermediate
,,Plasma,,,1,,,N,50597,5334,1,10116.0,10032,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL625875,A,,Plasma half-life period (0-8 h) was determined in Sprague-Dawley rat,Intermediate
,In vivo,Plasma,,,1,,,N,50597,5334,1,10116.0,10033,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL625876,A,,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,Intermediate
,In vivo,Plasma,,,1,,,N,50597,5334,1,10116.0,10034,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL631258,A,,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,Intermediate
,,Plasma,,,1,,,N,50597,4956,1,10116.0,10035,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL631259,A,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 h administration of the compound,Intermediate
,,Plasma,,,1,,,N,50597,4956,1,10116.0,10036,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL631260,A,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr administration of the compound; Not determined,Intermediate
,,Blood,,,1,,,N,50597,7768,1,10116.0,10037,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL631261,A,,"Distribution of radioactivity in blood of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.68-1.03",Intermediate
,,Blood,,,1,,,N,50597,7768,1,10116.0,10038,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL631262,A,,"Distribution of radioactivity in blood of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.45-0.48",Intermediate
,,Blood,,,1,,,N,50597,7768,1,10116.0,10039,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL631263,A,,"Distribution of radioactivity in blood of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range-0.81-1",Intermediate
,,,,,1,,,N,50597,7768,1,10116.0,10040,,BAO_0000218,Rattus norvegicus,,CHEMBL631264,A,,"Distribution of radioactivity in brain tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.007-0.008",Intermediate
,,,,,1,,,N,50597,7768,1,10116.0,10041,,BAO_0000218,Rattus norvegicus,,CHEMBL631265,A,,"Distribution of radioactivity in brain tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.18-0.22",Intermediate
,,,,,1,,,N,50597,7768,1,10116.0,10042,,BAO_0000218,Rattus norvegicus,,CHEMBL631266,A,,"Distribution of radioactivity in brain tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.77-0.97",Intermediate
,,,,,1,,,N,50597,7768,1,10116.0,10043,,BAO_0000218,Rattus norvegicus,,CHEMBL631267,A,,"Distribution of radioactivity in brain tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.08-0.13",Intermediate
,,,,,1,,,N,50597,7768,1,10116.0,10044,,BAO_0000218,Rattus norvegicus,,CHEMBL631268,A,,"Distribution of radioactivity in brain tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.25-0.37",Intermediate
,,,,,1,,,N,50597,7768,1,10116.0,10045,,BAO_0000218,Rattus norvegicus,,CHEMBL631269,A,,"Distribution of radioactivity in brain tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.04",Intermediate
,,,,,1,,,N,50597,7768,1,10116.0,10046,,BAO_0000218,Rattus norvegicus,,CHEMBL631270,A,,"Distribution of radioactivity in brain tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.74-0.94",Intermediate
,,Heart,,,1,,,N,50597,7768,1,10116.0,10047,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL631271,A,,"Distribution of radioactivity in heart tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",Intermediate
,,Heart,,,1,,,N,50597,7768,1,10116.0,10048,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL631272,A,,"Distribution of radioactivity in heart tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.5-0.63",Intermediate
,,Heart,,,1,,,N,50597,7768,1,10116.0,10049,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL631273,A,,"Distribution of radioactivity in heart tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.35-1.55",Intermediate
,,Heart,,,1,,,N,50597,7768,1,10116.0,10050,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL631274,A,,"Distribution of radioactivity in heart tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.24-0.38",Intermediate
,,Heart,,,1,,,N,50597,7768,1,10116.0,10051,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL631275,A,,"Distribution of radioactivity in heart tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.55-0.82",Intermediate
,,Heart,,,1,,,N,50597,7768,1,10116.0,10052,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL626984,A,,"Distribution of radioactivity in heart tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.16-0.2",Intermediate
,,Heart,,,1,,,N,50597,7768,1,10116.0,10053,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL626985,A,,"Distribution of radioactivity in heart tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.13-1.29",Intermediate
,,Liver,,,1,,,N,50597,7768,1,10116.0,10054,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL626986,A,,"Distribution of radioactivity in liver tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",Intermediate
,,Liver,,,1,,,N,50597,7768,1,10116.0,10055,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL626987,A,,"Distribution of radioactivity in liver tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.71-0.93",Intermediate
,,Liver,,,1,,,N,50597,7768,1,10116.0,10056,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL626988,A,,"Distribution of radioactivity in liver tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.91-3.53",Intermediate
,,Liver,,,1,,,N,50597,7768,1,10116.0,10057,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL626989,A,,"Distribution of radioactivity in liver tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.42-0.62",Intermediate
,,Liver,,,1,,,N,50597,7768,1,10116.0,10058,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL626990,A,,"Distribution of radioactivity in liver tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.97-1.41",Intermediate
,,Liver,,,1,,,N,50597,7768,1,10116.0,10059,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL626991,A,,"Distribution of radioactivity in liver tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.19-0.23",Intermediate
,,Liver,,,1,,,N,50597,7768,1,10116.0,10060,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL626992,A,,"Distribution of radioactivity in liver tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.49-2.82",Intermediate
,,Lung,,,1,,,N,50597,7768,1,10116.0,10061,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL626993,A,,"Distribution of radioactivity in lung tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.03",Intermediate
,,Lung,,,1,,,N,50597,7768,1,10116.0,10062,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL874593,A,,"Distribution of radioactivity in lung tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.66-0.77",Intermediate
,,Lung,,,1,,,N,50597,7768,1,10116.0,10063,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL626994,A,,"Distribution of radioactivity in lung tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.17-1.42",Intermediate
,,Lung,,,1,,,N,50597,7768,1,10116.0,10064,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL626995,A,,"Distribution of radioactivity in lung tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.47-0.58",Intermediate
,,Lung,,,1,,,N,50597,7768,1,10116.0,10065,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL626190,A,,"Distribution of radioactivity in lung tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.65-0.87",Intermediate
,,Lung,,,1,,,N,50597,7768,1,10116.0,10066,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL626191,A,,"Distribution of radioactivity in lung tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.28-0.31",Intermediate
,,Lung,,,1,,,N,50597,7768,1,10116.0,10067,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL626364,A,,"Distribution of radioactivity in lung tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.98-1.22",Intermediate
,,Thyroid gland,,,1,,,N,50597,7768,1,10116.0,10068,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL626365,A,,"Distribution of radioactivity in thyroid tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 406-499",Intermediate
,,Thyroid gland,,,1,,,N,50597,7768,1,10116.0,10069,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL626366,A,,"Distribution of radioactivity in thyroid tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 53.0-96",Intermediate
,,Thyroid gland,,,1,,,N,50597,7768,1,10116.0,10070,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL626367,A,,"Distribution of radioactivity in thyroid tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.65-8.0.8",Intermediate
,,Thyroid gland,,,1,,,N,50597,7768,1,10116.0,10071,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL626368,A,,"Distribution of radioactivity in thyroid tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 92-159",Intermediate
,,Thyroid gland,,,1,,,N,50597,7768,1,10116.0,10072,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL626369,A,,"Distribution of radioactivity in thyroid tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 18.74-30.84",Intermediate
,,Thyroid gland,,,1,,,N,50597,7768,1,10116.0,10073,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL626370,A,,"Distribution of radioactivity in thyroid tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 156-207",Intermediate
,In vivo,,,,1,,,N,50597,4498,1,10116.0,10074,,BAO_0000218,Rattus norvegicus,,CHEMBL626371,A,,"Bioavailability (F) was evaluated in rat, after administering 1 mg/kg intravenously",Intermediate
,In vivo,,,,1,,,N,50597,4498,1,10116.0,10075,,BAO_0000218,Rattus norvegicus,,CHEMBL626372,A,,"Bioavailability (F) was evaluated in rat, after administering 10 mg/kg orally",Intermediate
,In vivo,,,,1,,,N,50597,3603,1,10116.0,10076,,BAO_0000218,Rattus norvegicus,,CHEMBL626373,A,,Bioavailability after a dose of 10 mg/kg p.o.,Intermediate
,In vivo,,,,1,,,N,50597,6215,1,10116.0,10077,,BAO_0000218,Rattus norvegicus,,CHEMBL626374,A,,Bioavailability after peroral administration (10 mg/kg) was determined in rat,Intermediate
,In vivo,,,,1,,,N,50597,5710,1,10116.0,10078,,BAO_0000218,Rattus norvegicus,,CHEMBL626375,A,,Bioavailability in fasted male administration of 2 mg/Kg of compound p.o.,Intermediate
,In vivo,,,,1,,,N,50597,5710,1,10116.0,10079,,BAO_0000218,Rattus norvegicus,,CHEMBL626376,A,,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 2 mg/kg),Intermediate
,In vivo,,,,1,,,N,50597,5676,1,10116.0,10080,,BAO_0000218,Rattus norvegicus,,CHEMBL626377,A,,Bioavailability in rat po was determined,Intermediate
,In vivo,,,,1,,,N,50597,17667,1,10116.0,10081,,BAO_0000218,Rattus norvegicus,,CHEMBL626378,A,,Bioavailability of compound at 10 mg/kg in rat after oral administration,Intermediate
,In vivo,,,,1,,,N,50597,17667,1,10116.0,10082,,BAO_0000218,Rattus norvegicus,,CHEMBL626379,A,,Bioavailability of compound at 3 mg/kg in rat after i.v. administration,Intermediate
,In vivo,,,,1,,,N,50597,6848,1,10116.0,10083,,BAO_0000218,Rattus norvegicus,,CHEMBL626380,A,,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),Intermediate
,In vivo,,,,1,,,N,50597,6848,1,10116.0,10084,,BAO_0000218,Rattus norvegicus,,CHEMBL626381,A,,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),Intermediate
,In vivo,,,,1,,,N,50597,17267,1,10116.0,10085,,BAO_0000218,Rattus norvegicus,,CHEMBL626382,A,,Bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,6362,1,10116.0,10086,,BAO_0000218,Rattus norvegicus,,CHEMBL626383,A,,Bioavailability in rat (Sprague-Dawley) (female),Intermediate
,In vivo,,,,1,,,N,50597,17671,1,10116.0,10087,,BAO_0000218,Rattus norvegicus,,CHEMBL874652,A,,Bioavailability in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,17671,1,10116.0,10088,,BAO_0000218,Rattus norvegicus,,CHEMBL626384,A,,Bioavailability in rat (Sprague-Dawley) (male) (dose 10-20 mg/kg),Intermediate
,In vivo,,,,1,,,N,50597,4333,1,10116.0,10089,,BAO_0000218,Rattus norvegicus,,CHEMBL626385,A,,Bioavailability in rat (Sprague-Dawley) (male) (dose 1 mg/kg i.v. and 3 mg/kg p.o.) measured from 0.3 to 6 hr,Intermediate
,In vivo,,,,1,,,N,50597,6077,1,10116.0,10090,,BAO_0000218,Rattus norvegicus,,CHEMBL626386,A,,Bioavailability in rat at an oral dose of 2 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,3278,1,10116.0,10091,,BAO_0000218,Rattus norvegicus,,CHEMBL626387,A,,Bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,5964,1,10116.0,10092,,BAO_0000218,Rattus norvegicus,,CHEMBL626388,A,,Bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,4884,1,10116.0,10093,,BAO_0000218,Rattus norvegicus,,CHEMBL626389,A,,Bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,4905,1,10116.0,10094,,BAO_0000218,Rattus norvegicus,,CHEMBL626390,A,,Bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,4884,1,10116.0,10095,,BAO_0000218,Rattus norvegicus,,CHEMBL626391,A,,Bioavailability in rat was reported at the dose of 6 mg/kg in 25% PEG-300,Intermediate
,In vivo,,,,1,,,N,50597,6850,1,10116.0,10096,,BAO_0000218,Rattus norvegicus,,CHEMBL626392,A,,Bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,2864,1,10116.0,10097,,BAO_0000218,Rattus norvegicus,,CHEMBL626393,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,5780,1,10116.0,10098,,BAO_0000218,Rattus norvegicus,,CHEMBL623026,A,,Bioavailability was determined in rat,Intermediate
,In vivo,,,,1,,,N,50597,1465,1,10116.0,10099,,BAO_0000218,Rattus norvegicus,,CHEMBL623027,A,,Bioavailability,Intermediate
,In vivo,,,,1,,,N,50597,5199,1,10116.0,10100,,BAO_0000218,Rattus norvegicus,,CHEMBL623028,A,,Bioavailability,Intermediate
,In vivo,,,,1,,,N,50597,5765,1,10116.0,10101,,BAO_0000218,Rattus norvegicus,,CHEMBL623029,A,,Bioavailability in rat after 1 day dosing,Intermediate
,In vivo,,,,1,,,N,50597,5765,1,10116.0,10102,,BAO_0000218,Rattus norvegicus,,CHEMBL623030,A,,Bioavailability in rat after 4 day dosing,Intermediate
,In vivo,,,,1,,,N,50597,6518,1,10116.0,10103,,BAO_0000218,Rattus norvegicus,,CHEMBL623031,A,,Bioavailability after IV dosing at 0.5 mg/kg in rat; no data,Intermediate
,In vivo,,,,1,,,N,50597,6518,1,10116.0,10104,,BAO_0000218,Rattus norvegicus,,CHEMBL623032,A,,Bioavailability after IV dosing at 1 mg/kg in rat; no data,Intermediate
,In vivo,,,,1,,,N,50597,6518,1,10116.0,10105,,BAO_0000218,Rattus norvegicus,,CHEMBL623033,A,,Bioavailability after oral administration at a dose of 2 mg/kg in rat,Intermediate
,In vivo,,,,1,,,N,50597,6518,1,10116.0,10106,,BAO_0000218,Rattus norvegicus,,CHEMBL623034,A,,Bioavailability after oral administration at a dose of 4 mg/kg in rat,Intermediate
,In vivo,,,,1,,,N,50597,2083,1,10116.0,10107,,BAO_0000218,Rattus norvegicus,,CHEMBL623035,A,,Bioavailability at 4 hr after administration of 5 mg/kg dose peroral in rat,Intermediate
,In vivo,,,,1,,,N,50597,17260,1,10116.0,10108,,BAO_0000218,Rattus norvegicus,,CHEMBL623036,A,,Bioavailability at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,Intermediate
,In vivo,,,,1,,,N,50597,4956,1,10116.0,10109,,BAO_0000218,Rattus norvegicus,,CHEMBL623037,A,,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),Intermediate
,In vivo,,,,1,,,N,50597,4368,1,10116.0,10110,,BAO_0000218,Rattus norvegicus,,CHEMBL623038,A,,Bioavailability by intravenous administration of 3.4 mg/kg in rat,Intermediate
,In vivo,Plasma,,,1,,,N,50597,17752,1,10116.0,10111,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL874385,A,,Bioavailability from rat plasma at a single oral dose of 25 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,1446,1,10116.0,10112,,BAO_0000218,Rattus norvegicus,,CHEMBL623039,A,,Bioavailability in rat (Fisher) (fasted),Intermediate
,In vivo,,,,0,,,U,22224,2891,1,9443.0,10113,,BAO_0000218,Primates,,CHEMBL623040,A,,Bioavailability in monkey after po administration of 10 mg/kg dose,Intermediate
,In vivo,,,,0,,,U,22224,2891,1,9443.0,10114,,BAO_0000218,Primates,,CHEMBL623041,A,,Oral bioavailability in monkey (dose 10 mg/kg),Intermediate
,In vivo,,,,1,,,N,50597,6672,1,10116.0,10115,,BAO_0000218,Rattus norvegicus,,CHEMBL623741,A,,Bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,6673,1,10116.0,10116,,BAO_0000218,Rattus norvegicus,,CHEMBL623742,A,,Bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,17655,1,10116.0,10117,,BAO_0000218,Rattus norvegicus,,CHEMBL623743,A,,Bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,17796,1,10116.0,10118,,BAO_0000218,Rattus norvegicus,,CHEMBL623744,A,,Bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,17853,1,10116.0,10119,,BAO_0000218,Rattus norvegicus,,CHEMBL623745,A,,Bioavailability in rat (dose 2.0 mg/kg p.o.),Intermediate
,In vivo,,,,1,,,N,50597,4521,1,10116.0,10120,,BAO_0000218,Rattus norvegicus,,CHEMBL623746,A,,Bioavailability in rat (dose 5 mg/kg p.o. and 1 mg/kg i.v.),Intermediate
,In vivo,,,,1,,,N,50597,4940,1,10116.0,10121,,BAO_0000218,Rattus norvegicus,,CHEMBL623747,A,,Oral bioavailability in rat (dose 5 mg/kg p.o.),Intermediate
,In vivo,,,,0,,,U,22224,2891,1,10116.0,10122,,BAO_0000218,Rattus norvegicus,,CHEMBL623748,A,,Bioavailability in rat after po administration of 30 mg/kg dose,Intermediate
,In vivo,,,,0,,,U,22224,2891,1,10116.0,10123,,BAO_0000218,Rattus norvegicus,,CHEMBL623916,A,,Bioavailability in rat after po administration of 30 mg/kg dose,Intermediate
,In vivo,,,,1,,,N,50597,4521,1,10116.0,10124,,BAO_0000218,Rattus norvegicus,,CHEMBL623917,A,,Bioavailability in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,Intermediate
,In vivo,,,,1,,,N,50597,17686,1,10116.0,10125,,BAO_0000218,Rattus norvegicus,,CHEMBL623918,A,,Bioavailability in rat (dose 2 mg/kg i.v.),Intermediate
,In vivo,,,,1,,,N,50597,17796,1,10116.0,10126,,BAO_0000218,Rattus norvegicus,,CHEMBL874386,A,,Bioavailability in rat,Intermediate
,In vivo,Plasma,,,1,,,N,50597,17796,1,10116.0,10127,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623919,A,,Bioavailability in rat; Only traces detected in rat plasma,Intermediate
,In vivo,,,,1,,,N,50597,5064,1,10116.0,10128,,BAO_0000218,Rattus norvegicus,,CHEMBL623920,A,,Bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,5147,1,10116.0,10129,,BAO_0000218,Rattus norvegicus,,CHEMBL623148,A,,Bioavailability upon oral administration of compound,Intermediate
,In vivo,,,,1,,,N,50597,1916,1,10116.0,10130,,BAO_0000218,Rattus norvegicus,,CHEMBL623149,A,,Oral bioavailability in rat (Sprague-Dawley) (dose 15 mg/kg),Intermediate
,In vivo,,,,1,,,N,50597,6049,1,10116.0,10131,,BAO_0000218,Rattus norvegicus,,CHEMBL623150,A,,Bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,1445,1,10116.0,10132,,BAO_0000218,Rattus norvegicus,,CHEMBL623151,A,,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fasting state",Intermediate
,In vivo,,,,1,,,N,50597,1445,1,10116.0,10133,,BAO_0000218,Rattus norvegicus,,CHEMBL623152,A,,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fed state",Intermediate
,,,,,1,,,N,50597,2862,1,10116.0,10134,,BAO_0000218,Rattus norvegicus,,CHEMBL623153,F,,Streptococcal cell wall-washed arthritis model in rats at 3.0 mg/kg peroral dose,Expert
,,,,,1,,,N,50597,2862,1,10116.0,10135,,BAO_0000218,Rattus norvegicus,,CHEMBL623154,F,,Streptococcal cell wall-washed arthritis model in rats at 30.0 mg/kg peroral dose,Expert
,,,,,1,,,N,50597,4194,1,10116.0,10136,,BAO_0000218,Rattus norvegicus,,CHEMBL623155,A,,In vitro and metabolic stability was determined,Intermediate
,,,,,1,,,N,50597,4194,1,10116.0,10137,,BAO_0000218,Rattus norvegicus,,CHEMBL623156,A,,In vitro metabolic stability in rat hepatocytes,Intermediate
,,,,,1,,,N,50597,5486,1,10116.0,10138,,BAO_0000218,Rattus norvegicus,,CHEMBL623157,A,,In vitro metabolic stability in rat was measured as pmol/min/mg/protein,Intermediate
,In vitro,Liver,Hepatocyte,,1,,,N,50597,17582,1,10116.0,10139,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL623158,A,401.0,Metabolic rate for compound was observed in rat hepatocytes,Intermediate
,,,,,1,,,N,50597,5600,1,10116.0,10140,,BAO_0000218,Rattus norvegicus,,CHEMBL623159,A,,In vitro metabolic stability determined after 30 min of incubation in rat hepatic microsomes,Intermediate
,,,,,1,,,N,50597,14294,1,10116.0,10141,,BAO_0000218,Rattus norvegicus,,CHEMBL874390,A,,Metabolism of compound in rat S9 microsomes ('+''indicates <20% largest observed peak),Intermediate
,,,,,1,,,N,50597,14294,1,10116.0,10142,,BAO_0000218,Rattus norvegicus,,CHEMBL623160,A,,Metabolism of compound in rat S9 microsomes ('++++' indicates largest observed peak),Intermediate
,,,,,1,,,N,50597,14294,1,10116.0,10143,,BAO_0000218,Rattus norvegicus,,CHEMBL623161,A,,Metabolism of compound in rat S9 microsomes; Trace,Intermediate
,,,,,1,,,N,50597,17847,1,10116.0,10144,,BAO_0000218,Rattus norvegicus,,CHEMBL623162,A,,Metabolism was measured as percent loss at 4 hr in rat hepatocytes,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10145,,BAO_0000218,Rattus norvegicus,,CHEMBL623163,A,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HIAA,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10146,,BAO_0000218,Rattus norvegicus,,CHEMBL623164,A,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HT,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10147,,BAO_0000218,Rattus norvegicus,,CHEMBL623165,A,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DA,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10148,,BAO_0000218,Rattus norvegicus,,CHEMBL623166,A,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DOPAC,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10149,,BAO_0000218,Rattus norvegicus,,CHEMBL624983,A,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex HVA,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10150,,BAO_0000218,Rattus norvegicus,,CHEMBL624984,A,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex NE,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10151,,BAO_0000218,Rattus norvegicus,,CHEMBL624985,A,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Hippocampus 5-HIAA,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10152,,BAO_0000218,Rattus norvegicus,,CHEMBL622970,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus 5-HT,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10153,,BAO_0000218,Rattus norvegicus,,CHEMBL622971,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below level of detection,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10154,,BAO_0000218,Rattus norvegicus,,CHEMBL622972,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below the levels of detection,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10155,,BAO_0000218,Rattus norvegicus,,CHEMBL622973,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below level of detection,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10156,,BAO_0000218,Rattus norvegicus,,CHEMBL622974,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below the levels of detection,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10157,,BAO_0000218,Rattus norvegicus,,CHEMBL622975,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below level of detection,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10158,,BAO_0000218,Rattus norvegicus,,CHEMBL622976,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below the levels of detection,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10159,,BAO_0000218,Rattus norvegicus,,CHEMBL622977,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus NE,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10160,,BAO_0000218,Rattus norvegicus,,CHEMBL624351,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HIAA,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10161,,BAO_0000218,Rattus norvegicus,,CHEMBL624352,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HT,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10162,,BAO_0000218,Rattus norvegicus,,CHEMBL624353,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10163,,BAO_0000218,Rattus norvegicus,,CHEMBL622397,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DOPAC,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10164,,BAO_0000218,Rattus norvegicus,,CHEMBL622398,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex HVA,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10165,,BAO_0000218,Rattus norvegicus,,CHEMBL622399,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex NE,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10166,,BAO_0000218,Rattus norvegicus,,CHEMBL622400,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10167,,BAO_0000218,Rattus norvegicus,,CHEMBL628428,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HIAA,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10168,,BAO_0000218,Rattus norvegicus,,CHEMBL628590,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HT,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10169,,BAO_0000218,Rattus norvegicus,,CHEMBL628591,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below level of detection,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10170,,BAO_0000218,Rattus norvegicus,,CHEMBL628592,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below the levels of detection,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10171,,BAO_0000218,Rattus norvegicus,,CHEMBL628593,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10172,,BAO_0000218,Rattus norvegicus,,CHEMBL875333,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10173,,BAO_0000218,Rattus norvegicus,,CHEMBL628594,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,Intermediate
,,Plasma,,,1,,,N,50597,4969,1,10116.0,10174,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL628595,A,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr of administration,Intermediate
,,Plasma,,,1,,,N,50597,6737,1,10116.0,10175,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL628596,A,,Stability in rat plasma was determined,Intermediate
,,Plasma,,,1,,,N,50597,6737,1,10116.0,10176,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL628597,A,,Stability in rat plasma was determined; ND= no data,Intermediate
,,Plasma,,,1,,,N,50597,5089,1,10116.0,10177,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL628598,A,,Tested for plasma half life period in rat (0-8 hr),Intermediate
,,Plasma,,,1,,,N,50597,5089,1,10116.0,10178,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL628599,A,,Tested for plasma half life period in rat (0-8 hr); Not determined,Intermediate
,In vivo,,,,1,,,N,50597,1466,1,10116.0,10179,,BAO_0000218,Rattus norvegicus,,CHEMBL628600,A,,Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in rat,Intermediate
,In vivo,,,,1,,,N,50597,1466,1,10116.0,10180,,BAO_0000218,Rattus norvegicus,,CHEMBL628601,A,,Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in rat,Intermediate
,,,,,1,,,N,50597,4950,1,10116.0,10181,,BAO_0000218,Rattus norvegicus,,CHEMBL628602,A,,Tested for the half life in rat,Intermediate
,In vitro,,,,1,,,N,50597,2412,1,10116.0,10182,,BAO_0000218,Rattus norvegicus,,CHEMBL628603,A,,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase,Intermediate
,In vitro,,,,1,,,N,50597,2412,1,10116.0,10183,,BAO_0000218,Rattus norvegicus,,CHEMBL628604,A,,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase; ND=Not determined,Intermediate
,In vitro,,,,1,,,N,50597,2412,1,10116.0,10184,,BAO_0000218,Rattus norvegicus,,CHEMBL628605,A,,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase,Intermediate
,In vitro,,,,1,,,N,50597,2412,1,10116.0,10185,,BAO_0000218,Rattus norvegicus,,CHEMBL628606,A,,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase; ND=Not determined,Intermediate
,In vitro,,,,1,,,N,50597,2412,1,10116.0,10186,,BAO_0000218,Rattus norvegicus,,CHEMBL628607,A,,Tested in vitro for the time for half reactivation against rat small intestinal sucrase,Intermediate
,,,,,1,,,N,50597,15022,1,10116.0,10187,,BAO_0000218,Rattus norvegicus,,CHEMBL628608,A,,The biological half life the compound was measured at the dose of 100 umol/kg,Intermediate
,,,,,1,,,N,50597,15022,1,10116.0,10188,,BAO_0000218,Rattus norvegicus,,CHEMBL628609,A,,The biological half life the compound was measured at the dose of 30 umol/kg,Intermediate
,,Plasma,,,1,,,N,50597,406,1,10116.0,10189,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL628610,A,,The compound was evaluated for plasma half life period in rat,Intermediate
,In vivo,,,,1,,,N,50597,15078,1,10116.0,10190,,BAO_0000218,Rattus norvegicus,,CHEMBL873819,A,,"The half life value in female wistar rat at 100 mg/kg, p.o. dose",Intermediate
,In vivo,,,,1,,,N,50597,15078,1,10116.0,10191,,BAO_0000218,Rattus norvegicus,,CHEMBL628611,A,,"The half life value in male wistar rat at 100 mg/kg, p.o. dose",Intermediate
,In vivo,,,,1,,,N,50597,5247,1,10116.0,10192,,BAO_0000218,Rattus norvegicus,,CHEMBL628612,A,,The pharmacokinetic parameter half-life period in vivo in rats,Intermediate
,In vivo,,,,1,,,N,50597,5041,1,10116.0,10193,,BAO_0000218,Rattus norvegicus,,CHEMBL628613,A,,"The pharmacokinetic property, Half-life was determined",Intermediate
,In vivo,,,,1,,,N,50597,5041,1,10116.0,10194,,BAO_0000218,Rattus norvegicus,,CHEMBL628614,A,,"The pharmacokinetic property, Half-life in rat in vivo",Intermediate
,In vivo,,,,1,,,N,50597,5041,1,10116.0,10195,,BAO_0000218,Rattus norvegicus,,CHEMBL628615,A,,"The pharmacokinetic property, Half-life was determined; ND denotes no data",Intermediate
,In vivo,,,,1,,,N,50597,5041,1,10116.0,10196,,BAO_0000218,Rattus norvegicus,,CHEMBL628616,A,,"The pharmacokinetic property, Half-life was determined; ND denotes not determined",Intermediate
,,Plasma,,,1,,,N,50597,3918,1,10116.0,10197,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL627924,A,,The plasma half life period in rats,Intermediate
,,Liver,,,1,,,N,50597,2906,1,10116.0,10198,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL627925,A,,The release rate of the free drug from the substrate in rat liver lysosomal preparation by rat liver lysosomal assay,Intermediate
,In vivo,,,,1,,,N,50597,6467,1,10116.0,10199,,BAO_0000218,Rattus norvegicus,,CHEMBL627926,A,,half life in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,Intermediate
,,,,,1,,,N,50597,5510,1,10116.0,10200,,BAO_0000218,Rattus norvegicus,,CHEMBL627927,A,,t1/2 (apparent elimination)of the compound was determined,Intermediate
,,,,,1,,,N,50597,3788,1,10116.0,10201,,BAO_0000218,Rattus norvegicus,,CHEMBL627928,A,,t1/2 value in rat,Intermediate
,,,,,1,,,N,50597,17796,1,10116.0,10202,,BAO_0000218,Rattus norvegicus,,CHEMBL627539,A,,Half life in rat,Intermediate
,In vivo,Plasma,,,1,,,N,50597,12873,1,10116.0,10203,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL876790,A,,"Half life period calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",Intermediate
,In vivo,,,,1,,,N,50597,5983,1,10116.0,10204,,BAO_0000218,Rattus norvegicus,,CHEMBL858186,A,,Pharmacokinetic property (t1/2beta) was measured in rat at the dose of 0.32 mg/kg i.v.,Intermediate
,,,,,1,,,N,50597,15765,1,10116.0,10205,,BAO_0000218,Rattus norvegicus,,CHEMBL627540,A,,Half-life period in fasted rats,Intermediate
,In vivo,,,,1,,,N,50597,2661,1,10116.0,10206,,BAO_0000218,Rattus norvegicus,,CHEMBL627541,A,,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female wistar rats,Intermediate
,In vivo,,,,1,,,N,50597,2661,1,10116.0,10207,,BAO_0000218,Rattus norvegicus,,CHEMBL627715,A,,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to male wistar rats,Intermediate
,In vivo,,,,1,,,N,50597,429,1,10116.0,10208,,BAO_0000218,Rattus norvegicus,,CHEMBL627716,A,,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,Intermediate
,,,,,1,,,N,50597,17655,1,10116.0,10209,,BAO_0000218,Rattus norvegicus,,CHEMBL627717,A,,Maximum time required to achieve Cmax was determined in rat,Intermediate
,In vivo,,,,1,,,N,50597,17717,1,10116.0,10210,,BAO_0000218,Rattus norvegicus,,CHEMBL627718,A,,Time calculated to reach Cmax at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,Intermediate
,In vivo,,,,1,,,N,50597,17717,1,10116.0,10211,,BAO_0000218,Rattus norvegicus,,CHEMBL627719,A,,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,Intermediate
,In vivo,,,,1,,,N,50597,17717,1,10116.0,10212,,BAO_0000218,Rattus norvegicus,,CHEMBL627720,A,,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with control,Intermediate
,In vivo,,,,1,,,N,50597,6570,1,10116.0,10213,,BAO_0000218,Rattus norvegicus,,CHEMBL627721,A,,Time to reach maximum concentration in rat after 2 mg/kg peroral administration,Intermediate
,In vivo,,,,1,,,N,50597,6570,1,10116.0,10214,,BAO_0000218,Rattus norvegicus,,CHEMBL627722,A,,Time to reach maximum concentration in rat after 2 mg/kg peroral administration; 4-6,Intermediate
,In vivo,,,,1,,,N,50597,5978,1,10116.0,10215,,BAO_0000218,Rattus norvegicus,,CHEMBL627723,A,,Tmax of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,5978,1,10116.0,10216,,BAO_0000218,Rattus norvegicus,,CHEMBL626058,A,,Tmax of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,5978,1,10116.0,10217,,BAO_0000218,Rattus norvegicus,,CHEMBL626059,A,,Tmax of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,5978,1,10116.0,10218,,BAO_0000218,Rattus norvegicus,,CHEMBL626060,A,,Tmax of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate
,In vivo,Plasma,,,1,,,N,50597,17720,1,10116.0,10219,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626061,A,,Tmax at a dose of 4 mg/kg in Rat Plasma after iv administration,Intermediate
,In vivo,,,,1,,,N,50597,4723,1,10116.0,10220,,BAO_0000218,Rattus norvegicus,,CHEMBL876791,A,,Tmax determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Intermediate
,In vivo,,,,1,,,N,50597,4723,1,10116.0,10221,,BAO_0000218,Rattus norvegicus,,CHEMBL626062,A,,Tmax determined after 3 mg/kg oral administration in potassium oxonate treated rats,Intermediate
,In vivo,,,,1,,,N,50597,4756,1,10116.0,10222,,BAO_0000218,Rattus norvegicus,,CHEMBL626063,A,,Tmax at the dose of 2 mg/Kg administered perorally in rats,Intermediate
,In vivo,,,,1,,,N,50597,4756,1,10116.0,10223,,BAO_0000218,Rattus norvegicus,,CHEMBL626064,A,,Tmax at the dose of 5 mg/Kg administered perorally in rats,Intermediate
,In vivo,Plasma,,,1,,,N,50597,17720,1,10116.0,10224,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626065,A,,tmax at a dose of 100 mg/kg in Rat Plasma after iv administration,Intermediate
,In vivo,Plasma,,,1,,,N,50597,17720,1,10116.0,10225,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626066,A,,tmax at a dose of 50 mg/kg in Rat Plasma after iv administration,Intermediate
,In vivo,,,,1,,,N,50597,1466,1,10116.0,10226,,BAO_0000218,Rattus norvegicus,,CHEMBL626067,A,,tmax upon peroral administration of 10.0 mg/Kg dose in rat,Intermediate
,,,,,1,,,N,50597,7449,1,10116.0,10227,,BAO_0000218,Rattus norvegicus,,CHEMBL626068,F,,Percent total excretion of 3-(thiomethyl)acetaminophen glucuronide,Intermediate
,,,,,1,,,N,50597,7449,1,10116.0,10228,,BAO_0000218,Rattus norvegicus,,CHEMBL626069,F,,Percent total excretion of 3-(thiomethyl)acetaminophen sulfate,Intermediate
,,,,,1,,,N,50597,7449,1,10116.0,10229,,BAO_0000218,Rattus norvegicus,,CHEMBL626070,F,,Percent total excretion of 3-methoxyacetaminophen glucuronide,Intermediate
,,,,,1,,,N,50597,7449,1,10116.0,10230,,BAO_0000218,Rattus norvegicus,,CHEMBL626071,F,,Percent total excretion of N-methoxyacetaminophen glucuronide,Intermediate
,,,,,1,,,N,50597,7449,1,10116.0,10231,,BAO_0000218,Rattus norvegicus,,CHEMBL626072,F,,Percent total excretion of N-methoxyacetaminophen sulfate,Intermediate
,,,,,1,,,N,50597,7449,1,10116.0,10232,,BAO_0000218,Rattus norvegicus,,CHEMBL626073,F,,Percent total excretion of acetaminophen,Intermediate
,,Thyroid gland,,,1,,,N,50597,7768,1,10116.0,10233,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL626741,A,,"Distribution of radioactivity in thyroid tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.19-7.22",Intermediate
,,,,,1,,,N,50597,17655,1,10116.0,10234,,BAO_0000218,Rattus norvegicus,,CHEMBL626742,A,,"Percent instability was measured by Rat S9 liver slice metabolism assay, in vitro",Intermediate
,,,,,1,,,N,50597,17735,1,10116.0,10235,,BAO_0000218,Rattus norvegicus,,CHEMBL626743,A,,Plasma clearance following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats,Intermediate
,,,,,1,,,N,50597,5960,1,10116.0,10236,,BAO_0000218,Rattus norvegicus,,CHEMBL876792,A,,Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,Intermediate
,,,,,1,,,N,50597,17735,1,10116.0,10237,,BAO_0000218,Rattus norvegicus,,CHEMBL626744,A,,Volume of distribution following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,Intermediate
,,,,,1,,,N,50597,7116,1,10116.0,10238,,BAO_0000218,Rattus norvegicus,,CHEMBL626745,A,,Compound was tested for antidiuretic activity in rats,Intermediate
,In vivo,Plasma,,,1,,,N,50597,4878,1,10116.0,10239,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626746,A,,AUC in rat after 3mg/kg oral dose,Intermediate
,,,,,1,,,N,50597,5939,1,10116.0,10240,,BAO_0000218,Rattus norvegicus,,CHEMBL626747,A,,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 10 mg/kg,Intermediate
,,,,,1,,,N,50597,5939,1,10116.0,10241,,BAO_0000218,Rattus norvegicus,,CHEMBL626748,A,,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 5 mg/kg,Intermediate
,,,,,1,,,N,50597,16367,1,10116.0,10242,,BAO_0000218,Rattus norvegicus,,CHEMBL626749,A,,Bioavailability administered orally at a dose of 10 mg/kg to rats,Intermediate
,,,,,1,,,N,50597,16366,1,10116.0,10243,,BAO_0000218,Rattus norvegicus,,CHEMBL626750,A,,Oral Bioavailability was determined,Intermediate
,,,,,1,,,N,50597,4426,1,10116.0,10244,,BAO_0000218,Rattus norvegicus,,CHEMBL626751,A,,Oral bioavailability in rat,Intermediate
,,,,,1,,,N,50597,4426,1,10116.0,10245,,BAO_0000218,Rattus norvegicus,,CHEMBL626913,A,,Oral bioavailability in rat; Not performed.,Intermediate
,,,,,1,,,N,50597,5041,1,10116.0,10246,,BAO_0000218,Rattus norvegicus,,CHEMBL626914,A,,Bioavailability,Intermediate
,,,,,1,,,N,50597,5041,1,10116.0,10247,,BAO_0000218,Rattus norvegicus,,CHEMBL626915,A,,Bioavailability was determined; ND denotes no data,Intermediate
,,,,,1,,,N,50597,1500,1,10116.0,10248,,BAO_0000218,Rattus norvegicus,,CHEMBL626916,A,,Biliary excretion when administered intravenously at a dose of 2.5 mg/kg in rats,Intermediate
,,,,,1,,,N,50597,1500,1,10116.0,10249,,BAO_0000218,Rattus norvegicus,,CHEMBL626917,A,,Biliary excretion when administered intravenously at a dose of 5 mg/kg in rats,Intermediate
,,,,,1,,,N,50597,17409,1,10116.0,10250,,BAO_0000218,Rattus norvegicus,,CHEMBL626918,A,,Binding towards rat plasma protein at 10 uM,Intermediate
,,,,,1,,,N,50597,17409,1,10116.0,10251,,BAO_0000218,Rattus norvegicus,,CHEMBL626919,A,,Binding towards rat plasma protein at 100 uM,Intermediate
,In vivo,,,,1,,,N,50597,2959,1,10116.0,10252,,BAO_0000218,Rattus norvegicus,,CHEMBL626920,A,,Bioavailability in rat (dose 20 mg/kg p.o.),Intermediate
,In vivo,,,,1,,,N,50597,13501,1,10116.0,10253,,BAO_0000218,Rattus norvegicus,,CHEMBL621976,A,,Bioavailability was determined after oral administration of compound 18 at a dose of 4 mg/kg to rat,Intermediate
,In vivo,,,,1,,,N,50597,6567,1,10116.0,10254,,BAO_0000218,Rattus norvegicus,,CHEMBL877599,A,,Bioavailability in rat after 5 mg/kg oral gavage,Intermediate
,In vivo,,,,1,,,N,50597,6571,1,10116.0,10255,,BAO_0000218,Rattus norvegicus,,CHEMBL621977,A,,Bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,6715,1,10116.0,10256,,BAO_0000218,Rattus norvegicus,,CHEMBL621978,A,,Bioavailability in rat (dose 1 mg/kg i.v.),Intermediate
,In vivo,,,,1,,,N,50597,6715,1,10116.0,10257,,BAO_0000218,Rattus norvegicus,,CHEMBL621979,A,,Bioavailability in rat (dose 3 mg/kg p.o.),Intermediate
,In vivo,,,,1,,,N,50597,2932,1,10116.0,10258,,BAO_0000218,Rattus norvegicus,,CHEMBL621980,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,4171,1,10116.0,10259,,BAO_0000218,Rattus norvegicus,,CHEMBL621981,A,,Bioavailability of the compound in rats after administration of 30 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,17509,1,10116.0,10260,,BAO_0000218,Rattus norvegicus,,CHEMBL621982,A,,Bioavailability after administration of 10 mg/kg in rats,Intermediate
,In vivo,,,,1,,,N,50597,17509,1,10116.0,10261,,BAO_0000218,Rattus norvegicus,,CHEMBL882953,A,,Bioavailability after administration of 2 mg/kg in rats,Intermediate
,In vivo,,,,1,,,N,50597,4527,1,10116.0,10262,,BAO_0000218,Rattus norvegicus,,CHEMBL621983,A,,Bioavailability by oral administration at a dose of 100 uM/kg in rat was determined,Intermediate
,In vivo,,,,1,,,N,50597,4026,1,10116.0,10263,,BAO_0000218,Rattus norvegicus,,CHEMBL621984,A,,Bioavailability in dogs was determined; high,Intermediate
,In vivo,,,,1,,,N,50597,6659,1,10116.0,10264,,BAO_0000218,Rattus norvegicus,,CHEMBL621985,A,,Bioavailability in monkey after intravenous administration at 1 mpk,Intermediate
,In vivo,,,,1,,,N,50597,6659,1,10116.0,10265,,BAO_0000218,Rattus norvegicus,,CHEMBL621986,A,,Bioavailability in monkey after peroral administration at 10 mpk,Intermediate
,In vivo,,,,1,,,N,50597,6659,1,10116.0,10266,,BAO_0000218,Rattus norvegicus,,CHEMBL621987,A,,Bioavailability in rat after intravenous administration at 1 mpk,Intermediate
,In vivo,,,,1,,,N,50597,6659,1,10116.0,10267,,BAO_0000218,Rattus norvegicus,,CHEMBL877600,F,,Bioavailability in rat after intravenous administration at 2 mpk,Intermediate
,In vivo,,,,1,,,N,50597,6659,1,10116.0,10268,,BAO_0000218,Rattus norvegicus,,CHEMBL621988,A,,Bioavailability in rat after peroral administration at 30 mpk,Intermediate
,In vivo,,,,1,,,N,50597,6659,1,10116.0,10269,,BAO_0000218,Rattus norvegicus,,CHEMBL621989,F,,Bioavailability in rat after peroral administration at at 100 mpk,Intermediate
,In vivo,,,,1,,,N,50597,6597,1,10116.0,10270,,BAO_0000218,Rattus norvegicus,,CHEMBL621990,A,,Bioavailability in rats was evaluated,Intermediate
,In vivo,,,,1,,,N,50597,1202,1,10116.0,10271,,BAO_0000218,Rattus norvegicus,,CHEMBL621991,A,,Bioavailability was calculated after an intravenous dose of 0.3 mg/Kg in rats after 6 hr,Intermediate
,In vivo,,,,1,,,N,50597,1202,1,10116.0,10272,,BAO_0000218,Rattus norvegicus,,CHEMBL621992,A,,Bioavailability was calculated after an intravenous dose of 1 mg/Kg in rats after 6 hr,Intermediate
,In vivo,,,,1,,,N,50597,1202,1,10116.0,10273,,BAO_0000218,Rattus norvegicus,,CHEMBL621993,A,,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 4 hr,Intermediate
,In vivo,,,,1,,,N,50597,1202,1,10116.0,10274,,BAO_0000218,Rattus norvegicus,,CHEMBL621994,A,,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 6 hr,Intermediate
,In vivo,,,,1,,,N,50597,5207,1,10116.0,10275,,BAO_0000218,Rattus norvegicus,,CHEMBL621995,A,,Bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,5970,1,10116.0,10276,,BAO_0000218,Rattus norvegicus,,CHEMBL621996,A,,Bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,17538,1,10116.0,10277,,BAO_0000218,Rattus norvegicus,,CHEMBL621997,A,,Oral bioavailability in rat (dose 10 mg/kg),Intermediate
,In vivo,,,,1,,,N,50597,17538,1,10116.0,10278,,BAO_0000218,Rattus norvegicus,,CHEMBL621998,A,,Bioavailability in rat after po administration at a dose of 10 mg/kg; nd is not determined,Intermediate
,In vivo,,,,1,,,N,50597,1466,1,10116.0,10279,,BAO_0000218,Rattus norvegicus,,CHEMBL621999,A,,Bioavailability upon peroral administration of 10.0 mg/Kg dose in rat,Intermediate
,In vivo,,,,1,,,N,50597,2879,1,10116.0,10280,,BAO_0000218,Rattus norvegicus,,CHEMBL622000,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,2879,1,10116.0,10281,,BAO_0000218,Rattus norvegicus,,CHEMBL622001,A,,Bioavailability was measured in rat after oral administration; 2-4,Intermediate
,In vivo,,,,1,,,N,50597,2879,1,10116.0,10282,,BAO_0000218,Rattus norvegicus,,CHEMBL622002,A,,Bioavailability was measured in rat after oral administration; 3-7,Intermediate
,In vivo,,,,1,,,N,50597,3777,1,10116.0,10283,,BAO_0000218,Rattus norvegicus,,CHEMBL622003,A,,Bioavailability in rat (intraduodenal administration),Intermediate
,In vivo,,,,1,,,N,50597,3777,1,10116.0,10284,,BAO_0000218,Rattus norvegicus,,CHEMBL877601,A,,Bioavailability in rat (intraduodenal administration),Intermediate
,In vivo,,,,1,,,N,50597,3777,1,10116.0,10285,,BAO_0000218,Rattus norvegicus,,CHEMBL624871,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,3777,1,10116.0,10286,,BAO_0000218,Rattus norvegicus,,CHEMBL622004,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,5423,1,10116.0,10287,,BAO_0000218,Rattus norvegicus,,CHEMBL882954,A,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg p.o.),Intermediate
,In vivo,,,,1,,,N,50597,16365,1,10116.0,10288,,BAO_0000218,Rattus norvegicus,,CHEMBL622005,A,,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally,Intermediate
,In vivo,,,,1,,,N,50597,16365,1,10116.0,10289,,BAO_0000218,Rattus norvegicus,,CHEMBL622006,A,,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally to a fasting rat,Intermediate
,In vivo,,,,1,,,N,50597,4239,1,10116.0,10290,,BAO_0000218,Rattus norvegicus,,CHEMBL622007,A,,Bioavailability was measured in rat,Intermediate
,In vivo,,,,1,,,N,50597,5438,1,10116.0,10291,,BAO_0000218,Rattus norvegicus,,CHEMBL622008,A,,Bioavailability was reported,Intermediate
,In vivo,,,,1,,,N,50597,5334,1,10116.0,10292,,BAO_0000218,Rattus norvegicus,,CHEMBL622009,A,,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),Intermediate
,In vivo,,,,1,,,N,50597,5334,1,10116.0,10293,,BAO_0000218,Rattus norvegicus,,CHEMBL622010,A,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),Intermediate
,In vivo,,,,1,,,N,50597,4199,1,10116.0,10294,,BAO_0000218,Rattus norvegicus,,CHEMBL622011,A,,Bioavailability was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,Intermediate
,In vivo,,,,1,,,N,50597,4199,1,10116.0,10295,,BAO_0000218,Rattus norvegicus,,CHEMBL622012,A,,Bioavailability in rat (dose 2 mg/kg in 1% methylcellulose p.o.),Intermediate
,In vivo,,,,1,,,N,50597,4199,1,10116.0,10296,,BAO_0000218,Rattus norvegicus,,CHEMBL622013,A,,Bioavailability in rat (dose 3 mg/kg in 1% methylcellulose ),Intermediate
,In vivo,,,,1,,,N,50597,4890,1,10116.0,10297,,BAO_0000218,Rattus norvegicus,,CHEMBL622014,A,,Bioavailability was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,Intermediate
,In vivo,,,,1,,,N,50597,2792,1,10116.0,10298,,BAO_0000218,Rattus norvegicus,,CHEMBL624749,A,,Bioavailability was determined at 3 mg/kg po dose in rats,Intermediate
,In vivo,,,,1,,,N,50597,5529,1,10116.0,10299,,BAO_0000218,Rattus norvegicus,,CHEMBL624750,A,,Oral bioavailability in rat (dose 2 mg/kg),Intermediate
,In vivo,,,,1,,,N,50597,6685,1,10116.0,10300,,BAO_0000218,Rattus norvegicus,,CHEMBL624751,A,,"Bioavailability was determined in rats at 10 mg/kg, p.o. dose",Intermediate
,In vivo,,,,1,,,N,50597,6685,1,10116.0,10301,,BAO_0000218,Rattus norvegicus,,CHEMBL624752,A,,"Bioavailability was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",Intermediate
,In vivo,,,,1,,,N,50597,6685,1,10116.0,10302,,BAO_0000218,Rattus norvegicus,,CHEMBL624753,A,,"Bioavailability was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",Intermediate
,In vivo,,,,1,,,N,50597,6005,1,10116.0,10303,,BAO_0000218,Rattus norvegicus,,CHEMBL624754,A,,Bioavailability was evaluated in rat after peroral administration at a dose of 1 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,6410,1,10116.0,10304,,BAO_0000218,Rattus norvegicus,,CHEMBL624755,A,,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,Intermediate
,In vivo,,,,1,,,N,50597,6410,1,10116.0,10305,,BAO_0000218,Rattus norvegicus,,CHEMBL624756,A,,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,6103,1,10116.0,10306,,BAO_0000218,Rattus norvegicus,,CHEMBL624757,A,,Bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,6410,1,10116.0,10307,,BAO_0000218,Rattus norvegicus,,CHEMBL624758,A,,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,Intermediate
,In vivo,,,,1,,,N,50597,6410,1,10116.0,10308,,BAO_0000218,Rattus norvegicus,,CHEMBL622270,A,,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,5353,1,10116.0,10309,,BAO_0000218,Rattus norvegicus,,CHEMBL622271,A,,Bioavailability in rat (Sprague-Dawley),Intermediate
,In vivo,,,,1,,,N,50597,4727,1,10116.0,10310,,BAO_0000218,Rattus norvegicus,,CHEMBL622272,A,,Bioavailability in rat at the dose of 2 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,17804,1,10116.0,10311,,BAO_0000218,Rattus norvegicus,,CHEMBL622273,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,5809,1,10116.0,10312,,BAO_0000218,Rattus norvegicus,,CHEMBL622274,A,,Bioavailability in rat (cannulated) (dose 2 mg/kg),Intermediate
,In vivo,,,,1,,,N,50597,17804,1,10116.0,10313,,BAO_0000218,Rattus norvegicus,,CHEMBL622275,A,,Bioavailability value of compound in rats was determined after peroral administration,Intermediate
,In vivo,,,,1,,,N,50597,3634,1,10116.0,10314,,BAO_0000218,Rattus norvegicus,,CHEMBL622276,A,,Oral bioavailability in rat (dose 20 mg/kg),Intermediate
,In vivo,,,,1,,,N,50597,3341,1,10116.0,10315,,BAO_0000218,Rattus norvegicus,,CHEMBL622277,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,2690,1,10116.0,10316,,BAO_0000218,Rattus norvegicus,,CHEMBL622278,A,,Oral bioavailability in rat (dose 5 mg/kg),Intermediate
,In vivo,,,,1,,,N,50597,3184,1,10116.0,10317,,BAO_0000218,Rattus norvegicus,,CHEMBL622279,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,740,1,10116.0,10318,,BAO_0000218,Rattus norvegicus,,CHEMBL622280,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,1806,1,10116.0,10319,,BAO_0000218,Rattus norvegicus,,CHEMBL624083,A,,Compound was evaluated for oral bioavailability in rats; 15-27 %,Intermediate
,In vivo,,,,1,,,N,50597,4891,1,10116.0,10320,,BAO_0000218,Rattus norvegicus,,CHEMBL624084,A,,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 18 h,Intermediate
,In vivo,,,,1,,,N,50597,3634,1,10116.0,10321,,BAO_0000218,Rattus norvegicus,,CHEMBL624085,A,,Compound was evaluated for pharmacokinetic property in rats after an oral dose of 10 mg/kg and the value was reported as oral bioavailability (F),Intermediate
,In vivo,,,,1,,,N,50597,64,1,10116.0,10322,,BAO_0000218,Rattus norvegicus,,CHEMBL624086,A,,Compound was tested for bioavailability in rats,Intermediate
,In vivo,,,,1,,,N,50597,4839,1,10116.0,10323,,BAO_0000218,Rattus norvegicus,,CHEMBL624087,A,,Bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,1094,1,10116.0,10324,,BAO_0000218,Rattus norvegicus,,CHEMBL624088,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,0,,,U,22224,5005,1,9544.0,10325,,BAO_0000218,Macaca mulatta,,CHEMBL624089,A,,Compound was tested for oral bioavailability in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po.,Intermediate
,In vivo,,,,0,,,U,22224,5005,1,10116.0,10326,,BAO_0000218,Rattus norvegicus,,CHEMBL624090,A,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),Intermediate
,In vivo,,,,1,,,N,50597,4687,1,10116.0,10327,,BAO_0000218,Rattus norvegicus,,CHEMBL624091,A,,Evaluated for the bioavailability in rat (in vivo),Intermediate
,In vivo,,,,1,,,N,50597,17804,1,10116.0,10328,,BAO_0000218,Rattus norvegicus,,CHEMBL624092,A,,F value of compound in rats was determined after peroral administration,Intermediate
,In vivo,,,,1,,,N,50597,5974,1,10116.0,10329,,BAO_0000218,Rattus norvegicus,,CHEMBL624093,A,,In vivo Oral bioavailability (F)was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,5974,1,10116.0,10330,,BAO_0000218,Rattus norvegicus,,CHEMBL624094,A,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,5974,1,10116.0,10331,,BAO_0000218,Rattus norvegicus,,CHEMBL624095,A,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,5974,1,10116.0,10332,,BAO_0000218,Rattus norvegicus,,CHEMBL624096,A,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,1088,1,10116.0,10333,,BAO_0000218,Rattus norvegicus,,CHEMBL624097,A,,"In vivo percent of absolute bioavailability obtained from blood plasma levels analyzed by means of GC/MS (dose 5 uM/kg i.v. and 40 uM/kg, p.o.)",Intermediate
,In vivo,,,,1,,,N,50597,1742,1,10116.0,10334,,BAO_0000218,Rattus norvegicus,,CHEMBL624098,A,,Maximum fall in carotid flow in rat,Intermediate
,In vivo,,,,1,,,N,50597,4689,1,10116.0,10335,,BAO_0000218,Rattus norvegicus,,CHEMBL874392,A,,Oral Bioavailability after intravenous administration (1 mg/kg) in rat,Intermediate
,In vivo,,,,1,,,N,50597,2463,1,10116.0,10336,,BAO_0000218,Rattus norvegicus,,CHEMBL624099,A,,Oral bioavailability in rat (dose 5 mg/kg),Intermediate
,In vivo,,,,1,,,N,50597,5654,1,10116.0,10337,,BAO_0000218,Rattus norvegicus,,CHEMBL624100,A,,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,Intermediate
,In vivo,,,,1,,,N,50597,5654,1,10116.0,10338,,BAO_0000218,Rattus norvegicus,,CHEMBL624101,A,,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,Intermediate
,In vivo,,,,1,,,N,50597,6874,1,10116.0,10339,,BAO_0000218,Rattus norvegicus,,CHEMBL624102,A,,Oral bioavailability in rat (male Wistar),Intermediate
,In vivo,,,,1,,,N,50597,5633,1,10116.0,10340,,BAO_0000218,Rattus norvegicus,,CHEMBL624103,A,,Oral bioavailability after administration (30 mg/kg) in rat; good,Intermediate
,In vivo,,,,1,,,N,50597,5496,1,10116.0,10341,,BAO_0000218,Rattus norvegicus,,CHEMBL624104,A,,Oral bioavailability at the dose of 2 mg/kg in rat,Intermediate
,In vivo,,,,1,,,N,50597,2358,1,10116.0,10342,,BAO_0000218,Rattus norvegicus,,CHEMBL624105,A,,Oral bioavailability determined in rats,Intermediate
,In vivo,,,,1,,,N,50597,16456,1,10116.0,10343,,BAO_0000218,Rattus norvegicus,,CHEMBL624106,A,,Oral bioavailability in rat (Sprague-Dawley) (male) (dose 50 mg/kg p.o.),Intermediate
,In vivo,,,,1,,,N,50597,5302,1,10116.0,10344,,BAO_0000218,Rattus norvegicus,,CHEMBL624107,A,,Oral bioavailability in rat (dose single 10 mg/kg),Intermediate
,In vivo,,,,1,,,N,50597,5302,1,10116.0,10345,,BAO_0000218,Rattus norvegicus,,CHEMBL623943,A,,Oral bioavailability in rat (dose single 10 mg/kg),Intermediate
,In vivo,,,,1,,,N,50597,5302,1,10116.0,10346,,BAO_0000218,Rattus norvegicus,,CHEMBL623944,A,,Oral bioavailability in rat (dose 5 mg/kg,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10347,,BAO_0000218,Rattus norvegicus,,CHEMBL623945,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10348,,BAO_0000218,Rattus norvegicus,,CHEMBL623946,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus NE,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10349,,BAO_0000218,Rattus norvegicus,,CHEMBL623947,A,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HIAA,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10350,,BAO_0000218,Rattus norvegicus,,CHEMBL623948,A,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HT,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10351,,BAO_0000218,Rattus norvegicus,,CHEMBL623949,A,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DA,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10352,,BAO_0000218,Rattus norvegicus,,CHEMBL623950,A,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DOPAC,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10353,,BAO_0000218,Rattus norvegicus,,CHEMBL874398,A,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex HVA,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10354,,BAO_0000218,Rattus norvegicus,,CHEMBL623951,A,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex NE,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10355,,BAO_0000218,Rattus norvegicus,,CHEMBL623952,A,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HIAA,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10356,,BAO_0000218,Rattus norvegicus,,CHEMBL623953,A,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HT,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10357,,BAO_0000218,Rattus norvegicus,,CHEMBL623954,A,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below level of detection,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10358,,BAO_0000218,Rattus norvegicus,,CHEMBL623955,A,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below the levels of detection,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10359,,BAO_0000218,Rattus norvegicus,,CHEMBL623956,A,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below level of detection,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10360,,BAO_0000218,Rattus norvegicus,,CHEMBL627807,A,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below the levels of detection,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10361,,BAO_0000218,Rattus norvegicus,,CHEMBL627808,A,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below level of detection,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10362,,BAO_0000218,Rattus norvegicus,,CHEMBL627809,A,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below the levels of detection,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10363,,BAO_0000218,Rattus norvegicus,,CHEMBL627810,A,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus NE,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10364,,BAO_0000218,Rattus norvegicus,,CHEMBL627811,A,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HIAA",Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10365,,BAO_0000218,Rattus norvegicus,,CHEMBL627812,A,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HT",Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10366,,BAO_0000218,Rattus norvegicus,,CHEMBL627813,A,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DA",Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10367,,BAO_0000218,Rattus norvegicus,,CHEMBL627814,A,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DOPAC",Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10368,,BAO_0000218,Rattus norvegicus,,CHEMBL875336,A,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex HVA",Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10369,,BAO_0000218,Rattus norvegicus,,CHEMBL627815,A,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex NE",Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10370,,BAO_0000218,Rattus norvegicus,,CHEMBL627816,A,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus 5-HIAA",Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10371,,BAO_0000218,Rattus norvegicus,,CHEMBL627817,A,,"Momoamine and metabolic levels observed at 3 h postdrug against, at a dose of 20 mg/kg Hippocampus 5-HT",Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10372,,BAO_0000218,Rattus norvegicus,,CHEMBL627818,A,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DA; below the levels of detection",Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10373,,BAO_0000218,Rattus norvegicus,,CHEMBL627819,A,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection",Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10374,,BAO_0000218,Rattus norvegicus,,CHEMBL627820,A,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection",Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10375,,BAO_0000218,Rattus norvegicus,,CHEMBL627821,A,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus NE",Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10376,,BAO_0000218,Rattus norvegicus,,CHEMBL628464,A,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HIAA,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10377,,BAO_0000218,Rattus norvegicus,,CHEMBL626239,A,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HT,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10378,,BAO_0000218,Rattus norvegicus,,CHEMBL626240,A,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex DA,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10379,,BAO_0000218,Rattus norvegicus,,CHEMBL626241,A,,Momoamine and metabolic levels observed at 3 h postdrug against at a dose of 20 mg/kg Frontal cortex DOPAC,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10380,,BAO_0000218,Rattus norvegicus,,CHEMBL626242,A,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex HVA,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10381,,BAO_0000218,Rattus norvegicus,,CHEMBL626243,A,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex NE,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10382,,BAO_0000218,Rattus norvegicus,,CHEMBL626244,A,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HIAA,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10383,,BAO_0000218,Rattus norvegicus,,CHEMBL626907,A,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HT; below level of detection,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10384,,BAO_0000218,Rattus norvegicus,,CHEMBL626908,A,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DA; below level of detection,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10385,,BAO_0000218,Rattus norvegicus,,CHEMBL626909,A,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10386,,BAO_0000218,Rattus norvegicus,,CHEMBL626910,A,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,Intermediate
,,,,,1,,,N,50597,7449,1,10116.0,10387,,BAO_0000218,Rattus norvegicus,,CHEMBL875342,F,,Percent total excretion of acetaminophen cysteine conjugate,Intermediate
,,,,,1,,,N,50597,7449,1,10116.0,10388,,BAO_0000218,Rattus norvegicus,,CHEMBL626911,F,,Percent total excretion of acetaminophen glucuronide,Intermediate
,,,,,1,,,N,50597,7449,1,10116.0,10389,,BAO_0000218,Rattus norvegicus,,CHEMBL626912,F,,Percent total excretion of acetaminophen sulfate,Intermediate
,,,,,1,,,N,50597,7449,1,10116.0,10390,,BAO_0000218,Rattus norvegicus,,CHEMBL627065,F,,Percent total excretion of acetaminophen-mercapturic acid,Intermediate
,,Urine,,,1,,,N,50597,3172,1,10116.0,10391,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL627066,A,,Amount of urine output was measured in rat at a dose of 10 mg/kg administered orally,Intermediate
,In vivo,,,,1,,,N,50597,16456,1,10116.0,10392,,BAO_0000218,Rattus norvegicus,,CHEMBL627067,A,,Volume of distribution in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,Intermediate
,In vivo,Muscle tissue,,,0,,,U,22224,10839,1,8656.0,10393,,BAO_0000218,ratrat,2385.0,CHEMBL627068,A,,Biodistribution of compound in rat muscle after 5 min of administration,Autocuration
,In vivo,Muscle tissue,,,0,,,U,22224,10839,1,8656.0,10394,,BAO_0000218,ratrat,2385.0,CHEMBL627069,A,,Biodistribution of compound in rat muscle after 5 min of administration.,Autocuration
,In vivo,,,,0,,,U,22224,5334,1,9940.0,10395,,BAO_0000218,Ovis aries,,CHEMBL627070,A,,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),Autocuration
,In vivo,,,,0,,,U,22224,5334,1,9940.0,10396,,BAO_0000218,Ovis aries,,CHEMBL627071,A,,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),Autocuration
,In vivo,,,,0,,,U,22224,5334,1,9940.0,10397,,BAO_0000218,Ovis aries,,CHEMBL627072,A,,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),Autocuration
,In vivo,,,,0,,,U,22224,5334,1,9940.0,10398,,BAO_0000218,Ovis aries,,CHEMBL627073,A,,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),Autocuration
,In vivo,,,,0,,,U,22224,5334,1,9940.0,10399,,BAO_0000218,Ovis aries,,CHEMBL625387,A,,Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),Autocuration
,In vivo,,,,0,,,U,22224,5334,1,9940.0,10400,,BAO_0000218,Ovis aries,,CHEMBL625388,A,,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),Autocuration
,In vivo,Plasma,,,0,,,U,22224,5334,1,9940.0,10401,,BAO_0000218,Ovis aries,1969.0,CHEMBL625389,A,,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),Autocuration
,In vivo,Plasma,,,0,,,U,22224,5334,1,9940.0,10402,,BAO_0000218,Ovis aries,1969.0,CHEMBL875343,A,,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),Autocuration
,,,,,1,,,N,50497,1735,1,8570.0,10403,,BAO_0000218,Serpentes,,CHEMBL876795,A,,Biological half life period of compound was measured against snake venom phosphodiesterase (SVPDE),Intermediate
,,,,,1,,,N,50497,1469,1,8570.0,10404,,BAO_0000218,Serpentes,,CHEMBL626552,A,,Half life (t) of enzymatic phosphodiester hydrolysis of compound towards snake venom (SV-PDE) at a concentration of 4 microg,Intermediate
,,,,,1,,,N,50497,1336,1,8570.0,10405,,BAO_0000218,Serpentes,,CHEMBL626553,A,,Enzymatic stability was assessed with snake venom phosphodiesterase (SV PDE) exonuclase,Intermediate
,,Plasma,,,0,,,U,22224,12403,1,9606.0,10406,,BAO_0000366,Homo sapiens,1969.0,CHEMBL626554,A,,The human biological plasma half life of the compound,Autocuration
,,Urine,,,1,,,N,50597,8151,1,10116.0,10407,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL626555,A,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,Intermediate
,,,,,1,,,N,50597,8004,1,10116.0,10408,,BAO_0000218,Rattus norvegicus,,CHEMBL626556,A,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 120 min after iv administration compound,Intermediate
,,,,,1,,,N,50597,8004,1,10116.0,10409,,BAO_0000218,Rattus norvegicus,,CHEMBL626557,A,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 15 after iv administration of compound,Intermediate
,,,,,1,,,N,50597,8004,1,10116.0,10410,,BAO_0000218,Rattus norvegicus,,CHEMBL626558,A,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 240 min after iv administration compound,Intermediate
,,,,,1,,,N,50597,8004,1,10116.0,10411,,BAO_0000218,Rattus norvegicus,,CHEMBL626559,A,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 30 min after iv administration of compound,Intermediate
,,,,,1,,,N,50597,8004,1,10116.0,10412,,BAO_0000218,Rattus norvegicus,,CHEMBL626560,A,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 5 min after iv administration of compound,Intermediate
,,,,,1,,,N,50597,8004,1,10116.0,10413,,BAO_0000218,Rattus norvegicus,,CHEMBL876803,A,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 60 min after iv administration of compound,Intermediate
,,,,,1,,,N,50597,8004,1,10116.0,10414,,BAO_0000218,Rattus norvegicus,,CHEMBL627964,A,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 120 min after iv administration compound,Intermediate
,,,,,1,,,N,50597,8004,1,10116.0,10415,,BAO_0000218,Rattus norvegicus,,CHEMBL627965,A,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 15 min after iv administration of compound,Intermediate
,,,,,1,,,N,50597,8004,1,10116.0,10416,,BAO_0000218,Rattus norvegicus,,CHEMBL627966,A,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 240 min after iv administration compound,Intermediate
,,,,,1,,,N,50597,8004,1,10116.0,10417,,BAO_0000218,Rattus norvegicus,,CHEMBL627967,A,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 30 min after iv administration of compound,Intermediate
,,,,,1,,,N,50597,8004,1,10116.0,10418,,BAO_0000218,Rattus norvegicus,,CHEMBL627968,A,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 5 min after iv administration of compound,Intermediate
,,,,,1,,,N,50597,8004,1,10116.0,10419,,BAO_0000218,Rattus norvegicus,,CHEMBL627969,A,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 60 min after iv administration of compound,Intermediate
,,,,,1,,,N,50597,8004,1,10116.0,10420,,BAO_0000218,Rattus norvegicus,,CHEMBL627970,A,,Distribution of Se-75 activity in Liver of female Sprague-Dawley Rat 5 min after iv administration of compound,Intermediate
,,Blood,,,1,,,N,50597,8004,1,10116.0,10421,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL627971,A,,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 120 min after iv administration of compound,Intermediate
,,Blood,,,1,,,N,50597,8004,1,10116.0,10422,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL627972,A,,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 240 min after iv administration of compound,Intermediate
,,,,,9,,,D,180,15917,1,9606.0,10423,,BAO_0000357,Homo sapiens,,CHEMBL856029,B,,Dissociation constant against binding to human cyclophilin A,Expert
,,,,,8,,,H,11591,12396,1,9913.0,10424,,BAO_0000019,Bos taurus,,CHEMBL627973,B,,Michaelis-Menten constant for inhibitory activity against bovine liver glyoxalase II,Expert
,,,,,0,,,U,22224,7065,1,,10425,,BAO_0000019,,,CHEMBL627974,A,,-Log C was determined by performing the electroshock minimum test,Autocuration
,,,,,0,,,U,22224,7065,1,,10426,,BAO_0000019,,,CHEMBL627975,A,,-Log C was determined by performing the foot shock test,Autocuration
,,,,,0,,,U,22224,7065,1,,10427,,BAO_0000019,,,CHEMBL627976,A,,-Log C was determined by performing the incl screen test,Autocuration
,,,,,0,,,U,22224,7065,1,,10428,,BAO_0000019,,,CHEMBL627977,A,,-Log C was determined by performing the maximum electroshock test,Autocuration
,,,,,0,,,U,22224,7065,1,,10429,,BAO_0000019,,,CHEMBL627978,A,,-Log C was determined by performing the pentylenetetrazole test,Autocuration
,,,,,0,,,U,22224,12415,1,,10430,,BAO_0000019,,,CHEMBL627979,A,,Tested for experimental arotinoid inhibitory dose,Autocuration
,,,,,0,,,U,22224,10256,1,,10431,,BAO_0000019,,,CHEMBL876804,A,,Negative log transformed activity,Autocuration
,,,,,0,,,U,22224,7991,1,,10432,,BAO_0000019,,,CHEMBL627980,A,,"Negative log of Langmuir's alpha constant (-log alpha), which is inversely proportional to the effective binding constant (protein binding)",Autocuration
,,,,,1,,,N,50512,14342,1,10141.0,10433,,BAO_0000218,Cavia porcellus,,CHEMBL627981,A,,Dissociation constant was evaluated on guinea pig bladder at M3 muscarinic receptor,Intermediate
,,,,,1,,,N,50512,14342,1,10141.0,10434,,BAO_0000218,Cavia porcellus,,CHEMBL627982,A,,Dissociation constant was evaluated on guinea pig heart (force) at M2 muscarinic receptor,Intermediate
,,,,,1,,,N,50512,14342,1,10141.0,10435,,BAO_0000218,Cavia porcellus,,CHEMBL627983,A,,Dissociation constant was evaluated on guinea pig heart (rate) at M2 muscarinic receptor,Intermediate
,,Ileum,,,1,,,N,50512,14342,1,10141.0,10436,,BAO_0000218,Cavia porcellus,2116.0,CHEMBL627984,A,,Dissociation constant was evaluated on guinea pig ileum at M3 muscarinic receptor,Intermediate
,,,,,0,,,U,22229,6047,1,,10437,,BAO_0000100,,,CHEMBL627985,P,,Solubility in water was determined; values expressed as -log,Autocuration
,,,,,0,,,U,22224,17269,1,,10438,,BAO_0000019,,,CHEMBL627986,A,,Ratio of Kcat to that of Km was determined,Autocuration
,,,,,0,,,U,22224,10026,1,,10439,,BAO_0000019,,,CHEMBL627987,A,,Observed first order rate constant,Autocuration
,,,,,0,,,U,22224,14583,1,,10440,,BAO_0000019,,,CHEMBL627988,A,,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours,Autocuration
,In vivo,,,,1,,,N,50597,2661,1,10116.0,10441,,BAO_0000218,Rattus norvegicus,,CHEMBL627989,A,,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female wistar rats,Intermediate
,In vivo,,,,1,,,N,50597,2661,1,10116.0,10442,,BAO_0000218,Rattus norvegicus,,CHEMBL627990,A,,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to male wistar rats,Intermediate
,In vivo,,,,1,,,N,50597,4029,1,10116.0,10443,,BAO_0000218,Rattus norvegicus,,CHEMBL876805,A,,Oral Bioavailability after administration of 10 mg/kg in male rat,Intermediate
,In vivo,,,,1,,,N,50597,17735,1,10116.0,10444,,BAO_0000218,Rattus norvegicus,,CHEMBL627991,A,,Oral bioavailability in rat (dose 10 mg/kg i.v. and 50 mg/kg p.o.),Intermediate
,In vivo,,,,1,,,N,50597,4576,1,10116.0,10445,,BAO_0000218,Rattus norvegicus,,CHEMBL627992,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,17582,1,10116.0,10446,,BAO_0000218,Rattus norvegicus,,CHEMBL627993,A,,Oral bioavailability after oral (po) administration at a dose of 10 mg/kg was measured in rats,Intermediate
,In vivo,,,,1,,,N,50597,17651,1,10116.0,10447,,BAO_0000218,Rattus norvegicus,,CHEMBL622817,A,,Oral bioavailability at 1 mg/kg was determined in rat,Intermediate
,In vivo,,,,1,,,N,50597,17651,1,10116.0,10448,,BAO_0000218,Rattus norvegicus,,CHEMBL622818,A,,Oral bioavailability at 10 mg/kg was determined in rat,Intermediate
,In vivo,,,,1,,,N,50597,17670,1,10116.0,10449,,BAO_0000218,Rattus norvegicus,,CHEMBL622819,A,,"Oral bioavailability in fischer rats at 30 mg/kg dose, administered perorally",Intermediate
,In vivo,,,,1,,,N,50597,5045,1,10116.0,10450,,BAO_0000218,Rattus norvegicus,,CHEMBL872267,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,1696,1,10116.0,10451,,BAO_0000218,Rattus norvegicus,,CHEMBL622820,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,17764,1,10116.0,10452,,BAO_0000218,Rattus norvegicus,,CHEMBL622821,A,,Oral bioavailability after intravenous administration in rats at 24 uM/kg,Intermediate
,In vivo,,,,1,,,N,50597,6448,1,10116.0,10453,,BAO_0000218,Rattus norvegicus,,CHEMBL622822,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,6596,1,10116.0,10454,,BAO_0000218,Rattus norvegicus,,CHEMBL622823,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,17547,1,10116.0,10455,,BAO_0000218,Rattus norvegicus,,CHEMBL622824,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,17771,1,10116.0,10456,,BAO_0000218,Rattus norvegicus,,CHEMBL622825,A,,Oral bioavailability in rat at a dose of 3 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,6495,1,10116.0,10457,,BAO_0000218,Rattus norvegicus,,CHEMBL622901,A,,Oral bioavailability in rat after oral administration at 10 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,4558,1,10116.0,10458,,BAO_0000218,Rattus norvegicus,,CHEMBL622902,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,17596,1,10116.0,10459,,BAO_0000218,Rattus norvegicus,,CHEMBL621844,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,6827,1,10116.0,10460,,BAO_0000218,Rattus norvegicus,,CHEMBL621845,A,,Oral bioavailability in Dawley rats,Intermediate
,In vivo,,,,1,,,N,50597,4026,1,10116.0,10461,,BAO_0000218,Rattus norvegicus,,CHEMBL621846,A,,Oral bioavailability,Intermediate
,In vivo,,,,1,,,N,50597,10,1,10116.0,10462,,BAO_0000218,Rattus norvegicus,,CHEMBL621847,A,,Oral bioavailability in rat (dose 30 mg/kg),Intermediate
,In vivo,,,,1,,,N,50597,17717,1,10116.0,10463,,BAO_0000218,Rattus norvegicus,,CHEMBL877609,A,,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,Intermediate
,In vivo,,,,1,,,N,50597,17717,1,10116.0,10464,,BAO_0000218,Rattus norvegicus,,CHEMBL621848,A,,Bioavailability in rat (dose 3 mg/kg i.v.),Intermediate
,In vivo,,,,1,,,N,50597,17717,1,10116.0,10465,,BAO_0000218,Rattus norvegicus,,CHEMBL621849,A,,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,Intermediate
,In vivo,,,,1,,,N,50597,17717,1,10116.0,10466,,BAO_0000218,Rattus norvegicus,,CHEMBL622030,A,,Oral bioavailability in rat (dose 60 mg/kg p.o.),Intermediate
,In vivo,,,,1,,,N,50597,4796,1,10116.0,10467,,BAO_0000218,Rattus norvegicus,,CHEMBL622031,A,,Percent oral bioavailability determined in rats,Intermediate
,In vivo,,,,1,,,N,50597,4883,1,10116.0,10468,,BAO_0000218,Rattus norvegicus,,CHEMBL622032,A,,Tested for percent bioavailability after oral administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,2137,1,10116.0,10469,,BAO_0000218,Rattus norvegicus,,CHEMBL622033,A,,The compound was evaluated for bioavailability in rats; 32-51,Intermediate
,In vivo,,,,1,,,N,50597,2959,1,10116.0,10470,,BAO_0000218,Rattus norvegicus,,CHEMBL622034,A,,Bioavailability in rat (dose 20 mg/kg p.o.),Intermediate
,In vivo,,,,1,,,N,50597,1361,1,10116.0,10471,,BAO_0000218,Rattus norvegicus,,CHEMBL622035,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,4727,1,10116.0,10472,,BAO_0000218,Rattus norvegicus,,CHEMBL882966,A,,Bioavailability percent in rat at the dose of 2 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,16423,1,10116.0,10473,,BAO_0000218,Rattus norvegicus,,CHEMBL622036,A,,Bioavailability was evaluated after 20 uM/kg of peroral administration,Intermediate
,In vivo,,,,1,,,N,50597,5206,1,10116.0,10474,,BAO_0000218,Rattus norvegicus,,CHEMBL622037,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,6448,1,10116.0,10475,,BAO_0000218,Rattus norvegicus,,CHEMBL622038,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,17723,1,10116.0,10476,,BAO_0000218,Rattus norvegicus,,CHEMBL622039,A,,Bioavailability in rats,Intermediate
,In vivo,Blood,,,1,,,N,50597,17738,1,10116.0,10477,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL622040,A,,Biodistribution of radiolabeled compound in rat blood after 24 hr postinjection activity expressed as %ID/Organ,Intermediate
,In vivo,Blood,,,1,,,N,50597,17738,1,10116.0,10478,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL622041,A,,Biodistribution of radiolabeled compound in rat blood after 24 hr activity expressed as %ID/Organ,Intermediate
,In vivo,Blood,,,1,,,N,50597,17738,1,10116.0,10479,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL622042,A,,Biodistribution of radiolabeled compound in rat blood after 2 hr activity expressed as %ID/Organ,Intermediate
,In vivo,Blood,,,1,,,N,50597,17738,1,10116.0,10480,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL622043,A,,Biodistribution of radiolabeled compound in rat blood after 30 min activity expressed as %ID/Organ,Intermediate
,In vivo,Blood,,,1,,,N,50597,17738,1,10116.0,10481,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL622044,A,,Biodistribution of radiolabeled compound in rat blood after 5 min activity expressed as %ID/Organ,Intermediate
,In vivo,Bone,,,1,,,N,50597,17738,1,10116.0,10482,,BAO_0000218,Rattus norvegicus,10000001.0,CHEMBL622045,A,,Biodistribution of radiolabeled compound in rat bone after 24 hr activity expressed as %ID/Organ,Intermediate
,In vivo,Bone,,,1,,,N,50597,17738,1,10116.0,10483,,BAO_0000218,Rattus norvegicus,10000001.0,CHEMBL622046,A,,Biodistribution of radiolabeled compound in rat bone after 2 hr activity expressed as %ID/Organ,Intermediate
,In vivo,Bone,,,1,,,N,50597,17738,1,10116.0,10484,,BAO_0000218,Rattus norvegicus,10000001.0,CHEMBL622047,A,,Biodistribution of radiolabeled compound in rat bone after 30 min activity expressed as %ID/Organ,Intermediate
,In vivo,Bone,,,1,,,N,50597,17738,1,10116.0,10485,,BAO_0000218,Rattus norvegicus,10000001.0,CHEMBL877610,A,,Biodistribution of radiolabeled compound in rat bone after 5 min activity expressed as %ID/Organ,Intermediate
,In vivo,Brain,,,1,,,N,50597,17738,1,10116.0,10486,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL622048,A,,Biodistribution of radiolabeled compound in rat brain after 24 hr activity expressed as %ID/Organ,Intermediate
,In vivo,Brain,,,1,,,N,50597,17738,1,10116.0,10487,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL622049,A,,Biodistribution of radiolabeled compound in rat brain after 2 hr activity expressed as %ID/Organ,Intermediate
,In vivo,Brain,,,1,,,N,50597,17738,1,10116.0,10488,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL622050,A,,Biodistribution of radiolabeled compound in rat brain after 30 min activity expressed as %ID/Organ,Intermediate
,In vivo,Brain,,,1,,,N,50597,17738,1,10116.0,10489,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL622051,A,,Biodistribution of radiolabeled compound in rat brain after 5 min activity expressed as %ID/Organ,Intermediate
,In vivo,,,,1,,,N,50597,17738,1,10116.0,10490,,BAO_0000218,Rattus norvegicus,,CHEMBL622052,A,,Biodistribution of radiolabeled compound in rat fat after 24 hr activity expressed as %ID/Organ,Intermediate
,In vivo,,,,1,,,N,50597,17738,1,10116.0,10491,,BAO_0000218,Rattus norvegicus,,CHEMBL622053,A,,Biodistribution of radiolabeled compound in rat fat after 2 hr activity expressed as %ID/Organ,Intermediate
,In vivo,,,,1,,,N,50597,17738,1,10116.0,10492,,BAO_0000218,Rattus norvegicus,,CHEMBL622054,A,,Biodistribution of radiolabeled compound in rat fat after 30 min activity expressed as %ID/Organ,Intermediate
,In vivo,,,,1,,,N,50597,17738,1,10116.0,10493,,BAO_0000218,Rattus norvegicus,,CHEMBL622055,A,,Biodistribution of radiolabeled compound in rat fat after 5 min activity expressed as %ID/Organ,Intermediate
,In vivo,,,,1,,,N,50597,5237,1,10116.0,10494,,BAO_0000218,Rattus norvegicus,,CHEMBL622056,A,,Oral bioavailability in rats was determined; High,Intermediate
,In vivo,,,,1,,,N,50597,5503,1,10116.0,10495,,BAO_0000218,Rattus norvegicus,,CHEMBL622057,A,,Oral bioavailability in the rat was determined,Intermediate
,In vivo,,,,1,,,N,50597,15765,1,10116.0,10496,,BAO_0000218,Rattus norvegicus,,CHEMBL628008,A,,Oral bioavailability measured by the ratio of intravenous to oral area under concentration.,Intermediate
,In vivo,,,,1,,,N,50597,15660,1,10116.0,10497,,BAO_0000218,Rattus norvegicus,,CHEMBL622058,A,,Oral bioavailability in rat (dose 10 mg/kg p.o. and 3 mg/kg i.v.),Intermediate
,In vivo,,,,1,,,N,50597,5978,1,10116.0,10498,,BAO_0000218,Rattus norvegicus,,CHEMBL622059,A,,Oral bioavailability of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,5978,1,10116.0,10499,,BAO_0000218,Rattus norvegicus,,CHEMBL622060,A,,Oral bioavailability of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,5978,1,10116.0,10500,,BAO_0000218,Rattus norvegicus,,CHEMBL622061,A,,Oral bioavailability of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,5978,1,10116.0,10501,,BAO_0000218,Rattus norvegicus,,CHEMBL622062,A,,Oral bioavailability of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate
,In vivo,,,,1,,,N,50597,5656,1,10116.0,10502,,BAO_0000218,Rattus norvegicus,,CHEMBL622063,A,,Oral bioavailability of compound at a dose of 20 mg/kg was determined after oral administration in rat,Intermediate
,In vivo,,,,1,,,N,50597,3598,1,10116.0,10503,,BAO_0000218,Rattus norvegicus,,CHEMBL877611,A,,Oral bioavailability of compound determined in rat after iv administration at a dose of 10 mg/kg,Expert
,In vivo,,,,1,,,N,50597,4216,1,10116.0,10504,,BAO_0000218,Rattus norvegicus,,CHEMBL622064,A,,Oral bioavailability of compound in Sprague Dawley rats,Intermediate
,In vivo,,,,1,,,N,50597,17839,1,10116.0,10505,,BAO_0000218,Rattus norvegicus,,CHEMBL622065,A,,Oral bioavailability of compound in rat,Intermediate
,In vivo,,,,1,,,N,50597,6570,1,10116.0,10506,,BAO_0000218,Rattus norvegicus,,CHEMBL622066,A,,Oral bioavailability in rat (dose 2 mg/kg),Intermediate
,In vivo,,,,1,,,N,50597,5334,1,10116.0,10507,,BAO_0000218,Rattus norvegicus,,CHEMBL622067,A,,Oral bioavailability of compound in rat was determined,Intermediate
,In vivo,,,,1,,,N,50597,6886,1,10116.0,10508,,BAO_0000218,Rattus norvegicus,,CHEMBL622068,A,,Oral bioavailability of compound in rats,Intermediate
,In vivo,,,,1,,,N,50597,5210,1,10116.0,10509,,BAO_0000218,Rattus norvegicus,,CHEMBL622069,A,,Oral bioavailability of compound was determined in rats,Intermediate
,In vivo,,,,1,,,N,50597,4170,1,10116.0,10510,,BAO_0000218,Rattus norvegicus,,CHEMBL624796,A,,Oral bioavailability at a dose of 30 mg/kg in rats,Intermediate
,In vivo,,,,1,,,N,50597,6028,1,10116.0,10511,,BAO_0000218,Rattus norvegicus,,CHEMBL624797,A,,Oral bioavailability in rat (dose 10 mg/kg),Intermediate
,In vivo,,,,1,,,N,50597,6028,1,10116.0,10512,,BAO_0000218,Rattus norvegicus,,CHEMBL623053,A,,Oral bioavailability in rat (dose 10 mg/kg),Intermediate
,In vivo,,,,1,,,N,50597,6078,1,10116.0,10513,,BAO_0000218,Rattus norvegicus,,CHEMBL623054,A,,Oral bioavailability evaluated in rat,Intermediate
,In vivo,,,,1,,,N,50597,6168,1,10116.0,10514,,BAO_0000218,Rattus norvegicus,,CHEMBL623055,A,,Oral bioavailability in fasted rat,Intermediate
,In vivo,,,,1,,,N,50597,6168,1,10116.0,10515,,BAO_0000218,Rattus norvegicus,,CHEMBL623056,A,,Oral bioavailability in fed rat,Intermediate
,In vivo,,,,1,,,N,50597,5160,1,10116.0,10516,,BAO_0000218,Rattus norvegicus,,CHEMBL623057,A,,Oral bioavailability in rat (mature male) (dose 30 mg/kg),Intermediate
,In vivo,,,,1,,,N,50597,6057,1,10116.0,10517,,BAO_0000218,Rattus norvegicus,,CHEMBL623058,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,6535,1,10116.0,10518,,BAO_0000218,Rattus norvegicus,,CHEMBL623059,A,,Oral bioavailability in rat (dose 10 mg/kg p.o.),Intermediate
,In vivo,,,,1,,,N,50597,6535,1,10116.0,10519,,BAO_0000218,Rattus norvegicus,,CHEMBL623060,A,,Oral bioavailability in rat after administration of 10 mg/kg po,Intermediate
,In vivo,,,,1,,,N,50597,4194,1,10116.0,10520,,BAO_0000218,Rattus norvegicus,,CHEMBL623061,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,6230,1,10116.0,10521,,BAO_0000218,Rattus norvegicus,,CHEMBL623062,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,6619,1,10116.0,10522,,BAO_0000218,Rattus norvegicus,,CHEMBL623063,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,17607,1,10116.0,10523,,BAO_0000218,Rattus norvegicus,,CHEMBL623064,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,4942,1,10116.0,10524,,BAO_0000218,Rattus norvegicus,,CHEMBL623065,A,,Oral bioavailability in ratrs,Intermediate
,In vivo,,,,1,,,N,50597,4942,1,10116.0,10525,,BAO_0000218,Rattus norvegicus,,CHEMBL623066,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,6646,1,10116.0,10526,,BAO_0000218,Rattus norvegicus,,CHEMBL623067,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,5237,1,10116.0,10527,,BAO_0000218,Rattus norvegicus,,CHEMBL623068,A,,Oral bioavailability in rats was determined; High,Intermediate
,In vivo,,,,1,,,N,50597,6646,1,10116.0,10528,,BAO_0000218,Rattus norvegicus,,CHEMBL623069,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,4449,1,10116.0,10529,,BAO_0000218,Rattus norvegicus,,CHEMBL623070,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,6057,1,10116.0,10530,,BAO_0000218,Rattus norvegicus,,CHEMBL623071,A,,Oral bioavailability was calculated in rat,Intermediate
,In vivo,,,,1,,,N,50597,2552,1,10116.0,10531,,BAO_0000218,Rattus norvegicus,,CHEMBL623072,A,,Oral bioavailability,Intermediate
,In vivo,,,,1,,,N,50597,5496,1,10116.0,10532,,BAO_0000218,Rattus norvegicus,,CHEMBL623073,A,,Oral bioavailability,Intermediate
,In vivo,,,,1,,,N,50597,6484,1,10116.0,10533,,BAO_0000218,Rattus norvegicus,,CHEMBL623074,A,,Oral bioavailability,Intermediate
,In vivo,,,,1,,,N,50597,6485,1,10116.0,10534,,BAO_0000218,Rattus norvegicus,,CHEMBL623075,A,,Oral bioavailability,Intermediate
,In vivo,,,,1,,,N,50597,6616,1,10116.0,10535,,BAO_0000218,Rattus norvegicus,,CHEMBL623076,A,,Oral bioavailability after i.v. administration,Intermediate
,In vivo,,,,1,,,N,50597,4969,1,10116.0,10536,,BAO_0000218,Rattus norvegicus,,CHEMBL623077,A,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),Intermediate
,In vivo,,,,1,,,N,50597,5862,1,10116.0,10537,,BAO_0000218,Rattus norvegicus,,CHEMBL623078,A,,Oral bioavailability in rat (Sprague-Dawley),Intermediate
,In vivo,,,,1,,,N,50597,4514,1,10116.0,10538,,BAO_0000218,Rattus norvegicus,,CHEMBL623079,A,,Oral bioavailability in Sprague-Dawley rats,Intermediate
,In vivo,,,,1,,,N,50597,4514,1,10116.0,10539,,BAO_0000218,Rattus norvegicus,,CHEMBL623080,A,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),Intermediate
,In vivo,,,,1,,,N,50597,4514,1,10116.0,10540,,BAO_0000218,Rattus norvegicus,,CHEMBL623081,A,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),Intermediate
,In vivo,,,,1,,,N,50597,5546,1,10116.0,10541,,BAO_0000218,Rattus norvegicus,,CHEMBL623082,A,,Oral bioavailability in Sprague-Dawley rats at a dose of 2 mg/kg by po administration,Intermediate
,In vivo,,,,1,,,N,50597,6168,1,10116.0,10542,,BAO_0000218,Rattus norvegicus,,CHEMBL874400,A,,Oral bioavailability in fasted rat,Intermediate
,In vivo,,,,1,,,N,50597,6168,1,10116.0,10543,,BAO_0000218,Rattus norvegicus,,CHEMBL623083,A,,Oral bioavailability in fed rat,Intermediate
,In vivo,,,,1,,,N,50597,3624,1,10116.0,10544,,BAO_0000218,Rattus norvegicus,,CHEMBL623084,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,5213,1,10116.0,10545,,BAO_0000218,Rattus norvegicus,,CHEMBL623085,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,5496,1,10116.0,10546,,BAO_0000218,Rattus norvegicus,,CHEMBL623086,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,5553,1,10116.0,10547,,BAO_0000218,Rattus norvegicus,,CHEMBL623087,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,5833,1,10116.0,10548,,BAO_0000218,Rattus norvegicus,,CHEMBL623088,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,5836,1,10116.0,10549,,BAO_0000218,Rattus norvegicus,,CHEMBL623089,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,5865,1,10116.0,10550,,BAO_0000218,Rattus norvegicus,,CHEMBL623090,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,5960,1,10116.0,10551,,BAO_0000218,Rattus norvegicus,,CHEMBL623091,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,6249,1,10116.0,10552,,BAO_0000218,Rattus norvegicus,,CHEMBL623092,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,6448,1,10116.0,10553,,BAO_0000218,Rattus norvegicus,,CHEMBL623093,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,6453,1,10116.0,10554,,BAO_0000218,Rattus norvegicus,,CHEMBL874401,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,6640,1,10116.0,10555,,BAO_0000218,Rattus norvegicus,,CHEMBL623094,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,17607,1,10116.0,10556,,BAO_0000218,Rattus norvegicus,,CHEMBL623095,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,5939,1,10116.0,10557,,BAO_0000218,Rattus norvegicus,,CHEMBL623096,A,,Oral bioavailability in rat after peroral administration at 10 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,5939,1,10116.0,10558,,BAO_0000218,Rattus norvegicus,,CHEMBL624913,A,,Oral bioavailability in rat after peroral administration at 5 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,6281,1,10116.0,10559,,BAO_0000218,Rattus norvegicus,,CHEMBL624914,A,,Oral bioavailability in rat (dose 2.8 mg/kg p.o.),Intermediate
,In vivo,,,,1,,,N,50597,5874,1,10116.0,10560,,BAO_0000218,Rattus norvegicus,,CHEMBL624915,A,,Oral bioavailability in rat by po administration at a dose of 40 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,5213,1,10116.0,10561,,BAO_0000218,Rattus norvegicus,,CHEMBL624916,A,,Oral bioavailability in rat; Not measured,Intermediate
,In vivo,,,,1,,,N,50597,4964,1,10116.0,10562,,BAO_0000218,Rattus norvegicus,,CHEMBL624917,A,,Oral bioavailability in rat,Intermediate
,,,,,1,,,N,50597,11020,1,10116.0,10563,,BAO_0000218,Rattus norvegicus,,CHEMBL625157,A,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus NE,Intermediate
,,Liver,,,1,,,N,50597,6251,1,10116.0,10564,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL625158,A,,In vitro metabolic potential in rat liver microsomes,Intermediate
,In vivo,,,,1,,,N,50597,1568,1,10116.0,10565,,BAO_0000218,Rattus norvegicus,,CHEMBL625159,A,,"Oral availability was tested for plasma levels at a dose of 40 mg/kg, after 6 hr of in fed fisher rats.",Intermediate
,In vivo,,,,1,,,N,50597,3032,1,10116.0,10566,,BAO_0000218,Rattus norvegicus,,CHEMBL625160,A,,"In vivo percentage mean absolute bioavailability of compound in rat after an oral dose of 10 mg/kg (in water, N=4)",Intermediate
,In vivo,,,,1,,,N,50597,3748,1,10116.0,10567,,BAO_0000218,Rattus norvegicus,,CHEMBL625161,A,,Oral bioavailability of intravenously administered compound (3 mg/kg) was tested in rats,Intermediate
,In vivo,,,,1,,,N,50597,401,1,10116.0,10568,,BAO_0000218,Rattus norvegicus,,CHEMBL625162,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,6512,1,10116.0,10569,,BAO_0000218,Rattus norvegicus,,CHEMBL625163,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,17617,1,10116.0,10570,,BAO_0000218,Rattus norvegicus,,CHEMBL625164,A,,Oral bioavailability in rats at 10 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,6679,1,10116.0,10571,,BAO_0000218,Rattus norvegicus,,CHEMBL625165,A,,Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,Intermediate
,In vivo,,,,1,,,N,50597,6742,1,10116.0,10572,,BAO_0000218,Rattus norvegicus,,CHEMBL625166,A,,Oral bioavailability in rat,Intermediate
,,,,,1,,,N,50597,589,1,10116.0,10573,,BAO_0000218,Rattus norvegicus,,CHEMBL625167,A,,Tested for effective permeability across the rat intestinal membrane using mass balance analysis,Intermediate
,,,,,1,,,N,50597,589,1,10116.0,10574,,BAO_0000218,Rattus norvegicus,,CHEMBL625168,A,,Tested for effective permeability across the rat intestinal membrane using mass balance analysis at 0.01 mM concentration,Intermediate
,In vivo,,,,1,,,N,50597,3185,1,10116.0,10575,,BAO_0000218,Rattus norvegicus,,CHEMBL625169,A,,Plasma clearance of the compound,Intermediate
,In vivo,,,,1,,,N,50597,17596,1,10116.0,10576,,BAO_0000218,Rattus norvegicus,,CHEMBL626264,A,,Plasma clearance at 10 mg/kg in rat upon intravenous administration,Intermediate
,In vivo,,,,1,,,N,50597,2713,1,10116.0,10577,,BAO_0000218,Rattus norvegicus,,CHEMBL626265,A,,Plasma clearance upon intravenous administration of 1 mg/Kg in rats,Intermediate
,In vivo,Plasma,,,1,,,N,50597,12500,1,10116.0,10578,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626266,A,,The compound was tested for plasma clearance in rat,Intermediate
,In vivo,Plasma,,,1,,,N,50597,12500,1,10116.0,10579,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626267,A,,The compound was tested for plasma clearance in rat at dose of 3-10 mgkg,Intermediate
,,,,,1,,,N,50597,2713,1,10116.0,10580,,BAO_0000218,Rattus norvegicus,,CHEMBL626268,A,,Plasma concentration upon oral administration of 1 mg/Kg in rats,Intermediate
,,,,,1,,,N,50597,1446,1,10116.0,10581,,BAO_0000218,Rattus norvegicus,,CHEMBL626269,A,,Peak plasma level between 0.5 and 1.0 hour in Dawley rats; value ranges from 1021-2551,Intermediate
,,,,,1,,,N,50597,6227,1,10116.0,10582,,BAO_0000218,Rattus norvegicus,,CHEMBL626270,A,,Plasma level after intravenous administration in rat model of FeCl3-induced carotid thrombosis,Intermediate
,,,,,1,,,N,50597,4709,1,10116.0,10583,,BAO_0000218,Rattus norvegicus,,CHEMBL626271,A,,Plasma protein binding was determined after intravenous administration of 1 mg/kg in rat,Intermediate
,,,,,1,,,N,50597,5510,1,10116.0,10584,,BAO_0000218,Rattus norvegicus,,CHEMBL626272,A,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1",Intermediate
,,,,,1,,,N,50597,5510,1,10116.0,10585,,BAO_0000218,Rattus norvegicus,,CHEMBL626273,A,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",Intermediate
,,,,,1,,,N,50597,5510,1,10116.0,10586,,BAO_0000218,Rattus norvegicus,,CHEMBL875346,A,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",Intermediate
,,,,,1,,,N,50597,5510,1,10116.0,10587,,BAO_0000218,Rattus norvegicus,,CHEMBL626274,A,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not stable",Intermediate
,,,,,1,,,N,50597,4514,1,10116.0,10588,,BAO_0000218,Rattus norvegicus,,CHEMBL626275,A,,Compound was tested for protein binding in rat plasma,Intermediate
,,,,,1,,,N,50597,2713,1,10116.0,10589,,BAO_0000218,Rattus norvegicus,,CHEMBL624646,A,,Compound was evaluated for absorption of radioligand following oral administration to bile duct cannulated rat. ,Intermediate
,,,,,1,,,N,50597,2713,1,10116.0,10590,,BAO_0000218,Rattus norvegicus,,CHEMBL624647,A,,Compound was evaluated for absorption of radioligand upon oral administration to bile duct cannulated rats,Intermediate
,,Liver,,,1,,,N,50597,5340,1,10116.0,10591,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL624648,A,,In vitro metabolism in rat liver microsomes was evaluated to determine diminishing of glucuronidation rate,Intermediate
,,,,,1,,,N,50597,12058,1,10116.0,10592,,BAO_0000218,Rattus norvegicus,,CHEMBL624649,A,,Area under curve ratio was determined (po/iv) in rat,Intermediate
,,,,,1,,,N,50597,11195,1,10116.0,10593,,BAO_0000218,Rattus norvegicus,,CHEMBL624650,A,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 15 mins after i.v. administration,Intermediate
,,,,,1,,,N,50597,11195,1,10116.0,10594,,BAO_0000218,Rattus norvegicus,,CHEMBL624651,A,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 2 mins after i.v. administration,Intermediate
,,,,,1,,,N,50597,11195,1,10116.0,10595,,BAO_0000218,Rattus norvegicus,,CHEMBL624652,A,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 65 mins after i.v. administration,Intermediate
,,,,,1,,,N,50597,6495,1,10116.0,10596,,BAO_0000218,Rattus norvegicus,,CHEMBL624653,A,,Compound was tested for brain/plasma ratio after oral administration at 10 mg/kg,Intermediate
,,,,,1,,,N,50597,6078,1,10116.0,10597,,BAO_0000218,Rattus norvegicus,,CHEMBL624654,A,,Ratio of AUCbrain to AUCplasma,Intermediate
,,,,,1,,,N,50597,5656,1,10116.0,10598,,BAO_0000218,Rattus norvegicus,,CHEMBL624655,A,,Ratio of brain to plasma,Intermediate
,,,,,1,,,N,50597,4910,1,10116.0,10599,,BAO_0000218,Rattus norvegicus,,CHEMBL624656,A,,Ratio of the AUC values of brain and plasma after intravenous administration (4.7 mg/kg) to male rats was evaluated,Intermediate
,,,,,1,,,N,50597,4910,1,10116.0,10600,,BAO_0000218,Rattus norvegicus,,CHEMBL624657,A,,Ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,Intermediate
,,,,,1,,,N,50597,4910,1,10116.0,10601,,BAO_0000218,Rattus norvegicus,,CHEMBL624658,A,,Ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,Intermediate
,,,,,1,,,N,50597,10130,1,10116.0,10602,,BAO_0000218,Rattus norvegicus,,CHEMBL624659,A,,Selectivity ratio for biodistribution in brain and blood of rats after 15 minutes; Expressed as percent dose/gram ratio,Intermediate
,,,,,1,,,N,50597,10130,1,10116.0,10603,,BAO_0000218,Rattus norvegicus,,CHEMBL624660,A,,Selectivity ratio for biodistribution in brain and blood of rats after 2 minutes; Expressed as percent dose/gram ratio,Intermediate
,,,,,1,,,N,50597,10130,1,10116.0,10604,,BAO_0000218,Rattus norvegicus,,CHEMBL624661,A,,Selectivity ratio for biodistribution in brain and blood of rats after 60 minutes; Expressed as percent dose/gram ratio,Intermediate
,,,,,1,,,N,50597,5213,1,10116.0,10605,,BAO_0000218,Rattus norvegicus,,CHEMBL624662,A,,Steady state brain :blood ratio was determined,Intermediate
,,,,,1,,,N,50597,4910,1,10116.0,10606,,BAO_0000218,Rattus norvegicus,,CHEMBL625199,A,,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,Intermediate
,,,,,1,,,N,50597,4910,1,10116.0,10607,,BAO_0000218,Rattus norvegicus,,CHEMBL625200,A,,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,Intermediate
,,,,,1,,,N,50597,4910,1,10116.0,10608,,BAO_0000218,Rattus norvegicus,,CHEMBL625201,A,,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats,Intermediate
,,,,,1,,,N,50597,4910,1,10116.0,10609,,BAO_0000218,Rattus norvegicus,,CHEMBL625202,A,,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,Intermediate
,,,,,1,,,N,50597,2083,1,10116.0,10610,,BAO_0000218,Rattus norvegicus,,CHEMBL625203,A,,Percentage recovery after 3h incubation with rat hapatocytes was determined,Intermediate
,,,,,1,,,N,50597,2082,1,10116.0,10611,,BAO_0000218,Rattus norvegicus,,CHEMBL625204,A,,Percentage recovery in rat hepatic microsomal fractions under oxidative conditions after 1 hour,Intermediate
,,,,,1,,,N,50597,2082,1,10116.0,10612,,BAO_0000218,Rattus norvegicus,,CHEMBL625205,A,,Percentage recovery in rhesus monkey hepatic microsomal fractions under oxidative conditions after 1 hour,Intermediate
,,,,,1,,,N,50597,6351,1,10116.0,10613,,BAO_0000218,Rattus norvegicus,,CHEMBL625206,A,,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats,Intermediate
,,,,,0,,,U,22224,14583,1,,10614,,BAO_0000019,,,CHEMBL625207,A,,"Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured, No site available for protein conjugation.",Autocuration
,,,,,0,,,U,22224,14583,1,,10615,,BAO_0000019,,,CHEMBL625208,A,,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured.,Autocuration
,,,Caco-2,,1,,,N,50587,4608,1,9606.0,10616,,BAO_0000218,Homo sapiens,,CHEMBL625209,A,495.0,In vivo absorption in Caco-2 cell line monolayers was determined,Intermediate
,,,,,0,,,U,22229,13668,1,,10617,,BAO_0000100,,,CHEMBL625210,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,1,,,N,50597,5669,1,10116.0,10618,,BAO_0000218,Rattus norvegicus,,CHEMBL625211,A,,Area under curve was determine after peroral administration at 10 mpk in Rat,Intermediate
,,,,,1,,,N,50797,5669,1,9544.0,10619,,BAO_0000218,Macaca mulatta,,CHEMBL625212,A,,Area under curve was determine after peroral administration at 10 mpk in Rhesus,Intermediate
,,,,,1,,,N,50597,5669,1,10116.0,10620,,BAO_0000218,Rattus norvegicus,,CHEMBL625213,A,,Area under curve was determine after peroral administration at 160 mpk in Rat,Intermediate
,,,,,1,,,N,50597,5669,1,10116.0,10621,,BAO_0000218,Rattus norvegicus,,CHEMBL625214,A,,Area under curve was determine after peroral administration at 20 mpk in Rat,Intermediate
,,,,,1,,,N,50597,5669,1,10116.0,10622,,BAO_0000218,Rattus norvegicus,,CHEMBL874542,A,,Area under curve was determine after peroral administration at 50 mpk in Rat,Intermediate
,,,,,0,,,U,22229,6472,1,,10623,,BAO_0000100,,,CHEMBL625215,P,,Calculated partition coefficient (clogP) (AlogP),Autocuration
,,,,,0,,,U,22224,15106,1,,10624,,BAO_0000019,,,CHEMBL625216,A,,Activated partial thromboplastin time measured,Autocuration
,,,,,0,,,U,22224,15207,1,,10625,,BAO_0000100,,,CHEMBL625217,P,,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4),Autocuration
,,,,,0,,,U,22224,15207,1,,10626,,BAO_0000100,,,CHEMBL625218,P,,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4); ND=Not determined (AS mg/mL),Autocuration
,,Plasma,,,1,,,N,50588,13941,1,9615.0,10627,,BAO_0000218,Canis lupus familiaris,1969.0,CHEMBL622864,A,,AUC (Area under curve) was determined after intravenous administration at a dose 1 mg/kg in dog,Intermediate
,,Plasma,,,1,,,N,50597,13941,1,10116.0,10628,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622865,A,,AUC (Area under curve) was determined after intravenous administration at a dose 2 mg/kg in rat.,Intermediate
,,Plasma,,,1,,,N,50597,13941,1,10116.0,10629,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622866,A,,AUC (Area under curve) was determined after peroral administration at a dose 10 mg/kg in rat.,Intermediate
,,Plasma,,,1,,,N,50588,13941,1,9615.0,10630,,BAO_0000218,Canis lupus familiaris,1969.0,CHEMBL622867,A,,AUC (Area under curve) was determined after peroral administration at a dose 5 mg/kg in dog,Intermediate
,,Plasma,,,1,,,N,50512,15240,1,10141.0,10631,,BAO_0000218,Cavia porcellus,1969.0,CHEMBL876808,A,,AUC (ng h/mL) value after oral administration of 10 mg/kg in guinea pig.,Intermediate
,,Brain,,,0,,,U,22224,10655,1,,10632,,BAO_0000019,,955.0,CHEMBL627725,A,,AUC in brain,Autocuration
,,Serum,,,0,,,U,22224,10655,1,,10633,,BAO_0000019,,1977.0,CHEMBL627726,A,,AUC in serum,Autocuration
,,Plasma,,,0,,,U,22224,6504,1,,10634,,BAO_0000019,,1969.0,CHEMBL627727,A,,AUC was determined,Autocuration
,,Plasma,,,0,,,U,22224,10615,1,,10635,,BAO_0000019,,1969.0,CHEMBL627728,A,,AUC of the compound.,Autocuration
,,Plasma,,,0,,,U,22224,10353,1,,10636,,BAO_0000019,,1969.0,CHEMBL627729,A,,AUC value (0-4 hr),Autocuration
,,Plasma,,,0,,,U,22224,14907,1,,10637,,BAO_0000019,,1969.0,CHEMBL627730,A,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 150 uMol/kg,",Autocuration
,,Plasma,,,0,,,U,22224,14907,1,,10638,,BAO_0000019,,1969.0,CHEMBL627731,A,,AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,Autocuration
,,Plasma,,,0,,,U,22224,14907,1,,10639,,BAO_0000019,,1969.0,CHEMBL627732,A,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,",Autocuration
,,Plasma,,,0,,,U,22224,14907,1,,10640,,BAO_0000019,,1969.0,CHEMBL627733,A,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 700 uMol/kg,",Autocuration
,,Plasma,,,1,,,N,50597,16359,1,10116.0,10641,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL627734,A,,AUC(area under curve) was determined after intravenous administration in rats,Intermediate
,,Plasma,,,1,,,N,50597,16359,1,10116.0,10642,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL627735,A,,AUC(area under curve) was determined after oral administration in rats,Intermediate
,,Plasma,,,1,,,N,50512,15240,1,10141.0,10643,,BAO_0000218,Cavia porcellus,1969.0,CHEMBL627736,A,,AUC(ng h/mL)values after oral administration of 10 mg/kg in guinea pig.,Intermediate
,,Plasma,,,1,,,N,50597,15240,1,10116.0,10644,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL876809,A,,AUC(ng h/mL)values after oral administration of 10 mg/kg in rat.,Intermediate
,,,,,0,,,U,22224,15469,1,,10645,,BAO_0000019,,,CHEMBL627737,A,,Area Under Curve after oral dosing of 100 uM/Kg,Autocuration
,,,,,0,,,U,22224,15469,1,,10646,,BAO_0000019,,,CHEMBL627738,A,,Area Under Curve after oral dosing of 30 uM/Kg,Autocuration
,,,,,0,,,U,22224,13520,1,,10647,,BAO_0000019,,,CHEMBL627739,A,,Area Under Curve was measured by ploting the graph between concentration verses time,Autocuration
,,,,,1,,,N,50588,17025,1,9615.0,10648,,BAO_0000218,Canis lupus familiaris,,CHEMBL626143,A,,Area under concentration-time curve of compound was determined in dog at 25 mg/kg orally,Intermediate
,,,,,0,,,U,22224,17025,1,314293.0,10649,,BAO_0000218,Simiiformes,,CHEMBL626144,A,,Area under concentration-time curve of compound was determined in monkey at 25 mg/kg orally,Autocuration
,,,,,1,,,N,50592,17025,1,9986.0,10650,,BAO_0000218,Oryctolagus cuniculus,,CHEMBL626145,A,,Area under concentration-time curve of compound was determined in rabbit at 25 mg/kg orally,Intermediate
,,,,,1,,,N,50597,17025,1,10116.0,10651,,BAO_0000218,Rattus norvegicus,,CHEMBL626146,A,,Area under concentration-time curve of compound was determined in rat at 25 mg/kg orally,Intermediate
,,Blood,,,1,,,N,50597,12032,1,10116.0,10652,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL626147,A,,Area under curve (AUC) is the drug concentrations in blood samples of rats with arterial catheters at 5 min and 12 hr plotted against time,Intermediate
,,,,,0,,,U,22224,10291,1,,10653,,BAO_0000019,,,CHEMBL626148,A,,Area under curve (AUC) was determined,Autocuration
,,,,,0,,,U,22224,5767,1,,10654,,BAO_0000218,,,CHEMBL626149,A,,Area under curve (AUC) following ip administration at 1 mg/kg,Autocuration
,,,,,0,,,U,22224,1434,1,,10655,,BAO_0000019,,,CHEMBL626150,A,,Area under curve (AUC) was determined; ND is Not determined,Autocuration
,,,,,1,,,N,50588,14925,1,9615.0,10656,,BAO_0000218,Canis lupus familiaris,,CHEMBL626151,A,,Area under curve (AUC) was determined in dogs fed after intravenous administration of 25 mg/kg of the compound,Intermediate
,,,,,1,,,N,50588,14925,1,9615.0,10657,,BAO_0000218,Canis lupus familiaris,,CHEMBL626152,A,,Area under curve (AUC) was determined in dogs fed after oral administration of 25 mg/kg of the compound,Intermediate
,,,,,1,,,N,50588,14925,1,9615.0,10658,,BAO_0000218,Canis lupus familiaris,,CHEMBL626153,A,,Area under curve (AUC) was determined in fasted dogs after oral administration of 25 mg/kg of the compound,Intermediate
,,,,,0,,,U,22224,1434,1,,10659,,BAO_0000019,,,CHEMBL626154,A,,Area under curve (AUR) was determined,Autocuration
,,,,,0,,,U,22224,11883,1,,10660,,BAO_0000019,,,CHEMBL626155,A,,Area under curve at 1 uM/dg administered intravenously,Autocuration
,,,,,0,,,U,22224,11883,1,,10661,,BAO_0000019,,,CHEMBL626156,A,,Area under curve at 10 uM/dg administered perorally,Autocuration
,,,,,0,,,U,22224,11883,1,,10662,,BAO_0000019,,,CHEMBL626157,A,,Area under curve at 2 uM/dg administered intravenously,Autocuration
,,,,,0,,,U,22224,11883,1,,10663,,BAO_0000019,,,CHEMBL626158,A,,Area under curve at 20 uM/dg administered perorally,Autocuration
,,,,,1,,,N,50588,15233,1,9615.0,10664,,BAO_0000218,Canis lupus familiaris,,CHEMBL626159,A,,Area under curve at a peroral dose of 3 mg/kg in dog,Intermediate
,,,,,1,,,N,50597,15233,1,10116.0,10665,,BAO_0000218,Rattus norvegicus,,CHEMBL626160,A,,Area under curve at a peroral dose of 3 mg/kg in rat,Intermediate
,,,,,1,,,N,50588,15233,1,9615.0,10666,,BAO_0000218,Canis lupus familiaris,,CHEMBL626161,A,,Area under curve at an iv dose of 1 mg/kg in dog,Intermediate
,,,,,1,,,N,50597,15233,1,10116.0,10667,,BAO_0000218,Rattus norvegicus,,CHEMBL626162,A,,Area under curve at an iv dose of 1 mg/kg in rat,Intermediate
,,,,,0,,,U,22224,12978,1,,10668,,BAO_0000019,,,CHEMBL626163,A,,Area under curve gives the effective duration for the angiotensin II antagonist effect of the compound.,Autocuration
,,,,,0,,,U,22224,12978,1,,10669,,BAO_0000019,,,CHEMBL626164,A,,Area under curve gives the effective duration for the angiotensin II antagonist effect.,Autocuration
,,,,,1,,,N,50594,11355,1,10090.0,10670,,BAO_0000218,Mus musculus,,CHEMBL626165,A,,Area under curve measured as conc vs time after intravenous administration to mice.,Intermediate
,,,,,1,,,N,50594,11355,1,10090.0,10671,,BAO_0000218,Mus musculus,,CHEMBL626166,A,,Area under curve measured as conc vs time after peroral administration to mice.,Intermediate
,,,,,1,,,N,50588,12923,1,9615.0,10672,,BAO_0000218,Canis lupus familiaris,,CHEMBL626167,A,,Area under curve of acid 2a was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,Intermediate
,,,,,1,,,N,50588,12923,1,9615.0,10673,,BAO_0000218,Canis lupus familiaris,,CHEMBL626168,A,,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by capsule method in dog,Intermediate
,,,,,1,,,N,50588,12923,1,9615.0,10674,,BAO_0000218,Canis lupus familiaris,,CHEMBL877463,A,,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by gavage method in dog,Intermediate
,,,,,1,,,N,50588,12923,1,9615.0,10675,,BAO_0000218,Canis lupus familiaris,,CHEMBL626169,A,,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by capsule method in dog,Intermediate
,In vivo,Heart,,,1,,,N,50597,17738,1,10116.0,10676,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL626170,A,,Biodistribution of radiolabeled compound in rat heart after 24 hr activity expressed as %ID/Organ,Intermediate
,In vivo,Heart,,,1,,,N,50597,17738,1,10116.0,10677,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL626171,A,,Biodistribution of radiolabeled compound in rat heart after 2 hr activity expressed as %ID/Organ,Intermediate
,In vivo,Heart,,,1,,,N,50597,17738,1,10116.0,10678,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL626172,A,,Biodistribution of radiolabeled compound in rat heart after 30 min activity expressed as %ID/Organ,Intermediate
,In vivo,Heart,,,1,,,N,50597,17738,1,10116.0,10679,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL626173,A,,Biodistribution of radiolabeled compound in rat heart after 5 min activity expressed as %ID/Organ,Intermediate
,In vivo,Kidney,,,1,,,N,50597,17738,1,10116.0,10680,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL626174,A,,Biodistribution of radiolabeled compound in rat kidney after 24 hr postinjection activity expressed as %ID/Organ,Intermediate
,In vivo,Kidney,,,1,,,N,50597,17738,1,10116.0,10681,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL626175,A,,Biodistribution of radiolabeled compound in rat kidney after 24 hr activity expressed as %ID/Organ,Intermediate
,In vivo,Kidney,,,1,,,N,50597,17738,1,10116.0,10682,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL626176,A,,Biodistribution of radiolabeled compound in rat kidney after 2 hr activity expressed as %ID/Organ,Intermediate
,In vivo,Kidney,,,1,,,N,50597,17738,1,10116.0,10683,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL626177,A,,Biodistribution of radiolabeled compound in rat kidney after 30 min activity expressed as %ID/Organ,Intermediate
,In vivo,Kidney,,,1,,,N,50597,17738,1,10116.0,10684,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL622499,A,,Biodistribution of radiolabeled compound in rat kidney after 5 min activity expressed as %ID/Organ,Intermediate
,In vivo,Liver,,,1,,,N,50597,17738,1,10116.0,10685,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL622500,A,,Biodistribution of radiolabeled compound in rat liver after 24 hr postinjection activity expressed as %ID/Organ,Intermediate
,In vivo,Liver,,,1,,,N,50597,17738,1,10116.0,10686,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL622501,A,,Biodistribution of radiolabeled compound in rat liver after 24 hr activity expressed as %ID/Organ,Intermediate
,In vivo,Liver,,,1,,,N,50597,17738,1,10116.0,10687,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL622502,A,,Biodistribution of radiolabeled compound in rat liver after 2 hr activity expressed as %ID/Organ,Intermediate
,In vivo,Liver,,,1,,,N,50597,17738,1,10116.0,10688,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL622503,A,,Biodistribution of radiolabeled compound in rat liver after 30 min activity expressed as %ID/Organ,Intermediate
,In vivo,Liver,,,1,,,N,50597,17738,1,10116.0,10689,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL877614,A,,Biodistribution of radiolabeled compound in rat liver after 5 min activity expressed as %ID/Organ,Intermediate
,In vivo,Lung,,,1,,,N,50597,17738,1,10116.0,10690,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL624839,A,,Biodistribution of radiolabeled compound in rat lung after 24 hr activity expressed as %ID/Organ,Intermediate
,In vivo,Lung,,,1,,,N,50597,17738,1,10116.0,10691,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL624840,A,,Biodistribution of radiolabeled compound in rat lung after 2 hr activity expressed as %ID/Organ,Intermediate
,In vivo,Lung,,,1,,,N,50597,17738,1,10116.0,10692,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL624841,A,,Biodistribution of radiolabeled compound in rat lung after 30 min activity expressed as %ID/Organ,Intermediate
,In vivo,Lung,,,1,,,N,50597,17738,1,10116.0,10693,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL624842,A,,Biodistribution of radiolabeled compound in rat lung after 5 min activity expressed as %ID/Organ,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,17738,1,10116.0,10694,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL624843,A,,Biodistribution of radiolabeled compound in rat muscle after 24 hr activity expressed as %ID/Organ,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,17738,1,10116.0,10695,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL624844,A,,Biodistribution of radiolabeled compound in rat muscle after 2 hr activity expressed as %ID/Organ,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,17738,1,10116.0,10696,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL624845,A,,Biodistribution of radiolabeled compound in rat muscle after 30 min activity expressed as %ID/Organ,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,17738,1,10116.0,10697,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL621904,A,,Biodistribution of radiolabeled compound in rat muscle after 5 min activity expressed as %ID/Organ,Intermediate
,In vivo,Blood,,,1,,,N,50597,11195,1,10116.0,10698,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL621905,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 15 mins after i.v. administration,Intermediate
,In vivo,Blood,,,1,,,N,50597,11195,1,10116.0,10699,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL874382,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 2 mins after i.v. administration,Intermediate
,In vivo,Blood,,,1,,,N,50597,11195,1,10116.0,10700,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL621906,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 65 mins after i.v. administration,Intermediate
,In vivo,Brain,,,1,,,N,50597,11195,1,10116.0,10701,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL621907,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 15 mins after i.v. administration,Intermediate
,In vivo,Brain,,,1,,,N,50597,11195,1,10116.0,10702,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL622096,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 2 mins after i.v. administration,Intermediate
,In vivo,Brain,,,1,,,N,50597,11195,1,10116.0,10703,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL622097,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 65 mins after i.v. administration,Intermediate
,In vivo,Heart,,,1,,,N,50597,11195,1,10116.0,10704,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL622098,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 15 mins after i.v. administration,Intermediate
,In vivo,Heart,,,1,,,N,50597,11195,1,10116.0,10705,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL622099,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 2 mins after i.v. administration,Intermediate
,In vivo,Heart,,,1,,,N,50597,11195,1,10116.0,10706,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL622100,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 65 mins after i.v. administration,Intermediate
,In vivo,Kidney,,,1,,,N,50597,11195,1,10116.0,10707,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL622101,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 15 mins after i.v. administration,Intermediate
,In vivo,Kidney,,,1,,,N,50597,11195,1,10116.0,10708,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL622102,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 2 mins after i.v. administration,Intermediate
,In vivo,Kidney,,,1,,,N,50597,11195,1,10116.0,10709,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL622103,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 65 mins after i.v. administration,Intermediate
,In vivo,Liver,,,1,,,N,50597,11195,1,10116.0,10710,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL622104,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 15 mins after i.v. administration,Intermediate
,In vivo,Liver,,,1,,,N,50597,11195,1,10116.0,10711,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL622105,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 2 mins after i.v. administration,Intermediate
,In vivo,Liver,,,1,,,N,50597,11195,1,10116.0,10712,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL622106,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 65 mins after i.v. administration,Intermediate
,In vivo,Lung,,,1,,,N,50597,11195,1,10116.0,10713,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL622107,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 15 mins after i.v. administration,Intermediate
,In vivo,Lung,,,1,,,N,50597,11195,1,10116.0,10714,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL622108,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 2 mins after i.v. administration,Intermediate
,In vivo,Lung,,,1,,,N,50597,11195,1,10116.0,10715,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL622109,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 65 mins after i.v. administration,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,11195,1,10116.0,10716,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL622110,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 15 mins after i.v. administration,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,11195,1,10116.0,10717,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL622111,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 2 mins after i.v. administration,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,11195,1,10116.0,10718,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL874383,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 65 mins after i.v. administration,Intermediate
,In vivo,Zone of skin,,,1,,,N,50597,11195,1,10116.0,10719,,BAO_0000218,Rattus norvegicus,14.0,CHEMBL622112,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 15 mins after i.v. administration,Intermediate
,In vivo,Zone of skin,,,1,,,N,50597,11195,1,10116.0,10720,,BAO_0000218,Rattus norvegicus,14.0,CHEMBL622113,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 2 mins after i.v. administration,Intermediate
,In vivo,Zone of skin,,,1,,,N,50597,11195,1,10116.0,10721,,BAO_0000218,Rattus norvegicus,14.0,CHEMBL622114,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 65 mins after i.v. administration,Intermediate
,In vivo,Spleen,,,1,,,N,50597,11195,1,10116.0,10722,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL622115,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 15 mins after i.v. administration,Intermediate
,In vivo,Spleen,,,1,,,N,50597,11195,1,10116.0,10723,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL622116,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 2 mins after i.v. administration,Intermediate
,In vivo,,,,1,,,N,50597,6193,1,10116.0,10724,,BAO_0000218,Rattus norvegicus,,CHEMBL622117,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,6803,1,10116.0,10725,,BAO_0000218,Rattus norvegicus,,CHEMBL622118,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,6647,1,10116.0,10726,,BAO_0000218,Rattus norvegicus,,CHEMBL622119,A,,Oral bioavailability in rats at 6 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,6647,1,10116.0,10727,,BAO_0000218,Rattus norvegicus,,CHEMBL622120,A,,Oral bioavailability in rat (dose 6 mg/kg),Intermediate
,In vivo,,,,1,,,N,50597,6647,1,10116.0,10728,,BAO_0000218,Rattus norvegicus,,CHEMBL622121,A,,Oral bioavailability in rats at 6 mg/kg dose; Not tested,Intermediate
,In vivo,,,,1,,,N,50597,6640,1,10116.0,10729,,BAO_0000218,Rattus norvegicus,,CHEMBL622122,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,6641,1,10116.0,10730,,BAO_0000218,Rattus norvegicus,,CHEMBL622123,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,6641,1,10116.0,10731,,BAO_0000218,Rattus norvegicus,,CHEMBL622124,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,6642,1,10116.0,10732,,BAO_0000218,Rattus norvegicus,,CHEMBL622125,A,,Bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,5472,1,10116.0,10733,,BAO_0000218,Rattus norvegicus,,CHEMBL622126,A,,Oral bioavailability,Intermediate
,In vivo,,,,1,,,N,50597,6141,1,10116.0,10734,,BAO_0000218,Rattus norvegicus,,CHEMBL620455,A,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),Intermediate
,In vivo,,,,1,,,N,50597,4390,1,10116.0,10735,,BAO_0000218,Rattus norvegicus,,CHEMBL620456,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,5472,1,10116.0,10736,,BAO_0000218,Rattus norvegicus,,CHEMBL620457,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,5472,1,10116.0,10737,,BAO_0000218,Rattus norvegicus,,CHEMBL620458,A,,Oral bioavailability was evaluated; Not tested,Intermediate
,In vivo,,,,1,,,N,50597,5438,1,10116.0,10738,,BAO_0000218,Rattus norvegicus,,CHEMBL620459,A,,Oral bioavailability,Intermediate
,In vivo,,,,1,,,N,50597,4883,1,10116.0,10739,,BAO_0000218,Rattus norvegicus,,CHEMBL620460,A,,Oral bioavailability in rat by oral dosing,Intermediate
,In vivo,,,,1,,,N,50597,1908,1,10116.0,10740,,BAO_0000218,Rattus norvegicus,,CHEMBL620461,A,,Oral bioavailability in rat (dose 10 mg/kg p.o.),Intermediate
,In vivo,,,,1,,,N,50597,4853,1,10116.0,10741,,BAO_0000218,Rattus norvegicus,,CHEMBL620462,A,,Oral bioavailability in rat (Sprague-Dawley),Intermediate
,In vivo,,,,1,,,N,50597,4853,1,10116.0,10742,,BAO_0000218,Rattus norvegicus,,CHEMBL620463,A,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),Intermediate
,In vivo,,,,1,,,N,50597,4853,1,10116.0,10743,,BAO_0000218,Rattus norvegicus,,CHEMBL620464,A,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),Intermediate
,In vivo,,,,1,,,N,50597,4853,1,10116.0,10744,,BAO_0000218,Rattus norvegicus,,CHEMBL620465,A,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),Intermediate
,In vivo,,,,1,,,N,50597,4853,1,10116.0,10745,,BAO_0000218,Rattus norvegicus,,CHEMBL620466,A,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg p.o.),Intermediate
,In vivo,,,,1,,,N,50597,4853,1,10116.0,10746,,BAO_0000218,Rattus norvegicus,,CHEMBL620467,A,,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 1 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,4853,1,10116.0,10747,,BAO_0000218,Rattus norvegicus,,CHEMBL620468,A,,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 2 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,12873,1,10116.0,10748,,BAO_0000218,Rattus norvegicus,,CHEMBL620469,A,,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in solution form,Intermediate
,In vivo,,,,1,,,N,50597,12873,1,10116.0,10749,,BAO_0000218,Rattus norvegicus,,CHEMBL620470,A,,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in suspension form,Intermediate
,In vivo,,,,1,,,N,50597,3169,1,10116.0,10750,,BAO_0000218,Rattus norvegicus,,CHEMBL620471,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,6305,1,10116.0,10751,,BAO_0000218,Rattus norvegicus,,CHEMBL620472,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,4762,1,10116.0,10752,,BAO_0000218,Rattus norvegicus,,CHEMBL620473,A,,Oral bioavailability of compound at 5 mg/kg after po administration was determined in rat,Intermediate
,In vivo,,,,1,,,N,50597,17847,1,10116.0,10753,,BAO_0000218,Rattus norvegicus,,CHEMBL620474,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,6211,1,10116.0,10754,,BAO_0000218,Rattus norvegicus,,CHEMBL620475,A,,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 10 mg/kg),Intermediate
,In vivo,,,,1,,,N,50597,6011,1,10116.0,10755,,BAO_0000218,Rattus norvegicus,,CHEMBL620476,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,6317,1,10116.0,10756,,BAO_0000218,Rattus norvegicus,,CHEMBL620477,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,6644,1,10116.0,10757,,BAO_0000218,Rattus norvegicus,,CHEMBL620478,A,,Oral bioavailability in rat after oral administration at 10.5 mg/kg dose,Intermediate
,In vivo,,,,1,,,N,50597,6644,1,10116.0,10758,,BAO_0000218,Rattus norvegicus,,CHEMBL618768,A,,Oral bioavailability in rat after oral administration at 11.2 mg/kg dose,Intermediate
,In vivo,,,,1,,,N,50597,6644,1,10116.0,10759,,BAO_0000218,Rattus norvegicus,,CHEMBL618769,A,,Oral bioavailability in rat after oral administration at 13 mg/kg dose,Intermediate
,In vivo,,,,1,,,N,50597,6644,1,10116.0,10760,,BAO_0000218,Rattus norvegicus,,CHEMBL618770,A,,Oral bioavailability in rat after oral administration at 9.7 mg/kg dose,Intermediate
,In vivo,,,,1,,,N,50597,6113,1,10116.0,10761,,BAO_0000218,Rattus norvegicus,,CHEMBL618771,A,,Oral bioavailability (dose 20 mg/kg p.o.),Intermediate
,In vivo,,,,1,,,N,50597,5937,1,10116.0,10762,,BAO_0000218,Rattus norvegicus,,CHEMBL618772,A,,Oral bioavailability was determined in rat after oral administration at a concentration 1 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,5711,1,10116.0,10763,,BAO_0000218,Rattus norvegicus,,CHEMBL618773,A,,Oral bioavailability in rat at 10 mg/kg of the compound,Intermediate
,In vivo,,,,1,,,N,50597,17717,1,10116.0,10764,,BAO_0000218,Rattus norvegicus,,CHEMBL875842,A,,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,Intermediate
,In vivo,,,,1,,,N,50597,17717,1,10116.0,10765,,BAO_0000218,Rattus norvegicus,,CHEMBL618774,A,,Bioavailability in rat (dose 3 mg/kg i.v.),Intermediate
,In vivo,,,,1,,,N,50597,17717,1,10116.0,10766,,BAO_0000218,Rattus norvegicus,,CHEMBL618775,A,,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,Intermediate
,In vivo,,,,1,,,N,50597,17717,1,10116.0,10767,,BAO_0000218,Rattus norvegicus,,CHEMBL618776,A,,Oral bioavailability in rat (dose 60 mg/kg p.o.),Intermediate
,In vivo,,,,1,,,N,50597,4722,1,10116.0,10768,,BAO_0000218,Rattus norvegicus,,CHEMBL618777,A,,Percent bioavailability (F) in rats after iv administration,Intermediate
,In vivo,,,,1,,,N,50597,4722,1,10116.0,10769,,BAO_0000218,Rattus norvegicus,,CHEMBL618778,A,,Percent bioavailability (F) in rats after oral dose of 10 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,4353,1,10116.0,10770,,BAO_0000218,Rattus norvegicus,,CHEMBL618779,A,,Bioavailability in rat (dose 5 uM/kg p.o.),Intermediate
,In vivo,,,,1,,,N,50597,15662,1,10116.0,10771,,BAO_0000218,Rattus norvegicus,,CHEMBL618780,A,,Oral bioavailability,Intermediate
,In vivo,,,,1,,,N,50597,4756,1,10116.0,10772,,BAO_0000218,Rattus norvegicus,,CHEMBL618781,A,,Bioavailability in rat (dose 2 mg/kg p.o.),Intermediate
,In vivo,,,,1,,,N,50597,4756,1,10116.0,10773,,BAO_0000218,Rattus norvegicus,,CHEMBL618782,A,,Percent bioavailability at the dose of 5 mg/Kg administered perorally in rats,Intermediate
,In vivo,,,,1,,,N,50597,3436,1,10116.0,10774,,BAO_0000218,Rattus norvegicus,,CHEMBL618783,A,,Oral bioavailability in rat (dose 20 mg/kg),Intermediate
,In vivo,,,,1,,,N,50597,17800,1,10116.0,10775,,BAO_0000218,Rattus norvegicus,,CHEMBL618784,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,15762,1,10116.0,10776,,BAO_0000218,Rattus norvegicus,,CHEMBL618785,A,,Percent oral bioavailability evaluated in rat,Intermediate
,In vivo,,,,1,,,N,50597,5089,1,10116.0,10777,,BAO_0000218,Rattus norvegicus,,CHEMBL618786,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,5089,1,10116.0,10778,,BAO_0000218,Rattus norvegicus,,CHEMBL618787,A,,Percent oral bioavailability in rat; Not determined,Intermediate
,In vivo,,,,1,,,N,50597,3185,1,10116.0,10779,,BAO_0000218,Rattus norvegicus,,CHEMBL618788,A,,Oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,5145,1,10116.0,10780,,BAO_0000218,Rattus norvegicus,,CHEMBL618789,A,,Bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50597,3457,1,10116.0,10781,,BAO_0000218,Rattus norvegicus,,CHEMBL618790,A,,Pharmacokinetic property (oral bioavailability) in rat (dose given as a solution),Intermediate
,In vivo,,,,1,,,N,50597,3457,1,10116.0,10782,,BAO_0000218,Rattus norvegicus,,CHEMBL618791,A,,Pharmacokinetic property (oral bioavailability) in rat (dose given as a suspension),Intermediate
,In vivo,,,,1,,,N,50597,5983,1,10116.0,10783,,BAO_0000218,Rattus norvegicus,,CHEMBL875843,A,,Pharmacokinetic property (F) was measured in rat at the dose of 0.32 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,5739,1,10116.0,10784,,BAO_0000218,Rattus norvegicus,,CHEMBL618792,A,,Oral bioavailability in rat (dose 20 mg/kg p.o.),Intermediate
,In vivo,,,,1,,,N,50597,3579,1,10116.0,10785,,BAO_0000218,Rattus norvegicus,,CHEMBL623395,A,,Cmax at a dose of 30 mg/kg in rat,Intermediate
,In vivo,,,,0,,,U,22224,17788,1,314293.0,10786,,BAO_0000218,Simiiformes,,CHEMBL623396,A,,Cmax in monkeys at a dose of 1 mg/kg,Autocuration
,In vivo,,,,1,,,N,50597,14956,1,10116.0,10787,,BAO_0000218,Rattus norvegicus,,CHEMBL623397,A,,Cmax in rat,Intermediate
,In vivo,,,,1,,,N,50597,17788,1,10116.0,10788,,BAO_0000218,Rattus norvegicus,,CHEMBL623398,A,,Cmax in rats at a dose of 1 mg/kg,Intermediate
,In vivo,,,,1,,,N,50594,9750,1,10090.0,10789,,BAO_0000218,Mus musculus,,CHEMBL623399,A,,Cmax was measured in mice after an oral dose of 50 mg/kg.,Intermediate
,In vivo,,,,0,,,U,22224,12767,1,,10790,,BAO_0000218,,,CHEMBL623400,A,,"Cmax value at a dose of 12.7 uM/kg, po",Autocuration
,In vivo,,,,0,,,U,22224,12767,1,,10791,,BAO_0000218,,,CHEMBL623401,A,,"Cmax value at a dose of 6.3 uM/kg, iv",Autocuration
,In vivo,,,,0,,,U,22224,12767,1,,10792,,BAO_0000218,,,CHEMBL623402,A,,"Cmax value at a dose of 7.1 uM/kg, iv",Autocuration
,In vivo,,,,0,,,U,22224,12703,1,,10793,,BAO_0000218,,,CHEMBL623403,A,,Cmax value of compound was determined after 1 hr,Autocuration
,In vivo,,,,0,,,U,22224,15778,1,,10794,,BAO_0000218,,,CHEMBL623404,A,,Cmax value of the compound,Autocuration
,In vivo,,,,1,,,N,50597,12818,1,10116.0,10795,,BAO_0000218,Rattus norvegicus,,CHEMBL625997,A,,Cmax value administered intraintestinal in rats.,Intermediate
,In vivo,,,,1,,,N,50597,14964,1,10116.0,10796,,BAO_0000218,Rattus norvegicus,,CHEMBL625998,A,,Cmax value administered perorally was determined in rat; Not determined,Intermediate
,In vivo,,,,0,,,U,22224,15808,1,,10797,,BAO_0000218,,,CHEMBL625999,A,,Cmax value at the dose of 2.3 mg/kg,Autocuration
,In vivo,,,,0,,,U,22224,15808,1,,10798,,BAO_0000218,,,CHEMBL626000,A,,Cmax value at the dose of 5 mg/kg,Autocuration
,In vivo,,,,0,,,U,22224,15778,1,,10799,,BAO_0000218,,,CHEMBL626001,A,,Cmax value in the period of 8 hr after dosing. ,Autocuration
,In vivo,,,,0,,,U,22224,3715,1,,10800,,BAO_0000218,,,CHEMBL626002,A,,Cmax value at a oral dose of 20 mg/kg; Not tested,Autocuration
,In vivo,,,,0,,,U,22224,3715,1,,10801,,BAO_0000218,,,CHEMBL626003,A,,Cmax value at a oral dose of 20 mg/kg,Autocuration
,In vivo,,,,1,,,N,50597,1446,1,10116.0,10802,,BAO_0000218,Rattus norvegicus,,CHEMBL626004,A,,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,Intermediate
,In vivo,,,,1,,,N,50512,15240,1,10141.0,10803,,BAO_0000218,Cavia porcellus,,CHEMBL626005,A,,Cmax(ng /mL)values after oral administration of 10 mg/kg in guinea pig.,Intermediate
,In vivo,,,,1,,,N,50597,15240,1,10116.0,10804,,BAO_0000218,Rattus norvegicus,,CHEMBL626006,A,,Cmax(ng /mL)values after oral administration of 10 mg/kg in rat.,Intermediate
,In vivo,Plasma,,,1,,,N,50597,14810,1,10116.0,10805,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626007,A,,Compound at a dose of 10 mg/kg was orally administered to rats and maximum plasma concentration was reported,Intermediate
,In vivo,Plasma,,,1,,,N,50594,14239,1,10090.0,10806,,BAO_0000218,Mus musculus,1969.0,CHEMBL626008,A,,Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,Intermediate
,In vivo,Liver,,,1,,,N,50588,12555,1,9615.0,10807,,BAO_0000218,Canis lupus familiaris,2107.0,CHEMBL626009,A,,Compound was evaluated for maximum plasma concentration levels in dogs for the orally delivered compound in 0.05 M citric acid,Intermediate
,In vivo,,,,1,,,N,50588,10754,1,9615.0,10808,,BAO_0000218,Canis lupus familiaris,,CHEMBL626010,A,,Compound was evaluated in vivo for its concentration after a peroral administration 40 mg/kg in dogs.,Intermediate
,In vivo,Blood,,,1,,,N,50594,10754,1,10090.0,10809,,BAO_0000218,Mus musculus,178.0,CHEMBL626011,A,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a intramuscular administration 40 mg/kg in mice,Intermediate
,In vivo,Blood,,,1,,,N,50594,10754,1,10090.0,10810,,BAO_0000218,Mus musculus,178.0,CHEMBL626012,A,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration 40 mg/kg in mice,Intermediate
,In vivo,Blood,,,1,,,N,50594,10754,1,10090.0,10811,,BAO_0000218,Mus musculus,178.0,CHEMBL626013,A,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration of 40 mg/kg in mice,Intermediate
,In vivo,Blood,,,1,,,N,50594,10754,1,10090.0,10812,,BAO_0000218,Mus musculus,178.0,CHEMBL626014,A,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice,Intermediate
,In vivo,Blood,,,1,,,N,50594,10754,1,10090.0,10813,,BAO_0000218,Mus musculus,178.0,CHEMBL877496,A,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice.,Intermediate
,In vivo,,,,1,,,N,50588,14600,1,9615.0,10814,,BAO_0000218,Canis lupus familiaris,,CHEMBL626015,F,,Compound was tested Growth Hormone(GH) release after 0.5 mg/kg administration (Po) in Beagle dogs,Intermediate
,In vivo,,,,1,,,N,50588,14600,1,9615.0,10815,,BAO_0000218,Canis lupus familiaris,,CHEMBL626016,F,,Compound was tested Growth Hormone(GH) release after 10 mg/kg administration (Po) in Beagle dogs,Intermediate
,In vivo,,,,1,,,N,50588,14600,1,9615.0,10816,,BAO_0000218,Canis lupus familiaris,,CHEMBL626017,F,,Compound was tested Growth Hormone(GH) release after 2.5 mg/kg administration (Po) in Beagle dogs,Intermediate
,In vivo,Plasma,,,1,,,N,50588,13543,1,9615.0,10817,,BAO_0000218,Canis lupus familiaris,1969.0,CHEMBL626018,A,,Bioavailability as maximal plasma concentration in dogs,Intermediate
,In vivo,Plasma,,,1,,,N,50588,13543,1,9615.0,10818,,BAO_0000218,Canis lupus familiaris,1969.0,CHEMBL626692,A,,Bioavailability as maximal plasma concentration in dogs,Intermediate
,In vivo,Plasma,,,1,,,N,50597,13543,1,10116.0,10819,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626693,A,,Bioavailability as maximal plasma concentration in rats,Intermediate
,In vivo,Plasma,,,0,,,U,22224,13543,1,10116.0,10820,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626694,A,,Bioavailability as maximal plasma concentration in rats,Autocuration
,In vivo,Blood,,,1,,,N,50588,14600,1,9615.0,10821,,BAO_0000218,Canis lupus familiaris,178.0,CHEMBL626695,A,,Compound was tested for maximum blood concentration after 0.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Intermediate
,In vivo,Blood,,,1,,,N,50588,14600,1,9615.0,10822,,BAO_0000218,Canis lupus familiaris,178.0,CHEMBL626696,A,,Compound was tested for maximum blood concentration after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Intermediate
,In vivo,Blood,,,1,,,N,50588,14600,1,9615.0,10823,,BAO_0000218,Canis lupus familiaris,178.0,CHEMBL626697,A,,Compound was tested for maximum blood concentration after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Intermediate
,In vivo,Blood,,,1,,,N,50588,14600,1,9615.0,10824,,BAO_0000218,Canis lupus familiaris,178.0,CHEMBL626859,A,,Compound was tested for maximum concentration in blood after 0.5 mg/kg administration (Po) in Beagle dogs; nd = Not Detectable,Intermediate
,In vivo,Blood,,,1,,,N,50588,14600,1,9615.0,10825,,BAO_0000218,Canis lupus familiaris,178.0,CHEMBL626860,A,,Compound was tested for maximum concentration in blood after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Intermediate
,In vivo,Blood,,,1,,,N,50588,14600,1,9615.0,10826,,BAO_0000218,Canis lupus familiaris,178.0,CHEMBL626861,A,,Compound was tested for maximum concentration in blood after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Intermediate
,In vivo,,,,1,,,N,50597,14681,1,10116.0,10827,,BAO_0000218,Rattus norvegicus,,CHEMBL626296,A,,Compound was tested for maximum observed concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,Intermediate
,In vivo,,,,0,,,U,22224,15905,1,,10828,,BAO_0000218,,,CHEMBL626297,A,,Compound was tested for the max. conc. when administered perorally(po) 30 mg/kg,Autocuration
,In vivo,Plasma,,,0,,,U,22224,15905,1,,10829,,BAO_0000218,,1969.0,CHEMBL626298,A,,Compound was tested for the max. plasma conc. when administered intraperitoneally (ip) 30 mg/kg.,Autocuration
,In vivo,Plasma,,,1,,,N,50597,13304,1,10116.0,10830,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626299,A,,"Drug plasma level in rat was determined on the last day of dosing at 1,2,4.8 and 24 hr and ED50 was evaluated",Intermediate
,In vivo,Plasma,,,1,,,N,50597,15137,1,10116.0,10831,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626300,A,,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats after 30 min.,Intermediate
,In vivo,Plasma,,,1,,,N,50597,15137,1,10116.0,10832,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626301,A,,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats after 30 min.,Intermediate
,In vivo,Plasma,,,1,,,N,50597,15137,1,10116.0,10833,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626962,A,,Effect of ip administration of compound on plasma concentration of corticosterone (CTS) in rats after 30 min.,Intermediate
,In vivo,Plasma,,,1,,,N,50597,15137,1,10116.0,10834,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626963,A,,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats after 30 min.,Intermediate
,In vivo,Plasma,,,1,,,N,50597,15137,1,10116.0,10835,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626964,A,,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats after 30 min.,Intermediate
,In vivo,Plasma,,,1,,,N,100710,14839,1,9541.0,10836,,BAO_0000218,Macaca fascicularis,1969.0,CHEMBL626965,A,,In vivo antitumor efficacy expressed as maximum plasma concentration 0.4 hr after a peroral dose of 25 mg/kg in cynomolgus monkeys,Intermediate
,In vivo,Plasma,,,1,,,N,50594,14839,1,10090.0,10837,,BAO_0000218,Mus musculus,1969.0,CHEMBL626966,A,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Intermediate
,In vivo,Plasma,,,1,,,N,50594,14839,1,10090.0,10838,,BAO_0000218,Mus musculus,1969.0,CHEMBL626967,A,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Intermediate
,In vivo,Plasma,,,1,,,N,100710,14839,1,9541.0,10839,,BAO_0000218,Macaca fascicularis,1969.0,CHEMBL626968,A,,In vivo antitumor efficacy expressed as maximum plasma concentration after a peroral dose of 10 mg/kg in cynomolgus monkeys,Intermediate
,,Heart,,,1,,,N,50597,8418,1,10116.0,10840,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL626969,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.89-1.24,Intermediate
,,Heart,,,1,,,N,50597,8418,1,10116.0,10841,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL627126,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-2.58,Intermediate
,,Heart,,,1,,,N,50597,8418,1,10116.0,10842,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL631276,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.24-0.28,Intermediate
,,Heart,,,1,,,N,50597,8418,1,10116.0,10843,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL631277,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.52-0.62,Intermediate
,,Heart,,,1,,,N,50597,8418,1,10116.0,10844,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL631278,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.68-0.84,Intermediate
,,Heart,,,1,,,N,50597,8418,1,10116.0,10845,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL874457,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.75-1.03,Intermediate
,,Heart,,,1,,,N,50597,8418,1,10116.0,10846,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL631279,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.96-2.46,Intermediate
,,Heart,,,1,,,N,50597,8418,1,10116.0,10847,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL631280,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.36-0.42,Intermediate
,,Heart,,,1,,,N,50597,8418,1,10116.0,10848,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL631281,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.82,Intermediate
,,Heart,,,1,,,N,50597,8418,1,10116.0,10849,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL631968,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.24-1.46,Intermediate
,,Heart,,,1,,,N,50597,8418,1,10116.0,10850,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL631969,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.36-3.96,Intermediate
,,Heart,,,1,,,N,50597,8418,1,10116.0,10851,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL631970,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.24-0.29,Intermediate
,,Heart,,,1,,,N,50597,8418,1,10116.0,10852,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL631971,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.39-0.74,Intermediate
,,Heart,,,1,,,N,50597,8418,1,10116.0,10853,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL631972,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.79-0.85,Intermediate
,,Heart,,,1,,,N,50597,8418,1,10116.0,10854,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL630435,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.64-0.86,Intermediate
,,Heart,,,1,,,N,50597,8418,1,10116.0,10855,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL630436,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.68-2.23,Intermediate
,,Heart,,,1,,,N,50597,8418,1,10116.0,10856,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL630437,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.19-0.23,Intermediate
,,Heart,,,1,,,N,50597,8418,1,10116.0,10857,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL630438,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.22-0.29,Intermediate
,,Heart,,,1,,,N,50597,8418,1,10116.0,10858,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL630439,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.75,Intermediate
,,Kidney,,,1,,,N,50597,8418,1,10116.0,10859,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL630440,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.42-1.82,Intermediate
,,Kidney,,,1,,,N,50597,8418,1,10116.0,10860,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL630441,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-3.12,Intermediate
,,Kidney,,,1,,,N,50597,8418,1,10116.0,10861,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL630442,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.62-0.92,Intermediate
,,Kidney,,,1,,,N,50597,8418,1,10116.0,10862,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL625234,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.12-2.04,Intermediate
,,Kidney,,,1,,,N,50597,8418,1,10116.0,10863,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL625235,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.59-2.03,Intermediate
,,Kidney,,,1,,,N,50597,8418,1,10116.0,10864,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL625236,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.14-1.4,Intermediate
,,Kidney,,,1,,,N,50597,8418,1,10116.0,10865,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL625237,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.56-1.83,Intermediate
,,Kidney,,,1,,,N,50597,8418,1,10116.0,10866,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL626125,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.73,Intermediate
,,Kidney,,,1,,,N,50597,8418,1,10116.0,10867,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL626126,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.67-2.11,Intermediate
,,Kidney,,,1,,,N,50597,8418,1,10116.0,10868,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL626127,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.64-3.43,Intermediate
,,Kidney,,,1,,,N,50597,8418,1,10116.0,10869,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL626128,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.18-4.74,Intermediate
,,Kidney,,,1,,,N,50597,8418,1,10116.0,10870,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL626129,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.62-1.13,Intermediate
,,Kidney,,,1,,,N,50597,8418,1,10116.0,10871,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL626130,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.73-2.64,Intermediate
,,Kidney,,,1,,,N,50597,8418,1,10116.0,10872,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL626131,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 13.02-19.07,Intermediate
,,Kidney,,,1,,,N,50597,8418,1,10116.0,10873,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL626132,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.89-1.19,Intermediate
,,Kidney,,,1,,,N,50597,8418,1,10116.0,10874,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL626752,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.17-1.48,Intermediate
,,Kidney,,,1,,,N,50597,8418,1,10116.0,10875,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL626753,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.48-0.72,Intermediate
,,Kidney,,,1,,,N,50597,8418,1,10116.0,10876,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL626754,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.57,Intermediate
,,Kidney,,,1,,,N,50597,8418,1,10116.0,10877,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL626755,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.99-1.24,Intermediate
,,Liver,,,1,,,N,50597,8418,1,10116.0,10878,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL626756,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.23-1.78,Intermediate
,,Liver,,,1,,,N,50597,8418,1,10116.0,10879,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL626757,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.43-2.92,Intermediate
,,Liver,,,1,,,N,50597,8418,1,10116.0,10880,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL626758,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.81-1.18,Intermediate
,,Liver,,,1,,,N,50597,8418,1,10116.0,10881,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL626759,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.37-1.74,Intermediate
,,Liver,,,1,,,N,50597,8418,1,10116.0,10882,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL626760,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 4.01-4.81,Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,10883,,BAO_0000218,Canis lupus familiaris,,CHEMBL626394,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,10884,,BAO_0000218,Canis lupus familiaris,,CHEMBL626395,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration,Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,10885,,BAO_0000218,Canis lupus familiaris,,CHEMBL626396,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration (0-6 hr),Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,10886,,BAO_0000218,Canis lupus familiaris,,CHEMBL626397,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,10887,,BAO_0000218,Canis lupus familiaris,,CHEMBL626398,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,10888,,BAO_0000218,Canis lupus familiaris,,CHEMBL626399,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,10889,,BAO_0000218,Rattus norvegicus,,CHEMBL874653,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration,Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,10890,,BAO_0000218,Rattus norvegicus,,CHEMBL626400,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,10891,,BAO_0000218,Rattus norvegicus,,CHEMBL626401,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,10892,,BAO_0000218,Rattus norvegicus,,CHEMBL626402,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,10893,,BAO_0000218,Rattus norvegicus,,CHEMBL626403,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,10894,,BAO_0000218,Rattus norvegicus,,CHEMBL626404,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,10895,,BAO_0000218,Rattus norvegicus,,CHEMBL626405,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration,Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,10896,,BAO_0000218,Rattus norvegicus,,CHEMBL625529,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,10897,,BAO_0000218,Rattus norvegicus,,CHEMBL625530,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,10898,,BAO_0000218,Rattus norvegicus,,CHEMBL625531,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,10899,,BAO_0000218,Rattus norvegicus,,CHEMBL625532,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,10900,,BAO_0000218,Rattus norvegicus,,CHEMBL625533,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,10901,,BAO_0000218,Rattus norvegicus,,CHEMBL875474,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration,Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,10902,,BAO_0000218,Rattus norvegicus,,CHEMBL625534,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,10903,,BAO_0000218,Rattus norvegicus,,CHEMBL625535,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,10904,,BAO_0000218,Rattus norvegicus,,CHEMBL625536,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,10905,,BAO_0000218,Rattus norvegicus,,CHEMBL625537,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,10906,,BAO_0000218,Rattus norvegicus,,CHEMBL625538,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,10907,,BAO_0000218,Rattus norvegicus,,CHEMBL625539,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration,Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,10908,,BAO_0000218,Rattus norvegicus,,CHEMBL625540,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,10909,,BAO_0000218,Rattus norvegicus,,CHEMBL625541,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,10910,,BAO_0000218,Rattus norvegicus,,CHEMBL625542,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,10911,,BAO_0000218,Rattus norvegicus,,CHEMBL625543,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,10912,,BAO_0000218,Rattus norvegicus,,CHEMBL625544,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,10913,,BAO_0000218,Canis lupus familiaris,,CHEMBL625545,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.312 mg/kg after ip administration,Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,10914,,BAO_0000218,Canis lupus familiaris,,CHEMBL625546,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,10915,,BAO_0000218,Canis lupus familiaris,,CHEMBL625547,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.625 mg/kg after ip administration,Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,10916,,BAO_0000218,Canis lupus familiaris,,CHEMBL625548,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,10917,,BAO_0000218,Canis lupus familiaris,,CHEMBL625549,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,10918,,BAO_0000218,Canis lupus familiaris,,CHEMBL625550,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,10919,,BAO_0000218,Canis lupus familiaris,,CHEMBL625551,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,10920,,BAO_0000218,Canis lupus familiaris,,CHEMBL875475,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,10921,,BAO_0000218,Canis lupus familiaris,,CHEMBL625552,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,10922,,BAO_0000218,Canis lupus familiaris,,CHEMBL625553,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,10923,,BAO_0000218,Canis lupus familiaris,,CHEMBL625554,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,10924,,BAO_0000218,Canis lupus familiaris,,CHEMBL625555,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,10925,,BAO_0000218,Canis lupus familiaris,,CHEMBL625556,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,10926,,BAO_0000218,Canis lupus familiaris,,CHEMBL624986,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration,Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,10927,,BAO_0000218,Canis lupus familiaris,,CHEMBL624987,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,10928,,BAO_0000218,Canis lupus familiaris,,CHEMBL624988,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),Intermediate
,In vivo,Artery,,,1,,,N,50588,9025,1,9615.0,10929,,BAO_0000218,Canis lupus familiaris,1637.0,CHEMBL624989,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -2/-14,Intermediate
,In vivo,Artery,,,1,,,N,50588,9025,1,9615.0,10930,,BAO_0000218,Canis lupus familiaris,1637.0,CHEMBL624990,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -4/-4,Intermediate
,In vivo,Artery,,,1,,,N,50588,9025,1,9615.0,10931,,BAO_0000218,Canis lupus familiaris,1637.0,CHEMBL874391,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; 4/7,Intermediate
,In vivo,Artery,,,1,,,N,50588,9025,1,9615.0,10932,,BAO_0000218,Canis lupus familiaris,1637.0,CHEMBL624991,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3/10 range; -3/0/4,Intermediate
,In vivo,Artery,,,1,,,N,50588,9025,1,9615.0,10933,,BAO_0000218,Canis lupus familiaris,1637.0,CHEMBL624992,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; -6/0,Intermediate
,In vivo,Artery,,,1,,,N,50588,9025,1,9615.0,10934,,BAO_0000218,Canis lupus familiaris,1637.0,CHEMBL624993,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 10/31,Intermediate
,In vivo,Artery,,,1,,,N,50588,9025,1,9615.0,10935,,BAO_0000218,Canis lupus familiaris,1637.0,CHEMBL624994,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 11/-19,Intermediate
,In vivo,Artery,,,1,,,N,50588,9025,1,9615.0,10936,,BAO_0000218,Canis lupus familiaris,1637.0,CHEMBL624995,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 14/6,Intermediate
,In vivo,Artery,,,1,,,N,50588,9025,1,9615.0,10937,,BAO_0000218,Canis lupus familiaris,1637.0,CHEMBL624996,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/25,Intermediate
,In vivo,Artery,,,1,,,N,50588,9025,1,9615.0,10938,,BAO_0000218,Canis lupus familiaris,1637.0,CHEMBL624997,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/3,Intermediate
,In vivo,Artery,,,1,,,N,50588,9025,1,9615.0,10939,,BAO_0000218,Canis lupus familiaris,1637.0,CHEMBL624998,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 2/16,Intermediate
,In vivo,Artery,,,1,,,N,50588,9025,1,9615.0,10940,,BAO_0000218,Canis lupus familiaris,1637.0,CHEMBL624999,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 6/2,Intermediate
,In vivo,Artery,,,1,,,N,50588,9025,1,9615.0,10941,,BAO_0000218,Canis lupus familiaris,1637.0,CHEMBL882955,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 7/26,Intermediate
,In vivo,Artery,,,1,,,N,50588,9025,1,9615.0,10942,,BAO_0000218,Canis lupus familiaris,1637.0,CHEMBL625000,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/49,Intermediate
,In vivo,Artery,,,1,,,N,50588,9025,1,9615.0,10943,,BAO_0000218,Canis lupus familiaris,1637.0,CHEMBL625001,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/8,Intermediate
,In vivo,Artery,,,1,,,N,50588,9025,1,9615.0,10944,,BAO_0000218,Canis lupus familiaris,1637.0,CHEMBL625089,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 9/-18,Intermediate
,In vivo,Artery,,,1,,,N,50588,9025,1,9615.0,10945,,BAO_0000218,Canis lupus familiaris,1637.0,CHEMBL625090,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/60 range; 13/23,Intermediate
,In vivo,Artery,,,1,,,N,50588,9025,1,9615.0,10946,,BAO_0000218,Canis lupus familiaris,1637.0,CHEMBL625091,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3 range,Intermediate
,In vivo,Artery,,,1,,,N,50588,9025,1,9615.0,10947,,BAO_0000218,Canis lupus familiaris,1637.0,CHEMBL625092,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3/10 range; -7/-11,Intermediate
,In vivo,Artery,,,1,,,N,50588,9025,1,9615.0,10948,,BAO_0000218,Canis lupus familiaris,1637.0,CHEMBL625093,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 1/3 dose range; 6/-7,Intermediate
,In vivo,Artery,,,1,,,N,50588,9025,1,9615.0,10949,,BAO_0000218,Canis lupus familiaris,1637.0,CHEMBL625094,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 10/30 dose range; -13/19,Intermediate
,In vivo,Artery,,,1,,,N,50588,9025,1,9615.0,10950,,BAO_0000218,Canis lupus familiaris,1637.0,CHEMBL625095,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 3/10 dose range; 30/47,Intermediate
,In vivo,,,,1,,,N,50588,2249,1,9615.0,10951,,BAO_0000218,Canis lupus familiaris,,CHEMBL625096,A,,Compound was evaluated for its bioavailability in the dogs,Intermediate
,In vivo,,,,1,,,N,50597,2249,1,10116.0,10952,,BAO_0000218,Rattus norvegicus,,CHEMBL625097,A,,Compound was evaluated for its bioavailability in the rats,Intermediate
,In vivo,,,,0,,,U,22224,17515,1,,10953,,BAO_0000218,,,CHEMBL882956,A,,Compound was evaluated for oral bioavailability,Autocuration
,In vivo,,,,1,,,N,50597,14541,1,10116.0,10954,,BAO_0000218,Rattus norvegicus,,CHEMBL625098,A,,Compound was evaluated for percentage of Oral bioavailability in rats,Intermediate
,In vivo,,,,0,,,U,22224,12797,1,10141.0,10955,,BAO_0000218,Cavia porcellus,,CHEMBL625099,A,,Bioavailability in guinea pig,Autocuration
,In vivo,,,,1,,,N,50597,12797,1,10116.0,10956,,BAO_0000218,Rattus norvegicus,,CHEMBL625100,A,,Compound was evaluated for the oral bioavailability in rat,Intermediate
,In vivo,,,,1,,,N,50588,12797,1,9615.0,10957,,BAO_0000218,Canis lupus familiaris,,CHEMBL625101,A,,Compound was evaluated for the oral bioavailability in dog,Intermediate
,In vivo,,,,1,,,N,50597,12797,1,10116.0,10958,,BAO_0000218,Rattus norvegicus,,CHEMBL874396,A,,Compound was evaluated for the oral bioavailability in rat,Intermediate
,In vivo,,,,0,,,U,22224,11727,1,9615.0,10959,,BAO_0000218,Canis lupus familiaris,,CHEMBL625102,F,,Bioavailability in dog (dosed i.v.),Autocuration
,In vivo,,,,1,,,N,50588,13249,1,9615.0,10960,,BAO_0000218,Canis lupus familiaris,,CHEMBL625103,A,,Compound was tested for in vivo bioavailability in dog,Intermediate
,In vivo,,,,1,,,N,100712,13249,1,10026.0,10961,,BAO_0000218,Cricetinae,,CHEMBL625104,A,,Compound was tested for in vivo bioavailability in hamsters,Intermediate
,In vivo,,,,0,,,U,22224,13249,1,314293.0,10962,,BAO_0000218,Simiiformes,,CHEMBL625105,A,,Compound was tested for in vivo bioavailability in monkey,Autocuration
,In vivo,,,,1,,,N,50597,13249,1,10116.0,10963,,BAO_0000218,Rattus norvegicus,,CHEMBL625106,A,,Compound was tested for in vivo bioavailability in rat,Intermediate
,In vivo,,,,0,,,U,22224,9552,1,10090.0,10964,,BAO_0000218,Mus musculus,,CHEMBL625107,A,,Oral bioavailability in mouse,Autocuration
,In vivo,,,,1,,,N,50594,9552,1,10090.0,10965,,BAO_0000218,Mus musculus,,CHEMBL625108,A,,Compound was tested for percent of oral bioavailability in mice; 56-74,Intermediate
,In vivo,,,,0,,,U,22224,14839,1,10090.0,10966,,BAO_0000218,Mus musculus,,CHEMBL625109,A,,Oral bioavailability in mouse (nude) (dose of 25 mg/kg),Autocuration
,In vivo,,,,0,,,U,22224,14839,1,9541.0,10967,,BAO_0000218,Macaca fascicularis,,CHEMBL625110,A,,Bioavailability in cynomolgus monkey (dose 25 mg/kg i.v.),Autocuration
,In vivo,,,,0,,,U,22224,14839,1,9541.0,10968,,BAO_0000218,Macaca fascicularis,,CHEMBL625111,A,,Bioavailability in cynomolgus monkey (dose 5 mg/kg i.v.),Autocuration
,In vivo,,,,1,,,N,50594,14839,1,10090.0,10969,,BAO_0000218,Mus musculus,,CHEMBL625112,A,,Oral bioavailability in mouse (nude) (dose 25 mg/kg i.v.),Intermediate
,In vivo,,,,1,,,N,50594,14839,1,10090.0,10970,,BAO_0000218,Mus musculus,,CHEMBL875334,A,,Oral bioavailability in nude mice,Intermediate
,In vivo,,,,0,,,U,22224,11219,1,9443.0,10971,,BAO_0000218,Primates,,CHEMBL628617,A,,Bioavailability in monkey (i.d. dosing),Autocuration
,In vivo,,,,0,,,U,22224,9552,1,10116.0,10972,,BAO_0000218,Rattus norvegicus,,CHEMBL628618,A,,Bioavailability in rat,Autocuration
,In vivo,,,,0,,,U,22224,11732,1,,10973,,BAO_0000218,,,CHEMBL628619,A,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 10%,Autocuration
,In vivo,,,,0,,,U,22224,11732,1,,10974,,BAO_0000218,,,CHEMBL628620,A,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 20%,Autocuration
,In vivo,,,,1,,,N,100710,14839,1,9541.0,10975,,BAO_0000218,Macaca fascicularis,,CHEMBL628621,A,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",Intermediate
,In vivo,,,,1,,,N,100710,14839,1,9541.0,10976,,BAO_0000218,Macaca fascicularis,,CHEMBL628622,A,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",Intermediate
,In vivo,,,,1,,,N,100710,14839,1,9541.0,10977,,BAO_0000218,Macaca fascicularis,,CHEMBL628623,A,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",Intermediate
,In vivo,Plasma,,,1,,,N,100710,14839,1,9541.0,10978,,BAO_0000218,Macaca fascicularis,1969.0,CHEMBL628624,A,,Maximal plasma concentration in cynomolgus monkeys after 10 mg/kg oral dose,Intermediate
,In vivo,Plasma,,,1,,,N,50594,14839,1,10090.0,10979,,BAO_0000218,Mus musculus,1969.0,CHEMBL628625,A,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Intermediate
,In vivo,Plasma,,,1,,,N,100710,14839,1,9541.0,10980,,BAO_0000218,Macaca fascicularis,1969.0,CHEMBL628626,A,,Maximal plasma concentration in cynomolgus monkeys after 5 mg/kg oral dose,Intermediate
,In vivo,Plasma,,,1,,,N,50594,14839,1,10090.0,10981,,BAO_0000218,Mus musculus,1969.0,CHEMBL627041,A,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Intermediate
,In vivo,Plasma,,,1,,,N,50594,14839,1,10090.0,10982,,BAO_0000218,Mus musculus,1969.0,CHEMBL627042,A,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Intermediate
,In vivo,Plasma,,,1,,,N,50594,14839,1,10090.0,10983,,BAO_0000218,Mus musculus,1969.0,CHEMBL627043,A,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Intermediate
,In vivo,Plasma,,,0,,,U,22224,13932,1,,10984,,BAO_0000218,,1969.0,CHEMBL627044,A,,In vivo evaluation of maximum plasma concentration at a dose of 10 mg/kg,Autocuration
,In vivo,Plasma,,,1,,,N,50594,11637,1,10090.0,10985,,BAO_0000218,Mus musculus,1969.0,CHEMBL627045,A,,Cmax in mouse plasma,Intermediate
,In vivo,Plasma,,,0,,,U,22224,11637,1,,10986,,BAO_0000218,,1969.0,CHEMBL627046,A,,Max plasma concentration was measured by 40 mg/kg dose of peroral administration.,Autocuration
,In vivo,Plasma,,,1,,,N,50597,13960,1,10116.0,10987,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL627047,A,,Maximal plasma concentration in rat,Intermediate
,In vivo,Plasma,,,1,,,N,50597,15905,1,10116.0,10988,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL627048,A,,Maximal plasma level when administered 1 mg/kg perorally (po) in rat,Intermediate
,In vivo,,,,1,,,N,50597,14062,1,10116.0,10989,,BAO_0000218,Rattus norvegicus,,CHEMBL627049,A,,Maximum concentration at an intraduodenal dose of 5.2 mg/kg in rat,Intermediate
,In vivo,,,,1,,,N,50597,14062,1,10116.0,10990,,BAO_0000218,Rattus norvegicus,,CHEMBL627050,A,,Maximum concentration at an intraduodenal dose of 6.6 mg/kg in rat,Intermediate
,In vivo,,,,1,,,N,50597,14062,1,10116.0,10991,,BAO_0000218,Rattus norvegicus,,CHEMBL627051,A,,Maximum concentration at an intravenous dose of 5.5 mg/kg in rat,Intermediate
,In vivo,,,,1,,,N,50597,14062,1,10116.0,10992,,BAO_0000218,Rattus norvegicus,,CHEMBL627052,A,,Maximum concentration at an intravenous dose of 6.5 mg/kg in rat,Intermediate
,In vivo,,,,1,,,N,50597,14062,1,10116.0,10993,,BAO_0000218,Rattus norvegicus,,CHEMBL627053,A,,Maximum concentration at an peroral dose of 6.2 mg/kg in rat,Intermediate
,In vivo,,,,1,,,N,50597,14062,1,10116.0,10994,,BAO_0000218,Rattus norvegicus,,CHEMBL627054,A,,Maximum concentration at an peroral dose of 6.3 mg/kg in rat,Intermediate
,In vivo,,,,1,,,N,50594,15011,1,10090.0,10995,,BAO_0000218,Mus musculus,,CHEMBL627055,A,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,Intermediate
,In vivo,,,,1,,,N,50594,15011,1,10090.0,10996,,BAO_0000218,Mus musculus,,CHEMBL627056,A,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,Intermediate
,In vivo,,,,1,,,N,50594,15011,1,10090.0,10997,,BAO_0000218,Mus musculus,,CHEMBL627057,A,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),Intermediate
,In vivo,,,,1,,,N,50594,15011,1,10090.0,10998,,BAO_0000218,Mus musculus,,CHEMBL627058,A,,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,Intermediate
,In vivo,,,,1,,,N,50594,15011,1,10090.0,10999,,BAO_0000218,Mus musculus,,CHEMBL626211,A,,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,Intermediate
,In vivo,,,,0,,,U,22224,10291,1,,11000,,BAO_0000218,,,CHEMBL626212,A,,Maximum Concentration of the compound.,Autocuration
,In vivo,,,,1,,,N,50588,14599,1,9615.0,11001,,BAO_0000218,Canis lupus familiaris,,CHEMBL626213,A,,Maximum Concentration was measured after iv administration into Beagle dog,Intermediate
,In vivo,,,,1,,,N,50588,14599,1,9615.0,11002,,BAO_0000218,Canis lupus familiaris,,CHEMBL626214,A,,Maximum Concentration was measured after iv administration into Beagle dog.,Intermediate
,In vivo,,,,1,,,N,50588,14599,1,9615.0,11003,,BAO_0000218,Canis lupus familiaris,,CHEMBL626215,A,,Maximum Concentration was measured after po administration into Beagle dog,Intermediate
,In vivo,,,,1,,,N,50588,14599,1,9615.0,11004,,BAO_0000218,Canis lupus familiaris,,CHEMBL626216,A,,Maximum Concentration was measured after po administration into Beagle dog.,Intermediate
,In vivo,Blood,,,0,,,U,22224,12767,1,,11005,,BAO_0000218,,178.0,CHEMBL626217,A,,Maximum blood level reached after an dose of 10.6 uM/kg intravenously,Autocuration
,In vivo,Blood,,,0,,,U,22224,12767,1,,11006,,BAO_0000218,,178.0,CHEMBL626218,A,,Maximum blood level reached after an iv dose of 12.2 uM/kg,Autocuration
,In vivo,Blood,,,0,,,U,22224,12767,1,,11007,,BAO_0000218,,178.0,CHEMBL626219,A,,Maximum blood level reached after an oral dose 14.7 uM/kg oral route,Autocuration
,In vivo,Blood,,,0,,,U,22224,12767,1,,11008,,BAO_0000218,,178.0,CHEMBL626220,A,,Maximum blood level reached after an oral dose of 14.7 uM/kg intravenous route,Autocuration
,In vivo,Blood,,,0,,,U,22224,12767,1,,11009,,BAO_0000218,,178.0,CHEMBL626221,A,,Maximum blood level reached after an oral dose of 5.0 mg/kg,Autocuration
,In vivo,Blood,,,0,,,U,22224,12767,1,,11010,,BAO_0000218,,178.0,CHEMBL626222,A,,Maximum blood level reached at dose of 10.6 uM/kg orally,Autocuration
,In vivo,,,,1,,,N,50512,14706,1,10141.0,11011,,BAO_0000218,Cavia porcellus,,CHEMBL626223,A,,Maximum concentration (Cmax) in guinea pigs at 2 mg/kg after oral administration,Intermediate
,In vivo,,,,1,,,N,50512,14706,1,10141.0,11012,,BAO_0000218,Cavia porcellus,,CHEMBL626224,A,,Maximum concentration (Cmax) in guinea pigs at 3 mg/kg after oral administration,Intermediate
,In vivo,Brain,,,1,,,N,50597,14793,1,10116.0,11013,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL626225,A,,Maximum concentration achieved in rat brain when administered intraperitoneally at a dose of 10 mg/kg,Intermediate
,In vivo,Brain,,,1,,,N,50597,14793,1,10116.0,11014,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL626226,A,,Maximum concentration achieved in rat brain when administered intravenously at a dose of 10 mg/kg,Intermediate
,In vivo,Brain,,,1,,,N,50597,14793,1,10116.0,11015,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL626227,A,,Maximum concentration achieved in rat brain when administered perorally at a dose of 100 mg/kg,Intermediate
,In vivo,Brain,,,1,,,N,50597,14793,1,10116.0,11016,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL626228,A,,Maximum concentration achieved in rat brain when administered perorally at a dose of 10 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,14793,1,10116.0,11017,,BAO_0000218,Rattus norvegicus,,CHEMBL626229,A,,Maximum concentration achieved in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,14793,1,10116.0,11018,,BAO_0000218,Rattus norvegicus,,CHEMBL626921,A,,Maximum concentration achieved in rat plasma when administered intravenously at a dose of 10 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,14793,1,10116.0,11019,,BAO_0000218,Rattus norvegicus,,CHEMBL876793,A,,Maximum concentration achieved in rat plasma when administered perorally at a dose of 100 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,14793,1,10116.0,11020,,BAO_0000218,Rattus norvegicus,,CHEMBL625309,A,,Maximum concentration achieved in rat plasma when administered perorally at a dose of 10 mg/kg,Intermediate
,In vivo,,,,1,,,N,50278,10524,1,1423.0,11021,,BAO_0000218,Bacillus subtilis,,CHEMBL625310,A,,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),Intermediate
,In vivo,,,,0,,,U,22224,11871,1,314293.0,11022,,BAO_0000218,Simiiformes,,CHEMBL625311,A,,Maximum concentration determined in monkeys dosed intravenously with 30 mg/kg,Autocuration
,In vivo,,,,1,,,N,50597,11871,1,10116.0,11023,,BAO_0000218,Rattus norvegicus,,CHEMBL625312,A,,Maximum concentration determined in rats dosed intravenously with 20 mg/kg,Intermediate
,In vivo,,,,0,,,U,22224,3437,1,,11024,,BAO_0000218,,,CHEMBL625313,A,,Maximum concentration for the bioavailability at a dose of 20 mg/kg administered orally,Autocuration
,In vivo,,,,1,,,N,50594,12038,1,10090.0,11025,,BAO_0000218,Mus musculus,,CHEMBL625314,A,,Maximum concentration in male CD-1 mice after sc administration of 20 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,12038,1,10116.0,11026,,BAO_0000218,Rattus norvegicus,,CHEMBL625315,A,,Maximum concentration in male rats after iv administration of 20 mg/kg,Intermediate
,,Liver,,,1,,,N,50597,8418,1,10116.0,11027,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL625316,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.06-1.29,Intermediate
,,Liver,,,1,,,N,50597,8418,1,10116.0,11028,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL625317,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.77-2.08,Intermediate
,,Liver,,,1,,,N,50597,8418,1,10116.0,11029,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL625318,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.89,Intermediate
,,Liver,,,1,,,N,50597,8418,1,10116.0,11030,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL625319,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.57-1.66,Intermediate
,,Liver,,,1,,,N,50597,8418,1,10116.0,11031,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL625320,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.06-2.71,Intermediate
,,Liver,,,1,,,N,50597,8418,1,10116.0,11032,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL625321,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.98-3.22,Intermediate
,,Liver,,,1,,,N,50597,8418,1,10116.0,11033,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL625322,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.73-1.45,Intermediate
,,Liver,,,1,,,N,50597,8418,1,10116.0,11034,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL876801,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.03-1.31,Intermediate
,,Liver,,,1,,,N,50597,8418,1,10116.0,11035,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL625323,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 6.76-10.44,Intermediate
,,Liver,,,1,,,N,50597,8418,1,10116.0,11036,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL625324,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.47-1.17,Intermediate
,,Liver,,,1,,,N,50597,8418,1,10116.0,11037,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL625325,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.12-1.44,Intermediate
,,Liver,,,1,,,N,50597,8418,1,10116.0,11038,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL625326,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.38-0.57,Intermediate
,,Liver,,,1,,,N,50597,8418,1,10116.0,11039,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL625327,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.75-1.14,Intermediate
,,Liver,,,1,,,N,50597,8418,1,10116.0,11040,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL625328,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 1.36-1.74,Intermediate
,,Lung,,,1,,,N,50597,8418,1,10116.0,11041,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL625329,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.5,Intermediate
,,Lung,,,1,,,N,50597,8418,1,10116.0,11042,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL625330,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 3.10-3.77,Intermediate
,,Lung,,,1,,,N,50597,8418,1,10116.0,11043,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL627774,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.4-0.54,Intermediate
,,Lung,,,1,,,N,50597,8418,1,10116.0,11044,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL627775,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.58-0.86,Intermediate
,,Lung,,,1,,,N,50597,8418,1,10116.0,11045,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL627949,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.77-0.86,Intermediate
,,Lung,,,1,,,N,50597,8418,1,10116.0,11046,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL627950,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.86-1.13,Intermediate
,,Lung,,,1,,,N,50597,8418,1,10116.0,11047,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL627951,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 2.26-2.89,Intermediate
,,Lung,,,1,,,N,50597,8418,1,10116.0,11048,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL627952,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.7,Intermediate
,,Lung,,,1,,,N,50597,8418,1,10116.0,11049,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL627953,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.6-0.66,Intermediate
,,Lung,,,1,,,N,50597,8418,1,10116.0,11050,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL627954,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.35-1.74,Intermediate
,,Lung,,,1,,,N,50597,8418,1,10116.0,11051,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL627955,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.62-7.08,Intermediate
,,Lung,,,1,,,N,50597,8418,1,10116.0,11052,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL627956,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.47-0.56,Intermediate
,,Lung,,,1,,,N,50597,8418,1,10116.0,11053,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL876802,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.54-1.07,Intermediate
,,Lung,,,1,,,N,50597,8418,1,10116.0,11054,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL627957,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.76-0.91,Intermediate
,,Lung,,,1,,,N,50597,8418,1,10116.0,11055,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL627958,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.61-0.86,Intermediate
,,Lung,,,1,,,N,50597,8418,1,10116.0,11056,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL627959,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 2.11-3.79,Intermediate
,,Lung,,,1,,,N,50597,8418,1,10116.0,11057,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL627960,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.3-0.36,Intermediate
,,Lung,,,1,,,N,50597,8418,1,10116.0,11058,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL627961,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.36-0.44,Intermediate
,,Lung,,,1,,,N,50597,8418,1,10116.0,11059,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL627962,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.5-0.65,Intermediate
,,,,,1,,,N,50597,9796,1,10116.0,11060,,BAO_0000218,Rattus norvegicus,,CHEMBL627963,A,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,Intermediate
,,,,,1,,,N,50597,9796,1,10116.0,11061,,BAO_0000218,Rattus norvegicus,,CHEMBL624759,A,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate
,,,,,1,,,N,50597,9796,1,10116.0,11062,,BAO_0000218,Rattus norvegicus,,CHEMBL624760,A,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,Intermediate
,,,,,1,,,N,50597,9796,1,10116.0,11063,,BAO_0000218,Rattus norvegicus,,CHEMBL624761,A,,Distribution of radiolabeled compound in intestinal contents of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate
,,,,,1,,,N,50597,9796,1,10116.0,11064,,BAO_0000218,Rattus norvegicus,,CHEMBL877607,A,,Distribution of radiolabeled compound in intestinal contents of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate
,,Liver,,,1,,,N,50597,9796,1,10116.0,11065,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL624762,A,,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,Intermediate
,,Liver,,,1,,,N,50597,9796,1,10116.0,11066,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL624763,A,,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate
,,Liver,,,1,,,N,50597,9796,1,10116.0,11067,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL624764,A,,Distribution of radiolabeled compound in liver of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,Intermediate
,,Liver,,,1,,,N,50597,9796,1,10116.0,11068,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL624765,A,,Distribution of radiolabeled compound in liver of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate
,,Liver,,,1,,,N,50597,9796,1,10116.0,11069,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL624766,A,,Distribution of radiolabeled compound in liver of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,11070,,BAO_0000218,Canis lupus familiaris,,CHEMBL624767,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,11071,,BAO_0000218,Canis lupus familiaris,,CHEMBL624768,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration,Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,11072,,BAO_0000218,Canis lupus familiaris,,CHEMBL624769,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,11073,,BAO_0000218,Canis lupus familiaris,,CHEMBL624770,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,11074,,BAO_0000218,Canis lupus familiaris,,CHEMBL624771,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,11075,,BAO_0000218,Canis lupus familiaris,,CHEMBL624772,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,11076,,BAO_0000218,Rattus norvegicus,,CHEMBL624773,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration,Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,11077,,BAO_0000218,Rattus norvegicus,,CHEMBL624774,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,11078,,BAO_0000218,Rattus norvegicus,,CHEMBL624775,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,11079,,BAO_0000218,Rattus norvegicus,,CHEMBL624776,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,11080,,BAO_0000218,Rattus norvegicus,,CHEMBL624777,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,11081,,BAO_0000218,Rattus norvegicus,,CHEMBL624778,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,11082,,BAO_0000218,Rattus norvegicus,,CHEMBL624779,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration,Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,11083,,BAO_0000218,Rattus norvegicus,,CHEMBL624780,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,11084,,BAO_0000218,Rattus norvegicus,,CHEMBL624781,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,11085,,BAO_0000218,Rattus norvegicus,,CHEMBL877608,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,11086,,BAO_0000218,Rattus norvegicus,,CHEMBL624782,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,11087,,BAO_0000218,Rattus norvegicus,,CHEMBL624783,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,11088,,BAO_0000218,Rattus norvegicus,,CHEMBL624784,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration,Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,11089,,BAO_0000218,Rattus norvegicus,,CHEMBL624785,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,11090,,BAO_0000218,Rattus norvegicus,,CHEMBL624786,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,11091,,BAO_0000218,Rattus norvegicus,,CHEMBL624787,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,11092,,BAO_0000218,Rattus norvegicus,,CHEMBL628676,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,11093,,BAO_0000218,Rattus norvegicus,,CHEMBL621842,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration,Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,11094,,BAO_0000218,Rattus norvegicus,,CHEMBL621843,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,11095,,BAO_0000218,Rattus norvegicus,,CHEMBL623873,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,11096,,BAO_0000218,Rattus norvegicus,,CHEMBL623874,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,11097,,BAO_0000218,Rattus norvegicus,,CHEMBL623875,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,11098,,BAO_0000218,Rattus norvegicus,,CHEMBL623876,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,11099,,BAO_0000218,Canis lupus familiaris,,CHEMBL623877,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.312 mg/kg after ip administration,Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,11100,,BAO_0000218,Canis lupus familiaris,,CHEMBL623878,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,11101,,BAO_0000218,Canis lupus familiaris,,CHEMBL623879,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.625 mg/kg after ip administration,Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,11102,,BAO_0000218,Canis lupus familiaris,,CHEMBL623880,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,11103,,BAO_0000218,Canis lupus familiaris,,CHEMBL623881,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,11104,,BAO_0000218,Canis lupus familiaris,,CHEMBL623957,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,11105,,BAO_0000218,Canis lupus familiaris,,CHEMBL623958,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,11106,,BAO_0000218,Canis lupus familiaris,,CHEMBL623959,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,11107,,BAO_0000218,Canis lupus familiaris,,CHEMBL623960,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,11108,,BAO_0000218,Canis lupus familiaris,,CHEMBL623961,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,11109,,BAO_0000218,Canis lupus familiaris,,CHEMBL623962,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,11110,,BAO_0000218,Canis lupus familiaris,,CHEMBL624676,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,11111,,BAO_0000218,Canis lupus familiaris,,CHEMBL624677,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,11112,,BAO_0000218,Canis lupus familiaris,,CHEMBL624678,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration,Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,11113,,BAO_0000218,Canis lupus familiaris,,CHEMBL624679,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,11114,,BAO_0000218,Canis lupus familiaris,,CHEMBL624680,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),Intermediate
,In vivo,,,,0,,,U,22224,11732,1,,11115,,BAO_0000218,,,CHEMBL624849,A,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 27%,Autocuration
,In vivo,,,,0,,,U,22224,11732,1,,11116,,BAO_0000218,,,CHEMBL624850,A,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 4%,Autocuration
,In vivo,,,,0,,,U,22224,11732,1,,11117,,BAO_0000218,,,CHEMBL874399,A,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 54%,Autocuration
,In vivo,,,,0,,,U,22224,11732,1,,11118,,BAO_0000218,,,CHEMBL624851,A,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 72%,Autocuration
,In vivo,,,,0,,,U,22224,11732,1,,11119,,BAO_0000218,,,CHEMBL624852,A,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 76%,Autocuration
,In vivo,,,,0,,,U,22224,13359,1,10116.0,11120,,BAO_0000218,Rattus norvegicus,,CHEMBL624853,A,,Oral bioavailability in rat (dose 10 mg/kg),Autocuration
,In vivo,,,,0,,,U,22224,16618,1,10116.0,11121,,BAO_0000218,Rattus norvegicus,,CHEMBL624854,A,,Oral bioavailability in rat (Sprague-Dawley),Autocuration
,In vivo,,,,0,,,U,22224,13960,1,10116.0,11122,,BAO_0000218,Rattus norvegicus,,CHEMBL624855,A,,Oral bioavailability in rat,Autocuration
,In vivo,,,,0,,,U,22224,13917,1,10116.0,11123,,BAO_0000218,Rattus norvegicus,,CHEMBL624856,A,,Oral bioavailability in rats was determined in vivo,Autocuration
,In vivo,,,,0,,,U,22224,14266,1,9615.0,11124,,BAO_0000218,Canis lupus familiaris,,CHEMBL882957,A,,Oral bioavailability in dog,Autocuration
,In vivo,,,,0,,,U,22224,12359,1,314293.0,11125,,BAO_0000218,Simiiformes,,CHEMBL624857,A,,Oral bioavailability of compound in monkey,Autocuration
,In vivo,,,,1,,,N,50597,12359,1,10116.0,11126,,BAO_0000218,Rattus norvegicus,,CHEMBL622202,A,,Oral bioavailability of compound in rat,Intermediate
,In vivo,,,,0,,,U,22224,12359,1,10116.0,11127,,BAO_0000218,Rattus norvegicus,,CHEMBL622203,A,,Bioavailability in rat of PMEA prodrug,Autocuration
,In vivo,,,,1,,,N,50597,12359,1,10116.0,11128,,BAO_0000218,Rattus norvegicus,,CHEMBL625522,A,,Oral bioavailability of compound was evaluated relative to that of PMEA in rat; Not determined due to lack of solubility,Intermediate
,In vivo,,,,0,,,U,22224,10791,1,9544.0,11129,,BAO_0000218,Macaca mulatta,,CHEMBL622868,A,,Serum conc at 3 hours following 25 mg/kg dose,Autocuration
,In vivo,Urine,,,0,,,U,22224,10791,1,9544.0,11130,,BAO_0000218,Macaca mulatta,1088.0,CHEMBL622869,A,,Urine conc 0-5 hours following 25 mg/kg dose,Autocuration
,In vivo,Urine,,,0,,,U,22224,10791,1,9544.0,11131,,BAO_0000218,Macaca mulatta,1088.0,CHEMBL622870,A,,Urine conc 0-24 hours following 25 mg/kg dose,Autocuration
,In vivo,,,,0,,,U,22224,138,1,9534.0,11132,,BAO_0000218,Chlorocebus aethiops,,CHEMBL622871,A,,Oral bioavailability in African green monkeys; 20-25,Autocuration
,In vivo,,,,1,,,N,100710,14521,1,9541.0,11133,,BAO_0000218,Macaca fascicularis,,CHEMBL620560,A,,Oral bioavailability in cynomolgus monkey.,Intermediate
,In vivo,,,,0,,,U,22224,13953,1,9615.0,11134,,BAO_0000218,Canis lupus familiaris,,CHEMBL620561,A,,Oral bioavailability in dog,Autocuration
,In vivo,,,,1,,,N,50588,12836,1,9615.0,11135,,BAO_0000218,Canis lupus familiaris,,CHEMBL620562,A,,Oral bioavailability in dog at 10 mg/kg oral dose,Intermediate
,In vivo,,,,1,,,N,100712,12836,1,10026.0,11136,,BAO_0000218,Cricetinae,,CHEMBL620563,A,,Oral bioavailability in hamster at 10 mg/kg oral dose,Intermediate
,In vivo,,,,1,,,N,50597,12836,1,10116.0,11137,,BAO_0000218,Rattus norvegicus,,CHEMBL620564,A,,Oral bioavailability in rat at 10 mg/kg oral dose,Intermediate
,In vivo,,,,0,,,U,22224,14521,1,10116.0,11138,,BAO_0000218,Rattus norvegicus,,CHEMBL872265,A,,Oral bioavailability in rat,Autocuration
,In vivo,,,,0,,,U,22224,13953,1,10116.0,11139,,BAO_0000218,Rattus norvegicus,,CHEMBL620565,A,,Oral bioavailability in rat,Autocuration
,In vivo,,,,0,,,U,22224,6799,1,9347.0,11140,,BAO_0000218,Eutheria,,CHEMBL620566,A,,Oral bioavailability,Autocuration
,In vivo,,,,0,,,U,22224,11311,1,,11141,,BAO_0000218,,,CHEMBL620567,A,,Oral bioavailability was determined; range 49-102%,Autocuration
,In vivo,,,,1,,,N,50588,4013,1,9615.0,11142,,BAO_0000218,Canis lupus familiaris,,CHEMBL620568,A,,Oral bioavailability was determined in dogs,Intermediate
,In vivo,,,,0,,,U,22224,4013,1,10116.0,11143,,BAO_0000218,Rattus norvegicus,,CHEMBL620569,A,,Oral bioavailability in rat,Autocuration
,In vivo,,,,0,,,U,22224,17591,1,9347.0,11144,,BAO_0000218,Eutheria,,CHEMBL620570,A,,Oral bioavailability,Autocuration
,In vivo,,,,0,,,U,22224,17591,1,,11145,,BAO_0000218,,,CHEMBL620571,A,,Oral bioavailability was determined; Not orally available,Autocuration
,In vivo,,,,1,,,N,50594,15011,1,10090.0,11146,,BAO_0000218,Mus musculus,,CHEMBL620572,A,,Percent bioavailability was administered by using 0.4% Methyl cellulose (MC) as vehicle to nude mice at a dose of 25 mg/kg (micronized sample),Intermediate
,In vivo,,,,0,,,U,22224,15011,1,10090.0,11147,,BAO_0000218,Mus musculus,,CHEMBL620573,A,,Bioavailability in mouse (nude) (dose 0.4% Methylcellulose (MC) as vehicle 25 mg/kg),Autocuration
,In vivo,,,,0,,,U,22224,15011,1,10090.0,11148,,BAO_0000218,Mus musculus,,CHEMBL620574,A,,Bioavailability in mouse (nude) using 20% aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle 25 mg/kg,Autocuration
,In vivo,,,,0,,,U,22224,9552,1,9544.0,11149,,BAO_0000218,Macaca mulatta,,CHEMBL620575,A,,Oral bioavailability in Rhesus monkey,Autocuration
,In vivo,,,,0,,,U,22224,9552,1,9615.0,11150,,BAO_0000218,Canis lupus familiaris,,CHEMBL620576,A,,Oral bioavailability in dog (female mongrel),Autocuration
,In vivo,,,,0,,,U,22224,3639,1,,11151,,BAO_0000218,,,CHEMBL875846,A,,Percent oral bioavailability of perorally administered compound (30 mg/kg) was tested,Autocuration
,In vivo,,,,0,,,U,22224,13397,1,9615.0,11152,,BAO_0000218,Canis lupus familiaris,,CHEMBL620577,A,,Oral bioavailability in dog,Autocuration
,In vivo,,,,0,,,U,22224,3031,1,,11153,,BAO_0000218,,,CHEMBL620578,A,,Percentage Bioavailability was evaluated.,Autocuration
,In vivo,,,,0,,,U,22224,12818,1,10116.0,11154,,BAO_0000218,Rattus norvegicus,,CHEMBL620579,A,,Bioavailability in rat administered i.d.,Autocuration
,In vivo,,,,0,,,U,22224,4847,1,9347.0,11155,,BAO_0000218,Eutheria,,CHEMBL621248,A,,Bioavailability,Autocuration
,In vivo,,,,0,,,U,22224,12421,1,9615.0,11156,,BAO_0000218,Canis lupus familiaris,,CHEMBL625390,A,,Bioavailability in dog (male Beagle) i.v. administration,Autocuration
,In vivo,,,,0,,,U,22224,11966,1,10116.0,11157,,BAO_0000218,Rattus norvegicus,,CHEMBL625391,A,,"Bioavailability in rat (dose 20 mg/kg p.o. in 1% methocel, and 5 mg/kg i.v. in PEG400)",Autocuration
,In vivo,,,,0,,,U,22224,11218,1,9443.0,11158,,BAO_0000218,Primates,,CHEMBL872266,A,,Bioavailability in monkey (dose 10 mg/kg i.d. or 0.3 mg/kg i.v.),Autocuration
,In vivo,,,,0,,,U,22224,13129,1,10116.0,11159,,BAO_0000218,Rattus norvegicus,,CHEMBL625392,A,,Oral bioavailability in rat (Sprague-Dawley) (male),Autocuration
,In vivo,,,,1,,,N,50597,12350,1,10116.0,11160,,BAO_0000218,Rattus norvegicus,,CHEMBL625393,A,,The oral bioavailability was measured on rats after oral administration,Intermediate
,In vivo,,,,1,,,N,50597,2231,1,10116.0,11161,,BAO_0000218,Rattus norvegicus,,CHEMBL625394,A,,Bioavailability was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,Intermediate
,In vivo,,,,1,,,N,50797,2231,1,9544.0,11162,,BAO_0000218,Macaca mulatta,,CHEMBL625395,A,,Bioavailability was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,Intermediate
,In vivo,,,,0,,,U,22224,12187,1,10116.0,11163,,BAO_0000218,Rattus norvegicus,,CHEMBL625396,A,,Bioavailability in rat (dose 10 mg/kg i.d.),Autocuration
,In vivo,,,,0,,,U,22224,12421,1,9615.0,11164,,BAO_0000218,Canis lupus familiaris,,CHEMBL625397,A,,Bioavailability in dog (male Beagle) i.v. administration,Autocuration
,In vivo,,,,1,,,N,50594,13256,1,10090.0,11165,,BAO_0000218,Mus musculus,,CHEMBL625398,A,,Biodistribution in CD-1 mice was determined after 1 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate
,In vivo,Blood,,,1,,,N,50594,13256,1,10090.0,11166,,BAO_0000218,Mus musculus,178.0,CHEMBL625399,A,,Biodistribution in CD-1 mice was determined after 1 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate
,In vivo,Cerebellum,,,1,,,N,50594,13256,1,10090.0,11167,,BAO_0000218,Mus musculus,2037.0,CHEMBL626074,A,,Biodistribution in CD-1 mice was determined after 1 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate
,In vivo,,,,1,,,N,50594,13256,1,10090.0,11168,,BAO_0000218,Mus musculus,,CHEMBL626075,A,,Biodistribution in CD-1 mice was determined after 1 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate
,In vivo,Plasma,,,1,,,N,50597,2231,1,10116.0,11169,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626076,A,,Maximum concentration in plasma (Cmax) was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,Intermediate
,In vivo,Plasma,,,1,,,N,50797,2231,1,9544.0,11170,,BAO_0000218,Macaca mulatta,1969.0,CHEMBL626077,A,,Maximum concentration in plasma (Cmax) was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,Intermediate
,In vivo,Blood,,,1,,,N,50597,12178,1,10116.0,11171,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL626078,A,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 1 mg/kg in rat (normalized to a 1 mg/kg dose),Intermediate
,In vivo,Blood,,,0,,,U,22224,12178,1,,11172,,BAO_0000218,,178.0,CHEMBL625846,A,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 2.5 mg/kg in rat (normalized to a 1 mg/kg dose),Autocuration
,In vivo,Blood,,,0,,,U,22224,12178,1,,11173,,BAO_0000218,,178.0,CHEMBL625847,A,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 5.0 mg/kg GP (normalized to a 1 mg/kg dose),Autocuration
,In vivo,,,,1,,,N,50597,15633,1,10116.0,11174,,BAO_0000218,Rattus norvegicus,,CHEMBL625848,A,,Maximum concentration observed in rats at an oral dose of 50 mg/kg,Expert
,In vivo,Plasma,,,1,,,N,50597,14258,1,10116.0,11175,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL625849,A,,Maximum concentration of compound in plasma administered orally to rats,Intermediate
,In vivo,Plasma,,,1,,,N,50588,14224,1,9615.0,11176,,BAO_0000218,Canis lupus familiaris,1969.0,CHEMBL626023,A,,"Maximum concentration (10 mg/kg, orally) in plasma of dogs",Intermediate
,In vivo,Plasma,,,1,,,N,50588,14224,1,9615.0,11177,,BAO_0000218,Canis lupus familiaris,1969.0,CHEMBL626024,A,,"Maximum concentration (10 mg/kg, perorally) in plasma of dogs",Intermediate
,In vivo,Plasma,,,1,,,N,50588,14224,1,9615.0,11178,,BAO_0000218,Canis lupus familiaris,1969.0,CHEMBL626025,A,,"Maximum concentration (5 mg/kg, intravenously) in plasma of dogs",Intermediate
,In vivo,,,,0,,,U,22224,5566,1,,11179,,BAO_0000218,,,CHEMBL626026,A,,Maximum concentration after 10 mg/kg by oral administration,Autocuration
,In vivo,,,,0,,,U,22224,16935,1,,11180,,BAO_0000218,,,CHEMBL626027,A,,Maximum concentration at a dose of 1.5 mg/kg,Autocuration
,In vivo,,,,0,,,U,22224,16935,1,,11181,,BAO_0000218,,,CHEMBL626028,A,,Maximum concentration at a dose of 2.0 mg/kg,Autocuration
,In vivo,Plasma,,,1,,,N,50588,14224,1,9615.0,11182,,BAO_0000218,Canis lupus familiaris,1969.0,CHEMBL626029,A,,Maximum concentration in dog plasma,Intermediate
,In vivo,Plasma,,,0,,,U,22224,12536,1,,11183,,BAO_0000218,,1969.0,CHEMBL626030,A,,Maximum concentration in plasma after administration of 10 umol/kg dose perorally,Autocuration
,In vivo,Plasma,,,0,,,U,22224,12536,1,,11184,,BAO_0000218,,1969.0,CHEMBL626031,A,,Maximum concentration in plasma after administration of 2 umol/kg dose intravenously,Autocuration
,In vivo,Plasma,,,0,,,U,22224,12536,1,,11185,,BAO_0000218,,1969.0,CHEMBL626032,A,,Maximum concentration in plasma after administration of 4 umol/kg dose intravenously,Autocuration
,In vivo,Plasma,,,0,,,U,22224,12536,1,,11186,,BAO_0000218,,1969.0,CHEMBL626033,A,,Maximum concentration in plasma after administration of 40 umol/kg dose perorally,Autocuration
,In vivo,Plasma,,,0,,,U,22224,12536,1,,11187,,BAO_0000218,,1969.0,CHEMBL626034,A,,Maximum concentration in plasma after administration of 5 umol/kg dose intravenously,Autocuration
,In vivo,Plasma,,,1,,,N,50588,9994,1,9615.0,11188,,BAO_0000218,Canis lupus familiaris,1969.0,CHEMBL626035,A,,Maximum concentration in plasma after oral administration in dog (25 mg/kg),Intermediate
,In vivo,Plasma,,,0,,,U,22224,1434,1,,11189,,BAO_0000218,,1969.0,CHEMBL626036,A,,Maximum concentration in plasma at Tmax,Autocuration
,In vivo,Plasma,,,1,,,N,50588,12836,1,9615.0,11190,,BAO_0000218,Canis lupus familiaris,1969.0,CHEMBL626037,A,,Maximum concentration in plasma recorded 0-6 hr post dose in dog at 10 mg/kg oral dose,Expert
,In vivo,Plasma,,,1,,,N,100712,12836,1,10026.0,11191,,BAO_0000218,Cricetinae,1969.0,CHEMBL626038,A,,Maximum concentration in plasma recorded in the period 0-6 hr post dose in hamster at 10 mg/kg oral dose,Intermediate
,In vivo,Plasma,,,1,,,N,50597,12836,1,10116.0,11192,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626039,A,,Maximum concentration in plasma recorded in the period 0-6 hr post dose in rat at 10 mg/kg oral dose,Intermediate
,In vivo,Plasma,,,1,,,N,50597,12545,1,10116.0,11193,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626040,A,,Maximum concentration in plasma was determined by oral administration to rats at 20 mg/kg,Intermediate
,In vivo,Plasma,,,1,,,N,50592,13856,1,9986.0,11194,,BAO_0000218,Oryctolagus cuniculus,1969.0,CHEMBL626041,A,,Maximum concentration present in the rabbit plasma following peroral administration of 10 mg/kg,Intermediate
,In vivo,,,,0,,,U,22224,3550,1,,11195,,BAO_0000218,,,CHEMBL626042,A,,Maximum concentration was calculated,Autocuration
,In vivo,,,,0,,,U,22224,2632,1,,11196,,BAO_0000218,,,CHEMBL626043,A,,Maximum concentration was calculated.,Autocuration
,In vivo,,,,0,,,U,22224,5566,1,,11197,,BAO_0000218,,,CHEMBL626044,A,,Maximum concentration at a peroral dose of 10 mg/kg,Autocuration
,In vivo,,,,0,,,U,22224,11883,1,,11198,,BAO_0000218,,,CHEMBL626045,A,,Maximum concentration of the drug at 10 uM/dg administered perorally,Autocuration
,In vivo,,,,0,,,U,22224,11883,1,,11199,,BAO_0000218,,,CHEMBL626046,A,,Maximum concentration of the drug at 2 uM/dg administered intravenously,Autocuration
,In vivo,Plasma,,,1,,,N,50588,14122,1,9615.0,11200,,BAO_0000218,Canis lupus familiaris,1969.0,CHEMBL626047,A,,"Maximum concentration of the unchanged compound in dog plasma, recorded in the period 0-6 hr post dose.",Intermediate
,In vivo,Plasma,,,1,,,N,100712,14122,1,10026.0,11201,,BAO_0000218,Cricetinae,1969.0,CHEMBL626048,A,,"Maximum concentration of the unchanged compound in hamster plasma, recorded in the period 0-6 hr post dose.",Intermediate
,In vivo,Plasma,,,1,,,N,50597,14122,1,10116.0,11202,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626049,A,,"Maximum concentration of the unchanged compound in rat plasma, recorded in the period 0-6 hr post dose.",Intermediate
,In vivo,Plasma,,,1,,,N,50597,12542,1,10116.0,11203,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626050,A,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 60 mg/kg oral dose,Intermediate
,In vivo,Plasma,,,1,,,N,50588,12542,1,9615.0,11204,,BAO_0000218,Canis lupus familiaris,1969.0,CHEMBL874541,A,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in dog at 5 mg/kg oral dose,Intermediate
,In vivo,Plasma,,,1,,,N,100712,12542,1,10026.0,11205,,BAO_0000218,Cricetinae,1969.0,CHEMBL622826,A,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in hamster at 40 mg/kg oral dose,Intermediate
,In vivo,Plasma,,,1,,,N,100712,12542,1,10026.0,11206,,BAO_0000218,Cricetinae,1969.0,CHEMBL622827,A,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose to hamster at 40 mg/kg oral dose,Intermediate
,In vivo,Plasma,,,1,,,N,50597,12542,1,10116.0,11207,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622828,A,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 25 mg/kg oral dose,Intermediate
,In vivo,Plasma,,,1,,,N,50597,14080,1,10116.0,11208,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622829,A,,Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing,Intermediate
,In vivo,,,,1,,,N,50597,11911,1,10116.0,11209,,BAO_0000218,Rattus norvegicus,,CHEMBL876806,A,,Maximum concentration reached following intravenous administration in male rat,Intermediate
,In vivo,,,,1,,,N,50588,13204,1,9615.0,11210,,BAO_0000218,Canis lupus familiaris,,CHEMBL622830,A,,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 10 mg/kg dosage administered perorally in dog,Intermediate
,In vivo,,,,1,,,N,50597,13204,1,10116.0,11211,,BAO_0000218,Rattus norvegicus,,CHEMBL622831,A,,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 5 mg/kg dosage administered perorally in rats,Intermediate
,In vivo,,,,1,,,N,50588,14346,1,9615.0,11212,,BAO_0000218,Canis lupus familiaris,,CHEMBL626794,A,,Maximum concentration was measured after peroral administration of 10 mg/kg of drug in male Beagle dogs,Intermediate
,In vivo,,,,1,,,N,50597,14346,1,10116.0,11213,,BAO_0000218,Rattus norvegicus,,CHEMBL626795,A,,Maximum concentration was measured after peroral administration of 5.0 mg/kg of drug in male Dawley rats,Intermediate
,In vivo,,,,1,,,N,50597,14346,1,10116.0,11214,,BAO_0000218,Rattus norvegicus,,CHEMBL626796,A,,Maximum concentration was measured after peroral administration of 5.1 mg/kg of drug in male Dawley rats,Intermediate
,In vivo,,,,1,,,N,50597,14346,1,10116.0,11215,,BAO_0000218,Rattus norvegicus,,CHEMBL626797,A,,Maximum concentration was measured after peroral administration of 5.2 mg/kg of drug in male Dawley rats,Intermediate
,In vivo,,,,1,,,N,50597,14127,1,10116.0,11216,,BAO_0000218,Rattus norvegicus,,CHEMBL626798,A,,Maximum drug concentration is determined after oral dosing in rats.,Intermediate
,In vivo,,,,1,,,N,50588,14339,1,9615.0,11217,,BAO_0000218,Canis lupus familiaris,,CHEMBL626799,A,,Maximum observed concentration in oral (5 mg/kg) fasted dogs,Intermediate
,In vivo,,,,1,,,N,50588,14339,1,9615.0,11218,,BAO_0000218,Canis lupus familiaris,,CHEMBL626800,A,,Maximum observed concentration in oral (5 mg/kg) fed dogs,Intermediate
,In vivo,Plasma,,,0,,,U,22224,13494,1,,11219,,BAO_0000218,,1969.0,CHEMBL626801,A,,Maximum plasma concentration,Autocuration
,In vivo,Plasma,,,1,,,N,50597,14925,1,10116.0,11220,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL876816,A,,Maximum plasma concentration (Cmax) was determined in rats after intraduodenal administration of the drug,Intermediate
,In vivo,Plasma,,,1,,,N,50597,14474,1,10116.0,11221,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626802,A,,Maximum plasma concentration following oral administration of 26.3 mg/kg in rats,Intermediate
,In vivo,Plasma,,,1,,,N,50588,14474,1,9615.0,11222,,BAO_0000218,Canis lupus familiaris,1969.0,CHEMBL626803,A,,Maximum plasma concentration following oral administration of 3.8 mg/kg in Beagle dog,Intermediate
,In vivo,Plasma,,,0,,,U,22224,13917,1,,11223,,BAO_0000218,,1969.0,CHEMBL626804,A,,Maximum plasma concentration following oral administration of 30 umol/kg,Autocuration
,,Plasma,,,1,,,N,50597,9796,1,10116.0,11224,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626805,A,,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose,Intermediate
,,Plasma,,,1,,,N,50597,9796,1,10116.0,11225,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626309,A,,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,Intermediate
,,Plasma,,,1,,,N,50597,9796,1,10116.0,11226,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626310,A,,Distribution of radiolabeled compound in plasma of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,Intermediate
,,Plasma,,,1,,,N,50597,9796,1,10116.0,11227,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626311,A,,Distribution of radiolabeled compound in plasma of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate
,,Plasma,,,1,,,N,50597,9796,1,10116.0,11228,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626312,A,,Distribution of radiolabeled compound in plasma of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate
,,Uterus,,,1,,,N,50597,9796,1,10116.0,11229,,BAO_0000218,Rattus norvegicus,995.0,CHEMBL626313,A,,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate
,,Uterus,,,1,,,N,50597,9796,1,10116.0,11230,,BAO_0000218,Rattus norvegicus,995.0,CHEMBL626314,A,,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,Intermediate
,,Uterus,,,1,,,N,50597,9796,1,10116.0,11231,,BAO_0000218,Rattus norvegicus,995.0,CHEMBL626315,A,,Distribution of radiolabeled compound in uterus of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,Intermediate
,,Uterus,,,1,,,N,50597,9796,1,10116.0,11232,,BAO_0000218,Rattus norvegicus,995.0,CHEMBL626316,A,,Distribution of radiolabeled compound in uterus of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate
,,Uterus,,,1,,,N,50597,9796,1,10116.0,11233,,BAO_0000218,Rattus norvegicus,995.0,CHEMBL626317,A,,Distribution of radiolabeled compound in uterus of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate
,,,,,1,,,N,50597,8363,1,10116.0,11234,,BAO_0000218,Rattus norvegicus,,CHEMBL626318,A,,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Minus (-),Intermediate
,,,,,1,,,N,50597,8363,1,10116.0,11235,,BAO_0000218,Rattus norvegicus,,CHEMBL626319,A,,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Plus (+),Intermediate
,,,,,1,,,N,50597,8363,1,10116.0,11236,,BAO_0000218,Rattus norvegicus,,CHEMBL626320,A,,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Minus (-),Intermediate
,,,,,1,,,N,50597,8363,1,10116.0,11237,,BAO_0000218,Rattus norvegicus,,CHEMBL875053,A,,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Plus (+),Intermediate
,,,,,1,,,N,50597,8363,1,10116.0,11238,,BAO_0000218,Rattus norvegicus,,CHEMBL626321,A,,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Minus (-),Intermediate
,,,,,1,,,N,50597,8363,1,10116.0,11239,,BAO_0000218,Rattus norvegicus,,CHEMBL626322,A,,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Plus (+),Intermediate
,,,,,1,,,N,50597,8363,1,10116.0,11240,,BAO_0000218,Rattus norvegicus,,CHEMBL626323,A,,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Minus (-),Intermediate
,,,,,1,,,N,50597,8363,1,10116.0,11241,,BAO_0000218,Rattus norvegicus,,CHEMBL626324,A,,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Plus (+),Intermediate
,,,,,1,,,N,50597,8363,1,10116.0,11242,,BAO_0000218,Rattus norvegicus,,CHEMBL626325,A,,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Minus (-),Intermediate
,,,,,1,,,N,50597,8363,1,10116.0,11243,,BAO_0000218,Rattus norvegicus,,CHEMBL626326,A,,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Plus (+),Intermediate
,,,,,1,,,N,50597,8363,1,10116.0,11244,,BAO_0000218,Rattus norvegicus,,CHEMBL626327,A,,Distribution of rat erythrocytes for tube 7 on rate of aging in 2 mL of cell suspension; Plus (+),Intermediate
,,,,,1,,,N,50597,8363,1,10116.0,11245,,BAO_0000218,Rattus norvegicus,,CHEMBL626328,A,,Distribution of rat erythrocytes for tube 1 on rate of aging in 2 mL of cell suspension; Minus (-),Intermediate
,,Blood,,,1,,,N,50597,8684,1,10116.0,11246,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL626329,A,,"Distribution in blood of rat 5 min after intravenous administration, injected dose/gm",Intermediate
,,Blood,,,1,,,N,50597,8684,1,10116.0,11247,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL626330,A,,"Distribution in blood of rat, 15 min after intravenous administration, injected dose/gm",Intermediate
,,Blood,,,1,,,N,50597,8684,1,10116.0,11248,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL626331,A,,"Distribution in blood of rat, 1 hr after intravenous administration, injected dose/gm",Intermediate
,,Blood,,,1,,,N,50597,8684,1,10116.0,11249,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL626332,A,,"Distribution in blood of rat, 2 hr after intravenous administration, injected dose/gm",Intermediate
,,Blood,,,1,,,N,50597,8684,1,10116.0,11250,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL626333,A,,"Distribution in blood of rat, 30 min after intravenous administration, injected dose/gm",Intermediate
,,Blood,,,1,,,N,50597,8684,1,10116.0,11251,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL626334,A,,"Distribution in blood of rat, 4 hr after intravenous administration, injected dose/gm",Intermediate
,,Blood,,,1,,,N,50597,8684,1,10116.0,11252,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL626335,A,,"Distribution in blood of rat, 6 hr after intravenous administration, injected dose/gm",Intermediate
,,Blood,,,1,,,N,50597,8684,1,10116.0,11253,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL624798,A,,"Distribution in blood of rat, 8 hr after intravenous administration, injected dose/gm",Intermediate
,,Brain,,,1,,,N,50597,8684,1,10116.0,11254,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL624799,A,,"Distribution in brain of rat, 15 min after intravenous administered, injected dose/gm",Intermediate
,,Brain,,,1,,,N,50597,8684,1,10116.0,11255,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL624800,A,,"Distribution in brain of rat, 1 hr after intravenous administered, injected dose/gm",Intermediate
,,Brain,,,1,,,N,50597,8684,1,10116.0,11256,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL624801,A,,"Distribution in brain of rat, 2 hr after intravenous administered, injected dose/gm",Intermediate
,,Brain,,,1,,,N,50597,8684,1,10116.0,11257,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL624802,A,,"Distribution in brain of rat, 30 min after intravenous administered, injected dose/gm",Intermediate
,,Brain,,,1,,,N,50597,8684,1,10116.0,11258,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL624803,A,,"Distribution in brain of rat, 4 hr after intravenous administered, injected dose/gm",Intermediate
,,Brain,,,1,,,N,50597,8684,1,10116.0,11259,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL624804,A,,"Distribution in brain of rat, 5 min after intravenous administered, injected dose/gm",Intermediate
,,Brain,,,1,,,N,50597,8684,1,10116.0,11260,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL624805,A,,"Distribution in brain of rat, 6 hr after intravenous administered, injected dose/gm",Intermediate
,,Brain,,,1,,,N,50597,8684,1,10116.0,11261,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL624806,A,,"Distribution in brain of rat, 8 hr after intravenous administered, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11262,,BAO_0000218,Rattus norvegicus,,CHEMBL624807,A,,"Distribution in rat fat 15 min after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11263,,BAO_0000218,Rattus norvegicus,,CHEMBL624808,A,,"Distribution in rat fat 1 hr after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11264,,BAO_0000218,Rattus norvegicus,,CHEMBL624809,A,,"Distribution in rat fat 2 hr after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11265,,BAO_0000218,Rattus norvegicus,,CHEMBL624810,A,,"Distribution in rat fat 30 min after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11266,,BAO_0000218,Rattus norvegicus,,CHEMBL877618,A,,"Distribution in rat fat 4 hr after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11267,,BAO_0000218,Rattus norvegicus,,CHEMBL624811,A,,"Distribution in rat fat 5 min after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11268,,BAO_0000218,Rattus norvegicus,,CHEMBL624812,A,,"Distribution in rat fat 6 hr after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11269,,BAO_0000218,Rattus norvegicus,,CHEMBL624813,A,,"Distribution in rat fat 8 hr after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11270,,BAO_0000218,Rattus norvegicus,,CHEMBL624814,A,,"Distribution in rat heart 15 min after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11271,,BAO_0000218,Rattus norvegicus,,CHEMBL624815,A,,"Distribution in rat heart 1 hr after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11272,,BAO_0000218,Rattus norvegicus,,CHEMBL624816,A,,"Distribution in rat heart 2 hr after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11273,,BAO_0000218,Rattus norvegicus,,CHEMBL624817,A,,"Distribution in rat heart 30 min after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,11274,,BAO_0000218,Canis lupus familiaris,,CHEMBL624818,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,11275,,BAO_0000218,Canis lupus familiaris,,CHEMBL624819,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration,Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,11276,,BAO_0000218,Canis lupus familiaris,,CHEMBL624820,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,11277,,BAO_0000218,Canis lupus familiaris,,CHEMBL624821,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,11278,,BAO_0000218,Canis lupus familiaris,,CHEMBL624822,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,11279,,BAO_0000218,Canis lupus familiaris,,CHEMBL624823,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),Intermediate
,,,,,1,,,N,50212,15599,1,562.0,11280,,BAO_0000218,Escherichia coli,,CHEMBL624824,A,,Observed diffusion coefficient in organic solvent for Escherichia coli,Intermediate
,,Blood,,,1,,,N,50597,9614,1,10116.0,11281,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL624825,A,,"Concentration of compound in blood of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Intermediate
,,Blood,,,1,,,N,50597,9614,1,10116.0,11282,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL624826,A,,"Concentration of compound in blood of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Intermediate
,,Cardiac atrium,,,1,,,N,50597,9614,1,10116.0,11283,,BAO_0000218,Rattus norvegicus,2081.0,CHEMBL876817,A,,"Concentration of compound in left atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Intermediate
,,Cardiac atrium,,,1,,,N,50597,9614,1,10116.0,11284,,BAO_0000218,Rattus norvegicus,2081.0,CHEMBL624827,A,,"Concentration of compound in left atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Intermediate
,,,,,1,,,N,50597,9614,1,10116.0,11285,,BAO_0000218,Rattus norvegicus,,CHEMBL624828,A,,"Concentration of compound in left ventricle of of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Intermediate
,,,,,1,,,N,50597,9614,1,10116.0,11286,,BAO_0000218,Rattus norvegicus,,CHEMBL624829,A,,"Concentration of compound in left ventricle of of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Intermediate
,,Liver,,,1,,,N,50597,9614,1,10116.0,11287,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL624830,A,,"Concentration of compound in liver of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Intermediate
,,Liver,,,1,,,N,50597,9614,1,10116.0,11288,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL624831,A,,"Concentration of compound in liver of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Intermediate
,,Cardiac atrium,,,1,,,N,50597,9614,1,10116.0,11289,,BAO_0000218,Rattus norvegicus,2081.0,CHEMBL624832,A,,"Concentration of compound in right atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Intermediate
,,Cardiac atrium,,,1,,,N,50597,9614,1,10116.0,11290,,BAO_0000218,Rattus norvegicus,2081.0,CHEMBL624833,A,,"Concentration of compound in right atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Intermediate
,,,,,1,,,N,50597,9614,1,10116.0,11291,,BAO_0000218,Rattus norvegicus,,CHEMBL624834,A,,"Concentration of compound in right ventricle of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Intermediate
,,,,,1,,,N,50597,9614,1,10116.0,11292,,BAO_0000218,Rattus norvegicus,,CHEMBL624835,A,,"Concentration of compound in right ventricle of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Intermediate
,,Spleen,,,1,,,N,50597,9614,1,10116.0,11293,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL624836,A,,"Concentration of compound in spleen of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Intermediate
,,Spleen,,,1,,,N,50597,9614,1,10116.0,11294,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL624837,A,,"Concentration of compound in spleen of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Intermediate
,,Blood,,,1,,,N,50597,9071,1,10116.0,11295,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL624838,A,,Distribution of radioactivity of radiolabeled compound in blood of female rats 30 minutes after intravenous administration,Intermediate
,,Blood,,,1,,,N,50597,9071,1,10116.0,11296,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL622188,A,,Distribution of radioactivity of radiolabeled compound in blood of female rats 5 minutes after intravenous administration,Intermediate
,,Heart,,,1,,,N,50597,9071,1,10116.0,11297,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL622189,A,,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration,Intermediate
,,Heart,,,1,,,N,50597,9071,1,10116.0,11298,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL622190,A,,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration at,Intermediate
,,Heart,,,1,,,N,50597,9071,1,10116.0,11299,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL625170,A,,Distribution of radioactivity of radiolabeled compound in heart of female rats 5 minutes after intravenous administration,Intermediate
,,Kidney,,,1,,,N,50597,9071,1,10116.0,11300,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL625171,A,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,Intermediate
,,Kidney,,,1,,,N,50597,9071,1,10116.0,11301,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL625172,A,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,Intermediate
,,Kidney,,,1,,,N,50597,9071,1,10116.0,11302,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL625173,A,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 5 minutes after intravenous administration,Intermediate
,,Liver,,,1,,,N,50597,9071,1,10116.0,11303,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL625174,A,,Distribution of radioactivity of radiolabeled compound in liver of female rats 30 minutes after intravenous administration,Intermediate
,,Liver,,,1,,,N,50597,9071,1,10116.0,11304,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL625175,A,,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration,Intermediate
,,Liver,,,1,,,N,50597,9071,1,10116.0,11305,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL625176,A,,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration at,Intermediate
,,Lung,,,1,,,N,50597,9071,1,10116.0,11306,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL625177,A,,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,Intermediate
,,Lung,,,1,,,N,50597,9071,1,10116.0,11307,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL625178,A,,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration,Intermediate
,,Lung,,,1,,,N,50597,9071,1,10116.0,11308,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL625179,A,,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration at,Intermediate
,,Lung,,,1,,,N,50597,9071,1,10116.0,11309,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL625180,A,,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,Intermediate
,,,,,0,,,U,22224,10677,1,,11310,,BAO_0000218,,,CHEMBL625181,A,,"Original dose appeared in the bile as unchanged compound, which was eliminated at a fairly constant rate over the first 4 hr following the iv administration",Autocuration
,,Urine,,,1,,,N,50594,9750,1,10090.0,11311,,BAO_0000218,Mus musculus,1088.0,CHEMBL625182,A,,Percentage of dose recovered after 0-6 hr in the urine of mice was measured.,Intermediate
,,,,,1,,,N,50597,8319,1,10116.0,11312,,BAO_0000218,Rattus norvegicus,,CHEMBL625183,A,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,Intermediate
,,,,,1,,,N,50597,8319,1,10116.0,11313,,BAO_0000218,Rattus norvegicus,,CHEMBL875848,A,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,Intermediate
,,,,,1,,,N,50597,8319,1,10116.0,11314,,BAO_0000218,Rattus norvegicus,,CHEMBL622260,A,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,Intermediate
,,,,,1,,,N,50597,8319,1,10116.0,11315,,BAO_0000218,Rattus norvegicus,,CHEMBL622261,A,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,Intermediate
,,,,,1,,,N,50597,8319,1,10116.0,11316,,BAO_0000218,Rattus norvegicus,,CHEMBL622262,A,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,Intermediate
,,Kidney,,,1,,,N,50597,8319,1,10116.0,11317,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL622263,A,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,Intermediate
,,Kidney,,,1,,,N,50597,8319,1,10116.0,11318,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL622418,A,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,Intermediate
,,Liver,,,1,,,N,50597,8319,1,10116.0,11319,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL622419,A,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,Intermediate
,In vivo,,,,1,,,N,50594,13256,1,10090.0,11320,,BAO_0000218,Mus musculus,,CHEMBL623388,A,,Biodistribution in CD-1 mice was determined after 1 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate
,In vivo,Liver,,,1,,,N,50594,13256,1,10090.0,11321,,BAO_0000218,Mus musculus,2107.0,CHEMBL623389,A,,Biodistribution in CD-1 mice was determined after 1 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate
,In vivo,,,,1,,,N,50594,13256,1,10090.0,11322,,BAO_0000218,Mus musculus,,CHEMBL623390,A,,Biodistribution in CD-1 mice was determined after 1 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate
,In vivo,,,,1,,,N,50594,13256,1,10090.0,11323,,BAO_0000218,Mus musculus,,CHEMBL623391,A,,Biodistribution in CD-1 mice was determined after 120 minutes in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate
,In vivo,Blood,,,1,,,N,50594,13256,1,10090.0,11324,,BAO_0000218,Mus musculus,178.0,CHEMBL623392,A,,Biodistribution in CD-1 mice was determined after 120 minutes in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate
,In vivo,Cerebellum,,,1,,,N,50594,13256,1,10090.0,11325,,BAO_0000218,Mus musculus,2037.0,CHEMBL623393,A,,Biodistribution in CD-1 mice was determined after 120 minutes in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate
,In vivo,,,,1,,,N,50594,13256,1,10090.0,11326,,BAO_0000218,Mus musculus,,CHEMBL623394,A,,Biodistribution in CD-1 mice was determined after 120 minutes in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate
,In vivo,,,,1,,,N,50594,13256,1,10090.0,11327,,BAO_0000218,Mus musculus,,CHEMBL618885,A,,Biodistribution in CD-1 mice was determined after 120 minutes in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate
,In vivo,Liver,,,1,,,N,50594,13256,1,10090.0,11328,,BAO_0000218,Mus musculus,2107.0,CHEMBL618886,A,,Biodistribution in CD-1 mice was determined after 120 minutes in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate
,In vivo,,,,1,,,N,50594,13256,1,10090.0,11329,,BAO_0000218,Mus musculus,,CHEMBL618887,A,,Biodistribution in CD-1 mice was determined after 120 minutes in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate
,In vivo,,,,1,,,N,50594,13256,1,10090.0,11330,,BAO_0000218,Mus musculus,,CHEMBL619535,A,,Biodistribution in CD-1 mice was determined after 30 minutes in Striatum (expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate
,In vivo,Blood,,,1,,,N,50594,13256,1,10090.0,11331,,BAO_0000218,Mus musculus,178.0,CHEMBL619536,A,,Biodistribution in CD-1 mice was determined after 30 minutes in blood (expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate
,In vivo,Cerebellum,,,1,,,N,50594,13256,1,10090.0,11332,,BAO_0000218,Mus musculus,2037.0,CHEMBL619537,A,,Biodistribution in CD-1 mice was determined after 30 minutes in cerebellum (expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate
,In vivo,,,,1,,,N,50594,13256,1,10090.0,11333,,BAO_0000218,Mus musculus,,CHEMBL619705,A,,Biodistribution in CD-1 mice was determined after 30 minutes in cortex (expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate
,In vivo,,,,1,,,N,50594,13256,1,10090.0,11334,,BAO_0000218,Mus musculus,,CHEMBL619706,A,,Biodistribution in CD-1 mice was determined after 30 minutes in femur (expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate
,In vivo,Liver,,,1,,,N,50594,13256,1,10090.0,11335,,BAO_0000218,Mus musculus,2107.0,CHEMBL619707,A,,Biodistribution in CD-1 mice was determined after 30 minutes in liver (expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate
,In vivo,,,,1,,,N,50594,13256,1,10090.0,11336,,BAO_0000218,Mus musculus,,CHEMBL619708,A,,Biodistribution in CD-1 mice was determined after 30 minutes in lung (expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate
,In vivo,,,,1,,,N,50594,13256,1,10090.0,11337,,BAO_0000218,Mus musculus,,CHEMBL625219,A,,Biodistribution in CD-1 mice was determined after 5 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate
,In vivo,Blood,,,1,,,N,50594,13256,1,10090.0,11338,,BAO_0000218,Mus musculus,178.0,CHEMBL625220,A,,Biodistribution in CD-1 mice was determined after 5 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate
,In vivo,Cerebellum,,,1,,,N,50594,13256,1,10090.0,11339,,BAO_0000218,Mus musculus,2037.0,CHEMBL625221,A,,Biodistribution in CD-1 mice was determined after 5 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate
,In vivo,,,,1,,,N,50594,13256,1,10090.0,11340,,BAO_0000218,Mus musculus,,CHEMBL625222,A,,Biodistribution in CD-1 mice was determined after 5 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate
,In vivo,,,,1,,,N,50594,13256,1,10090.0,11341,,BAO_0000218,Mus musculus,,CHEMBL625223,A,,Biodistribution in CD-1 mice was determined after 5 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate
,In vivo,Liver,,,1,,,N,50594,13256,1,10090.0,11342,,BAO_0000218,Mus musculus,2107.0,CHEMBL625224,A,,Biodistribution in CD-1 mice was determined after 5 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate
,In vivo,,,,1,,,N,50594,13256,1,10090.0,11343,,BAO_0000218,Mus musculus,,CHEMBL625225,A,,Biodistribution in CD-1 mice was determined after 5 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate
,In vivo,Blood,,,1,,,N,50597,8829,1,10116.0,11344,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL625226,A,,Biodistribution in Rat blood after 24 hours of iv administration,Intermediate
,In vivo,Blood,,,1,,,N,50597,8829,1,10116.0,11345,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL625227,A,,Biodistribution in Rat blood after 24 hours of iv administration; per g of tissue,Intermediate
,In vivo,Blood,,,1,,,N,50597,8829,1,10116.0,11346,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL625228,A,,Biodistribution in Rat blood after 30 minutes of iv administration,Intermediate
,In vivo,Blood,,,1,,,N,50597,8829,1,10116.0,11347,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL875354,A,,Biodistribution in Rat blood after 30 minutes of iv administration; per g of tissue,Intermediate
,In vivo,Blood,,,1,,,N,50597,8829,1,10116.0,11348,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL625229,A,,Biodistribution in Rat blood after 5 minutes of iv administration,Intermediate
,In vivo,Blood,,,1,,,N,50597,8829,1,10116.0,11349,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL625230,A,,Biodistribution in Rat blood after 5 minutes of iv administration; per g of tissue,Intermediate
,In vivo,Heart,,,1,,,N,50597,8829,1,10116.0,11350,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL625231,A,,Biodistribution in Rat heart after 24 hours of iv administration,Intermediate
,In vivo,Heart,,,1,,,N,50597,8829,1,10116.0,11351,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL625900,A,,Biodistribution in Rat heart after 24 hours of iv administration; per g of tissue,Intermediate
,In vivo,Heart,,,1,,,N,50597,8829,1,10116.0,11352,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL625901,A,,Biodistribution in Rat heart after 30 minutes of iv administration,Intermediate
,In vivo,Heart,,,1,,,N,50597,8829,1,10116.0,11353,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL625902,A,,Biodistribution in Rat heart after 30 minutes of iv administration; per g of tissue,Intermediate
,In vivo,Heart,,,1,,,N,50597,8829,1,10116.0,11354,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL625903,A,,Biodistribution in Rat heart after 5 minutes of iv administration,Intermediate
,In vivo,Heart,,,1,,,N,50597,8829,1,10116.0,11355,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL625904,A,,Biodistribution in Rat heart after 5 minutes of iv administration; per g of tissue,Intermediate
,In vivo,Liver,,,1,,,N,50597,8829,1,10116.0,11356,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL625905,A,,Biodistribution in Rat liver after 24 hours of iv administration,Intermediate
,In vivo,Liver,,,1,,,N,50597,8829,1,10116.0,11357,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL627861,A,,Biodistribution in Rat liver after 24 hours of iv administration; per g of tissue,Intermediate
,In vivo,Liver,,,1,,,N,50597,8829,1,10116.0,11358,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL627862,A,,Biodistribution in Rat liver after 30 minutes of iv administration,Intermediate
,In vivo,Liver,,,1,,,N,50597,8829,1,10116.0,11359,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL627863,A,,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,Intermediate
,In vivo,Liver,,,1,,,N,50597,8829,1,10116.0,11360,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL627769,A,,Biodistribution in Rat liver after 30 minutes of iv administration,Intermediate
,In vivo,Plasma,,,1,,,N,50588,13249,1,9615.0,11361,,BAO_0000218,Canis lupus familiaris,1969.0,CHEMBL627770,A,,Maximum plasma concentration in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,Intermediate
,In vivo,,,,1,,,N,100710,13622,1,9541.0,11362,,BAO_0000218,Macaca fascicularis,,CHEMBL627771,A,,Cmax in cynomolgus monkey (PO dose),Intermediate
,In vivo,,,,1,,,N,50597,13622,1,10116.0,11363,,BAO_0000218,Rattus norvegicus,,CHEMBL627772,A,,Cmax in rat (PO dose),Intermediate
,In vivo,,,,1,,,N,50597,13622,1,10116.0,11364,,BAO_0000218,Rattus norvegicus,,CHEMBL627773,A,,Cmax in rat (PO dose),Intermediate
,In vivo,Plasma,,,1,,,N,50597,13494,1,10116.0,11365,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL621922,A,,Maximum plasma concentration in rats after an oral dose of 5 mg/kg,Intermediate
,In vivo,Plasma,,,1,,,N,50597,12170,1,10116.0,11366,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL621923,A,,Cmax in rat plasma after oral dose (10 mg/kg),Intermediate
,In vivo,Plasma,,,0,,,U,22224,12170,1,,11367,,BAO_0000218,,1969.0,CHEMBL621924,A,,Cmax in plasma after oral dose (10 mg/kg),Autocuration
,In vivo,Plasma,,,1,,,N,50588,17025,1,9615.0,11368,,BAO_0000218,Canis lupus familiaris,1969.0,CHEMBL621925,A,,Maximum plasma concentration of compound was determined in dog at 25 mg/kg orally,Intermediate
,In vivo,Plasma,,,0,,,U,22224,17025,1,314293.0,11369,,BAO_0000218,Simiiformes,1969.0,CHEMBL621926,A,,Maximum plasma concentration of compound was determined in monkey at 25 mg/kg orally,Autocuration
,In vivo,Plasma,,,1,,,N,50592,17025,1,9986.0,11370,,BAO_0000218,Oryctolagus cuniculus,1969.0,CHEMBL621927,A,,Maximum plasma concentration of compound was determined in rabbit at 25 mg/kg orally,Intermediate
,In vivo,Plasma,,,1,,,N,50597,17025,1,10116.0,11371,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL621928,A,,Maximum plasma concentration of compound was determined in rat at 25 mg/kg orally,Intermediate
,In vivo,Plasma,,,1,,,N,50597,14187,1,10116.0,11372,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL621929,A,,Maximum plasma concentration after p.o. (10 mpk) administration in rats.,Intermediate
,In vivo,Plasma,,,1,,,N,50594,14816,1,10090.0,11373,,BAO_0000218,Mus musculus,1969.0,CHEMBL621930,A,,Maximum plasma concentration (Cmax) after p.o. administration of 200 mg/kg in mice,Intermediate
,In vivo,Plasma,,,1,,,N,50597,17820,1,10116.0,11374,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL621931,A,,Maximum plasma concentration after oral dosing in rat,Intermediate
,In vivo,Plasma,,,0,,,U,22224,14380,1,,11375,,BAO_0000218,,1969.0,CHEMBL621932,A,,Maximum plasma concentration evaluated in 100% PEG solution at a dose of 20 mg/kg orally,Autocuration
,In vivo,Plasma,,,0,,,U,22224,14380,1,,11376,,BAO_0000218,,1969.0,CHEMBL621933,A,,Maximum plasma concentration evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,Autocuration
,In vivo,Plasma,,,1,,,N,50588,14691,1,9615.0,11377,,BAO_0000218,Canis lupus familiaris,1969.0,CHEMBL621934,A,,Maximum plasma concentration in dogs at 0.5 mg/kg dose upon oral administration,Intermediate
,In vivo,Plasma,,,1,,,N,50588,14691,1,9615.0,11378,,BAO_0000218,Canis lupus familiaris,1969.0,CHEMBL621935,A,,Maximum plasma concentration in dogs at 1 mg/kg dose upon oral administration,Intermediate
,In vivo,Plasma,,,1,,,N,50597,13375,1,10116.0,11379,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL621936,A,,Maximum plasma concentration in rat upon oral administration of 40 mg/kg,Intermediate
,In vivo,Plasma,,,0,,,U,22224,6236,1,,11380,,BAO_0000218,,1969.0,CHEMBL621937,A,,Maximum plasma concentration was determined,Autocuration
,In vivo,Plasma,,,0,,,U,22224,14380,1,,11381,,BAO_0000218,,1969.0,CHEMBL621938,A,,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,Autocuration
,In vivo,Plasma,,,0,,,U,22224,14380,1,,11382,,BAO_0000218,,1969.0,CHEMBL621939,A,,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,Autocuration
,In vivo,Plasma,,,0,,,U,22224,14380,1,,11383,,BAO_0000218,,1969.0,CHEMBL621940,A,,Maximum plasma concentration was evaluated in 10% of PEG suspension at a dose of 20 mg/kg orally,Autocuration
,In vivo,Plasma,,,0,,,U,22224,14380,1,,11384,,BAO_0000218,,1969.0,CHEMBL621941,A,,Maximum plasma concentration was evaluated in 100% of PEG solution at a dose of 20 mg/kg orally,Autocuration
,In vivo,Plasma,,,0,,,U,22224,14380,1,,11385,,BAO_0000218,,1969.0,CHEMBL621942,A,,Maximum plasma concentration was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,Autocuration
,In vivo,Plasma,,,0,,,U,22224,14380,1,,11386,,BAO_0000218,,1969.0,CHEMBL626178,A,,Maximum plasma concentration was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,Autocuration
,In vivo,Plasma,,,0,,,U,22224,14380,1,,11387,,BAO_0000218,,1969.0,CHEMBL626179,A,,Maximum plasma concentration was evaluated in Hp-beta-CD solution at a dose of 20 mg/kg orally,Autocuration
,In vivo,Plasma,,,0,,,U,22224,14380,1,,11388,,BAO_0000218,,1969.0,CHEMBL626180,A,,Maximum plasma concentration was evaluated in saline solution at a dose of 20 mg/kg orally,Autocuration
,In vivo,Plasma,,,1,,,N,50597,13622,1,10116.0,11389,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626181,A,,Plasma Cmax in rat (PO dose),Intermediate
,In vivo,,,,1,,,N,50597,15372,1,10116.0,11390,,BAO_0000218,Rattus norvegicus,,CHEMBL626182,A,,Maximum serum concentration after po dose of 5.22 mg/kg in rats,Intermediate
,In vivo,,,,1,,,N,50597,15372,1,10116.0,11391,,BAO_0000218,Rattus norvegicus,,CHEMBL626183,A,,Maximum serum concentration after po dose of 5.46 mg/kg in rats,Intermediate
,In vivo,,,,1,,,N,50597,15372,1,10116.0,11392,,BAO_0000218,Rattus norvegicus,,CHEMBL626184,A,,Maximum serum concentration was determined for the compound after po dose of 5.01 mg/kg in rats,Intermediate
,In vivo,,,,1,,,N,50597,15372,1,10116.0,11393,,BAO_0000218,Rattus norvegicus,,CHEMBL626185,A,,Maximum serum concentration was determined for the compound after po dose of 5.03 mg/kg in rats,Intermediate
,In vivo,Plasma,,,1,,,N,50588,14925,1,9615.0,11394,,BAO_0000218,Canis lupus familiaris,1969.0,CHEMBL626186,A,,Maximum plasma concentration (Cmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.,Intermediate
,In vivo,Plasma,,,1,,,N,50588,14925,1,9615.0,11395,,BAO_0000218,Canis lupus familiaris,1969.0,CHEMBL877589,A,,Maximum plasma concentration (Cmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.,Intermediate
,In vivo,,,,0,,,U,22224,11883,1,,11396,,BAO_0000218,,,CHEMBL626187,A,,Maximum concentration of the drug at 1 uM/dg administered intravenously,Autocuration
,In vivo,,,,0,,,U,22224,11883,1,,11397,,BAO_0000218,,,CHEMBL626188,A,,Maximum concentration of the drug at 20 uM/dg administered perorally,Autocuration
,In vivo,,,,0,,,U,22224,13391,1,,11398,,BAO_0000218,,,CHEMBL626189,A,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg,Autocuration
,In vivo,Blood,,,0,,,U,22224,13391,1,,11399,,BAO_0000218,,178.0,CHEMBL626855,A,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,Autocuration
,In vivo,Blood,,,0,,,U,22224,13391,1,,11400,,BAO_0000218,,178.0,CHEMBL623781,A,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,Autocuration
,In vivo,Blood,,,0,,,U,22224,13391,1,,11401,,BAO_0000218,,178.0,CHEMBL623782,A,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,Autocuration
,In vivo,Plasma,,,1,,,N,50597,16360,1,10116.0,11402,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623783,A,,Oral absorption expressed as peak plasma conc (Cmax) after oral dosing of 50 mg/kg in rat,Intermediate
,In vivo,Plasma,,,1,,,N,50588,3673,1,9615.0,11403,,BAO_0000218,Canis lupus familiaris,1969.0,CHEMBL623784,A,,Cmax in dog plasma after 1mg/kg oral dose,Intermediate
,In vivo,Plasma,,,1,,,N,50588,14431,1,9615.0,11404,,BAO_0000218,Canis lupus familiaris,1969.0,CHEMBL623785,A,,Bioavailability as maximal plasma concentration in dogs after 2.5 mg/kg oral dose,Intermediate
,In vivo,Plasma,,,1,,,N,50597,14431,1,10116.0,11405,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623786,A,,Bioavailability as maximal plasma concentration in rats after 10 mg/kg oral dose,Intermediate
,In vivo,,,,1,,,N,50597,14964,1,10116.0,11406,,BAO_0000218,Rattus norvegicus,,CHEMBL623787,A,,Oral maximum concentration in rat,Intermediate
,In vivo,,,,1,,,N,50597,14964,1,10116.0,11407,,BAO_0000218,Rattus norvegicus,,CHEMBL623788,A,,Oral maximum concentration in rat,Intermediate
,In vivo,Plasma,,,1,,,N,50594,14209,1,10090.0,11408,,BAO_0000218,Mus musculus,1969.0,CHEMBL623789,A,,Oral plasma concentration in mice at 100 mg/kg dosage within 4-hr time frame.,Intermediate
,In vivo,Blood,,,1,,,N,50594,11355,1,10090.0,11409,,BAO_0000218,Mus musculus,178.0,CHEMBL623790,A,,Peak concentration in blood after intravenous administration to mice,Intermediate
,In vivo,Blood,,,1,,,N,50594,11355,1,10090.0,11410,,BAO_0000218,Mus musculus,178.0,CHEMBL623791,A,,Peak concentration in blood after peroral administration to mice,Intermediate
,In vivo,Plasma,,,1,,,N,50597,11966,1,10116.0,11411,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623792,A,,Peak concentration in rat plasma was determined,Intermediate
,In vivo,Plasma,,,0,,,U,22224,8918,1,314293.0,11412,,BAO_0000218,Simiiformes,1969.0,CHEMBL623793,A,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of monkey after oral administration of 0.05 mmol/kg,Autocuration
,In vivo,Plasma,,,1,,,N,50594,8918,1,10090.0,11413,,BAO_0000218,Mus musculus,1969.0,CHEMBL623794,A,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of mouse after oral administration of 0.05 mmol/kg,Intermediate
,In vivo,Plasma,,,1,,,N,50597,8918,1,10116.0,11414,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623795,A,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of rat after oral administration of 0.05 mmol/kg,Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11415,,BAO_0000218,Rattus norvegicus,,CHEMBL623796,A,,"Distribution in rat heart 4 hr after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11416,,BAO_0000218,Rattus norvegicus,,CHEMBL623797,A,,"Distribution in rat heart 5 min after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11417,,BAO_0000218,Rattus norvegicus,,CHEMBL623798,A,,"Distribution in rat heart 6 hr after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11418,,BAO_0000218,Rattus norvegicus,,CHEMBL623799,A,,"Distribution in rat heart 8 hr after intravenous administration, injected dose/gm",Intermediate
,,Intestine,,,1,,,N,50597,8684,1,10116.0,11419,,BAO_0000218,Rattus norvegicus,160.0,CHEMBL624490,A,,"Distribution in rat intestine 15 min after intravenous administration, injected dose/gm",Intermediate
,,Intestine,,,1,,,N,50597,8684,1,10116.0,11420,,BAO_0000218,Rattus norvegicus,160.0,CHEMBL624491,A,,"Distribution in rat intestine 1 hr after intravenous administration, injected dose/gm",Intermediate
,,Intestine,,,1,,,N,50597,8684,1,10116.0,11421,,BAO_0000218,Rattus norvegicus,160.0,CHEMBL624492,A,,"Distribution in rat intestine 2 hr after intravenous administration, injected dose/gm",Intermediate
,,Intestine,,,1,,,N,50597,8684,1,10116.0,11422,,BAO_0000218,Rattus norvegicus,160.0,CHEMBL624493,A,,"Distribution in rat intestine 30 min after intravenous administration, injected dose/gm",Intermediate
,,Intestine,,,1,,,N,50597,8684,1,10116.0,11423,,BAO_0000218,Rattus norvegicus,160.0,CHEMBL877595,A,,"Distribution in rat intestine 4 hr after intravenous administration, injected dose/gm",Intermediate
,,Intestine,,,1,,,N,50597,8684,1,10116.0,11424,,BAO_0000218,Rattus norvegicus,160.0,CHEMBL624494,A,,"Distribution in rat intestine 5 min after intravenous administration, injected dose/gm",Intermediate
,,Intestine,,,1,,,N,50597,8684,1,10116.0,11425,,BAO_0000218,Rattus norvegicus,160.0,CHEMBL624495,A,,"Distribution in rat intestine 6 hr after intravenous administration, injected dose/gm",Intermediate
,,Intestine,,,1,,,N,50597,8684,1,10116.0,11426,,BAO_0000218,Rattus norvegicus,160.0,CHEMBL624681,A,,"Distribution in rat intestine 8 hr after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11427,,BAO_0000218,Rattus norvegicus,,CHEMBL624682,A,,"Distribution in rat kidney, 15 min after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11428,,BAO_0000218,Rattus norvegicus,,CHEMBL624683,A,,"Distribution in rat kidney, 1 hr after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11429,,BAO_0000218,Rattus norvegicus,,CHEMBL624684,A,,"Distribution in rat kidney, 2 hr after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11430,,BAO_0000218,Rattus norvegicus,,CHEMBL624685,A,,"Distribution in rat kidney, 30 min after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11431,,BAO_0000218,Rattus norvegicus,,CHEMBL624686,A,,"Distribution in rat kidney, 4 hr after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11432,,BAO_0000218,Rattus norvegicus,,CHEMBL624687,A,,"Distribution in rat kidney, 5 min after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11433,,BAO_0000218,Rattus norvegicus,,CHEMBL624688,A,,"Distribution in rat kidney, 6 hr after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11434,,BAO_0000218,Rattus norvegicus,,CHEMBL627161,A,,"Distribution in rat kidney, 8 hr after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11435,,BAO_0000218,Rattus norvegicus,,CHEMBL622127,A,,"Distribution in rat liver 15 min after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11436,,BAO_0000218,Rattus norvegicus,,CHEMBL622128,A,,"Distribution in rat liver 1 hr after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11437,,BAO_0000218,Rattus norvegicus,,CHEMBL874384,A,,"Distribution in rat liver 2 hr after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11438,,BAO_0000218,Rattus norvegicus,,CHEMBL624898,A,,"Distribution in rat liver 30 min after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11439,,BAO_0000218,Rattus norvegicus,,CHEMBL624899,A,,"Distribution in rat liver 4 hr after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11440,,BAO_0000218,Rattus norvegicus,,CHEMBL624900,A,,"Distribution in rat liver 5 min after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11441,,BAO_0000218,Rattus norvegicus,,CHEMBL624901,A,,"Distribution in rat liver 6 hr after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11442,,BAO_0000218,Rattus norvegicus,,CHEMBL624902,A,,"Distribution in rat liver 8 hr after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11443,,BAO_0000218,Rattus norvegicus,,CHEMBL624903,A,,"Distribution in rat lungs 15 min after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11444,,BAO_0000218,Rattus norvegicus,,CHEMBL624904,A,,"Distribution in rat lungs 1 hr after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11445,,BAO_0000218,Rattus norvegicus,,CHEMBL624905,A,,"Distribution in rat lungs 2 hr after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11446,,BAO_0000218,Rattus norvegicus,,CHEMBL624906,A,,"Distribution in rat lungs 30 min after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11447,,BAO_0000218,Rattus norvegicus,,CHEMBL624907,A,,"Distribution in rat lungs 4 hr after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11448,,BAO_0000218,Rattus norvegicus,,CHEMBL624908,A,,"Distribution in rat lungs 5 min after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11449,,BAO_0000218,Rattus norvegicus,,CHEMBL624909,A,,"Distribution in rat lungs 6 hr after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11450,,BAO_0000218,Rattus norvegicus,,CHEMBL624910,A,,"Distribution in rat lungs 8 hr after intravenous administration, injected dose/gm",Intermediate
,,Muscle tissue,,,1,,,N,50597,8684,1,10116.0,11451,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL624911,A,,"Distribution in rat muscle 15 min after intravenous administration, injected dose/gm",Intermediate
,,Muscle tissue,,,1,,,N,50597,8684,1,10116.0,11452,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL874388,A,,"Distribution in rat muscle 1 hr after intravenous administration, injected dose/gm",Intermediate
,,Muscle tissue,,,1,,,N,50597,8684,1,10116.0,11453,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL624912,A,,"Distribution in rat muscle 2 hr after intravenous administration, injected dose/gm",Intermediate
,,Muscle tissue,,,1,,,N,50597,8684,1,10116.0,11454,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL622930,A,,"Distribution in rat muscle 30 min after intravenous administration, injected dose/gm",Intermediate
,,Muscle tissue,,,1,,,N,50597,8684,1,10116.0,11455,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL623121,A,,"Distribution in rat muscle 4 hr after intravenous administration, injected dose/gm",Intermediate
,,Muscle tissue,,,1,,,N,50597,8684,1,10116.0,11456,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL623122,A,,"Distribution in rat muscle 5 min after intravenous administration, injected dose/gm",Intermediate
,,Muscle tissue,,,1,,,N,50597,8684,1,10116.0,11457,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL623123,A,,"Distribution in rat muscle 6 hr after intravenous administration, injected dose/gm",Intermediate
,,Muscle tissue,,,1,,,N,50597,8684,1,10116.0,11458,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL623124,A,,"Distribution in rat muscle 8 hr after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11459,,BAO_0000218,Rattus norvegicus,,CHEMBL623125,A,,"Distribution in rat pancreas 15 min after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11460,,BAO_0000218,Rattus norvegicus,,CHEMBL623126,A,,"Distribution in rat pancreas 1 hr after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11461,,BAO_0000218,Rattus norvegicus,,CHEMBL623127,A,,"Distribution in rat pancreas 2 hr after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11462,,BAO_0000218,Rattus norvegicus,,CHEMBL623128,A,,"Distribution in rat pancreas 30 min after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11463,,BAO_0000218,Rattus norvegicus,,CHEMBL623129,A,,"Distribution in rat pancreas 4 hr after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11464,,BAO_0000218,Rattus norvegicus,,CHEMBL623130,A,,"Distribution in rat pancreas 5 min after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11465,,BAO_0000218,Rattus norvegicus,,CHEMBL623131,A,,"Distribution in rat pancreas 6 hr after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11466,,BAO_0000218,Rattus norvegicus,,CHEMBL623132,A,,"Distribution in rat pancreas 8 hr after intravenous administration, injected dose/gm",Intermediate
,,Liver,,,1,,,N,50597,8319,1,10116.0,11467,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL623133,A,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,Intermediate
,,,,,1,,,N,50597,8319,1,10116.0,11468,,BAO_0000218,Rattus norvegicus,,CHEMBL623134,A,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,Intermediate
,,,,,1,,,N,50597,8319,1,10116.0,11469,,BAO_0000218,Rattus norvegicus,,CHEMBL874389,A,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,Intermediate
,,,,,1,,,N,50597,8319,1,10116.0,11470,,BAO_0000218,Rattus norvegicus,,CHEMBL623135,A,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,Intermediate
,,,,,1,,,N,50597,8319,1,10116.0,11471,,BAO_0000218,Rattus norvegicus,,CHEMBL623136,A,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,Intermediate
,,,,,1,,,N,50597,8319,1,10116.0,11472,,BAO_0000218,Rattus norvegicus,,CHEMBL623137,A,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,Intermediate
,,,,,1,,,N,50597,8319,1,10116.0,11473,,BAO_0000218,Rattus norvegicus,,CHEMBL623138,A,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,Intermediate
,,Kidney,,,1,,,N,50597,8319,1,10116.0,11474,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL623139,A,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,Intermediate
,,Kidney,,,1,,,N,50597,8319,1,10116.0,11475,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL623140,A,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,Intermediate
,,Liver,,,1,,,N,50597,8319,1,10116.0,11476,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL623141,A,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,Intermediate
,,Liver,,,1,,,N,50597,8319,1,10116.0,11477,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL623142,A,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,Intermediate
,,,,,1,,,N,50597,8319,1,10116.0,11478,,BAO_0000218,Rattus norvegicus,,CHEMBL623143,A,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,Intermediate
,,Urine,,,1,,,N,50594,14571,1,10090.0,11479,,BAO_0000218,Mus musculus,1088.0,CHEMBL623144,A,,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in mouse.,Intermediate
,,Urine,,,1,,,N,50597,14571,1,10116.0,11480,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL623405,A,,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in rat.,Intermediate
,,,,,1,,,N,50597,8319,1,10116.0,11481,,BAO_0000218,Rattus norvegicus,,CHEMBL624074,A,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,Intermediate
,,,,,1,,,N,50597,8319,1,10116.0,11482,,BAO_0000218,Rattus norvegicus,,CHEMBL624075,A,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,Intermediate
,,,,,1,,,N,50597,8319,1,10116.0,11483,,BAO_0000218,Rattus norvegicus,,CHEMBL624076,A,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,Intermediate
,,,,,1,,,N,50597,8319,1,10116.0,11484,,BAO_0000218,Rattus norvegicus,,CHEMBL624077,A,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,Intermediate
,,,,,1,,,N,50597,8319,1,10116.0,11485,,BAO_0000218,Rattus norvegicus,,CHEMBL624078,A,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,Intermediate
,,Kidney,,,1,,,N,50597,8319,1,10116.0,11486,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL624079,A,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,Intermediate
,,Kidney,,,1,,,N,50597,8319,1,10116.0,11487,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL624261,A,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,Intermediate
,,,,,1,,,N,50597,8319,1,10116.0,11488,,BAO_0000218,Rattus norvegicus,,CHEMBL624262,A,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,Intermediate
,,,,,1,,,N,50597,8319,1,10116.0,11489,,BAO_0000218,Rattus norvegicus,,CHEMBL624263,A,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,Intermediate
,,,,,1,,,N,50597,8319,1,10116.0,11490,,BAO_0000218,Rattus norvegicus,,CHEMBL624264,A,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,Intermediate
,,,,,1,,,N,50597,8319,1,10116.0,11491,,BAO_0000218,Rattus norvegicus,,CHEMBL624265,A,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,Intermediate
,,,,,1,,,N,50597,8319,1,10116.0,11492,,BAO_0000218,Rattus norvegicus,,CHEMBL624266,A,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,Intermediate
,,,,,1,,,N,50597,8319,1,10116.0,11493,,BAO_0000218,Rattus norvegicus,,CHEMBL624267,A,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,Intermediate
,,,,,1,,,N,50597,8319,1,10116.0,11494,,BAO_0000218,Rattus norvegicus,,CHEMBL624268,A,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,Intermediate
,,,,,1,,,N,50597,8319,1,10116.0,11495,,BAO_0000218,Rattus norvegicus,,CHEMBL875227,A,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,Intermediate
,,Kidney,,,1,,,N,50597,8319,1,10116.0,11496,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL624269,A,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,Intermediate
,,Kidney,,,1,,,N,50597,8319,1,10116.0,11497,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL624270,A,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,Intermediate
,,,,,1,,,N,50597,8319,1,10116.0,11498,,BAO_0000218,Rattus norvegicus,,CHEMBL624271,A,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,Intermediate
,,,,,1,,,N,50597,8319,1,10116.0,11499,,BAO_0000218,Rattus norvegicus,,CHEMBL624272,A,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,Intermediate
,,,,,1,,,N,50597,8319,1,10116.0,11500,,BAO_0000218,Rattus norvegicus,,CHEMBL624273,A,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,Intermediate
,,Urine,,,1,,,N,50597,12064,1,10116.0,11501,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL624274,A,,Urinary excretion in rat after 0-4 hours of oral administration at 50 mg/kg,Intermediate
,,Urine,,,1,,,N,50597,12064,1,10116.0,11502,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL624275,A,,Urinary excretion in rat after 4-8 hours of oral administration at 50 mg/kg,Intermediate
,,Urine,,,1,,,N,50597,12064,1,10116.0,11503,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL624276,A,,Urinary excretion in rat after 8-24 hours of oral administration at 50 mg/kg,Intermediate
,,Urine,,,1,,,N,50597,12038,1,10116.0,11504,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL624277,A,,Urinary recovery expressed as percentage dose in male rats after iv administration of 20 mg/kg,Intermediate
,,,,,0,,,U,22224,14314,1,,11505,,BAO_0000019,,,CHEMBL624278,A,,% dose converted to 2-amino-5-chlorophenyl sulfate,Autocuration
,,,,,0,,,U,22224,14314,1,,11506,,BAO_0000019,,,CHEMBL624279,A,,% dose converted to 4-(S-amino-N-{[(4-chlorophenyl)amino]carbonyl}sulfonimidoyl)benzoic acid (compound 41),Autocuration
,,Feces,,,1,,,N,50597,11488,1,10116.0,11507,,BAO_0000218,Rattus norvegicus,1988.0,CHEMBL624280,A,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",Intermediate
,,Feces,,,1,,,N,50597,11488,1,10116.0,11508,,BAO_0000218,Rattus norvegicus,1988.0,CHEMBL624281,A,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",Intermediate
,,Feces,,,1,,,N,50597,11488,1,10116.0,11509,,BAO_0000218,Rattus norvegicus,1988.0,CHEMBL622933,A,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",Intermediate
,,Feces,,,1,,,N,50597,11488,1,10116.0,11510,,BAO_0000218,Rattus norvegicus,1988.0,CHEMBL622934,A,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",Intermediate
,In vivo,Liver,,,1,,,N,50597,8829,1,10116.0,11511,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL622935,A,,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,Intermediate
,In vivo,Liver,,,1,,,N,50597,8829,1,10116.0,11512,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL622936,A,,Biodistribution in Rat liver after 5 minutes of iv administration,Intermediate
,In vivo,Liver,,,1,,,N,50597,8829,1,10116.0,11513,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL875228,A,,Biodistribution in Rat liver after 5 minutes of iv administration; per g of tissue,Intermediate
,In vivo,Lung,,,1,,,N,50597,8829,1,10116.0,11514,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL622937,A,,Biodistribution in Rat lung after 24 hours of iv administration,Intermediate
,In vivo,Lung,,,1,,,N,50597,8829,1,10116.0,11515,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL622938,A,,Biodistribution in Rat lung after 24 hours of iv administration; per g of tissue,Intermediate
,In vivo,Lung,,,1,,,N,50597,8829,1,10116.0,11516,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL619736,A,,Biodistribution in Rat lung after 30 minutes of iv administration,Intermediate
,In vivo,Lung,,,1,,,N,50597,8829,1,10116.0,11517,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL625117,A,,Biodistribution in Rat lung after 30 minutes of iv administration; per g of tissue,Intermediate
,In vivo,Lung,,,1,,,N,50597,8829,1,10116.0,11518,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL625118,A,,Biodistribution in Rat lung after 5 minutes of iv administration,Intermediate
,In vivo,Lung,,,1,,,N,50597,8829,1,10116.0,11519,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL625119,A,,Biodistribution in Rat lung after 5 minutes of iv administration; per g of tissue,Intermediate
,In vivo,Cerebellum,,,1,,,N,50597,14972,1,10116.0,11520,,BAO_0000218,Rattus norvegicus,2037.0,CHEMBL625120,A,,"Biodistribution in rat cerebellum, expressed as percent I.D./g tissue",Intermediate
,In vivo,,,,1,,,N,50597,14972,1,10116.0,11521,,BAO_0000218,Rattus norvegicus,,CHEMBL625121,A,,"Biodistribution in rat superior coliculus, expressed as percent I.D./g tissue",Intermediate
,In vivo,Thalamus,,,1,,,N,50597,14972,1,10116.0,11522,,BAO_0000218,Rattus norvegicus,10000006.0,CHEMBL625122,A,,"Biodistribution in rat thalamus, expressed as percent I.D./g tissue",Intermediate
,In vivo,Blood,,,1,,,N,50597,14608,1,10116.0,11523,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL622204,A,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate
,In vivo,Blood,,,1,,,N,50597,14608,1,10116.0,11524,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL877503,A,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate
,In vivo,Blood,,,1,,,N,50597,14608,1,10116.0,11525,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL627127,A,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate
,In vivo,Hippocampus,,,0,,,U,22224,14608,1,,11526,,BAO_0000218,,10000000.0,CHEMBL627128,A,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 2 min,Autocuration
,In vivo,Hippocampus,,,0,,,U,22224,14608,1,,11527,,BAO_0000218,,10000000.0,CHEMBL627129,A,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 30 min,Autocuration
,In vivo,Hippocampus,,,0,,,U,22224,14608,1,,11528,,BAO_0000218,,10000000.0,CHEMBL627130,A,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 60 min,Autocuration
,In vivo,Brain,,,1,,,N,50597,14608,1,10116.0,11529,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL627131,A,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate
,In vivo,Brain,,,1,,,N,50597,14608,1,10116.0,11530,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL627132,A,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate
,In vivo,Brain,,,1,,,N,50597,14608,1,10116.0,11531,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL627133,A,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate
,In vivo,Cerebellum,,,1,,,N,50597,14608,1,10116.0,11532,,BAO_0000218,Rattus norvegicus,2037.0,CHEMBL627134,A,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate
,In vivo,Cerebellum,,,1,,,N,50597,14608,1,10116.0,11533,,BAO_0000218,Rattus norvegicus,2037.0,CHEMBL627135,A,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate
,In vivo,Cerebellum,,,1,,,N,50597,14608,1,10116.0,11534,,BAO_0000218,Rattus norvegicus,2037.0,CHEMBL627136,A,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate
,In vivo,,,,1,,,N,50597,14608,1,10116.0,11535,,BAO_0000218,Rattus norvegicus,,CHEMBL628435,A,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate
,In vivo,,,,1,,,N,50597,14608,1,10116.0,11536,,BAO_0000218,Rattus norvegicus,,CHEMBL628436,A,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate
,In vivo,,,,1,,,N,50597,14608,1,10116.0,11537,,BAO_0000218,Rattus norvegicus,,CHEMBL628437,A,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate
,In vivo,Heart,,,1,,,N,50597,14608,1,10116.0,11538,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL628438,A,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate
,In vivo,Heart,,,1,,,N,50597,14608,1,10116.0,11539,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL628439,A,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate
,In vivo,Heart,,,1,,,N,50597,14608,1,10116.0,11540,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL628440,A,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate
,In vivo,Hippocampus,,,1,,,N,50597,14608,1,10116.0,11541,,BAO_0000218,Rattus norvegicus,10000000.0,CHEMBL628441,A,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate
,In vivo,Hippocampus,,,1,,,N,50597,14608,1,10116.0,11542,,BAO_0000218,Rattus norvegicus,10000000.0,CHEMBL628442,A,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate
,In vivo,Hippocampus,,,1,,,N,50597,14608,1,10116.0,11543,,BAO_0000218,Rattus norvegicus,10000000.0,CHEMBL628443,A,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate
,In vivo,Kidney,,,1,,,N,50597,14608,1,10116.0,11544,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL628444,A,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate
,In vivo,Kidney,,,1,,,N,50597,14608,1,10116.0,11545,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL628445,A,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate
,In vivo,Kidney,,,1,,,N,50597,14608,1,10116.0,11546,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL877504,A,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate
,In vivo,Liver,,,1,,,N,50597,14608,1,10116.0,11547,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL628446,A,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate
,In vivo,Liver,,,1,,,N,50597,14608,1,10116.0,11548,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL626874,A,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate
,In vivo,Liver,,,1,,,N,50597,14608,1,10116.0,11549,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL626875,A,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate
,In vivo,Lung,,,1,,,N,50597,14608,1,10116.0,11550,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL626876,A,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate
,In vivo,Lung,,,1,,,N,50597,14608,1,10116.0,11551,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL626877,A,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate
,In vivo,Lung,,,1,,,N,50597,14608,1,10116.0,11552,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL626878,A,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,14608,1,10116.0,11553,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL626879,A,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate
,In vivo,Plasma,,,0,,,U,22224,8918,1,314293.0,11554,,BAO_0000218,Simiiformes,1969.0,CHEMBL626880,A,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of monkey after oral administration of 0.05 mmol/kg,Autocuration
,In vivo,Plasma,,,1,,,N,50594,8918,1,10090.0,11555,,BAO_0000218,Mus musculus,1969.0,CHEMBL626881,A,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of mouse after oral administration of 0.05 mmol/kg,Intermediate
,In vivo,Plasma,,,1,,,N,50597,8918,1,10116.0,11556,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626882,A,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of rat after oral administration of 0.05 mmol/kg,Intermediate
,In vivo,Plasma,,,1,,,N,50588,14470,1,9615.0,11557,,BAO_0000218,Canis lupus familiaris,1969.0,CHEMBL626883,A,,Peak plasma concentration was measured in dogs,Intermediate
,In vivo,,,,1,,,N,50597,14393,1,10116.0,11558,,BAO_0000218,Rattus norvegicus,,CHEMBL626884,A,,Pharmacokinetic Parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,Intermediate
,In vivo,,,,1,,,N,50597,14886,1,10116.0,11559,,BAO_0000218,Rattus norvegicus,,CHEMBL626885,A,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,14886,1,10116.0,11560,,BAO_0000218,Rattus norvegicus,,CHEMBL626886,A,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,14886,1,10116.0,11561,,BAO_0000218,Rattus norvegicus,,CHEMBL626887,A,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,14393,1,10116.0,11562,,BAO_0000218,Rattus norvegicus,,CHEMBL626888,A,,Pharmacokinetic parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,Intermediate
,In vivo,,,,1,,,N,50588,13465,1,9615.0,11563,,BAO_0000218,Canis lupus familiaris,,CHEMBL626889,A,,Pharmacokinetic parameter Cmax determined after intravenous administration of 15 mg/kg to dog,Intermediate
,In vivo,,,,0,,,U,22224,13465,1,314293.0,11564,,BAO_0000218,Simiiformes,,CHEMBL626761,A,,Pharmacokinetic parameter Cmax determined after intravenous administration of 25 mg/kg to monkey,Autocuration
,In vivo,,,,1,,,N,50588,13465,1,9615.0,11565,,BAO_0000218,Canis lupus familiaris,,CHEMBL626762,A,,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg abd antacid (CaCO3 dosed orally 10 min prior to and 60 min postdosing) to dog,Intermediate
,In vivo,,,,1,,,N,50588,13465,1,9615.0,11566,,BAO_0000218,Canis lupus familiaris,,CHEMBL626763,A,,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg to dog,Intermediate
,In vivo,,,,1,,,N,50597,13465,1,10116.0,11567,,BAO_0000218,Rattus norvegicus,,CHEMBL626764,A,,Pharmacokinetic parameter Cmax determined after intravenous administration of 50 mg/kg to rat,Intermediate
,In vivo,,,,1,,,N,50597,13465,1,10116.0,11568,,BAO_0000218,Rattus norvegicus,,CHEMBL626765,A,,Pharmacokinetic parameter Cmax determined after intravenous administration of 60 mg/kg to rat,Intermediate
,In vivo,,,,1,,,N,50588,13465,1,9615.0,11569,,BAO_0000218,Canis lupus familiaris,,CHEMBL626766,A,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to dog,Intermediate
,In vivo,,,,1,,,N,50597,13465,1,10116.0,11570,,BAO_0000218,Rattus norvegicus,,CHEMBL626767,A,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat,Intermediate
,In vivo,,,,1,,,N,50597,13465,1,10116.0,11571,,BAO_0000218,Rattus norvegicus,,CHEMBL626768,A,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat; No levels,Intermediate
,In vivo,,,,1,,,N,50588,13465,1,9615.0,11572,,BAO_0000218,Canis lupus familiaris,,CHEMBL626769,A,,Pharmacokinetic parameter Cmax determined after peroral administration of 15 mg/kg to dog,Intermediate
,In vivo,,,,1,,,N,50588,13465,1,9615.0,11573,,BAO_0000218,Canis lupus familiaris,,CHEMBL874463,A,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to dog,Intermediate
,In vivo,,,,0,,,U,22224,13465,1,314293.0,11574,,BAO_0000218,Simiiformes,,CHEMBL626770,A,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey,Autocuration
,In vivo,,,,0,,,U,22224,13465,1,314293.0,11575,,BAO_0000218,Simiiformes,,CHEMBL626771,A,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey; No levels,Autocuration
,In vivo,,,,1,,,N,50597,13465,1,10116.0,11576,,BAO_0000218,Rattus norvegicus,,CHEMBL626772,A,,Pharmacokinetic parameter Cmax determined after peroral administration of 50 mg/kg to rat,Intermediate
,In vivo,,,,1,,,N,100710,14731,1,9541.0,11577,,BAO_0000218,Macaca fascicularis,,CHEMBL626773,A,,Pharmacokinetic parameter Cmax for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,Intermediate
,In vivo,,,,1,,,N,50594,14731,1,10090.0,11578,,BAO_0000218,Mus musculus,,CHEMBL626774,A,,Pharmacokinetic parameter Cmax for the compound was evaluated in nude mice after oral administration. ,Intermediate
,In vivo,,,,1,,,N,50588,13376,1,9615.0,11579,,BAO_0000218,Canis lupus familiaris,,CHEMBL626775,A,,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 375 mg/kg,Intermediate
,In vivo,,,,1,,,N,50588,13376,1,9615.0,11580,,BAO_0000218,Canis lupus familiaris,,CHEMBL626776,A,,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 500 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,14443,1,10116.0,11581,,BAO_0000218,Rattus norvegicus,,CHEMBL626777,A,,Maximum concentration (Cmax) in rat when administered orally,Intermediate
,In vivo,Plasma,,,0,,,U,22224,13465,1,314293.0,11582,,BAO_0000218,Simiiformes,1969.0,CHEMBL626778,A,,Maximal concentration in monkey plasma after 25 mg/kg oral dose,Autocuration
,In vivo,,,,0,,,U,22224,16359,1,10116.0,11583,,BAO_0000218,Rattus norvegicus,,CHEMBL626779,A,,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.17-0.20)",Autocuration
,In vivo,,,,0,,,U,22224,16359,1,10116.0,11584,,BAO_0000218,Rattus norvegicus,,CHEMBL626780,A,,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.4-0.8)",Autocuration
,In vivo,Plasma,,,0,,,U,22224,15618,1,,11585,,BAO_0000218,,1969.0,CHEMBL626781,A,,Cmax in rat plasma after single 5 mg/kg oral cassette gavage dose,Autocuration
,In vivo,,,,1,,,N,50597,14554,1,10116.0,11586,,BAO_0000218,Rattus norvegicus,,CHEMBL632164,A,,Pharmacokinetic profile Cmax was evaluated in rats,Intermediate
,In vivo,,,,1,,,N,50588,11537,1,9615.0,11587,,BAO_0000218,Canis lupus familiaris,,CHEMBL632165,A,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in dog (25 mg/kg),Intermediate
,In vivo,,,,1,,,N,50594,11537,1,10090.0,11588,,BAO_0000218,Mus musculus,,CHEMBL632166,A,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in mice (50 mg/kg),Intermediate
,In vivo,,,,1,,,N,50588,11537,1,9615.0,11589,,BAO_0000218,Canis lupus familiaris,,CHEMBL632167,A,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to dog (25 mg/kg),Intermediate
,In vivo,,,,1,,,N,50594,11537,1,10090.0,11590,,BAO_0000218,Mus musculus,,CHEMBL632168,A,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to mice (50 mg/kg),Intermediate
,In vivo,Plasma,,,0,,,U,22224,2021,1,10116.0,11591,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL632169,A,,Cmax in rat plasma,Autocuration
,In vivo,Plasma,,,1,,,N,50588,5932,1,9615.0,11592,,BAO_0000218,Canis lupus familiaris,1969.0,CHEMBL632170,A,,Cmax in dog plasma after 30mg/kg oral dose,Intermediate
,In vivo,Plasma,,,1,,,N,50597,5932,1,10116.0,11593,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL632171,A,,Cmax in rat plasma after 30mg/kg oral dose,Intermediate
,In vivo,Plasma,,,1,,,N,50597,17320,1,10116.0,11594,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL632172,A,,Plasma level in rats at 30 mg/kg,Intermediate
,In vivo,Plasma,,,1,,,N,50594,15831,1,10090.0,11595,,BAO_0000218,Mus musculus,1969.0,CHEMBL632173,A,,Tested for maximum plasma concentration in mice,Intermediate
,In vivo,,,,1,,,N,50597,15078,1,10116.0,11596,,BAO_0000218,Rattus norvegicus,,CHEMBL632174,A,,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",Intermediate
,In vivo,,,,1,,,N,50597,14941,1,10116.0,11597,,BAO_0000218,Rattus norvegicus,,CHEMBL632175,A,,The Cmax values in female wistar rats.,Intermediate
,In vivo,Plasma,,,1,,,N,50588,15343,1,9615.0,11598,,BAO_0000218,Canis lupus familiaris,1969.0,CHEMBL632176,A,,The Peak plasma concentration was measured in dogs after oral administration of 1 mg/kg dose,Intermediate
,In vivo,Plasma,,,1,,,N,50597,15343,1,10116.0,11599,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL632177,A,,The Peak plasma concentration was measured in rats after oral administration of 1 mg/kg dose,Intermediate
,In vivo,Plasma,,,1,,,N,50597,14856,1,10116.0,11600,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL632178,A,,The compound tested for maximum observed plasma concentration in rats and is expressed in microgram/mL.,Intermediate
,In vivo,,,,1,,,N,50597,13129,1,10116.0,11601,,BAO_0000218,Rattus norvegicus,,CHEMBL632179,A,,The compound was tested for Cmax value pharmacokinetic parameter in the male Sprague-Dawley rat.,Intermediate
,In vivo,Blood,,,1,,,N,50597,13098,1,10116.0,11602,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL632180,A,,The compound was tested for maximum blood level reached in rats at 15.9 uM/kg after peroral administration.,Intermediate
,In vivo,Blood,,,1,,,N,50597,13098,1,10116.0,11603,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL632181,A,,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after intravenous administration.,Intermediate
,In vivo,Blood,,,1,,,N,50597,13098,1,10116.0,11604,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL632182,A,,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after peroral administration.,Intermediate
,In vivo,Blood,,,0,,,U,22224,15478,1,10090.0,11605,,BAO_0000218,Mus musculus,178.0,CHEMBL632183,A,,The maximum concentration observed (Cmax) in the blood sample at indicated time point (tmax) at a dose 50 mg/Kg administered orally in mice.,Autocuration
,In vivo,,,,1,,,N,50588,15341,1,9615.0,11606,,BAO_0000218,Canis lupus familiaris,,CHEMBL632184,A,,The maximum concentration of the compound was measured in dog at dose 5 mg/kg after peroral administration.,Intermediate
,In vivo,,,,1,,,N,50597,15341,1,10116.0,11607,,BAO_0000218,Rattus norvegicus,,CHEMBL874470,A,,The maximum concentration of the compound was measured in rat at dose 1 mg/kg after peroral administration.,Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11608,,BAO_0000218,Rattus norvegicus,,CHEMBL631302,A,,"Distribution in rat skin 15 min after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11609,,BAO_0000218,Rattus norvegicus,,CHEMBL631303,A,,"Distribution in rat skin 1 hr after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11610,,BAO_0000218,Rattus norvegicus,,CHEMBL631304,A,,"Distribution in rat skin 2 hr after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11611,,BAO_0000218,Rattus norvegicus,,CHEMBL631305,A,,"Distribution in rat skin 30 min after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11612,,BAO_0000218,Rattus norvegicus,,CHEMBL631306,A,,"Distribution in rat skin 4 hr after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11613,,BAO_0000218,Rattus norvegicus,,CHEMBL631307,A,,"Distribution in rat skin 5 min after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11614,,BAO_0000218,Rattus norvegicus,,CHEMBL631308,A,,"Distribution in rat skin 6 hr after intravenous administration, injected dose/gm",Intermediate
,,,,,1,,,N,50597,8684,1,10116.0,11615,,BAO_0000218,Rattus norvegicus,,CHEMBL625557,A,,"Distribution in rat skin 8 hr after intravenous administration, injected dose/gm",Intermediate
,,Spleen,,,1,,,N,50597,8684,1,10116.0,11616,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL625558,A,,"Distribution in rat spleen 15 min after intravenous administration, injected dose/gm",Intermediate
,,Spleen,,,1,,,N,50597,8684,1,10116.0,11617,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL625559,A,,"Distribution in rat spleen 1 hr after intravenous administration, injected dose/gm",Intermediate
,,Spleen,,,1,,,N,50597,8684,1,10116.0,11618,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL625560,A,,"Distribution in rat spleen 2 hr after intravenous administration, injected dose/gm",Intermediate
,,Spleen,,,1,,,N,50597,8684,1,10116.0,11619,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL625561,A,,"Distribution in rat spleen 30 min after intravenous administration, injected dose/gm",Intermediate
,,Spleen,,,1,,,N,50597,8684,1,10116.0,11620,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL625562,A,,"Distribution in rat spleen 4 hr after intravenous administration, injected dose/gm",Intermediate
,,Spleen,,,1,,,N,50597,8684,1,10116.0,11621,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL875320,A,,"Distribution in rat spleen 5 min after intravenous administration, injected dose/gm",Intermediate
,,Spleen,,,1,,,N,50597,8684,1,10116.0,11622,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL625563,A,,"Distribution in rat spleen 6 hr after intravenous administration, injected dose/gm",Intermediate
,,Spleen,,,1,,,N,50597,8684,1,10116.0,11623,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL625564,A,,"Distribution in rat spleen 8 hr after intravenous administration, injected dose/gm",Intermediate
,,Uterus,,,1,,,N,50597,8684,1,10116.0,11624,,BAO_0000218,Rattus norvegicus,995.0,CHEMBL625565,A,,"Distribution in rat uterus 15 min after intravenous administration, injected dose/gm",Intermediate
,,Uterus,,,1,,,N,50597,8684,1,10116.0,11625,,BAO_0000218,Rattus norvegicus,995.0,CHEMBL625566,A,,"Distribution in rat uterus 1 hr after intravenous administration, injected dose/gm",Intermediate
,,Uterus,,,1,,,N,50597,8684,1,10116.0,11626,,BAO_0000218,Rattus norvegicus,995.0,CHEMBL625567,A,,"Distribution in rat uterus 2 hr after intravenous administration, injected dose/gm",Intermediate
,,Uterus,,,1,,,N,50597,8684,1,10116.0,11627,,BAO_0000218,Rattus norvegicus,995.0,CHEMBL625568,A,,"Distribution in rat uterus 30 min after intravenous administration, injected dose/gm",Intermediate
,,Uterus,,,1,,,N,50597,8684,1,10116.0,11628,,BAO_0000218,Rattus norvegicus,995.0,CHEMBL628217,A,,"Distribution in rat uterus 4 hr after intravenous administration, injected dose/gm",Intermediate
,,Uterus,,,1,,,N,50597,8684,1,10116.0,11629,,BAO_0000218,Rattus norvegicus,995.0,CHEMBL628218,A,,"Distribution in rat uterus 5 min after intravenous administration, injected dose/gm",Intermediate
,,Uterus,,,1,,,N,50597,8684,1,10116.0,11630,,BAO_0000218,Rattus norvegicus,995.0,CHEMBL628219,A,,"Distribution in rat uterus 6 hr after intravenous administration, injected dose/gm",Intermediate
,,Uterus,,,1,,,N,50597,8684,1,10116.0,11631,,BAO_0000218,Rattus norvegicus,995.0,CHEMBL628220,A,,"Distribution in rat uterus 8 hr after intravenous administration, injected dose/gm",Intermediate
,,,,,0,,,U,22224,8926,1,,11632,,BAO_0000019,,,CHEMBL628221,A,,Distribution in the blood after 120 min of intravenous administration,Autocuration
,,,,,0,,,U,22224,8926,1,,11633,,BAO_0000019,,,CHEMBL628222,A,,Distribution in the blood after 15 min of intravenous administration,Autocuration
,,,,,0,,,U,22224,8926,1,,11634,,BAO_0000019,,,CHEMBL628223,A,,Distribution in the blood after 30 min of intravenous administration,Autocuration
,,,,,0,,,U,22224,8926,1,,11635,,BAO_0000019,,,CHEMBL628224,A,,Distribution in the blood after 5 min of intravenous administration,Autocuration
,,,,,0,,,U,22224,8926,1,,11636,,BAO_0000019,,,CHEMBL628225,A,,Distribution in the blood after 60 min of intravenous administration,Autocuration
,,,,,0,,,U,22224,8926,1,,11637,,BAO_0000019,,,CHEMBL628226,A,,Distribution in the blood after 90 min of intravenous administration,Autocuration
,,,,,0,,,U,22224,8926,1,,11638,,BAO_0000019,,,CHEMBL628227,A,,Distribution in the bone after 120 min of intravenous administration,Autocuration
,,,,,0,,,U,22224,8926,1,,11639,,BAO_0000019,,,CHEMBL875481,A,,Distribution in the bone after 15 min of intravenous administration,Autocuration
,,,,,0,,,U,22224,8926,1,,11640,,BAO_0000019,,,CHEMBL628228,A,,Distribution in the bone after 30 min of intravenous administration,Autocuration
,,,,,0,,,U,22224,8926,1,,11641,,BAO_0000019,,,CHEMBL628229,A,,Distribution in the bone after 5 min of intravenous administration,Autocuration
,,,,,0,,,U,22224,8926,1,,11642,,BAO_0000019,,,CHEMBL628230,A,,Distribution in the bone after 60 min of intravenous administration,Autocuration
,,,,,0,,,U,22224,8926,1,,11643,,BAO_0000019,,,CHEMBL628231,A,,Distribution in the bone after 90 min of intravenous administration,Autocuration
,,,,,0,,,U,22224,8926,1,,11644,,BAO_0000019,,,CHEMBL628232,A,,Distribution in the heart after 120 min of intravenous administration,Autocuration
,,,,,0,,,U,22224,8926,1,,11645,,BAO_0000019,,,CHEMBL628233,A,,Distribution in the heart after 15 min of intravenous administration,Autocuration
,,,,,0,,,U,22224,8926,1,,11646,,BAO_0000019,,,CHEMBL628234,A,,Distribution in the heart after 30 min of intravenous administration,Autocuration
,,,,,0,,,U,22224,8926,1,,11647,,BAO_0000019,,,CHEMBL628235,A,,Distribution in the heart after 5 min of intravenous administration,Autocuration
,,,,,0,,,U,22224,8926,1,,11648,,BAO_0000019,,,CHEMBL628236,A,,Distribution in the heart after 60 min of intravenous administration,Autocuration
,,,,,0,,,U,22224,8926,1,,11649,,BAO_0000019,,,CHEMBL628237,A,,Distribution in the heart after 90 min of intravenous administration,Autocuration
,,,,,0,,,U,22224,8926,1,,11650,,BAO_0000019,,,CHEMBL628238,A,,Distribution in the kidneys after 120 min of intravenous administration,Autocuration
,,,,,0,,,U,22224,8926,1,,11651,,BAO_0000019,,,CHEMBL628239,A,,Distribution in the kidneys after 15 min of intravenous administration,Autocuration
,,,,,0,,,U,22224,8926,1,,11652,,BAO_0000019,,,CHEMBL628240,A,,Distribution in the kidneys after 30 min of intravenous administration,Autocuration
,,,,,0,,,U,22224,8926,1,,11653,,BAO_0000019,,,CHEMBL628241,A,,Distribution in the kidneys after 5 min of intravenous administration,Autocuration
,,,,,0,,,U,22224,8926,1,,11654,,BAO_0000019,,,CHEMBL628242,A,,Distribution in the kidneys after 60 min of intravenous administration,Autocuration
,,,,,0,,,U,22224,8926,1,,11655,,BAO_0000019,,,CHEMBL875482,A,,Distribution in the kidneys after 90 min of intravenous administration,Autocuration
,,,,,0,,,U,22224,8926,1,,11656,,BAO_0000019,,,CHEMBL628243,A,,Distribution in the liver after 120 min of intravenous administration,Autocuration
,,,,,0,,,U,22224,8926,1,,11657,,BAO_0000019,,,CHEMBL628244,A,,Distribution in the liver after 15 min of intravenous administration,Autocuration
,,,,,0,,,U,22224,8926,1,,11658,,BAO_0000019,,,CHEMBL628245,A,,Distribution in the liver after 30 min of intravenous administration,Autocuration
,,,,,0,,,U,22224,8926,1,,11659,,BAO_0000019,,,CHEMBL628246,A,,Distribution in the liver after 5 min of intravenous administration,Autocuration
,,,,,0,,,U,22224,8926,1,,11660,,BAO_0000019,,,CHEMBL628247,A,,Distribution in the liver after 60 min of intravenous administration,Autocuration
,,,,,0,,,U,22224,8926,1,,11661,,BAO_0000019,,,CHEMBL628248,A,,Distribution in the liver after 90 min of intravenous administration,Autocuration
,,,,,0,,,U,22224,8926,1,,11662,,BAO_0000019,,,CHEMBL628249,A,,Distribution in the lung after 120 min of intravenous administration,Autocuration
,,,,,1,,,N,50594,14839,1,10090.0,11663,,BAO_0000218,Mus musculus,,CHEMBL625452,A,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, iv and the total drug exposure was determined. (0-24hr)",Intermediate
,,,,,1,,,N,50594,14839,1,10090.0,11664,,BAO_0000218,Mus musculus,,CHEMBL625453,A,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, perorally and the total drug exposure was determined (0-24hr)",Intermediate
,,,,,1,,,N,50594,14839,1,10090.0,11665,,BAO_0000218,Mus musculus,,CHEMBL625454,A,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, iv and the total drug exposure was determined. (0-24hr)",Intermediate
,,,,,1,,,N,50594,14839,1,10090.0,11666,,BAO_0000218,Mus musculus,,CHEMBL623844,A,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, perorally and the total drug exposure was determined (0-24hr)",Intermediate
,,,,,1,,,N,50597,12178,1,10116.0,11667,,BAO_0000218,Rattus norvegicus,,CHEMBL623845,A,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 1 mg/kg (normalized to a 1 mg/kg dose) in rat,Intermediate
,,,,,1,,,N,50597,12178,1,10116.0,11668,,BAO_0000218,Rattus norvegicus,,CHEMBL623846,A,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 2.5 mg/kg (normalized to a 1 mg/kg dose) in rat,Intermediate
,,,,,0,,,U,22224,12178,1,,11669,,BAO_0000218,,,CHEMBL623847,A,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 5.0 mg/kg (normalized to a 1 mg/kg dose) GP,Autocuration
,,,,,1,,,N,100710,12186,1,9541.0,11670,,BAO_0000218,Macaca fascicularis,,CHEMBL623848,A,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,Intermediate
,,,,,1,,,N,100710,12186,1,9541.0,11671,,BAO_0000218,Macaca fascicularis,,CHEMBL623849,A,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,Intermediate
,,,,,1,,,N,100710,12186,1,9541.0,11672,,BAO_0000218,Macaca fascicularis,,CHEMBL623850,A,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,Intermediate
,,,,,1,,,N,100710,12186,1,9541.0,11673,,BAO_0000218,Macaca fascicularis,,CHEMBL623851,A,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,Intermediate
,,,,,0,,,U,22224,12187,1,314293.0,11674,,BAO_0000218,Simiiformes,,CHEMBL623852,A,,Integrated area under the plasma drug level-time curve was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,Autocuration
,,,,,1,,,N,50506,12187,1,9669.0,11675,,BAO_0000218,Mustela putorius furo,,CHEMBL624551,A,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,Intermediate
,,,,,1,,,N,50506,12187,1,9669.0,11676,,BAO_0000218,Mustela putorius furo,,CHEMBL624552,A,,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",Intermediate
,,,,,0,,,U,22224,12187,1,314293.0,11677,,BAO_0000218,Simiiformes,,CHEMBL624553,A,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,Autocuration
,,,,,0,,,U,22224,12187,1,314293.0,11678,,BAO_0000218,Simiiformes,,CHEMBL624554,A,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey determined by renin inhibition assay,Autocuration
,,,,,1,,,N,50597,12187,1,10116.0,11679,,BAO_0000218,Rattus norvegicus,,CHEMBL624555,A,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,Intermediate
,,,,,1,,,N,50597,12187,1,10116.0,11680,,BAO_0000218,Rattus norvegicus,,CHEMBL624741,A,,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",Intermediate
,,,,,1,,,N,50588,14122,1,9615.0,11681,,BAO_0000218,Canis lupus familiaris,,CHEMBL624742,A,,"Intravenous integrated area under the concentration vs time curve, for compound in dog plasma",Intermediate
,,,,,1,,,N,100712,14122,1,10026.0,11682,,BAO_0000218,Cricetinae,,CHEMBL624743,A,,"Intravenous integrated area under the concentration vs time curve, for compound in hamster plasma",Intermediate
,,,,,1,,,N,50597,14122,1,10116.0,11683,,BAO_0000218,Rattus norvegicus,,CHEMBL877606,A,,"Intravenous integrated area under the concentration vs time curve, for compound in rat plasma",Intermediate
,,,,,0,,,U,22224,13391,1,,11684,,BAO_0000218,,,CHEMBL624744,A,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg,Autocuration
,,Blood,,,0,,,U,22224,13391,1,,11685,,BAO_0000218,,178.0,CHEMBL624745,A,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,Autocuration
,,Blood,,,0,,,U,22224,13391,1,,11686,,BAO_0000218,,178.0,CHEMBL624746,A,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,Autocuration
,,Blood,,,0,,,U,22224,13391,1,,11687,,BAO_0000218,,178.0,CHEMBL624747,A,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,Autocuration
,,,,,0,,,U,22224,16360,1,,11688,,BAO_0000019,,,CHEMBL624748,A,,Oral absorption expressed as Area under curve was determined,Autocuration
,,,,,1,,,N,50588,3673,1,9615.0,11689,,BAO_0000218,Canis lupus familiaris,,CHEMBL622504,A,,Oral absorption kinetics (AUC) was determined after administration of compound orally at 1 mg/kg in dogs,Intermediate
,,,,,1,,,N,50588,14122,1,9615.0,11690,,BAO_0000218,Canis lupus familiaris,,CHEMBL622505,A,,"Oral integrated area under the concentration vs time curve, for compound in dog plasma",Intermediate
,,,,,1,,,N,100712,14122,1,10026.0,11691,,BAO_0000218,Cricetinae,,CHEMBL622506,A,,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",Intermediate
,,,,,1,,,N,100712,14122,1,10026.0,11692,,BAO_0000218,Cricetinae,,CHEMBL622507,A,,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",Intermediate
,,,,,1,,,N,50597,14122,1,10116.0,11693,,BAO_0000218,Rattus norvegicus,,CHEMBL622508,A,,"Oral integrated area under the concentration vs time curve, for compound in rat plasma",Intermediate
,,,,,0,,,U,22224,13889,1,,11694,,BAO_0000019,,,CHEMBL622509,A,,Pharmacokinetic parameter AUC in mice following a single dose intravenous administration of the compound,Autocuration
,,,,,1,,,N,50597,14393,1,10116.0,11695,,BAO_0000218,Rattus norvegicus,,CHEMBL622510,A,,Pharmacokinetic Parameter [Area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,Intermediate
,,,,,1,,,N,50597,17279,1,10116.0,11696,,BAO_0000218,Rattus norvegicus,,CHEMBL622511,A,,Pharmacokinetic parameter (AUC) was determined after administering 1 mg/kg of compound intravenously in rat no.3 belonging to phenotype EM (extensive metabolizer),Intermediate
,,,,,1,,,N,100710,14548,1,9541.0,11697,,BAO_0000218,Macaca fascicularis,,CHEMBL622512,A,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,Intermediate
,,,,,1,,,N,100710,14548,1,9541.0,11698,,BAO_0000218,Macaca fascicularis,,CHEMBL622513,A,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,Intermediate
,,,,,1,,,N,100710,14548,1,9541.0,11699,,BAO_0000218,Macaca fascicularis,,CHEMBL622514,A,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered po at 5 mg/kg concentration,Intermediate
,,,,,1,,,N,50588,14548,1,9615.0,11700,,BAO_0000218,Canis lupus familiaris,,CHEMBL622515,A,,Pharmacokinetic parameter AUC calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,Intermediate
,,,,,1,,,N,50588,14548,1,9615.0,11701,,BAO_0000218,Canis lupus familiaris,,CHEMBL622516,A,,Pharmacokinetic parameter AUC calculated in dog when the compound was administered po at 5 mg/kg concentration,Intermediate
,,,,,1,,,N,50597,14548,1,10116.0,11702,,BAO_0000218,Rattus norvegicus,,CHEMBL622517,A,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,Intermediate
,,,,,1,,,N,50597,14548,1,10116.0,11703,,BAO_0000218,Rattus norvegicus,,CHEMBL622518,A,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 12 mg/kg concentration,Intermediate
,,,,,1,,,N,50597,14548,1,10116.0,11704,,BAO_0000218,Rattus norvegicus,,CHEMBL622519,A,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 20 mg/kg concentration,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,14608,1,10116.0,11705,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL622520,A,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,14608,1,10116.0,11706,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL622521,A,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate
,In vivo,Zone of skin,,,1,,,N,50594,14608,1,10090.0,11707,,BAO_0000218,Mus musculus,14.0,CHEMBL625113,A,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate
,In vivo,Zone of skin,,,1,,,N,50597,14608,1,10116.0,11708,,BAO_0000218,Rattus norvegicus,14.0,CHEMBL625114,A,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate
,In vivo,Zone of skin,,,1,,,N,50597,14608,1,10116.0,11709,,BAO_0000218,Rattus norvegicus,14.0,CHEMBL874397,A,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate
,In vivo,Spleen,,,1,,,N,50597,14608,1,10116.0,11710,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL625115,A,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate
,In vivo,Spleen,,,1,,,N,50597,14608,1,10116.0,11711,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL625116,A,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate
,In vivo,Spleen,,,1,,,N,50597,14608,1,10116.0,11712,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL623932,A,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate
,In vivo,Striatum,,,1,,,N,50597,14608,1,10116.0,11713,,BAO_0000218,Rattus norvegicus,2435.0,CHEMBL623933,A,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate
,In vivo,Striatum,,,1,,,N,50597,14608,1,10116.0,11714,,BAO_0000218,Rattus norvegicus,2435.0,CHEMBL623934,A,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate
,In vivo,Striatum,,,1,,,N,50597,14608,1,10116.0,11715,,BAO_0000218,Rattus norvegicus,2435.0,CHEMBL623935,A,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate
,In vivo,Thyroid gland,,,1,,,N,50597,14608,1,10116.0,11716,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL623936,A,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate
,In vivo,Thyroid gland,,,1,,,N,50597,14608,1,10116.0,11717,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL623937,A,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate
,In vivo,Thyroid gland,,,1,,,N,50597,14608,1,10116.0,11718,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL623938,A,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate
,,,,,1,,,N,50594,15383,1,10090.0,11719,,BAO_0000218,Mus musculus,,CHEMBL623939,A,,In vivo biodistribution in mice blood bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Intermediate
,,,,,1,,,N,50594,15383,1,10090.0,11720,,BAO_0000218,Mus musculus,,CHEMBL623940,A,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 10 ug/g,Intermediate
,,,,,1,,,N,50594,15383,1,10090.0,11721,,BAO_0000218,Mus musculus,,CHEMBL623941,A,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 20 ug/g,Intermediate
,,,,,1,,,N,50594,15383,1,10090.0,11722,,BAO_0000218,Mus musculus,,CHEMBL627216,A,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Intermediate
,,,,,1,,,N,50594,15383,1,10090.0,11723,,BAO_0000218,Mus musculus,,CHEMBL623942,A,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Intermediate
,,Brain,,,1,,,N,50594,15383,1,10090.0,11724,,BAO_0000218,Mus musculus,955.0,CHEMBL618793,A,,In vivo biodistribution in mice brain bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Intermediate
,,Brain,,,1,,,N,50594,15383,1,10090.0,11725,,BAO_0000218,Mus musculus,955.0,CHEMBL618794,A,,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Intermediate
,,Brain,,,1,,,N,50594,15383,1,10090.0,11726,,BAO_0000218,Mus musculus,955.0,CHEMBL618795,A,,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Intermediate
,,,,,1,,,N,50594,15383,1,10090.0,11727,,BAO_0000218,Mus musculus,,CHEMBL618796,A,,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Intermediate
,,,,,1,,,N,50594,15383,1,10090.0,11728,,BAO_0000218,Mus musculus,,CHEMBL618797,A,,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Intermediate
,,Kidney,,,1,,,N,50594,15383,1,10090.0,11729,,BAO_0000218,Mus musculus,2113.0,CHEMBL618798,A,,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,Intermediate
,,Kidney,,,1,,,N,50594,15383,1,10090.0,11730,,BAO_0000218,Mus musculus,2113.0,CHEMBL618799,A,,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Intermediate
,,Kidney,,,1,,,N,50594,15383,1,10090.0,11731,,BAO_0000218,Mus musculus,2113.0,CHEMBL618800,A,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 10 ug/g,Intermediate
,,Kidney,,,1,,,N,50594,15383,1,10090.0,11732,,BAO_0000218,Mus musculus,2113.0,CHEMBL618801,A,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 20 ug/g,Intermediate
,,Kidney,,,1,,,N,50594,15383,1,10090.0,11733,,BAO_0000218,Mus musculus,2113.0,CHEMBL618802,A,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Intermediate
,,Kidney,,,1,,,N,50594,15383,1,10090.0,11734,,BAO_0000218,Mus musculus,2113.0,CHEMBL618803,A,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Intermediate
,,Liver,,,1,,,N,50594,15383,1,10090.0,11735,,BAO_0000218,Mus musculus,2107.0,CHEMBL618804,A,,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,Intermediate
,,Liver,,,1,,,N,50594,15383,1,10090.0,11736,,BAO_0000218,Mus musculus,2107.0,CHEMBL618805,A,,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Intermediate
,,Liver,,,1,,,N,50594,15383,1,10090.0,11737,,BAO_0000218,Mus musculus,2107.0,CHEMBL618806,A,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 10 ug/g,Intermediate
,,Liver,,,1,,,N,50594,15383,1,10090.0,11738,,BAO_0000218,Mus musculus,2107.0,CHEMBL618807,A,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 20 ug/g,Intermediate
,,Liver,,,1,,,N,50594,15383,1,10090.0,11739,,BAO_0000218,Mus musculus,2107.0,CHEMBL618808,A,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Intermediate
,,Liver,,,1,,,N,50594,15383,1,10090.0,11740,,BAO_0000218,Mus musculus,2107.0,CHEMBL618809,A,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Intermediate
,,Muscle tissue,,,1,,,N,50594,15383,1,10090.0,11741,,BAO_0000218,Mus musculus,2385.0,CHEMBL618810,A,,In vivo biodistribution in mice muscle bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Intermediate
,,Muscle tissue,,,1,,,N,50594,15383,1,10090.0,11742,,BAO_0000218,Mus musculus,2385.0,CHEMBL618811,A,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 10 ug/g,Intermediate
,,Muscle tissue,,,1,,,N,50594,15383,1,10090.0,11743,,BAO_0000218,Mus musculus,2385.0,CHEMBL875844,A,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 20 ug/g,Intermediate
,,Muscle tissue,,,1,,,N,50594,15383,1,10090.0,11744,,BAO_0000218,Mus musculus,2385.0,CHEMBL618812,A,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Intermediate
,,Muscle tissue,,,1,,,N,50594,15383,1,10090.0,11745,,BAO_0000218,Mus musculus,2385.0,CHEMBL618813,A,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Intermediate
,,,,,1,,,N,50594,15383,1,10090.0,11746,,BAO_0000218,Mus musculus,,CHEMBL618814,A,,In vivo biodistribution in mice skin bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Intermediate
,,,,,1,,,N,50594,15383,1,10090.0,11747,,BAO_0000218,Mus musculus,,CHEMBL618815,A,,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Intermediate
,,,,,1,,,N,50594,15383,1,10090.0,11748,,BAO_0000218,Mus musculus,,CHEMBL618816,A,,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Intermediate
,,,,,1,,,N,50594,15383,1,10090.0,11749,,BAO_0000218,Mus musculus,,CHEMBL618817,A,,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Intermediate
,,,,,1,,,N,50594,15383,1,10090.0,11750,,BAO_0000218,Mus musculus,,CHEMBL620544,A,,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Intermediate
,In vivo,,,,1,,,N,50597,15341,1,10116.0,11751,,BAO_0000218,Rattus norvegicus,,CHEMBL626230,A,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intraperitoneal administration.,Intermediate
,In vivo,,,,1,,,N,50597,15341,1,10116.0,11752,,BAO_0000218,Rattus norvegicus,,CHEMBL626231,A,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intravenous administration.,Intermediate
,In vivo,,,,1,,,N,50597,15341,1,10116.0,11753,,BAO_0000218,Rattus norvegicus,,CHEMBL626232,A,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after peroral administration.,Intermediate
,In vivo,Plasma,,,1,,,N,50588,14906,1,9615.0,11754,,BAO_0000218,Canis lupus familiaris,1969.0,CHEMBL626233,A,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on dog.,Intermediate
,In vivo,Plasma,,,1,,,N,50597,14906,1,10116.0,11755,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626234,A,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat,Intermediate
,In vivo,Plasma,,,1,,,N,50597,14906,1,10116.0,11756,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL875341,A,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat.,Intermediate
,In vivo,Plasma,,,1,,,N,50587,14215,1,9606.0,11757,,BAO_0000218,Homo sapiens,1969.0,CHEMBL626235,A,,The maximum plasma concentration (100 mg/kg) administered orally in human,Intermediate
,In vivo,Plasma,,,0,,,U,22224,14215,1,9481.0,11758,,BAO_0000218,Callithrix,1969.0,CHEMBL626236,A,,The maximum plasma concentration (12.5 mg/kg) administered intravenously in marmoset,Autocuration
,In vivo,Plasma,,,0,,,U,22224,14215,1,314293.0,11759,,BAO_0000218,Simiiformes,1969.0,CHEMBL626237,A,,The maximum plasma concentration (12.5 mg/kg) administered intravenously in monkey,Autocuration
,In vivo,Plasma,,,1,,,N,50588,14215,1,9615.0,11760,,BAO_0000218,Canis lupus familiaris,1969.0,CHEMBL626238,A,,The maximum plasma concentration (15 mg/kg) administered intravenously in dog,Intermediate
,In vivo,Plasma,,,1,,,N,50587,14215,1,9606.0,11761,,BAO_0000218,Homo sapiens,1969.0,CHEMBL622412,A,,The maximum plasma concentration (200 mg/kg) administered orally in human,Intermediate
,In vivo,Plasma,,,1,,,N,50597,14215,1,10116.0,11762,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623114,A,,The maximum plasma concentration (25 mg/kg) administered intravenously in rat,Intermediate
,In vivo,Plasma,,,0,,,U,22224,14215,1,9481.0,11763,,BAO_0000218,Callithrix,1969.0,CHEMBL623115,A,,The maximum plasma concentration (25 mg/kg) administered orally in marmoset,Autocuration
,In vivo,Plasma,,,0,,,U,22224,14215,1,314293.0,11764,,BAO_0000218,Simiiformes,1969.0,CHEMBL623116,A,,The maximum plasma concentration (25 mg/kg) administered orally in monkey,Autocuration
,In vivo,Plasma,,,0,,,U,22224,14215,1,9615.0,11765,,BAO_0000218,Canis lupus familiaris,1969.0,CHEMBL623117,A,,The maximum plasma concentration (30 mg/kg) administered orally in dog,Autocuration
,In vivo,Plasma,,,1,,,N,50587,14215,1,9606.0,11766,,BAO_0000218,Homo sapiens,1969.0,CHEMBL623118,A,,The maximum plasma concentration (400 mg/kg) administered orally in human,Intermediate
,In vivo,Plasma,,,1,,,N,50597,14215,1,10116.0,11767,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623119,A,,The maximum plasma concentration (50 mg/kg) administered orally in fasted rat,Intermediate
,In vivo,Plasma,,,1,,,N,50597,14215,1,10116.0,11768,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623120,A,,The maximum plasma concentration (50 mg/kg) administered orally in rat,Intermediate
,In vivo,Plasma,,,1,,,N,50587,14215,1,9606.0,11769,,BAO_0000218,Homo sapiens,1969.0,CHEMBL623286,A,,The maximum plasma concentration (800 mg/kg) administered orally in human,Intermediate
,In vivo,Plasma,,,1,,,N,50597,14067,1,10116.0,11770,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623287,A,,The maximum plasma concentration was measured on rats,Intermediate
,In vivo,Plasma,,,1,,,N,50597,12350,1,10116.0,11771,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623288,A,,The maximum plasma concentration was measured on rats after oral administration,Intermediate
,In vivo,Plasma,,,1,,,N,50597,14813,1,10116.0,11772,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623289,A,,Plasma drug Cmax in rat (PO dose),Intermediate
,In vivo,,,,0,,,U,22224,12536,1,,11773,,BAO_0000218,,,CHEMBL623290,A,,Time taken to reach maximum concentration after administration of 2 umol/kg dose intravenously,Autocuration
,In vivo,Plasma,,,1,,,N,50588,14169,1,9615.0,11774,,BAO_0000218,Canis lupus familiaris,1969.0,CHEMBL623291,A,,maximum Plasma concentration in Dog was determined after Peroral administration,Intermediate
,In vivo,Plasma,,,1,,,N,50597,14169,1,10116.0,11775,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623292,A,,maximum Plasma concentration in Rats was determined after Peroral administration,Intermediate
,In vivo,Plasma,,,1,,,N,50588,15604,1,9615.0,11776,,BAO_0000218,Canis lupus familiaris,1969.0,CHEMBL623293,A,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,Intermediate
,In vivo,Plasma,,,0,,,U,22224,15604,1,314293.0,11777,,BAO_0000218,Simiiformes,1969.0,CHEMBL623294,A,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,Autocuration
,In vivo,Plasma,,,1,,,N,50597,15604,1,10116.0,11778,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623295,A,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,Intermediate
,In vivo,,,,1,,,N,50594,14387,1,10090.0,11779,,BAO_0000218,Mus musculus,,CHEMBL623296,A,,maximum concentration was measured when administered through oral route in mice,Intermediate
,,,,,1,,,N,50594,15115,1,10090.0,11780,,BAO_0000218,Mus musculus,,CHEMBL875349,A,,Compound was evaluated for Cmax/Tmax when administered through oral route in mouse; Value is 0.93/1,Intermediate
,,,,,0,,,U,22224,15115,1,314293.0,11781,,BAO_0000019,Simiiformes,,CHEMBL623297,A,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.34/1,Autocuration
,,,,,0,,,U,22224,15115,1,314293.0,11782,,BAO_0000019,Simiiformes,,CHEMBL623298,A,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.81/1.6,Autocuration
,,,,,0,,,U,22224,15115,1,314293.0,11783,,BAO_0000019,Simiiformes,,CHEMBL623299,A,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 1.1/1.3,Autocuration
,,,,,1,,,N,50597,16359,1,10116.0,11784,,BAO_0000218,Rattus norvegicus,,CHEMBL623300,A,,Pharmacokinetic parameter was evaluated in rats,Intermediate
,,,,,1,,,N,50594,12829,1,10090.0,11785,,BAO_0000218,Mus musculus,,CHEMBL623301,A,,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,Intermediate
,,,,,1,,,N,50594,12829,1,10090.0,11786,,BAO_0000218,Mus musculus,,CHEMBL623302,A,,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle,Intermediate
,,,,,1,,,N,50594,12829,1,10090.0,11787,,BAO_0000218,Mus musculus,,CHEMBL623303,A,,Plasma concentration at time-0 was measured in mice at 120 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,Intermediate
,,,,,1,,,N,50594,12829,1,10090.0,11788,,BAO_0000218,Mus musculus,,CHEMBL623304,A,,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle,Intermediate
,,,,,1,,,N,50594,12829,1,10090.0,11789,,BAO_0000218,Mus musculus,,CHEMBL623305,A,,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with 90% DMSO as vehicle,Intermediate
,,Plasma,,,1,,,N,50597,15137,1,10116.0,11790,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623306,A,,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats(Cerebral Cortex) after 30 min.,Intermediate
,,Plasma,,,1,,,N,50597,15137,1,10116.0,11791,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623307,A,,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats(Cerebral Cortex) after 30 min.,Intermediate
,,Plasma,,,1,,,N,50597,15137,1,10116.0,11792,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL623308,A,,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats(Cerebral Cortex) after 30 min.,Intermediate
,,Plasma,,,1,,,N,50594,15137,1,10090.0,11793,,BAO_0000218,Mus musculus,1969.0,CHEMBL623309,A,,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats(Cerebral Cortex) after 30 min.,Intermediate
,,,,,1,,,N,50594,13509,1,10090.0,11794,,BAO_0000218,Mus musculus,,CHEMBL623310,A,,Plasma Concentration after 120 min of oral administration to mice,Intermediate
,,,,,1,,,N,50594,13509,1,10090.0,11795,,BAO_0000218,Mus musculus,,CHEMBL623311,A,,Plasma Concentration after 30 min of oral administration to mice,Intermediate
,,,,,1,,,N,100710,13509,1,9541.0,11796,,BAO_0000218,Macaca fascicularis,,CHEMBL623312,A,,Plasma Concentration after 60 min of oral administration to mice,Intermediate
,,,,,1,,,N,50594,13509,1,10090.0,11797,,BAO_0000218,Mus musculus,,CHEMBL875350,A,,Plasma Concentration after 60 min of oral administration to mice; Not determined,Intermediate
,,,,,1,,,N,50594,13509,1,10090.0,11798,,BAO_0000218,Mus musculus,,CHEMBL628635,A,,Plasma Concentration after 90 min of oral administration to mice,Intermediate
,,,,,1,,,N,50597,12064,1,10116.0,11799,,BAO_0000218,Rattus norvegicus,,CHEMBL628636,A,,Plasma concentration level in rat after 1 hour of oral administration at 50 mg/kg,Intermediate
,,,,,1,,,N,50597,12064,1,10116.0,11800,,BAO_0000218,Rattus norvegicus,,CHEMBL628637,A,,Plasma concentration level in rat after 15 hours of oral administration at 50 mg/kg,Intermediate
,,,,,1,,,N,50597,12064,1,10116.0,11801,,BAO_0000218,Rattus norvegicus,,CHEMBL628058,A,,Plasma concentration level in rat after 4 hours of oral administration at 50 mg/kg,Intermediate
,,,,,1,,,N,50597,10677,1,10116.0,11802,,BAO_0000218,Rattus norvegicus,,CHEMBL628059,A,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 0-1 hr time,Intermediate
,,,,,1,,,N,50597,10677,1,10116.0,11803,,BAO_0000218,Rattus norvegicus,,CHEMBL628060,A,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 1-2 hr time,Intermediate
,,,,,0,,,U,22224,8926,1,,11804,,BAO_0000019,,,CHEMBL628061,A,,Distribution in the lung after 15 min of intravenous administration,Autocuration
,,,,,0,,,U,22224,8926,1,,11805,,BAO_0000019,,,CHEMBL628062,A,,Distribution in the lung after 30 min of intravenous administration,Autocuration
,,,,,0,,,U,22224,8926,1,,11806,,BAO_0000019,,,CHEMBL628063,A,,Distribution in the lung after 5 min of intravenous administration,Autocuration
,,,,,0,,,U,22224,8926,1,,11807,,BAO_0000019,,,CHEMBL628064,A,,Distribution in the lung after 60 min of intravenous administration,Autocuration
,,,,,0,,,U,22224,8926,1,,11808,,BAO_0000019,,,CHEMBL628065,A,,Distribution in the lung after 90 min of intravenous administration,Autocuration
,,Muscle tissue,,,0,,,U,22224,8926,1,,11809,,BAO_0000019,,2385.0,CHEMBL628066,A,,Distribution in the muscle after 120 min of intravenous administration,Autocuration
,,Muscle tissue,,,0,,,U,22224,8926,1,,11810,,BAO_0000019,,2385.0,CHEMBL628067,A,,Distribution in the muscle after 15 min of intravenous administration,Autocuration
,,Muscle tissue,,,1,,,N,50594,8926,1,10090.0,11811,,BAO_0000218,Mus musculus,2385.0,CHEMBL874646,A,,Distribution in the muscle after 30 min of intravenous administration,Intermediate
,,Muscle tissue,,,0,,,U,22224,8926,1,,11812,,BAO_0000019,,2385.0,CHEMBL628068,A,,Distribution in the muscle after 5 min of intravenous administration,Autocuration
,,Muscle tissue,,,0,,,U,22224,8926,1,,11813,,BAO_0000019,,2385.0,CHEMBL628069,A,,Distribution in the muscle after 60 min of intravenous administration,Autocuration
,,Muscle tissue,,,0,,,U,22224,8926,1,,11814,,BAO_0000019,,2385.0,CHEMBL628070,A,,Distribution in the muscle after 90 min of intravenous administration,Autocuration
,,Spleen,,,0,,,U,22224,8926,1,,11815,,BAO_0000019,,2106.0,CHEMBL628071,A,,Distribution in the spleen after 120 min of intravenous administration,Autocuration
,,Spleen,,,0,,,U,22224,8926,1,,11816,,BAO_0000019,,2106.0,CHEMBL628072,A,,Distribution in the spleen after 15 min of intravenous administration,Autocuration
,,Spleen,,,0,,,U,22224,8926,1,,11817,,BAO_0000019,,2106.0,CHEMBL628073,A,,Distribution in the spleen after 30 min of intravenous administration,Autocuration
,,Spleen,,,0,,,U,22224,8926,1,,11818,,BAO_0000019,,2106.0,CHEMBL628074,A,,Distribution in the spleen after 5 min of intravenous administration,Autocuration
,,Spleen,,,0,,,U,22224,8926,1,,11819,,BAO_0000019,,2106.0,CHEMBL628075,A,,Distribution in the spleen after 60 min of intravenous administration,Autocuration
,,Spleen,,,0,,,U,22224,8926,1,,11820,,BAO_0000019,,2106.0,CHEMBL628076,A,,Distribution in the spleen after 90 min of intravenous administration,Autocuration
,,Adrenal cortex,,,1,,,N,50597,7570,1,10116.0,11821,,BAO_0000218,Rattus norvegicus,1235.0,CHEMBL628077,A,,Evaluated for distribution at 0.5 hr after intravenous administration in adrenal cortex of female Sprague Dawley rats,Intermediate
,,Blood,,,1,,,N,50597,7570,1,10116.0,11822,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL628078,A,,Evaluated for distribution at 0.5 hr after intravenous administration in blood of female Sprague Dawley rats,Intermediate
,,Liver,,,1,,,N,50597,7570,1,10116.0,11823,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL628079,A,,Evaluated for distribution at 0.5 hr after intravenous administration in liver of female Sprague Dawley rats,Intermediate
,,Female gonad,,,1,,,N,50597,7570,1,10116.0,11824,,BAO_0000218,Rattus norvegicus,992.0,CHEMBL628080,A,,Evaluated for distribution at 0.5 hr after intravenous administration in ovary of female Sprague Dawley rats,Intermediate
,,Thyroid gland,,,1,,,N,50597,7570,1,10116.0,11825,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL628081,A,,Evaluated for distribution at 0.5 hr after intravenous administration in thyroid of female Sprague Dawley rats,Intermediate
,,Adrenal cortex,,,1,,,N,50597,7570,1,10116.0,11826,,BAO_0000218,Rattus norvegicus,1235.0,CHEMBL628082,A,,Evaluated for distribution at 24 hours after intravenous administration in adrenal cortex of female Sprague Dawley rats,Intermediate
,,Blood,,,1,,,N,50597,7570,1,10116.0,11827,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL874647,A,,Evaluated for distribution at 24 hours after intravenous administration in blood of female Sprague Dawley rats,Intermediate
,,Liver,,,1,,,N,50597,7570,1,10116.0,11828,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL626406,A,,Evaluated for distribution at 24 hours after intravenous administration in liver of female Sprague Dawley rats,Intermediate
,,Female gonad,,,1,,,N,50597,7570,1,10116.0,11829,,BAO_0000218,Rattus norvegicus,992.0,CHEMBL626407,A,,Evaluated for distribution at 24 hours after intravenous administration in ovary of female Sprague Dawley rats,Intermediate
,,Thyroid gland,,,1,,,N,50597,7570,1,10116.0,11830,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL626408,A,,Evaluated for distribution at 24 hours after intravenous administration in thyroid of female Sprague Dawley rats,Intermediate
,,Blood,,,1,,,N,50597,8608,1,10116.0,11831,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL626409,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.07-0.09",Intermediate
,,Blood,,,1,,,N,50597,8608,1,10116.0,11832,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL626410,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.10-0.13",Intermediate
,,Blood,,,1,,,N,50597,8608,1,10116.0,11833,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL626411,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.18-0.24",Intermediate
,,Blood,,,1,,,N,50597,8608,1,10116.0,11834,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL626412,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.19-0.24",Intermediate
,,Blood,,,1,,,N,50597,8608,1,10116.0,11835,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL626413,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.22-0.32",Intermediate
,,Blood,,,1,,,N,50597,8608,1,10116.0,11836,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL626414,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.25-0.32",Intermediate
,,Blood,,,1,,,N,50597,8608,1,10116.0,11837,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL626415,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.10-0.14",Intermediate
,,Blood,,,1,,,N,50597,8608,1,10116.0,11838,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL626416,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.25-0.34",Intermediate
,,Blood,,,1,,,N,50597,8608,1,10116.0,11839,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL627062,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.27-0.33",Intermediate
,,Blood,,,1,,,N,50597,8608,1,10116.0,11840,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL627063,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.32-0.46",Intermediate
,,Blood,,,1,,,N,50597,8608,1,10116.0,11841,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL627064,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.40-0.45",Intermediate
,,Blood,,,1,,,N,50597,8608,1,10116.0,11842,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL627227,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.44-0.52",Intermediate
,,Blood,,,1,,,N,50597,8608,1,10116.0,11843,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL627228,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.08-0.09",Intermediate
,,Blood,,,1,,,N,50597,8608,1,10116.0,11844,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL627229,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.12-0.14",Intermediate
,,Blood,,,1,,,N,50597,8608,1,10116.0,11845,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL625792,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.13-0.15",Intermediate
,,Blood,,,1,,,N,50597,8608,1,10116.0,11846,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL625793,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.20",Intermediate
,,Blood,,,1,,,N,50597,8608,1,10116.0,11847,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL625794,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.23",Intermediate
,,Blood,,,1,,,N,50597,8608,1,10116.0,11848,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL625795,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.16-0.21",Intermediate
,,,,,1,,,N,50594,13792,1,10090.0,11849,,BAO_0000218,Mus musculus,,CHEMBL625796,A,,Pharmacokinetic parameter AUC for the compound after intravenous administration into BALB/c Mice in plasma samples.,Intermediate
,,,,,1,,,N,50588,13376,1,9615.0,11850,,BAO_0000218,Canis lupus familiaris,,CHEMBL625797,A,,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 375 mg/kg,Intermediate
,,,,,1,,,N,50588,13376,1,9615.0,11851,,BAO_0000218,Canis lupus familiaris,,CHEMBL625798,A,,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 500 mg/kg,Intermediate
,,,,,0,,,U,22224,14380,1,,11852,,BAO_0000218,,,CHEMBL875613,A,,Pharmacokinetic parameter AUC evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,Autocuration
,,,,,0,,,U,22224,14380,1,,11853,,BAO_0000218,,,CHEMBL625799,A,,Pharmacokinetic parameter AUC was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,Autocuration
,,,,,0,,,U,22224,14380,1,,11854,,BAO_0000218,,,CHEMBL625800,A,,Pharmacokinetic parameter AUC was evaluated in 10% PEG suspension at a dose of 20 mg/kg orally,Autocuration
,,,,,0,,,U,22224,14380,1,,11855,,BAO_0000218,,,CHEMBL625801,A,,Pharmacokinetic parameter AUC was evaluated in 100% PEG solution at a dose of 20 mg/kg orally,Autocuration
,,,,,0,,,U,22224,14380,1,,11856,,BAO_0000218,,,CHEMBL625802,A,,Pharmacokinetic parameter AUC was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,Autocuration
,,,,,0,,,U,22224,14380,1,,11857,,BAO_0000218,,,CHEMBL625803,A,,Pharmacokinetic parameter AUC was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,Autocuration
,,,,,0,,,U,22224,14380,1,,11858,,BAO_0000019,,,CHEMBL625804,A,,Pharmacokinetic parameter AUC was evaluated in Hp-beta-CD solution,Autocuration
,,,,,0,,,U,22224,14380,1,,11859,,BAO_0000218,,,CHEMBL622530,A,,Pharmacokinetic parameter AUC was evaluated in saline solution at a dose of 20 mg/kg orally,Autocuration
,,,,,1,,,N,50594,13701,1,10090.0,11860,,BAO_0000218,Mus musculus,,CHEMBL622531,A,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h); not detected,Intermediate
,,,,,1,,,N,50594,13701,1,10090.0,11861,,BAO_0000218,Mus musculus,,CHEMBL622532,A,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),Intermediate
,,,,,1,,,N,50594,13701,1,10090.0,11862,,BAO_0000218,Mus musculus,,CHEMBL623176,A,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),Intermediate
,,,,,1,,,N,50594,13701,1,10090.0,11863,,BAO_0000218,Mus musculus,,CHEMBL623177,A,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),Intermediate
,,,,,1,,,N,50594,13701,1,10090.0,11864,,BAO_0000218,Mus musculus,,CHEMBL623178,A,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),Intermediate
,,,,,1,,,N,50594,13701,1,10090.0,11865,,BAO_0000218,Mus musculus,,CHEMBL623179,A,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration using FMAddA as substrate in mice brain; AUC 0-r (mM.h); not detected,Intermediate
,,,,,1,,,N,50594,13701,1,10090.0,11866,,BAO_0000218,Mus musculus,,CHEMBL623180,A,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),Intermediate
,,,,,1,,,N,50594,13701,1,10090.0,11867,,BAO_0000218,Mus musculus,,CHEMBL623181,A,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),Intermediate
,,,,,1,,,N,50594,13701,1,10090.0,11868,,BAO_0000218,Mus musculus,,CHEMBL624131,A,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),Intermediate
,,,,,1,,,N,50594,13701,1,10090.0,11869,,BAO_0000218,Mus musculus,,CHEMBL624132,A,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration using 2`-F-ara-ddI as substrate in mice serum; AUC (mM.h),Intermediate
,,,,,1,,,N,50594,13701,1,10090.0,11870,,BAO_0000218,Mus musculus,,CHEMBL624133,A,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),Intermediate
,,,,,1,,,N,50594,13701,1,10090.0,11871,,BAO_0000218,Mus musculus,,CHEMBL624846,A,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h).,Intermediate
,,,,,1,,,N,50594,13701,1,10090.0,11872,,BAO_0000218,Mus musculus,,CHEMBL624847,A,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),Intermediate
,,,,,1,,,N,50594,13701,1,10090.0,11873,,BAO_0000218,Mus musculus,,CHEMBL624848,A,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),Intermediate
,,,,,1,,,N,50594,13701,1,10090.0,11874,,BAO_0000218,Mus musculus,,CHEMBL625012,A,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),Intermediate
,,,,,1,,,N,50594,13701,1,10090.0,11875,,BAO_0000218,Mus musculus,,CHEMBL625013,A,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),Intermediate
,,,,,1,,,N,50594,13701,1,10090.0,11876,,BAO_0000218,Mus musculus,,CHEMBL625014,A,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain; AUC 0-r (mM.h); not detected,Intermediate
,,,,,1,,,N,50594,13701,1,10090.0,11877,,BAO_0000218,Mus musculus,,CHEMBL625015,A,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC (mM.h),Intermediate
,,,,,1,,,N,50594,13701,1,10090.0,11878,,BAO_0000218,Mus musculus,,CHEMBL625016,A,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),Intermediate
,,,,,1,,,N,50594,13701,1,10090.0,11879,,BAO_0000218,Mus musculus,,CHEMBL625017,A,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral in mice brain; AUC (mM.h); not detected,Intermediate
,,,,,1,,,N,50594,13701,1,10090.0,11880,,BAO_0000218,Mus musculus,,CHEMBL625018,A,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),Intermediate
,,,,,1,,,N,50594,13701,1,10090.0,11881,,BAO_0000218,Mus musculus,,CHEMBL625019,A,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration mice serum.; AUC 0-r (mM.h),Intermediate
,,,,,1,,,N,50594,13701,1,10090.0,11882,,BAO_0000218,Mus musculus,,CHEMBL625020,A,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain.; AUC 0-r (mM.h),Intermediate
,,,,,1,,,N,50594,13701,1,10090.0,11883,,BAO_0000218,Mus musculus,,CHEMBL625021,A,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum.,Intermediate
,,,,,1,,,N,50597,14393,1,10116.0,11884,,BAO_0000218,Rattus norvegicus,,CHEMBL625022,A,,Pharmacokinetic parameter [area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,Intermediate
,,,,,1,,,N,50594,14731,1,10090.0,11885,,BAO_0000218,Mus musculus,,CHEMBL625023,A,,Pharmacokinetic parameter area under the curve (0-24 hr) for the compound was evaluated in nude mice after oral administration. ,Intermediate
,,,,,1,,,N,100710,14731,1,9541.0,11886,,BAO_0000218,Macaca fascicularis,,CHEMBL625024,A,,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration,Intermediate
,,,,,1,,,N,100710,14731,1,9541.0,11887,,BAO_0000218,Macaca fascicularis,,CHEMBL627626,A,,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,Intermediate
,,Brain,,,0,,,U,22224,13758,1,,11888,,BAO_0000218,,955.0,CHEMBL627627,A,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,Autocuration
,,Serum,,,0,,,U,22224,13758,1,,11889,,BAO_0000218,,1977.0,CHEMBL627628,A,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in serum,Autocuration
,,Brain,,,0,,,U,22224,13758,1,,11890,,BAO_0000218,,955.0,CHEMBL627629,A,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,Autocuration
,,Serum,,,0,,,U,22224,13758,1,,11891,,BAO_0000218,,1977.0,CHEMBL627630,A,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in serum,Autocuration
,,,,,0,,,U,22224,16359,1,,11892,,BAO_0000019,,,CHEMBL627631,A,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/Kg orally; range (0.19-0.35),Autocuration
,,,,,0,,,U,22224,16359,1,,11893,,BAO_0000218,,,CHEMBL629515,A,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/kg intravenously; range (2.1-2.3),Autocuration
,,Spleen,,,1,,,N,50594,15383,1,10090.0,11894,,BAO_0000218,Mus musculus,2106.0,CHEMBL629516,A,,In vivo biodistribution in mice spleen bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Intermediate
,,Spleen,,,1,,,N,50594,15383,1,10090.0,11895,,BAO_0000218,Mus musculus,2106.0,CHEMBL629517,A,,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Intermediate
,,Spleen,,,1,,,N,50594,15383,1,10090.0,11896,,BAO_0000218,Mus musculus,2106.0,CHEMBL629518,A,,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Intermediate
,,,,,1,,,N,50594,15383,1,10090.0,11897,,BAO_0000218,Mus musculus,,CHEMBL877499,A,,In vivo biodistribution in mice tumor bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Intermediate
,,,,,1,,,N,50594,15383,1,10090.0,11898,,BAO_0000218,Mus musculus,,CHEMBL629519,A,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 20 ug/g,Intermediate
,,,,,1,,,N,50594,15383,1,10090.0,11899,,BAO_0000218,Mus musculus,,CHEMBL629520,A,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Intermediate
,,,,,1,,,N,50594,15383,1,10090.0,11900,,BAO_0000218,Mus musculus,,CHEMBL629521,A,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Intermediate
,,,,,1,,,N,50594,14439,1,10090.0,11901,,BAO_0000218,Mus musculus,,CHEMBL629522,A,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Blood (B),Intermediate
,,,,,1,,,N,50594,14439,1,10090.0,11902,,BAO_0000218,Mus musculus,,CHEMBL629523,A,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Lung (L),Intermediate
,,,,,1,,,N,50594,14439,1,10090.0,11903,,BAO_0000218,Mus musculus,,CHEMBL629524,A,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and Muscle (M),Intermediate
,,,,,1,,,N,50594,14439,1,10090.0,11904,,BAO_0000218,Mus musculus,,CHEMBL629525,A,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and blood (B),Intermediate
,,,,,1,,,N,50594,14439,1,10090.0,11905,,BAO_0000218,Mus musculus,,CHEMBL629526,A,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Blood (B),Intermediate
,,,,,1,,,N,50594,14439,1,10090.0,11906,,BAO_0000218,Mus musculus,,CHEMBL629527,A,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Lung (L),Intermediate
,,,,,1,,,N,50594,14439,1,10090.0,11907,,BAO_0000218,Mus musculus,,CHEMBL629528,A,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and Muscle (M),Intermediate
,,,,,1,,,N,50594,14439,1,10090.0,11908,,BAO_0000218,Mus musculus,,CHEMBL629529,A,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and blood (B),Intermediate
,,,,,1,,,N,50594,14439,1,10090.0,11909,,BAO_0000218,Mus musculus,,CHEMBL629530,A,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Blood (B),Intermediate
,,,,,1,,,N,50594,14439,1,10090.0,11910,,BAO_0000218,Mus musculus,,CHEMBL629531,A,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Lung (L),Intermediate
,,,,,1,,,N,50594,14439,1,10090.0,11911,,BAO_0000218,Mus musculus,,CHEMBL628656,A,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and Muscle (M),Intermediate
,,,,,1,,,N,50594,14439,1,10090.0,11912,,BAO_0000218,Mus musculus,,CHEMBL628657,A,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and blood (B),Intermediate
,In vivo,,,,1,,,N,50597,13751,1,10116.0,11913,,BAO_0000218,Rattus norvegicus,,CHEMBL628658,A,,"Biodistribution in abdominal Dawley rat after 30min, expressed as percent injected dose/g",Intermediate
,In vivo,,,,1,,,N,50597,13751,1,10116.0,11914,,BAO_0000218,Rattus norvegicus,,CHEMBL628659,A,,"Biodistribution in abdominal of mature female Dawley rat after 10min, expressed as percent injected dose/g",Intermediate
,In vivo,,,,1,,,N,50597,13751,1,10116.0,11915,,BAO_0000218,Rattus norvegicus,,CHEMBL877500,A,,"Biodistribution in abdominal of mature female Dawley rat after 15min, expressed as percent injected dose/g",Intermediate
,In vivo,,,,1,,,N,50597,13751,1,10116.0,11916,,BAO_0000218,Rattus norvegicus,,CHEMBL628660,A,,"Biodistribution in abdominal of mature female Dawley rat after 1h, expressed as percent injected dose/g",Intermediate
,In vivo,,,,1,,,N,50597,13751,1,10116.0,11917,,BAO_0000218,Rattus norvegicus,,CHEMBL628661,A,,"Biodistribution in abdominal of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Intermediate
,In vivo,,,,1,,,N,50597,13751,1,10116.0,11918,,BAO_0000218,Rattus norvegicus,,CHEMBL628662,A,,"Biodistribution in abdominal of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate
,In vivo,,,,1,,,N,50597,13751,1,10116.0,11919,,BAO_0000218,Rattus norvegicus,,CHEMBL628663,A,,"Biodistribution in abdominal of mature female Dawley rat after 45min, expressed as percent injected dose/g",Intermediate
,In vivo,,,,1,,,N,50597,13751,1,10116.0,11920,,BAO_0000218,Rattus norvegicus,,CHEMBL628664,A,,"Biodistribution in abdominal of mature female Dawley rat after 5min, expressed as percent injected dose/g",Intermediate
,In vivo,Blood,,,1,,,N,50597,13751,1,10116.0,11921,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL628665,A,,"Biodistribution in blood of mature female Dawley rat after 10min, expressed as percent injected dose/g",Intermediate
,In vivo,Blood,,,1,,,N,50597,13751,1,10116.0,11922,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL628666,A,,"Biodistribution in blood of mature female Dawley rat after 15min, expressed as percent injected dose/g",Intermediate
,In vivo,Blood,,,1,,,N,50597,13751,1,10116.0,11923,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL628667,A,,"Biodistribution in blood of mature female Dawley rat after 1h, expressed as percent injected dose/g",Intermediate
,In vivo,Blood,,,1,,,N,50597,13751,1,10116.0,11924,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL628668,A,,"Biodistribution in blood of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Intermediate
,In vivo,Blood,,,1,,,N,50597,13751,1,10116.0,11925,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL628669,A,,"Biodistribution in blood of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate
,In vivo,Blood,,,1,,,N,50597,13751,1,10116.0,11926,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL628670,A,,"Biodistribution in blood of mature female Dawley rat after 45min, expressed as percent injected dose/g",Intermediate
,In vivo,Blood,,,1,,,N,50597,13751,1,10116.0,11927,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL628671,A,,"Biodistribution in blood of mature female Dawley rat after 5min, expressed as percent injected dose/g",Intermediate
,In vivo,Bone,,,1,,,N,50597,13751,1,10116.0,11928,,BAO_0000218,Rattus norvegicus,10000001.0,CHEMBL628672,A,,"Biodistribution in bone of mature female Dawley rat after 10min, expressed as percent injected dose/g",Intermediate
,In vivo,Bone,,,1,,,N,50597,13751,1,10116.0,11929,,BAO_0000218,Rattus norvegicus,10000001.0,CHEMBL630300,A,,"Biodistribution in bone of mature female Dawley rat after 1h, expressed as percent injected dose/g",Intermediate
,In vivo,Bone,,,1,,,N,50597,13751,1,10116.0,11930,,BAO_0000218,Rattus norvegicus,10000001.0,CHEMBL629787,A,,"Biodistribution in bone of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Intermediate
,In vivo,Bone,,,1,,,N,50597,13751,1,10116.0,11931,,BAO_0000218,Rattus norvegicus,10000001.0,CHEMBL629788,A,,"Biodistribution in bone of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate
,In vivo,Brain,,,1,,,N,50597,13751,1,10116.0,11932,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL629789,A,,"Biodistribution in brain of mature female Dawley rat after 10min, expressed as percent injected dose/g",Intermediate
,In vivo,Brain,,,1,,,N,50597,13751,1,10116.0,11933,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL629790,A,,"Biodistribution in brain of mature female Dawley rat after 15min, expressed as percent injected dose/g",Intermediate
,In vivo,Brain,,,1,,,N,50597,13751,1,10116.0,11934,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL629791,A,,"Biodistribution in brain of mature female Dawley rat after 1h, expressed as percent injected dose/g",Intermediate
,In vivo,Brain,,,1,,,N,50597,13751,1,10116.0,11935,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL629792,A,,"Biodistribution in brain of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Intermediate
,In vivo,Brain,,,1,,,N,50597,13751,1,10116.0,11936,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL629793,A,,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate
,In vivo,Brain,,,1,,,N,50597,13751,1,10116.0,11937,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL629794,A,,"Biodistribution in brain of mature female Dawley rat after 45min, expressed as percent injected dose/g",Intermediate
,,,,,1,,,N,50597,10677,1,10116.0,11938,,BAO_0000218,Rattus norvegicus,,CHEMBL874459,A,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 2-3 hr time,Intermediate
,,,,,1,,,N,50597,10677,1,10116.0,11939,,BAO_0000218,Rattus norvegicus,,CHEMBL629795,A,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 3-4 hr time,Intermediate
,,,,,1,,,N,50597,10677,1,10116.0,11940,,BAO_0000218,Rattus norvegicus,,CHEMBL629796,A,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 4-5 hr time,Intermediate
,,,,,1,,,N,50597,10677,1,10116.0,11941,,BAO_0000218,Rattus norvegicus,,CHEMBL629797,A,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 5-6 hr time,Intermediate
,,,,,1,,,N,50597,10677,1,10116.0,11942,,BAO_0000218,Rattus norvegicus,,CHEMBL629798,A,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 6-24 h time,Intermediate
,In vivo,Adrenal gland,,,1,,,N,50597,10911,1,10116.0,11943,,BAO_0000218,Rattus norvegicus,2369.0,CHEMBL629799,A,,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate
,In vivo,Adrenal gland,,,1,,,N,50597,10911,1,10116.0,11944,,BAO_0000218,Rattus norvegicus,2369.0,CHEMBL629800,A,,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate
,In vivo,Adrenal gland,,,1,,,N,50597,10911,1,10116.0,11945,,BAO_0000218,Rattus norvegicus,2369.0,CHEMBL629801,A,,Biodistribution studied in the adrenals of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate
,In vivo,Adrenal gland,,,1,,,N,50597,10911,1,10116.0,11946,,BAO_0000218,Rattus norvegicus,2369.0,CHEMBL629802,A,,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour,Intermediate
,In vivo,Adrenal gland,,,1,,,N,50597,10911,1,10116.0,11947,,BAO_0000218,Rattus norvegicus,2369.0,CHEMBL629803,A,,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate
,In vivo,Blood,,,1,,,N,50597,10911,1,10116.0,11948,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL629804,A,,Biodistribution studied in the blood of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate
,In vivo,Blood,,,1,,,N,50597,10911,1,10116.0,11949,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL629805,A,,Biodistribution studied in the blood of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate
,In vivo,Blood,,,1,,,N,50597,10911,1,10116.0,11950,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL629806,A,,Biodistribution studied in the blood of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,Intermediate
,In vivo,Blood,,,1,,,N,50597,10911,1,10116.0,11951,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL629807,A,,Biodistribution studied in the blood of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate
,In vivo,Blood,,,1,,,N,50597,10911,1,10116.0,11952,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL629808,A,,Biodistribution studied in the blood of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate
,In vivo,Brain,,,1,,,N,50597,10911,1,10116.0,11953,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL629809,A,,Biodistribution studied in the brain of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate
,In vivo,Brain,,,1,,,N,50597,10911,1,10116.0,11954,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL629810,A,,Biodistribution studied in the brain of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate
,In vivo,Brain,,,1,,,N,50597,10911,1,10116.0,11955,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL629811,A,,Biodistribution studied in the brain of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,Intermediate
,In vivo,Brain,,,1,,,N,50597,10911,1,10116.0,11956,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL629812,A,,Biodistribution studied in the brain of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate
,In vivo,Brain,,,1,,,N,50597,10911,1,10116.0,11957,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL629813,A,,Biodistribution studied in the brain of immature Fischer female rats at 5 hou; activity is expressed as inductive dose / gram,Intermediate
,In vivo,Brain,,,1,,,N,50597,10911,1,10116.0,11958,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL874460,A,,Biodistribution studied in the brain of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate
,In vivo,,,,1,,,N,50597,10911,1,10116.0,11959,,BAO_0000218,Rattus norvegicus,,CHEMBL629814,A,,Biodistribution studied in the fat of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate
,In vivo,,,,1,,,N,50597,10911,1,10116.0,11960,,BAO_0000218,Rattus norvegicus,,CHEMBL629815,A,,Biodistribution studied in the fat of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate
,In vivo,,,,1,,,N,50597,10911,1,10116.0,11961,,BAO_0000218,Rattus norvegicus,,CHEMBL629816,A,,Biodistribution studied in the fat of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate
,In vivo,,,,1,,,N,50597,10911,1,10116.0,11962,,BAO_0000218,Rattus norvegicus,,CHEMBL629817,A,,Biodistribution studied in the fat of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate
,In vivo,Kidney,,,1,,,N,50597,10911,1,10116.0,11963,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL626643,A,,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate
,In vivo,Kidney,,,1,,,N,50597,10911,1,10116.0,11964,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL626644,A,,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate
,In vivo,Kidney,,,1,,,N,50597,10911,1,10116.0,11965,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL626806,A,,Biodistribution studied in the kidneys of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate
,In vivo,Kidney,,,1,,,N,50597,10911,1,10116.0,11966,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL626807,A,,Biodistribution studied in the kidneys of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate
,In vivo,Liver,,,1,,,N,50597,10911,1,10116.0,11967,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL627261,A,,Biodistribution studied in the liver of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate
,In vivo,Liver,,,1,,,N,50597,10911,1,10116.0,11968,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL627262,A,,Biodistribution studied in the liver of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate
,In vivo,Liver,,,1,,,N,50597,10911,1,10116.0,11969,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL627263,A,,Biodistribution studied in the liver of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate
,In vivo,Liver,,,1,,,N,50597,10911,1,10116.0,11970,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL627264,A,,Biodistribution studied in the liver of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate
,In vivo,Lung,,,1,,,N,50597,10911,1,10116.0,11971,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL627265,A,,Biodistribution studied in the lungs of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate
,In vivo,Lung,,,1,,,N,50597,10911,1,10116.0,11972,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL627266,A,,Biodistribution studied in the lungs of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate
,In vivo,Lung,,,1,,,N,50597,10911,1,10116.0,11973,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL627267,A,,Biodistribution studied in the lungs of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate
,In vivo,Lung,,,1,,,N,50597,10911,1,10116.0,11974,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL627268,A,,Biodistribution studied in the lungs of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,10911,1,10116.0,11975,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL627269,A,,Biodistribution studied in the muscle of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,10911,1,10116.0,11976,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL627270,A,,Biodistribution studied in the muscle of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate
,,,,,1,,,N,50597,8608,1,10116.0,11977,,BAO_0000218,Rattus norvegicus,,CHEMBL627271,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 0.95-1.44",Intermediate
,,,,,1,,,N,50597,8608,1,10116.0,11978,,BAO_0000218,Rattus norvegicus,,CHEMBL627946,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 1.39-2.43",Intermediate
,,,,,1,,,N,50597,8608,1,10116.0,11979,,BAO_0000218,Rattus norvegicus,,CHEMBL875472,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.47-2.96",Intermediate
,,,,,1,,,N,50597,8608,1,10116.0,11980,,BAO_0000218,Rattus norvegicus,,CHEMBL627947,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-3.69",Intermediate
,,,,,1,,,N,50597,8608,1,10116.0,11981,,BAO_0000218,Rattus norvegicus,,CHEMBL627948,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-4.31",Intermediate
,,,,,1,,,N,50597,8608,1,10116.0,11982,,BAO_0000218,Rattus norvegicus,,CHEMBL628113,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 3.17-4.70",Intermediate
,,,,,1,,,N,50597,8608,1,10116.0,11983,,BAO_0000218,Rattus norvegicus,,CHEMBL628114,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration.; dose/g, range 2.20-2.97",Intermediate
,,,,,1,,,N,50597,8608,1,10116.0,11984,,BAO_0000218,Rattus norvegicus,,CHEMBL628115,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 0.90-1.46",Intermediate
,,,,,1,,,N,50597,8608,1,10116.0,11985,,BAO_0000218,Rattus norvegicus,,CHEMBL628116,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.72-3.52",Intermediate
,,,,,1,,,N,50597,8608,1,10116.0,11986,,BAO_0000218,Rattus norvegicus,,CHEMBL628117,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.78-3.62",Intermediate
,,,,,1,,,N,50597,8608,1,10116.0,11987,,BAO_0000218,Rattus norvegicus,,CHEMBL628118,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.82-3.86",Intermediate
,,,,,1,,,N,50597,8608,1,10116.0,11988,,BAO_0000218,Rattus norvegicus,,CHEMBL628119,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 3.80-5.74",Intermediate
,,,,,1,,,N,50597,8608,1,10116.0,11989,,BAO_0000218,Rattus norvegicus,,CHEMBL628120,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.05-1.57",Intermediate
,,,,,1,,,N,50597,8608,1,10116.0,11990,,BAO_0000218,Rattus norvegicus,,CHEMBL628121,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.93-3.58",Intermediate
,,,,,1,,,N,50597,8608,1,10116.0,11991,,BAO_0000218,Rattus norvegicus,,CHEMBL628122,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 2.88-4.32",Intermediate
,,,,,1,,,N,50597,8608,1,10116.0,11992,,BAO_0000218,Rattus norvegicus,,CHEMBL627297,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3-3.70",Intermediate
,,,,,1,,,N,50597,8608,1,10116.0,11993,,BAO_0000218,Rattus norvegicus,,CHEMBL627298,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.21-3.92",Intermediate
,,,,,1,,,N,50597,8608,1,10116.0,11994,,BAO_0000218,Rattus norvegicus,,CHEMBL627299,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.51-5.44",Intermediate
,,,,,1,,,N,50597,8608,1,10116.0,11995,,BAO_0000218,Rattus norvegicus,,CHEMBL627300,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 0.24-0.31",Intermediate
,,,,,1,,,N,50597,8608,1,10116.0,11996,,BAO_0000218,Rattus norvegicus,,CHEMBL627301,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 10.5-14.4",Intermediate
,,,,,1,,,N,50597,8608,1,10116.0,11997,,BAO_0000218,Rattus norvegicus,,CHEMBL627302,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.28-7.41",Intermediate
,,,,,1,,,N,50597,8608,1,10116.0,11998,,BAO_0000218,Rattus norvegicus,,CHEMBL627303,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.47-10.2",Intermediate
,,,,,1,,,N,50597,8608,1,10116.0,11999,,BAO_0000218,Rattus norvegicus,,CHEMBL627304,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 7.21-7.95",Intermediate
,,,,,1,,,N,50597,8608,1,10116.0,12000,,BAO_0000218,Rattus norvegicus,,CHEMBL627305,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 8.28-10.72",Intermediate
,,,,,1,,,N,50597,8608,1,10116.0,12001,,BAO_0000218,Rattus norvegicus,,CHEMBL627306,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 1.04-2.56",Intermediate
,,,,,1,,,N,50597,8608,1,10116.0,12002,,BAO_0000218,Rattus norvegicus,,CHEMBL623982,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 10.7-16.9",Intermediate
,,,,,1,,,N,50597,8608,1,10116.0,12003,,BAO_0000218,Rattus norvegicus,,CHEMBL623983,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 11.7-14.6",Intermediate
,,,,,1,,,N,50597,8608,1,10116.0,12004,,BAO_0000218,Rattus norvegicus,,CHEMBL623984,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 14.4-20.1",Intermediate
,,,,,1,,,N,50597,8608,1,10116.0,12005,,BAO_0000218,Rattus norvegicus,,CHEMBL623985,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 4.78-9.72",Intermediate
,,,,,1,,,N,50597,8608,1,10116.0,12006,,BAO_0000218,Rattus norvegicus,,CHEMBL623986,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 9.87-11.9",Intermediate
,,,,,1,,,N,50597,8608,1,10116.0,12007,,BAO_0000218,Rattus norvegicus,,CHEMBL623987,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 0.17-0.25",Intermediate
,,,,,1,,,N,50597,8608,1,10116.0,12008,,BAO_0000218,Rattus norvegicus,,CHEMBL623988,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 3.33-4.68",Intermediate
,,,,,1,,,N,50597,8608,1,10116.0,12009,,BAO_0000218,Rattus norvegicus,,CHEMBL623989,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.59-8.81",Intermediate
,,,,,1,,,N,50597,8608,1,10116.0,12010,,BAO_0000218,Rattus norvegicus,,CHEMBL622215,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.62-5.60",Intermediate
,,,,,1,,,N,50597,8608,1,10116.0,12011,,BAO_0000218,Rattus norvegicus,,CHEMBL622216,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.02-6.57",Intermediate
,,,,,1,,,N,50597,8608,1,10116.0,12012,,BAO_0000218,Rattus norvegicus,,CHEMBL877481,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.67-8.41",Intermediate
,,,,,0,,,U,22224,16359,1,,12013,,BAO_0000218,,,CHEMBL622217,A,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered orally a dose of 5 mg/kg; range (4.2-8.8),Autocuration
,,,,,1,,,N,50594,13701,1,10090.0,12014,,BAO_0000218,Mus musculus,,CHEMBL622218,A,,Pharmacokinetic parameters was measured at 55 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),Intermediate
,,,,,1,,,N,50597,14554,1,10116.0,12015,,BAO_0000218,Rattus norvegicus,,CHEMBL622219,A,,Pharmacokinetic profile AUC was evaluated in rats,Intermediate
,,,,,0,,,U,22224,6241,1,,12016,,BAO_0000019,,,CHEMBL622220,A,,Pharmacokinetic property (Area under curve),Autocuration
,,,,,1,,,N,50588,11537,1,9615.0,12017,,BAO_0000218,Canis lupus familiaris,,CHEMBL622221,A,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in dog (25 mg/kg).",Intermediate
,,,,,1,,,N,50594,11537,1,10090.0,12018,,BAO_0000218,Mus musculus,,CHEMBL622222,A,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in mice (50 mg/kg).",Intermediate
,,,,,1,,,N,50588,11537,1,9615.0,12019,,BAO_0000218,Canis lupus familiaris,,CHEMBL622223,A,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to dog (25 mg/kg).",Intermediate
,,,,,1,,,N,50594,11537,1,10090.0,12020,,BAO_0000218,Mus musculus,,CHEMBL622224,A,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to mice (50 mg/kg).",Intermediate
,,,,,0,,,U,22224,13118,1,,12021,,BAO_0000019,,,CHEMBL622225,A,,Plasma concentration (AUC) was determined,Autocuration
,,,,,0,,,U,22224,13118,1,,12022,,BAO_0000019,,,CHEMBL622226,A,,Plasma concentration (AUC) was determined; Not detectable,Autocuration
,,,,,1,,,N,50512,9562,1,10141.0,12023,,BAO_0000218,Cavia porcellus,,CHEMBL624154,A,,Prolongation of time to collapse in guinea pig treated with aerosolized histamine was measured in vivo as area under curve (AUC),Intermediate
,,,,,1,,,N,50597,10363,1,10116.0,12024,,BAO_0000218,Rattus norvegicus,,CHEMBL624155,A,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg,Intermediate
,,,,,1,,,N,50597,10363,1,10116.0,12025,,BAO_0000218,Rattus norvegicus,,CHEMBL624156,A,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,Intermediate
,,,,,1,,,N,50597,10363,1,10116.0,12026,,BAO_0000218,Rattus norvegicus,,CHEMBL624157,A,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 60 mg/kg,Intermediate
,,,,,1,,,N,50597,10363,1,10116.0,12027,,BAO_0000218,Rattus norvegicus,,CHEMBL624158,A,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 7.5 mg/kg,Intermediate
,,,,,1,,,N,50597,12504,1,10116.0,12028,,BAO_0000218,Rattus norvegicus,,CHEMBL624159,A,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 1,Intermediate
,,,,,1,,,N,50597,12504,1,10116.0,12029,,BAO_0000218,Rattus norvegicus,,CHEMBL624160,A,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 2,Intermediate
,,,,,1,,,N,50597,12504,1,10116.0,12030,,BAO_0000218,Rattus norvegicus,,CHEMBL624161,A,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 3,Intermediate
,,,,,1,,,N,50597,12504,1,10116.0,12031,,BAO_0000218,Rattus norvegicus,,CHEMBL624162,A,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 4,Intermediate
,,,,,1,,,N,50588,13317,1,9615.0,12032,,BAO_0000218,Canis lupus familiaris,,CHEMBL624163,A,,Tested for pharmacokinetic parameter in fasted Beagle dogs (Area Under Curve value) iv administration.,Intermediate
,,,,,1,,,N,50597,15078,1,10116.0,12033,,BAO_0000218,Rattus norvegicus,,CHEMBL624164,A,,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",Intermediate
,,,,,1,,,N,50597,14941,1,10116.0,12034,,BAO_0000218,Rattus norvegicus,,CHEMBL624165,A,,The AUC(0-infinity) values in female wistar rats.,Intermediate
,,,,,1,,,N,50597,15078,1,10116.0,12035,,BAO_0000218,Rattus norvegicus,,CHEMBL624166,A,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",Intermediate
,,,,,1,,,N,50597,15078,1,10116.0,12036,,BAO_0000218,Rattus norvegicus,,CHEMBL624167,A,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose in mice",Intermediate
,,,,,1,,,N,50597,14941,1,10116.0,12037,,BAO_0000218,Rattus norvegicus,,CHEMBL624168,A,,The AUC(0-t)values in female wistar rats.,Intermediate
,,,,,1,,,N,50597,14067,1,10116.0,12038,,BAO_0000218,Rattus norvegicus,,CHEMBL624169,A,,The Area under the concentration time curve of compound was measured on rats,Intermediate
,,,,,1,,,N,50587,14215,1,9606.0,12039,,BAO_0000218,Homo sapiens,,CHEMBL624170,A,,The area under curve (100 mg/kg) administered orally in humans,Intermediate
,,,,,0,,,U,22224,14215,1,9481.0,12040,,BAO_0000218,Callithrix,,CHEMBL624171,A,,The area under curve (12.5 mg/kg) administered intravenously in marmoset,Autocuration
,,,,,0,,,U,22224,14215,1,314293.0,12041,,BAO_0000218,Simiiformes,,CHEMBL624172,A,,The area under curve (12.5 mg/kg) administered intravenously in monkey,Autocuration
,,,,,1,,,N,50588,14215,1,9615.0,12042,,BAO_0000218,Canis lupus familiaris,,CHEMBL624173,A,,The area under curve (15 mg/kg) administered intravenously in dog,Intermediate
,,,,,1,,,N,50587,14215,1,9606.0,12043,,BAO_0000218,Homo sapiens,,CHEMBL877488,A,,The area under curve (200 mg/kg) administered orally in humans,Intermediate
,,,,,1,,,N,50597,14215,1,10116.0,12044,,BAO_0000218,Rattus norvegicus,,CHEMBL624174,A,,The area under curve (25 mg/kg) administered intravenously in rat,Intermediate
,,,,,0,,,U,22224,14215,1,9481.0,12045,,BAO_0000218,Callithrix,,CHEMBL624175,A,,The area under curve (25 mg/kg) administered orally in marmoset,Autocuration
,,,,,0,,,U,22224,14215,1,314293.0,12046,,BAO_0000218,Simiiformes,,CHEMBL624176,A,,The area under curve (25 mg/kg) administered orally in monkey,Autocuration
,,,,,1,,,N,50588,14215,1,9615.0,12047,,BAO_0000218,Canis lupus familiaris,,CHEMBL624177,A,,The area under curve (30 mg/kg) administered orally in dog,Intermediate
,,,,,1,,,N,50587,14215,1,9606.0,12048,,BAO_0000218,Homo sapiens,,CHEMBL624178,A,,The area under curve (400 mg/kg) administered orally in humans,Intermediate
,,,,,1,,,N,50597,14215,1,10116.0,12049,,BAO_0000218,Rattus norvegicus,,CHEMBL624179,A,,The area under curve (50 mg/kg) administered orally in fasted rat,Intermediate
,,,,,1,,,N,50597,14215,1,10116.0,12050,,BAO_0000218,Rattus norvegicus,,CHEMBL627689,A,,The area under curve (50 mg/kg) administered orally in rat,Intermediate
,,,,,1,,,N,50587,14215,1,9606.0,12051,,BAO_0000218,Homo sapiens,,CHEMBL627690,A,,The area under curve (800 mg/kg) administered orally in humans,Intermediate
,,,,,0,,,U,22224,11324,1,,12052,,BAO_0000019,,,CHEMBL627691,A,,The compound was evaluated for area under the curve,Autocuration
,,,,,0,,,U,22224,11324,1,9481.0,12053,,BAO_0000019,Callithrix,,CHEMBL627692,A,,The compound was evaluated for area under the curve in marmosets,Autocuration
,,,,,0,,,U,22224,11324,1,9481.0,12054,,BAO_0000019,Callithrix,,CHEMBL627693,A,,The compound was evaluated for area under the curve in marmosets,Autocuration
,,,,,1,,,N,50597,13875,1,10116.0,12055,,BAO_0000218,Rattus norvegicus,,CHEMBL627694,A,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,Intermediate
,,,,,1,,,N,50597,13875,1,10116.0,12056,,BAO_0000218,Rattus norvegicus,,CHEMBL627695,A,,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po) in conscious spontaneously hypertensive rat,Intermediate
,,,,,0,,,U,22224,13875,1,,12057,,BAO_0000218,,,CHEMBL627696,A,,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po),Autocuration
,,,,,1,,,N,50597,13875,1,10116.0,12058,,BAO_0000218,Rattus norvegicus,,CHEMBL627697,A,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,Intermediate
,,,,,1,,,N,50597,13875,1,10116.0,12059,,BAO_0000218,Rattus norvegicus,,CHEMBL627698,A,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,Intermediate
,,,,,1,,,N,50597,13875,1,10116.0,12060,,BAO_0000218,Rattus norvegicus,,CHEMBL627699,A,,The compound was tested for the area of the change in MABP versus time curve at dose 5 mg/kg (po) in conscious spontaneously hypertensive rat,Intermediate
,,,,,1,,,N,50597,13807,1,10116.0,12061,,BAO_0000218,Rattus norvegicus,,CHEMBL627700,A,,Total absorption was estimated by area under curve (AUC) after intravenous administration in rat,Intermediate
,,,,,1,,,N,50597,14127,1,10116.0,12062,,BAO_0000218,Rattus norvegicus,,CHEMBL627701,A,,Total drug exposure is determined after oral dosing in rats.,Intermediate
,,,,,0,,,U,22224,15116,1,,12063,,BAO_0000218,,,CHEMBL627702,A,,Total drug exposure (5 mg/kg) when administered intravenously,Autocuration
,,,,,0,,,U,22224,15116,1,,12064,,BAO_0000218,,,CHEMBL627703,A,,Total drug exposure (5 mg/kg) when administered orally,Autocuration
,,,,,0,,,U,22224,15604,1,314293.0,12065,,BAO_0000218,Simiiformes,,CHEMBL626873,A,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,Autocuration
,,,,,1,,,N,50597,15604,1,10116.0,12066,,BAO_0000218,Rattus norvegicus,,CHEMBL629583,A,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,Intermediate
,,,,,1,,,N,50588,15604,1,9615.0,12067,,BAO_0000218,Canis lupus familiaris,,CHEMBL629584,A,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,Intermediate
,,,,,1,,,N,50588,15604,1,9615.0,12068,,BAO_0000218,Canis lupus familiaris,,CHEMBL629585,A,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,Intermediate
,In vivo,Brain,,,1,,,N,50597,13751,1,10116.0,12069,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL629586,A,,"Biodistribution in brain of mature female Dawley rat after 5min, expressed as percent injected dose/g",Intermediate
,In vivo,Brain,,,1,,,N,50597,13751,1,10116.0,12070,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL629587,A,,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate
,In vivo,,,,1,,,N,50597,13751,1,10116.0,12071,,BAO_0000218,Rattus norvegicus,,CHEMBL629588,A,,"Biodistribution in fat of mature female Dawley rat after 10min, expressed as percent injected dose/g",Intermediate
,In vivo,,,,1,,,N,50597,13751,1,10116.0,12072,,BAO_0000218,Rattus norvegicus,,CHEMBL629589,A,,"Biodistribution in fat of mature female Dawley rat after 15min, expressed as percent injected dose/g",Intermediate
,In vivo,,,,1,,,N,50597,13751,1,10116.0,12073,,BAO_0000218,Rattus norvegicus,,CHEMBL629590,A,,"Biodistribution in fat of mature female Dawley rat after 1h, expressed as percent injected dose/g",Intermediate
,In vivo,,,,1,,,N,50597,13751,1,10116.0,12074,,BAO_0000218,Rattus norvegicus,,CHEMBL629591,A,,"Biodistribution in fat of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Intermediate
,In vivo,,,,1,,,N,50597,13751,1,10116.0,12075,,BAO_0000218,Rattus norvegicus,,CHEMBL629592,A,,"Biodistribution in fat of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate
,In vivo,,,,1,,,N,50597,13751,1,10116.0,12076,,BAO_0000218,Rattus norvegicus,,CHEMBL629593,A,,"Biodistribution in fat of mature female Dawley rat after 45min, expressed as percent injected dose/g",Intermediate
,In vivo,,,,1,,,N,50597,13751,1,10116.0,12077,,BAO_0000218,Rattus norvegicus,,CHEMBL629594,A,,"Biodistribution in fat of mature female Dawley rat after 5min, expressed as percent injected dose/g",Intermediate
,In vivo,Heart,,,1,,,N,50597,13751,1,10116.0,12078,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL629595,A,,"Biodistribution in heart of mature female Dawley rat after 10min, expressed as percent injected dose/g",Intermediate
,In vivo,Heart,,,1,,,N,50597,13751,1,10116.0,12079,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL630290,A,,"Biodistribution in heart of mature female Dawley rat after 15min, expressed as percent injected dose/g",Intermediate
,In vivo,Heart,,,1,,,N,50597,13751,1,10116.0,12080,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL627137,A,,"Biodistribution in heart of mature female Dawley rat after 1h, expressed as percent injected dose/g",Intermediate
,In vivo,Heart,,,1,,,N,50597,13751,1,10116.0,12081,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL627138,A,,"Biodistribution in heart of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Intermediate
,In vivo,Heart,,,1,,,N,50597,13751,1,10116.0,12082,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL627139,A,,"Biodistribution in heart of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate
,In vivo,Heart,,,1,,,N,50597,13751,1,10116.0,12083,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL627140,A,,"Biodistribution in heart of mature female Dawley rat after 45min, expressed as percent injected dose/g",Intermediate
,In vivo,Heart,,,1,,,N,50597,13751,1,10116.0,12084,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL627141,A,,"Biodistribution in heart of mature female Dawley rat after 5min, expressed as percent injected dose/g",Intermediate
,In vivo,Kidney,,,1,,,N,50597,13751,1,10116.0,12085,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL627142,A,,"Biodistribution in kidney of mature female Dawley rat after 10min, expressed as percent injected dose/g",Intermediate
,In vivo,Kidney,,,1,,,N,50597,13751,1,10116.0,12086,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL627143,A,,"Biodistribution in kidney of mature female Dawley rat after 15min, expressed as percent injected dose/g",Intermediate
,In vivo,Kidney,,,1,,,N,50597,13751,1,10116.0,12087,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL874449,A,,"Biodistribution in kidney of mature female Dawley rat after 1h, expressed as percent injected dose/g",Intermediate
,In vivo,Kidney,,,1,,,N,50597,13751,1,10116.0,12088,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL627144,A,,"Biodistribution in kidney of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Intermediate
,In vivo,Kidney,,,1,,,N,50597,13751,1,10116.0,12089,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL627145,A,,"Biodistribution in kidney of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate
,In vivo,Kidney,,,1,,,N,50597,13751,1,10116.0,12090,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL627146,A,,"Biodistribution in kidney of mature female Dawley rat after 45min, expressed as percent injected dose/g",Intermediate
,In vivo,Kidney,,,1,,,N,50597,13751,1,10116.0,12091,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL627147,A,,"Biodistribution in kidney of mature female Dawley rat after 5min, expressed as percent injected dose/g",Intermediate
,In vivo,Liver,,,1,,,N,50597,13751,1,10116.0,12092,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL627148,A,,"Biodistribution in liver of mature female Dawley rat after 10min, expressed as percent injected dose/g",Intermediate
,In vivo,Lung,,,1,,,N,50597,13751,1,10116.0,12093,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL627149,A,,"Biodistribution in lung of mature female Dawley rat after 10min, expressed as percent injected dose/g",Intermediate
,In vivo,Lung,,,1,,,N,50597,13751,1,10116.0,12094,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL632160,A,,"Biodistribution in lung of mature female Dawley rat after 15min, expressed as percent injected dose/g",Intermediate
,In vivo,Lung,,,1,,,N,50597,13751,1,10116.0,12095,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL632161,A,,"Biodistribution in lung of mature female Dawley rat after 1h, expressed as percent injected dose/g",Intermediate
,In vivo,Lung,,,1,,,N,50597,13751,1,10116.0,12096,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL632162,A,,"Biodistribution in lung of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Intermediate
,In vivo,Lung,,,1,,,N,50597,13751,1,10116.0,12097,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL632163,A,,"Biodistribution in lung of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate
,In vivo,Lung,,,1,,,N,50597,13751,1,10116.0,12098,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL874469,A,,"Biodistribution in lung of mature female Dawley rat after 45min, expressed as percent injected dose/g",Intermediate
,In vivo,Lung,,,1,,,N,50597,13751,1,10116.0,12099,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL627182,A,,"Biodistribution in lung of mature female Dawley rat after 5min, expressed as percent injected dose/g",Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,13751,1,10116.0,12100,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL627183,A,,"Biodistribution in muscle of mature female Dawley rat after 10min, expressed as percent injected dose/g",Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,13751,1,10116.0,12101,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL627184,A,,"Biodistribution in muscle of mature female Dawley rat after 15min, expressed as percent injected dose/g",Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,13751,1,10116.0,12102,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL627185,A,,"Biodistribution in muscle of mature female Dawley rat after 1h, expressed as percent injected dose/g",Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,13751,1,10116.0,12103,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL627186,A,,"Biodistribution in muscle of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,13751,1,10116.0,12104,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL627187,A,,"Biodistribution in muscle of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,13751,1,10116.0,12105,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL627188,A,,"Biodistribution in muscle of mature female Dawley rat after 45min, expressed as percent injected dose/g",Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,13751,1,10116.0,12106,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL627189,A,,"Biodistribution in muscle of mature female Dawley rat after 5min, expressed as percent injected dose/g",Intermediate
,In vivo,,,,1,,,N,50597,13751,1,10116.0,12107,,BAO_0000218,Rattus norvegicus,,CHEMBL627190,A,,"Biodistribution inl ilver of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate
,In vivo,Liver,,,1,,,N,50597,13751,1,10116.0,12108,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL627191,A,,"Biodistribution inl iver of mature female Dawley rat after 15min, expressed as percent injected dose/g",Intermediate
,In vivo,Liver,,,1,,,N,50597,13751,1,10116.0,12109,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL627192,A,,"Biodistribution inl iver of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Intermediate
,In vivo,Liver,,,1,,,N,50597,13751,1,10116.0,12110,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL627193,A,,"Biodistribution inl iver of mature female Dawley rat after 5min, expressed as percent injected dose/g",Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,10911,1,10116.0,12111,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL874590,A,,Biodistribution studied in the muscle of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,10911,1,10116.0,12112,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL627194,A,,Biodistribution studied in the muscle of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,10911,1,10116.0,12113,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL627195,A,,Biodistribution studied in the muscle of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate
,In vivo,Female gonad,,,1,,,N,50597,10911,1,10116.0,12114,,BAO_0000218,Rattus norvegicus,992.0,CHEMBL627196,A,,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate
,In vivo,Female gonad,,,1,,,N,50597,10911,1,10116.0,12115,,BAO_0000218,Rattus norvegicus,992.0,CHEMBL627197,A,,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate
,In vivo,Female gonad,,,1,,,N,50597,10911,1,10116.0,12116,,BAO_0000218,Rattus norvegicus,992.0,CHEMBL627198,A,,Biodistribution studied in the ovaries of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate
,In vivo,Female gonad,,,1,,,N,50597,10911,1,10116.0,12117,,BAO_0000218,Rattus norvegicus,992.0,CHEMBL627199,A,,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour,Intermediate
,In vivo,Female gonad,,,1,,,N,50597,10911,1,10116.0,12118,,BAO_0000218,Rattus norvegicus,992.0,CHEMBL627200,A,,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate
,In vivo,Plasma,,,1,,,N,50597,10911,1,10116.0,12119,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL627201,A,,Biodistribution studied in the plasma of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate
,In vivo,Plasma,,,1,,,N,50597,10911,1,10116.0,12120,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL627202,A,,Biodistribution studied in the plasma of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate
,In vivo,Plasma,,,1,,,N,50597,10911,1,10116.0,12121,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL627203,A,,Biodistribution studied in the plasma of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate
,In vivo,Plasma,,,1,,,N,50597,10911,1,10116.0,12122,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL627204,A,,Biodistribution studied in the plasma of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate
,In vivo,Spleen,,,1,,,N,50597,10911,1,10116.0,12123,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL627205,A,,Biodistribution studied in the spleen of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate
,In vivo,Spleen,,,1,,,N,50597,10911,1,10116.0,12124,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL627206,A,,Biodistribution studied in the spleen of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate
,In vivo,Spleen,,,1,,,N,50597,10911,1,10116.0,12125,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL627207,A,,Biodistribution studied in the spleen of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate
,In vivo,Spleen,,,1,,,N,50597,10911,1,10116.0,12126,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL627208,A,,Biodistribution studied in the spleen of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate
,In vivo,Thyroid gland,,,1,,,N,50597,10911,1,10116.0,12127,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL627209,A,,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate
,In vivo,Thyroid gland,,,1,,,N,50597,10911,1,10116.0,12128,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL627210,A,,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate
,In vivo,Thyroid gland,,,1,,,N,50597,10911,1,10116.0,12129,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL627211,A,,Biodistribution studied in the thyroid of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate
,In vivo,Thyroid gland,,,1,,,N,50597,10911,1,10116.0,12130,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL627212,A,,Biodistribution studied in the thyroid of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate
,In vivo,Uterus,,,1,,,N,50597,10911,1,10116.0,12131,,BAO_0000218,Rattus norvegicus,995.0,CHEMBL627213,A,,Biodistribution studied in the uterus of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate
,In vivo,Uterus,,,1,,,N,50597,10911,1,10116.0,12132,,BAO_0000218,Rattus norvegicus,995.0,CHEMBL626599,A,,Biodistribution studied in the uterus of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate
,In vivo,Uterus,,,1,,,N,50597,10911,1,10116.0,12133,,BAO_0000218,Rattus norvegicus,995.0,CHEMBL626600,A,,Biodistribution studied in the uterus of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate
,In vivo,Uterus,,,1,,,N,50597,10911,1,10116.0,12134,,BAO_0000218,Rattus norvegicus,995.0,CHEMBL626601,A,,Biodistribution studied in the uterus of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate
,,,,,0,,,U,22224,8081,1,,12135,,BAO_0000019,,,CHEMBL627484,A,,C(f=2) is the concentration at which the half life (t1/2) in the time course of inhibition of BChE by DFP increased by twofold in the presence of compound,Autocuration
,,Plasma,,,1,,,N,100710,17248,1,9541.0,12136,,BAO_0000218,Macaca fascicularis,1969.0,CHEMBL627485,A,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg),Intermediate
,,Plasma,,,1,,,N,100710,17248,1,9541.0,12137,,BAO_0000218,Macaca fascicularis,1969.0,CHEMBL628147,A,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not applicable,Intermediate
,,Plasma,,,1,,,N,100710,17248,1,9541.0,12138,,BAO_0000218,Macaca fascicularis,1969.0,CHEMBL628148,A,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not determined,Intermediate
,,Plasma,,,1,,,N,50588,17248,1,9615.0,12139,,BAO_0000218,Canis lupus familiaris,1969.0,CHEMBL628149,A,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg),Intermediate
,,Plasma,,,1,,,N,50588,17248,1,9615.0,12140,,BAO_0000218,Canis lupus familiaris,1969.0,CHEMBL628150,A,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 1,Intermediate
,,Plasma,,,1,,,N,50588,17248,1,9615.0,12141,,BAO_0000218,Canis lupus familiaris,1969.0,CHEMBL628318,A,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 2,Intermediate
,,Plasma,,,1,,,N,50588,17248,1,9615.0,12142,,BAO_0000218,Canis lupus familiaris,1969.0,CHEMBL628319,A,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg); Not applicable,Intermediate
,,,,,1,,,N,50588,15592,1,9615.0,12143,,BAO_0000218,Canis lupus familiaris,,CHEMBL875609,A,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",Intermediate
,,,,,0,,,U,22224,7040,1,,12144,,BAO_0000019,,,CHEMBL628320,A,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10,Autocuration
,,,,,0,,,U,22224,7040,1,,12145,,BAO_0000019,,,CHEMBL628321,A,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10.5,Autocuration
,,,,,0,,,U,22224,7040,1,,12146,,BAO_0000019,,,CHEMBL628322,A,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 6.8,Autocuration
,,,,,0,,,U,22224,7040,1,,12147,,BAO_0000019,,,CHEMBL628323,A,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.2,Autocuration
,,,,,0,,,U,22224,7040,1,,12148,,BAO_0000019,,,CHEMBL628324,A,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.6,Autocuration
,,,,,0,,,U,22224,7040,1,,12149,,BAO_0000019,,,CHEMBL628325,A,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 8.2,Autocuration
,,,,,0,,,U,22224,7040,1,,12150,,BAO_0000019,,,CHEMBL628326,A,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 9.6,Autocuration
,,Adrenal medulla,,,1,,,N,50588,9614,1,9615.0,12151,,BAO_0000218,Canis lupus familiaris,1236.0,CHEMBL628327,A,,"Concentration of compound in adrenal medulla of dog 2, after administering intravenously",Intermediate
,,Adrenal medulla,,,1,,,N,50588,9614,1,9615.0,12152,,BAO_0000218,Canis lupus familiaris,1236.0,CHEMBL628328,A,,"Concentration of compound in adrenal medulla of dog1, after administering intravenously",Intermediate
,,Blood,,,1,,,N,50588,9614,1,9615.0,12153,,BAO_0000218,Canis lupus familiaris,178.0,CHEMBL628329,A,,"Concentration of compound in blood of dog 1, after administering intravenously",Intermediate
,,Liver,,,1,,,N,50597,8608,1,10116.0,12154,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL628330,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration.; dose/g, range 0.23-0.29",Intermediate
,,Liver,,,1,,,N,50597,8608,1,10116.0,12155,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL628331,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.22-0.30",Intermediate
,,Liver,,,1,,,N,50597,8608,1,10116.0,12156,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL628332,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.55-0.71",Intermediate
,,Liver,,,1,,,N,50597,8608,1,10116.0,12157,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL628333,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.57-0.72",Intermediate
,,Liver,,,1,,,N,50597,8608,1,10116.0,12158,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL628334,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 1.51-2.23",Intermediate
,,Liver,,,1,,,N,50597,8608,1,10116.0,12159,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL628335,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 2.30-3.12",Intermediate
,,Liver,,,1,,,N,50597,8608,1,10116.0,12160,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL628336,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 0.93-1.20",Intermediate
,,Liver,,,1,,,N,50597,8608,1,10116.0,12161,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL628337,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.04-2.56",Intermediate
,,Liver,,,1,,,N,50597,8608,1,10116.0,12162,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL628338,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.06-1.70",Intermediate
,,Liver,,,1,,,N,50597,8608,1,10116.0,12163,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL875610,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.26-2.45",Intermediate
,,Liver,,,1,,,N,50597,8608,1,10116.0,12164,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL628339,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 3.12-4.56",Intermediate
,,Liver,,,1,,,N,50597,8608,1,10116.0,12165,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL628340,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 4.12-6.30",Intermediate
,,Liver,,,1,,,N,50597,8608,1,10116.0,12166,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL628341,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.14-0.19",Intermediate
,,Liver,,,1,,,N,50597,8608,1,10116.0,12167,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL622214,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.15-0.19",Intermediate
,,Liver,,,1,,,N,50597,8608,1,10116.0,12168,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL623167,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.24-0.30",Intermediate
,,Liver,,,1,,,N,50597,8608,1,10116.0,12169,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL623168,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.44-0.54",Intermediate
,,Liver,,,1,,,N,50597,8608,1,10116.0,12170,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL623169,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.73-1.19",Intermediate
,,Liver,,,1,,,N,50597,8608,1,10116.0,12171,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL623170,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 1.08-2.31",Intermediate
,,Lung,,,1,,,N,50597,8608,1,10116.0,12172,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL627224,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration.; dose/g, range 0.34-0.47",Intermediate
,,Lung,,,1,,,N,50597,8608,1,10116.0,12173,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL875634,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.83-1.21",Intermediate
,,Lung,,,1,,,N,50597,8608,1,10116.0,12174,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL627225,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.91-1.74",Intermediate
,,Lung,,,1,,,N,50597,8608,1,10116.0,12175,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL627226,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.99-1.23",Intermediate
,,Lung,,,1,,,N,50597,8608,1,10116.0,12176,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL626083,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.07-1.30",Intermediate
,,Lung,,,1,,,N,50597,8608,1,10116.0,12177,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL626084,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.12-1.39",Intermediate
,,Lung,,,1,,,N,50597,8608,1,10116.0,12178,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL626085,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.51-0.66",Intermediate
,,Lung,,,1,,,N,50597,8608,1,10116.0,12179,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL626086,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.95-1.49",Intermediate
,,Lung,,,1,,,N,50597,8608,1,10116.0,12180,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL626087,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.96-1.35",Intermediate
,,Lung,,,1,,,N,50597,8608,1,10116.0,12181,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL626088,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.18-1.44",Intermediate
,,Lung,,,1,,,N,50597,8608,1,10116.0,12182,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL626089,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.20-1.52",Intermediate
,,Lung,,,1,,,N,50597,8608,1,10116.0,12183,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL626090,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.41-2.17",Intermediate
,,Lung,,,1,,,N,50597,8608,1,10116.0,12184,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL626091,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.28-0.33",Intermediate
,,Lung,,,1,,,N,50597,8608,1,10116.0,12185,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL626092,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.81-1.13",Intermediate
,,Lung,,,1,,,N,50597,8608,1,10116.0,12186,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL626093,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.83-2.11",Intermediate
,,Lung,,,1,,,N,50597,8608,1,10116.0,12187,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL626094,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.94-1.36",Intermediate
,,Lung,,,1,,,N,50597,8608,1,10116.0,12188,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL626095,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.97-1.54",Intermediate
,,Lung,,,1,,,N,50597,8608,1,10116.0,12189,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL626096,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 1.07-1.26",Intermediate
,,,,,0,,,U,22224,15604,1,314293.0,12190,,BAO_0000218,Simiiformes,,CHEMBL626097,A,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,Autocuration
,,,,,1,,,N,50597,15604,1,10116.0,12191,,BAO_0000218,Rattus norvegicus,,CHEMBL626098,A,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,Intermediate
,,Plasma,,,0,,,U,22224,1806,1,,12192,,BAO_0000218,,1969.0,CHEMBL626099,A,,compound was evaluated for area under the plasma concentration vs. time curve at different dose 27.5 mg/kg DMP323 equiv,Autocuration
,,Plasma,,,0,,,U,22224,1806,1,,12193,,BAO_0000218,,1969.0,CHEMBL626100,A,,compound was evaluated for area under the plasma concentration vs. time curve at different dose 7.7 mg/kg DMP323 equiv,Autocuration
,,Plasma,,,1,,,N,50588,17237,1,9615.0,12194,,BAO_0000218,Canis lupus familiaris,1969.0,CHEMBL626101,A,,AUC 0-inf in dog,Intermediate
,,Plasma,,,1,,,N,50512,17237,1,10141.0,12195,,BAO_0000218,Cavia porcellus,1969.0,CHEMBL626102,A,,AUC 0-inf in guinea pig,Intermediate
,,Plasma,,,1,,,N,50588,17237,1,9615.0,12196,,BAO_0000218,Canis lupus familiaris,1969.0,CHEMBL626103,A,,AUC 0-t in dog,Intermediate
,,Plasma,,,1,,,N,50512,17237,1,10141.0,12197,,BAO_0000218,Cavia porcellus,1969.0,CHEMBL628391,A,,AUC 0-t in guinea pig,Intermediate
,,,,,1,,,N,50597,15194,1,10116.0,12198,,BAO_0000218,Rattus norvegicus,,CHEMBL628392,A,,The compound was tested for brain to plasma partition in rat,Intermediate
,,,,,1,,,N,50597,15194,1,10116.0,12199,,BAO_0000218,Rattus norvegicus,,CHEMBL628393,A,,The compound was tested for brain to plasma partition in rat.,Intermediate
,,Blood,,,0,,,U,22224,8787,1,,12200,,BAO_0000019,,178.0,CHEMBL628394,A,,Area under curve was determined for 0-6 hr duration using dihydralazine as reference drug for the peak blood pressure,Autocuration
,,,,,1,,,N,50588,17025,1,9615.0,12201,,BAO_0000218,Canis lupus familiaris,,CHEMBL628395,A,,Area under concentration-time curve of compound was determined in dog at 5 mg/kg intravenously admn.,Intermediate
,,,,,0,,,U,22224,17025,1,314293.0,12202,,BAO_0000218,Simiiformes,,CHEMBL628396,A,,Area under concentration-time curve of compound was determined in monkey at 5 mg/kg intravenously admn.,Autocuration
,,,,,1,,,N,50592,17025,1,9986.0,12203,,BAO_0000218,Oryctolagus cuniculus,,CHEMBL628397,A,,Area under concentration-time curve of compound was determined in rabbit at 5 mg/kg intravenously admn.,Intermediate
,,,,,1,,,N,50597,17025,1,10116.0,12204,,BAO_0000218,Rattus norvegicus,,CHEMBL628398,A,,Area under concentration-time curve of compound was determined in rat at 5 mg/kg intravenously admn.,Intermediate
,,,,,1,,,N,50797,4236,1,9544.0,12205,,BAO_0000218,Macaca mulatta,,CHEMBL628399,A,,Area under curve obtained at a dose of 10 mg/kg when administered orally to rhesus monkey,Intermediate
,,,,,1,,,N,50588,15343,1,9615.0,12206,,BAO_0000218,Canis lupus familiaris,,CHEMBL628400,A,,The Plasma area under the compound concentration -time curve was measured in dogs after oral administration of 1 mg/kg dose,Intermediate
,,,,,1,,,N,50597,15343,1,10116.0,12207,,BAO_0000218,Rattus norvegicus,,CHEMBL874907,A,,The Plasma area under the compound concentration -time curve was measured in rats after oral administration of 1 mg/kg dose,Intermediate
,,,,,0,,,U,22224,17720,1,,12208,,BAO_0000019,,,CHEMBL628401,A,,Area under curve of the compound was determined,Autocuration
,,Plasma,,,0,,,U,22224,17788,1,314293.0,12209,,BAO_0000218,Simiiformes,1969.0,CHEMBL628402,A,,AUC in monkeys at a dose of 1 mg/kg,Autocuration
,,Plasma,,,1,,,N,50597,17788,1,10116.0,12210,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL628403,A,,AUC in rats at a dose of 1 mg/kg,Intermediate
,,,,,0,,,U,22224,8778,1,,12211,,BAO_0000019,,,CHEMBL628404,A,,Compound was evaluated for the overall absorbance loss at pH of 2,Autocuration
,,,,,0,,,U,22224,8778,1,,12212,,BAO_0000019,,,CHEMBL628405,A,,Compound was evaluated for the overall absorbance loss at pH of 4,Autocuration
,,,,,0,,,U,22224,8778,1,,12213,,BAO_0000019,,,CHEMBL628406,A,,Compound was evaluated for the overall absorbance loss at pH of 7,Autocuration
,,,,,1,,,N,50597,2249,1,10116.0,12214,,BAO_0000218,Rattus norvegicus,,CHEMBL628407,A,,Compound was evaluated for its absorption in the rats,Intermediate
,,Urine,,,1,,,N,50597,8881,1,10116.0,12215,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL628408,A,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,Intermediate
,,Urine,,,1,,,N,50597,8881,1,10116.0,12216,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL629171,A,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight.,Intermediate
,,Urine,,,1,,,N,50597,8881,1,10116.0,12217,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL629172,A,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,Intermediate
,,Urine,,,1,,,N,50597,8881,1,10116.0,12218,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL629173,A,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of per moiety tranexamic acid,Intermediate
,,,,,1,,,N,50597,15286,1,10116.0,12219,,BAO_0000218,Rattus norvegicus,,CHEMBL629174,A,,In vitro percent permeability into rat ileum,Intermediate
,,,,,1,,,N,50597,15286,1,10116.0,12220,,BAO_0000218,Rattus norvegicus,,CHEMBL629175,A,,In vitro percent permeability into rat ileum; Range is 10-17,Intermediate
,,,,,1,,,N,50597,15286,1,10116.0,12221,,BAO_0000218,Rattus norvegicus,,CHEMBL629176,A,,In vitro percent permeability into rat ileum; Range is 10-18,Intermediate
,,,,,1,,,N,50597,15286,1,10116.0,12222,,BAO_0000218,Rattus norvegicus,,CHEMBL629177,A,,In vitro percent permeability into rat ileum; Range is 10-19,Intermediate
,,,,,1,,,N,50597,15286,1,10116.0,12223,,BAO_0000218,Rattus norvegicus,,CHEMBL629178,A,,In vitro percent permeability into rat ileum; Range is 12-15,Intermediate
,,,,,1,,,N,50597,15286,1,10116.0,12224,,BAO_0000218,Rattus norvegicus,,CHEMBL631869,A,,In vitro percent permeability into rat ileum; Range is 13-19,Intermediate
,,,,,1,,,N,50597,15286,1,10116.0,12225,,BAO_0000218,Rattus norvegicus,,CHEMBL631870,A,,In vitro percent permeability into rat ileum; Range is 14-17,Intermediate
,,,,,1,,,N,50597,15286,1,10116.0,12226,,BAO_0000218,Rattus norvegicus,,CHEMBL631871,A,,In vitro percent permeability into rat ileum; Range is 15-18,Intermediate
,,,,,1,,,N,50597,15286,1,10116.0,12227,,BAO_0000218,Rattus norvegicus,,CHEMBL631872,A,,In vitro percent permeability into rat ileum; Range is 2-5,Intermediate
,,Ileum,,,0,,,U,22224,15286,1,,12228,,BAO_0000221,,2116.0,CHEMBL875775,A,,In vitro percent permeability into rat ileum; Range is 23-42,Autocuration
,,,,,1,,,N,50597,15286,1,10116.0,12229,,BAO_0000218,Rattus norvegicus,,CHEMBL631873,A,,In vitro percent permeability into rat ileum; Range is 28-36,Intermediate
,,,,,1,,,N,50597,15286,1,10116.0,12230,,BAO_0000218,Rattus norvegicus,,CHEMBL631874,A,,In vitro percent permeability into rat ileum; Range is 29-35,Intermediate
,,,,,1,,,N,50597,15286,1,10116.0,12231,,BAO_0000218,Rattus norvegicus,,CHEMBL631875,A,,In vitro percent permeability into rat ileum; Range is 46-66,Intermediate
,,,,,1,,,N,50597,15286,1,10116.0,12232,,BAO_0000218,Rattus norvegicus,,CHEMBL631876,A,,In vitro percent permeability into rat ileum; Range is 50-68,Intermediate
,,,,,1,,,N,50597,15286,1,10116.0,12233,,BAO_0000218,Rattus norvegicus,,CHEMBL631877,A,,In vitro percent permeability into rat ileum; Range is 78-81,Intermediate
,,,,,1,,,N,50597,15286,1,10116.0,12234,,BAO_0000218,Rattus norvegicus,,CHEMBL631878,A,,In vitro percent permeability into rat ileum; insol indicates not soluble in aqueous buffer,Intermediate
,,,,,1,,,N,50597,15286,1,10116.0,12235,,BAO_0000218,Rattus norvegicus,,CHEMBL631879,A,,In vitro percent permeability into rat ileum; nd indicates not detected,Intermediate
,,,,,1,,,N,50597,15286,1,10116.0,12236,,BAO_0000218,Rattus norvegicus,,CHEMBL631880,A,,In vitro percent permeability into rat ileum; nt indicates not detected,Intermediate
,,,,,1,,,N,50597,15286,1,10116.0,12237,,BAO_0000218,Rattus norvegicus,,CHEMBL631881,A,,In vitro percent permeability into rat ileum; nt indicates not tested,Intermediate
,,,,,1,,,N,50597,13770,1,10116.0,12238,,BAO_0000218,Rattus norvegicus,,CHEMBL631882,A,,Compound was tested for oral absorption in bile-duct cannulated rats,Intermediate
,,,,,1,,,N,50597,13770,1,10116.0,12239,,BAO_0000218,Rattus norvegicus,,CHEMBL630749,A,,Compound was tested for oral absorption in bile-duct cannulated rats.,Intermediate
,,,,,1,,,N,50587,5202,1,9606.0,12240,,BAO_0000218,Homo sapiens,,CHEMBL630750,A,,Oral absorption using Caco-2 cell monolayers.,Intermediate
,,,,,1,,,N,50587,14920,1,9606.0,12241,,BAO_0000218,Homo sapiens,,CHEMBL630253,A,,Percent of the drug absorbed after administration to humans was determined,Intermediate
,,Plasma,,,1,,,N,50597,14103,1,10116.0,12242,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL630254,A,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 120 minutes.,Intermediate
,,Plasma,,,1,,,N,50597,14103,1,10116.0,12243,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL630255,A,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 15 minutes.,Intermediate
,,Plasma,,,1,,,N,50597,14103,1,10116.0,12244,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL630256,A,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 180 minutes.,Intermediate
,In vivo,Liver,,,1,,,N,50597,13751,1,10116.0,12245,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL875781,A,,"Biodistribution inl liver of mature female Dawley rat after 1h, expressed as percent injected dose/g",Intermediate
,In vivo,Liver,,,1,,,N,50597,13751,1,10116.0,12246,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL630257,A,,"Biodistribution inl liver of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate
,In vivo,Liver,,,1,,,N,50597,13751,1,10116.0,12247,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL630258,A,,"Biodistribution inl liver of mature female Dawley rat after 45min, expressed as percent injected dose/g",Intermediate
,,,,,1,,,N,50597,15807,1,10116.0,12248,,BAO_0000218,Rattus norvegicus,,CHEMBL630259,A,,"Distribution of radioactivity in rat blood after 2 minutes of iv administration at the dose of 10.05-0.07 gram of tissue, expressed as percent injected dose per gram of tissue",Intermediate
,,Striatum,,,1,,,N,50597,15807,1,10116.0,12249,,BAO_0000218,Rattus norvegicus,2435.0,CHEMBL630260,A,,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 1.89-3.73 g of tissue, expressed as percent injected dose per gram of tissue",Intermediate
,,Striatum,,,1,,,N,50597,15807,1,10116.0,12250,,BAO_0000218,Rattus norvegicus,2435.0,CHEMBL630261,A,,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 3.44-4.80 g of tissue, expressed as percent injected dose per gram of tissue",Intermediate
,,,,,1,,,N,50597,14950,1,10116.0,12251,,BAO_0000218,Rattus norvegicus,,CHEMBL630262,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat and 5-alpha-DHT was reported,Intermediate
,,,,,1,,,N,50597,14950,1,10116.0,12252,,BAO_0000218,Rattus norvegicus,,CHEMBL630263,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 1 hour time,Intermediate
,,,,,1,,,N,50597,14950,1,10116.0,12253,,BAO_0000218,Rattus norvegicus,,CHEMBL630264,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 2 hours time,Intermediate
,,,,,1,,,N,50597,14950,1,10116.0,12254,,BAO_0000218,Rattus norvegicus,,CHEMBL630265,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 0.5 hours time,Intermediate
,,,,,1,,,N,50597,14950,1,10116.0,12255,,BAO_0000218,Rattus norvegicus,,CHEMBL630266,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 4 hours time,Intermediate
,,Kidney,,,1,,,N,50597,14950,1,10116.0,12256,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL630267,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 0.5 hours time,Intermediate
,,Kidney,,,1,,,N,50597,14950,1,10116.0,12257,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL630268,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 4 hours time,Intermediate
,,,,,1,,,N,50597,14950,1,10116.0,12258,,BAO_0000218,Rattus norvegicus,,CHEMBL630269,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 1 hour time,Intermediate
,,,,,1,,,N,50597,14950,1,10116.0,12259,,BAO_0000218,Rattus norvegicus,,CHEMBL630270,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 2 hours time,Intermediate
,,Lung,,,1,,,N,50597,14950,1,10116.0,12260,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL630141,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 1 hour time,Intermediate
,,Lung,,,1,,,N,50597,14950,1,10116.0,12261,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL630142,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 2 hours time,Intermediate
,,Muscle tissue,,,1,,,N,50597,14950,1,10116.0,12262,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL630143,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 0.5 hours time,Intermediate
,,Muscle tissue,,,1,,,N,50597,14950,1,10116.0,12263,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL630144,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 4 hours time,Intermediate
,,Prostate gland,,,1,,,N,50597,14950,1,10116.0,12264,,BAO_0000218,Rattus norvegicus,2367.0,CHEMBL630145,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 0.5 hours time,Intermediate
,,Prostate gland,,,1,,,N,50597,14950,1,10116.0,12265,,BAO_0000218,Rattus norvegicus,2367.0,CHEMBL630146,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 4 hours time,Intermediate
,,,,,1,,,N,50597,14950,1,10116.0,12266,,BAO_0000218,Rattus norvegicus,,CHEMBL630147,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood,Intermediate
,,,,,1,,,N,50597,14950,1,10116.0,12267,,BAO_0000218,Rattus norvegicus,,CHEMBL630148,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 1 hours time,Intermediate
,,,,,1,,,N,50597,14950,1,10116.0,12268,,BAO_0000218,Rattus norvegicus,,CHEMBL630149,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 2 hours time,Intermediate
,,Spleen,,,1,,,N,50597,14950,1,10116.0,12269,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL630150,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 1 hour time,Intermediate
,,Spleen,,,1,,,N,50597,14950,1,10116.0,12270,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL630151,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 2 hours time,Intermediate
,,Thyroid gland,,,1,,,N,50597,14950,1,10116.0,12271,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL632031,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 0.5 hours time,Intermediate
,,Thyroid gland,,,1,,,N,50597,14950,1,10116.0,12272,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL632032,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 4 hours time,Intermediate
,,,,,1,,,N,50597,14950,1,10116.0,12273,,BAO_0000218,Rattus norvegicus,,CHEMBL632033,A,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat fat at 1 hour time,Intermediate
,,,,,1,,,N,50597,14950,1,10116.0,12274,,BAO_0000218,Rattus norvegicus,,CHEMBL632034,A,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat kidney at 1 hour time,Intermediate
,,Muscle tissue,,,1,,,N,50597,14950,1,10116.0,12275,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL632035,A,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat muscle at 1 hour time,Intermediate
,,,,,1,,,N,50597,14950,1,10116.0,12276,,BAO_0000218,Rattus norvegicus,,CHEMBL632036,A,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat prostrateat 1 hour time,Intermediate
,,Thyroid gland,,,1,,,N,50597,14950,1,10116.0,12277,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL632037,A,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat thyroid at 1 hour time,Intermediate
,,Blood,,,1,,,N,50597,8631,1,10116.0,12278,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL632038,A,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,Intermediate
,,Blood,,,1,,,N,50597,8631,1,10116.0,12279,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL632039,A,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,Intermediate
,,Blood,,,1,,,N,50597,8631,1,10116.0,12280,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL632040,A,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,Intermediate
,,Blood,,,1,,,N,50597,8631,1,10116.0,12281,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL632041,A,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,Intermediate
,,Blood,,,1,,,N,50588,9614,1,9615.0,12282,,BAO_0000218,Canis lupus familiaris,178.0,CHEMBL632042,A,,"Concentration of compound in blood of dog 2, after administering intravenously",Intermediate
,,,,,1,,,N,50588,9614,1,9615.0,12283,,BAO_0000218,Canis lupus familiaris,,CHEMBL632043,A,,"Concentration of compound in left ventricle of dog 1, after administering intravenously",Intermediate
,,,,,1,,,N,50588,9614,1,9615.0,12284,,BAO_0000218,Canis lupus familiaris,,CHEMBL632044,A,,"Concentration of compound in left ventricle of dog 2, after administering intravenously",Intermediate
,,Liver,,,1,,,N,50588,9614,1,9615.0,12285,,BAO_0000218,Canis lupus familiaris,2107.0,CHEMBL632045,A,,"Concentration of compound in liver of dog 1, after administering intravenously",Intermediate
,,Liver,,,1,,,N,50588,9614,1,9615.0,12286,,BAO_0000218,Canis lupus familiaris,2107.0,CHEMBL632046,A,,"Concentration of compound in liver of dog 2, after administering intravenously",Intermediate
,,Lung,,,1,,,N,50588,9614,1,9615.0,12287,,BAO_0000218,Canis lupus familiaris,2048.0,CHEMBL632047,A,,"Concentration of compound in lung of dog 1, after administering intravenously",Intermediate
,,Lung,,,1,,,N,50588,9614,1,9615.0,12288,,BAO_0000218,Canis lupus familiaris,2048.0,CHEMBL632048,A,,"Concentration of compound in lung of dog 2, after administering intravenously",Intermediate
,,Muscle tissue,,,1,,,N,50588,9614,1,9615.0,12289,,BAO_0000218,Canis lupus familiaris,2385.0,CHEMBL632049,A,,"Concentration of compound in muscle of dog 1, after administering intravenously",Intermediate
,,Muscle tissue,,,1,,,N,50588,9614,1,9615.0,12290,,BAO_0000218,Canis lupus familiaris,2385.0,CHEMBL876418,A,,"Concentration of compound in muscle of dog 2, after administering intravenously",Intermediate
,,Spleen,,,1,,,N,50588,9614,1,9615.0,12291,,BAO_0000218,Canis lupus familiaris,2106.0,CHEMBL632050,A,,"Concentration of compound in spleen of dog 1,after administering intravenously",Intermediate
,,Spleen,,,1,,,N,50588,9614,1,9615.0,12292,,BAO_0000218,Canis lupus familiaris,2106.0,CHEMBL632051,A,,"Concentration of compound in spleen of dog 2, after administering intravenously",Intermediate
,,,,,0,,,U,22224,10353,1,,12293,,BAO_0000218,,,CHEMBL632052,F,,Concentration of liberated compound in serum after 120 min at the dose of 50 mg/kg (po).,Autocuration
,,,,,0,,,U,22224,10353,1,,12294,,BAO_0000218,,,CHEMBL632053,F,,Concentration of liberated compound in serum after 240 min at the dose of 50 mg/kg (po).,Autocuration
,,,,,0,,,U,22224,10353,1,,12295,,BAO_0000218,,,CHEMBL632054,A,,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,Autocuration
,,,,,0,,,U,22224,10353,1,,12296,,BAO_0000218,,,CHEMBL632055,F,,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,Autocuration
,,,,,0,,,U,22224,10353,1,,12297,,BAO_0000218,,,CHEMBL631181,F,,Concentration of liberated compound in serum after 60 min at the dose of 50 mg/kg (po).,Autocuration
,,,,,0,,,U,22224,9196,1,,12298,,BAO_0000218,,,CHEMBL631182,A,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous after 1.5 hr,Autocuration
,,,,,0,,,U,22224,9196,1,,12299,,BAO_0000218,,,CHEMBL631183,A,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,Autocuration
,,,,,0,,,U,22224,9196,1,,12300,,BAO_0000218,,,CHEMBL631184,A,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,Autocuration
,,,,,0,,,U,22224,9196,1,,12301,,BAO_0000218,,,CHEMBL629774,A,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,Autocuration
,,,,,0,,,U,22224,9196,1,,12302,,BAO_0000218,,,CHEMBL629775,A,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,Autocuration
,,,,,0,,,U,22224,9196,1,,12303,,BAO_0000218,,,CHEMBL876549,A,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,Autocuration
,,,,,0,,,U,22224,9196,1,,12304,,BAO_0000218,,,CHEMBL628172,A,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,Autocuration
,,,,,0,,,U,22224,9196,1,,12305,,BAO_0000218,,,CHEMBL628173,A,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,Autocuration
,,,,,0,,,U,22224,9196,1,,12306,,BAO_0000218,,,CHEMBL628174,A,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous after 1.5 hr,Autocuration
,,,,,0,,,U,22224,9196,1,,12307,,BAO_0000218,,,CHEMBL628175,A,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 4.0 hr,Autocuration
,,,,,0,,,U,22224,9196,1,,12308,,BAO_0000218,,,CHEMBL628176,A,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,Autocuration
,,,,,0,,,U,22224,9196,1,,12309,,BAO_0000218,,,CHEMBL628177,A,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,Autocuration
,,,,,0,,,U,22224,9196,1,,12310,,BAO_0000218,,,CHEMBL628178,A,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,Autocuration
,,,,,0,,,U,22224,9196,1,,12311,,BAO_0000218,,,CHEMBL628179,A,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,Autocuration
,,,,,0,,,U,22224,9196,1,,12312,,BAO_0000218,,,CHEMBL628180,A,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg i intravenous dosage after 1.0 hr; insufficient gastric juice produced,Autocuration
,,,,,0,,,U,22224,9196,1,,12313,,BAO_0000218,,,CHEMBL628181,A,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 2.5 hr,Autocuration
,,,,,0,,,U,22224,9196,1,,12314,,BAO_0000218,,,CHEMBL628182,A,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,Autocuration
,,,,,0,,,U,22224,9196,1,,12315,,BAO_0000218,,,CHEMBL628183,A,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,Autocuration
,,,,,0,,,U,22224,9196,1,,12316,,BAO_0000218,,,CHEMBL628184,A,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr; ND means not determined,Autocuration
,,,,,0,,,U,22224,9196,1,,12317,,BAO_0000218,,,CHEMBL628185,A,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,Autocuration
,,,,,0,,,U,22224,9196,1,,12318,,BAO_0000218,,,CHEMBL875617,A,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,Autocuration
,,,,,0,,,U,22224,9196,1,,12319,,BAO_0000218,,,CHEMBL628186,A,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr; ND means not determined,Autocuration
,,,,,0,,,U,22224,9196,1,,12320,,BAO_0000218,,,CHEMBL628187,A,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,Autocuration
,,,,,0,,,U,22224,9196,1,,12321,,BAO_0000218,,,CHEMBL628188,A,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,Autocuration
,,,,,0,,,U,22224,9196,1,,12322,,BAO_0000218,,,CHEMBL628189,A,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,Autocuration
,,,,,0,,,U,22224,9196,1,,12323,,BAO_0000218,,,CHEMBL628190,A,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr; ND means not determined,Autocuration
,,,,,0,,,U,22224,9196,1,,12324,,BAO_0000218,,,CHEMBL628191,A,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,Autocuration
,,,,,0,,,U,22224,9196,1,,12325,,BAO_0000218,,,CHEMBL626513,A,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr; ND means not determined,Autocuration
,,Thyroid gland,,,1,,,N,50597,8608,1,10116.0,12326,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL626514,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 19-24",Intermediate
,,Thyroid gland,,,1,,,N,50597,8608,1,10116.0,12327,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL626515,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 26-40",Intermediate
,,Thyroid gland,,,1,,,N,50597,8608,1,10116.0,12328,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL626516,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 29-44",Intermediate
,,Thyroid gland,,,1,,,N,50597,8608,1,10116.0,12329,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL626517,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 32-42",Intermediate
,,Thyroid gland,,,1,,,N,50597,8608,1,10116.0,12330,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL626518,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 33-60",Intermediate
,,Thyroid gland,,,1,,,N,50597,8608,1,10116.0,12331,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL626519,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 4-7",Intermediate
,,Thyroid gland,,,1,,,N,50597,8608,1,10116.0,12332,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL626520,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 13-18",Intermediate
,,Thyroid gland,,,1,,,N,50597,8608,1,10116.0,12333,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL626521,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 16-32",Intermediate
,,Thyroid gland,,,1,,,N,50597,8608,1,10116.0,12334,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL626522,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 22-25",Intermediate
,,Thyroid gland,,,1,,,N,50597,8608,1,10116.0,12335,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL626523,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 26-49",Intermediate
,,Thyroid gland,,,1,,,N,50597,8608,1,10116.0,12336,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL626524,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 29-36",Intermediate
,,Thyroid gland,,,1,,,N,50597,8608,1,10116.0,12337,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL626688,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 5-8",Intermediate
,,Thyroid gland,,,1,,,N,50597,8608,1,10116.0,12338,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL626689,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 26-42",Intermediate
,,Thyroid gland,,,1,,,N,50597,8608,1,10116.0,12339,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL626690,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 30-53",Intermediate
,,Thyroid gland,,,1,,,N,50597,8608,1,10116.0,12340,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL626691,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 32-43",Intermediate
,,Thyroid gland,,,1,,,N,50597,8608,1,10116.0,12341,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL627319,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 35-53",Intermediate
,,Thyroid gland,,,1,,,N,50597,8608,1,10116.0,12342,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL624052,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 5-12",Intermediate
,,Thyroid gland,,,1,,,N,50597,8608,1,10116.0,12343,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL624053,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 55-102",Intermediate
,,,,,1,,,N,50597,8085,1,10116.0,12344,,BAO_0000218,Rattus norvegicus,,CHEMBL624054,A,,In vivo distribution of the drug in plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Intermediate
,,,,,1,,,N,50597,8085,1,10116.0,12345,,BAO_0000218,Rattus norvegicus,,CHEMBL624055,A,,In vivo distribution of the drug in plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Intermediate
,,,,,1,,,N,50597,8085,1,10116.0,12346,,BAO_0000218,Rattus norvegicus,,CHEMBL624056,A,,In vivo distribution of the drug in plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,Intermediate
,,Uterus,,,1,,,N,50597,8085,1,10116.0,12347,,BAO_0000218,Rattus norvegicus,995.0,CHEMBL624057,A,,In vivo distribution of the drug in uterus was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Intermediate
,,Uterus,,,1,,,N,50597,8085,1,10116.0,12348,,BAO_0000218,Rattus norvegicus,995.0,CHEMBL622281,A,,In vivo distribution of the drug in uterus was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Intermediate
,,Uterus,,,1,,,N,50597,8085,1,10116.0,12349,,BAO_0000218,Rattus norvegicus,995.0,CHEMBL622282,A,,In vivo distribution of the drug in uterus was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,Intermediate
,,Uterus,,,1,,,N,50597,8085,1,10116.0,12350,,BAO_0000218,Rattus norvegicus,995.0,CHEMBL622283,A,,In vivo distribution of the drug in uterus/plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Intermediate
,,Uterus,,,1,,,N,50597,8085,1,10116.0,12351,,BAO_0000218,Rattus norvegicus,995.0,CHEMBL622284,A,,In vivo distribution of the drug in uterus/plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Intermediate
,,Uterus,,,1,,,N,50597,8085,1,10116.0,12352,,BAO_0000218,Rattus norvegicus,995.0,CHEMBL622285,A,,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,Intermediate
,,Uterus,,,1,,,N,50597,8085,1,10116.0,12353,,BAO_0000218,Rattus norvegicus,995.0,CHEMBL622286,A,,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,Intermediate
,,,,,0,,,U,22224,7657,1,,12354,,BAO_0000100,,,CHEMBL622287,P,,Distribution coefficient (D %) between octanol and buffer of pH 7.4,Autocuration
,,,,,1,,,N,50594,8935,1,10090.0,12355,,BAO_0000218,Mus musculus,,CHEMBL622288,A,,Partition coefficient (logD7.4),Intermediate
,,,,,1,,,N,50594,13792,1,10090.0,12356,,BAO_0000218,Mus musculus,,CHEMBL622289,A,,"Percentage of radioactivity in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",Intermediate
,,Brain,,,1,,,N,50594,13792,1,10090.0,12357,,BAO_0000218,Mus musculus,955.0,CHEMBL622290,A,,"Percentage of radioactivity in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",Intermediate
,,,,,1,,,N,50594,13792,1,10090.0,12358,,BAO_0000218,Mus musculus,,CHEMBL622291,A,,Percentage of radioactivity in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,Intermediate
,,Brain,,,1,,,N,50594,13792,1,10090.0,12359,,BAO_0000218,Mus musculus,955.0,CHEMBL622292,A,,Percentage of radioactivity in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,Intermediate
,,,,,1,,,N,50594,13792,1,10090.0,12360,,BAO_0000218,Mus musculus,,CHEMBL622293,A,,"Percentage of total protein recovered in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",Intermediate
,,Brain,,,1,,,N,50594,13792,1,10090.0,12361,,BAO_0000218,Mus musculus,955.0,CHEMBL622294,A,,"Percentage of total protein recovered in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",Intermediate
,,,,,1,,,N,50594,13792,1,10090.0,12362,,BAO_0000218,Mus musculus,,CHEMBL622295,A,,Percentage of total protein recovered in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,Intermediate
,,Brain,,,1,,,N,50597,13792,1,10116.0,12363,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL622296,A,,Percentage of total protein recovered in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,Intermediate
,,Plasma,,,1,,,N,50597,14103,1,10116.0,12364,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL874409,A,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 2 minutes.,Intermediate
,,Plasma,,,1,,,N,50597,14103,1,10116.0,12365,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622297,A,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 240 minutes.,Intermediate
,,Plasma,,,1,,,N,50597,14103,1,10116.0,12366,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622298,A,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 30 minutes.,Intermediate
,,Plasma,,,1,,,N,50597,14103,1,10116.0,12367,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622299,A,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 45 minutes.,Intermediate
,,Plasma,,,1,,,N,50597,14103,1,10116.0,12368,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622300,A,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 5 minutes.,Intermediate
,,Plasma,,,1,,,N,50597,14103,1,10116.0,12369,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622301,A,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 60 minutes.,Intermediate
,,Plasma,,,1,,,N,50597,14103,1,10116.0,12370,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622302,A,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 90 minutes.,Intermediate
,,Plasma,,,1,,,N,50597,14103,1,10116.0,12371,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622303,A,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 120 minutes.,Intermediate
,,Plasma,,,1,,,N,50597,14103,1,10116.0,12372,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622304,A,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes.,Intermediate
,,Plasma,,,1,,,N,50597,14103,1,10116.0,12373,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622305,A,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes;nd=not determined,Intermediate
,,Plasma,,,1,,,N,50597,14103,1,10116.0,12374,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622306,A,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 180 minutes.,Intermediate
,,Plasma,,,1,,,N,50597,14103,1,10116.0,12375,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626864,A,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 2 minutes;nd=not determined,Intermediate
,,Plasma,,,1,,,N,50597,14103,1,10116.0,12376,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626865,A,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes.,Intermediate
,,Plasma,,,1,,,N,50597,14103,1,10116.0,12377,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626866,A,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes;nd=not determined,Intermediate
,,Plasma,,,1,,,N,50597,14103,1,10116.0,12378,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626867,A,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 30 minutes.,Intermediate
,,Plasma,,,1,,,N,50597,14103,1,10116.0,12379,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626868,A,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes.,Intermediate
,,Plasma,,,1,,,N,50597,14103,1,10116.0,12380,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626869,A,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes;nd=not determined,Intermediate
,,Plasma,,,1,,,N,50597,14103,1,10116.0,12381,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626870,A,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes.,Intermediate
,,Plasma,,,1,,,N,50597,14103,1,10116.0,12382,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626871,A,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes;nd=not determined,Intermediate
,,Plasma,,,1,,,N,50597,14103,1,10116.0,12383,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626872,A,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 60 minutes.,Intermediate
,,Plasma,,,1,,,N,50597,14103,1,10116.0,12384,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL632185,A,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes.,Intermediate
,,Plasma,,,1,,,N,50597,14103,1,10116.0,12385,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL632186,A,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes;nd=not determined,Intermediate
,,,,,0,,,U,22224,12904,1,,12386,,BAO_0000019,,,CHEMBL629310,A,,Amount of acetic acid produced by the compound,Autocuration
,,,,,0,,,U,22224,12904,1,,12387,,BAO_0000019,,,CHEMBL629311,A,,Apparent first-order rate of solvolysis for the bipinnatin-A(A4) was determined,Autocuration
,,,,,1,,,N,50597,9663,1,10116.0,12388,,BAO_0000218,Rattus norvegicus,,CHEMBL629312,A,,Log of (Cbrain/Cblood) in rats,Intermediate
,,,,,0,,,U,22224,7652,1,,12389,,BAO_0000221,,,CHEMBL629313,A,,Compound in absence of MPM cell homogenate at pH 3 to isolate compound 4 (ng),Autocuration
,,,,,0,,,U,22224,7652,1,,12390,,BAO_0000221,,,CHEMBL629314,A,,Compound in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),Autocuration
,,,,,0,,,U,22224,7652,1,,12391,,BAO_0000221,,,CHEMBL629315,A,,Compound in absence of MPM cell homogenate at pH 7 to isolate compound 4 (ng),Autocuration
,,,,,0,,,U,22224,7652,1,,12392,,BAO_0000219,,,CHEMBL629316,B,,Compound in presence of MPM cells and in absence of inactivator at pH 8 to isolate compound 4 (ng),Autocuration
,,,,,0,,,U,22224,7652,1,,12393,,BAO_0000221,,,CHEMBL629317,A,,Compound treated in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),Autocuration
,,,,,0,,,U,22224,7652,1,,12394,,BAO_0000019,,,CHEMBL629318,A,,Compound treated with MPM cell homogenate at pH 3 to isolate compound 4 (ng),Autocuration
,,,,,0,,,U,22224,7652,1,,12395,,BAO_0000019,,,CHEMBL877497,A,,Compound treated with MPM cell homogenate at pH 3.5 to isolate compound 4 (ng),Autocuration
,,,,,0,,,U,22224,7652,1,,12396,,BAO_0000019,,,CHEMBL629319,A,,Compound treated with MPM cell homogenate at pH 4 to isolate compound 4 (ng),Autocuration
,,,,,0,,,U,22224,7652,1,,12397,,BAO_0000019,,,CHEMBL629320,A,,Compound treated with MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),Autocuration
,,,,,0,,,U,22224,7652,1,,12398,,BAO_0000019,,,CHEMBL629496,A,,Compound treated with MPM cell homogenate at pH 5 to isolate compound 4 (ng),Autocuration
,,,,,0,,,U,22224,7652,1,,12399,,BAO_0000019,,,CHEMBL629497,A,,Compound treated with MPM cell homogenate at pH 5.5 to isolate compound 4 (ng),Autocuration
,,,,,0,,,U,22224,7652,1,,12400,,BAO_0000019,,,CHEMBL629498,A,,Compound treated with MPM cell homogenate at pH 6 to isolate compound 4 (ng),Autocuration
,,,,,0,,,U,22224,7652,1,,12401,,BAO_0000019,,,CHEMBL629499,A,,Compound treated with MPM cell homogenate at pH 6.5 to isolate compound 4 (ng),Autocuration
,,,,,0,,,U,22224,7652,1,,12402,,BAO_0000019,,,CHEMBL629500,A,,Compound treated with MPM cell homogenate at pH 7 to isolate compound 4 (ng),Autocuration
,,,,,0,,,U,22224,7652,1,,12403,,BAO_0000019,,,CHEMBL629501,A,,Compound treated with MPM cell homogenate at pH 7.5 to isolate compound 4 (ng),Autocuration
,,,,,0,,,U,22224,7652,1,,12404,,BAO_0000019,,,CHEMBL629502,A,,Compound treated with MPM cell homogenate at pH 8 to isolate compound 4 (ng),Autocuration
,In vivo,,,,0,,,U,22224,8267,1,,12405,,BAO_0000218,,,CHEMBL629503,F,,Compound was evaluated for its urinary recovery after oral administration (100 mg) to Beagle dogs,Autocuration
,,,,,1,,,N,50588,8267,1,9615.0,12406,,BAO_0000218,Canis lupus familiaris,,CHEMBL629504,A,,Compound was evaluated for its urinary recovery after oral administration (200 mg) to Beagle dogs,Intermediate
,,,,,0,,,U,22224,14479,1,,12407,,BAO_0000019,,,CHEMBL629505,A,,Compound was evaluated for the rate of degradation by Carboxypeptidase A.,Autocuration
,,,,,0,,,U,22224,17515,1,,12408,,BAO_0000019,,,CHEMBL629506,A,,Compound was evaluated for total body clearance,Autocuration
,,,,,0,,,U,22224,17515,1,,12409,,BAO_0000019,,,CHEMBL629507,A,,Compound was evaluated for volume of distribution at steady state,Autocuration
,,,,,0,,,U,22224,8142,1,,12410,,BAO_0000019,,,CHEMBL877498,A,,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant KOH- was reported.,Autocuration
,,,,,0,,,U,22224,14849,1,,12411,,BAO_0000019,,,CHEMBL629508,A,,Percentage of the diamine which is monoprotonated at pH 7.4,Autocuration
,,,,,0,,,U,22224,7653,1,,12412,,BAO_0000019,,,CHEMBL629509,A,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells,Autocuration
,,Blood,,,1,,,N,50597,8631,1,10116.0,12413,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL629510,A,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,Intermediate
,,Blood,,,1,,,N,50597,8631,1,10116.0,12414,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL629511,A,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,Intermediate
,,Blood,,,1,,,N,50597,8631,1,10116.0,12415,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL629512,A,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,Intermediate
,,Blood,,,1,,,N,50597,8631,1,10116.0,12416,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL629513,A,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,Intermediate
,,Blood,,,1,,,N,50597,8631,1,10116.0,12417,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL629514,A,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,Intermediate
,,Blood,,,1,,,N,50597,8631,1,10116.0,12418,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL628447,A,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,Intermediate
,,Blood,,,1,,,N,50597,8631,1,10116.0,12419,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL628448,A,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,Intermediate
,,Blood,,,1,,,N,50597,8631,1,10116.0,12420,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL628449,A,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,Intermediate
,,Blood,,,1,,,N,50597,8631,1,10116.0,12421,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL631119,A,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,Intermediate
,,Blood,,,1,,,N,50597,8631,1,10116.0,12422,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL631120,A,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,Intermediate
,,Blood,,,1,,,N,50597,8631,1,10116.0,12423,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL631121,A,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,Intermediate
,,Blood,,,1,,,N,50597,8631,1,10116.0,12424,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL874458,A,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 min,Intermediate
,,Blood,,,1,,,N,50597,8631,1,10116.0,12425,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL631122,A,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,Intermediate
,,Blood,,,1,,,N,50597,8631,1,10116.0,12426,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL631123,A,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,Intermediate
,,Blood,,,1,,,N,50597,8631,1,10116.0,12427,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL631124,A,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,Intermediate
,,Blood,,,1,,,N,50597,8631,1,10116.0,12428,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL631125,A,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,Intermediate
,,Blood,,,1,,,N,50597,8631,1,10116.0,12429,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL631290,A,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,Intermediate
,,Blood,,,1,,,N,50597,8631,1,10116.0,12430,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL631291,A,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,Intermediate
,,Blood,,,1,,,N,50597,8631,1,10116.0,12431,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL631292,A,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,Intermediate
,,Blood,,,1,,,N,50597,8631,1,10116.0,12432,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL631293,A,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,Intermediate
,,Blood,,,1,,,N,50597,8631,1,10116.0,12433,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL631294,A,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,Intermediate
,,Blood,,,1,,,N,50597,8631,1,10116.0,12434,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL631295,A,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,Intermediate
,,Blood,,,1,,,N,50597,8631,1,10116.0,12435,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL631296,A,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,Intermediate
,,Blood,,,1,,,N,50597,8631,1,10116.0,12436,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL631297,A,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,Intermediate
,,,,,0,,,U,22224,10263,1,,12437,,BAO_0000218,,,CHEMBL631298,A,,Maximum biodistribution (Bmax) was determined.,Autocuration
,,,,,1,,,N,50594,12364,1,10090.0,12438,,BAO_0000218,Mus musculus,,CHEMBL631299,A,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 1.5625 (mg/kg) intravenous dose in 6 mice,Intermediate
,,,,,1,,,N,50594,12364,1,10090.0,12439,,BAO_0000218,Mus musculus,,CHEMBL631300,A,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 10 (mg/kg) intravenous dose in 6 mice,Intermediate
,,,,,1,,,N,50594,12364,1,10090.0,12440,,BAO_0000218,Mus musculus,,CHEMBL631301,A,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 3.125 (mg/kg) intravenous dose in 6 mice,Intermediate
,,,,,1,,,N,50594,12364,1,10090.0,12441,,BAO_0000218,Mus musculus,,CHEMBL630291,A,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 6.25 (mg/kg) intravenous dose in 6 mice,Intermediate
,,,,,0,,,U,22224,14793,1,,12442,,BAO_0000218,,,CHEMBL630292,A,,Brain concentration after 0.25 hr at a dose of 10 mg/kg when administered intraperitoneally,Autocuration
,,,,,0,,,U,22224,14793,1,,12443,,BAO_0000218,,,CHEMBL630293,A,,Brain concentration after 0.25 h at a dose of 10 mg/kg when administered intravenously,Autocuration
,,,,,0,,,U,22224,14793,1,,12444,,BAO_0000218,,,CHEMBL630294,A,,Brain concentration after 0.5 h at a dose of 100 mg/kg when administered perorally,Autocuration
,,,,,0,,,U,22224,14793,1,,12445,,BAO_0000218,,,CHEMBL630295,A,,Brain concentration after 0.5 h at a dose of 10 mg/kg when administered intraperitoneally,Autocuration
,,,,,0,,,U,22224,14793,1,,12446,,BAO_0000218,,,CHEMBL630296,A,,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered intravenously,Autocuration
,,,,,0,,,U,22224,14793,1,,12447,,BAO_0000218,,,CHEMBL626782,A,,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered perorally,Autocuration
,,,,,0,,,U,22224,14793,1,,12448,,BAO_0000218,,,CHEMBL626783,A,,Brain concentration after 1 hr at a dose of 100 mg/kg when administered perorally,Autocuration
,,,,,0,,,U,22224,14793,1,,12449,,BAO_0000218,,,CHEMBL626784,A,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intraperitoneally,Autocuration
,,,,,0,,,U,22224,14793,1,,12450,,BAO_0000218,,,CHEMBL626785,A,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intravenously,Autocuration
,,,,,0,,,U,22224,14793,1,,12451,,BAO_0000218,,,CHEMBL626786,A,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered perorally,Autocuration
,,,,,0,,,U,22224,9196,1,,12452,,BAO_0000218,,,CHEMBL626787,A,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,Autocuration
,,,,,0,,,U,22224,9196,1,,12453,,BAO_0000218,,,CHEMBL626788,A,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr; ND means not determined,Autocuration
,,,,,0,,,U,22224,9196,1,,12454,,BAO_0000218,,,CHEMBL625927,A,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,Autocuration
,,Blood,,,1,,,N,50597,8374,1,10116.0,12455,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL625928,A,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate
,,Blood,,,1,,,N,50597,8374,1,10116.0,12456,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL625929,A,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,Intermediate
,,Blood,,,1,,,N,50597,8374,1,10116.0,12457,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL625930,A,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected.,Intermediate
,,Blood,,,1,,,N,50597,8374,1,10116.0,12458,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL625931,A,,"Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound, Compound was found to be in trace amount.",Intermediate
,,Blood,,,1,,,N,50597,8374,1,10116.0,12459,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL627230,A,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected.,Intermediate
,,Blood,,,1,,,N,50597,8374,1,10116.0,12460,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL627231,A,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate
,,Blood,,,1,,,N,50597,8374,1,10116.0,12461,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL627232,A,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,Intermediate
,,Blood,,,1,,,N,50597,8374,1,10116.0,12462,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL627233,A,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected.,Intermediate
,,Blood,,,1,,,N,50597,8374,1,10116.0,12463,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL875470,A,,Concentration 5a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate
,,Blood,,,1,,,N,50597,8374,1,10116.0,12464,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL627234,A,,Concentration 5a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate
,,Blood,,,1,,,N,50597,8374,1,10116.0,12465,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL627235,A,,Concentration 5b detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate
,,Blood,,,1,,,N,50597,8374,1,10116.0,12466,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL627236,A,,Concentration 5b detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate
,,Blood,,,1,,,N,50597,8374,1,10116.0,12467,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL627237,A,,Concentration 5c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate
,,Blood,,,1,,,N,50597,8374,1,10116.0,12468,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL627238,A,,Concentration 5c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate
,,Blood,,,1,,,N,50597,8374,1,10116.0,12469,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL627239,A,,Concentration 5d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate
,,Blood,,,1,,,N,50597,8374,1,10116.0,12470,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL627240,A,,Concentration 5d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate
,,Blood,,,1,,,N,50597,8374,1,10116.0,12471,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL627241,A,,Concentration 5e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate
,,Blood,,,1,,,N,50597,8374,1,10116.0,12472,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL627242,A,,Concentration 5e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate
,,Blood,,,1,,,N,50597,8374,1,10116.0,12473,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL627243,A,,Concentration 5f detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected,Intermediate
,,Blood,,,1,,,N,50597,8374,1,10116.0,12474,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL627244,A,,Concentration 5f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,Intermediate
,,Blood,,,1,,,N,50597,8374,1,10116.0,12475,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL627245,A,,Concentration 6a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate
,,Blood,,,1,,,N,50597,8374,1,10116.0,12476,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL627246,A,,Concentration 6a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate
,,Blood,,,1,,,N,50597,8374,1,10116.0,12477,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL627247,A,,Concentration 6c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate
,,Blood,,,1,,,N,50597,8374,1,10116.0,12478,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL627248,A,,Concentration 6c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate
,,Blood,,,1,,,N,50597,8374,1,10116.0,12479,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL627249,A,,Concentration 6d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate
,,Blood,,,1,,,N,50597,8374,1,10116.0,12480,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL625569,A,,Concentration 6d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate
,,Blood,,,1,,,N,50597,8374,1,10116.0,12481,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL625570,A,,Concentration 6e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate
,,Blood,,,1,,,N,50597,8374,1,10116.0,12482,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL625571,A,,Concentration 6e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate
,,Blood,,,1,,,N,50597,8374,1,10116.0,12483,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL625572,A,,Concentration 6f detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,Intermediate
,,Blood,,,1,,,N,50597,8374,1,10116.0,12484,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL625573,A,,Concentration 6f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,Intermediate
,,Blood,,,1,,,N,50597,8374,1,10116.0,12485,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL625574,A,,Concentration detected in blood of rat 1 hr after an oral dose of 200 mg/kg,Intermediate
,,Blood,,,1,,,N,50597,8374,1,10116.0,12486,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL626245,A,,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,Intermediate
,,Blood,,,1,,,N,50597,8374,1,10116.0,12487,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL626246,A,,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate
,,,,,0,,,U,22224,9196,1,,12488,,BAO_0000218,,,CHEMBL626247,A,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,Autocuration
,,,,,0,,,U,22224,9196,1,,12489,,BAO_0000218,,,CHEMBL626248,A,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,Autocuration
,,,,,0,,,U,22224,9196,1,,12490,,BAO_0000218,,,CHEMBL626249,A,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,Autocuration
,,,,,0,,,U,22224,9196,1,,12491,,BAO_0000218,,,CHEMBL626420,A,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,Autocuration
,,,,,0,,,U,22224,9196,1,,12492,,BAO_0000218,,,CHEMBL626421,A,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,Autocuration
,,,,,0,,,U,22224,9196,1,,12493,,BAO_0000218,,,CHEMBL626422,A,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,Autocuration
,,,,,0,,,U,22224,9196,1,,12494,,BAO_0000218,,,CHEMBL626423,A,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,Autocuration
,,,,,0,,,U,22224,9196,1,,12495,,BAO_0000218,,,CHEMBL626424,A,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,Autocuration
,,,,,1,,,N,50588,12023,1,9615.0,12496,,BAO_0000218,Canis lupus familiaris,,CHEMBL626425,A,,Volume of distribution in Beagles dog at a dose of 1 mg/kg given intravenously,Intermediate
,,,,,1,,,N,50597,12023,1,10116.0,12497,,BAO_0000218,Rattus norvegicus,,CHEMBL875476,A,,Volume of distribution in CD rat at a dose of 5 mg/kg given intravenously,Intermediate
,,,,,1,,,N,100710,12023,1,9541.0,12498,,BAO_0000218,Macaca fascicularis,,CHEMBL626426,A,,Volume of distribution in Cynomolgus monkey at a dose of 5 mg/kg given intravenously,Intermediate
,,,,,0,,,U,22224,10580,1,,12499,,BAO_0000100,,,CHEMBL626427,P,,Distribution coefficient and iron(III) complex was measured at an aqueous phase buffered at pH 7.4 and octanol,Autocuration
,,,,,0,,,U,22224,10580,1,,12500,,BAO_0000100,,,CHEMBL626428,P,,Distribution coefficient was measured at an aqueous phase buffered at pH 7.4 and octanol,Autocuration
,,,,,0,,,U,22224,16032,1,,12501,,BAO_0000019,,,CHEMBL626429,A,,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in bile by subcutaneous dose of 150 umol/kg,Autocuration
,,Urine,,,0,,,U,22224,16032,1,,12502,,BAO_0000019,,1088.0,CHEMBL625025,A,,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in urine by subcutaneous dose of 150 umol/kg,Autocuration
,,Blood,,,1,,,N,50597,8594,1,10116.0,12503,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL625026,A,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Intermediate
,,Blood,,,1,,,N,50597,8594,1,10116.0,12504,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL625027,A,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Intermediate
,,Blood,,,1,,,N,50597,8594,1,10116.0,12505,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL874410,A,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Intermediate
,,Blood,,,1,,,N,50597,8594,1,10116.0,12506,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL625028,A,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Intermediate
,,Blood,,,1,,,N,50597,8594,1,10116.0,12507,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL625029,A,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Intermediate
,,Blood,,,1,,,N,50597,8594,1,10116.0,12508,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL625030,A,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Intermediate
,,Blood,,,1,,,N,50597,8594,1,10116.0,12509,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL625031,A,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Intermediate
,,Blood,,,1,,,N,50597,8594,1,10116.0,12510,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL625032,A,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Intermediate
,,Blood,,,1,,,N,50597,8594,1,10116.0,12511,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL625033,A,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Intermediate
,,Blood,,,1,,,N,50597,8594,1,10116.0,12512,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL625034,A,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Intermediate
,,Heart,,,1,,,N,50597,8594,1,10116.0,12513,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL624872,A,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Intermediate
,,Heart,,,1,,,N,50597,8594,1,10116.0,12514,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL624873,A,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Intermediate
,,Heart,,,1,,,N,50597,8594,1,10116.0,12515,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL624874,A,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Intermediate
,,Heart,,,1,,,N,50597,8594,1,10116.0,12516,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL624875,A,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Intermediate
,,Heart,,,1,,,N,50597,8594,1,10116.0,12517,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL624876,A,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Intermediate
,,Heart,,,1,,,N,50597,8594,1,10116.0,12518,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL624877,A,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Intermediate
,,Heart,,,1,,,N,50597,8594,1,10116.0,12519,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL624878,A,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Intermediate
,,Heart,,,1,,,N,50597,8594,1,10116.0,12520,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL624879,A,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Intermediate
,,Heart,,,1,,,N,50597,8594,1,10116.0,12521,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL624880,A,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Intermediate
,,Heart,,,1,,,N,50597,8594,1,10116.0,12522,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL624881,A,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 10 min (radiolabeled with [125I]-,Intermediate
,,Heart,,,1,,,N,50597,8594,1,10116.0,12523,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL624882,A,,"Concentration was measured in heart tissue of unfasted Fischer 344 rats, administered intravenous, after 5 minute (radiolabeled with [125I]-",Intermediate
,,Kidney,,,1,,,N,50597,8594,1,10116.0,12524,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL624883,A,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Intermediate
,,Kidney,,,1,,,N,50597,8594,1,10116.0,12525,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL624884,A,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Intermediate
,,Kidney,,,1,,,N,50597,8594,1,10116.0,12526,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL624885,A,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Intermediate
,,Kidney,,,1,,,N,50597,8594,1,10116.0,12527,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL624886,A,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Intermediate
,,Kidney,,,1,,,N,50597,8594,1,10116.0,12528,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL624887,A,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Intermediate
,,Kidney,,,1,,,N,50597,8594,1,10116.0,12529,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL624888,A,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Intermediate
,,Kidney,,,1,,,N,50597,8594,1,10116.0,12530,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL624889,A,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Intermediate
,,Kidney,,,1,,,N,50597,8594,1,10116.0,12531,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL624890,A,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Intermediate
,,Kidney,,,1,,,N,50597,8594,1,10116.0,12532,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL621964,A,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Intermediate
,,Kidney,,,1,,,N,50597,8594,1,10116.0,12533,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL621965,A,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Intermediate
,,Liver,,,1,,,N,50597,8594,1,10116.0,12534,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL621966,A,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Intermediate
,,Liver,,,1,,,N,50597,8594,1,10116.0,12535,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL621967,A,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Intermediate
,,Liver,,,1,,,N,50597,8594,1,10116.0,12536,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL622164,A,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Intermediate
,,,,,0,,,U,22224,7653,1,,12537,,BAO_0000019,,,CHEMBL623097,A,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (nucleic acids),Autocuration
,,,,,0,,,U,22224,7653,1,,12538,,BAO_0000019,,,CHEMBL623098,A,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (protein),Autocuration
,,,,,0,,,U,22224,7653,1,,12539,,BAO_0000019,,,CHEMBL623099,A,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid soluble,Autocuration
,,,,,0,,,U,22224,7653,1,,12540,,BAO_0000019,,,CHEMBL623100,A,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; total uptake,Autocuration
,,,,,1,,,N,50597,9104,1,10116.0,12541,,BAO_0000218,Rattus norvegicus,,CHEMBL628673,A,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated Number of new tumors observed",Intermediate
,,,,,1,,,N,50597,9104,1,10116.0,12542,,BAO_0000218,Rattus norvegicus,,CHEMBL628674,A,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated complete percent remission indicates tumor not palpable.",Intermediate
,,,,,1,,,N,50597,9104,1,10116.0,12543,,BAO_0000218,Rattus norvegicus,,CHEMBL628675,A,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated number of tumors at the beginning of the test.",Intermediate
,,,,,1,,,N,50597,9104,1,10116.0,12544,,BAO_0000218,Rattus norvegicus,,CHEMBL627644,A,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated of percent static tumors indicates size of tumor 51-150% of the initial size",Intermediate
,,,,,1,,,N,50597,9104,1,10116.0,12545,,BAO_0000218,Rattus norvegicus,,CHEMBL627645,A,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated partial percent remission indicates reduction of initial tumor size <=50%.",Intermediate
,,,,,1,,,N,50597,9104,1,10116.0,12546,,BAO_0000218,Rattus norvegicus,,CHEMBL627646,A,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent progress in tumor size indicates >150% of the initial size",Intermediate
,,,,,1,,,N,50597,9104,1,10116.0,12547,,BAO_0000218,Rattus norvegicus,,CHEMBL627647,A,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent static tumors indicates size of tumor 51-150% of the initial size",Intermediate
,,,,,1,,,N,50597,9104,1,10116.0,12548,,BAO_0000218,Rattus norvegicus,,CHEMBL627648,A,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent tumor area measured as the average on the 28th day of therapy.",Intermediate
,,,,,1,,,N,50597,12902,1,10116.0,12549,,BAO_0000218,Rattus norvegicus,,CHEMBL627649,A,,Free level in rat plasma,Intermediate
,,,,,0,,,U,22224,6614,1,,12550,,BAO_0000019,,,CHEMBL628313,A,,Level reaching in blood plasma of rat or human was determined,Autocuration
,,,,,1,,,N,50597,9663,1,10116.0,12551,,BAO_0000218,Rattus norvegicus,,CHEMBL628314,A,,Log (Cbrain/Cblood) in rats,Intermediate
,,,,,0,,,U,22224,17658,1,,12552,,BAO_0000019,,,CHEMBL628315,A,,Mean percentage of compound transport through P-glycoprotein; expressed as p-glycoprotein affinity,Autocuration
,,,,,0,,,U,22224,17658,1,,12553,,BAO_0000019,,,CHEMBL628316,A,,Mean percentage of compound transport through membrane; expressed as membrane transport,Autocuration
,,,,,0,,,U,22224,14314,1,,12554,,BAO_0000218,,,CHEMBL628317,A,,Metabolic breakdown to the o-sulfate of p-chloroaniline (2-amino-5-chlorophenyl sulfate) by giving 100 mg/kg oral doses of the compound,Autocuration
,,,,,0,,,U,22224,7385,1,,12555,,BAO_0000019,,,CHEMBL628473,A,,Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5,Autocuration
,,,,,0,,,U,22224,7385,1,,12556,,BAO_0000019,,,CHEMBL628474,A,,"Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5, ND=Not determined",Autocuration
,,,,,0,,,U,22224,7385,1,,12557,,BAO_0000019,,,CHEMBL628475,A,,Michaelis-Menten constant was measured in the inactivation of trypsin; Km x 10 e5,Autocuration
,,,,,0,,,U,22224,1329,1,,12558,,BAO_0000019,,,CHEMBL628476,A,,Net water uptake by a carrier mediated transport (%cm) mechanism,Autocuration
,,,,,0,,,U,22224,12187,1,314293.0,12559,,BAO_0000218,Simiiformes,,CHEMBL628477,A,,Peak concentration was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,Autocuration
,,,,,1,,,N,50506,12187,1,9669.0,12560,,BAO_0000218,Mustela putorius furo,,CHEMBL628478,A,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,Intermediate
,,,,,1,,,N,50506,12187,1,9669.0,12561,,BAO_0000218,Mustela putorius furo,,CHEMBL628479,A,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",Intermediate
,,,,,0,,,U,22224,12187,1,314293.0,12562,,BAO_0000218,Simiiformes,,CHEMBL628480,A,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,Autocuration
,,,,,0,,,U,22224,12187,1,314293.0,12563,,BAO_0000218,Simiiformes,,CHEMBL628481,A,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey, determined by renin inhibition assay",Autocuration
,,,,,1,,,N,50597,12187,1,10116.0,12564,,BAO_0000218,Rattus norvegicus,,CHEMBL628482,A,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,Intermediate
,,,,,1,,,N,50597,12187,1,10116.0,12565,,BAO_0000218,Rattus norvegicus,,CHEMBL628483,A,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",Intermediate
,,Plasma,,,1,,,N,50597,9278,1,10116.0,12566,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL628484,A,,"Peak plasma concentration at a dose of 10 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",Intermediate
,,Plasma,,,1,,,N,50597,9278,1,10116.0,12567,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL628485,A,,"Peak plasma concentration at a dose of 100 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",Intermediate
,,Plasma,,,1,,,N,100710,9278,1,9541.0,12568,,BAO_0000218,Macaca fascicularis,1969.0,CHEMBL628486,A,,"Peak plasma concentration at a dose of 20 mg/kg, oral route in monkey (Macaca fascicularis) suspended in carboxymethyl cellulose (CMC);Range is between (5.5-6)",Intermediate
,,Plasma,,,1,,,N,50587,9278,1,9606.0,12569,,BAO_0000218,Homo sapiens,1969.0,CHEMBL628487,A,,"Peak plasma concentration at a dose of 200 mg/kg, oral route in human",Intermediate
,,Plasma,,,1,,,N,50597,9278,1,10116.0,12570,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL628488,A,,"Peak plasma concentration at a dose of 25 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",Intermediate
,,Plasma,,,1,,,N,50597,9278,1,10116.0,12571,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL628489,A,,"Peak plasma concentration at a dose of 25 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",Intermediate
,,Plasma,,,1,,,N,50597,9278,1,10116.0,12572,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL628490,A,,"Peak plasma concentration at a dose of 50 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",Intermediate
,,,,,1,,,N,100710,12186,1,9541.0,12573,,BAO_0000218,Macaca fascicularis,,CHEMBL628491,A,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,Intermediate
,,,,,1,,,N,100710,12186,1,9541.0,12574,,BAO_0000218,Macaca fascicularis,,CHEMBL877507,A,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,Intermediate
,,,,,0,,,U,22224,12186,1,,12575,,BAO_0000218,,,CHEMBL628492,A,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,Autocuration
,,,,,0,,,U,22224,12041,1,314293.0,12576,,BAO_0000019,Simiiformes,,CHEMBL628493,A,,% metabolized in monkey S-9 after 2 hours (10 ug/mL),Autocuration
,,,,,0,,,U,22224,12041,1,314293.0,12577,,BAO_0000019,Simiiformes,,CHEMBL628494,A,,% metabolized in monkey S-9 after 2 hours (1 ug/ml),Autocuration
,,,,,0,,,U,22224,12041,1,314293.0,12578,,BAO_0000019,Simiiformes,,CHEMBL628495,A,,% metabolized in monkey S-9 after 2 hours (10 ug/ml),Autocuration
,,,,,1,,,N,50587,6737,1,9606.0,12579,,BAO_0000218,Homo sapiens,,CHEMBL628496,A,,Permeability in Caco-2 assay at 10E-6,Intermediate
,,Brain,,,0,,,U,22224,13758,1,,12580,,BAO_0000218,,955.0,CHEMBL628497,A,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,Autocuration
,,Brain,,,0,,,U,22224,13758,1,,12581,,BAO_0000218,,955.0,CHEMBL628498,A,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,Autocuration
,,,,,0,,,U,22224,5676,1,,12582,,BAO_0000019,,,CHEMBL628499,A,,Plasma protein binding was determined,Autocuration
,,,,,0,,,U,22224,14793,1,,12583,,BAO_0000218,,,CHEMBL627656,A,,Brain concentration after 2 hr at a dose of 100 mg/kg when administered perorally,Autocuration
,,,,,0,,,U,22224,14793,1,,12584,,BAO_0000218,,,CHEMBL627657,A,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intraperitoneally,Autocuration
,,,,,0,,,U,22224,14793,1,,12585,,BAO_0000218,,,CHEMBL626808,A,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intravenously,Autocuration
,,,,,0,,,U,22224,14793,1,,12586,,BAO_0000218,,,CHEMBL626809,A,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered perorally,Autocuration
,,,,,0,,,U,22224,14793,1,,12587,,BAO_0000218,,,CHEMBL626810,A,,Brain concentration after 4 hr at a dose of 100 mg/kg when administered perorally,Autocuration
,,,,,0,,,U,22224,14793,1,,12588,,BAO_0000218,,,CHEMBL626811,A,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intraperitoneally,Autocuration
,,,,,0,,,U,22224,14793,1,,12589,,BAO_0000218,,,CHEMBL874465,A,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intravenously,Autocuration
,,,,,0,,,U,22224,14793,1,,12590,,BAO_0000218,,,CHEMBL626812,A,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered perorally,Autocuration
,,,,,0,,,U,22224,14793,1,,12591,,BAO_0000218,,,CHEMBL626813,A,,Brain concentration after 6 hr at a dose of 100 mg/kg when administered perorally,Autocuration
,,,,,0,,,U,22224,14793,1,,12592,,BAO_0000218,,,CHEMBL626814,A,,Brain concentration after 6 hr at a dose of 10 mg/kg when administered perorally,Autocuration
,,,,,0,,,U,22224,14000,1,,12593,,BAO_0000019,,,CHEMBL626815,A,,Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.,Autocuration
,,,,,0,,,U,22224,5948,1,,12594,,BAO_0000019,,,CHEMBL628566,A,,Partition coefficient (logP),Autocuration
,,,,,0,,,U,22229,13824,1,,12595,,BAO_0000100,,,CHEMBL628567,P,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),Autocuration
,,,,,0,,,U,22229,10778,1,,12596,,BAO_0000100,,,CHEMBL628568,P,,Calculated partition coefficient (clogP),Autocuration
,In vivo,,,,1,,,N,50588,17237,1,9615.0,12597,,BAO_0000218,Canis lupus familiaris,,CHEMBL628569,A,,C max in dog,Intermediate
,In vivo,,,,1,,,N,50512,17237,1,10141.0,12598,,BAO_0000218,Cavia porcellus,,CHEMBL628570,A,,C max in guinea pig,Intermediate
,In vivo,,,,0,,,U,22224,2809,1,,12599,,BAO_0000218,,,CHEMBL628571,A,,C max value was evaluated,Autocuration
,In vivo,,,,0,,,U,22224,11954,1,,12600,,BAO_0000218,,,CHEMBL628572,A,,Cmax value after oral dose of 0.1 mg//kg,Autocuration
,In vivo,,,,0,,,U,22224,11954,1,,12601,,BAO_0000218,,,CHEMBL628573,A,,Cmax value after oral dose of 0.3 mg/kg,Autocuration
,In vivo,,,,0,,,U,22224,11954,1,,12602,,BAO_0000218,,,CHEMBL628574,A,,Cmax value after oral dose of 1 mg/kg,Autocuration
,In vivo,,,,0,,,U,22224,11954,1,,12603,,BAO_0000218,,,CHEMBL628575,A,,Cmax value after oral dose of 10 mg/kg,Autocuration
,In vivo,,,,0,,,U,22224,11954,1,,12604,,BAO_0000218,,,CHEMBL628576,A,,Cmax value after oral dose of 23.4 mg/kg,Autocuration
,In vivo,,,,0,,,U,22224,11954,1,,12605,,BAO_0000218,,,CHEMBL628577,A,,Cmax value after oral dose of 3 mg/kg,Autocuration
,In vivo,,,,0,,,U,22224,11954,1,,12606,,BAO_0000218,,,CHEMBL628578,A,,Cmax value after oral dose of 3.87 mg/kg,Autocuration
,In vivo,,,,1,,,N,50588,12768,1,9615.0,12607,,BAO_0000218,Canis lupus familiaris,,CHEMBL874466,A,,Cmax value in female Beagle dogs,Intermediate
,In vivo,,,,1,,,N,50597,12768,1,10116.0,12608,,BAO_0000218,Rattus norvegicus,,CHEMBL628579,A,,Cmax value in male rats,Intermediate
,In vivo,Plasma,,,1,,,N,50597,12780,1,10116.0,12609,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL628580,A,,Cmax value in rat plasma when administered 20 mg/kg perorally,Intermediate
,In vivo,Plasma,,,1,,,N,50588,15592,1,9615.0,12610,,BAO_0000218,Canis lupus familiaris,1969.0,CHEMBL628581,A,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,Intermediate
,In vivo,Plasma,,,1,,,N,50588,15592,1,9615.0,12611,,BAO_0000218,Canis lupus familiaris,1969.0,CHEMBL628582,A,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,Intermediate
,,,,,1,,,N,50588,17025,1,9615.0,12612,,BAO_0000218,Canis lupus familiaris,,CHEMBL628583,A,,Peak concentration of compound at Time = 0 was determined in dog at 5 mg/kg intravenously admn.,Intermediate
,,,,,0,,,U,22224,17025,1,314293.0,12613,,BAO_0000218,Simiiformes,,CHEMBL625782,A,,Peak concentration of compound at Time = 0 was determined in monkey at 5 mg/kg intravenously admn.,Autocuration
,,,,,1,,,N,50592,17025,1,9986.0,12614,,BAO_0000218,Oryctolagus cuniculus,,CHEMBL625783,A,,Peak concentration of compound at Time = 0 was determined in rabbit at 5 mg/kg intravenously admn.,Intermediate
,,,,,1,,,N,50597,17025,1,10116.0,12615,,BAO_0000218,Rattus norvegicus,,CHEMBL625784,A,,Peak concentration of compound at Time = 0 was determined in rat at 5 mg/kg intravenously admn.,Intermediate
,,Plasma,,,1,,,N,50797,4236,1,9544.0,12616,,BAO_0000218,Macaca mulatta,1969.0,CHEMBL625785,A,,Total plasma concentration at 24 hr at a dose of 10 mg/kg when administered orally to rhesus monkey,Intermediate
,,,,,1,,,N,50597,15791,1,10116.0,12617,,BAO_0000218,Rattus norvegicus,,CHEMBL625786,A,,C5min (nM) value was determined in rats after intravenous dose of 5 mg/kg,Intermediate
,,,,,0,,,U,22224,11149,1,,12618,,BAO_0000019,,,CHEMBL874467,A,,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate,Autocuration
,,,,,1,,,N,50588,15592,1,9615.0,12619,,BAO_0000218,Canis lupus familiaris,,CHEMBL625787,A,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",Intermediate
,,,,,1,,,N,50677,15778,1,12721.0,12620,,BAO_0000218,Human immunodeficiency virus,,CHEMBL625964,A,,cytotoxicity against HIV protease enzyme.,Intermediate
,,,,,1,,,N,50594,12745,1,10090.0,12621,,BAO_0000218,Mus musculus,,CHEMBL625965,A,,Apparent clearance in mice after intravenous administration of 105.1 mg/kg of dose,Intermediate
,,,,,1,,,N,50594,12745,1,10090.0,12622,,BAO_0000218,Mus musculus,,CHEMBL625966,A,,Apparent clearance in mice after oral administration of 100 mg/kg of dose,Intermediate
,In vivo,Plasma,,,1,,,N,50588,13941,1,9615.0,12623,,BAO_0000218,Canis lupus familiaris,1969.0,CHEMBL625967,A,,The plasma clearance in dog.,Intermediate
,In vivo,Plasma,,,1,,,N,50597,13941,1,10116.0,12624,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL625968,A,,The plasma clearance in rat.,Intermediate
,In vivo,Plasma,,,1,,,N,50597,16449,1,10116.0,12625,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL625969,A,,Clearance from plasma in male Sprague-Dawley rats,Intermediate
,In vivo,Plasma,,,1,,,N,100710,16449,1,9541.0,12626,,BAO_0000218,Macaca fascicularis,1969.0,CHEMBL625970,A,,Clearance from plasma in male cynomolgus monkeys,Intermediate
,In vivo,Plasma,,,1,,,N,50588,14224,1,9615.0,12627,,BAO_0000218,Canis lupus familiaris,1969.0,CHEMBL625971,A,,"Clearance of compound (5 mg/kg, intravenously), in dog plasma",Intermediate
,In vivo,Plasma,,,1,,,N,50588,14224,1,9615.0,12628,,BAO_0000218,Canis lupus familiaris,1969.0,CHEMBL625972,A,,Clearance of compound in dog plasma,Intermediate
,In vivo,Plasma,,,1,,,N,50587,14224,1,9606.0,12629,,BAO_0000218,Homo sapiens,1969.0,CHEMBL625973,A,,Clearance of compound in human plasma,Intermediate
,In vivo,,,,1,,,N,50588,14317,1,9615.0,12630,,BAO_0000218,Canis lupus familiaris,,CHEMBL625974,A,,Clearance of compound when administered intravenously as a mixture (five-in-one dose) to a single dog.,Intermediate
,In vivo,,,,1,,,N,50588,14317,1,9615.0,12631,,BAO_0000218,Canis lupus familiaris,,CHEMBL625975,A,,Clearance of compound when administered intravenously as an individual dose to a single dog.,Intermediate
,In vivo,Plasma,,,1,,,N,50588,14224,1,9615.0,12632,,BAO_0000218,Canis lupus familiaris,1969.0,CHEMBL625976,A,,"Clearance (10 mg/kg, intravenously) in dog plasma",Intermediate
,In vivo,,,,1,,,N,50588,17237,1,9615.0,12633,,BAO_0000218,Canis lupus familiaris,,CHEMBL625977,A,,Clearance value in dog,Intermediate
,In vivo,,,,1,,,N,50512,17237,1,10141.0,12634,,BAO_0000218,Cavia porcellus,,CHEMBL625978,A,,Clearance value in guinea pig,Intermediate
,In vivo,,,,1,,,N,50597,14187,1,10116.0,12635,,BAO_0000218,Rattus norvegicus,,CHEMBL874468,A,,Clearance values in rats after iv administration.,Intermediate
,In vivo,Plasma,,,0,,,U,22224,4806,1,,12636,,BAO_0000218,,1969.0,CHEMBL625421,A,,Compound was tested for plasma clearance on administered orally as aqueous solutions at 1 mpk and by iv at 0.2 mpk,Autocuration
,In vivo,,,,1,,,N,50592,15025,1,9986.0,12637,,BAO_0000218,Oryctolagus cuniculus,,CHEMBL625422,A,,In vivo clearance (5 mg/kg) was determined in rabbits,Intermediate
,In vivo,,,,1,,,N,50597,13197,1,10116.0,12638,,BAO_0000218,Rattus norvegicus,,CHEMBL625423,A,,Plasma Clearance rate was determined for the compound in rats,Intermediate
,In vivo,,,,0,,,U,22224,13197,1,9520.0,12639,,BAO_0000218,Saimiri,,CHEMBL625424,A,,Plasma Clearance rate was determined for the compound in squirrel monkeys,Autocuration
,In vivo,,,,1,,,N,50597,13960,1,10116.0,12640,,BAO_0000218,Rattus norvegicus,,CHEMBL625425,A,,Plasma clearance in rat,Intermediate
,In vivo,,,,0,,,U,22224,17820,1,,12641,,BAO_0000218,,,CHEMBL625426,A,,Plasma clearance of the compound,Autocuration
,In vivo,,,,1,,,N,50512,14706,1,10141.0,12642,,BAO_0000218,Cavia porcellus,,CHEMBL625427,A,,Plasma clearance in guinea pigs at 2 mg/kg after iv administration,Intermediate
,In vivo,,,,1,,,N,50512,14706,1,10141.0,12643,,BAO_0000218,Cavia porcellus,,CHEMBL625428,A,,Plasma clearance in guinea pigs at 3 mg/kg after iv administration,Intermediate
,In vivo,,,,0,,,U,22224,6504,1,,12644,,BAO_0000218,,,CHEMBL625429,A,,Plasma clearance was determined,Autocuration
,In vivo,,,,1,,,N,50588,14925,1,9615.0,12645,,BAO_0000218,Canis lupus familiaris,,CHEMBL625430,A,,Plasma clearance rate (CL) was determined in dogs after intravenous administration of 25 mg/kg of the compound.,Intermediate
,In vivo,,,,1,,,N,50597,13197,1,10116.0,12646,,BAO_0000218,Rattus norvegicus,,CHEMBL625431,A,,Plasma clearance rate was determined for the compound in rats,Intermediate
,In vivo,,,,0,,,U,22224,13197,1,9520.0,12647,,BAO_0000218,Saimiri,,CHEMBL627307,A,,Plasma clearance rate was determined for the compound in squirrel monkeys,Autocuration
,In vivo,,,,0,,,U,22224,3437,1,,12648,,BAO_0000218,,,CHEMBL627308,A,,Slow clearance (CL) was determined,Autocuration
,,,,,0,,,U,22224,9196,1,,12649,,BAO_0000218,,,CHEMBL627309,A,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,Autocuration
,,,,,0,,,U,22224,9196,1,,12650,,BAO_0000218,,,CHEMBL627310,A,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr; insufficient gastric juice produced,Autocuration
,,,,,0,,,U,22224,9196,1,,12651,,BAO_0000218,,,CHEMBL627311,A,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,Autocuration
,,,,,0,,,U,22224,9196,1,,12652,,BAO_0000218,,,CHEMBL627312,A,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,Autocuration
,,,,,0,,,U,22224,9196,1,,12653,,BAO_0000218,,,CHEMBL627313,A,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,Autocuration
,,,,,0,,,U,22224,9196,1,,12654,,BAO_0000218,,,CHEMBL627314,A,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,Autocuration
,,,,,0,,,U,22224,9196,1,,12655,,BAO_0000218,,,CHEMBL627315,A,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,Autocuration
,,,,,0,,,U,22224,9196,1,,12656,,BAO_0000218,,,CHEMBL627316,A,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,Autocuration
,,,,,0,,,U,22224,9196,1,,12657,,BAO_0000218,,,CHEMBL627317,A,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,Autocuration
,,,,,0,,,U,22224,9196,1,,12658,,BAO_0000218,,,CHEMBL627318,A,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,Autocuration
,,,,,0,,,U,22224,9196,1,,12659,,BAO_0000218,,,CHEMBL627999,A,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,Autocuration
,,,,,0,,,U,22224,9196,1,,12660,,BAO_0000218,,,CHEMBL628000,A,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,Autocuration
,,,,,0,,,U,22224,9196,1,,12661,,BAO_0000218,,,CHEMBL628001,A,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,Autocuration
,,,,,0,,,U,22224,9196,1,,12662,,BAO_0000218,,,CHEMBL628002,A,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,Autocuration
,,,,,0,,,U,22224,9196,1,,12663,,BAO_0000218,,,CHEMBL625610,A,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,Autocuration
,,,,,0,,,U,22224,9196,1,,12664,,BAO_0000218,,,CHEMBL625611,A,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,Autocuration
,,,,,0,,,U,22224,9196,1,,12665,,BAO_0000218,,,CHEMBL625612,A,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,Autocuration
,,,,,0,,,U,22224,9196,1,,12666,,BAO_0000218,,,CHEMBL625613,A,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,Autocuration
,,,,,0,,,U,22224,9196,1,,12667,,BAO_0000218,,,CHEMBL875479,A,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,Autocuration
,,,,,0,,,U,22224,9196,1,,12668,,BAO_0000218,,,CHEMBL625614,A,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,Autocuration
,,,,,0,,,U,22224,9196,1,,12669,,BAO_0000218,,,CHEMBL625615,A,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,Autocuration
,,,,,0,,,U,22224,9196,1,,12670,,BAO_0000218,,,CHEMBL626302,A,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,Autocuration
,,Blood,,,1,,,N,50597,8374,1,10116.0,12671,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL626303,A,,Cumulative concentration 6b and compound 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate
,,Blood,,,1,,,N,50597,8374,1,10116.0,12672,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL627420,A,,Cumulative concentration 6b and compound 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate
,,,,,1,,,N,50597,13477,1,10116.0,12673,,BAO_0000218,Rattus norvegicus,,CHEMBL627421,A,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 1 hour relative to initial concentration of 1 uM,Intermediate
,,,,,1,,,N,50597,13477,1,10116.0,12674,,BAO_0000218,Rattus norvegicus,,CHEMBL625695,A,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 24 hour relative to initial concentration of 1 uM,Intermediate
,,,,,1,,,N,50597,13477,1,10116.0,12675,,BAO_0000218,Rattus norvegicus,,CHEMBL625696,A,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 4 hour relative to initial concentration of 1 uM,Intermediate
,,Brain,,,1,,,N,50594,10009,1,10090.0,12676,,BAO_0000218,Mus musculus,955.0,CHEMBL875606,A,,Distribution of compound in mice brain was measured after 1 hr,Intermediate
,,Brain,,,1,,,N,50594,10009,1,10090.0,12677,,BAO_0000218,Mus musculus,955.0,CHEMBL625697,A,,Distribution of compound in mice brain was measured after 24 hr r,Intermediate
,,Brain,,,1,,,N,50594,10009,1,10090.0,12678,,BAO_0000218,Mus musculus,955.0,CHEMBL625698,A,,Distribution of compound in mice brain was measured after 2 hr,Intermediate
,,Brain,,,1,,,N,50594,10009,1,10090.0,12679,,BAO_0000218,Mus musculus,955.0,CHEMBL625699,A,,Distribution of compound in mice brain was measured after 3 hr,Intermediate
,,Brain,,,1,,,N,50594,10009,1,10090.0,12680,,BAO_0000218,Mus musculus,955.0,CHEMBL625700,A,,Distribution of compound in mice brain was measured after 6 hr,Intermediate
,,,,,1,,,N,50594,10009,1,10090.0,12681,,BAO_0000218,Mus musculus,,CHEMBL625701,A,,Distribution of compound in mice liver was measured after 1 hr,Intermediate
,,,,,1,,,N,50594,10009,1,10090.0,12682,,BAO_0000218,Mus musculus,,CHEMBL625702,A,,Distribution of compound in mice liver was measured after 24 hr; b=Undetected,Intermediate
,,,,,1,,,N,50594,10009,1,10090.0,12683,,BAO_0000218,Mus musculus,,CHEMBL625703,A,,Distribution of compound in mice liver was measured after 2 hr,Intermediate
,,,,,1,,,N,50594,10009,1,10090.0,12684,,BAO_0000218,Mus musculus,,CHEMBL625704,A,,Distribution of compound in mice liver was measured after 3 hr,Intermediate
,,,,,1,,,N,50594,10009,1,10090.0,12685,,BAO_0000218,Mus musculus,,CHEMBL625705,A,,Distribution of compound in mice liver was measured after 6 hr,Intermediate
,,Adrenal medulla,,,1,,,N,50588,8170,1,9615.0,12686,,BAO_0000218,Canis lupus familiaris,1236.0,CHEMBL625706,A,,Distribution in dog adrenal medulla 30 min after administration.,Intermediate
,,Adrenal medulla,,,1,,,N,50588,8170,1,9615.0,12687,,BAO_0000218,Canis lupus familiaris,1236.0,CHEMBL625707,A,,Distribution in dog adrenal medulla 72 hours after administration.,Intermediate
,,,,,1,,,N,50588,8170,1,9615.0,12688,,BAO_0000218,Canis lupus familiaris,,CHEMBL625708,A,,Distribution in female dog Ovary 24 hours after administration.,Intermediate
,,,,,1,,,N,50588,8170,1,9615.0,12689,,BAO_0000218,Canis lupus familiaris,,CHEMBL625709,A,,Distribution in female dog Ovary 72 hours after administration.,Intermediate
,,,,,1,,,N,50588,8170,1,9615.0,12690,,BAO_0000218,Canis lupus familiaris,,CHEMBL624180,A,,Distribution in female dog adipose 24 hours after administration.,Intermediate
,,,,,1,,,N,50588,8170,1,9615.0,12691,,BAO_0000218,Canis lupus familiaris,,CHEMBL624181,A,,Distribution in female dog adipose 72 hours after administration.,Intermediate
,,Adrenal cortex,,,1,,,N,50588,8170,1,9615.0,12692,,BAO_0000218,Canis lupus familiaris,1235.0,CHEMBL624182,A,,Distribution in female dog adrenal cortex 72 hours after administration.,Intermediate
,,Adrenal cortex,,,1,,,N,50588,8170,1,9615.0,12693,,BAO_0000218,Canis lupus familiaris,1235.0,CHEMBL624183,A,,Distribution in female dog adrenal cortex 72 hours after administration.,Intermediate
,,Liver,,,1,,,N,50597,8594,1,10116.0,12694,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL624184,A,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Intermediate
,,Liver,,,1,,,N,50597,8594,1,10116.0,12695,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL877489,A,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Intermediate
,,Liver,,,1,,,N,50597,8594,1,10116.0,12696,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL624185,A,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Intermediate
,,Liver,,,1,,,N,50597,8594,1,10116.0,12697,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL624186,A,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Intermediate
,,Liver,,,1,,,N,50597,8594,1,10116.0,12698,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL624187,A,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Intermediate
,,Liver,,,1,,,N,50597,8594,1,10116.0,12699,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL624188,A,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Intermediate
,,Lung,,,1,,,N,50597,8594,1,10116.0,12700,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL624189,A,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Intermediate
,,Lung,,,1,,,N,50597,8594,1,10116.0,12701,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL624190,A,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Intermediate
,,Lung,,,1,,,N,50597,8594,1,10116.0,12702,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL624191,A,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Intermediate
,,Lung,,,1,,,N,50597,8594,1,10116.0,12703,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL624192,A,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Intermediate
,,Lung,,,1,,,N,50597,8594,1,10116.0,12704,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL624193,A,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Intermediate
,,Lung,,,1,,,N,50597,8594,1,10116.0,12705,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL624194,A,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Intermediate
,,Lung,,,1,,,N,50597,8594,1,10116.0,12706,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL624891,A,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Intermediate
,,Lung,,,1,,,N,50597,8594,1,10116.0,12707,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL624892,A,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Intermediate
,,Lung,,,1,,,N,50597,8594,1,10116.0,12708,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL624893,A,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Intermediate
,,Lung,,,1,,,N,50597,8594,1,10116.0,12709,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL627632,A,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Intermediate
,,,,,1,,,N,50597,8594,1,10116.0,12710,,BAO_0000218,Rattus norvegicus,,CHEMBL627633,A,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Intermediate
,,,,,1,,,N,50597,8594,1,10116.0,12711,,BAO_0000218,Rattus norvegicus,,CHEMBL627634,A,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Intermediate
,,,,,1,,,N,50597,8594,1,10116.0,12712,,BAO_0000218,Rattus norvegicus,,CHEMBL627635,A,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Intermediate
,,,,,1,,,N,50597,8594,1,10116.0,12713,,BAO_0000218,Rattus norvegicus,,CHEMBL627636,A,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Intermediate
,,,,,1,,,N,50597,8594,1,10116.0,12714,,BAO_0000218,Rattus norvegicus,,CHEMBL626816,A,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Intermediate
,,,,,1,,,N,50597,8594,1,10116.0,12715,,BAO_0000218,Rattus norvegicus,,CHEMBL626817,A,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Intermediate
,,,,,1,,,N,50597,8594,1,10116.0,12716,,BAO_0000218,Rattus norvegicus,,CHEMBL626818,A,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Intermediate
,,,,,1,,,N,50597,8594,1,10116.0,12717,,BAO_0000218,Rattus norvegicus,,CHEMBL626819,A,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Intermediate
,,,,,1,,,N,50597,8594,1,10116.0,12718,,BAO_0000218,Rattus norvegicus,,CHEMBL626820,A,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Intermediate
,,,,,1,,,N,50597,8594,1,10116.0,12719,,BAO_0000218,Rattus norvegicus,,CHEMBL626821,A,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Intermediate
,,Thyroid gland,,,1,,,N,50597,8594,1,10116.0,12720,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL626822,A,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Intermediate
,,Thyroid gland,,,1,,,N,50597,8594,1,10116.0,12721,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL626823,A,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Intermediate
,,Thyroid gland,,,1,,,N,50597,8594,1,10116.0,12722,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL626824,A,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Intermediate
,,Thyroid gland,,,1,,,N,50597,8594,1,10116.0,12723,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL626825,A,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Intermediate
,,Thyroid gland,,,1,,,N,50597,8594,1,10116.0,12724,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL626826,A,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Intermediate
,,Thyroid gland,,,1,,,N,50597,8594,1,10116.0,12725,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL626827,A,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Intermediate
,,Thyroid gland,,,1,,,N,50597,8594,1,10116.0,12726,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL626828,A,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Intermediate
,,Thyroid gland,,,1,,,N,50597,8594,1,10116.0,12727,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL626829,A,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Intermediate
,,Thyroid gland,,,1,,,N,50597,8594,1,10116.0,12728,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL626830,A,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Intermediate
,,,,,1,,,N,50597,8594,1,10116.0,12729,,BAO_0000218,Rattus norvegicus,,CHEMBL627150,A,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Intermediate
,,,,,1,,,N,50597,8594,1,10116.0,12730,,BAO_0000218,Rattus norvegicus,,CHEMBL627151,A,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Intermediate
,,,,,1,,,N,50597,8594,1,10116.0,12731,,BAO_0000218,Rattus norvegicus,,CHEMBL627152,A,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Intermediate
,,,,,1,,,N,50597,8594,1,10116.0,12732,,BAO_0000218,Rattus norvegicus,,CHEMBL627153,A,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Intermediate
,,,,,0,,,U,22224,12904,1,,12733,,BAO_0000019,,,CHEMBL627154,A,,Rate of acetate production by the compound was determined,Autocuration
,,,,,0,,,U,22224,12904,1,,12734,,BAO_0000019,,,CHEMBL627155,A,,Rate of acetate production by the compound was determined; Not determined,Autocuration
,,,,,0,,,U,22224,3730,1,,12735,,BAO_0000019,,,CHEMBL627156,A,,Rate of hydrolysis of nitrocefin by compound was evaluated in water,Autocuration
,,,,,0,,,U,22224,3627,1,,12736,,BAO_0000019,,,CHEMBL627157,A,,Reductive elimination of leaving group was determined at pH 7.4; expressed as loss of parent,Autocuration
,,,,,1,,,N,50592,13799,1,9986.0,12737,,BAO_0000218,Oryctolagus cuniculus,,CHEMBL627158,A,,Relative concentration of compound (70 mg/Kg) in brain compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,Intermediate
,,Plasma,,,1,,,N,50592,13799,1,9986.0,12738,,BAO_0000218,Oryctolagus cuniculus,1969.0,CHEMBL627159,A,,Relative concentration of compound (70 mg/Kg) in lung compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,Intermediate
,,,,,1,,,N,50594,13799,1,10090.0,12739,,BAO_0000218,Mus musculus,,CHEMBL627160,A,,Relative concentration of compound in brain compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,Intermediate
,,,,,1,,,N,50597,13799,1,10116.0,12740,,BAO_0000218,Rattus norvegicus,,CHEMBL628540,A,,Relative concentration of compound in brain compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,Intermediate
,,Plasma,,,1,,,N,50597,13799,1,10116.0,12741,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL628541,A,,Relative concentration of compound in lung compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,Intermediate
,,Plasma,,,1,,,N,50597,13799,1,10116.0,12742,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL628542,A,,Relative concentration of compound in lung compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,Intermediate
,,,,,0,,,U,22229,6629,1,,12743,,BAO_0000100,,,CHEMBL628543,P,,Solubility after at a pH 1.2,Autocuration
,,,,,0,,,U,22229,6629,1,,12744,,BAO_0000100,,,CHEMBL628544,P,,Solubility after at pH 1.2,Autocuration
,,,,,0,,,U,22229,6629,1,,12745,,BAO_0000100,,,CHEMBL628545,P,,Solubility after injection of water,Autocuration
,,,,,0,,,U,22224,14000,1,,12746,,BAO_0000019,,,CHEMBL628546,A,,Statistical significance of IC 50 values; Expressed as R value,Autocuration
,,,,,0,,,U,22224,8267,1,,12747,,BAO_0000019,,,CHEMBL874455,A,,Systemic availability with respect to methyldopa was determined,Autocuration
,,,,,1,,,N,50597,13799,1,10116.0,12748,,BAO_0000218,Rattus norvegicus,,CHEMBL628547,A,,Tissue distribution of the in rat brain relative to plasma concentration of 1 ug/kg; relative concentration,Intermediate
,,Plasma,,,1,,,N,50597,13799,1,10116.0,12749,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL628548,A,,Tissue distribution of the in rat lung relative to plasma concentration of 1 ug/kg; relative concentration,Intermediate
,,Feces,,,1,,,N,50592,7132,1,9986.0,12750,,BAO_0000218,Oryctolagus cuniculus,1988.0,CHEMBL628549,A,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated",Intermediate
,,Feces,,,1,,,N,50592,7132,1,9986.0,12751,,BAO_0000218,Oryctolagus cuniculus,1988.0,CHEMBL628550,A,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 liver, and radioactivity content in feces was estimated",Intermediate
,,Feces,,,1,,,N,50592,7132,1,9986.0,12752,,BAO_0000218,Oryctolagus cuniculus,1988.0,CHEMBL628551,A,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit3, and radioactivity content in feces was estimated at total hours",Intermediate
,,Urine,,,1,,,N,50592,7132,1,9986.0,12753,,BAO_0000218,Oryctolagus cuniculus,1088.0,CHEMBL628552,A,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit1, and radioactivity content in urine was estimated at 0-2 hr",Intermediate
,,Urine,,,1,,,N,50592,7132,1,9986.0,12754,,BAO_0000218,Oryctolagus cuniculus,1088.0,CHEMBL628553,A,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-24 hr",Intermediate
,,Urine,,,1,,,N,50592,7132,1,9986.0,12755,,BAO_0000218,Oryctolagus cuniculus,1088.0,CHEMBL628554,A,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-48 hr",Intermediate
,,Urine,,,1,,,N,50592,7132,1,9986.0,12756,,BAO_0000218,Oryctolagus cuniculus,1088.0,CHEMBL628555,A,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 24-48 h",Intermediate
,,Urine,,,1,,,N,50592,7132,1,9986.0,12757,,BAO_0000218,Oryctolagus cuniculus,1088.0,CHEMBL628556,A,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 48-72 h",Intermediate
,,Kidney,,,1,,,N,50592,7132,1,9986.0,12758,,BAO_0000218,Oryctolagus cuniculus,2113.0,CHEMBL628557,A,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit kidney, and radioactivity content in feces was estimated",Intermediate
,,Feces,,,1,,,N,50592,7132,1,9986.0,12759,,BAO_0000218,Oryctolagus cuniculus,1988.0,CHEMBL628558,A,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated",Intermediate
,,Feces,,,1,,,N,50592,7132,1,9986.0,12760,,BAO_0000218,Oryctolagus cuniculus,1988.0,CHEMBL628559,A,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated at",Intermediate
,,Feces,,,1,,,N,50592,7132,1,9986.0,12761,,BAO_0000218,Oryctolagus cuniculus,1988.0,CHEMBL628560,A,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit1plasma, and radioactivity content in feces was estimated",Intermediate
,,Urine,,,1,,,N,50592,7132,1,9986.0,12762,,BAO_0000218,Oryctolagus cuniculus,1088.0,CHEMBL874456,A,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at total hours",Intermediate
,,Feces,,,1,,,N,50592,7132,1,9986.0,12763,,BAO_0000218,Oryctolagus cuniculus,1988.0,CHEMBL628561,A,,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at 0-48 hr",Intermediate
,,Feces,,,1,,,N,50592,7132,1,9986.0,12764,,BAO_0000218,Oryctolagus cuniculus,1988.0,CHEMBL628562,A,,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at total hours",Intermediate
,,Urine,,,1,,,N,50592,7132,1,9986.0,12765,,BAO_0000218,Oryctolagus cuniculus,1088.0,CHEMBL628563,A,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit2, and radioactivity content in urine was estimated at 0-4 hr",Intermediate
,,Urine,,,1,,,N,50592,7132,1,9986.0,12766,,BAO_0000218,Oryctolagus cuniculus,1088.0,CHEMBL628564,A,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at",Intermediate
,,Urine,,,1,,,N,50592,7132,1,9986.0,12767,,BAO_0000218,Oryctolagus cuniculus,1088.0,CHEMBL628565,A,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 24-48 h",Intermediate
,,Urine,,,1,,,N,50592,7132,1,9986.0,12768,,BAO_0000218,Oryctolagus cuniculus,1088.0,CHEMBL631248,A,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 48-72 h",Intermediate
,,Urine,,,1,,,N,50592,7132,1,9986.0,12769,,BAO_0000218,Oryctolagus cuniculus,1088.0,CHEMBL631249,A,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at total hours",Intermediate
,,Kidney,,,1,,,N,50592,7132,1,9986.0,12770,,BAO_0000218,Oryctolagus cuniculus,2113.0,CHEMBL627214,A,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 kidney, and radioactivity content in feces was estimated",Intermediate
,,Feces,,,1,,,N,50592,7132,1,9986.0,12771,,BAO_0000218,Oryctolagus cuniculus,1988.0,CHEMBL874591,A,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 liver, and radioactivity content in feces was estimated",Intermediate
,,Feces,,,1,,,N,50592,7132,1,9986.0,12772,,BAO_0000218,Oryctolagus cuniculus,1988.0,CHEMBL627215,A,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 lung, and radioactivity content in feces was estimated",Intermediate
,,Feces,,,1,,,N,50592,7132,1,9986.0,12773,,BAO_0000218,Oryctolagus cuniculus,1988.0,CHEMBL625471,A,,200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 plasma and radioactivity content in feces was estimated,Intermediate
,,,,,1,,,N,50592,7132,1,9986.0,12774,,BAO_0000218,Oryctolagus cuniculus,,CHEMBL625472,A,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 1,Intermediate
,,,,,1,,,N,50592,7132,1,9986.0,12775,,BAO_0000218,Oryctolagus cuniculus,,CHEMBL625473,A,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 3 by Gas-liquid chromatographic analysis,Intermediate
,In vivo,,,,1,,,N,50588,13317,1,9615.0,12776,,BAO_0000218,Canis lupus familiaris,,CHEMBL625474,A,,Tested for pharmacokinetic parameter in fasted Beagle dogs (Clearance value of the compound) iv administration.,Intermediate
,In vivo,,,,1,,,N,50588,15341,1,9615.0,12777,,BAO_0000218,Canis lupus familiaris,,CHEMBL625475,A,,The clearance was measured in dog at dose 5 mg/kg after intravenous administration.,Intermediate
,In vivo,,,,1,,,N,50597,15341,1,10116.0,12778,,BAO_0000218,Rattus norvegicus,,CHEMBL625476,A,,The clearance was measured in rat at dose 12 mg/kg after intravenous administration.,Intermediate
,In vivo,,,,1,,,N,50597,15341,1,10116.0,12779,,BAO_0000218,Rattus norvegicus,,CHEMBL625477,A,,The clearance was measured in rat at dose 1 mg/kg after intravenous administration.,Intermediate
,In vivo,,,,1,,,N,50597,15341,1,10116.0,12780,,BAO_0000218,Rattus norvegicus,,CHEMBL625478,A,,The clearance was measured in rat at dose 30 mg/kg after intravenous administration.,Intermediate
,In vitro,esophageal tunica muscularis mucosae,,,1,,,N,50597,12801,1,10116.0,12781,,BAO_0000218,Rattus norvegicus,,CHEMBL625479,A,,The compound was evaluated for clearance value in rat isolated esophageal tunica muscularis mucose,Intermediate
,In vitro,esophageal tunica muscularis mucosae,,,1,,,N,50597,12801,1,10116.0,12782,,BAO_0000218,Rattus norvegicus,,CHEMBL625480,A,,The compound was evaluated for the value in rat isolated esophageal tunica muscularis mucose,Intermediate
,In vivo,Plasma,,,1,,,N,50597,14856,1,10116.0,12783,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL625481,A,,The compound was tested for systemic plasma clearance(CL) in rats and is expressed in mL/min/kg.,Intermediate
,In vivo,,,,1,,,N,50597,14062,1,10116.0,12784,,BAO_0000218,Rattus norvegicus,,CHEMBL625482,A,,Total body clearance at an intravenous dose of 5.2 mg/kg in rat,Intermediate
,In vivo,,,,1,,,N,50597,14062,1,10116.0,12785,,BAO_0000218,Rattus norvegicus,,CHEMBL625483,A,,Total body clearance at an intravenous dose of 5.5 mg/kg in rat,Intermediate
,In vivo,,,,1,,,N,50597,14062,1,10116.0,12786,,BAO_0000218,Rattus norvegicus,,CHEMBL625484,A,,Total body clearance at an intravenous dose of 6.3 mg/kg in rat,Intermediate
,In vivo,,,,1,,,N,50597,14062,1,10116.0,12787,,BAO_0000218,Rattus norvegicus,,CHEMBL625485,A,,Total body clearance at an intravenous dose of 6.5 mg/kg in rat,Intermediate
,In vivo,Plasma,,,1,,,N,50588,14346,1,9615.0,12788,,BAO_0000218,Canis lupus familiaris,1969.0,CHEMBL625486,A,,Total plasma clearance value was obtained after intravenous administration of 1.8 mg/kg of drug in male Beagle dogs,Intermediate
,In vivo,Plasma,,,1,,,N,50597,14346,1,10116.0,12789,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL625487,A,,Total plasma clearance value was obtained after intravenous administration of 2.5 mg/kg of drug in male Dawley rats,Intermediate
,In vivo,Plasma,,,1,,,N,50597,14346,1,10116.0,12790,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL625488,A,,Total plasma clearance value was obtained after intravenous administration of 2.6 mg/kg of drug in male Dawley rats,Intermediate
,In vivo,Plasma,,,1,,,N,50597,14346,1,10116.0,12791,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL625489,A,,Total plasma clearance value was obtained after intravenous administration of 2.7 mg/kg of drug in male Dawley rats,Intermediate
,In vivo,Plasma,,,1,,,N,50597,14346,1,10116.0,12792,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL625490,A,,Total plasma clearance value was obtained after intravenous administration of 2.8 mg/kg of drug in male Dawley rats,Intermediate
,In vivo,Plasma,,,1,,,N,50588,14346,1,9615.0,12793,,BAO_0000218,Canis lupus familiaris,1969.0,CHEMBL625491,A,,Total plasma clearance value was obtained after intravenous administration of 4.9 mg/kg of drug in male Beagle dogs,Intermediate
,In vivo,Plasma,,,1,,,N,50597,14346,1,10116.0,12794,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL625492,A,,Total plasma clearance value was obtained after intravenous administration of 5.1 mg/kg of drug in male Dawley rats,Intermediate
,In vivo,Plasma,,,1,,,N,50587,15711,1,9606.0,12795,,BAO_0000218,Homo sapiens,1969.0,CHEMBL625493,A,,plasma clearance in human,Intermediate
,In vivo,,,,1,,,N,50597,14886,1,10116.0,12796,,BAO_0000218,Rattus norvegicus,,CHEMBL625494,A,,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,14886,1,10116.0,12797,,BAO_0000218,Rattus norvegicus,,CHEMBL625495,A,,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,Intermediate
,In vivo,,,,1,,,N,50597,14886,1,10116.0,12798,,BAO_0000218,Rattus norvegicus,,CHEMBL625496,A,,Pharmacokinetic parameter (CL/F) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,Intermediate
,,,,,0,,,U,22229,4115,1,,12799,,BAO_0000100,,,CHEMBL625497,P,,1-Octanol/water partition coefficient measured at 7.4,Autocuration
,,,,,0,,,U,22229,13733,1,,12800,,BAO_0000100,,,CHEMBL625498,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22224,12102,1,,12801,,BAO_0000019,,,CHEMBL625499,A,,Partition coefficient (logP),Autocuration
,,,,,0,,,U,22229,12676,1,,12802,,BAO_0000100,,,CHEMBL625500,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22229,13733,1,,12803,,BAO_0000100,,,CHEMBL625501,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22229,13740,1,,12804,,BAO_0000100,,,CHEMBL625502,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22229,12766,1,,12805,,BAO_0000100,,,CHEMBL625503,P,,Calculated partition coefficient (clogP) (relative to BAY K 8644),Autocuration
,,,,,0,,,U,22229,2764,1,,12806,,BAO_0000100,,,CHEMBL625504,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22229,12355,1,,12807,,BAO_0000100,,,CHEMBL625505,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22229,11314,1,,12808,,BAO_0000100,,,CHEMBL625506,P,,Calculated partition coefficient of the compound,Autocuration
,,,,,0,,,U,22224,12706,1,,12809,,BAO_0000019,,,CHEMBL625507,A,,Partition coefficient (logP),Autocuration
,,,,,0,,,U,22229,12645,1,,12810,,BAO_0000100,,,CHEMBL625508,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22229,13668,1,,12811,,BAO_0000100,,,CHEMBL625509,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22229,12819,1,,12812,,BAO_0000100,,,CHEMBL625510,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22229,13668,1,,12813,,BAO_0000100,,,CHEMBL883125,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22229,13017,1,,12814,,BAO_0000100,,,CHEMBL625511,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22224,2448,1,,12815,,BAO_0000019,,,CHEMBL874650,A,,Partition coefficient of the compound,Autocuration
,,,,,0,,,U,22224,11526,1,,12816,,BAO_0000019,,,CHEMBL625512,A,,Partition coefficient of the compound,Autocuration
,,,,,0,,,U,22224,12426,1,,12817,,BAO_0000019,,,CHEMBL625513,A,,Partition coefficient of compound was determined,Autocuration
,,,,,0,,,U,22224,2448,1,,12818,,BAO_0000019,,,CHEMBL625514,A,,Partition coefficient was determined,Autocuration
,,,,,0,,,U,22229,12001,1,,12819,,BAO_0000100,,,CHEMBL625515,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22229,12426,1,,12820,,BAO_0000100,,,CHEMBL625516,P,,partition coefficient of compound was determined,Autocuration
,In vivo,,,,1,,,N,50588,13204,1,9615.0,12821,,BAO_0000218,Canis lupus familiaris,,CHEMBL625517,A,,The total body administered intravenously in dog,Intermediate
,In vivo,,,,1,,,N,50597,13204,1,10116.0,12822,,BAO_0000218,Rattus norvegicus,,CHEMBL625518,A,,The total body administered intravenously in rats,Intermediate
,,,,,1,,,N,50594,13889,1,10090.0,12823,,BAO_0000218,Mus musculus,,CHEMBL625519,A,,Time taken for the administration to female NIH mice weighing 25-30 g.,Intermediate
,,,,,0,,,U,22224,13889,1,,12824,,BAO_0000019,,,CHEMBL625520,A,,Time taken for the administration,Autocuration
,In vivo,,,,1,,,N,50588,17025,1,9615.0,12825,,BAO_0000218,Canis lupus familiaris,,CHEMBL874651,A,,Total clearance of compound was determined in dog at 5 mg/kg intravenously admn.,Intermediate
,In vivo,,,,0,,,U,22224,17025,1,314293.0,12826,,BAO_0000218,Simiiformes,,CHEMBL625521,A,,Total clearance of compound was determined in monkey at 5 mg/kg intravenously admn.,Autocuration
,In vivo,,,,1,,,N,50592,17025,1,9986.0,12827,,BAO_0000218,Oryctolagus cuniculus,,CHEMBL623171,A,,Total clearance of compound was determined in rabbit at 5 mg/kg intravenously admn.,Intermediate
,In vivo,,,,1,,,N,50597,17025,1,10116.0,12828,,BAO_0000218,Rattus norvegicus,,CHEMBL623853,A,,Total clearance of compound was determined in rat at 5 mg/kg intravenously admn.,Intermediate
,,,,,0,,,U,22224,15067,1,,12829,,BAO_0000019,,,CHEMBL623854,A,,Plasma clearance for the compound was determined.,Autocuration
,,,,,0,,,U,22224,3091,1,,12830,,BAO_0000100,,,CHEMBL874405,P,,CLog P value of the compound,Autocuration
,,,,,0,,,U,22229,15592,1,,12831,,BAO_0000100,,,CHEMBL623855,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22229,14738,1,,12832,,BAO_0000100,,,CHEMBL623856,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22224,14738,1,,12833,,BAO_0000100,,,CHEMBL623857,P,,ClogP value of the compound; nd ='no data',Autocuration
,,,,,0,,,U,22224,14738,1,,12834,,BAO_0000100,,,CHEMBL623858,P,,ClogP value of the compound; nd ='not determined',Autocuration
,,,,,0,,,U,22224,6076,1,,12835,,BAO_0000100,,,CHEMBL623859,P,,CLog P was determined,Autocuration
,,,,,0,,,U,22229,17840,1,,12836,,BAO_0000100,,,CHEMBL839829,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22224,13589,1,,12837,,BAO_0000019,,,CHEMBL623860,A,,CLogP was calculated,Autocuration
,,,,,0,,,U,22224,17655,1,,12838,,BAO_0000019,,,CHEMBL623861,A,,CLogP value was determined,Autocuration
,,,,,0,,,U,22224,5867,1,,12839,,BAO_0000019,,,CHEMBL623862,A,,CLogP value was evaluated using http://esc.syrres.com/interkow/kowdemo.htm.,Autocuration
,,,,,0,,,U,22229,5867,1,,12840,,BAO_0000100,,,CHEMBL874406,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22229,10783,1,,12841,,BAO_0000100,,,CHEMBL623863,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22229,14849,1,,12842,,BAO_0000100,,,CHEMBL624021,P,,Calculated partition coefficient (clogP),Autocuration
,,Adrenal medulla,,,1,,,N,50588,8170,1,9615.0,12843,,BAO_0000218,Canis lupus familiaris,1236.0,CHEMBL624022,A,,Distribution in female dog adrenal medulla 24 hours after administration.,Intermediate
,,Adrenal medulla,,,1,,,N,50588,8170,1,9615.0,12844,,BAO_0000218,Canis lupus familiaris,1236.0,CHEMBL624023,A,,Distribution in female dog adrenal medulla 72 hours after administration.,Intermediate
,,,,,1,,,N,50588,8170,1,9615.0,12845,,BAO_0000218,Canis lupus familiaris,,CHEMBL624024,A,,Distribution in female dog bile 24 hours after administration.,Intermediate
,,,,,1,,,N,50588,8170,1,9615.0,12846,,BAO_0000218,Canis lupus familiaris,,CHEMBL624025,A,,Distribution in female dog bile 72 hr after administration.,Intermediate
,,,,,1,,,N,50588,8170,1,9615.0,12847,,BAO_0000218,Canis lupus familiaris,,CHEMBL624026,A,,Distribution in female dog blood 24 hours after administration.,Intermediate
,,,,,1,,,N,50588,8170,1,9615.0,12848,,BAO_0000218,Canis lupus familiaris,,CHEMBL624027,A,,Distribution in female dog blood 72 hours after administration.,Intermediate
,,,,,1,,,N,50588,8170,1,9615.0,12849,,BAO_0000218,Canis lupus familiaris,,CHEMBL624028,A,,Distribution in female dog heart 24 hours after administration.,Intermediate
,,,,,1,,,N,50588,8170,1,9615.0,12850,,BAO_0000218,Canis lupus familiaris,,CHEMBL624029,A,,Distribution in female dog heart 72 hours after administration.,Intermediate
,,,,,1,,,N,50588,8170,1,9615.0,12851,,BAO_0000218,Canis lupus familiaris,,CHEMBL624030,A,,Distribution in female dog kidney 24 hours after administration.,Intermediate
,,,,,1,,,N,50588,8170,1,9615.0,12852,,BAO_0000218,Canis lupus familiaris,,CHEMBL624031,A,,Distribution in female dog kidney 72 hours after administration.,Intermediate
,,Intestine,,,1,,,N,50588,8170,1,9615.0,12853,,BAO_0000218,Canis lupus familiaris,160.0,CHEMBL624032,A,,Distribution in female dog large intestine 24 hours after administration.,Intermediate
,,Intestine,,,1,,,N,50588,8170,1,9615.0,12854,,BAO_0000218,Canis lupus familiaris,160.0,CHEMBL874407,A,,Distribution in female dog large intestine 72 hours after administration.,Intermediate
,,,,,1,,,N,50588,8170,1,9615.0,12855,,BAO_0000218,Canis lupus familiaris,,CHEMBL624033,A,,Distribution in female dog liver 24 hours after administration.,Intermediate
,,,,,1,,,N,50588,8170,1,9615.0,12856,,BAO_0000218,Canis lupus familiaris,,CHEMBL624034,A,,Distribution in female dog liver 72 hours after administration.,Intermediate
,,,,,1,,,N,50588,8170,1,9615.0,12857,,BAO_0000218,Canis lupus familiaris,,CHEMBL624035,A,,Distribution in female dog lung 24 hours after administration.,Intermediate
,,,,,1,,,N,50588,8170,1,9615.0,12858,,BAO_0000218,Canis lupus familiaris,,CHEMBL624036,A,,Distribution in female dog lung 72 hours after administration.,Intermediate
,,Muscle tissue,,,1,,,N,50588,8170,1,9615.0,12859,,BAO_0000218,Canis lupus familiaris,2385.0,CHEMBL624037,A,,Distribution in female dog muscle 24 hours after administration.,Intermediate
,,Muscle tissue,,,1,,,N,50588,8170,1,9615.0,12860,,BAO_0000218,Canis lupus familiaris,2385.0,CHEMBL624038,A,,Distribution in female dog muscle 72 hours after administration.,Intermediate
,,,,,1,,,N,50588,8170,1,9615.0,12861,,BAO_0000218,Canis lupus familiaris,,CHEMBL624039,A,,Distribution in female dog pancreas 24 hours after administration.,Intermediate
,,,,,1,,,N,50588,8170,1,9615.0,12862,,BAO_0000218,Canis lupus familiaris,,CHEMBL624040,A,,Distribution in female dog pancreas 72 hours after administration.,Intermediate
,,Intestine,,,1,,,N,50588,8170,1,9615.0,12863,,BAO_0000218,Canis lupus familiaris,160.0,CHEMBL624041,A,,Distribution in female dog small intestine 24 hours after administration.,Intermediate
,,Intestine,,,1,,,N,50588,8170,1,9615.0,12864,,BAO_0000218,Canis lupus familiaris,160.0,CHEMBL624042,A,,Distribution in female dog small intestine 72 hours after administration.,Intermediate
,,Spleen,,,1,,,N,50588,8170,1,9615.0,12865,,BAO_0000218,Canis lupus familiaris,2106.0,CHEMBL624043,A,,Distribution in female dog spleen 24 hours after administration.,Intermediate
,,Spleen,,,1,,,N,50588,8170,1,9615.0,12866,,BAO_0000218,Canis lupus familiaris,2106.0,CHEMBL624044,A,,Distribution in female dog spleen 72 hours after administration.,Intermediate
,,Stomach,,,1,,,N,50588,8170,1,9615.0,12867,,BAO_0000218,Canis lupus familiaris,945.0,CHEMBL624045,A,,Distribution in female dog stomach 24 hours after administration.,Intermediate
,,Stomach,,,1,,,N,50588,8170,1,9615.0,12868,,BAO_0000218,Canis lupus familiaris,945.0,CHEMBL624046,A,,Distribution in female dog stomach 72 hours after administration.,Intermediate
,,Thyroid gland,,,1,,,N,50588,8170,1,9615.0,12869,,BAO_0000218,Canis lupus familiaris,2046.0,CHEMBL624047,A,,Distribution in female dog thyroid 24 hours after administration.,Intermediate
,,Thyroid gland,,,1,,,N,50588,8170,1,9615.0,12870,,BAO_0000218,Canis lupus familiaris,2046.0,CHEMBL624048,A,,Distribution in female dog thyroid 72 hours after administration.,Intermediate
,,Urine,,,1,,,N,50588,8170,1,9615.0,12871,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL874408,A,,Distribution in female dog urine 24 hours after administration.,Intermediate
,,Urine,,,1,,,N,50588,8170,1,9615.0,12872,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL624049,A,,Distribution in female dog urine 72 hr after administration.,Intermediate
,,Plasma,,,0,,,U,22224,14283,1,,12873,,BAO_0000218,,1969.0,CHEMBL624050,A,,Mean plasma concentration measured 1 h following an oral dose of 30 mg/kg,Autocuration
,,,,,0,,,U,22224,5623,1,,12874,,BAO_0000019,,,CHEMBL624051,A,,Plasma concentration at 7 hr after intravenous dosing,Autocuration
,,,,,1,,,N,50597,13477,1,10116.0,12875,,BAO_0000218,Rattus norvegicus,,CHEMBL623278,A,,Plasma concentration of 3 mg/kg iv after 0.25 hr in rats,Intermediate
,,,,,1,,,N,50597,13477,1,10116.0,12876,,BAO_0000218,Rattus norvegicus,,CHEMBL623279,A,,Plasma concentration of 3 mg/kg iv after 0.5 hr in rats,Intermediate
,,,,,1,,,N,50597,13477,1,10116.0,12877,,BAO_0000218,Rattus norvegicus,,CHEMBL623280,A,,Plasma concentration of 3 mg/kg iv after 1 hr in rats,Intermediate
,,,,,1,,,N,50597,13477,1,10116.0,12878,,BAO_0000218,Rattus norvegicus,,CHEMBL623963,A,,Plasma concentration of 3 mg/kg iv after 2 hr in rats,Intermediate
,,,,,1,,,N,50597,13477,1,10116.0,12879,,BAO_0000218,Rattus norvegicus,,CHEMBL623964,A,,Plasma concentration of 3 mg/kg iv after 4 hr in rats,Intermediate
,,,,,1,,,N,50597,13477,1,10116.0,12880,,BAO_0000218,Rattus norvegicus,,CHEMBL623965,A,,Plasma concentration of 3 mg/kg iv after 6 hr in rats,Intermediate
,,,,,1,,,N,50597,13477,1,10116.0,12881,,BAO_0000218,Rattus norvegicus,,CHEMBL623966,A,,Plasma concentration of 3 mg/kg po after 0.083 hr in rats,Intermediate
,,,,,1,,,N,50597,13477,1,10116.0,12882,,BAO_0000218,Rattus norvegicus,,CHEMBL874415,A,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.083 h,Intermediate
,,,,,1,,,N,50597,13477,1,10116.0,12883,,BAO_0000218,Rattus norvegicus,,CHEMBL623967,A,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.25 hr,Intermediate
,,,,,1,,,N,50597,13477,1,10116.0,12884,,BAO_0000218,Rattus norvegicus,,CHEMBL623968,A,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.5 hr,Intermediate
,,,,,1,,,N,50597,13477,1,10116.0,12885,,BAO_0000218,Rattus norvegicus,,CHEMBL623969,A,,Plasma concentration after 3 mg/kg peroral dosing in rat at 1 hr,Intermediate
,,,,,1,,,N,50597,13477,1,10116.0,12886,,BAO_0000218,Rattus norvegicus,,CHEMBL628409,A,,Plasma concentration after 3 mg/kg peroral dosing in rat at 2 hr,Intermediate
,,,,,1,,,N,50597,13477,1,10116.0,12887,,BAO_0000218,Rattus norvegicus,,CHEMBL628410,A,,Plasma concentration after 3 mg/kg peroral dosing in rat at 4 hr,Intermediate
,,,,,1,,,N,50597,13477,1,10116.0,12888,,BAO_0000218,Rattus norvegicus,,CHEMBL628411,A,,Plasma concentration after 3 mg/kg peroral dosing in rat at 6 hr,Intermediate
,,,,,1,,,N,50597,13477,1,10116.0,12889,,BAO_0000218,Rattus norvegicus,,CHEMBL628412,A,,Plasma concentration after 3 mg/kg peroral dosing in rat at 8 hr,Intermediate
,,,,,0,,,U,22224,12553,1,,12890,,BAO_0000019,,,CHEMBL628413,A,,Tested for the highest concentration at which toxicity was not observed or the concentration which provided the highest number of net grain counts,Autocuration
,,Plasma,,,0,,,U,22224,14548,1,,12891,,BAO_0000019,,1969.0,CHEMBL628414,A,,The concentration in plasmat; Not determined,Autocuration
,,,,,1,,,N,50597,14393,1,10116.0,12892,,BAO_0000218,Rattus norvegicus,,CHEMBL628415,A,,Tissue level at 10 mg/kg/po in wistar rats in blood,Intermediate
,,,,,1,,,N,50597,14393,1,10116.0,12893,,BAO_0000218,Rattus norvegicus,,CHEMBL628416,A,,Tissue level at 10 mg/kg/po in wistar rats in brown fat,Intermediate
,,,,,1,,,N,50597,14393,1,10116.0,12894,,BAO_0000218,Rattus norvegicus,,CHEMBL628417,A,,Tissue level at 10 mg/kg/po in wistar rats in heart,Intermediate
,,Liver,,,1,,,N,50597,14393,1,10116.0,12895,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL874908,A,,Tissue level at 10 mg/kg/po in wistar rats in liver,Intermediate
,,,,,1,,,N,50597,14393,1,10116.0,12896,,BAO_0000218,Rattus norvegicus,,CHEMBL628418,A,,Tissue level at 10 mg/kg/po in wistar rats in plasma,Intermediate
,,Muscle tissue,,,1,,,N,50597,14393,1,10116.0,12897,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL628419,A,,Tissue level at 10 mg/kg/po in wistar rats in skeletal muscle,Intermediate
,,,,,1,,,N,50597,14393,1,10116.0,12898,,BAO_0000218,Rattus norvegicus,,CHEMBL628420,A,,Tissue level at 10 mg/kg/po in wistar rats in subcutaneous fat,Intermediate
,,,,,0,,,U,22224,1629,1,,12899,,BAO_0000019,,,CHEMBL628421,A,,Water solubility at 37 degree C.,Autocuration
,,,,,0,,,U,22229,8194,1,,12900,,BAO_0000100,,,CHEMBL626726,P,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,Autocuration
,,,,,0,,,U,22229,8194,1,,12901,,BAO_0000100,,,CHEMBL626727,P,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,Autocuration
,,Blood,,,1,,,N,50597,8594,1,10116.0,12902,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL626728,A,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Intermediate
,,Blood,,,1,,,N,50597,8594,1,10116.0,12903,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL626729,A,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Intermediate
,,Blood,,,1,,,N,50597,8594,1,10116.0,12904,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL626730,A,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Intermediate
,,Blood,,,1,,,N,50597,8594,1,10116.0,12905,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL626731,A,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Intermediate
,,Blood,,,1,,,N,50597,8594,1,10116.0,12906,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL626732,A,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Intermediate
,,Heart,,,1,,,N,50597,8594,1,10116.0,12907,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL626733,A,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Intermediate
,,Heart,,,1,,,N,50597,8594,1,10116.0,12908,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL626734,A,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Intermediate
,,Heart,,,1,,,N,50597,8594,1,10116.0,12909,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL626735,A,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Intermediate
,,Heart,,,1,,,N,50597,8594,1,10116.0,12910,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL874909,A,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Intermediate
,,Heart,,,1,,,N,50597,8594,1,10116.0,12911,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL626736,A,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Intermediate
,,Kidney,,,1,,,N,50597,8594,1,10116.0,12912,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL626737,A,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Intermediate
,,Kidney,,,1,,,N,50597,8594,1,10116.0,12913,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL630999,A,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Intermediate
,,Kidney,,,1,,,N,50597,8594,1,10116.0,12914,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL631000,A,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Intermediate
,,Kidney,,,1,,,N,50597,8594,1,10116.0,12915,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL631001,A,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Intermediate
,,Kidney,,,1,,,N,50597,8594,1,10116.0,12916,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL631002,A,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Intermediate
,,Liver,,,1,,,N,50597,8594,1,10116.0,12917,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL631003,A,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Intermediate
,,Liver,,,1,,,N,50597,8594,1,10116.0,12918,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL631004,A,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Intermediate
,,Liver,,,1,,,N,50597,8594,1,10116.0,12919,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL631005,A,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Intermediate
,,Liver,,,1,,,N,50597,8594,1,10116.0,12920,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL631006,A,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Intermediate
,,Liver,,,1,,,N,50597,8594,1,10116.0,12921,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL631007,A,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Intermediate
,,Lung,,,1,,,N,50597,8594,1,10116.0,12922,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL631008,A,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Intermediate
,,Lung,,,1,,,N,50597,8594,1,10116.0,12923,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL631009,A,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Intermediate
,,Lung,,,1,,,N,50597,8594,1,10116.0,12924,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL631010,A,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Intermediate
,,Lung,,,1,,,N,50597,8594,1,10116.0,12925,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL631011,A,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Intermediate
,,Lung,,,1,,,N,50597,8594,1,10116.0,12926,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL631012,A,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Intermediate
,,Thyroid gland,,,1,,,N,50597,8594,1,10116.0,12927,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL630271,A,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Intermediate
,,Thyroid gland,,,1,,,N,50597,8594,1,10116.0,12928,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL630272,A,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Intermediate
,,Thyroid gland,,,1,,,N,50597,8594,1,10116.0,12929,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL630273,A,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Intermediate
,,Thyroid gland,,,1,,,N,50597,8594,1,10116.0,12930,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL630274,A,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Intermediate
,,Thyroid gland,,,1,,,N,50597,8594,1,10116.0,12931,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL630275,A,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Intermediate
,,,,,1,,,N,50597,8594,1,10116.0,12932,,BAO_0000218,Rattus norvegicus,,CHEMBL875782,A,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 15 minutes (radiolabeled with [125I]-,Intermediate
,,,,,1,,,N,50597,8594,1,10116.0,12933,,BAO_0000218,Rattus norvegicus,,CHEMBL630276,A,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 2 minutes (radiolabeled with [125I]-,Intermediate
,,,,,1,,,N,50597,8594,1,10116.0,12934,,BAO_0000218,Rattus norvegicus,,CHEMBL630277,A,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 30 minutes (radiolabeled with [125I]-,Intermediate
,,,,,1,,,N,50597,8594,1,10116.0,12935,,BAO_0000218,Rattus norvegicus,,CHEMBL630278,A,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 5 minutes (radiolabeled with [125I]-,Intermediate
,,,,,1,,,N,50597,8594,1,10116.0,12936,,BAO_0000218,Rattus norvegicus,,CHEMBL630279,A,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 60 minutes (radiolabeled with [125I]-,Intermediate
,,,,,0,,,U,22224,8151,1,,12937,,BAO_0000019,,,CHEMBL630280,A,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg,Autocuration
,,,,,0,,,U,22224,8151,1,,12938,,BAO_0000019,,,CHEMBL630281,A,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,Autocuration
,,,,,1,,,N,50592,7132,1,9986.0,12939,,BAO_0000218,Oryctolagus cuniculus,,CHEMBL630282,A,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 4 by Gas-liquid chromatographic analysis,Intermediate
,,,,,1,,,N,50592,7132,1,9986.0,12940,,BAO_0000218,Oryctolagus cuniculus,,CHEMBL630283,A,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 2,Intermediate
,,,,,0,,,U,22224,5797,1,,12941,,BAO_0000019,,,CHEMBL630284,A,,Alkylating activity (0.1 mM) was determined at pH 7.4; expressed as OD (540n m)/mM of drug),Autocuration
,,,,,0,,,U,22224,7849,1,,12942,,BAO_0000019,,,CHEMBL630285,A,,Alkylating activity was determined,Autocuration
Microsomes,,,,,0,,,U,22224,14220,1,,12943,,BAO_0000251,,,CHEMBL630286,A,,Amount of metabolites in the microsomal medium after 90 min incubation of BTCP (500 uM),Autocuration
,,,,,1,,,N,50592,8650,1,9986.0,12944,,BAO_0000218,Oryctolagus cuniculus,,CHEMBL630069,A,,"Formation of metabolite by rabbit liver microsomal preparation in absence of NADPH, at 2 hours",Intermediate
,,,,,1,,,N,50592,8650,1,9986.0,12945,,BAO_0000218,Oryctolagus cuniculus,,CHEMBL630070,A,,"Formation of metabolite by rabbit liver microsomal preparation in presence of Co-O2 (90:10),at 2 hour",Intermediate
,,,,,1,,,N,50592,8650,1,9986.0,12946,,BAO_0000218,Oryctolagus cuniculus,,CHEMBL630071,A,,"Formation of metabolite by rabbit liver microsomal preparation in presence of N2,at 2 hour",Intermediate
,,,,,1,,,N,50592,8650,1,9986.0,12947,,BAO_0000218,Oryctolagus cuniculus,,CHEMBL630072,A,,"Formation of metabolite by rabbit liver microsomal preparation in presence of NADPH, at 2 hours",Intermediate
,,,,,1,,,N,50592,8650,1,9986.0,12948,,BAO_0000218,Oryctolagus cuniculus,,CHEMBL875110,A,,"Formation of metabolite by rabbit liver microsomal preparation in presence of SKF525A,at 2 hour",Intermediate
,,,,,1,,,N,50597,7116,1,10116.0,12949,,BAO_0000218,Rattus norvegicus,,CHEMBL630073,A,,Compound was tested for antidiuretic activity in rats,Intermediate
,,,,,0,,,U,22224,14131,1,,12950,,BAO_0000019,,,CHEMBL630074,A,,Compound was tested for inactivation kinetic values,Autocuration
,In vivo,,,,0,,,U,22224,7415,1,,12951,,BAO_0000218,,,CHEMBL630075,A,,Compound was evaluated for the average apparent volume of distribution when administered through intravenous route,Autocuration
,,,,,0,,,U,22224,13178,1,,12952,,BAO_0000019,,,CHEMBL630076,A,,Dissociation rate calculated from the first-order equation using the t1/2 value,Autocuration
,,,,,0,,,U,22229,8815,1,,12953,,BAO_0000100,,,CHEMBL630077,P,,Compound was evaluated for pKa by titration of the compounds in 1:2 methyl alcohol and water,Autocuration
,,,,,0,,,U,22229,1450,1,,12954,,BAO_0000100,,,CHEMBL630078,P,,Aqueous solubility was measured,Autocuration
,,,,,0,,,U,22229,1450,1,,12955,,BAO_0000100,,,CHEMBL630079,P,,Aqueous solubility was measured at a pH 4,Autocuration
,,,,,0,,,U,22229,1450,1,,12956,,BAO_0000100,,,CHEMBL630080,P,,Aqueous solubility (pH 7),Autocuration
,,,,,0,,,U,22229,1450,1,,12957,,BAO_0000100,,,CHEMBL630081,P,,Aqueous solubility was measured at a pH 9,Autocuration
,,,,,0,,,U,22224,12711,1,,12958,,BAO_0000019,,,CHEMBL630082,A,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents",Autocuration
,,,,,0,,,U,22224,12711,1,,12959,,BAO_0000019,,,CHEMBL630083,A,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",Autocuration
,,,,,0,,,U,22224,12711,1,,12960,,BAO_0000019,,,CHEMBL630084,A,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",Autocuration
,,,,,0,,,U,22229,15032,1,,12961,,BAO_0000100,,,CHEMBL629198,P,,Aqueous solubility of the compound,Autocuration
,,,,,0,,,U,22229,9964,1,,12962,,BAO_0000100,,,CHEMBL629199,P,,Aqueous solubility at 37 degree Celsius at pH 7.38,Autocuration
,,,,,0,,,U,22229,14962,1,,12963,,BAO_0000100,,,CHEMBL629200,P,,Aqueous solubility in pH 7.4 phosphate buffer,Autocuration
,,,,,1,,,N,50588,12487,1,9615.0,12964,,BAO_0000218,Canis lupus familiaris,,CHEMBL629201,A,,Mean arterial pressure response following 10 mg/kg intraduodenal administration to salt depleted dog,Intermediate
,,,,,1,,,N,50588,12487,1,9615.0,12965,,BAO_0000218,Canis lupus familiaris,,CHEMBL629202,A,,Mean arterial pressure response following 1 mg/kg intravenous administration to salt depleted dog,Intermediate
,,,,,1,,,N,50587,10026,1,9606.0,12966,,BAO_0000218,Homo sapiens,,CHEMBL875111,A,,Percentage of aspirin formed during hydrolysis in 10% human plasma at pH 7.4 at 37 degrees celsius,Intermediate
,,,,,1,,,N,50587,10026,1,9606.0,12967,,BAO_0000218,Homo sapiens,,CHEMBL629203,A,,Percentage of aspirin formed during hydrolysis in undiluted human plasma at pH 7.4 at 37 degrees celsius,Intermediate
,,,,,1,,,N,50587,10026,1,9606.0,12968,,BAO_0000218,Homo sapiens,,CHEMBL629204,A,,The percentage of aspirin formed during hydrolysis in 100% human plasma at pH 7.4 at 37 degrees celsius,Intermediate
,,,,,1,,,N,50587,10026,1,9606.0,12969,,BAO_0000218,Homo sapiens,,CHEMBL629205,A,,The percentage of aspirin formed during hydrolysis in 20% human plasma at pH 7.4 at 37 degrees celsius,Intermediate
,,,,,1,,,N,50587,10026,1,9606.0,12970,,BAO_0000218,Homo sapiens,,CHEMBL629206,A,,The percentage of aspirin formed during hydrolysis in 60% human plasma at pH 7.4 at 37 degrees celsius,Intermediate
,,,,,0,,,U,22224,10026,1,,12971,,BAO_0000019,,,CHEMBL631185,A,,The percentage of aspirin formed during hydrolysis in 80% human plasma at pH 7.4 at 37 degrees celsius,Autocuration
,,,,,1,,,N,50597,7415,1,10116.0,12972,,BAO_0000218,Rattus norvegicus,,CHEMBL631186,A,,Compound was evaluated for the average bile flow rat in rats,Intermediate
,,,,,1,,,N,50592,17025,1,9986.0,12973,,BAO_0000218,Oryctolagus cuniculus,,CHEMBL631187,A,,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 15 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",Intermediate
,,,,,1,,,N,50592,17025,1,9986.0,12974,,BAO_0000218,Oryctolagus cuniculus,,CHEMBL631188,A,,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 25 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",Intermediate
,,,,,0,,,U,22224,10184,1,,12975,,BAO_0000019,,,CHEMBL876419,A,,Average half life period was determined,Autocuration
,,,,,0,,,U,22224,10184,1,,12976,,BAO_0000019,,,CHEMBL631189,A,,Average half life period was determined,Autocuration
,,,,,1,,,N,50602,8613,1,10298.0,12977,,BAO_0000218,Human herpesvirus 1,,CHEMBL631190,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,Intermediate
,,,,,1,,,N,50602,8613,1,10298.0,12978,,BAO_0000218,Human herpesvirus 1,,CHEMBL631191,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,Intermediate
,,,,,1,,,N,50602,8613,1,10298.0,12979,,BAO_0000218,Human herpesvirus 1,,CHEMBL631192,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day.,Intermediate
,,,,,1,,,N,50602,8613,1,10298.0,12980,,BAO_0000218,Human herpesvirus 1,,CHEMBL632400,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day.,Intermediate
,,,,,1,,,N,50602,8613,1,10298.0,12981,,BAO_0000218,Human herpesvirus 1,,CHEMBL630564,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,Intermediate
,,,,,1,,,N,50602,8613,1,10298.0,12982,,BAO_0000218,Human herpesvirus 1,,CHEMBL630565,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,Intermediate
,,,,,1,,,N,50602,8613,1,10298.0,12983,,BAO_0000218,Human herpesvirus 1,,CHEMBL630566,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day.,Intermediate
,,,,,1,,,N,50602,8613,1,10298.0,12984,,BAO_0000218,Human herpesvirus 1,,CHEMBL631229,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day.,Intermediate
,,,,,1,,,N,50602,8613,1,10298.0,12985,,BAO_0000218,Human herpesvirus 1,,CHEMBL631230,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day.,Intermediate
,,,,,0,,,U,22229,6030,1,,12986,,BAO_0000100,,,CHEMBL876428,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22229,6147,1,,12987,,BAO_0000100,,,CHEMBL631231,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22229,14556,1,,12988,,BAO_0000100,,,CHEMBL631232,P,,Calculated partition coefficient (clogP) (MacLogP),Autocuration
,,,,,0,,,U,22224,768,1,,12989,,BAO_0000019,,,CHEMBL631233,A,,Hydrophilicity was determined,Autocuration
,,,,,0,,,U,22229,14452,1,,12990,,BAO_0000100,,,CHEMBL631234,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22224,5237,1,,12991,,BAO_0000019,,,CHEMBL883126,A,,Increased absorption was determined,Autocuration
,,,,,0,,,U,22224,14378,1,,12992,,BAO_0000100,,,CHEMBL631235,P,,Lipophilicity value was evaluated,Autocuration
,,,,,0,,,U,22224,14418,1,,12993,,BAO_0000100,,,CHEMBL631236,P,,Log P value of the compound.,Autocuration
,,,,,0,,,U,22224,5249,1,,12994,,BAO_0000019,,,CHEMBL631237,A,,Partition coefficient of compound was determined,Autocuration
,,,,,0,,,U,22229,14621,1,,12995,,BAO_0000100,,,CHEMBL631238,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22229,12542,1,,12996,,BAO_0000100,,,CHEMBL876429,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22224,12542,1,,12997,,BAO_0000019,,,CHEMBL631414,A,,Partition coefficient was measured by medchem software; Not calculated,Autocuration
,,,,,0,,,U,22224,12542,1,,12998,,BAO_0000100,,,CHEMBL631415,P,,Partition coefficient was measured by octanol-water using standard shake-flask method,Autocuration
,,,,,0,,,U,22229,15462,1,,12999,,BAO_0000100,,,CHEMBL631416,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22224,14884,1,,13000,,BAO_0000019,,,CHEMBL631417,A,,Partition coefficient (logP),Autocuration
,,,,,0,,,U,22229,16526,1,,13001,,BAO_0000100,,,CHEMBL631418,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22229,13693,1,,13002,,BAO_0000100,,,CHEMBL631419,P,,The Octanol/Water partition coefficient CLogP,Autocuration
,,,,,0,,,U,22224,13693,1,,13003,,BAO_0000019,,,CHEMBL631420,A,,The pharmacokinetic parameter C Log p was reported,Autocuration
,,,,,0,,,U,22229,13779,1,,13004,,BAO_0000100,,,CHEMBL631421,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22229,14772,1,,13005,,BAO_0000100,,,CHEMBL631422,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22229,14393,1,,13006,,BAO_0000100,,,CHEMBL631423,P,,Calculated partition coefficient (clogP),Autocuration
,In vivo,Plasma,,,1,,,N,50597,14793,1,10116.0,13007,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL876430,A,,Clearance rate in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,Intermediate
,In vivo,Plasma,,,1,,,N,50597,14793,1,10116.0,13008,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL631424,A,,Clearance rate in rat plasma when administered intravenously at a dose of 10 mg/kg,Intermediate
,In vivo,Plasma,,,1,,,N,50588,13744,1,9615.0,13009,,BAO_0000218,Canis lupus familiaris,1969.0,CHEMBL631425,A,,Compound was administered intravenously in dog to evaluate plasma clearance values,Intermediate
,In vivo,Plasma,,,0,,,U,22224,13744,1,314293.0,13010,,BAO_0000218,Simiiformes,1969.0,CHEMBL631426,A,,Compound was administered intravenously in monkey to evaluate plasma clearance values,Autocuration
,In vivo,Plasma,,,1,,,N,50594,13744,1,10090.0,13011,,BAO_0000218,Mus musculus,1969.0,CHEMBL631427,A,,Compound was administered intravenously in mouse to evaluate plasma clearance values,Intermediate
,In vivo,Plasma,,,1,,,N,50588,13207,1,9615.0,13012,,BAO_0000218,Canis lupus familiaris,1969.0,CHEMBL631428,A,,Compound was evaluated in vivo for plasma clearance in dog after intravenous dose at 2 mg/Kg,Intermediate
Microsomes,In vitro,Liver,,,1,,,N,50797,5669,1,9544.0,13013,,BAO_0000218,Macaca mulatta,2107.0,CHEMBL631429,A,,Intrinsic clearance in Rhesus liver microsome,Intermediate
Microsomes,In vitro,Liver,,,1,,,N,50588,5669,1,9615.0,13014,,BAO_0000218,Canis lupus familiaris,2107.0,CHEMBL631430,A,,Intrinsic clearance in dog liver microsome,Intermediate
Microsomes,In vitro,Liver,,,1,,,N,50597,5669,1,10116.0,13015,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL631431,A,,Intrinsic clearance in rat liver microsome,Intermediate
,In vivo,Plasma,,,1,,,N,50797,4853,1,9544.0,13016,,BAO_0000218,Macaca mulatta,1969.0,CHEMBL631432,A,,Low plasma clearance was calculated in rhesus monkey,Intermediate
,In vivo,,,,1,,,N,50588,16452,1,9615.0,13017,,BAO_0000218,Canis lupus familiaris,,CHEMBL631433,A,,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,Intermediate
,In vivo,,,,0,,,U,22224,11954,1,,13018,,BAO_0000218,,,CHEMBL631434,A,,Plasma clearance after intravenous dose of 0.3 mg/kg,Autocuration
,In vivo,,,,0,,,U,22224,11954,1,,13019,,BAO_0000218,,,CHEMBL631435,A,,Plasma clearance after intravenous dose of 1 mg/kg,Autocuration
,In vivo,,,,0,,,U,22224,11954,1,,13020,,BAO_0000218,,,CHEMBL631436,A,,Plasma clearance after intravenous dose of 3 mg/kg,Autocuration
,In vivo,,,,0,,,U,22224,11954,1,,13021,,BAO_0000218,,,CHEMBL631437,A,,Plasma clearance after intravenous dose of 3.87 mg/kg,Autocuration
,In vivo,,,,1,,,N,50597,5669,1,10116.0,13022,,BAO_0000218,Rattus norvegicus,,CHEMBL631438,A,,Plasma clearance after peroral administration at 10 mpk in Rat,Intermediate
,In vivo,,,,1,,,N,50797,5669,1,9544.0,13023,,BAO_0000218,Macaca mulatta,,CHEMBL876431,A,,Plasma clearance after peroral administration at 10 mpk in Rhesus,Intermediate
,In vivo,,,,1,,,N,50588,5669,1,9615.0,13024,,BAO_0000218,Canis lupus familiaris,,CHEMBL631439,A,,Plasma clearance after peroral administration at 10 mpk in dog,Intermediate
,In vivo,,,,1,,,N,50597,13662,1,10116.0,13025,,BAO_0000218,Rattus norvegicus,,CHEMBL631440,A,,Totla clearance of compound reported after 5 mg/kg i.v. dose in rat,Intermediate
,,,,,0,,,U,22224,8272,1,,13026,,BAO_0000019,,,CHEMBL631441,A,,Compound was evaluated for physico-chemical property of Critical micellar concentration (CMC),Autocuration
,,,,,0,,,U,22224,13410,1,,13027,,BAO_0000019,,,CHEMBL631442,A,,Critical Micellar concentration was determined,Autocuration
,,,,,0,,,U,22224,13410,1,,13028,,BAO_0000019,,,CHEMBL626525,A,,Critical Micellar concentration of the compound. was determined,Autocuration
,,,,,0,,,U,22224,12628,1,,13029,,BAO_0000019,,,CHEMBL627168,A,,Critical micelle concentration determined from the plots of the fluorescence intensity as a function of compound concentration,Autocuration
,,,,,0,,,U,22224,9675,1,,13030,,BAO_0000019,,,CHEMBL875618,A,,Critical micellar concentration was measured in water by the dye solubilization method,Autocuration
,,,,,0,,,U,22224,12628,1,,13031,,BAO_0000019,,,CHEMBL626612,B,,Hydrolysis turn over determined from the plots of the fluorescence assay quantified by HPLC,Autocuration
,,,,,0,,,U,22224,12766,1,,13032,,BAO_0000019,,,CHEMBL626613,A,,CMR value (relative to BAY K 8644),Autocuration
,,,,,0,,,U,22224,7849,1,,13033,,BAO_0000019,,,CHEMBL626614,A,,Carbamoylating activity was determined,Autocuration
,,,,,0,,,U,22224,12187,1,314293.0,13034,,BAO_0000218,Simiiformes,,CHEMBL626615,A,,Hypotension peak is percentage change from predose baseline pressure observed after intraduodenal dose of 10 mg/kg in monkey,Autocuration
,,,,,0,,,U,22224,2040,1,,13035,,BAO_0000019,,,CHEMBL626616,A,,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.,Autocuration
,,,,,0,,,U,22224,2040,1,,13036,,BAO_0000019,,,CHEMBL626617,A,,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.,Autocuration
,In vivo,Plasma,,,1,,,N,50588,14180,1,9615.0,13037,,BAO_0000218,Canis lupus familiaris,1969.0,CHEMBL626618,A,,Clearance from dog plasma after intravenous injection of 1 mg/kg of compound,Intermediate
,In vivo,Plasma,,,1,,,N,50597,14180,1,10116.0,13038,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626619,A,,Clearance from rat plasma after intravenous injection of 1 mg/kg of compound,Intermediate
,In vivo,,,,1,,,N,50588,14474,1,9615.0,13039,,BAO_0000218,Canis lupus familiaris,,CHEMBL626620,A,,"Clearance rate at 0.46 mg/kg, iv, in dogs",Intermediate
,In vivo,,,,1,,,N,50597,14474,1,10116.0,13040,,BAO_0000218,Rattus norvegicus,,CHEMBL626621,A,,"Clearance rate at 5.5 mg/kg, iv, in rat",Intermediate
,In vivo,,,,1,,,N,100710,14548,1,9541.0,13041,,BAO_0000218,Macaca fascicularis,,CHEMBL626622,A,,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,Intermediate
,In vivo,,,,1,,,N,100710,14548,1,9541.0,13042,,BAO_0000218,Macaca fascicularis,,CHEMBL626623,A,,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,Intermediate
,In vivo,,,,1,,,N,50588,14548,1,9615.0,13043,,BAO_0000218,Canis lupus familiaris,,CHEMBL626624,A,,Pharmacokinetic parameter Cl calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,Intermediate
,In vivo,,,,1,,,N,50597,14548,1,10116.0,13044,,BAO_0000218,Rattus norvegicus,,CHEMBL626625,A,,Pharmacokinetic parameter Cl calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,Intermediate
,Ex vivo,Liver,,,1,,,N,50597,6125,1,10116.0,13045,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL626626,A,,Clearance rate constant using isolated perfused rat liver (IPRL) assay,Intermediate
,In vivo,,,,0,,,U,22224,6874,1,,13046,,BAO_0000218,,,CHEMBL626627,A,,Tested for the total clearance of the compound,Autocuration
,In vivo,,,,1,,,N,50588,15343,1,9615.0,13047,,BAO_0000218,Canis lupus familiaris,,CHEMBL626628,A,,The clearance was measured in dogs after intravenous administration of 1 mg/kg dose,Intermediate
,In vivo,,,,0,,,U,22224,6236,1,,13048,,BAO_0000218,,,CHEMBL626629,A,,Total body clearance was determined,Autocuration
,,,,,1,,,N,50597,11510,1,10116.0,13049,,BAO_0000218,Rattus norvegicus,,CHEMBL626630,A,,Mean Chlorine excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13050,,BAO_0000218,Rattus norvegicus,,CHEMBL626631,A,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,Intermediate
,,,,,0,,,U,22229,8194,1,,13051,,BAO_0000100,,,CHEMBL626632,P,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,Autocuration
,,,,,0,,,U,22229,8194,1,,13052,,BAO_0000100,,,CHEMBL626633,P,,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,Autocuration
,,,,,0,,,U,22229,8194,1,,13053,,BAO_0000100,,,CHEMBL626634,P,,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 8.0 hr,Autocuration
,,,,,0,,,U,22229,8194,1,,13054,,BAO_0000100,,,CHEMBL626635,P,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,Autocuration
,,,,,0,,,U,22229,8194,1,,13055,,BAO_0000100,,,CHEMBL626636,P,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,Autocuration
,,,,,0,,,U,22229,8194,1,,13056,,BAO_0000100,,,CHEMBL626637,P,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,Autocuration
,,,,,1,,,N,50339,13273,1,4754.0,13057,,BAO_0000218,Pneumocystis carinii,,CHEMBL626638,A,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 10.9 uM/Kg/day),Intermediate
,,,,,1,,,N,50339,13273,1,4754.0,13058,,BAO_0000218,Pneumocystis carinii,,CHEMBL626639,A,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.3 uM/Kg/day,Intermediate
,,,,,1,,,N,50339,13273,1,4754.0,13059,,BAO_0000218,Pneumocystis carinii,,CHEMBL626640,A,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 23.3 uM/Kg/day,Intermediate
,,,,,1,,,N,50339,13273,1,4754.0,13060,,BAO_0000218,Pneumocystis carinii,,CHEMBL626641,A,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 4.8 uM/Kg/day,Intermediate
,,,,,1,,,N,50339,13273,1,4754.0,13061,,BAO_0000218,Pneumocystis carinii,,CHEMBL627272,A,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 9.2 uM/Kg/day,Intermediate
,,,,,1,,,N,50339,13273,1,4754.0,13062,,BAO_0000218,Pneumocystis carinii,,CHEMBL627273,A,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted uM/Kg/day,Intermediate
,,,,,1,,,N,50339,13273,1,4754.0,13063,,BAO_0000218,Pneumocystis carinii,,CHEMBL627441,A,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.027 (uM/kg/day),Intermediate
,,,,,1,,,N,50339,13273,1,4754.0,13064,,BAO_0000218,Pneumocystis carinii,,CHEMBL628355,A,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.27 (uM/kg/day),Intermediate
,,,,,1,,,N,50339,13273,1,4754.0,13065,,BAO_0000218,Pneumocystis carinii,,CHEMBL628356,A,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 13.3 (uM/kg/day),Intermediate
,,,,,1,,,N,50339,13273,1,4754.0,13066,,BAO_0000218,Pneumocystis carinii,,CHEMBL628357,A,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.7 (uM/kg/day),Intermediate
,,,,,1,,,N,50339,13273,1,4754.0,13067,,BAO_0000218,Pneumocystis carinii,,CHEMBL628358,A,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 22.1 (uM/kg/day),Intermediate
,,,,,1,,,N,50339,13273,1,4754.0,13068,,BAO_0000218,Pneumocystis carinii,,CHEMBL622307,A,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 66.3 (uM/kg/day),Intermediate
,,,,,0,,,U,22224,13118,1,,13069,,BAO_0000019,,,CHEMBL622527,A,,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0,Autocuration
,,,,,0,,,U,22224,13118,1,,13070,,BAO_0000019,,,CHEMBL622528,A,,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0; Not detectable,Autocuration
,,,,,0,,,U,22224,13118,1,,13071,,BAO_0000019,,,CHEMBL622529,A,,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4,Autocuration
,,,,,0,,,U,22224,13118,1,,13072,,BAO_0000019,,,CHEMBL622992,A,,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4; Not detectable,Autocuration
,,,,,0,,,U,22224,13118,1,,13073,,BAO_0000019,,,CHEMBL622993,A,,Conversion rate by hydrolysis of compound in plasma after 6 hr. ,Autocuration
,,,,,0,,,U,22224,13118,1,,13074,,BAO_0000019,,,CHEMBL622994,A,,Conversion rate by hydrolysis of compound in plasma after 6 h; Not detectable,Autocuration
,,,,,1,,,N,50597,10633,1,10116.0,13075,,BAO_0000218,Rattus norvegicus,,CHEMBL622995,A,,"In vitro rate constant, correlation coefficient for the conversion to progesterone in rat liver homogenate",Intermediate
,,,,,1,,,N,50597,10633,1,10116.0,13076,,BAO_0000218,Rattus norvegicus,,CHEMBL622996,A,,"In vitro rate constant, correlation coefficient for the conversion to progesterone in whole rat blood.",Intermediate
,,,,,1,,,N,50597,10633,1,10116.0,13077,,BAO_0000218,Rattus norvegicus,,CHEMBL622997,A,,"In vitro rate constant, correlation coefficient for the disappearance in rat liver homogenate",Intermediate
,,,,,1,,,N,50597,10633,1,10116.0,13078,,BAO_0000218,Rattus norvegicus,,CHEMBL622998,A,,"In vitro rate constant, correlation coefficient for the disappearance in rat brain homogenate",Intermediate
,,,,,0,,,U,22224,5767,1,,13079,,BAO_0000218,,,CHEMBL622999,A,,Cp max following ip administration at 1 mg/kg,Autocuration
,In vivo,Plasma,,,0,,,U,22224,3302,1,,13080,,BAO_0000218,,1969.0,CHEMBL623000,A,,Maximum concentration in plasma was reported at 0.5 hour,Autocuration
,In vivo,Plasma,,,0,,,U,22224,3302,1,,13081,,BAO_0000218,,1969.0,CHEMBL623001,A,,Maximum concentration in plasma was reported at 2 hour,Autocuration
,,,,,1,,,N,50594,12467,1,10090.0,13082,,BAO_0000218,Mus musculus,,CHEMBL623002,A,,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK3 murine fibrosarcoma cells,Intermediate
,,,,,0,,,U,22229,11778,1,,13083,,BAO_0000100,,,CHEMBL623003,P,,Aqueous solubility in 25 mM N-glycyl-glycine and 10 mM MgSO4 (pH 7.8),Autocuration
,,,,,0,,,U,22224,4321,1,,13084,,BAO_0000019,,,CHEMBL623004,A,,Steady state concentration was evaluated,Autocuration
,,,,,0,,,U,22224,14884,1,,13085,,BAO_0000019,,,CHEMBL623005,A,,Partition coefficient (logP),Autocuration
,,,,,0,,,U,22224,15234,1,,13086,,BAO_0000019,,,CHEMBL623006,A,,Partition coefficient (logD7.4),Autocuration
,In vivo,Liver,,,1,,,N,50597,14198,1,10116.0,13087,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL623007,A,,Biodistribution of {18]Fluoro-CGP 12388 (60 minutes post injection) in liver of male wistar rats,Intermediate
,In vivo,Bone,,,1,,,N,50597,14198,1,10116.0,13088,,BAO_0000218,Rattus norvegicus,10000001.0,CHEMBL623008,A,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in bone of male wistar rats,Intermediate
,In vivo,Cerebellum,,,1,,,N,50597,14198,1,10116.0,13089,,BAO_0000218,Rattus norvegicus,2037.0,CHEMBL876654,A,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cerebellum of male wistar rats,Intermediate
,In vivo,,,,1,,,N,50597,14198,1,10116.0,13090,,BAO_0000218,Rattus norvegicus,,CHEMBL623009,A,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cortex of male wistar rats,Intermediate
,In vivo,,,,1,,,N,50597,14198,1,10116.0,13091,,BAO_0000218,Rattus norvegicus,,CHEMBL623010,A,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in fat of male wistar rats,Intermediate
,In vivo,Heart,,,1,,,N,50597,14198,1,10116.0,13092,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL623011,A,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in heart of male wistar rats,Intermediate
,In vivo,Intestine,,,1,,,N,50597,14198,1,10116.0,13093,,BAO_0000218,Rattus norvegicus,160.0,CHEMBL623012,A,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in intestine of male wistar rats,Intermediate
,,,,,0,,,U,22224,8151,1,,13094,,BAO_0000019,,,CHEMBL623013,A,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,Autocuration
,,,,,0,,,U,22224,8151,1,,13095,,BAO_0000019,,,CHEMBL623014,A,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,Autocuration
,,Urine,,,0,,,U,22224,8151,1,,13096,,BAO_0000019,,1088.0,CHEMBL623015,A,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 10 mg/Kg,Autocuration
,,Urine,,,0,,,U,22224,8151,1,,13097,,BAO_0000019,,1088.0,CHEMBL623016,A,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,Autocuration
,,Urine,,,0,,,U,22224,8151,1,,13098,,BAO_0000019,,1088.0,CHEMBL624858,A,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 25 mg/Kg,Autocuration
,,,,,1,,,N,50597,8151,1,10116.0,13099,,BAO_0000218,Rattus norvegicus,,CHEMBL624859,A,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg.,Intermediate
,,,,,1,,,N,50597,8151,1,10116.0,13100,,BAO_0000218,Rattus norvegicus,,CHEMBL624860,A,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,Intermediate
,,,,,1,,,N,50597,8151,1,10116.0,13101,,BAO_0000218,Rattus norvegicus,,CHEMBL624861,A,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,Intermediate
,,,,,1,,,N,50597,8151,1,10116.0,13102,,BAO_0000218,Rattus norvegicus,,CHEMBL624862,A,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,Intermediate
,,,,,1,,,N,50597,8151,1,10116.0,13103,,BAO_0000218,Rattus norvegicus,,CHEMBL624863,A,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg.,Intermediate
,,,,,1,,,N,50597,8151,1,10116.0,13104,,BAO_0000218,Rattus norvegicus,,CHEMBL876655,A,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,13105,,BAO_0000218,Canis lupus familiaris,,CHEMBL624864,A,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,13106,,BAO_0000218,Canis lupus familiaris,,CHEMBL624865,A,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,13107,,BAO_0000218,Canis lupus familiaris,,CHEMBL624866,A,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,13108,,BAO_0000218,Canis lupus familiaris,,CHEMBL624867,F,,Salidiuretic activity in dog following i.v. dosing at 5 mg/kg,Expert
,,,,,1,,,N,50588,6996,1,9615.0,13109,,BAO_0000218,Canis lupus familiaris,,CHEMBL624868,A,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,13110,,BAO_0000218,Canis lupus familiaris,,CHEMBL628450,A,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600- 799,Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,13111,,BAO_0000218,Canis lupus familiaris,,CHEMBL628451,A,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,13112,,BAO_0000218,Canis lupus familiaris,,CHEMBL628452,A,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,13113,,BAO_0000218,Canis lupus familiaris,,CHEMBL628453,A,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,13114,,BAO_0000218,Canis lupus familiaris,,CHEMBL628454,A,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; act above 5 mg/kg,Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,13115,,BAO_0000218,Canis lupus familiaris,,CHEMBL628455,A,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,13116,,BAO_0000218,Canis lupus familiaris,,CHEMBL628456,A,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,13117,,BAO_0000218,Canis lupus familiaris,,CHEMBL628457,A,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,13118,,BAO_0000218,Canis lupus familiaris,,CHEMBL877505,A,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-299,Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,13119,,BAO_0000218,Canis lupus familiaris,,CHEMBL628458,A,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 250-399,Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,13120,,BAO_0000218,Canis lupus familiaris,,CHEMBL628459,A,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,13121,,BAO_0000218,Canis lupus familiaris,,CHEMBL628460,A,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,13122,,BAO_0000218,Canis lupus familiaris,,CHEMBL628461,A,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,Intermediate
,,,,,0,,,U,22224,6996,1,,13123,,BAO_0000218,,,CHEMBL628462,B,,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 16.5 mg/kg",Autocuration
,,,,,1,,,N,50588,6996,1,9615.0,13124,,BAO_0000218,Canis lupus familiaris,,CHEMBL628463,A,,Compound administered orally at a dose of 1 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,13125,,BAO_0000218,Rattus norvegicus,,CHEMBL625666,F,,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 50 mg/kg",Expert
,,,,,0,,,U,22224,6996,1,,13126,,BAO_0000218,,,CHEMBL625667,B,,Compound administered orally at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,Autocuration
,,,,,1,,,N,50597,6996,1,10116.0,13127,,BAO_0000218,Rattus norvegicus,,CHEMBL625668,A,,Compound administered orally at a dose of 81 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,Expert
,,,,,1,,,N,50597,6996,1,10116.0,13128,,BAO_0000218,Rattus norvegicus,,CHEMBL625669,A,,Compound administered orally was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,Intermediate
,,,,,0,,,U,22224,7114,1,,13129,,BAO_0000019,,,CHEMBL625670,A,,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry,Autocuration
,,,,,1,,,N,50597,7114,1,10116.0,13130,,BAO_0000218,Rattus norvegicus,,CHEMBL625671,A,,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry in rat,Intermediate
,,,,,1,,,N,50602,8613,1,10298.0,13131,,BAO_0000218,Human herpesvirus 1,,CHEMBL625672,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day.,Intermediate
,,,,,1,,,N,50602,8613,1,10298.0,13132,,BAO_0000218,Human herpesvirus 1,,CHEMBL625673,A,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously,Intermediate
,,,,,1,,,N,50602,8613,1,10298.0,13133,,BAO_0000218,Human herpesvirus 1,,CHEMBL625674,A,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously.,Intermediate
,,,,,1,,,N,50602,8613,1,10298.0,13134,,BAO_0000218,Human herpesvirus 1,,CHEMBL625675,A,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously,Intermediate
,,,,,1,,,N,50602,8613,1,10298.0,13135,,BAO_0000218,Human herpesvirus 1,,CHEMBL627637,A,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,Intermediate
,,,,,1,,,N,50602,8613,1,10298.0,13136,,BAO_0000218,Human herpesvirus 1,,CHEMBL627638,A,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered orally.,Intermediate
,,,,,1,,,N,50602,8613,1,10298.0,13137,,BAO_0000218,Human herpesvirus 1,,CHEMBL627639,A,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously,Intermediate
,,,,,1,,,N,50602,8613,1,10298.0,13138,,BAO_0000218,Human herpesvirus 1,,CHEMBL627640,A,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously.,Intermediate
,,,,,1,,,N,50602,8613,1,10298.0,13139,,BAO_0000218,Human herpesvirus 1,,CHEMBL627641,A,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered orally.,Intermediate
,,,,,1,,,N,50602,8613,1,10298.0,13140,,BAO_0000218,Human herpesvirus 1,,CHEMBL627642,A,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,Intermediate
,,,,,1,,,N,50602,8613,1,10298.0,13141,,BAO_0000218,Human herpesvirus 1,,CHEMBL877506,A,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,Intermediate
,,,,,1,,,N,50594,8613,1,10090.0,13142,,BAO_0000218,Mus musculus,,CHEMBL627275,A,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,Intermediate
,,,,,1,,,N,50506,11219,1,9669.0,13143,,BAO_0000218,Mustela putorius furo,,CHEMBL627643,A,,"Average area under curve value dosed at 0.3 mg/kg, iv in ferrets.",Intermediate
,,,,,1,,,N,50506,11219,1,9669.0,13144,,BAO_0000218,Mustela putorius furo,,CHEMBL631246,A,,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",Intermediate
,,,,,1,,,N,50506,11219,1,9669.0,13145,,BAO_0000218,Mustela putorius furo,,CHEMBL631247,A,,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",Intermediate
,,,,,1,,,N,50506,11219,1,9669.0,13146,,BAO_0000218,Mustela putorius furo,,CHEMBL629532,A,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,Intermediate
,,,,,1,,,N,50506,11219,1,9669.0,13147,,BAO_0000218,Mustela putorius furo,,CHEMBL629533,A,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from arterial blood).,Intermediate
,,,,,1,,,N,50506,11219,1,9669.0,13148,,BAO_0000218,Mustela putorius furo,,CHEMBL629534,A,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,Intermediate
,,,,,1,,,N,50506,11219,1,9669.0,13149,,BAO_0000218,Mustela putorius furo,,CHEMBL629535,A,,Average peak plasma drug concentration after iv dose of 0.3 mg/kg in ferrets.,Intermediate
,,,,,0,,,U,22224,14837,1,,13150,,BAO_0000019,,,CHEMBL625932,A,,Pharmacokinetic parameter :drug bound to plasma was reported,Autocuration
,,,,,0,,,U,22224,14837,1,,13151,,BAO_0000019,,,CHEMBL625933,A,,compound was evaluated for drug bound in plasma,Autocuration
,,,,,1,,,N,50597,15343,1,10116.0,13152,,BAO_0000218,Rattus norvegicus,,CHEMBL625934,A,,The Brain concentration compared to plasma concentration in rats after oral administration of 1 mg/kg dose,Intermediate
,,,,,0,,,U,22224,13761,1,9347.0,13153,,BAO_0000218,Eutheria,,CHEMBL625935,A,,Bioavailability,Autocuration
,,,,,1,,,N,50597,14810,1,10116.0,13154,,BAO_0000218,Rattus norvegicus,,CHEMBL625936,A,,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported,Intermediate
,,,,,1,,,N,50597,14810,1,10116.0,13155,,BAO_0000218,Rattus norvegicus,,CHEMBL625937,A,,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported; Not tested,Intermediate
,,,,,1,,,N,50588,13249,1,9615.0,13156,,BAO_0000218,Canis lupus familiaris,,CHEMBL625938,A,,Oral bioavailability in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,Intermediate
,,Bile,,,1,,,N,50597,9267,1,10116.0,13157,,BAO_0000218,Rattus norvegicus,1970.0,CHEMBL625939,A,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-1 hr after the treatment.,Intermediate
,,Bile,,,1,,,N,50597,9267,1,10116.0,13158,,BAO_0000218,Rattus norvegicus,1970.0,CHEMBL625940,A,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-2 hr after the treatment.,Intermediate
,,Bile,,,1,,,N,50597,9267,1,10116.0,13159,,BAO_0000218,Rattus norvegicus,1970.0,CHEMBL874464,A,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-3 hr after the treatment.,Intermediate
,,Bile,,,1,,,N,50597,9267,1,10116.0,13160,,BAO_0000218,Rattus norvegicus,1970.0,CHEMBL625941,A,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-4 hr after the treatment.,Intermediate
,,Bile,,,1,,,N,50597,9267,1,10116.0,13161,,BAO_0000218,Rattus norvegicus,1970.0,CHEMBL625942,A,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-5 hr after the treatment.,Intermediate
,,Bile,,,1,,,N,50597,9267,1,10116.0,13162,,BAO_0000218,Rattus norvegicus,1970.0,CHEMBL625943,A,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-6 hr after the treatment.,Intermediate
,,Serum,,,1,,,N,50587,15549,1,9606.0,13163,,BAO_0000218,Homo sapiens,1977.0,CHEMBL625944,A,,In vitro protein binding in human serum at 5 ug/ml,Intermediate
,,,,,0,,,U,22224,10929,1,,13164,,BAO_0000019,,,CHEMBL625945,A,,Serum protein binding ability was measured,Autocuration
,,,,,0,,,U,22224,15444,1,,13165,,BAO_0000019,,,CHEMBL625946,A,,The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),Autocuration
,In vivo,,,,0,,,U,22224,12860,1,9615.0,13166,,BAO_0000218,Canis lupus familiaris,,CHEMBL625947,A,,Oral bioavailability in dog,Autocuration
,In vivo,,,,1,,,N,50597,12170,1,10116.0,13167,,BAO_0000218,Rattus norvegicus,,CHEMBL625948,A,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,Intermediate
,In vivo,,,,0,,,U,22224,15173,1,,13168,,BAO_0000218,,,CHEMBL625949,A,,Absolute oral bioavailability at an iv dose of 14 mg/kg,Autocuration
,In vivo,,,,0,,,U,22224,15173,1,,13169,,BAO_0000218,,,CHEMBL625950,A,,Absolute oral bioavailability at an iv dose of 15.2 mg/kg,Autocuration
,In vivo,,,,0,,,U,22224,15173,1,9347.0,13170,,BAO_0000218,Eutheria,,CHEMBL625951,A,,Oral bioavailability (dose 15 mg/kg i.v.),Autocuration
,In vivo,,,,0,,,U,22224,15173,1,,13171,,BAO_0000218,,,CHEMBL625952,A,,Absolute oral bioavailability at an peroral dose of 15 mg/kg orally.,Autocuration
,In vivo,,,,0,,,U,22224,15173,1,,13172,,BAO_0000218,,,CHEMBL625953,A,,Absolute oral bioavailability at an peroral dose of 30 mg/kg orally,Autocuration
,In vivo,,,,0,,,U,22224,15173,1,,13173,,BAO_0000218,,,CHEMBL625954,A,,Absolute oral bioavailability at an peroral dose of 30.2 mg/kg orally.,Autocuration
,In vivo,,,,0,,,U,22224,15173,1,,13174,,BAO_0000218,,,CHEMBL882959,A,,Absolute oral bioavailability at an peroral dose of 30.3 mg/kg orally.,Autocuration
,In vivo,,,,1,,,N,50588,11767,1,9615.0,13175,,BAO_0000218,Canis lupus familiaris,,CHEMBL625955,A,,Apparent bioavailability in dogs at 15 mg/kg in an iv vs po dosing regimen,Intermediate
,In vivo,,,,0,,,U,22224,11219,1,9669.0,13176,,BAO_0000218,Mustela putorius furo,,CHEMBL625956,A,,Bioavailability in ferret,Autocuration
,In vivo,,,,1,,,N,100710,12186,1,9541.0,13177,,BAO_0000218,Macaca fascicularis,,CHEMBL625957,A,,Bioavailability after intraduodenal administration at a dose 10 mg/kg in cynomolgus monkeys using renin inhibition assay,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13178,,BAO_0000218,Rattus norvegicus,,CHEMBL625958,A,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13179,,BAO_0000218,Rattus norvegicus,,CHEMBL625959,A,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13180,,BAO_0000218,Rattus norvegicus,,CHEMBL626642,A,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13181,,BAO_0000218,Rattus norvegicus,,CHEMBL631330,A,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13182,,BAO_0000218,Rattus norvegicus,,CHEMBL631331,A,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13183,,BAO_0000218,Rattus norvegicus,,CHEMBL631332,A,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13184,,BAO_0000218,Rattus norvegicus,,CHEMBL631333,A,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13185,,BAO_0000218,Rattus norvegicus,,CHEMBL632018,A,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13186,,BAO_0000218,Rattus norvegicus,,CHEMBL632019,A,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13187,,BAO_0000218,Rattus norvegicus,,CHEMBL632020,A,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13188,,BAO_0000218,Rattus norvegicus,,CHEMBL632021,A,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13189,,BAO_0000218,Rattus norvegicus,,CHEMBL632022,A,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13190,,BAO_0000218,Rattus norvegicus,,CHEMBL632023,A,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13191,,BAO_0000218,Rattus norvegicus,,CHEMBL632024,A,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13192,,BAO_0000218,Rattus norvegicus,,CHEMBL874472,A,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13193,,BAO_0000218,Rattus norvegicus,,CHEMBL632025,A,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13194,,BAO_0000218,Rattus norvegicus,,CHEMBL632026,A,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13195,,BAO_0000218,Rattus norvegicus,,CHEMBL632027,A,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13196,,BAO_0000218,Rattus norvegicus,,CHEMBL632028,A,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13197,,BAO_0000218,Rattus norvegicus,,CHEMBL626430,A,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13198,,BAO_0000218,Rattus norvegicus,,CHEMBL626431,A,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13199,,BAO_0000218,Rattus norvegicus,,CHEMBL626432,A,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13200,,BAO_0000218,Rattus norvegicus,,CHEMBL626433,A,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13201,,BAO_0000218,Rattus norvegicus,,CHEMBL626434,A,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13202,,BAO_0000218,Rattus norvegicus,,CHEMBL627280,A,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13203,,BAO_0000218,Rattus norvegicus,,CHEMBL627281,A,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13204,,BAO_0000218,Rattus norvegicus,,CHEMBL627282,A,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,Intermediate
,,,,,0,,,U,22224,7199,1,,13205,,BAO_0000019,,,CHEMBL627283,A,,Total body clearance was measured at given dose,Autocuration
,,,,,0,,,U,22224,7199,1,,13206,,BAO_0000218,,,CHEMBL627284,A,,Total body clearance was measured at given dose.,Autocuration
,,,,,1,,,N,50597,7095,1,10116.0,13207,,BAO_0000218,Rattus norvegicus,,CHEMBL627285,A,,Metabolic clearance from the body in rat,Intermediate
,In vivo,,,,0,,,U,22224,7095,1,,13208,,BAO_0000218,,,CHEMBL627286,A,,Renal clearance from the body,Autocuration
,In vivo,,,,1,,,N,50597,7095,1,10116.0,13209,,BAO_0000218,Rattus norvegicus,,CHEMBL875477,A,,Renal clearance from the body in rat,Intermediate
,In vivo,,,,1,,,N,50597,12528,1,10116.0,13210,,BAO_0000218,Rattus norvegicus,,CHEMBL627287,A,,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 12 mg/kg in rat,Intermediate
,In vivo,,,,1,,,N,50588,12528,1,9615.0,13211,,BAO_0000218,Canis lupus familiaris,,CHEMBL627288,A,,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 2.5 mg/kg in dog,Intermediate
,,,,,1,,,N,50597,7095,1,10116.0,13212,,BAO_0000218,Rattus norvegicus,,CHEMBL627289,A,,Total clearance from the body in rat,Intermediate
,In vivo,Plasma,,,1,,,N,50597,14223,1,10116.0,13213,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL627290,A,,Clearance into cortex from rat plasma or PBS,Intermediate
,In vivo,,,,0,,,U,22224,13569,1,,13214,,BAO_0000218,,,CHEMBL627291,A,,Clearance at an iv dose of 15 mg/Kg and po dose of 120 mg/Kg,Autocuration
,In vivo,,,,0,,,U,22224,13569,1,,13215,,BAO_0000218,,,CHEMBL627292,A,,Clearance at an iv dose of 15 mg/Kg and po dose of 240 mg/Kg,Autocuration
,In vivo,,,,0,,,U,22224,13569,1,,13216,,BAO_0000218,,,CHEMBL627293,A,,Clearance at an iv dose of 15 mg/Kg and po dose of 29.1 mg/Kg,Autocuration
,In vivo,,,,0,,,U,22224,13569,1,,13217,,BAO_0000218,,,CHEMBL627294,A,,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,Autocuration
,In vivo,,,,0,,,U,22224,13569,1,,13218,,BAO_0000218,,,CHEMBL875478,A,,Clearance at an iv dose of 15 mg/Kg and po dose of 60 mg/Kg,Autocuration
,In vivo,,,,0,,,U,22224,13979,1,,13219,,BAO_0000218,,,CHEMBL627295,A,,Clearance was determined,Autocuration
,In vivo,,,,1,,,N,50594,14315,1,10090.0,13220,,BAO_0000218,Mus musculus,,CHEMBL627296,A,,Clearance was measured in mouse after administration of compound 20 mg/kg intravenously,Intermediate
,In vivo,,,,1,,,N,50592,14315,1,9986.0,13221,,BAO_0000218,Oryctolagus cuniculus,,CHEMBL626119,A,,Clearance was measured in rabbit after administration of compound 20 mg/kg intravenously,Intermediate
,In vivo,,,,1,,,N,50597,14315,1,10116.0,13222,,BAO_0000218,Rattus norvegicus,,CHEMBL626120,A,,Clearance was measured in rat after administration of compound 20 mg/kg intravenously,Intermediate
,In vivo,,,,1,,,N,50597,12174,1,10116.0,13223,,BAO_0000218,Rattus norvegicus,,CHEMBL626121,A,,Clearance in rat after iv dose (100 ug/kg),Intermediate
,In vivo,,,,0,,,U,22224,12797,1,10141.0,13224,,BAO_0000218,Cavia porcellus,,CHEMBL626122,A,,Clearance in guinea pig,Autocuration
,In vivo,,,,1,,,N,50597,12797,1,10116.0,13225,,BAO_0000218,Rattus norvegicus,,CHEMBL626123,A,,Compound was evaluated for clearance in rat,Intermediate
,In vivo,,,,1,,,N,50588,12797,1,9615.0,13226,,BAO_0000218,Canis lupus familiaris,,CHEMBL623456,A,,Compound was evaluated for the clearance in dog,Intermediate
,In vivo,,,,1,,,N,50597,12797,1,10116.0,13227,,BAO_0000218,Rattus norvegicus,,CHEMBL623457,A,,Compound was evaluated for the clearance in rat,Intermediate
,In vivo,,,,1,,,N,50597,11500,1,10116.0,13228,,BAO_0000218,Rattus norvegicus,,CHEMBL623458,A,,Compound was tested in vivo for clearance after iv administration in the rat,Intermediate
,In vivo,,,,0,,,U,22224,15173,1,,13229,,BAO_0000218,,,CHEMBL623459,A,,IV clearance determined at an iv dose of 14 mg/kg,Autocuration
,In vivo,,,,0,,,U,22224,15173,1,,13230,,BAO_0000218,,,CHEMBL875484,A,,IV clearance determined at an iv dose of 15.2 mg/kg,Autocuration
,In vivo,,,,0,,,U,22224,15173,1,,13231,,BAO_0000218,,,CHEMBL623460,A,,IV clearance determined at an iv dose of 15 mg/kg,Autocuration
,In vivo,,,,0,,,U,22224,15173,1,,13232,,BAO_0000218,,,CHEMBL623461,A,,IV clearance determined at an peroral dose of 30 mg/kg.,Autocuration
,In vivo,,,,0,,,U,22224,15173,1,,13233,,BAO_0000218,,,CHEMBL623462,A,,IV clearance determined at an peroral dose of 30.2 mg/kg.,Autocuration
,In vivo,,,,0,,,U,22224,15173,1,,13234,,BAO_0000218,,,CHEMBL627386,A,,IV clearance determined at an peroral dose of 30.3 mg/kg.,Autocuration
,In vivo,Kidney,,,1,,,N,50597,14198,1,10116.0,13235,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL627387,A,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in kidney of male wistar rats,Intermediate
,In vivo,Liver,,,1,,,N,50597,14198,1,10116.0,13236,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL627388,A,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in liver of male wistar rats,Intermediate
,In vivo,Lung,,,1,,,N,50597,14198,1,10116.0,13237,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL627389,A,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in lung of male wistar rats,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,14198,1,10116.0,13238,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL627390,A,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in muscle of male wistar rats,Intermediate
,In vivo,Plasma,,,1,,,N,50597,14198,1,10116.0,13239,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL627391,A,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in plasma of male wistar rats,Intermediate
,In vivo,,,,1,,,N,50597,14198,1,10116.0,13240,,BAO_0000218,Rattus norvegicus,,CHEMBL627392,A,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in red blood cells of male wistar rats,Intermediate
,In vivo,Spleen,,,1,,,N,50597,14198,1,10116.0,13241,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL627393,A,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in spleen of male wistar rats,Intermediate
,In vivo,Trachea,,,1,,,N,50597,14198,1,10116.0,13242,,BAO_0000218,Rattus norvegicus,3126.0,CHEMBL627394,A,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in trachea of male wistar rats,Intermediate
,In vivo,Bone,,,1,,,N,50597,14198,1,10116.0,13243,,BAO_0000218,Rattus norvegicus,10000001.0,CHEMBL627395,A,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in bone of male wistar rats,Intermediate
,In vivo,Cerebellum,,,1,,,N,50597,14198,1,10116.0,13244,,BAO_0000218,Rattus norvegicus,2037.0,CHEMBL875485,A,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cerebellum of male wistar rats,Intermediate
,In vivo,,,,1,,,N,50597,14198,1,10116.0,13245,,BAO_0000218,Rattus norvegicus,,CHEMBL627396,A,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cortex of male wistar rats,Intermediate
,In vivo,,,,1,,,N,50597,14198,1,10116.0,13246,,BAO_0000218,Rattus norvegicus,,CHEMBL627397,A,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in fat of male wistar rats,Intermediate
,In vivo,Heart,,,1,,,N,50597,14198,1,10116.0,13247,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL627398,A,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in heart of male wistar rats,Intermediate
,In vivo,Bone,,,1,,,N,50597,14198,1,10116.0,13248,,BAO_0000218,Rattus norvegicus,10000001.0,CHEMBL627399,A,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in intestine bone of male wistar rats,Intermediate
,In vivo,Kidney,,,1,,,N,50597,14198,1,10116.0,13249,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL627400,A,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in kidney of male wistar rats,Intermediate
,In vivo,Liver,,,1,,,N,50597,14198,1,10116.0,13250,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL627401,A,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in liver of male wistar rats,Intermediate
,In vivo,Lung,,,1,,,N,50597,14198,1,10116.0,13251,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL627402,A,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in lung of male wistar rats,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,14198,1,10116.0,13252,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL627403,A,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in muscle of male wistar rats,Intermediate
,In vivo,Plasma,,,1,,,N,50597,14198,1,10116.0,13253,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL627404,A,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in plasma of male wistar rats,Intermediate
,In vivo,,,,1,,,N,50597,14198,1,10116.0,13254,,BAO_0000218,Rattus norvegicus,,CHEMBL623101,A,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in red blood cells of male wistar rats,Intermediate
,In vivo,Spleen,,,1,,,N,50597,14198,1,10116.0,13255,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL877480,A,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in spleen of male wistar rats,Intermediate
,In vivo,Trachea,,,1,,,N,50597,14198,1,10116.0,13256,,BAO_0000218,Rattus norvegicus,3126.0,CHEMBL623102,A,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in trachea of male wistar rats,Intermediate
,In vivo,Bone,,,1,,,N,50597,14198,1,10116.0,13257,,BAO_0000218,Rattus norvegicus,10000001.0,CHEMBL623103,A,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in bone of male wistar rats,Intermediate
,In vivo,Cerebellum,,,1,,,N,50597,14198,1,10116.0,13258,,BAO_0000218,Rattus norvegicus,2037.0,CHEMBL623104,A,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cerebellum of male wistar rats,Intermediate
,In vivo,,,,1,,,N,50597,14198,1,10116.0,13259,,BAO_0000218,Rattus norvegicus,,CHEMBL623105,A,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cortex of male wistar rats,Intermediate
,In vivo,,,,1,,,N,50597,14198,1,10116.0,13260,,BAO_0000218,Rattus norvegicus,,CHEMBL623106,A,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in fat of male wistar rats,Intermediate
,In vivo,Heart,,,1,,,N,50597,14198,1,10116.0,13261,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL623107,A,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in heart of male wistar rats,Intermediate
,In vivo,Intestine,,,1,,,N,50597,14198,1,10116.0,13262,,BAO_0000218,Rattus norvegicus,160.0,CHEMBL623108,A,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in intestine of male wistar rats,Intermediate
,In vivo,Kidney,,,1,,,N,50597,14198,1,10116.0,13263,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL623109,A,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in kidney of male wistar rats,Intermediate
,In vivo,Liver,,,1,,,N,50597,14198,1,10116.0,13264,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL623110,A,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in liver of male wistar rats,Intermediate
,In vivo,Lung,,,1,,,N,50597,14198,1,10116.0,13265,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL623111,A,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in lung of male wistar rats,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,14198,1,10116.0,13266,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL625060,A,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in muscle of male wistar rats,Intermediate
,In vivo,Plasma,,,1,,,N,50597,14198,1,10116.0,13267,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL625061,A,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in plasma of male wistar rats,Intermediate
,In vivo,,,,1,,,N,50597,14198,1,10116.0,13268,,BAO_0000218,Rattus norvegicus,,CHEMBL625062,A,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in red blood cells of male wistar rats,Intermediate
,In vivo,Spleen,,,1,,,N,50597,14198,1,10116.0,13269,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL625063,A,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in spleen of male wistar rats,Intermediate
,In vivo,Trachea,,,1,,,N,50597,14198,1,10116.0,13270,,BAO_0000218,Rattus norvegicus,3126.0,CHEMBL625064,A,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in trachea of male wistar rats,Intermediate
,In vivo,Bone,,,1,,,N,50597,14198,1,10116.0,13271,,BAO_0000218,Rattus norvegicus,10000001.0,CHEMBL625065,A,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in bone of male wistar rats,Intermediate
,In vivo,Cerebellum,,,1,,,N,50597,14198,1,10116.0,13272,,BAO_0000218,Rattus norvegicus,2037.0,CHEMBL625066,A,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cerebellum of male wistar rats,Intermediate
,In vivo,,,,1,,,N,50597,14198,1,10116.0,13273,,BAO_0000218,Rattus norvegicus,,CHEMBL625067,A,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cortex of male wistar rats,Intermediate
,In vivo,,,,1,,,N,50597,14198,1,10116.0,13274,,BAO_0000218,Rattus norvegicus,,CHEMBL625068,A,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in fat of male wistar rats,Intermediate
,In vivo,Heart,,,1,,,N,50597,14198,1,10116.0,13275,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL622159,A,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in heart of male wistar rats,Intermediate
,In vivo,Intestine,,,1,,,N,50597,14198,1,10116.0,13276,,BAO_0000218,Rattus norvegicus,160.0,CHEMBL622160,A,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in intestine of male wistar rats,Intermediate
,In vivo,Kidney,,,1,,,N,50597,14198,1,10116.0,13277,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL622161,A,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in kidney of male wistar rats,Intermediate
,In vivo,Lung,,,1,,,N,50597,14198,1,10116.0,13278,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL622162,A,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in lung of male wistar rats,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,14198,1,10116.0,13279,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL622163,A,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in muscle of male wistar rats,Intermediate
,In vivo,Plasma,,,1,,,N,50597,14198,1,10116.0,13280,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622313,A,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in plasma of male wistar rats,Intermediate
,In vivo,,,,1,,,N,50597,14198,1,10116.0,13281,,BAO_0000218,Rattus norvegicus,,CHEMBL622314,A,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in red blood cells of male wistar rats,Intermediate
,In vivo,Spleen,,,1,,,N,50597,14198,1,10116.0,13282,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL622315,A,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in spleen of male wistar rats,Intermediate
,In vivo,Trachea,,,1,,,N,50597,14198,1,10116.0,13283,,BAO_0000218,Rattus norvegicus,3126.0,CHEMBL622316,A,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in trachea of male wistar rats,Intermediate
,,,,,1,,,N,50212,15599,1,562.0,13284,,BAO_0000218,Escherichia coli,,CHEMBL877486,A,,Normal diffusion coefficient in water for Escherichia coli,Intermediate
,,,,,0,,,U,22224,8204,1,,13285,,BAO_0000019,,,CHEMBL622317,A,,Average max percent decrease in RVR (renal vascular resistance) was determined,Autocuration
,,,,,0,,,U,22224,8204,1,,13286,,BAO_0000019,,,CHEMBL622318,A,,Average max percent decrease in RVR (renal vascular resistance) was determined.,Autocuration
,,,,,0,,,U,22224,6154,1,,13287,,BAO_0000019,,,CHEMBL622319,A,,In vitro stability to pepsin promoting hydrolysis after 1 hr incubation time,Autocuration
,,,,,0,,,U,22224,6154,1,,13288,,BAO_0000019,,,CHEMBL622320,A,,In vitro stability to pepsin promoting hydrolysis after 2 hr incubation time,Autocuration
,,,,,0,,,U,22224,6154,1,,13289,,BAO_0000019,,,CHEMBL622321,A,,In vitro stability to pepsin promoting hydrolysis after 64h incubation time,Autocuration
,,,,,0,,,U,22224,6154,1,,13290,,BAO_0000019,,,CHEMBL622322,A,,In vitro stability to pepsin promoting hydrolysis after 84 hr incubation time,Autocuration
,,,,,0,,,U,22224,7114,1,,13291,,BAO_0000019,,,CHEMBL622323,A,,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry,Autocuration
,,,,,1,,,N,50597,7114,1,10116.0,13292,,BAO_0000218,Rattus norvegicus,,CHEMBL622324,A,,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry in rat,Intermediate
,,Urine,,,1,,,N,50588,8133,1,9615.0,13293,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL622325,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",Intermediate
,,Urine,,,1,,,N,50588,8133,1,9615.0,13294,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL622326,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",Intermediate
,,Urine,,,1,,,N,50588,8133,1,9615.0,13295,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL877487,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 10.0 mg/kg, po",Intermediate
,,Urine,,,1,,,N,50588,8133,1,9615.0,13296,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL622327,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",Intermediate
,,Urine,,,1,,,N,50588,8133,1,9615.0,13297,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL622328,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3.0 mg/kg, po",Intermediate
,,Urine,,,1,,,N,50588,8133,1,9615.0,13298,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL622329,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",Intermediate
,,Urine,,,1,,,N,50588,8133,1,9615.0,13299,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL622330,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",Intermediate
,,Urine,,,1,,,N,50588,8133,1,9615.0,13300,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL622331,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 0.3mg/kg, po",Intermediate
,,Urine,,,1,,,N,50588,8133,1,9615.0,13301,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL622332,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",Intermediate
,,Urine,,,1,,,N,50588,8133,1,9615.0,13302,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL622333,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3 mg/kg, po",Intermediate
,,Urine,,,0,,,U,22224,8133,1,314293.0,13303,,BAO_0000218,Simiiformes,1088.0,CHEMBL627658,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",Autocuration
,,Urine,,,0,,,U,22224,8133,1,314293.0,13304,,BAO_0000218,Simiiformes,1088.0,CHEMBL630428,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 10mg/kg, po",Autocuration
,,Urine,,,0,,,U,22224,8133,1,314293.0,13305,,BAO_0000218,Simiiformes,1088.0,CHEMBL630429,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",Autocuration
,,Urine,,,0,,,U,22224,8133,1,314293.0,13306,,BAO_0000218,Simiiformes,1088.0,CHEMBL630430,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 30 mg/kg, po",Autocuration
,,Urine,,,0,,,U,22224,8133,1,314293.0,13307,,BAO_0000218,Simiiformes,1088.0,CHEMBL630431,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 3 mg/kg, po",Autocuration
,,Urine,,,1,,,N,50597,8133,1,10116.0,13308,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL630432,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",Intermediate
,,Urine,,,1,,,N,50597,8133,1,10116.0,13309,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL630433,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",Intermediate
,,Urine,,,1,,,N,50597,8133,1,10116.0,13310,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL630434,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",Intermediate
,,Urine,,,1,,,N,50597,8133,1,10116.0,13311,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL629372,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",Intermediate
,,Urine,,,1,,,N,50597,8133,1,10116.0,13312,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL629553,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 100.0mg/kg, po",Intermediate
,,Urine,,,1,,,N,50597,8133,1,10116.0,13313,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL629554,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",Intermediate
,,Urine,,,1,,,N,50597,8133,1,10116.0,13314,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL874447,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",Intermediate
,,Urine,,,1,,,N,50597,8133,1,10116.0,13315,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL629555,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",Intermediate
,,Urine,,,1,,,N,50597,8133,1,10116.0,13316,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL629556,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",Intermediate
,,Urine,,,1,,,N,50597,8133,1,10116.0,13317,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL629557,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded rats at 30.0 mg/kg, po",Intermediate
,,Urine,,,1,,,N,50597,8133,1,10116.0,13318,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL629558,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",Intermediate
,,Urine,,,1,,,N,50597,8133,1,10116.0,13319,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL629559,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",Intermediate
,,Urine,,,1,,,N,50597,8133,1,10116.0,13320,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL629560,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",Intermediate
,,Urine,,,1,,,N,50588,8133,1,9615.0,13321,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL629561,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",Intermediate
,,Urine,,,1,,,N,50588,8133,1,9615.0,13322,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL629562,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",Intermediate
,,Urine,,,1,,,N,50588,8133,1,9615.0,13323,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL629563,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.3mg/kg, po",Intermediate
,,Urine,,,1,,,N,50588,8133,1,9615.0,13324,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL629564,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",Intermediate
,,Urine,,,1,,,N,50588,8133,1,9615.0,13325,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL629565,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10.0mg/kg, po",Intermediate
,,Urine,,,1,,,N,50588,8133,1,9615.0,13326,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL629566,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",Intermediate
,,Urine,,,1,,,N,50588,8133,1,9615.0,13327,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL629567,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1 mg/kg, po",Intermediate
,,Urine,,,1,,,N,50588,8133,1,9615.0,13328,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL629568,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",Intermediate
,,Urine,,,1,,,N,50588,8133,1,9615.0,13329,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL629569,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 30mg/kg, po",Intermediate
,,Urine,,,1,,,N,50588,8133,1,9615.0,13330,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL629570,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",Intermediate
,,Urine,,,0,,,U,22224,8133,1,314293.0,13331,,BAO_0000218,Simiiformes,1088.0,CHEMBL629571,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",Autocuration
,In vivo,,,,0,,,U,22224,12170,1,10116.0,13332,,BAO_0000218,Rattus norvegicus,,CHEMBL629572,A,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,Autocuration
,In vivo,,,,0,,,U,22224,12170,1,10116.0,13333,,BAO_0000218,Rattus norvegicus,,CHEMBL629573,A,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,Autocuration
,In vivo,,,,0,,,U,22224,4985,1,9347.0,13334,,BAO_0000218,Eutheria,,CHEMBL629574,A,,Bioavailability (dose 20 mg/kg),Autocuration
,In vivo,,,,0,,,U,22224,15145,1,9615.0,13335,,BAO_0000218,Canis lupus familiaris,,CHEMBL629575,A,,Bioavailability in dog,Autocuration
,In vivo,,,,0,,,U,22224,14080,1,10116.0,13336,,BAO_0000218,Rattus norvegicus,,CHEMBL874448,A,,Bioavailability in rat (Sprague-Dawley) (male),Autocuration
,In vivo,,,,0,,,U,22224,11219,1,9443.0,13337,,BAO_0000218,Primates,,CHEMBL629576,A,,Bioavailability in monkey (dose 10 mg/kg i.d.),Autocuration
,In vivo,,,,0,,,U,22224,15145,1,10116.0,13338,,BAO_0000218,Rattus norvegicus,,CHEMBL629577,A,,Bioavailability in rat,Autocuration
,In vivo,,,,0,,,U,22224,15145,1,10116.0,13339,,BAO_0000218,Rattus norvegicus,,CHEMBL629578,A,,Bioavailability in rat,Autocuration
,In vivo,,,,0,,,U,22224,1202,1,9615.0,13340,,BAO_0000218,Canis lupus familiaris,,CHEMBL629579,A,,Bioavailability in dog (dose 3.0 mg/kg p.o.),Autocuration
,In vivo,,,,0,,,U,22224,1202,1,9615.0,13341,,BAO_0000218,Canis lupus familiaris,,CHEMBL882958,A,,Bioavailability in dog (dose of 1.0 mg/kg i.v.) 0.5 hr,Autocuration
,In vivo,,,,1,,,N,50505,1202,1,9598.0,13342,,BAO_0000218,Pan troglodytes,,CHEMBL629580,A,,Bioavailability was calculated after peroral dose of 10 mg/Kg in chimp,Intermediate
,In vivo,,,,0,,,U,22224,4026,1,9347.0,13343,,BAO_0000218,Eutheria,,CHEMBL629581,A,,Bioavailability,Autocuration
,In vivo,,,,0,,,U,22224,1492,1,9520.0,13344,,BAO_0000218,Saimiri,,CHEMBL629582,A,,Bioavailability in squirrel monkey,Autocuration
,In vivo,,,,1,,,N,50588,12793,1,9615.0,13345,,BAO_0000218,Canis lupus familiaris,,CHEMBL628522,A,,Bioavailability was evaluated in dog,Intermediate
,In vivo,,,,1,,,N,100712,12793,1,10026.0,13346,,BAO_0000218,Cricetinae,,CHEMBL625432,A,,Bioavailability was evaluated in hamster,Intermediate
,In vivo,,,,0,,,U,22224,12793,1,10116.0,13347,,BAO_0000218,Rattus norvegicus,,CHEMBL625433,A,,Bioavailability in rat,Autocuration
,In vivo,Plasma,,,1,,,N,50597,14793,1,10116.0,13348,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL625434,A,,Bioavailability was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,Intermediate
,In vivo,Plasma,,,1,,,N,50597,14793,1,10116.0,13349,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL625435,A,,Bioavailability was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg; <Tr>,Intermediate
,In vivo,,,,0,,,U,22224,14793,1,10116.0,13350,,BAO_0000218,Rattus norvegicus,,CHEMBL625436,A,,Bioavailability in rat (dose 10 mg/kg p.o.),Autocuration
,In vivo,,,,1,,,N,100710,14731,1,9541.0,13351,,BAO_0000218,Macaca fascicularis,,CHEMBL874588,A,,Bioavailability was measured in cynomolgus monkeys.,Intermediate
,In vivo,,,,1,,,N,50594,14731,1,10090.0,13352,,BAO_0000218,Mus musculus,,CHEMBL625437,A,,Bioavailability was measured in nude mice.,Intermediate
,In vivo,,,,0,,,U,22224,12187,1,9669.0,13353,,BAO_0000218,Mustela putorius furo,,CHEMBL625438,A,,Bioavailability in ferret (dose 10 mg/kg i.d.),Autocuration
,In vivo,,,,0,,,U,22224,12187,1,314293.0,13354,,BAO_0000218,Simiiformes,,CHEMBL625439,A,,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose),Autocuration
,In vivo,,,,0,,,U,22224,12187,1,314293.0,13355,,BAO_0000218,Simiiformes,,CHEMBL625440,A,,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose), determined by renin inhibition assay",Autocuration
,In vivo,,,,0,,,U,22224,12187,1,314293.0,13356,,BAO_0000218,Simiiformes,,CHEMBL625441,A,,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 1 mg/kg intravenous dose),Autocuration
,In vivo,,,,0,,,U,22224,12187,1,10116.0,13357,,BAO_0000218,Rattus norvegicus,,CHEMBL625442,A,,Bioavailability in rat (dose 10 mg/kg i.d.),Autocuration
,In vivo,,,,1,,,N,50597,12187,1,10116.0,13358,,BAO_0000218,Rattus norvegicus,,CHEMBL625443,A,,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",Intermediate
,In vivo,,,,0,,,U,22224,17431,1,,13359,,BAO_0000218,,,CHEMBL625444,A,,Bioavailability was determined; extremely poor,Autocuration
,In vivo,,,,1,,,N,50594,13318,1,10090.0,13360,,BAO_0000218,Mus musculus,,CHEMBL625445,A,,% bioavailability in mice after oral administration of prodrug,Intermediate
,In vivo,,,,1,,,N,50588,9025,1,9615.0,13361,,BAO_0000218,Canis lupus familiaris,,CHEMBL625446,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose 10/30 range (low/high); -21/-5,Intermediate
,In vivo,,,,1,,,N,50588,9025,1,9615.0,13362,,BAO_0000218,Canis lupus familiaris,,CHEMBL882960,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -2/6,Intermediate
,In vivo,,,,1,,,N,50588,9025,1,9615.0,13363,,BAO_0000218,Canis lupus familiaris,,CHEMBL625447,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -4/-14,Intermediate
,In vivo,,,,1,,,N,50588,9025,1,9615.0,13364,,BAO_0000218,Canis lupus familiaris,,CHEMBL625448,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -5/-12,Intermediate
,In vivo,,,,1,,,N,50588,9025,1,9615.0,13365,,BAO_0000218,Canis lupus familiaris,,CHEMBL625449,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3/10 range (low/high); -1/-7/-11,Intermediate
,In vivo,,,,1,,,N,50588,9025,1,9615.0,13366,,BAO_0000218,Canis lupus familiaris,,CHEMBL874589,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high),Intermediate
,In vivo,,,,1,,,N,50588,9025,1,9615.0,13367,,BAO_0000218,Canis lupus familiaris,,CHEMBL625450,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -1/-9,Intermediate
,In vivo,,,,1,,,N,50588,9025,1,9615.0,13368,,BAO_0000218,Canis lupus familiaris,,CHEMBL625451,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -11/-28,Intermediate
,In vivo,,,,1,,,N,50588,9025,1,9615.0,13369,,BAO_0000218,Canis lupus familiaris,,CHEMBL626584,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/-29,Intermediate
,In vivo,,,,1,,,N,50588,9025,1,9615.0,13370,,BAO_0000218,Canis lupus familiaris,,CHEMBL626585,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/30,Intermediate
,In vivo,,,,1,,,N,50588,9025,1,9615.0,13371,,BAO_0000218,Canis lupus familiaris,,CHEMBL626586,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-18,Intermediate
,In vivo,,,,1,,,N,50588,9025,1,9615.0,13372,,BAO_0000218,Canis lupus familiaris,,CHEMBL626587,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-35,Intermediate
,In vivo,,,,1,,,N,50588,9025,1,9615.0,13373,,BAO_0000218,Canis lupus familiaris,,CHEMBL626588,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -19/-50,Intermediate
,In vivo,,,,1,,,N,50588,9025,1,9615.0,13374,,BAO_0000218,Canis lupus familiaris,,CHEMBL626589,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -21/-29,Intermediate
,In vivo,,,,1,,,N,50588,9025,1,9615.0,13375,,BAO_0000218,Canis lupus familiaris,,CHEMBL626590,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -24/-56,Intermediate
,In vivo,,,,1,,,N,50588,9025,1,9615.0,13376,,BAO_0000218,Canis lupus familiaris,,CHEMBL626591,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -25/-33,Intermediate
,In vivo,,,,1,,,N,50588,9025,1,9615.0,13377,,BAO_0000218,Canis lupus familiaris,,CHEMBL627181,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -3/-13,Intermediate
,In vivo,,,,1,,,N,50588,9025,1,9615.0,13378,,BAO_0000218,Canis lupus familiaris,,CHEMBL628083,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -5/-47,Intermediate
,In vivo,,,,0,,,U,22224,15173,1,,13379,,BAO_0000218,,,CHEMBL628084,A,,IV clearance determined at an peroral dose of 15 mg/kg.,Autocuration
,In vivo,,,,1,,,N,50064,7732,1,102285.0,13380,,BAO_0000218,Hymenolepis nana,,CHEMBL628085,F,,Mouse oral clearance was measured against Hymenolepiasis nana.,Expert
,In vivo,,,,1,,,N,50545,7732,1,6339.0,13381,,BAO_0000218,Heligmosomoides polygyrus,,CHEMBL628086,F,,Mouse oral clearance was measured against Nematospiroides dubius,Expert
,In vivo,,,,0,,,U,22224,7732,1,,13382,,BAO_0000218,,,CHEMBL628087,F,,Mouse oral clearance was measured against N. dubius; NT is Not Tested,Autocuration
,In vivo,,,,1,,,N,50594,7732,1,10090.0,13383,,BAO_0000218,Mus musculus,,CHEMBL628088,A,,Mouse oral clearance was measured against N. nana; NT is Not Tested,Intermediate
,In vivo,,,,0,,,U,22224,7732,1,,13384,,BAO_0000218,,,CHEMBL628089,B,,Mouse oral clearance was measured against N. nana; NT is Not Tested,Autocuration
,In vivo,,,,0,,,U,22224,8328,1,,13385,,BAO_0000218,,,CHEMBL628090,A,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation,Autocuration
,In vivo,,,,0,,,U,22224,8328,1,,13386,,BAO_0000218,,,CHEMBL628091,A,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation,Autocuration
,In vivo,,,,0,,,U,22224,8328,1,,13387,,BAO_0000218,,,CHEMBL628092,A,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation,Autocuration
,In vivo,,,,0,,,U,22224,8328,1,,13388,,BAO_0000218,,,CHEMBL628093,A,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 9 J/cm e2 ultraviolet-A radiation,Autocuration
,In vivo,,,,0,,,U,22224,8328,1,,13389,,BAO_0000218,,,CHEMBL875607,A,,Percentage of clearance of psoriatic lesions by the compound at dose of 10 J/cm e2 ultraviolet-A radiation,Autocuration
,In vivo,,,,0,,,U,22224,8328,1,,13390,,BAO_0000218,,,CHEMBL625710,A,,Percentage of clearance of psoriatic lesions by the compound at dose of 4 J/cm e2 ultraviolet-A radiation,Autocuration
,In vivo,,,,0,,,U,22224,8328,1,,13391,,BAO_0000218,,,CHEMBL625711,A,,Percentage of clearance of psoriatic lesions by the compound at dose of 6 J/cm e2 ultraviolet-A radiation,Autocuration
,In vivo,,,,0,,,U,22224,8328,1,,13392,,BAO_0000218,,,CHEMBL625712,A,,Percentage of clearance of psoriatic lesions by the compound at dose of 8 J/cm e2 ultraviolet-A radiation,Autocuration
,In vivo,,,,0,,,U,22224,8328,1,,13393,,BAO_0000218,,,CHEMBL625713,A,,Percentage of clearance of psoriatic lesions by the compound at dose of 9 J/cm e2 ultraviolet-A radiation,Autocuration
,In vivo,,,,1,,,N,50588,13376,1,9615.0,13394,,BAO_0000218,Canis lupus familiaris,,CHEMBL625714,A,,Pharmacokinetic parameter clearance was determined in fed Beagle dogs after iv administration of 1.5 mg/kg,Intermediate
,In vivo,,,,1,,,N,50797,13477,1,9544.0,13395,,BAO_0000218,Macaca mulatta,,CHEMBL625715,A,,Plasma clearance after intravenous administration dosing (30 mg/kg) in Rhesus monkey,Intermediate
,In vivo,,,,1,,,N,50597,13477,1,10116.0,13396,,BAO_0000218,Rattus norvegicus,,CHEMBL625716,A,,Plasma clearance after intravenous administration dosing (30 mg/kg) in rat,Intermediate
,In vivo,,,,1,,,N,50597,13477,1,10116.0,13397,,BAO_0000218,Rattus norvegicus,,CHEMBL625717,A,,Plasma clearance after intravenous administration iv dosing of 3 mg/kg in rat,Intermediate
,In vivo,,,,1,,,N,50597,13313,1,10116.0,13398,,BAO_0000218,Rattus norvegicus,,CHEMBL625718,A,,Plasma clearance was determined for the compound in rats,Intermediate
,In vivo,,,,1,,,N,50597,12504,1,10116.0,13399,,BAO_0000218,Rattus norvegicus,,CHEMBL625719,A,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 1,Intermediate
,In vivo,,,,1,,,N,50597,12504,1,10116.0,13400,,BAO_0000218,Rattus norvegicus,,CHEMBL625720,A,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 2,Intermediate
,In vivo,,,,1,,,N,50597,12504,1,10116.0,13401,,BAO_0000218,Rattus norvegicus,,CHEMBL625721,A,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 3,Intermediate
,In vivo,,,,1,,,N,50597,12504,1,10116.0,13402,,BAO_0000218,Rattus norvegicus,,CHEMBL625722,A,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 4,Intermediate
,In vivo,,,,1,,,N,50597,13129,1,10116.0,13403,,BAO_0000218,Rattus norvegicus,,CHEMBL625723,A,,The compound was tested for systemic clearance pharmacokinetic parameter in the male Sprague-Dawley rat.,Intermediate
,In vivo,,,,1,,,N,50545,7732,1,6339.0,13404,,BAO_0000218,Heligmosomoides polygyrus,,CHEMBL625724,A,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.0125 concentration of diet.,Intermediate
,In vivo,,,,1,,,N,50545,7732,1,6339.0,13405,,BAO_0000218,Heligmosomoides polygyrus,,CHEMBL625725,A,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.025 concentration of diet.,Intermediate
,In vivo,,,,1,,,N,50545,7732,1,6339.0,13406,,BAO_0000218,Heligmosomoides polygyrus,,CHEMBL625726,A,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.05 concentration of diet.,Intermediate
,In vivo,,,,1,,,N,50545,7732,1,6339.0,13407,,BAO_0000218,Heligmosomoides polygyrus,,CHEMBL875608,A,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.1 concentration of diet.,Intermediate
,In vivo,,,,1,,,N,50545,7732,1,6339.0,13408,,BAO_0000218,Heligmosomoides polygyrus,,CHEMBL625727,A,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.2 concentration of diet.,Intermediate
,In vivo,Urine,,,0,,,U,22224,9278,1,10116.0,13409,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL625728,A,,Urinary clearance was determined in rat at 100 mg/kg os dosage;ND is defined as no-data.,Autocuration
,In vivo,,,,0,,,U,22224,9278,1,10116.0,13410,,BAO_0000218,Rattus norvegicus,,CHEMBL625729,A,,Total clearance was determined in rat at 10 mg/kg intraperitoneal dosage,Autocuration
,In vivo,,,,0,,,U,22224,9278,1,10116.0,13411,,BAO_0000218,Rattus norvegicus,,CHEMBL625730,A,,Total clearance was determined in rat at 25 mg/kg os dosage;ND is defined as no-data.,Autocuration
,In vivo,Urine,,,0,,,U,22224,9278,1,10116.0,13412,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL625731,A,,Urinary clearance was determined in rat at 10 mg/kg intraperitoneal dosage,Autocuration
,In vivo,Urine,,,0,,,U,22224,9278,1,10116.0,13413,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL626417,A,,Urinary clearance was determined in rat at 25 mg/kg os dosage,Autocuration
,In vivo,Urine,,,1,,,N,50587,9278,1,9606.0,13414,,BAO_0000218,Homo sapiens,1088.0,CHEMBL626418,A,,Urinary clearance was determined at 100 mg/kg oral dosage in human,Intermediate
,In vivo,Urine,,,1,,,N,50588,9278,1,9615.0,13415,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL626419,A,,Urinary clearance was determined at 20 mg/kg oral dosage in dog(beagle);ND is defined as no-data.,Intermediate
,In vivo,Plasma,,,1,,,N,50588,5932,1,9615.0,13416,,BAO_0000218,Canis lupus familiaris,1969.0,CHEMBL626592,A,,Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,Intermediate
,In vivo,Plasma,,,1,,,N,50597,5932,1,10116.0,13417,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626593,A,,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,Intermediate
,In vivo,,,,1,,,N,50597,5182,1,10116.0,13418,,BAO_0000218,Rattus norvegicus,,CHEMBL626594,A,,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,Intermediate
,In vivo,,,,1,,,N,50588,10499,1,9615.0,13419,,BAO_0000218,Canis lupus familiaris,,CHEMBL625035,A,,Clearance rate in dogs,Intermediate
,In vitro,,,,0,,,U,22224,6051,1,,13420,,BAO_0000019,,,CHEMBL625036,A,,Compound was measured for intrinsic clearance,Autocuration
,,,,,0,,,U,22229,17508,1,,13421,,BAO_0000100,,,CHEMBL625037,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22229,6228,1,,13422,,BAO_0000100,,,CHEMBL625038,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22229,6231,1,,13423,,BAO_0000100,,,CHEMBL625039,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22229,17740,1,,13424,,BAO_0000100,,,CHEMBL625040,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22229,6495,1,,13425,,BAO_0000100,,,CHEMBL625041,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22229,2171,1,,13426,,BAO_0000100,,,CHEMBL625042,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22224,3255,1,,13427,,BAO_0000019,,,CHEMBL874411,A,,Partition coefficient of the compound,Autocuration
,,,,,0,,,U,22224,6821,1,,13428,,BAO_0000019,,,CHEMBL625043,A,,Permeability,Autocuration
,,,,,0,,,U,22229,2685,1,,13429,,BAO_0000100,,,CHEMBL625044,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22224,17584,1,,13430,,BAO_0000019,,,CHEMBL625045,A,,Partition coefficient (logD),Autocuration
,,,,,0,,,U,22229,13824,1,,13431,,BAO_0000100,,,CHEMBL625046,P,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),Autocuration
,,,,,0,,,U,22229,13824,1,,13432,,BAO_0000100,,,CHEMBL625047,P,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),Autocuration
,,,,,0,,,U,22229,16479,1,,13433,,BAO_0000100,,,CHEMBL625048,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22229,11997,1,,13434,,BAO_0000100,,,CHEMBL625049,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22229,2988,1,,13435,,BAO_0000100,,,CHEMBL625050,P,,Calculated logarithm of partition coefficient (P) was determined,Autocuration
,,,,,0,,,U,22229,931,1,,13436,,BAO_0000100,,,CHEMBL625051,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22229,4381,1,,13437,,BAO_0000100,,,CHEMBL874412,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22229,4397,1,,13438,,BAO_0000100,,,CHEMBL625052,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22229,5889,1,,13439,,BAO_0000100,,,CHEMBL625053,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22224,6154,1,,13440,,BAO_0000019,,,CHEMBL623250,A,,In vitro stability to pepsin promoting hydrolysis after 8 hr incubation time,Autocuration
,,,,,0,,,U,22224,6154,1,,13441,,BAO_0000019,,,CHEMBL623251,A,,In vitro stability to trypsin promoting hydrolysis after 1 hr incubation time,Autocuration
,,,,,0,,,U,22224,6154,1,,13442,,BAO_0000019,,,CHEMBL623252,A,,In vitro stability to trypsin promoting hydrolysis after 2 hr incubation time,Autocuration
,,,,,0,,,U,22224,6154,1,,13443,,BAO_0000019,,,CHEMBL623253,A,,In vitro stability to trypsin promoting hydrolysis after 64h incubation time,Autocuration
,,,,,0,,,U,22224,6154,1,,13444,,BAO_0000019,,,CHEMBL623254,A,,In vitro stability to trypsin promoting hydrolysis after 84 hr incubation time,Autocuration
,,,,,0,,,U,22224,6154,1,,13445,,BAO_0000019,,,CHEMBL623255,A,,In vitro stability to trypsin promoting hydrolysis after 8 hr incubation time,Autocuration
,,,,,0,,,U,22224,6887,1,,13446,,BAO_0000019,,,CHEMBL626831,A,,Percent degradation of compound at a pH of 1 over a 18 hr period,Autocuration
,,,,,0,,,U,22224,6887,1,,13447,,BAO_0000019,,,CHEMBL877494,A,,Percent degradation of compound at pH of 1 over an 18 hr period,Autocuration
,,,,,0,,,U,22224,14116,1,,13448,,BAO_0000019,,,CHEMBL626832,A,,Delta Logarithm of Partition Coefficient value was determined.,Autocuration
,,,,,0,,,U,22224,11137,1,,13449,,BAO_0000019,,,CHEMBL626833,A,,Delta logPoct-cyc,Autocuration
,,,,,0,,,U,22224,7230,1,,13450,,BAO_0000100,,,CHEMBL626834,P,,Lipophilicity estimated on reversed phase TLC,Autocuration
,,,,,0,,,U,22224,15741,1,,13451,,BAO_0000019,,,CHEMBL626835,A,,Delta Tm value ( Tmdrug-DNA )-TmDNA ) was obtained for the covalently cross-linked compound in the absence of formaldehyde using calf thymus DNA.,Autocuration
,,,,,0,,,U,22224,9663,1,,13452,,BAO_0000019,,,CHEMBL626836,A,,Delta logPoct-cyc,Autocuration
,,,,,0,,,U,22229,9663,1,,13453,,BAO_0000100,,,CHEMBL626837,P,,Change in logarithm of partition coefficient of the compound,Autocuration
,,,,,0,,,U,22224,13807,1,,13454,,BAO_0000019,,,CHEMBL626838,A,,Delta logD (pH 6.5),Autocuration
,,,,,0,,,U,22224,13807,1,,13455,,BAO_0000100,,,CHEMBL626839,P,,"Partition coefficient by standard shake-flask techniquesat 37 C, using octanol and cyclohexane",Autocuration
,,,,,0,,,U,22224,17425,1,,13456,,BAO_0000019,,,CHEMBL626840,A,,Oxygen pressure at which hemoglobin is 50% oxygenated; negative sign indicates that P50 of modified Hb is lower than that of unmodified Hb,Autocuration
,,,,,0,,,U,22224,12143,1,,13457,,BAO_0000019,,,CHEMBL626841,A,,Deoxyribose-damaging property as a measure of hydroxyl-radical formation (uM of malondialdehyde/mmol of deoxyribose released by 75 uM test compound),Autocuration
,,,,,0,,,U,22224,12608,1,,13458,,BAO_0000219,,,CHEMBL626842,A,,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in nine cells,Autocuration
,,,,,0,,,U,22224,12608,1,,13459,,BAO_0000219,,,CHEMBL626843,A,,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in six cells,Autocuration
,,,,,1,,,N,50597,8649,1,10116.0,13460,,BAO_0000218,Rattus norvegicus,,CHEMBL626844,A,,Amount of deuterium retained was reported after normal workup in beta-naphthoflavone-treated male rats with the substrate rac 7-D,Intermediate
,,,,,1,,,N,50597,8649,1,10116.0,13461,,BAO_0000218,Rattus norvegicus,,CHEMBL877495,A,,Amount of deuterium retained was reported after normal workup in rats,Intermediate
,,,,,1,,,N,50597,8649,1,10116.0,13462,,BAO_0000218,Rattus norvegicus,,CHEMBL626845,A,,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats,Intermediate
,,,,,1,,,N,50597,8649,1,10116.0,13463,,BAO_0000218,Rattus norvegicus,,CHEMBL626846,A,,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats with rac 8-D,Intermediate
,,,,,1,,,N,50597,8649,1,10116.0,13464,,BAO_0000218,Rattus norvegicus,,CHEMBL626847,A,,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,Intermediate
,,,,,1,,,N,50597,8649,1,10116.0,13465,,BAO_0000218,Rattus norvegicus,,CHEMBL628677,A,,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,Intermediate
,,,,,1,,,N,50597,8649,1,10116.0,13466,,BAO_0000218,Rattus norvegicus,,CHEMBL628678,A,,Compound incubated with microsomal preparations from phenobarbital treated male rats with the substrate rac 8-D and the amount of deuterium retained was reported after normal workup,Intermediate
,,,,,0,,,U,22224,9659,1,,13467,,BAO_0000019,,,CHEMBL628679,A,,Compound was subjected to electrochemical oxidation,Autocuration
,,,,,0,,,U,22224,9659,1,,13468,,BAO_0000019,,,CHEMBL628680,A,,Compound was subjected to photochemical oxidation,Autocuration
,,,,,0,,,U,22224,9659,1,,13469,,BAO_0000019,,,CHEMBL628681,A,,Oxidation of compound by Chloroperoxidase in presence of ethylperoxide,Autocuration
,,,,,0,,,U,22224,9659,1,,13470,,BAO_0000019,,,CHEMBL628682,A,,Oxidation of compound by horseradish peroxidase in presence of hydroperoxide,Autocuration
,,,,,0,,,U,22224,9659,1,,13471,,BAO_0000019,,,CHEMBL628683,A,,Oxidation of compound by methemoglobin in presence of hydroperoxide,Autocuration
,,,,,1,,,N,50597,9607,1,10116.0,13472,,BAO_0000218,Rattus norvegicus,,CHEMBL628684,A,,Percent diffusion through fuzzy rat skin after 48 h of incubation,Intermediate
,,,,,0,,,U,22229,7057,1,,13473,,BAO_0000100,,,CHEMBL877501,P,,Dissociation constant (pKa),Autocuration
,,,,,0,,,U,22224,7057,1,,13474,,BAO_0000100,,,CHEMBL628685,P,,Dissociation constant value of the compound; ND means not determined.,Autocuration
,,Blood,,,1,,,N,50597,7911,1,10116.0,13475,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL628686,A,,% distribution of the radioiron in blood of rat followed by intravenous injection of chelating agent,Intermediate
,,Blood,,,1,,,N,50597,7911,1,10116.0,13476,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL628687,A,,% distribution of the radioiron in blood of rats followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,Intermediate
,,,,,1,,,N,50597,7911,1,10116.0,13477,,BAO_0000218,Rattus norvegicus,,CHEMBL628688,A,,% distribution of the radioiron in rat kidney followed by intravenous injection of chelating agent,Intermediate
,,,,,1,,,N,50597,7911,1,10116.0,13478,,BAO_0000218,Rattus norvegicus,,CHEMBL628689,A,,% distribution of the radioiron in rat kidney followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,Intermediate
,,Liver,,,1,,,N,50597,7911,1,10116.0,13479,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL628690,A,,% distribution of the radioiron in rat liver followed by intravenous injection of chelating agent,Intermediate
,,Liver,,,1,,,N,50597,7911,1,10116.0,13480,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL629363,A,,% distribution of the radioiron in rat liver followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,Intermediate
,,Spleen,,,1,,,N,50597,7911,1,10116.0,13481,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL629364,A,,% distribution of the radioiron in rat spleen followed by intravenous injection of chelating agent,Intermediate
,,Spleen,,,1,,,N,50597,7911,1,10116.0,13482,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL629365,A,,% distribution of the radioiron in rat spleen followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,Intermediate
,,,,,1,,,N,50597,7911,1,10116.0,13483,,BAO_0000218,Rattus norvegicus,,CHEMBL629366,A,,% excretion of ferritin determined in faces of rat followed by intravenous injection of chelating agent,Intermediate
,,Urine,,,1,,,N,50597,7911,1,10116.0,13484,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL629367,A,,% excretion of ferritin determined in urine of rat followed by intravenous injection of chelating agent,Intermediate
,,Feces,,,1,,,N,50597,7911,1,10116.0,13485,,BAO_0000218,Rattus norvegicus,1988.0,CHEMBL629368,A,,% excretion of radioiron determined in feces of rat followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,Intermediate
,,Urine,,,1,,,N,50597,7911,1,10116.0,13486,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL877502,A,,% excretion of radioiron determined in urine of rat followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,Intermediate
,,Cerebellum,,,1,,,N,50594,13792,1,10090.0,13487,,BAO_0000218,Mus musculus,2037.0,CHEMBL629369,A,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cerebellum,Intermediate
,,Brain,,,1,,,N,50594,13792,1,10090.0,13488,,BAO_0000218,Mus musculus,955.0,CHEMBL629370,A,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cortex,Intermediate
,,Urine,,,0,,,U,22224,8133,1,314293.0,13489,,BAO_0000218,Simiiformes,1088.0,CHEMBL629371,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded monkey at 10 mg/kg, po",Autocuration
,,Urine,,,0,,,U,22224,8133,1,314293.0,13490,,BAO_0000218,Simiiformes,1088.0,CHEMBL626276,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",Autocuration
,,Urine,,,0,,,U,22224,8133,1,314293.0,13491,,BAO_0000218,Simiiformes,1088.0,CHEMBL626277,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",Autocuration
,,Urine,,,0,,,U,22224,8133,1,314293.0,13492,,BAO_0000218,Simiiformes,1088.0,CHEMBL631250,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",Autocuration
,,Urine,,,1,,,N,50597,8133,1,10116.0,13493,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL631251,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",Intermediate
,,Urine,,,1,,,N,50597,8133,1,10116.0,13494,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL631252,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",Intermediate
,,Urine,,,1,,,N,50597,8133,1,10116.0,13495,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL631253,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 1.0 mg/kg, po",Intermediate
,,Urine,,,1,,,N,50597,8133,1,10116.0,13496,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL631254,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",Intermediate
,,Urine,,,1,,,N,50597,8133,1,10116.0,13497,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL631255,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",Intermediate
,,Urine,,,1,,,N,50597,8133,1,10116.0,13498,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL631256,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",Intermediate
,,Urine,,,1,,,N,50597,8133,1,10116.0,13499,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL631257,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",Intermediate
,,Urine,,,1,,,N,50597,8133,1,10116.0,13500,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL628009,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 207.6 mg/kg, po",Intermediate
,,Urine,,,1,,,N,50597,8133,1,10116.0,13501,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL628010,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",Intermediate
,,Urine,,,1,,,N,50597,8133,1,10116.0,13502,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL628011,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",Intermediate
,,Urine,,,1,,,N,50597,8133,1,10116.0,13503,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL628012,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 6.9 mg/kg, po",Intermediate
,,Urine,,,1,,,N,50597,8133,1,10116.0,13504,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL628013,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",Intermediate
,,Urine,,,1,,,N,50597,8133,1,10116.0,13505,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL628014,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",Intermediate
,,Urine,,,1,,,N,50588,8133,1,9615.0,13506,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL628015,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.03 mg/kg, po",Intermediate
,,Urine,,,1,,,N,50588,8133,1,9615.0,13507,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL628016,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",Intermediate
,,Urine,,,1,,,N,50588,8133,1,9615.0,13508,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL874461,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.3 mg/kg, po",Intermediate
,,Urine,,,1,,,N,50588,8133,1,9615.0,13509,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL628017,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",Intermediate
,,Urine,,,1,,,N,50588,8133,1,9615.0,13510,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL628018,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 10.0mg/kg, po",Intermediate
,,Urine,,,1,,,N,50588,8133,1,9615.0,13511,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL628019,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",Intermediate
,,Urine,,,1,,,N,50588,8133,1,9615.0,13512,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL628020,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",Intermediate
,,Urine,,,1,,,N,50588,8133,1,9615.0,13513,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL628021,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",Intermediate
,,Urine,,,1,,,N,50588,8133,1,9615.0,13514,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL628022,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",Intermediate
,,Urine,,,1,,,N,50588,8133,1,9615.0,13515,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL628023,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",Intermediate
,,Urine,,,0,,,U,22224,8133,1,314293.0,13516,,BAO_0000218,Simiiformes,1088.0,CHEMBL628024,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",Autocuration
,,Urine,,,0,,,U,22224,8133,1,314293.0,13517,,BAO_0000218,Simiiformes,1088.0,CHEMBL628025,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 10mg/kg, po",Autocuration
,,Urine,,,0,,,U,22224,8133,1,314293.0,13518,,BAO_0000218,Simiiformes,1088.0,CHEMBL628026,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",Autocuration
,,Urine,,,0,,,U,22224,8133,1,314293.0,13519,,BAO_0000218,Simiiformes,1088.0,CHEMBL628027,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",Autocuration
,,Urine,,,0,,,U,22224,8133,1,314293.0,13520,,BAO_0000218,Simiiformes,1088.0,CHEMBL628028,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",Autocuration
,,Urine,,,1,,,N,50597,8133,1,10116.0,13521,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL628029,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",Intermediate
,,Urine,,,1,,,N,50597,8133,1,10116.0,13522,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL628030,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 0.3 mg/kg, po",Intermediate
,,Urine,,,1,,,N,50597,8133,1,10116.0,13523,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL628031,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",Intermediate
,,Urine,,,1,,,N,50597,8133,1,10116.0,13524,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL628032,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 10.0 mg/kg, po",Intermediate
,,Urine,,,1,,,N,50597,8133,1,10116.0,13525,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL628033,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",Intermediate
,,Urine,,,1,,,N,50597,8133,1,10116.0,13526,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL628034,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 2.08 mg/kg, po",Intermediate
,,Urine,,,1,,,N,50597,8133,1,10116.0,13527,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL628035,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",Intermediate
,,Urine,,,1,,,N,50597,8133,1,10116.0,13528,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL628036,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 3.0 mg/kg, po",Intermediate
,,Urine,,,1,,,N,50597,8133,1,10116.0,13529,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL874462,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",Intermediate
,In vivo,,,,1,,,N,50588,9025,1,9615.0,13530,,BAO_0000218,Canis lupus familiaris,,CHEMBL628037,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -8/-38,Intermediate
,In vivo,,,,1,,,N,50588,9025,1,9615.0,13531,,BAO_0000218,Canis lupus familiaris,,CHEMBL628123,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 13/-25,Intermediate
,In vivo,,,,1,,,N,50588,9025,1,9615.0,13532,,BAO_0000218,Canis lupus familiaris,,CHEMBL628124,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 27/-15,Intermediate
,In vivo,,,,1,,,N,50588,9025,1,9615.0,13533,,BAO_0000218,Canis lupus familiaris,,CHEMBL628125,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -2/-19,Intermediate
,In vivo,,,,1,,,N,50588,9025,1,9615.0,13534,,BAO_0000218,Canis lupus familiaris,,CHEMBL628126,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/60 range (low/high); -3/-4,Intermediate
,In vivo,,,,1,,,N,50588,9025,1,9615.0,13535,,BAO_0000218,Canis lupus familiaris,,CHEMBL628127,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3 range (low/high),Intermediate
,In vivo,,,,1,,,N,50588,9025,1,9615.0,13536,,BAO_0000218,Canis lupus familiaris,,CHEMBL628128,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); -9/24,Intermediate
,In vivo,,,,1,,,N,50588,9025,1,9615.0,13537,,BAO_0000218,Canis lupus familiaris,,CHEMBL628129,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); 3/-1,Intermediate
,In vivo,,,,1,,,N,50588,9025,1,9615.0,13538,,BAO_0000218,Canis lupus familiaris,,CHEMBL628130,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/030 range (low/high); 12/23,Intermediate
,In vivo,,,,1,,,N,50588,9025,1,9615.0,13539,,BAO_0000218,Canis lupus familiaris,,CHEMBL628131,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 1/3,Intermediate
,In vivo,,,,1,,,N,50588,9025,1,9615.0,13540,,BAO_0000218,Canis lupus familiaris,,CHEMBL628132,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 6/16,Intermediate
,In vivo,,,,1,,,N,50588,9025,1,9615.0,13541,,BAO_0000218,Canis lupus familiaris,,CHEMBL628133,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 7/14,Intermediate
,In vivo,,,,1,,,N,50588,9025,1,9615.0,13542,,BAO_0000218,Canis lupus familiaris,,CHEMBL628134,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3/10 range (low/high); 4/4/23,Intermediate
,In vivo,,,,1,,,N,50588,9025,1,9615.0,13543,,BAO_0000218,Canis lupus familiaris,,CHEMBL628135,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 10/14,Intermediate
,In vivo,,,,1,,,N,50588,9025,1,9615.0,13544,,BAO_0000218,Canis lupus familiaris,,CHEMBL628136,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/15,Intermediate
,In vivo,,,,1,,,N,50588,9025,1,9615.0,13545,,BAO_0000218,Canis lupus familiaris,,CHEMBL628137,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/44,Intermediate
,In vivo,,,,1,,,N,50588,9025,1,9615.0,13546,,BAO_0000218,Canis lupus familiaris,,CHEMBL628138,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 14/28,Intermediate
,In vivo,,,,1,,,N,50588,9025,1,9615.0,13547,,BAO_0000218,Canis lupus familiaris,,CHEMBL628139,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 15-28,Intermediate
,In vivo,,,,1,,,N,50588,9025,1,9615.0,13548,,BAO_0000218,Canis lupus familiaris,,CHEMBL628140,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 2/3,Intermediate
,In vivo,,,,1,,,N,50588,9025,1,9615.0,13549,,BAO_0000218,Canis lupus familiaris,,CHEMBL628141,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 26/32,Intermediate
,In vivo,,,,1,,,N,50588,9025,1,9615.0,13550,,BAO_0000218,Canis lupus familiaris,,CHEMBL628142,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/1,Intermediate
,In vivo,,,,1,,,N,50588,9025,1,9615.0,13551,,BAO_0000218,Canis lupus familiaris,,CHEMBL628143,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/12,Intermediate
,In vivo,,,,1,,,N,50588,9025,1,9615.0,13552,,BAO_0000218,Canis lupus familiaris,,CHEMBL628144,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 6/7,Intermediate
,In vivo,,,,1,,,N,50588,9025,1,9615.0,13553,,BAO_0000218,Canis lupus familiaris,,CHEMBL628145,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 7/6,Intermediate
,In vivo,,,,1,,,N,50588,9025,1,9615.0,13554,,BAO_0000218,Canis lupus familiaris,,CHEMBL628146,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/12,Intermediate
,In vivo,,,,1,,,N,50588,9025,1,9615.0,13555,,BAO_0000218,Canis lupus familiaris,,CHEMBL625355,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/27,Intermediate
,In vivo,,,,1,,,N,50588,9025,1,9615.0,13556,,BAO_0000218,Canis lupus familiaris,,CHEMBL625356,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/14,Intermediate
,In vivo,,,,1,,,N,50588,9025,1,9615.0,13557,,BAO_0000218,Canis lupus familiaris,,CHEMBL625357,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/16,Intermediate
,In vivo,,,,1,,,N,50588,9025,1,9615.0,13558,,BAO_0000218,Canis lupus familiaris,,CHEMBL625527,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/60 range (low/high); 12/23,Intermediate
,In vivo,,,,1,,,N,50588,9025,1,9615.0,13559,,BAO_0000218,Canis lupus familiaris,,CHEMBL875473,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3 range (low/high),Intermediate
,In vivo,,,,1,,,N,50588,9025,1,9615.0,13560,,BAO_0000218,Canis lupus familiaris,,CHEMBL625528,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 10/22,Intermediate
,In vivo,,,,1,,,N,50597,9025,1,10116.0,13561,,BAO_0000218,Rattus norvegicus,,CHEMBL626304,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 4/12,Intermediate
,In vivo,Artery,,,1,,,N,50588,9025,1,9615.0,13562,,BAO_0000218,Canis lupus familiaris,1637.0,CHEMBL624138,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a 10/30 dose range; 11/-11,Intermediate
,,,,,0,,,U,22229,6448,1,,13563,,BAO_0000100,,,CHEMBL624139,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22229,17221,1,,13564,,BAO_0000100,,,CHEMBL624140,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22229,6545,1,,13565,,BAO_0000100,,,CHEMBL624141,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22229,577,1,,13566,,BAO_0000100,,,CHEMBL624142,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22229,6285,1,,13567,,BAO_0000100,,,CHEMBL624143,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22229,6500,1,,13568,,BAO_0000100,,,CHEMBL624144,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22229,6716,1,,13569,,BAO_0000100,,,CHEMBL624145,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22229,13658,1,,13570,,BAO_0000100,,,CHEMBL624146,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22229,6549,1,,13571,,BAO_0000100,,,CHEMBL624147,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22229,14685,1,,13572,,BAO_0000100,,,CHEMBL883123,P,,Calculated partition coefficient (clogP) (MacLogP),Autocuration
,,,,,0,,,U,22224,6893,1,,13573,,BAO_0000019,,,CHEMBL624148,A,,Partition coefficient (logP),Autocuration
,,,,,0,,,U,22224,3687,1,,13574,,BAO_0000019,,,CHEMBL874416,A,,Kinetic parameter was determined,Autocuration
,,,,,0,,,U,22229,4207,1,,13575,,BAO_0000100,,,CHEMBL624149,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22229,4626,1,,13576,,BAO_0000100,,,CHEMBL624150,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22224,1021,1,,13577,,BAO_0000100,,,CHEMBL624151,P,,Lipophilicity was determined,Autocuration
,,,,,0,,,U,22224,3777,1,,13578,,BAO_0000100,,,CHEMBL624152,P,,Lipophilicity was determined,Autocuration
,,,,,0,,,U,22224,17533,1,,13579,,BAO_0000100,,,CHEMBL622139,P,,Lipophilicity was determined,Autocuration
,,,,,0,,,U,22229,6524,1,,13580,,BAO_0000100,,,CHEMBL622140,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22224,17533,1,,13581,,BAO_0000100,,,CHEMBL622141,P,,Lipophilicity was determined,Autocuration
,,,,,0,,,U,22224,6480,1,,13582,,BAO_0000100,,,CHEMBL622142,P,,Lipophilicity in octanol-water,Autocuration
,,,,,0,,,U,22229,17606,1,,13583,,BAO_0000100,,,CHEMBL622143,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22229,6863,1,,13584,,BAO_0000100,,,CHEMBL622144,P,,Octanol-water partition coefficient was determined,Autocuration
,,,,,0,,,U,22224,1356,1,,13585,,BAO_0000019,,,CHEMBL877473,A,,Partition coefficient (logP),Autocuration
,,,,,0,,,U,22229,3326,1,,13586,,BAO_0000100,,,CHEMBL622145,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22224,1356,1,,13587,,BAO_0000019,,,CHEMBL622146,A,,Partition coefficient was determined; ND means not determined,Autocuration
,,,,,0,,,U,22229,12984,1,,13588,,BAO_0000100,,,CHEMBL622147,P,,Calculated partition coefficient (clogP),Autocuration
,,,,,0,,,U,22224,17363,1,,13589,,BAO_0000019,,,CHEMBL622148,A,,Partition coefficient of the compound,Autocuration
,,,,,0,,,U,22224,6827,1,,13590,,BAO_0000019,,,CHEMBL883124,A,,Permeability was determined,Autocuration
,,,,,0,,,U,22229,261,1,,13591,,BAO_0000100,,,CHEMBL622149,P,,The compound was evaluated for the partition coefficient,Autocuration
,,,,,0,,,U,22224,2685,1,,13592,,BAO_0000019,,,CHEMBL622150,A,,Partition coefficient (logP),Autocuration
,,,,,0,,,U,22224,414,1,,13593,,BAO_0000100,,,CHEMBL622151,P,,The lipophilicity was reported,Autocuration
,,,,,0,,,U,22229,15769,1,,13594,,BAO_0000100,,,CHEMBL622152,P,,logarithm of the octanol-water partition coefficient for the compound,Autocuration
,,,,,0,,,U,22224,17248,1,,13595,,BAO_0000019,,,CHEMBL622153,A,,Clogp value was determined,Autocuration
,In vivo,,,,0,,,U,22224,16935,1,,13596,,BAO_0000218,,,CHEMBL877474,A,,Clp at a dose of 1.5 mg/kg,Autocuration
,In vivo,,,,0,,,U,22224,16935,1,,13597,,BAO_0000218,,,CHEMBL622154,A,,Clp at a dose of 2.0 mg/kg,Autocuration
,In vivo,Plasma,,,0,,,U,22224,14832,1,,13598,,BAO_0000218,,1969.0,CHEMBL622155,A,,"Clp, plasma clearance at a dose of 10 mg/kg",Autocuration
,In vivo,Plasma,,,0,,,U,22224,14832,1,,13599,,BAO_0000218,,1969.0,CHEMBL622156,A,,"Clp, plasma clearance at a dose of 50 mg/kg",Autocuration
,In vivo,Plasma,,,1,,,N,50597,2399,1,10116.0,13600,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622157,A,,Compound was tested for plasma clearance in rat,Intermediate
,In vivo,Plasma,,,1,,,N,50597,2399,1,10116.0,13601,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622158,A,,Compound was tested for plasma clearance in rat; Not determined,Intermediate
,In vivo,,,,1,,,N,50597,6227,1,10116.0,13602,,BAO_0000218,Rattus norvegicus,,CHEMBL622807,A,,Plasma clearance (pharmacokinetic parameter) in rat (in vivo) at a dose of 10 mg/kg,Intermediate
,In vivo,,,,1,,,N,50797,6227,1,9544.0,13603,,BAO_0000218,Macaca mulatta,,CHEMBL622808,A,,Plasma clearance (pharmacokinetic parameter) in rhesus (in vivo) at a dose of 5 mg/kg,Intermediate
,In vivo,,,,0,,,U,22224,5623,1,,13604,,BAO_0000218,,,CHEMBL622809,A,,Plasma clearance by iv administration at a dose 0.003 ug/mL,Autocuration
,In vivo,,,,0,,,U,22224,4854,1,,13605,,BAO_0000218,,,CHEMBL622810,A,,Plasma clearance determined,Autocuration
,In vivo,,,,1,,,N,100712,4493,1,10026.0,13606,,BAO_0000218,Cricetinae,,CHEMBL876653,A,,Plasma clearance after iv administration at 3 mg/kg in hamster,Intermediate
,In vivo,,,,1,,,N,100712,4493,1,10026.0,13607,,BAO_0000218,Cricetinae,,CHEMBL622811,A,,Plasma clearance after iv administration at 4 mg/kg in hamster,Intermediate
,In vivo,,,,1,,,N,50597,14956,1,10116.0,13608,,BAO_0000218,Rattus norvegicus,,CHEMBL622986,A,,Rate of clearance in rat was determined,Intermediate
,In vivo,Plasma,,,1,,,N,50597,15372,1,10116.0,13609,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622987,A,,Total plasma clearance Clp was determined for the compound after iv dose of 5.06 mg/kg in rats,Intermediate
,In vivo,Plasma,,,1,,,N,50597,15372,1,10116.0,13610,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622988,A,,Total plasma clearance after iv dose of 5.10 mg/kg in rats,Intermediate
,In vivo,Plasma,,,1,,,N,50597,15372,1,10116.0,13611,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622989,A,,Total plasma clearance was determined for the compound after iv dose of 4.74 mg/kg in rats,Intermediate
,In vivo,Plasma,,,1,,,N,50597,15372,1,10116.0,13612,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622990,A,,Total plasma clearance was determined for the compound after iv dose of 4.97 mg/kg in rats,Intermediate
,In vivo,Plasma,,,0,,,U,22224,15604,1,314293.0,13613,,BAO_0000218,Simiiformes,1969.0,CHEMBL622991,A,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,Autocuration
,In vivo,Plasma,,,1,,,N,50597,15604,1,10116.0,13614,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL622227,A,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,Intermediate
,In vivo,Plasma,,,1,,,N,50588,15604,1,9615.0,13615,,BAO_0000218,Canis lupus familiaris,1969.0,CHEMBL622228,A,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,Intermediate
,In vivo,,,,1,,,N,50597,14964,1,10116.0,13616,,BAO_0000218,Rattus norvegicus,,CHEMBL622229,A,,Clpl value in rat,Intermediate
,In vivo,,,,1,,,N,50512,15240,1,10141.0,13617,,BAO_0000218,Cavia porcellus,,CHEMBL622230,A,,Cmax (ng /mL) value after oral administration of 10 mg/kg in guinea pig.,Intermediate
,In vivo,,,,1,,,N,50597,16449,1,10116.0,13618,,BAO_0000218,Rattus norvegicus,,CHEMBL622231,A,,Cmax after an oral dose of 10 uM/Kg in male Sprague-Dawley rats,Intermediate
,In vivo,,,,1,,,N,100710,16449,1,9541.0,13619,,BAO_0000218,Macaca fascicularis,,CHEMBL622232,A,,Cmax after an oral dose of 10 uM/Kg in male cynomolgus monkeys,Intermediate
,In vivo,,,,0,,,U,22224,12902,1,,13620,,BAO_0000218,,,CHEMBL622233,A,,Cmax in minutes at a iv dose of 1.0(pmol/g/h).,Autocuration
,In vivo,,,,0,,,U,22224,12902,1,,13621,,BAO_0000218,,,CHEMBL622234,A,,Cmax in minutes at a iv dose of 2.0(pmol/g/h).,Autocuration
,In vivo,,,,0,,,U,22224,12902,1,,13622,,BAO_0000218,,,CHEMBL622235,A,,Cmax in minutes at a iv dose of 4.0(pmol/g/h).,Autocuration
,In vivo,,,,0,,,U,22224,12902,1,,13623,,BAO_0000218,,,CHEMBL622236,A,,Cmax in minutes at a iv dose of 5.0(pmol/g/h).,Autocuration
,In vivo,,,,0,,,U,22224,12902,1,,13624,,BAO_0000218,,,CHEMBL622237,A,,Cmax in minutes at a iv dose of 54.0(pmol/g/h).,Autocuration
,In vivo,,,,0,,,U,22224,12902,1,,13625,,BAO_0000218,,,CHEMBL877482,A,,Cmax in minutes at a po dose of 10.0(pmol/g/h).,Autocuration
,In vivo,,,,0,,,U,22224,12902,1,,13626,,BAO_0000218,,,CHEMBL622238,A,,Cmax in minutes at a po dose of 20.0(pmol/g/h).,Autocuration
,In vivo,,,,0,,,U,22224,12902,1,,13627,,BAO_0000218,,,CHEMBL622239,A,,Cmax in minutes at a po dose of 40.0(pmol/g/h).,Autocuration
,In vivo,Blood,,,0,,,U,22224,11149,1,,13628,,BAO_0000218,,178.0,CHEMBL622240,A,,Cmax was calculated as maximum concentration reached in the blood,Autocuration
,In vivo,Blood,,,0,,,U,22224,11149,1,,13629,,BAO_0000218,,178.0,CHEMBL622241,A,,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate,Autocuration
,In vivo,,,,1,,,N,50597,5669,1,10116.0,13630,,BAO_0000218,Rattus norvegicus,,CHEMBL631013,A,,Cmax was determine after peroral administration at 10 mpk in Rat,Intermediate
,In vivo,,,,1,,,N,50797,5669,1,9544.0,13631,,BAO_0000218,Macaca mulatta,,CHEMBL631014,A,,Cmax was determine after peroral administration at 10 mpk in Rhesus,Intermediate
,In vivo,,,,1,,,N,50588,5669,1,9615.0,13632,,BAO_0000218,Canis lupus familiaris,,CHEMBL631015,A,,Cmax was determine after peroral administration at 10 mpk in dog,Intermediate
,In vivo,,,,1,,,N,50597,5669,1,10116.0,13633,,BAO_0000218,Rattus norvegicus,,CHEMBL631016,A,,Cmax was determine after peroral administration at 160 mpk in Rat,Intermediate
,In vivo,,,,1,,,N,50597,5669,1,10116.0,13634,,BAO_0000218,Rattus norvegicus,,CHEMBL631017,A,,Cmax was determine after peroral administration at 20 mpk in Rat,Intermediate
,In vivo,,,,1,,,N,50597,5669,1,10116.0,13635,,BAO_0000218,Rattus norvegicus,,CHEMBL631018,A,,Cmax was determine after peroral administration at 50 mpk in Rat,Intermediate
,In vivo,,,,0,,,U,22224,4236,1,,13636,,BAO_0000218,,,CHEMBL631019,A,,Cmax was determined,Autocuration
,,Brain,,,1,,,N,50594,13792,1,10090.0,13637,,BAO_0000218,Mus musculus,955.0,CHEMBL875761,A,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hippocampus,Intermediate
,,Brain,,,1,,,N,50594,13792,1,10090.0,13638,,BAO_0000218,Mus musculus,955.0,CHEMBL631020,A,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hypothalamus,Intermediate
,,Brain,,,1,,,N,50594,13792,1,10090.0,13639,,BAO_0000218,Mus musculus,955.0,CHEMBL631669,A,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into pons and medulla,Intermediate
,,Brain,,,1,,,N,50594,13792,1,10090.0,13640,,BAO_0000218,Mus musculus,955.0,CHEMBL631670,A,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into rest of the brain,Intermediate
,,Striatum,,,1,,,N,50594,13792,1,10090.0,13641,,BAO_0000218,Mus musculus,2435.0,CHEMBL631671,A,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into striatum,Intermediate
,,Blood,,,1,,,N,50597,8418,1,10116.0,13642,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL631672,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.31-0.4,Intermediate
,,Blood,,,1,,,N,50597,8418,1,10116.0,13643,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL631673,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.97-1.12,Intermediate
,,Blood,,,1,,,N,50597,8418,1,10116.0,13644,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL631856,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.35-0.37,Intermediate
,,Blood,,,1,,,N,50597,8418,1,10116.0,13645,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL631857,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.72-1.03,Intermediate
,,Blood,,,1,,,N,50597,8418,1,10116.0,13646,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL631858,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.95-1.06,Intermediate
,,Blood,,,1,,,N,50597,8418,1,10116.0,13647,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL631859,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.35-0.4,Intermediate
,,Blood,,,1,,,N,50597,8418,1,10116.0,13648,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL631860,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.73-0.85,Intermediate
,,Blood,,,1,,,N,50597,8418,1,10116.0,13649,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL631861,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.65-0.83,Intermediate
,,Blood,,,1,,,N,50597,8418,1,10116.0,13650,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL631862,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.69-0.84,Intermediate
,,Blood,,,1,,,N,50597,8418,1,10116.0,13651,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL631863,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.46,Intermediate
,,Blood,,,1,,,N,50597,8418,1,10116.0,13652,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL631864,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.38-1.5,Intermediate
,,Blood,,,1,,,N,50597,8418,1,10116.0,13653,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL631865,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.34-0.48,Intermediate
,,Blood,,,1,,,N,50597,8418,1,10116.0,13654,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL631866,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.58-1.17,Intermediate
,,Blood,,,1,,,N,50597,8418,1,10116.0,13655,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL629360,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.0-1.24,Intermediate
,,Blood,,,1,,,N,50597,8418,1,10116.0,13656,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL629361,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.28-0.37,Intermediate
,,Blood,,,1,,,N,50597,8418,1,10116.0,13657,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL629362,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.54-0.63,Intermediate
,,Blood,,,1,,,N,50597,8418,1,10116.0,13658,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL630740,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.25-0.32,Intermediate
,,Blood,,,1,,,N,50597,8418,1,10116.0,13659,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL630741,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.58,Intermediate
,,Blood,,,1,,,N,50597,8418,1,10116.0,13660,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL630742,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.77,Intermediate
,,,,,1,,,N,50597,8418,1,10116.0,13661,,BAO_0000218,Rattus norvegicus,,CHEMBL630743,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.20-0.25,Intermediate
,,,,,1,,,N,50597,8418,1,10116.0,13662,,BAO_0000218,Rattus norvegicus,,CHEMBL630744,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.25,Intermediate
,,,,,1,,,N,50597,8418,1,10116.0,13663,,BAO_0000218,Rattus norvegicus,,CHEMBL630745,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.03,Intermediate
,,,,,1,,,N,50597,8418,1,10116.0,13664,,BAO_0000218,Rattus norvegicus,,CHEMBL630746,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.06,Intermediate
,,,,,1,,,N,50597,8418,1,10116.0,13665,,BAO_0000218,Rattus norvegicus,,CHEMBL630747,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.34-0.5,Intermediate
,,,,,1,,,N,50597,8418,1,10116.0,13666,,BAO_0000218,Rattus norvegicus,,CHEMBL630748,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.17-0.20,Intermediate
,,,,,1,,,N,50597,8418,1,10116.0,13667,,BAO_0000218,Rattus norvegicus,,CHEMBL632056,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.81-1.26,Intermediate
,,,,,1,,,N,50597,8418,1,10116.0,13668,,BAO_0000218,Rattus norvegicus,,CHEMBL632057,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.03-0.06,Intermediate
,,,,,1,,,N,50597,8418,1,10116.0,13669,,BAO_0000218,Rattus norvegicus,,CHEMBL632058,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.18-0.36,Intermediate
,,,,,1,,,N,50597,8418,1,10116.0,13670,,BAO_0000218,Rattus norvegicus,,CHEMBL632059,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.37,Intermediate
,,,,,1,,,N,50597,8418,1,10116.0,13671,,BAO_0000218,Rattus norvegicus,,CHEMBL632060,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.97-2.17,Intermediate
,,,,,1,,,N,50597,8418,1,10116.0,13672,,BAO_0000218,Rattus norvegicus,,CHEMBL632061,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.02-0.03,Intermediate
,,,,,1,,,N,50597,8418,1,10116.0,13673,,BAO_0000218,Rattus norvegicus,,CHEMBL629207,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.05-0.07,Intermediate
,,,,,1,,,N,50597,8418,1,10116.0,13674,,BAO_0000218,Rattus norvegicus,,CHEMBL629208,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.35-0.72,Intermediate
,,,,,1,,,N,50597,8418,1,10116.0,13675,,BAO_0000218,Rattus norvegicus,,CHEMBL629209,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.15-0.19,Intermediate
,,,,,1,,,N,50597,8418,1,10116.0,13676,,BAO_0000218,Rattus norvegicus,,CHEMBL629210,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.76-1.42,Intermediate
,,,,,1,,,N,50597,8418,1,10116.0,13677,,BAO_0000218,Rattus norvegicus,,CHEMBL629211,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.02-0.03,Intermediate
,,,,,1,,,N,50597,8418,1,10116.0,13678,,BAO_0000218,Rattus norvegicus,,CHEMBL629212,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.03-0.06,Intermediate
,,,,,1,,,N,50597,8418,1,10116.0,13679,,BAO_0000218,Rattus norvegicus,,CHEMBL629213,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.05-0.06,Intermediate
,,Urine,,,1,,,N,50597,8133,1,10116.0,13680,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL629214,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",Intermediate
,,Urine,,,1,,,N,50597,8133,1,10116.0,13681,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL629215,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 69.2 mg/kg, po",Intermediate
,,Urine,,,1,,,N,50597,8133,1,10116.0,13682,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL635154,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 691.9 mg/kg, po",Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,13683,,BAO_0000218,Rattus norvegicus,,CHEMBL629216,A,,Oral diuretic activity measured by Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,13684,,BAO_0000218,Rattus norvegicus,,CHEMBL629217,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration,Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,13685,,BAO_0000218,Rattus norvegicus,,CHEMBL629218,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,13686,,BAO_0000218,Rattus norvegicus,,CHEMBL629219,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration (0-5 hr),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,13687,,BAO_0000218,Rattus norvegicus,,CHEMBL629220,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,13688,,BAO_0000218,Rattus norvegicus,,CHEMBL629221,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,13689,,BAO_0000218,Rattus norvegicus,,CHEMBL631127,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,13690,,BAO_0000218,Rattus norvegicus,,CHEMBL631128,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration,Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,13691,,BAO_0000218,Rattus norvegicus,,CHEMBL631129,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,13692,,BAO_0000218,Rattus norvegicus,,CHEMBL631130,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration (0-5 hr),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,13693,,BAO_0000218,Rattus norvegicus,,CHEMBL631131,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,13694,,BAO_0000218,Rattus norvegicus,,CHEMBL631132,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,13695,,BAO_0000218,Rattus norvegicus,,CHEMBL631133,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,13696,,BAO_0000218,Rattus norvegicus,,CHEMBL631134,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration,Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,13697,,BAO_0000218,Rattus norvegicus,,CHEMBL875120,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,13698,,BAO_0000218,Rattus norvegicus,,CHEMBL631135,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration (0-5 hr),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,13699,,BAO_0000218,Rattus norvegicus,,CHEMBL631136,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,13700,,BAO_0000218,Rattus norvegicus,,CHEMBL631137,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,13701,,BAO_0000218,Rattus norvegicus,,CHEMBL631138,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,13702,,BAO_0000218,Rattus norvegicus,,CHEMBL631139,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration,Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,13703,,BAO_0000218,Rattus norvegicus,,CHEMBL631140,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,13704,,BAO_0000218,Rattus norvegicus,,CHEMBL631141,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration (0-5 hr),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,13705,,BAO_0000218,Rattus norvegicus,,CHEMBL631142,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,13706,,BAO_0000218,Rattus norvegicus,,CHEMBL631143,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),Intermediate
,,,,,1,,,N,50597,6996,1,10116.0,13707,,BAO_0000218,Rattus norvegicus,,CHEMBL631144,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,13708,,BAO_0000218,Canis lupus familiaris,,CHEMBL631145,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.312 mg/kg after ip administration,Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,13709,,BAO_0000218,Canis lupus familiaris,,CHEMBL631146,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,13710,,BAO_0000218,Canis lupus familiaris,,CHEMBL631147,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.625 mg/kg after ip administration,Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,13711,,BAO_0000218,Canis lupus familiaris,,CHEMBL631148,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,13712,,BAO_0000218,Canis lupus familiaris,,CHEMBL631149,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,13713,,BAO_0000218,Canis lupus familiaris,,CHEMBL631150,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration (0-6 hr),Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,13714,,BAO_0000218,Canis lupus familiaris,,CHEMBL631151,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,13715,,BAO_0000218,Canis lupus familiaris,,CHEMBL631152,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,13716,,BAO_0000218,Canis lupus familiaris,,CHEMBL631443,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,13717,,BAO_0000218,Canis lupus familiaris,,CHEMBL631444,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration (0-6 hr),Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,13718,,BAO_0000218,Canis lupus familiaris,,CHEMBL631445,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,13719,,BAO_0000218,Canis lupus familiaris,,CHEMBL631446,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,13720,,BAO_0000218,Canis lupus familiaris,,CHEMBL631447,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg g after ip administration (0-6 hr),Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,13721,,BAO_0000218,Canis lupus familiaris,,CHEMBL631448,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,13722,,BAO_0000218,Canis lupus familiaris,,CHEMBL631449,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration,Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,13723,,BAO_0000218,Canis lupus familiaris,,CHEMBL631450,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration (0-6 hr),Intermediate
,,,,,1,,,N,50588,6996,1,9615.0,13724,,BAO_0000218,Canis lupus familiaris,,CHEMBL629724,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),Intermediate
,In vivo,Zone of skin,,,1,,,N,50594,9716,1,10090.0,13725,,BAO_0000218,Mus musculus,14.0,CHEMBL629725,A,,"Biodistribution in mice skin, after 24 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate
,In vivo,Zone of skin,,,1,,,N,50594,9716,1,10090.0,13726,,BAO_0000218,Mus musculus,14.0,CHEMBL629726,A,,"Biodistribution in mice skin, after 48 hr of intravenous administration of 1-2 ug ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate
,In vivo,Spleen,,,1,,,N,50594,9716,1,10090.0,13727,,BAO_0000218,Mus musculus,2106.0,CHEMBL629727,A,,"Biodistribution in mice spleen, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate
,In vivo,Spleen,,,1,,,N,50594,9716,1,10090.0,13728,,BAO_0000218,Mus musculus,2106.0,CHEMBL630404,A,,"Biodistribution in mice spleen, after 1 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate
,In vivo,Spleen,,,1,,,N,50594,9716,1,10090.0,13729,,BAO_0000218,Mus musculus,2106.0,CHEMBL630405,A,,"Biodistribution in mice spleen, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate
,In vivo,Spleen,,,1,,,N,50594,9716,1,10090.0,13730,,BAO_0000218,Mus musculus,2106.0,CHEMBL630406,A,,"Biodistribution in mice spleen, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate
,In vivo,Stomach,,,1,,,N,50594,9716,1,10090.0,13731,,BAO_0000218,Mus musculus,945.0,CHEMBL630407,A,,"Biodistribution in mice stomach, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate
,In vivo,Stomach,,,1,,,N,50594,9716,1,10090.0,13732,,BAO_0000218,Mus musculus,945.0,CHEMBL630573,A,,"Biodistribution in mice stomach, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate
,In vivo,Stomach,,,1,,,N,50594,9716,1,10090.0,13733,,BAO_0000218,Mus musculus,945.0,CHEMBL630574,A,,"Biodistribution in mice stomach, after 24 hr of intravenous administration of 1-2 ug of ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate
,In vivo,Stomach,,,1,,,N,50594,9716,1,10090.0,13734,,BAO_0000218,Mus musculus,945.0,CHEMBL630575,A,,"Biodistribution in mice stomach, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate
,In vivo,,,,1,,,N,50594,9716,1,10090.0,13735,,BAO_0000218,Mus musculus,,CHEMBL630576,A,,"Biodistribution in mice tail, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate
,In vivo,,,,1,,,N,50594,9716,1,10090.0,13736,,BAO_0000218,Mus musculus,,CHEMBL630577,A,,"Biodistribution in mice tail, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate
,In vivo,,,,1,,,N,50594,9716,1,10090.0,13737,,BAO_0000218,Mus musculus,,CHEMBL630578,A,,"Biodistribution in mice tail, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate
,In vivo,,,,1,,,N,50594,9716,1,10090.0,13738,,BAO_0000218,Mus musculus,,CHEMBL630579,A,,"Biodistribution in mice tail, after 48 hr of intravenous administration of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate
,,Kidney,,,1,,,N,50594,12192,1,10090.0,13739,,BAO_0000218,Mus musculus,2113.0,CHEMBL630580,A,,Percent of injected 238-Plutonium(IV) in mice kidney at 24 hr (orally administered),Intermediate
,,Kidney,,,1,,,N,50594,12192,1,10090.0,13740,,BAO_0000218,Mus musculus,2113.0,CHEMBL630581,A,,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 h,Intermediate
,,Kidney,,,1,,,N,50594,12192,1,10090.0,13741,,BAO_0000218,Mus musculus,2113.0,CHEMBL630582,A,,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 hr (orally administered),Intermediate
,,,,,1,,,N,50594,12192,1,10090.0,13742,,BAO_0000218,Mus musculus,,CHEMBL630583,A,,Percent of injected 238-Plutonium(IV) in mice liver at 24 h,Intermediate
,,,,,1,,,N,50594,12192,1,10090.0,13743,,BAO_0000218,Mus musculus,,CHEMBL630584,A,,Percent of injected 238-Plutonium(IV) in mice liver at 24 hr (orally administered),Intermediate
,,,,,1,,,N,50594,12192,1,10090.0,13744,,BAO_0000218,Mus musculus,,CHEMBL630585,A,,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 h,Intermediate
,,,,,1,,,N,50594,12192,1,10090.0,13745,,BAO_0000218,Mus musculus,,CHEMBL630586,A,,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 hr (orally administered),Intermediate
,,,,,1,,,N,50594,12192,1,10090.0,13746,,BAO_0000218,Mus musculus,,CHEMBL630587,A,,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 h,Intermediate
,,,,,1,,,N,50594,12192,1,10090.0,13747,,BAO_0000218,Mus musculus,,CHEMBL630588,A,,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 hr (orally administered),Intermediate
,,,,,1,,,N,50594,12192,1,10090.0,13748,,BAO_0000218,Mus musculus,,CHEMBL630589,A,,Percent of injected 238-Plutonium(IV) in mice whole body at 24 h,Intermediate
,,,,,1,,,N,50594,12192,1,10090.0,13749,,BAO_0000218,Mus musculus,,CHEMBL630590,A,,Percent of injected 238-Plutonium(IV) in mice whole body at 24 hr (orally administered),Intermediate
,,Feces,,,0,,,U,22224,12192,1,,13750,,BAO_0000019,,1988.0,CHEMBL630591,A,,Removal of 238-Plutonium(IV) in feces at 24 h,Autocuration
,,Feces,,,0,,,U,22224,12192,1,,13751,,BAO_0000019,,1988.0,CHEMBL630592,A,,Removal of 238-Plutonium(IV) in feces at 24 hr (orally administered),Autocuration
,,,,,0,,,U,22224,12192,1,,13752,,BAO_0000019,,,CHEMBL630593,A,,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 h,Autocuration
,,,,,0,,,U,22224,12192,1,,13753,,BAO_0000019,,,CHEMBL630594,A,,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 hr (orally administered),Autocuration
,,Urine,,,0,,,U,22224,12192,1,,13754,,BAO_0000019,,1088.0,CHEMBL630595,A,,Removal of 238-Plutonium(IV) in urine 0-4 h (orally administered),Autocuration
,,Urine,,,0,,,U,22224,12192,1,,13755,,BAO_0000019,,1088.0,CHEMBL630596,A,,Removal of 238-Plutonium(IV) in urine 4-24 hr (orally administered),Autocuration
,,Urine,,,0,,,U,22224,12192,1,,13756,,BAO_0000019,,1088.0,CHEMBL630597,A,,Removal of 238-Plutonium(IV) in urine after 0-24 h,Autocuration
,,Urine,,,0,,,U,22224,12192,1,,13757,,BAO_0000019,,1088.0,CHEMBL630598,A,,Removal of 238-Plutonium(IV) in urine after 0-24 hr (orally administered),Autocuration
,,Urine,,,0,,,U,22224,12192,1,,13758,,BAO_0000019,,1088.0,CHEMBL630599,A,,Removal of 238-Plutonium(IV) in urine after 0-4 h,Autocuration
,,Urine,,,0,,,U,22224,12192,1,,13759,,BAO_0000019,,1088.0,CHEMBL630600,A,,Removal of 238-Plutonium(IV) in urine after 0-4 hr (orally administered),Autocuration
,,Urine,,,0,,,U,22224,12192,1,,13760,,BAO_0000019,,1088.0,CHEMBL630601,A,,Removal of 238-Plutonium(IV) in urine after 4-24 h,Autocuration
,,Urine,,,0,,,U,22224,12192,1,,13761,,BAO_0000019,,1088.0,CHEMBL630602,A,,Removal of 238-Plutonium(IV) in urine after 4-24 hr (orally administered),Autocuration
,,Urine,,,0,,,U,22224,12192,1,,13762,,BAO_0000019,,1088.0,CHEMBL630603,A,,Removal of 238-Plutonium(IV) in urine at 0-4 hr (orally administered),Autocuration
,,Urine,,,0,,,U,22224,12192,1,,13763,,BAO_0000019,,1088.0,CHEMBL630604,A,,Removal of 238-Plutonium(IV) in urine at 4-24 hr (orally administered),Autocuration
,In vivo,Blood,,,1,,,N,50597,12017,1,10116.0,13764,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL624869,A,,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Blood,,,1,,,N,50597,12017,1,10116.0,13765,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL624870,A,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Blood,,,1,,,N,50597,12017,1,10116.0,13766,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL623189,A,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate
,In vivo,Blood,,,1,,,N,50597,12017,1,10116.0,13767,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL623190,A,,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Blood,,,1,,,N,50597,12017,1,10116.0,13768,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL623191,A,,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,,,,1,,,N,50597,12017,1,10116.0,13769,,BAO_0000218,Rattus norvegicus,,CHEMBL623192,A,,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,,,,1,,,N,50597,12017,1,10116.0,13770,,BAO_0000218,Rattus norvegicus,,CHEMBL623193,A,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,,,,1,,,N,50597,12017,1,10116.0,13771,,BAO_0000218,Rattus norvegicus,,CHEMBL623194,A,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate
,In vivo,,,,1,,,N,50597,12017,1,10116.0,13772,,BAO_0000218,Rattus norvegicus,,CHEMBL623195,A,,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,,,,1,,,N,50597,12017,1,10116.0,13773,,BAO_0000218,Rattus norvegicus,,CHEMBL623196,A,,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,,,,,1,,,N,50597,11836,1,10116.0,13774,,BAO_0000218,Rattus norvegicus,,CHEMBL623197,A,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 15 microCi of the drug and 15 micro g of estradiol,Intermediate
,,,,,1,,,N,50597,11836,1,10116.0,13775,,BAO_0000218,Rattus norvegicus,,CHEMBL623198,A,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,Intermediate
,,,,,1,,,N,50597,11836,1,10116.0,13776,,BAO_0000218,Rattus norvegicus,,CHEMBL623199,A,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,Intermediate
,,Muscle tissue,,,1,,,N,50597,11836,1,10116.0,13777,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL623200,A,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 100 microCi of drug in 10%ethanol saline,Intermediate
,,Muscle tissue,,,1,,,N,50597,11836,1,10116.0,13778,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL623201,A,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 120 microCi of drug in 10%ethanol saline,Intermediate
,,Muscle tissue,,,1,,,N,50597,11836,1,10116.0,13779,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL623202,A,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 15 microCi of drug in 10%ethanol saline,Intermediate
,,Muscle tissue,,,1,,,N,50597,11836,1,10116.0,13780,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL623203,A,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 50 microCi of drug in 10%ethanol saline,Intermediate
,,Muscle tissue,,,1,,,N,50597,11836,1,10116.0,13781,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL623204,A,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of drug in 10%ethanol saline,Intermediate
,,Muscle tissue,,,1,,,N,50597,11836,1,10116.0,13782,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL623205,A,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of the drug and 15 ug of estradiol,Intermediate
,,Muscle tissue,,,1,,,N,50597,11836,1,10116.0,13783,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL623206,A,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,Intermediate
,,Muscle tissue,,,1,,,N,50597,11836,1,10116.0,13784,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL623207,A,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of the drug and 15 micro g of estradiol,Intermediate
,,Muscle tissue,,,1,,,N,50597,11836,1,10116.0,13785,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL623208,A,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 15 microCi of the drug and 15 ug of estradiol,Intermediate
,,Muscle tissue,,,1,,,N,50597,11836,1,10116.0,13786,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL623209,A,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,Intermediate
,,Muscle tissue,,,1,,,N,50597,11836,1,10116.0,13787,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL623210,A,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,Intermediate
,,,,,1,,,N,50597,11836,1,10116.0,13788,,BAO_0000218,Rattus norvegicus,,CHEMBL623211,A,,Tested in vivo for the biodistribution in rat fat at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,Intermediate
,,Uterus,,,1,,,N,50597,11836,1,10116.0,13789,,BAO_0000218,Rattus norvegicus,995.0,CHEMBL623212,A,,Tested in vivo for the biodistribution in rat uterus at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,Intermediate
,,,,,0,,,U,22224,12640,1,,13790,,BAO_0000019,,,CHEMBL623213,A,,Tested in vitro for intrinsic activity relative to quinpirole,Autocuration
,,,,,0,,,U,22224,14218,1,,13791,,BAO_0000019,,,CHEMBL623214,A,,"Relative ion enhancement, determined in pulsed ultrafiltration",Autocuration
,,,,,0,,,U,22224,11296,1,,13792,,BAO_0000019,,,CHEMBL623215,A,,% ionization at the pH 7.4 at 37 degree Centigrade,Autocuration
,,,,,0,,,U,22224,10929,1,,13793,,BAO_0000019,,,CHEMBL623216,A,,Percentage ionization was measured,Autocuration
,,,,,1,,,N,50591,13841,1,9913.0,13794,,BAO_0000218,Bos taurus,,CHEMBL623217,A,,Association constant of binding of compound with calf thymus DNA was determined by using equilibrium dialysis.,Intermediate
,,,,,0,,,U,22224,10431,1,,13795,,BAO_0000019,,,CHEMBL623218,A,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 Pseudo-first-order rate constant,Autocuration
,,,,,0,,,U,22224,10431,1,,13796,,BAO_0000019,,,CHEMBL623913,A,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer Pseudo-first-order rate constant,Autocuration
,,,,,0,,,U,22224,10431,1,,13797,,BAO_0000019,,,CHEMBL623914,A,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer pseudo-first-order rate constant 0.1 mM EDTA,Autocuration
,,,,,0,,,U,22229,8826,1,,13798,,BAO_0000100,,,CHEMBL623915,P,,Compound was evaluated for the partition coefficient in octanol/water,Autocuration
,,,,,0,,,U,22229,8826,1,,13799,,BAO_0000100,,,CHEMBL624080,P,,Compound was evaluated for the partition coefficient in octanol/water (1-octanol / 10 mM phosphate buffer at pH 7.4),Autocuration
,,,,,0,,,U,22224,9884,1,,13800,,BAO_0000019,,,CHEMBL624081,A,,Equilibrium constant measured by the pulse radiolysis at pH 7,Autocuration
,,,,,1,,,N,50587,9827,1,9606.0,13801,,BAO_0000218,Homo sapiens,,CHEMBL624082,A,,In vitro hydrolytic rate constant determined in human blood,Intermediate
,,,,,1,,,N,50587,10009,1,9606.0,13802,,BAO_0000218,Homo sapiens,,CHEMBL625054,A,,In vitro oxidation of compound to its pyridinium salt (3) in presence of human plasma,Intermediate
,,,,,0,,,U,22224,10009,1,,13803,,BAO_0000019,,,CHEMBL877485,A,,In vitro oxidation of compound to its pyridinium salt (3) in presence of hydrogen peroxide,Autocuration
,,,,,1,,,N,50594,10009,1,10090.0,13804,,BAO_0000218,Mus musculus,,CHEMBL625055,A,,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse brain homogenate,Intermediate
,,,,,1,,,N,50594,10009,1,10090.0,13805,,BAO_0000218,Mus musculus,,CHEMBL625056,A,,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse liver homogenate,Intermediate
,,,,,1,,,N,50587,10009,1,9606.0,13806,,BAO_0000218,Homo sapiens,,CHEMBL625057,A,,In vitro oxidation of compound in presence of human plasma,Intermediate
,,,,,0,,,U,22224,10009,1,,13807,,BAO_0000019,,,CHEMBL625058,A,,In vitro oxidation of compound in presence of hydrogen peroxide,Autocuration
,,,,,1,,,N,50594,10009,1,10090.0,13808,,BAO_0000218,Mus musculus,,CHEMBL625059,A,,In vitro oxidation of compound in presence of mouse brain homogenate,Intermediate
,,,,,1,,,N,50594,10009,1,10090.0,13809,,BAO_0000218,Mus musculus,,CHEMBL629536,A,,In vitro oxidation of compound in presence of mouse liver homogenate,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13810,,BAO_0000218,Rattus norvegicus,,CHEMBL629537,A,,Mean potassium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13811,,BAO_0000218,Rattus norvegicus,,CHEMBL629538,A,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13812,,BAO_0000218,Rattus norvegicus,,CHEMBL629539,A,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13813,,BAO_0000218,Rattus norvegicus,,CHEMBL874445,A,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13814,,BAO_0000218,Rattus norvegicus,,CHEMBL629540,A,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13815,,BAO_0000218,Rattus norvegicus,,CHEMBL629541,A,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13816,,BAO_0000218,Rattus norvegicus,,CHEMBL629542,A,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13817,,BAO_0000218,Rattus norvegicus,,CHEMBL630243,A,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13818,,BAO_0000218,Rattus norvegicus,,CHEMBL630244,A,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13819,,BAO_0000218,Rattus norvegicus,,CHEMBL630245,A,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13820,,BAO_0000218,Rattus norvegicus,,CHEMBL630246,A,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13821,,BAO_0000218,Rattus norvegicus,,CHEMBL630247,A,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13822,,BAO_0000218,Rattus norvegicus,,CHEMBL630248,A,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,Intermediate
,In vivo,Blood,,,1,,,N,50597,13100,1,10116.0,13823,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL630249,A,,Biodistribution in rat blood at 240 minutes after dose administration.,Intermediate
,In vivo,Blood,,,1,,,N,50597,13100,1,10116.0,13824,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL630250,A,,Biodistribution in rat blood at 30 minutes after dose administration.,Intermediate
,In vivo,Blood,,,1,,,N,50597,13100,1,10116.0,13825,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL630251,A,,Biodistribution in rat blood at 360 minutes after dose administration.,Intermediate
,In vivo,Blood,,,1,,,N,50597,13100,1,10116.0,13826,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL630252,A,,Biodistribution in rat blood at 3 hr after dose administration.,Intermediate
,In vivo,Blood,,,1,,,N,50597,13100,1,10116.0,13827,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL630408,A,,Biodistribution in rat blood at 60 minutes after dose administration.,Intermediate
,In vivo,Cerebellum,,,1,,,N,50597,13100,1,10116.0,13828,,BAO_0000218,Rattus norvegicus,2037.0,CHEMBL630409,A,,Biodistribution in rat cerebellum at 120 minutes after dose administration.,Intermediate
,In vivo,Cerebellum,,,1,,,N,50597,13100,1,10116.0,13829,,BAO_0000218,Rattus norvegicus,2037.0,CHEMBL874446,A,,Biodistribution in rat cerebellum at 1440 minutes after dose administration.,Intermediate
,In vivo,Cerebellum,,,1,,,N,50597,13100,1,10116.0,13830,,BAO_0000218,Rattus norvegicus,2037.0,CHEMBL630410,A,,Biodistribution in rat cerebellum at 15 minutes after dose administration.,Intermediate
,In vivo,Cerebellum,,,1,,,N,50597,13100,1,10116.0,13831,,BAO_0000218,Rattus norvegicus,2037.0,CHEMBL630411,A,,Biodistribution in rat cerebellum at 240 minutes after dose administration.,Intermediate
,In vivo,Cerebellum,,,1,,,N,50597,13100,1,10116.0,13832,,BAO_0000218,Rattus norvegicus,2037.0,CHEMBL630412,A,,Biodistribution in rat cerebellum at 30 minutes after dose administration.,Intermediate
,In vivo,Cerebellum,,,1,,,N,50597,13100,1,10116.0,13833,,BAO_0000218,Rattus norvegicus,2037.0,CHEMBL630413,A,,Biodistribution in rat cerebellum at 360 minutes after dose administration.,Intermediate
,In vivo,Cerebellum,,,1,,,N,50597,13100,1,10116.0,13834,,BAO_0000218,Rattus norvegicus,2037.0,CHEMBL630414,A,,Biodistribution in rat cerebellum at 3 hr after dose administration.,Intermediate
,In vivo,Cerebellum,,,1,,,N,50597,13100,1,10116.0,13835,,BAO_0000218,Rattus norvegicus,2037.0,CHEMBL630415,A,,Biodistribution in rat cerebellum at 60 minutes after dose administration.,Intermediate
,In vivo,,,,1,,,N,50597,13100,1,10116.0,13836,,BAO_0000218,Rattus norvegicus,,CHEMBL630416,A,,Biodistribution in rat cortex at 120 minutes after dose administration.,Intermediate
,In vivo,,,,1,,,N,50597,13100,1,10116.0,13837,,BAO_0000218,Rattus norvegicus,,CHEMBL630417,A,,Biodistribution in rat cortex at 1440 minutes after dose administration.,Intermediate
,In vivo,,,,1,,,N,50597,13100,1,10116.0,13838,,BAO_0000218,Rattus norvegicus,,CHEMBL630418,A,,Biodistribution in rat cortex at 15 minutes after dose administration.,Intermediate
,In vivo,,,,1,,,N,50597,13100,1,10116.0,13839,,BAO_0000218,Rattus norvegicus,,CHEMBL630419,A,,Biodistribution in rat cortex at 240 minutes after dose administration.,Intermediate
,In vivo,,,,1,,,N,50597,13100,1,10116.0,13840,,BAO_0000218,Rattus norvegicus,,CHEMBL630420,A,,Biodistribution in rat cortex at 30 minutes after dose administration.,Intermediate
,In vivo,,,,1,,,N,50597,13100,1,10116.0,13841,,BAO_0000218,Rattus norvegicus,,CHEMBL630421,A,,Biodistribution in rat cortex at 360 minutes after dose administration.,Intermediate
,In vivo,,,,1,,,N,50597,13100,1,10116.0,13842,,BAO_0000218,Rattus norvegicus,,CHEMBL630422,A,,Biodistribution in rat cortex at 3 hr after dose administration.,Intermediate
,In vivo,,,,1,,,N,50597,13100,1,10116.0,13843,,BAO_0000218,Rattus norvegicus,,CHEMBL630423,A,,Biodistribution in rat cortex at 60 minutes after dose administration.,Intermediate
,In vivo,Heart,,,1,,,N,50597,13100,1,10116.0,13844,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL630424,A,,Biodistribution in rat heart at 120 minutes after dose administration.,Intermediate
,In vivo,Heart,,,1,,,N,50597,13100,1,10116.0,13845,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL630425,A,,Biodistribution in rat heart at 15 minutes after dose administration.,Intermediate
,In vivo,Heart,,,1,,,N,50597,13100,1,10116.0,13846,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL629462,A,,Biodistribution in rat heart at 240 minutes after dose administration.,Intermediate
,In vivo,Heart,,,1,,,N,50597,13100,1,10116.0,13847,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL630426,A,,Biodistribution in rat heart at 30 minutes after dose administration.,Intermediate
,In vivo,Heart,,,1,,,N,50597,13100,1,10116.0,13848,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL630427,A,,Biodistribution in rat heart at 360 minutes after dose administration.,Intermediate
,In vivo,Heart,,,1,,,N,50597,13100,1,10116.0,13849,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL625877,A,,Biodistribution in rat heart at 3 hr after dose administration.,Intermediate
,In vivo,Heart,,,1,,,N,50597,13100,1,10116.0,13850,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL625878,A,,Biodistribution in rat heart at 60 minutes after dose administration.,Intermediate
,In vivo,Hippocampus,,,1,,,N,50597,13100,1,10116.0,13851,,BAO_0000218,Rattus norvegicus,10000000.0,CHEMBL625879,A,,Biodistribution in rat hippocampus at 1440 minutes after dose administration.,Intermediate
,In vivo,Hippocampus,,,1,,,N,50597,13100,1,10116.0,13852,,BAO_0000218,Rattus norvegicus,10000000.0,CHEMBL625880,A,,Biodistribution in rat hippocampus at 240 minutes after dose administration.,Intermediate
,In vivo,Hippocampus,,,1,,,N,50597,13100,1,10116.0,13853,,BAO_0000218,Rattus norvegicus,10000000.0,CHEMBL625881,A,,Biodistribution in rat hippocampus at 30 minutes after dose administration.,Intermediate
,In vivo,Hippocampus,,,1,,,N,50597,13100,1,10116.0,13854,,BAO_0000218,Rattus norvegicus,10000000.0,CHEMBL625882,A,,Biodistribution in rat hippocampus at 360 minutes after dose administration.,Intermediate
,In vivo,Hippocampus,,,1,,,N,50597,13100,1,10116.0,13855,,BAO_0000218,Rattus norvegicus,10000000.0,CHEMBL625883,A,,Biodistribution in rat hippocampus at 15 minutes after dose administration.,Intermediate
,In vivo,Kidney,,,1,,,N,50597,13100,1,10116.0,13856,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL625884,A,,Biodistribution in rat kidney at 120 minutes after dose administration.,Intermediate
,In vivo,Kidney,,,1,,,N,50597,13100,1,10116.0,13857,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL625885,A,,Biodistribution in rat kidney at 1440 minutes after dose administration.,Intermediate
,In vivo,Kidney,,,1,,,N,50597,13100,1,10116.0,13858,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL628649,A,,Biodistribution in rat kidney at 15 minutes after dose administration.,Intermediate
,In vivo,Kidney,,,1,,,N,50597,13100,1,10116.0,13859,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL628650,A,,Biodistribution in rat kidney at 240 minutes after dose administration.,Intermediate
,In vivo,Kidney,,,1,,,N,50597,13100,1,10116.0,13860,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL628651,A,,Biodistribution in rat kidney at 30 minutes after dose administration.,Intermediate
,In vivo,Kidney,,,1,,,N,50597,13100,1,10116.0,13861,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL628652,A,,Biodistribution in rat kidney at 360 minutes after dose administration.,Intermediate
,In vivo,Kidney,,,1,,,N,50597,13100,1,10116.0,13862,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL628653,A,,Biodistribution in rat kidney at 60 minutes after dose administration.,Intermediate
,In vivo,Liver,,,1,,,N,50597,13100,1,10116.0,13863,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL628654,A,,Biodistribution in rat liver at 120 minutes after dose administration.,Intermediate
,In vivo,Liver,,,1,,,N,50597,13100,1,10116.0,13864,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL628655,A,,Biodistribution in rat liver at 1440 minutes after dose administration.,Intermediate
,In vivo,Liver,,,1,,,N,50597,13100,1,10116.0,13865,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL625238,A,,Biodistribution in rat liver at 15 minutes after dose administration.,Intermediate
,In vivo,Liver,,,1,,,N,50597,13100,1,10116.0,13866,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL625239,A,,Biodistribution in rat liver at 240 minutes after dose administration.,Intermediate
,In vivo,Liver,,,1,,,N,50597,13100,1,10116.0,13867,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL625240,A,,Biodistribution in rat liver at 30 minutes after dose administration.,Intermediate
,In vivo,Liver,,,1,,,N,50597,13100,1,10116.0,13868,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL625241,A,,Biodistribution in rat liver at 360 minutes after dose administration.,Intermediate
,In vivo,Liver,,,1,,,N,50597,13100,1,10116.0,13869,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL625242,A,,Biodistribution in rat liver at 60 minutes after dose administration.,Intermediate
,In vivo,Lung,,,1,,,N,50597,13100,1,10116.0,13870,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL874587,A,,Biodistribution in rat lung at 120 minutes after dose administration.,Intermediate
,In vivo,Lung,,,1,,,N,50597,13100,1,10116.0,13871,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL625405,A,,Biodistribution in rat lung at 1440 minutes after dose administration.,Intermediate
,In vivo,Lung,,,1,,,N,50597,13100,1,10116.0,13872,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL625406,A,,Biodistribution in rat lung at 15 minutes after dose administration.,Intermediate
,In vivo,Lung,,,1,,,N,50597,13100,1,10116.0,13873,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL625407,A,,Biodistribution in rat lung at 240 minutes after dose administration.,Intermediate
,In vivo,Lung,,,1,,,N,50597,13100,1,10116.0,13874,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL625408,A,,Biodistribution in rat lung at 30 minutes after dose administration.,Intermediate
,In vivo,Lung,,,1,,,N,50597,13100,1,10116.0,13875,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL625409,A,,Biodistribution in rat lung at 360 minutes after dose administration.,Intermediate
,,Thoracic aorta,,,1,,,N,50597,12361,1,10116.0,13876,,BAO_0000218,Rattus norvegicus,1515.0,CHEMBL625410,A,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer,Intermediate
,,Thoracic aorta,,,1,,,N,50597,12361,1,10116.0,13877,,BAO_0000218,Rattus norvegicus,1515.0,CHEMBL625411,A,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of nifedipine,Intermediate
,,Thoracic aorta,,,1,,,N,50597,12361,1,10116.0,13878,,BAO_0000218,Rattus norvegicus,1515.0,CHEMBL625412,A,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of verapamil,Intermediate
,,Thoracic aorta,,,1,,,N,50597,12361,1,10116.0,13879,,BAO_0000218,Rattus norvegicus,1515.0,CHEMBL625413,A,,Percent of maximal contractile response to compound in rat thoracic aorta strips presence of PBZ and CIR,Intermediate
,,Thoracic aorta,,,1,,,N,50597,12361,1,10116.0,13880,,BAO_0000218,Rattus norvegicus,1515.0,CHEMBL625414,A,,Percent of maximal contractile response to compound in rat thoracic aorta strips v,Intermediate
,,Thoracic aorta,,,1,,,N,50597,12361,1,10116.0,13881,,BAO_0000218,Rattus norvegicus,1515.0,CHEMBL625415,A,,Percent of maximal contractile response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips,Intermediate
,,Thoracic aorta,,,1,,,N,50597,12361,1,10116.0,13882,,BAO_0000218,Rattus norvegicus,1515.0,CHEMBL625416,A,,Percent of maximal contractile response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips,Intermediate
,,Urine,,,1,,,N,50597,12712,1,10116.0,13883,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL625417,A,,% of the total radioactive dose of compound present in the 0-24 hour urine after a single 5 mg/kg dose administered intravenously in rats,Intermediate
,,Feces,,,1,,,N,50597,7415,1,10116.0,13884,,BAO_0000218,Rattus norvegicus,1988.0,CHEMBL625418,A,,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through feces,Intermediate
,,Urine,,,1,,,N,50597,7415,1,10116.0,13885,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL625419,A,,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through urine,Intermediate
,,,,,1,,,N,50597,7415,1,10116.0,13886,,BAO_0000218,Rattus norvegicus,,CHEMBL625420,A,,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 1 mg/kg,Intermediate
,,,,,1,,,N,50597,7415,1,10116.0,13887,,BAO_0000218,Rattus norvegicus,,CHEMBL626996,A,,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 10 mg/kg,Intermediate
,,Feces,,,1,,,N,50597,7415,1,10116.0,13888,,BAO_0000218,Rattus norvegicus,1988.0,CHEMBL626997,A,,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through feces",Intermediate
,,Urine,,,1,,,N,50597,7415,1,10116.0,13889,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL626998,A,,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through urine",Intermediate
,,,,,1,,,N,50597,7415,1,10116.0,13890,,BAO_0000218,Rattus norvegicus,,CHEMBL626999,A,,"Compound was evaluated for the in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour biliary excretion",Intermediate
,,,,,1,,,N,50594,8050,1,10090.0,13891,,BAO_0000218,Mus musculus,,CHEMBL627000,A,,faecal levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-30h,Intermediate
,,,,,1,,,N,50594,8050,1,10090.0,13892,,BAO_0000218,Mus musculus,,CHEMBL627001,A,,fecal levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-30h,Intermediate
,,,,,1,,,N,50594,8050,1,10090.0,13893,,BAO_0000218,Mus musculus,,CHEMBL627002,A,,fecal levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-30h,Intermediate
,,,,,1,,,N,50594,8050,1,10090.0,13894,,BAO_0000218,Mus musculus,,CHEMBL627003,A,,fecal levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-30h,Intermediate
,,Urine,,,1,,,N,50594,8050,1,10090.0,13895,,BAO_0000218,Mus musculus,1088.0,CHEMBL627004,A,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-24 hr,Intermediate
,,Urine,,,1,,,N,50594,8050,1,10090.0,13896,,BAO_0000218,Mus musculus,1088.0,CHEMBL627005,A,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-6 hr,Intermediate
,,Urine,,,1,,,N,50594,8050,1,10090.0,13897,,BAO_0000218,Mus musculus,1088.0,CHEMBL874594,A,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 24-30 hr,Intermediate
,,Urine,,,1,,,N,50594,8050,1,10090.0,13898,,BAO_0000218,Mus musculus,1088.0,CHEMBL627006,A,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-24 hr,Intermediate
,,Urine,,,1,,,N,50594,8050,1,10090.0,13899,,BAO_0000218,Mus musculus,1088.0,CHEMBL627007,A,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-6 hr,Intermediate
,,Urine,,,1,,,N,50594,8050,1,10090.0,13900,,BAO_0000218,Mus musculus,1088.0,CHEMBL627884,A,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 24-30 hr,Intermediate
,,Urine,,,1,,,N,50594,8050,1,10090.0,13901,,BAO_0000218,Mus musculus,1088.0,CHEMBL627885,A,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-24 hr,Intermediate
,,Urine,,,1,,,N,50594,8050,1,10090.0,13902,,BAO_0000218,Mus musculus,1088.0,CHEMBL627886,A,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-6 hr,Intermediate
,,Urine,,,1,,,N,50594,8050,1,10090.0,13903,,BAO_0000218,Mus musculus,1088.0,CHEMBL627887,A,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 24-30 hr,Intermediate
,,Urine,,,1,,,N,50594,8050,1,10090.0,13904,,BAO_0000218,Mus musculus,1088.0,CHEMBL627888,A,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-24 hr,Intermediate
,,Urine,,,1,,,N,50594,8050,1,10090.0,13905,,BAO_0000218,Mus musculus,1088.0,CHEMBL628057,A,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-6 hr,Intermediate
,,Urine,,,1,,,N,50594,8050,1,10090.0,13906,,BAO_0000218,Mus musculus,1088.0,CHEMBL627405,A,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 24-30 hr,Intermediate
,,Urine,,,1,,,N,50588,12582,1,9615.0,13907,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL627406,A,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50588,12582,1,9615.0,13908,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL627407,A,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50588,12582,1,9615.0,13909,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL627408,A,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50588,12582,1,9615.0,13910,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL627409,A,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50588,12582,1,9615.0,13911,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL875486,A,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50588,12582,1,9615.0,13912,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL627410,A,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50588,12582,1,9615.0,13913,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL627411,A,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50588,12582,1,9615.0,13914,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL627412,A,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50588,12582,1,9615.0,13915,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL627413,A,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50588,12582,1,9615.0,13916,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL627414,A,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50588,12582,1,9615.0,13917,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL627415,A,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 10.1 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50588,12582,1,9615.0,13918,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL627416,A,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 102 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50588,12582,1,9615.0,13919,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL627417,A,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.40 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50588,12582,1,9615.0,13920,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL627418,A,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.76 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50588,12582,1,9615.0,13921,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL627419,A,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 34.1 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50588,12582,1,9615.0,13922,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL627320,A,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 50.8 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50588,12582,1,9615.0,13923,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL627321,A,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 68.1 uM/Kg of drug,Intermediate
,In vivo,Kidney,,,1,,,N,50597,12017,1,10116.0,13924,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL627322,A,,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Kidney,,,1,,,N,50597,12017,1,10116.0,13925,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL627323,A,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Kidney,,,1,,,N,50597,12017,1,10116.0,13926,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL627491,A,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate
,In vivo,Kidney,,,1,,,N,50597,12017,1,10116.0,13927,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL627492,A,,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Kidney,,,1,,,N,50597,12017,1,10116.0,13928,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL627493,A,,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Liver,,,1,,,N,50597,12017,1,10116.0,13929,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL627494,A,,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Liver,,,1,,,N,50597,12017,1,10116.0,13930,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL627495,A,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Liver,,,1,,,N,50597,12017,1,10116.0,13931,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL627496,A,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate
,In vivo,Liver,,,1,,,N,50597,12017,1,10116.0,13932,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL627497,A,,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Liver,,,1,,,N,50597,12017,1,10116.0,13933,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL627498,A,,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Lung,,,1,,,N,50597,12017,1,10116.0,13934,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL627499,A,,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Lung,,,1,,,N,50597,12017,1,10116.0,13935,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL627500,A,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Lung,,,1,,,N,50597,12017,1,10116.0,13936,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL627501,A,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate
,In vivo,Lung,,,1,,,N,50597,12017,1,10116.0,13937,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL625616,A,,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Lung,,,1,,,N,50597,12017,1,10116.0,13938,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL625617,A,,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,12017,1,10116.0,13939,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL625618,A,,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,12017,1,10116.0,13940,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL625619,A,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,12017,1,10116.0,13941,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL625620,A,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,12017,1,10116.0,13942,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL625621,A,,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,12017,1,10116.0,13943,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL625622,A,,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Spleen,,,1,,,N,50597,12017,1,10116.0,13944,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL625788,A,,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Spleen,,,1,,,N,50597,12017,1,10116.0,13945,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL625789,A,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Spleen,,,1,,,N,50597,12017,1,10116.0,13946,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL625790,A,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate
,In vivo,Spleen,,,1,,,N,50597,12017,1,10116.0,13947,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL625791,A,,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Spleen,,,1,,,N,50597,12017,1,10116.0,13948,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL622334,A,,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Thyroid gland,,,1,,,N,50597,12017,1,10116.0,13949,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL622335,A,,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Thyroid gland,,,1,,,N,50597,12017,1,10116.0,13950,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL622336,A,,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Thyroid gland,,,1,,,N,50597,12017,1,10116.0,13951,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL622337,A,,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate
,In vivo,Thyroid gland,,,1,,,N,50597,12017,1,10116.0,13952,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL622338,A,,Biodistribution in thyroid of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Thyroid gland,,,1,,,N,50597,12017,1,10116.0,13953,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL622339,A,,Biodistribution in thyroid of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,,,,1,,,N,50597,12017,1,10116.0,13954,,BAO_0000218,Rattus norvegicus,,CHEMBL624153,A,,Biodistribution in uterus / blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,,,,1,,,N,50597,12017,1,10116.0,13955,,BAO_0000218,Rattus norvegicus,,CHEMBL628430,A,,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,,,,1,,,N,50597,12017,1,10116.0,13956,,BAO_0000218,Rattus norvegicus,,CHEMBL628431,A,,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate
,In vivo,,,,1,,,N,50597,12017,1,10116.0,13957,,BAO_0000218,Rattus norvegicus,,CHEMBL628432,A,,Biodistribution in uterus / blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,,,,1,,,N,50597,12017,1,10116.0,13958,,BAO_0000218,Rattus norvegicus,,CHEMBL628433,A,,Biodistribution in uterus / blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Spleen,,,1,,,N,50597,12017,1,10116.0,13959,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL628434,A,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Intermediate
,In vivo,Spleen,,,1,,,N,50597,12017,1,10116.0,13960,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL626789,A,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Intermediate
,In vivo,Spleen,,,1,,,N,50597,12017,1,10116.0,13961,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL626790,A,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)",Intermediate
,In vivo,Spleen,,,1,,,N,50597,12017,1,10116.0,13962,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL626791,A,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Intermediate
,In vivo,Spleen,,,1,,,N,50597,12017,1,10116.0,13963,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL626792,A,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Intermediate
,In vivo,Spleen,,,1,,,N,50597,12017,1,10116.0,13964,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL626793,A,,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13965,,BAO_0000218,Rattus norvegicus,,CHEMBL627436,A,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13966,,BAO_0000218,Rattus norvegicus,,CHEMBL627437,A,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13967,,BAO_0000218,Rattus norvegicus,,CHEMBL627438,A,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13968,,BAO_0000218,Rattus norvegicus,,CHEMBL627439,A,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13969,,BAO_0000218,Rattus norvegicus,,CHEMBL627440,A,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13970,,BAO_0000218,Rattus norvegicus,,CHEMBL627602,A,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13971,,BAO_0000218,Rattus norvegicus,,CHEMBL627603,A,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13972,,BAO_0000218,Rattus norvegicus,,CHEMBL627604,A,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13973,,BAO_0000218,Rattus norvegicus,,CHEMBL627605,A,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13974,,BAO_0000218,Rattus norvegicus,,CHEMBL627606,A,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13975,,BAO_0000218,Rattus norvegicus,,CHEMBL627607,A,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13976,,BAO_0000218,Rattus norvegicus,,CHEMBL627608,A,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13977,,BAO_0000218,Rattus norvegicus,,CHEMBL627609,A,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13978,,BAO_0000218,Rattus norvegicus,,CHEMBL627610,A,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13979,,BAO_0000218,Rattus norvegicus,,CHEMBL627611,A,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,13980,,BAO_0000218,Rattus norvegicus,,CHEMBL627612,A,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,Intermediate
,,,,,0,,,U,22229,8362,1,,13981,,BAO_0000100,,,CHEMBL627613,P,,Octanol:water partition coefficient is evaluated,Autocuration
,,,,,0,,,U,22224,8257,1,,13982,,BAO_0000100,,,CHEMBL627614,P,,Partition coefficient in 1-octanol/water system,Autocuration
,,,,,0,,,U,22224,8257,1,,13983,,BAO_0000100,,,CHEMBL627615,P,,Partition coefficient in 1-octanol/water system measured using radio active compounds,Autocuration
,,,,,0,,,U,22224,9468,1,,13984,,BAO_0000100,,,CHEMBL627616,P,,Partition coefficient in octanol/water system was determined,Autocuration
,,,,,0,,,U,22224,9468,1,,13985,,BAO_0000100,,,CHEMBL627617,P,,Partition coefficient in octanol/water system was determined using [14C]-labeled compounds.,Autocuration
,,,,,0,,,U,22224,10568,1,,13986,,BAO_0000019,,,CHEMBL627618,A,,Pseudo-first-order rate constant at pH 10 and 35 degrees Centigrade,Autocuration
,,,,,0,,,U,22224,10568,1,,13987,,BAO_0000019,,,CHEMBL627619,A,,"Pseudo-first-order rate constant at pH 10, micro=0.5, 35 degrees Centigrade",Autocuration
,,,,,0,,,U,22224,15359,1,,13988,,BAO_0000019,,,CHEMBL627620,A,,Pseudo-first-order rate constant of the compound,Autocuration
,,,,,0,,,U,22224,15359,1,,13989,,BAO_0000019,,,CHEMBL627621,A,,Pseudo-first-order rate constant with 1-min time point,Autocuration
,,,,,0,,,U,22224,15359,1,,13990,,BAO_0000019,,,CHEMBL627622,A,,Pseudo-first-order rate constant without 1-min time point,Autocuration
,,,,,0,,,U,22224,10431,1,,13991,,BAO_0000019,,,CHEMBL627623,A,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 0.5 mM EDTA,Autocuration
,,,,,0,,,U,22224,10431,1,,13992,,BAO_0000019,,,CHEMBL627624,A,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 50 mM EDTA,Autocuration
,,,,,0,,,U,22224,10431,1,,13993,,BAO_0000019,,,CHEMBL627625,A,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 70 mM EDTA,Autocuration
,,,,,0,,,U,22224,15704,1,,13994,,BAO_0000019,,,CHEMBL628523,A,,Rate constants determined using 31P NMR Kinetics experiments at 37 degrees Centigrade,Autocuration
,,,,,0,,,U,22224,15287,1,,13995,,BAO_0000019,,,CHEMBL628524,A,,The alkaline hydrolysis second order rate constant(K OH) of the compound,Autocuration
,,,,,0,,,U,22224,7516,1,,13996,,BAO_0000019,,,CHEMBL628525,A,,The efflux rate constant of the compound,Autocuration
,,,,,0,,,U,22224,12973,1,,13997,,BAO_0000019,,,CHEMBL625732,A,,The reaction rate constant (K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,Autocuration
,,,,,0,,,U,22224,12973,1,,13998,,BAO_0000019,,,CHEMBL625733,A,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,Autocuration
,,,,,0,,,U,22224,12973,1,,13999,,BAO_0000019,,,CHEMBL625734,F,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,Autocuration
,,,,,0,,,U,22224,12973,1,,14000,,BAO_0000019,,,CHEMBL625913,A,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine; ND= not determined,Autocuration
,,,,,0,,,U,22224,8696,1,,14001,,BAO_0000019,,,CHEMBL625914,A,,Association constant was evaluated towards synthetic peptidoglycan analogue Ac2-Lys-D-Ala-D-Ala,Autocuration
,,,,,0,,,U,22224,15052,1,,14002,,BAO_0000019,,,CHEMBL625915,A,,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of electroneutral DMPC in PBSbuffer at pH 7.4 and 37 C,Autocuration
,,,,,0,,,U,22224,15052,1,,14003,,BAO_0000019,,,CHEMBL625916,A,,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of negatively charged DMPG in PBS buffer at pH 7.4 and 37 C,Autocuration
,,,,,0,,,U,22224,10503,1,,14004,,BAO_0000019,,,CHEMBL625917,A,,Evaluated for the mustard reactivity by determining rate constant for hydrolysis of mustard in aqueous acetone (K H),Autocuration
,,,,,0,,,U,22224,8354,1,,14005,,BAO_0000019,,,CHEMBL625918,A,,"Effective biomolecular rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration
,,,,,0,,,U,22224,8354,1,,14006,,BAO_0000019,,,CHEMBL625919,A,,"Effective biomolecular rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration
,,,,,0,,,U,22224,8354,1,,14007,,BAO_0000019,,,CHEMBL625920,A,,"Effective biomolecular rate constant at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration
,,,,,0,,,U,22224,8354,1,,14008,,BAO_0000019,,,CHEMBL874453,A,,"Effective biomolecular rate constant at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration
,,,,,0,,,U,22224,8354,1,,14009,,BAO_0000019,,,CHEMBL625921,A,,"Effective biomolecular rate constant in the conditions of 25degreeC,pH 7.6",Autocuration
,,,,,0,,,U,22224,10503,1,,14010,,BAO_0000019,,,CHEMBL625922,A,,Evaluated for the mustard reactivity by determining rate constant for alkylation of 4-(4-nitrobenzyl)pyridine using NBP alkylation assay,Autocuration
,,,,,0,,,U,22224,8354,1,,14011,,BAO_0000019,,,CHEMBL625923,A,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration
,,,,,0,,,U,22224,8354,1,,14012,,BAO_0000019,,,CHEMBL625924,A,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration
,,,,,0,,,U,22224,8354,1,,14013,,BAO_0000019,,,CHEMBL625925,A,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration
,,,,,0,,,U,22224,8354,1,,14014,,BAO_0000019,,,CHEMBL625926,A,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration
,In vivo,Lung,,,1,,,N,50597,13100,1,10116.0,14015,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL627704,A,,Biodistribution in rat lung at 60 minutes after dose administration.,Intermediate
,In vivo,,,,1,,,N,50597,13100,1,10116.0,14016,,BAO_0000218,Rattus norvegicus,,CHEMBL627705,A,,Biodistribution in rat pons/medulla at 120 minutes after dose administration.,Intermediate
,In vivo,,,,1,,,N,50597,13100,1,10116.0,14017,,BAO_0000218,Rattus norvegicus,,CHEMBL627706,A,,Biodistribution in rat pons/medulla at 15 minutes after dose administration.,Intermediate
,In vivo,,,,1,,,N,50597,13100,1,10116.0,14018,,BAO_0000218,Rattus norvegicus,,CHEMBL627707,A,,Biodistribution in rat pons/medulla at 240 minutes after dose administration.,Intermediate
,In vivo,,,,1,,,N,50597,13100,1,10116.0,14019,,BAO_0000218,Rattus norvegicus,,CHEMBL627708,A,,Biodistribution in rat pons/medulla at 30 minutes after dose administration.,Intermediate
,In vivo,,,,1,,,N,50597,13100,1,10116.0,14020,,BAO_0000218,Rattus norvegicus,,CHEMBL628361,A,,Biodistribution in rat pons/medulla at 360 minutes after dose administration.,Intermediate
,In vivo,,,,1,,,N,50597,13100,1,10116.0,14021,,BAO_0000218,Rattus norvegicus,,CHEMBL628362,A,,Biodistribution in rat pons/medulla at 60 minutes after dose administration.,Intermediate
,In vivo,Striatum,,,1,,,N,50597,13100,1,10116.0,14022,,BAO_0000218,Rattus norvegicus,2435.0,CHEMBL628363,A,,Biodistribution in rat striatum at 120 minutes after dose administration.,Intermediate
,In vivo,Striatum,,,1,,,N,50597,13100,1,10116.0,14023,,BAO_0000218,Rattus norvegicus,2435.0,CHEMBL628364,A,,Biodistribution in rat striatum at 1440 minutes after dose administration.,Intermediate
,In vivo,Striatum,,,1,,,N,50597,13100,1,10116.0,14024,,BAO_0000218,Rattus norvegicus,2435.0,CHEMBL628365,A,,Biodistribution in rat striatum at 15 minutes after dose administration.,Intermediate
,In vivo,Striatum,,,1,,,N,50597,13100,1,10116.0,14025,,BAO_0000218,Rattus norvegicus,2435.0,CHEMBL874454,A,,Biodistribution in rat striatum at 240 minutes after dose administration.,Intermediate
,In vivo,Striatum,,,1,,,N,50597,13100,1,10116.0,14026,,BAO_0000218,Rattus norvegicus,2435.0,CHEMBL628531,A,,Biodistribution in rat striatum at 30 minutes after dose administration.,Intermediate
,In vivo,Striatum,,,1,,,N,50597,13100,1,10116.0,14027,,BAO_0000218,Rattus norvegicus,2435.0,CHEMBL628532,A,,Biodistribution in rat striatum at 360 minutes after dose administration.,Intermediate
,In vivo,Striatum,,,1,,,N,50597,13100,1,10116.0,14028,,BAO_0000218,Rattus norvegicus,2435.0,CHEMBL628533,A,,Biodistribution in rat striatum at 3 hr after dose administration.,Intermediate
,In vivo,Striatum,,,1,,,N,50597,13100,1,10116.0,14029,,BAO_0000218,Rattus norvegicus,2435.0,CHEMBL628534,A,,Biodistribution in rat striatum at 60 minutes after dose administration.,Intermediate
,In vivo,Thyroid gland,,,1,,,N,50597,13100,1,10116.0,14030,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL628535,A,,Biodistribution in rat thyroid at 120 minutes after dose administration.,Intermediate
,In vivo,Thyroid gland,,,1,,,N,50597,13100,1,10116.0,14031,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL628536,A,,Biodistribution in rat thyroid at 1440 minutes after dose administration.,Intermediate
,In vivo,Thyroid gland,,,1,,,N,50597,13100,1,10116.0,14032,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL628537,A,,Biodistribution in rat thyroid at 15 minutes after dose administration.,Intermediate
,In vivo,Thyroid gland,,,1,,,N,50597,13100,1,10116.0,14033,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL628538,A,,Biodistribution in rat thyroid at 240 minutes after dose administration.,Intermediate
,In vivo,Thyroid gland,,,1,,,N,50597,13100,1,10116.0,14034,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL628539,A,,Biodistribution in rat thyroid at 30 minutes after dose administration.,Intermediate
,In vivo,Thyroid gland,,,1,,,N,50597,13100,1,10116.0,14035,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL630297,A,,Biodistribution in rat thyroid at 360 minutes after dose administration.,Intermediate
,In vivo,Thyroid gland,,,1,,,N,50597,13100,1,10116.0,14036,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL630298,A,,Biodistribution in rat thyroid at 60 minutes after dose administration.,Intermediate
,In vivo,Brain,,,1,,,N,50597,13100,1,10116.0,14037,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL630299,A,,Biodistribution in rest of brain of rat 120 minutes after dose administration.,Intermediate
,In vivo,Brain,,,1,,,N,50597,13100,1,10116.0,14038,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL628094,A,,Biodistribution in rest of brain of rat at 1440 minutes after dose administration.,Intermediate
,In vivo,Brain,,,1,,,N,50597,13100,1,10116.0,14039,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL628095,A,,Biodistribution in rest of brain of rat at 15 minutes after dose administration.,Intermediate
,In vivo,Brain,,,1,,,N,50597,13100,1,10116.0,14040,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL874648,A,,Biodistribution in rest of brain of rat at 240 minutes after dose administration.,Intermediate
,In vivo,Brain,,,1,,,N,50597,13100,1,10116.0,14041,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL628096,A,,Biodistribution in rest of brain of rat at 30 minutes after dose administration.,Intermediate
,In vivo,Brain,,,1,,,N,50597,13100,1,10116.0,14042,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL628097,A,,Biodistribution in rest of brain of rat at 360 minutes after dose administration.,Intermediate
,In vivo,Brain,,,1,,,N,50597,13100,1,10116.0,14043,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL628098,A,,Biodistribution in rest of brain of rat at 60 minutes after dose administration.,Intermediate
,,,,,0,,,U,22224,13331,1,,14044,,BAO_0000019,,,CHEMBL628099,A,,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (10:1)",Autocuration
,,,,,0,,,U,22224,13331,1,,14045,,BAO_0000019,,,CHEMBL628100,A,,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",Autocuration
,,,,,0,,,U,22224,13331,1,,14046,,BAO_0000019,,,CHEMBL628101,A,,Mean rate constant for the hydrolysis of compound in buffers at pH 7.4 at 37 degrees Centigrade in incubation mixture - d(A)-d(T) (10:!),Autocuration
,,,,,0,,,U,22224,13331,1,,14047,,BAO_0000019,,,CHEMBL628102,A,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - 5'-GMP/5'-CMP (1:1)",Autocuration
,,,,,0,,,U,22224,13331,1,,14048,,BAO_0000019,,,CHEMBL628103,A,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (1:1)",Autocuration
,,,,,0,,,U,22224,13331,1,,14049,,BAO_0000019,,,CHEMBL628104,A,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",Autocuration
,,,,,0,,,U,22224,13331,1,,14050,,BAO_0000019,,,CHEMBL628105,A,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (1:1)",Autocuration
,,,,,0,,,U,22224,13331,1,,14051,,BAO_0000019,,,CHEMBL628106,A,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(T) (10:1)",Autocuration
,,Urine,,,1,,,N,50597,10086,1,10116.0,14052,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL628107,A,,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,Intermediate
,,Urine,,,0,,,U,22224,10086,1,,14053,,BAO_0000218,,1088.0,CHEMBL628108,F,,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,Autocuration
,,Urine,,,1,,,N,50597,10086,1,10116.0,14054,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL628109,A,,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,Intermediate
,,Urine,,,0,,,U,22224,10086,1,,14055,,BAO_0000218,,1088.0,CHEMBL625299,F,,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,Autocuration
,,Urine,,,1,,,N,50597,10086,1,10116.0,14056,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL625300,A,,Mean urine volume excretion in conscious rats at a dose of 10 mg/kg given orally,Intermediate
,,Urine,,,1,,,N,50597,10086,1,10116.0,14057,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL625301,A,,Mean urine volume excretion in conscious rats at a dose of 100 mg/kg given orally,Intermediate
,,Urine,,,1,,,N,50597,10086,1,10116.0,14058,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL625302,A,,Mean urine volume excretion in conscious rats at a dose of 3.0 mg/kg given orally,Intermediate
,,Urine,,,1,,,N,50597,10086,1,10116.0,14059,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL874649,A,,Mean urine volume excretion in conscious rats at a dose of 30 mg/kg given orally,Intermediate
,,,,,1,,,N,50597,13248,1,10116.0,14060,,BAO_0000218,Rattus norvegicus,,CHEMBL625303,A,,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes,Intermediate
,,,,,1,,,N,50597,13248,1,10116.0,14061,,BAO_0000218,Rattus norvegicus,,CHEMBL625463,A,,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes; NA= Not tested,Intermediate
,,Liver,,,1,,,N,50587,14527,1,9606.0,14062,,BAO_0000218,Homo sapiens,2107.0,CHEMBL625464,A,,In vitro metabolism in human liver microsomes,Intermediate
,,,,,1,,,N,50587,3008,1,9606.0,14063,,BAO_0000218,Homo sapiens,,CHEMBL625465,A,,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated.,Intermediate
,,Urine,,,1,,,N,50588,12582,1,9615.0,14064,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL625466,A,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.06 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50588,12582,1,9615.0,14065,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL625467,A,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.6 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14066,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL625468,A,,Total electrolytic excretion of chlorine in urine of rats after intravenous administration of 7.94 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14067,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL625469,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 0 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14068,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL625470,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.01 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14069,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL632418,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.13 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14070,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL627250,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 10.1 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14071,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL627251,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 102 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14072,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL627252,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 105 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14073,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL627253,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 11.3 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14074,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL627254,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 113 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14075,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL875471,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 19.5 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14076,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL627255,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 195 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14077,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL627256,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 21.7 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14078,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL627257,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 217 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14079,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL627258,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 23.9 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14080,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL627259,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 239 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14081,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL627260,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 24.9 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14082,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL623256,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 249 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14083,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL874413,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 25.9 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14084,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL623257,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 259 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14085,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL623258,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 26.5 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14086,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL623259,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 265 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14087,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL623260,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14088,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL623261,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27.9 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14089,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL623262,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 270 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14090,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL623263,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 279 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14091,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL623264,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.2 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14092,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL623265,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.22 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14093,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL623266,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.9 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14094,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL623267,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 282 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14095,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL623268,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 289 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14096,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL623269,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.40 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14097,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL623270,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.76 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14098,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL623271,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 30.2 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14099,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL623272,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 302 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14100,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL623273,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 31.6 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14101,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL623274,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 316 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14102,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL874414,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 32.4 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14103,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL623275,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 324 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14104,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL629150,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.0 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14105,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL623276,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.1 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14106,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL623277,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.8 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14107,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL623112,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 341 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14108,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL623113,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 348 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14109,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL623800,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 37.6 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14110,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL623801,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 58.4 uM/Kg of drug,Intermediate
,In vivo,Spleen,,,1,,,N,50597,12017,1,10116.0,14111,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL623802,A,,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Intermediate
,In vivo,Uterus,,,1,,,N,50597,12017,1,10116.0,14112,,BAO_0000218,Rattus norvegicus,995.0,CHEMBL623803,A,,Biodistribution in uterus of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Uterus,,,1,,,N,50597,12017,1,10116.0,14113,,BAO_0000218,Rattus norvegicus,995.0,CHEMBL623970,A,,Biodistribution in uterus of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Uterus,,,1,,,N,50597,12017,1,10116.0,14114,,BAO_0000218,Rattus norvegicus,995.0,CHEMBL623971,A,,Biodistribution in uterus of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Blood,,,1,,,N,50597,14045,1,10116.0,14115,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL623972,A,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 10 min post injection (Average of three to five animals),Intermediate
,In vivo,Blood,,,1,,,N,50597,14045,1,10116.0,14116,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL623973,A,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 30 min post injection (Average of three to five animals),Intermediate
,In vivo,Blood,,,1,,,N,50597,14045,1,10116.0,14117,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL623974,A,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 5 min post injection (Average of three to five animals),Intermediate
,In vivo,Blood,,,1,,,N,50597,14045,1,10116.0,14118,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL623975,A,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 60 min post injection (Average of three to five animals),Intermediate
,In vivo,Brain,,,1,,,N,50597,14045,1,10116.0,14119,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL623976,A,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 10 min post injection (Average of three to five animals),Intermediate
,In vivo,Brain,,,1,,,N,50597,14045,1,10116.0,14120,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL623977,A,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 30 min post injection (Average of three to five animals),Intermediate
,In vivo,Brain,,,1,,,N,50597,14045,1,10116.0,14121,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL623978,A,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 5 min post injection (Average of three to five animals),Intermediate
,In vivo,Brain,,,1,,,N,50597,14045,1,10116.0,14122,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL623979,A,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 60 min post injection (Average of three to five animals),Intermediate
,In vivo,,,,1,,,N,50597,14045,1,10116.0,14123,,BAO_0000218,Rattus norvegicus,,CHEMBL623980,A,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 10 min post injection (Average of three to five animals),Intermediate
,In vivo,,,,1,,,N,50597,14045,1,10116.0,14124,,BAO_0000218,Rattus norvegicus,,CHEMBL623981,A,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 30 min post injection (Average of three to five animals),Intermediate
,In vivo,,,,1,,,N,50597,14045,1,10116.0,14125,,BAO_0000218,Rattus norvegicus,,CHEMBL626278,A,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 5 min post injection (Average of three to five animals),Intermediate
,In vivo,,,,1,,,N,50597,14045,1,10116.0,14126,,BAO_0000218,Rattus norvegicus,,CHEMBL626279,A,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 60 min post injection (Average of three to five animals),Intermediate
,In vivo,,,,1,,,N,50594,14045,1,10090.0,14127,,BAO_0000218,Mus musculus,,CHEMBL626280,A,,Biodistribution in mice bladder plus excreted urine was determined,Intermediate
,,,,,1,,,N,50594,14045,1,10090.0,14128,,BAO_0000218,Mus musculus,,CHEMBL626281,A,,"Percentage biodistribution in mouse blood, 10 minutes post injection",Intermediate
,,,,,1,,,N,50594,14045,1,10090.0,14129,,BAO_0000218,Mus musculus,,CHEMBL626282,A,,"Percentage biodistribution in mouse blood, 30 minutes post injection",Intermediate
,,,,,1,,,N,50594,14045,1,10090.0,14130,,BAO_0000218,Mus musculus,,CHEMBL626283,A,,"Percentage biodistribution in mouse blood, 5 minutes post injection",Intermediate
,,,,,1,,,N,50594,14045,1,10090.0,14131,,BAO_0000218,Mus musculus,,CHEMBL626284,A,,"Percentage biodistribution in mouse blood, 60 minutes post injection",Intermediate
,,Brain,,,1,,,N,50594,14045,1,10090.0,14132,,BAO_0000218,Mus musculus,955.0,CHEMBL626285,A,,"Percentage biodistribution in mouse brain, 10 minutes post injection",Intermediate
,,Brain,,,1,,,N,50594,14045,1,10090.0,14133,,BAO_0000218,Mus musculus,955.0,CHEMBL626286,A,,"Percentage biodistribution in mouse brain, 30 minutes post injection",Intermediate
,,Brain,,,1,,,N,50594,14045,1,10090.0,14134,,BAO_0000218,Mus musculus,955.0,CHEMBL626287,A,,"Percentage biodistribution in mouse brain, 5 minutes post injection",Intermediate
,,Brain,,,1,,,N,50594,14045,1,10090.0,14135,,BAO_0000218,Mus musculus,955.0,CHEMBL626288,A,,"Percentage biodistribution in mouse brain, 60 minutes post injection",Intermediate
,,,,,1,,,N,50594,14045,1,10090.0,14136,,BAO_0000218,Mus musculus,,CHEMBL626289,A,,"Percentage biodistribution in mouse heart, 10 minutes post injection",Intermediate
,,,,,1,,,N,50594,14045,1,10090.0,14137,,BAO_0000218,Mus musculus,,CHEMBL626290,A,,"Percentage biodistribution in mouse heart, 30 minutes post injection",Intermediate
,,,,,1,,,N,50594,14045,1,10090.0,14138,,BAO_0000218,Mus musculus,,CHEMBL626291,A,,"Percentage biodistribution in mouse heart, 5 minutes post injection",Intermediate
,,,,,1,,,N,50594,14045,1,10090.0,14139,,BAO_0000218,Mus musculus,,CHEMBL839888,A,,"Percentage biodistribution in mouse heart, 60 minutes post injection",Intermediate
,,Intestine,,,1,,,N,50594,14045,1,10090.0,14140,,BAO_0000218,Mus musculus,160.0,CHEMBL626292,A,,"Percentage biodistribution in mouse intestine, 10 minutes post injection",Intermediate
,,Intestine,,,1,,,N,50594,14045,1,10090.0,14141,,BAO_0000218,Mus musculus,160.0,CHEMBL626293,A,,"Percentage biodistribution in mouse intestine, 30 minutes post injection",Intermediate
,,Intestine,,,1,,,N,50594,14045,1,10090.0,14142,,BAO_0000218,Mus musculus,160.0,CHEMBL626294,A,,"Percentage biodistribution in mouse intestine, 5 minutes post injection",Intermediate
,,Intestine,,,1,,,N,50594,14045,1,10090.0,14143,,BAO_0000218,Mus musculus,160.0,CHEMBL626295,A,,"Percentage biodistribution in mouse intestine, 60 minutes post injection",Intermediate
,,Liver,,,1,,,N,50594,14045,1,10090.0,14144,,BAO_0000218,Mus musculus,2107.0,CHEMBL627659,A,,"Percentage biodistribution in mouse liver, 10 minutes post injection",Intermediate
,,Liver,,,1,,,N,50594,14045,1,10090.0,14145,,BAO_0000218,Mus musculus,2107.0,CHEMBL627660,A,,"Percentage biodistribution in mouse liver, 30 minutes of post injection",Intermediate
,,Liver,,,1,,,N,50594,14045,1,10090.0,14146,,BAO_0000218,Mus musculus,2107.0,CHEMBL627661,A,,"Percentage biodistribution in mouse liver, 5 minutes post injection",Intermediate
,In vivo,Liver,,,1,,,N,50594,14045,1,10090.0,14147,,BAO_0000218,Mus musculus,2107.0,CHEMBL627662,A,,Biodistribution in mice liver at 60 minutes of post injection,Intermediate
,In vivo,Lung,,,1,,,N,50594,14045,1,10090.0,14148,,BAO_0000218,Mus musculus,2048.0,CHEMBL627663,A,,Biodistribution in mice lungs at 10 min of post injection,Intermediate
,,,,,1,,,N,50594,14045,1,10090.0,14149,,BAO_0000218,Mus musculus,,CHEMBL627664,A,,"Percentage biodistribution in mouse lung, 30 minutes post injection",Intermediate
,,,,,1,,,N,50594,14045,1,10090.0,14150,,BAO_0000218,Mus musculus,,CHEMBL627665,A,,"Percentage biodistribution in mousee lung, 5 minutes post injection",Intermediate
,In vivo,Lung,,,1,,,N,50594,14045,1,10090.0,14151,,BAO_0000218,Mus musculus,2048.0,CHEMBL627666,A,,Biodistribution in mice lungs at 60 min of post injection,Intermediate
,,Spleen,,,1,,,N,50594,14045,1,10090.0,14152,,BAO_0000218,Mus musculus,2106.0,CHEMBL627667,A,,Percentage biodistribution in mouse spleen,Intermediate
,,Stomach,,,1,,,N,50594,14045,1,10090.0,14153,,BAO_0000218,Mus musculus,945.0,CHEMBL627668,A,,Percentage biodistribution in mouse stomach,Intermediate
,,Urine,,,1,,,N,50594,11745,1,10090.0,14154,,BAO_0000218,Mus musculus,1088.0,CHEMBL627669,A,,Mean biodistribution and elimination data in urine was reported 24 h after administering compound intravenously in tumor-bearing female BALB-C mice.,Intermediate
,In vivo,Urinary bladder,,,0,,,U,22224,13257,1,,14155,,BAO_0000218,,1255.0,CHEMBL627670,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bladder,Autocuration
,In vivo,Blood,,,0,,,U,22224,13257,1,,14156,,BAO_0000218,,178.0,CHEMBL627671,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in blood,Autocuration
,In vivo,Bone element,,,0,,,U,22224,13257,1,,14157,,BAO_0000218,,1474.0,CHEMBL627672,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bone,Autocuration
,In vivo,,,,0,,,U,22224,13257,1,,14158,,BAO_0000218,,,CHEMBL627673,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in fat,Autocuration
,In vivo,Kidney,,,0,,,U,22224,13257,1,,14159,,BAO_0000218,,2113.0,CHEMBL627674,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in kidney,Autocuration
,In vivo,Liver,,,0,,,U,22224,13257,1,,14160,,BAO_0000218,,2107.0,CHEMBL627675,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in liver,Autocuration
,In vivo,Lung,,,0,,,U,22224,13257,1,,14161,,BAO_0000218,,2048.0,CHEMBL627676,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in lung,Autocuration
,In vivo,Muscle tissue,,,0,,,U,22224,13257,1,,14162,,BAO_0000218,,2385.0,CHEMBL627677,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in muscle,Autocuration
,,,,,0,,,U,22224,8354,1,,14163,,BAO_0000019,,,CHEMBL627678,A,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator in the conditions of 25degreeC,pH 7.6",Autocuration
,,Serum,,,1,,,N,50597,7095,1,10116.0,14164,,BAO_0000218,Rattus norvegicus,1977.0,CHEMBL627679,A,,Affinity for protein binding expressed as association constant in fresh rat serum,Intermediate
,,,,,0,,,U,22224,12185,1,,14165,,BAO_0000019,,,CHEMBL627680,A,,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,Autocuration
,,,,,0,,,U,22224,12185,1,,14166,,BAO_0000019,,,CHEMBL627681,A,,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,Autocuration
,,,,,0,,,U,22224,12185,1,,14167,,BAO_0000019,,,CHEMBL627682,A,,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,Autocuration
,,,,,0,,,U,22224,12185,1,,14168,,BAO_0000019,,,CHEMBL627683,A,,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,Autocuration
,,,,,0,,,U,22224,12686,1,,14169,,BAO_0000019,,,CHEMBL627684,A,,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4,Autocuration
,,,,,0,,,U,22224,12686,1,,14170,,BAO_0000019,,,CHEMBL874441,A,,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",Autocuration
,,,,,0,,,U,22224,12686,1,,14171,,BAO_0000019,,,CHEMBL627685,A,,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; No cyclization detected over 4 h,Autocuration
,,,,,0,,,U,22224,12686,1,,14172,,BAO_0000019,,,CHEMBL627686,A,,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",Autocuration
,,,,,0,,,U,22224,8057,1,,14173,,BAO_0000019,,,CHEMBL627687,A,,Apparent rate constant Koff for inactivation of dTMP synthase.,Autocuration
,,,,,0,,,U,22224,15778,1,,14174,,BAO_0000019,,,CHEMBL627688,A,,The irreversible inhibitor activity by second order rate equation.,Autocuration
,,,,,1,,,N,50597,12375,1,10116.0,14175,,BAO_0000218,Rattus norvegicus,,CHEMBL628038,A,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 1 mg/kg concentration,Intermediate
,,,,,1,,,N,50597,12375,1,10116.0,14176,,BAO_0000218,Rattus norvegicus,,CHEMBL628039,A,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 5 mg/kg concentration,Intermediate
,,,,,1,,,N,50597,12375,1,10116.0,14177,,BAO_0000218,Rattus norvegicus,,CHEMBL628040,A,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at vehicle concentration,Intermediate
,,,,,0,,,U,22224,13588,1,,14178,,BAO_0000019,,,CHEMBL628041,A,,Dissociation rate calculated from the first-order equation using t1/2 value,Autocuration
,,,,,0,,,U,22224,15039,1,,14179,,BAO_0000019,,,CHEMBL630226,A,,The compound was tested for Binding constant against DNA,Autocuration
,,,,,0,,,U,22224,9500,1,,14180,,BAO_0000019,,,CHEMBL628042,A,,First order rate constant for cyclization of the compound,Autocuration
,,,,,0,,,U,22224,10014,1,,14181,,BAO_0000019,,,CHEMBL625232,A,,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,Autocuration
,,,,,0,,,U,22224,10014,1,,14182,,BAO_0000019,,,CHEMBL625233,A,,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,Autocuration
,,,,,0,,,U,22224,568,1,,14183,,BAO_0000019,,,CHEMBL625979,A,,Hydrolysis rate constant was determined,Autocuration
,,,,,0,,,U,22224,10026,1,,14184,,BAO_0000019,,,CHEMBL625980,A,,Observed first order rate constant,Autocuration
,,,,,0,,,U,22224,10281,1,,14185,,BAO_0000019,,,CHEMBL625981,A,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,Autocuration
,,,,,0,,,U,22224,10281,1,,14186,,BAO_0000019,,,CHEMBL625982,A,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,Autocuration
,,,,,0,,,U,22224,9680,1,,14187,,BAO_0000019,,,CHEMBL625983,A,,Second-order rate constant for attack on PNPA at 25 degree Centigrade,Autocuration
,,,,,0,,,U,22224,13028,1,,14188,,BAO_0000019,,,CHEMBL625984,A,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration
,,,,,0,,,U,22224,13028,1,,14189,,BAO_0000019,,,CHEMBL625985,A,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration
,,,,,0,,,U,22224,13028,1,,14190,,BAO_0000019,,,CHEMBL625986,A,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration
,,,,,0,,,U,22224,13028,1,,14191,,BAO_0000019,,,CHEMBL625987,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration
,,,,,0,,,U,22224,13028,1,,14192,,BAO_0000019,,,CHEMBL625988,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration
,,,,,0,,,U,22224,13028,1,,14193,,BAO_0000019,,,CHEMBL625989,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration
,,,,,0,,,U,22224,13028,1,,14194,,BAO_0000019,,,CHEMBL625990,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration
,,,,,0,,,U,22224,13028,1,,14195,,BAO_0000019,,,CHEMBL625991,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration
,,,,,0,,,U,22224,13028,1,,14196,,BAO_0000019,,,CHEMBL625992,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration
,,,,,0,,,U,22224,13028,1,,14197,,BAO_0000019,,,CHEMBL625993,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration
,,,,,0,,,U,22224,13028,1,,14198,,BAO_0000019,,,CHEMBL631973,A,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration
,,,,,0,,,U,22224,13028,1,,14199,,BAO_0000019,,,CHEMBL632143,A,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration
,,,,,0,,,U,22224,13028,1,,14200,,BAO_0000019,,,CHEMBL632144,A,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration
,,,,,0,,,U,22224,13028,1,,14201,,BAO_0000019,,,CHEMBL632145,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration
,,,,,0,,,U,22224,13028,1,,14202,,BAO_0000019,,,CHEMBL632146,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration
,,,,,0,,,U,22224,13028,1,,14203,,BAO_0000019,,,CHEMBL632147,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration
,,,,,0,,,U,22224,13028,1,,14204,,BAO_0000019,,,CHEMBL632148,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration
,,,,,0,,,U,22224,13028,1,,14205,,BAO_0000019,,,CHEMBL632149,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration
,,,,,0,,,U,22224,13028,1,,14206,,BAO_0000019,,,CHEMBL632150,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration
,,,,,0,,,U,22224,13028,1,,14207,,BAO_0000019,,,CHEMBL632151,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration
,,,,,1,,,N,50587,3008,1,9606.0,14208,,BAO_0000218,Homo sapiens,,CHEMBL632152,A,,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated; not detected,Intermediate
,,,,,1,,,N,50587,4509,1,9606.0,14209,,BAO_0000218,Homo sapiens,,CHEMBL632153,A,,Metabolism after 30 min of incubation with human liver microsomes in the absence of cofactor NADH (2.0 mM) at a concentration of 25 uM,Intermediate
,,,,,1,,,N,50587,4509,1,9606.0,14210,,BAO_0000218,Homo sapiens,,CHEMBL632154,A,,Metabolism after 30 min of incubation with human liver microsomes in the presence of cofactor NADH (2.0 mM) at a concentration of 25 uM,Intermediate
,,,,,1,,,N,50602,8613,1,10298.0,14211,,BAO_0000218,Human herpesvirus 1,,CHEMBL632155,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Tested mice 10,Intermediate
,,,,,1,,,N,50602,8613,1,10298.0,14212,,BAO_0000218,Human herpesvirus 1,,CHEMBL632156,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Total mice tested 10,Intermediate
,,,,,1,,,N,50602,8613,1,10298.0,14213,,BAO_0000218,Human herpesvirus 1,,CHEMBL632157,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day; Tested mice 10,Intermediate
,,,,,1,,,N,50602,8613,1,10298.0,14214,,BAO_0000218,Human herpesvirus 1,,CHEMBL632158,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Tested mice 10,Intermediate
,,,,,1,,,N,50602,8613,1,10298.0,14215,,BAO_0000218,Human herpesvirus 1,,CHEMBL632159,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Total mice tested 10,Intermediate
,,,,,1,,,N,50602,8613,1,10298.0,14216,,BAO_0000218,Human herpesvirus 1,,CHEMBL626305,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 0.8 mg/kg per day; Tested mice 10,Intermediate
,,,,,1,,,N,50602,8613,1,10298.0,14217,,BAO_0000218,Human herpesvirus 1,,CHEMBL626306,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 3.1 mg/kg per day; Total mice tested 10,Intermediate
,,,,,1,,,N,50602,8613,1,10298.0,14218,,BAO_0000218,Human herpesvirus 1,,CHEMBL626307,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day; Tested mice 10,Intermediate
,,,,,1,,,N,50602,8613,1,10298.0,14219,,BAO_0000218,Human herpesvirus 1,,CHEMBL626308,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day; Tested mice 10,Intermediate
,,,,,1,,,N,50602,8613,1,10298.0,14220,,BAO_0000218,Human herpesvirus 1,,CHEMBL626479,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day; Tested mice 10,Intermediate
,,,,,1,,,N,50602,8613,1,10298.0,14221,,BAO_0000218,Human herpesvirus 1,,CHEMBL626480,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day; Tested mice 10,Intermediate
,,,,,0,,,U,22229,6021,1,,14222,,BAO_0000100,,,CHEMBL626481,P,,Calculated partition coefficient (clogP) (MlogP),Autocuration
,,,,,0,,,U,22224,9348,1,,14223,,BAO_0000019,,,CHEMBL626482,A,,Equipotent potent ratio relative to carbachol (nicotinic activity),Autocuration
,,,,,1,,,N,50588,15592,1,9615.0,14224,,BAO_0000218,Canis lupus familiaris,,CHEMBL626483,A,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 ); NA denotes not available",Intermediate
,,,,,1,,,N,50588,15592,1,9615.0,14225,,BAO_0000218,Canis lupus familiaris,,CHEMBL626484,A,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 );NA denotes not available",Intermediate
,,,,,0,,,U,22229,15592,1,,14226,,BAO_0000100,,,CHEMBL626485,P,,Solubility at pH 7.4 in micro g/mL;NA denotes available,Autocuration
,,,,,0,,,U,22229,15592,1,,14227,,BAO_0000100,,,CHEMBL626486,P,,Solubility at pH 7.4 in micro g/mL;NA denotes not available,Autocuration
,,,,,0,,,U,22229,15592,1,,14228,,BAO_0000100,,,CHEMBL626487,P,,Solubility at pH 7.4 in ug/mL;NA denotes not available,Autocuration
,In vivo,Plasma,,,1,,,N,50588,15592,1,9615.0,14229,,BAO_0000218,Canis lupus familiaris,1969.0,CHEMBL626488,A,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,Intermediate
,,Serum,,,1,,,N,50597,7095,1,10116.0,14230,,BAO_0000218,Rattus norvegicus,1977.0,CHEMBL626489,A,,Affinity for protein binding expressed as association constant in fresh rat serum; ND is Not Determined.,Intermediate
,,,,,0,,,U,22224,16618,1,,14231,,BAO_0000019,,,CHEMBL626490,A,,Area under the MAP curve measured over 5 min; ND means Not determined,Autocuration
,,,,,0,,,U,22224,16835,1,,14232,,BAO_0000100,,,CHEMBL626491,P,,Lipophilicity expressed as the negative logarithm of the equilibrium constant; ND denotes no data.,Autocuration
,,,,,0,,,U,22229,15284,1,,14233,,BAO_0000100,,,CHEMBL626492,P,,The apparent partition coefficient(D) in cyclohexane-0.05 M phosphate buffer (pH 7.4) at 21 degree celsius; not determined,Autocuration
,,,,,0,,,U,22224,15750,1,,14234,,BAO_0000019,,,CHEMBL626493,A,,Half-life was measured in the presence of NADPH at 20 uM; No inhibition,Autocuration
,In vivo,,,,1,,,N,50597,16618,1,10116.0,14235,,BAO_0000218,Rattus norvegicus,,CHEMBL626494,A,,Half life after oral administration to Sprague-Dawley rats; NT is Not tested,Intermediate
,In vivo,,,,0,,,U,22224,16618,1,,14236,,BAO_0000218,,,CHEMBL626495,A,,Half life after oral tested,Autocuration
,,Plasma,,,1,,,N,50597,15812,1,10116.0,14237,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626496,A,,Half life was determined in plasma of rat; NT indicates not tested,Intermediate
,In vivo,,,,1,,,N,50597,16618,1,10116.0,14238,,BAO_0000218,Rattus norvegicus,,CHEMBL626497,A,,Oral bioavailability after oral administration to Sprague-Dawley rats; NT is Not tested,Intermediate
,In vivo,,,,0,,,U,22224,16618,1,,14239,,BAO_0000218,,,CHEMBL626498,A,,Oral bioavailability after oral tested,Autocuration
,,,,,1,,,N,50597,13098,1,10116.0,14240,,BAO_0000218,Rattus norvegicus,,CHEMBL626499,A,,The bioavailability in rats at 15.9 uM/Kg after intravenous administration; NT=Not tested (F),Intermediate
,,,,,1,,,N,50597,13098,1,10116.0,14241,,BAO_0000218,Rattus norvegicus,,CHEMBL626500,A,,The compound was tested for volume of distribution in rat at 15.9 uM/Kg after peroral administration; NT=Not tested (Vd L/Kg),Intermediate
,,Plasma,,,1,,,N,50597,15812,1,10116.0,14242,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626501,A,,half life was determined in plasma of rat; NT indicates not tested,Intermediate
,,Plasma,,,1,,,N,50597,15812,1,10116.0,14243,,BAO_0000218,Rattus norvegicus,1969.0,CHEMBL626502,A,,half life was determined in plasma of rat; NT means not tested,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14244,,BAO_0000218,Rattus norvegicus,,CHEMBL626503,A,,Mean sodium excretion in rats (Control/Drug treatment value); Value 0.41/2.32,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14245,,BAO_0000218,Rattus norvegicus,,CHEMBL626504,A,,Mean sodium excretion in rats (Control/Drug treatment value); inactive,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14246,,BAO_0000218,Rattus norvegicus,,CHEMBL626505,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.17/0.43,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14247,,BAO_0000218,Rattus norvegicus,,CHEMBL626506,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.2/0.38,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14248,,BAO_0000218,Rattus norvegicus,,CHEMBL626507,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.26/0.23,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14249,,BAO_0000218,Rattus norvegicus,,CHEMBL626508,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.28/0.26,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14250,,BAO_0000218,Rattus norvegicus,,CHEMBL626509,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.31/0.35,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14251,,BAO_0000218,Rattus norvegicus,,CHEMBL875480,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.35/2.88,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14252,,BAO_0000218,Rattus norvegicus,,CHEMBL626510,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.29,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14253,,BAO_0000218,Rattus norvegicus,,CHEMBL626511,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.47,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14254,,BAO_0000218,Rattus norvegicus,,CHEMBL626512,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.49,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14255,,BAO_0000218,Rattus norvegicus,,CHEMBL628208,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.38/0.23,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14256,,BAO_0000218,Rattus norvegicus,,CHEMBL628209,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.39/0.22,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14257,,BAO_0000218,Rattus norvegicus,,CHEMBL628210,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/0.48,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14258,,BAO_0000218,Rattus norvegicus,,CHEMBL628211,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/1.49,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14259,,BAO_0000218,Rattus norvegicus,,CHEMBL628212,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/2.06,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14260,,BAO_0000218,Rattus norvegicus,,CHEMBL628213,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.42/0.65,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14261,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL628214,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 65.2 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14262,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL628215,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.6 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14263,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL628216,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.8 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14264,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL626595,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 74.8 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14265,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL626596,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 77.5 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14266,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL626597,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 79.4 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14267,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL626598,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 80.9 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14268,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL622242,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 83.8 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14269,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL622243,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.5 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14270,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL622244,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.7 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14271,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL622245,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.7 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14272,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL622246,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.9 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14273,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL622247,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 9.06 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14274,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL622248,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 90.6 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14275,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL877483,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 94.9 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14276,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL622249,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 97.1 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50588,12582,1,9615.0,14277,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL622250,A,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50588,12582,1,9615.0,14278,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL622251,A,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50588,12582,1,9615.0,14279,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL622252,A,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50588,12582,1,9615.0,14280,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL622253,A,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50588,12582,1,9615.0,14281,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL622254,A,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50588,12582,1,9615.0,14282,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL622255,A,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50588,12582,1,9615.0,14283,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL622256,A,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50588,12582,1,9615.0,14284,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL622257,A,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50588,12582,1,9615.0,14285,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL622258,A,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50588,12582,1,9615.0,14286,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL622259,A,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50588,12582,1,9615.0,14287,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL622927,A,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50588,12582,1,9615.0,14288,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL622928,A,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50588,12582,1,9615.0,14289,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL622929,A,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50588,12582,1,9615.0,14290,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL623182,A,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.06 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50588,12582,1,9615.0,14291,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL623183,A,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14292,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL623184,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 0 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14293,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL623185,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.01 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14294,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL877484,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.13 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14295,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL627274,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 10.1 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14296,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL623186,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 102 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14297,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL623187,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 105 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14298,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL623188,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 11.3 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14299,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL628055,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 113 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14300,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL628056,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 19.5 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14301,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL628200,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 195 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14302,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL628201,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 21.7 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14303,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL628202,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 217 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14304,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL628203,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 23.9 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14305,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL628204,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 239 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14306,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL628205,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 24.9 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14307,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL628206,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 249 uM/Kg of drug,Intermediate
,In vivo,Prostate gland,,,0,,,U,22224,13257,1,,14308,,BAO_0000218,,2367.0,CHEMBL628207,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d),Autocuration
,In vivo,Prostate gland,,,0,,,U,22224,13257,1,,14309,,BAO_0000218,,2367.0,CHEMBL627220,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/biood,Autocuration
,In vivo,Muscle tissue,,,0,,,U,22224,13257,1,,14310,,BAO_0000218,,2385.0,CHEMBL627221,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/muscle,Autocuration
,In vivo,Prostate gland,,,0,,,U,22224,13257,1,,14311,,BAO_0000218,,2367.0,CHEMBL627222,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v),Autocuration
,In vivo,,,,0,,,U,22224,13257,1,,14312,,BAO_0000218,,,CHEMBL627223,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/blood,Autocuration
,In vivo,Muscle tissue,,,0,,,U,22224,13257,1,,14313,,BAO_0000218,,2385.0,CHEMBL632062,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/muscle,Autocuration
,In vivo,Spleen,,,0,,,U,22224,13257,1,,14314,,BAO_0000218,,2106.0,CHEMBL632063,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in spleen,Autocuration
,In vivo,Urinary bladder,,,0,,,U,22224,13257,1,,14315,,BAO_0000218,,1255.0,CHEMBL632064,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bladder,Autocuration
,In vivo,Blood,,,0,,,U,22224,13257,1,,14316,,BAO_0000218,,178.0,CHEMBL632065,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in blood,Autocuration
,In vivo,Bone element,,,0,,,U,22224,13257,1,,14317,,BAO_0000218,,1474.0,CHEMBL632066,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bone,Autocuration
,In vivo,,,,0,,,U,22224,13257,1,,14318,,BAO_0000218,,,CHEMBL632067,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in fat,Autocuration
,In vivo,Kidney,,,0,,,U,22224,13257,1,,14319,,BAO_0000218,,2113.0,CHEMBL629188,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in kidney,Autocuration
,In vivo,Liver,,,0,,,U,22224,13257,1,,14320,,BAO_0000218,,2107.0,CHEMBL629189,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in liver,Autocuration
,In vivo,Lung,,,0,,,U,22224,13257,1,,14321,,BAO_0000218,,2048.0,CHEMBL629190,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in lung,Autocuration
,In vivo,Muscle tissue,,,0,,,U,22224,13257,1,,14322,,BAO_0000218,,2385.0,CHEMBL629191,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in muscle,Autocuration
,In vivo,Prostate gland,,,0,,,U,22224,13257,1,,14323,,BAO_0000218,,2367.0,CHEMBL629192,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d),Autocuration
,In vivo,Muscle tissue,,,0,,,U,22224,13257,1,,14324,,BAO_0000218,,2385.0,CHEMBL629193,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d)/muscle,Autocuration
,In vivo,Prostate gland,,,0,,,U,22224,13257,1,,14325,,BAO_0000218,,2367.0,CHEMBL629194,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v),Autocuration
,In vivo,,,,0,,,U,22224,13257,1,,14326,,BAO_0000218,,,CHEMBL629195,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/blood,Autocuration
,In vivo,Muscle tissue,,,0,,,U,22224,13257,1,,14327,,BAO_0000218,,2385.0,CHEMBL629373,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/muscle,Autocuration
,In vivo,Spleen,,,0,,,U,22224,13257,1,,14328,,BAO_0000218,,2106.0,CHEMBL629374,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in spleen,Autocuration
,In vivo,Prostate gland,,,0,,,U,22224,13257,1,,14329,,BAO_0000218,,2367.0,CHEMBL629375,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked)i n prostate (d)/biood,Autocuration
,In vivo,Urinary bladder,,,0,,,U,22224,13257,1,,14330,,BAO_0000218,,1255.0,CHEMBL629376,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bladder,Autocuration
,In vivo,Blood,,,0,,,U,22224,13257,1,,14331,,BAO_0000218,,178.0,CHEMBL629377,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in blood,Autocuration
,In vivo,Bone element,,,0,,,U,22224,13257,1,,14332,,BAO_0000218,,1474.0,CHEMBL629378,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bone,Autocuration
,In vivo,,,,0,,,U,22224,13257,1,,14333,,BAO_0000218,,,CHEMBL629379,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in fat,Autocuration
,In vivo,Kidney,,,0,,,U,22224,13257,1,,14334,,BAO_0000218,,2113.0,CHEMBL629151,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in kidney,Autocuration
,In vivo,Liver,,,0,,,U,22224,13257,1,,14335,,BAO_0000218,,2107.0,CHEMBL629152,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in liver,Autocuration
,In vivo,Lung,,,0,,,U,22224,13257,1,,14336,,BAO_0000218,,2048.0,CHEMBL629153,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in lung,Autocuration
,In vivo,Muscle tissue,,,0,,,U,22224,13257,1,,14337,,BAO_0000218,,2385.0,CHEMBL629154,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in muscle,Autocuration
,In vivo,Prostate gland,,,0,,,U,22224,13257,1,,14338,,BAO_0000218,,2367.0,CHEMBL629155,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d),Autocuration
,In vivo,Prostate gland,,,0,,,U,22224,13257,1,,14339,,BAO_0000218,,2367.0,CHEMBL629156,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/biood,Autocuration
,In vivo,Muscle tissue,,,0,,,U,22224,13257,1,,14340,,BAO_0000218,,2385.0,CHEMBL629157,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/muscle,Autocuration
,In vivo,Prostate gland,,,0,,,U,22224,13257,1,,14341,,BAO_0000218,,2367.0,CHEMBL629158,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v),Autocuration
,In vivo,,,,0,,,U,22224,13257,1,,14342,,BAO_0000218,,,CHEMBL629159,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/blood,Autocuration
,In vivo,Muscle tissue,,,0,,,U,22224,13257,1,,14343,,BAO_0000218,,2385.0,CHEMBL629160,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/muscle,Autocuration
,In vivo,Spleen,,,0,,,U,22224,13257,1,,14344,,BAO_0000218,,2106.0,CHEMBL629161,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in spleen,Autocuration
,In vivo,Urinary bladder,,,0,,,U,22224,13257,1,,14345,,BAO_0000218,,1255.0,CHEMBL629162,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bladder,Autocuration
,In vivo,Blood,,,0,,,U,22224,13257,1,,14346,,BAO_0000218,,178.0,CHEMBL629163,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in blood,Autocuration
,In vivo,Bone element,,,0,,,U,22224,13257,1,,14347,,BAO_0000218,,1474.0,CHEMBL629164,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bone,Autocuration
,In vivo,,,,0,,,U,22224,13257,1,,14348,,BAO_0000218,,,CHEMBL629165,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in fat,Autocuration
,In vivo,Liver,,,0,,,U,22224,13257,1,,14349,,BAO_0000218,,2107.0,CHEMBL629166,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in liver,Autocuration
,In vivo,Lung,,,0,,,U,22224,13257,1,,14350,,BAO_0000218,,2048.0,CHEMBL629167,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in lung,Autocuration
,In vivo,Muscle tissue,,,0,,,U,22224,13257,1,,14351,,BAO_0000218,,2385.0,CHEMBL629168,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in muscle,Autocuration
,,,,,0,,,U,22224,2193,1,,14352,,BAO_0000019,,,CHEMBL629169,A,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM,Autocuration
,,,,,0,,,U,22224,2193,1,,14353,,BAO_0000019,,,CHEMBL629170,A,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM; no inhibition is observed at this concentration,Autocuration
,,,,,0,,,U,22224,2193,1,,14354,,BAO_0000019,,,CHEMBL631153,A,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM,Autocuration
,,,,,0,,,U,22224,2193,1,,14355,,BAO_0000019,,,CHEMBL875121,A,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM; too active and complete inhibition is observed,Autocuration
,,,,,0,,,U,22224,2193,1,,14356,,BAO_0000019,,,CHEMBL631154,A,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM,Autocuration
,,,,,0,,,U,22224,2193,1,,14357,,BAO_0000019,,,CHEMBL631155,A,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM; too active and complete inhibition is observed,Autocuration
,,,,,0,,,U,22224,568,1,,14358,,BAO_0000019,,,CHEMBL631156,A,,Hydrolysis rate constant was determined,Autocuration
,,,,,0,,,U,22224,9680,1,,14359,,BAO_0000019,,,CHEMBL631157,A,,"K2, The intrinsic biomolecular reactivation rate constant on VX at 25 degree Centigrade",Autocuration
,,,,,0,,,U,22224,9680,1,,14360,,BAO_0000019,,,CHEMBL631158,A,,"K2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",Autocuration
,,,,,0,,,U,22224,9680,1,,14361,,BAO_0000019,,,CHEMBL631159,A,,"K2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",Autocuration
,,,,,0,,,U,22224,10026,1,,14362,,BAO_0000019,,,CHEMBL631160,A,,Observed second order rate constant,Autocuration
,,,,,0,,,U,22224,10281,1,,14363,,BAO_0000019,,,CHEMBL631161,A,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,Autocuration
,,,,,0,,,U,22224,10014,1,,14364,,BAO_0000019,,,CHEMBL631162,A,,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,Autocuration
,,,,,0,,,U,22224,10014,1,,14365,,BAO_0000019,,,CHEMBL630313,A,,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,Autocuration
,,,,,0,,,U,22224,9680,1,,14366,,BAO_0000019,,,CHEMBL630314,A,,"k2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",Autocuration
,,,,,0,,,U,22224,9680,1,,14367,,BAO_0000019,,,CHEMBL630315,A,,"k2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",Autocuration
,,,,,0,,,U,22224,13028,1,,14368,,BAO_0000019,,,CHEMBL630316,A,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration
,,,,,0,,,U,22224,13028,1,,14369,,BAO_0000019,,,CHEMBL630986,A,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration
,,,,,0,,,U,22224,13028,1,,14370,,BAO_0000019,,,CHEMBL630987,A,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration
,,,,,0,,,U,22224,13028,1,,14371,,BAO_0000019,,,CHEMBL630988,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0(or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration
,,,,,0,,,U,22224,13028,1,,14372,,BAO_0000019,,,CHEMBL630989,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration
,,,,,0,,,U,22224,13028,1,,14373,,BAO_0000019,,,CHEMBL630990,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration
,,,,,0,,,U,22224,13028,1,,14374,,BAO_0000019,,,CHEMBL630991,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration
,,,,,0,,,U,22224,13028,1,,14375,,BAO_0000019,,,CHEMBL630992,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration
,,,,,0,,,U,22224,13028,1,,14376,,BAO_0000019,,,CHEMBL630993,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration
,,,,,0,,,U,22224,13028,1,,14377,,BAO_0000019,,,CHEMBL630994,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration
,,,,,1,,,N,50597,10014,1,10116.0,14378,,BAO_0000218,Rattus norvegicus,,CHEMBL630995,A,,Rate constants of compound was determined at muscarinic receptor in the rat cerebral cortex,Intermediate
,,,,,0,,,U,22224,9962,1,,14379,,BAO_0000019,,,CHEMBL629252,A,,Association constant for compound at 31 degree C was determined,Autocuration
,,,,,0,,,U,22224,12029,1,,14380,,BAO_0000019,,,CHEMBL629253,A,,Calculated antagonist equilibrium dissociation constant of the compound,Autocuration
,,,,,0,,,U,22224,12029,1,,14381,,BAO_0000019,,,CHEMBL629944,A,,Calculated antagonist equilibrium dissociation constant of the compound; No statistically significant antagonism observed,Autocuration
,,Trachea,,,1,,,N,50512,10583,1,10141.0,14382,,BAO_0000218,Cavia porcellus,3126.0,CHEMBL629945,A,,Dissociation constants vs LTE4 on guinea pig trachea,Intermediate
,,,,,0,,,U,22224,568,1,,14383,,BAO_0000019,,,CHEMBL629946,A,,"Tested for hydrolysis in presence of boric acid by UV spectrophotometry, dissociation constant was evaluated at the pH < 8",Autocuration
,,,,,0,,,U,22224,568,1,,14384,,BAO_0000019,,,CHEMBL629947,A,,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 8.5",Autocuration
,,,,,0,,,U,22224,568,1,,14385,,BAO_0000019,,,CHEMBL629948,A,,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 9.5",Autocuration
,,,,,0,,,U,22224,568,1,,14386,,BAO_0000019,,,CHEMBL856024,A,,"Tested for hydrolysis in presence of phenylboronic acid, rate constant was evaluated at the pH 9.5",Autocuration
,,,,,0,,,U,22224,7493,1,,14387,,BAO_0000019,,,CHEMBL629949,A,,Affinity constant KD value was derived from TMP,Autocuration
,,,,,0,,,U,22224,8371,1,,14388,,BAO_0000019,,,CHEMBL629950,A,,Apparent dissociation (binding) rate constant was evaluated,Autocuration
,,,,,0,,,U,22224,13114,1,,14389,,BAO_0000100,,,CHEMBL630127,P,,Dissociation constant (KD) of the compound,Autocuration
,,,,,0,,,U,22224,15515,1,,14390,,BAO_0000100,,,CHEMBL630128,P,,Dissociation constant determined by heteronuclear 1H/15N correlation NMR spectroscopy,Autocuration
,,,,,0,,,U,22224,522,1,,14391,,BAO_0000100,,,CHEMBL630129,P,,Dissociation constant from ESR titration experiments,Autocuration
,,,,,0,,,U,22224,13888,1,,14392,,BAO_0000019,,,CHEMBL630130,,,Dissociation constant was evaluated which is similar to Ki (inhibitory constant),Autocuration
,,,,,0,,,U,22224,2616,1,,14393,,BAO_0000100,,,CHEMBL875234,P,,Dissociation constant was evaluated.,Autocuration
,,,,,0,,,U,22224,3798,1,,14394,,BAO_0000100,,,CHEMBL630131,P,,Dissociation constant was reported,Autocuration
,,,,,1,,,N,50597,8731,1,10116.0,14395,,BAO_0000218,Rattus norvegicus,,CHEMBL630132,A,,Dissociation constant was determined in rat pituitary cells.,Intermediate
,,,,,0,,,U,22224,11892,1,,14396,,BAO_0000019,,,CHEMBL630133,A,,Equilibrium dissociation constant of CA complex for enantiomer 1 of compound,Autocuration
,,,,,0,,,U,22224,11892,1,,14397,,BAO_0000019,,,CHEMBL630134,A,,Equilibrium dissociation constant of CA complex for enantiomer 2 of compound,Autocuration
,,,,,0,,,U,22224,2582,1,,14398,,BAO_0000019,,,CHEMBL630135,A,,Equilibrium dissociation constant of the compound,Autocuration
,,,,,0,,,U,22224,11892,1,,14399,,BAO_0000019,,,CHEMBL630136,A,,Equilibrium dissociation constant was determined,Autocuration
,,,,,0,,,U,22224,13396,1,,14400,,BAO_0000019,,,CHEMBL630137,A,,Kinetic constant KD was evaluated,Autocuration
,,,,,0,,,U,22224,603,1,,14401,,BAO_0000019,,,CHEMBL630138,A,,Tested for dissociation constant of the compound; Value ranges from 0.1-0.3,Autocuration
,,,,,0,,,U,22224,15673,1,,14402,,BAO_0000019,,,CHEMBL630139,A,,Equilibrium association constant interacting with unilamellar vesicles of electroneutral in PBS buffer at pH 7.4,Autocuration
,,,,,0,,,U,22224,10368,1,,14403,,BAO_0000019,,,CHEMBL630140,A,,Rate constant for hydrolysis in aqueous acetone.,Autocuration
,,,,,0,,,U,22224,14228,1,,14404,,BAO_0000019,,,CHEMBL875235,A,,Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex,Autocuration
,,,,,1,,,N,50597,11510,1,10116.0,14405,,BAO_0000218,Rattus norvegicus,,CHEMBL876439,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.43/2.86,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14406,,BAO_0000218,Rattus norvegicus,,CHEMBL630605,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.44/2.68,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14407,,BAO_0000218,Rattus norvegicus,,CHEMBL630606,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.45/1.55,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14408,,BAO_0000218,Rattus norvegicus,,CHEMBL630607,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.48/0.95,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14409,,BAO_0000218,Rattus norvegicus,,CHEMBL630608,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.5/1.79,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14410,,BAO_0000218,Rattus norvegicus,,CHEMBL630609,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.51/0.66,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14411,,BAO_0000218,Rattus norvegicus,,CHEMBL630610,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.52/2.02,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14412,,BAO_0000218,Rattus norvegicus,,CHEMBL630611,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.61//0.37,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14413,,BAO_0000218,Rattus norvegicus,,CHEMBL629552,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.71/0.36,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14414,,BAO_0000218,Rattus norvegicus,,CHEMBL629733,A,,Mean sodium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14415,,BAO_0000218,Rattus norvegicus,,CHEMBL629734,A,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14416,,BAO_0000218,Rattus norvegicus,,CHEMBL629735,A,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14417,,BAO_0000218,Rattus norvegicus,,CHEMBL629736,A,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14418,,BAO_0000218,Rattus norvegicus,,CHEMBL629737,A,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14419,,BAO_0000218,Rattus norvegicus,,CHEMBL629738,A,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14420,,BAO_0000218,Rattus norvegicus,,CHEMBL629739,A,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14421,,BAO_0000218,Rattus norvegicus,,CHEMBL629740,A,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14422,,BAO_0000218,Rattus norvegicus,,CHEMBL629741,A,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14423,,BAO_0000218,Rattus norvegicus,,CHEMBL629742,A,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14424,,BAO_0000218,Rattus norvegicus,,CHEMBL629743,A,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14425,,BAO_0000218,Rattus norvegicus,,CHEMBL629744,A,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14426,,BAO_0000218,Rattus norvegicus,,CHEMBL629745,A,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14427,,BAO_0000218,Rattus norvegicus,,CHEMBL629746,A,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14428,,BAO_0000218,Rattus norvegicus,,CHEMBL629747,A,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14429,,BAO_0000218,Rattus norvegicus,,CHEMBL629748,A,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14430,,BAO_0000218,Rattus norvegicus,,CHEMBL629749,A,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14431,,BAO_0000218,Rattus norvegicus,,CHEMBL629750,A,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14432,,BAO_0000218,Rattus norvegicus,,CHEMBL629751,A,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14433,,BAO_0000218,Rattus norvegicus,,CHEMBL629752,A,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14434,,BAO_0000218,Rattus norvegicus,,CHEMBL629753,A,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14435,,BAO_0000218,Rattus norvegicus,,CHEMBL629754,A,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14436,,BAO_0000218,Rattus norvegicus,,CHEMBL629755,A,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14437,,BAO_0000218,Rattus norvegicus,,CHEMBL629756,A,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14438,,BAO_0000218,Rattus norvegicus,,CHEMBL629757,A,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14439,,BAO_0000218,Rattus norvegicus,,CHEMBL629758,A,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14440,,BAO_0000218,Rattus norvegicus,,CHEMBL629759,A,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14441,,BAO_0000218,Rattus norvegicus,,CHEMBL629760,A,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,Intermediate
,,,,,1,,,N,50597,11510,1,10116.0,14442,,BAO_0000218,Rattus norvegicus,,CHEMBL876443,A,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,Intermediate
,,,,,1,,,N,50588,8310,1,9615.0,14443,,BAO_0000218,Canis lupus familiaris,,CHEMBL629761,A,,Na+ excretion mequiv /kg in 6 conscious female dogs administered perorally during 0-6 hr,Intermediate
,,,,,1,,,N,50588,8310,1,9615.0,14444,,BAO_0000218,Canis lupus familiaris,,CHEMBL629762,A,,Na+ excretion mequiv /kg in conscious female dogs administered perorally during 0-6 hr,Intermediate
,,,,,1,,,N,50594,8310,1,10090.0,14445,,BAO_0000218,Mus musculus,,CHEMBL629763,A,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,Intermediate
,,,,,1,,,N,50594,8310,1,10090.0,14446,,BAO_0000218,Mus musculus,,CHEMBL629764,A,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,Intermediate
,,,,,1,,,N,50594,8310,1,10090.0,14447,,BAO_0000218,Mus musculus,,CHEMBL629765,A,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,Intermediate
,,,,,1,,,N,50594,8310,1,10090.0,14448,,BAO_0000218,Mus musculus,,CHEMBL629766,A,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 50 ml/kg perorally,Intermediate
,,,,,1,,,N,50594,8310,1,10090.0,14449,,BAO_0000218,Mus musculus,,CHEMBL629767,A,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,Intermediate
,,,,,1,,,N,50588,8310,1,9615.0,14450,,BAO_0000218,Canis lupus familiaris,,CHEMBL629768,A,,Na+ excretion mequiv/kg in 4 conscious female dogs administered perorally during 0-6 hr,Intermediate
,,,,,1,,,N,50594,8310,1,10090.0,14451,,BAO_0000218,Mus musculus,,CHEMBL629769,A,,Na+ excretion mequiv/kg in 4 saline-loaded mice administered at a dose 50 ml/kg perorally,Intermediate
,,,,,1,,,N,50588,8310,1,9615.0,14452,,BAO_0000218,Canis lupus familiaris,,CHEMBL629770,A,,Na+ excretion mequiv/kg in 6 conscious female dogs administered perorally during 0-6 hr,Intermediate
,,,,,1,,,N,50588,8310,1,9615.0,14453,,BAO_0000218,Canis lupus familiaris,,CHEMBL629771,A,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 0.3 ml/kg perorally,Intermediate
,,,,,1,,,N,50594,8310,1,10090.0,14454,,BAO_0000218,Mus musculus,,CHEMBL629772,A,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,Intermediate
,,,,,1,,,N,50594,8310,1,10090.0,14455,,BAO_0000218,Mus musculus,,CHEMBL629773,A,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,Intermediate
,,,,,1,,,N,50594,8310,1,10090.0,14456,,BAO_0000218,Mus musculus,,CHEMBL625455,A,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 2 ml/kg perorally,Intermediate
,,,,,1,,,N,50594,8310,1,10090.0,14457,,BAO_0000218,Mus musculus,,CHEMBL625456,A,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 250 ml/kg perorally,Intermediate
,,,,,1,,,N,50594,8310,1,10090.0,14458,,BAO_0000218,Mus musculus,,CHEMBL625457,A,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 3 ml/kg perorally,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14459,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL625458,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 25.9 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14460,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL625459,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 259 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14461,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL875483,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 26.5 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14462,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL634779,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 265 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14463,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL625460,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14464,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL626117,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27.9 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14465,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL626118,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 270 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14466,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL628342,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 279 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14467,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL628343,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.2 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14468,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL628344,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.22 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14469,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL628345,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.9 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14470,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL628346,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 282 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14471,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL628347,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 289 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14472,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL628348,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.40 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14473,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL628349,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.76 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14474,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL875611,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 30.2 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14475,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL628350,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 302 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14476,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL628351,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 31.6 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14477,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL628352,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 316 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14478,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL628353,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 32.4 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14479,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL628354,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 324 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14480,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL626667,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.0 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14481,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL626668,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.1 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14482,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL626669,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.8 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14483,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL626670,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 341 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14484,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL626671,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 348 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14485,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL626672,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 37.6 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14486,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL626673,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 50.8 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14487,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL626674,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 58.4 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14488,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL626675,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 65.2 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14489,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL626676,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 68.1 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14490,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL626677,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 7.94 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14491,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL626678,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.6 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14492,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL626679,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.8 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14493,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL875612,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 74.8 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14494,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL626680,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 77.5 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14495,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL626681,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 79.4 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14496,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL626682,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 80.9 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14497,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL626683,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 83.8 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14498,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL626684,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.5 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14499,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL626685,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.7 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14500,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL626686,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.7 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14501,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL626687,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.9 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14502,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL624978,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 9.06 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14503,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL624979,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 90.6 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14504,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL624980,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 94.9 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14505,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL624981,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 97.1 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50588,12582,1,9615.0,14506,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL624982,A,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,Intermediate
,In vivo,Prostate gland,,,0,,,U,22224,13257,1,,14507,,BAO_0000218,,2367.0,CHEMBL627564,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d),Autocuration
,In vivo,Prostate gland,,,0,,,U,22224,13257,1,,14508,,BAO_0000218,,2367.0,CHEMBL627565,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v),Autocuration
,In vivo,,,,0,,,U,22224,13257,1,,14509,,BAO_0000218,,,CHEMBL627566,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/blood,Autocuration
,In vivo,Muscle tissue,,,0,,,U,22224,13257,1,,14510,,BAO_0000218,,2385.0,CHEMBL627567,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/muscle,Autocuration
,In vivo,Spleen,,,0,,,U,22224,13257,1,,14511,,BAO_0000218,,2106.0,CHEMBL627568,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in spleen,Autocuration
,In vivo,Kidney,,,0,,,U,22224,13257,1,,14512,,BAO_0000218,,2113.0,CHEMBL627569,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hr in kidney,Autocuration
,In vivo,Urinary bladder,,,0,,,U,22224,13257,1,,14513,,BAO_0000218,,1255.0,CHEMBL627570,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bladder,Autocuration
,In vivo,Blood,,,0,,,U,22224,13257,1,,14514,,BAO_0000218,,178.0,CHEMBL627571,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in blood,Autocuration
,In vivo,Bone element,,,0,,,U,22224,13257,1,,14515,,BAO_0000218,,1474.0,CHEMBL627572,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bone,Autocuration
,In vivo,,,,0,,,U,22224,13257,1,,14516,,BAO_0000218,,,CHEMBL627573,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in fat,Autocuration
,In vivo,Kidney,,,0,,,U,22224,13257,1,,14517,,BAO_0000218,,2113.0,CHEMBL627574,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in kidney,Autocuration
,In vivo,Liver,,,0,,,U,22224,13257,1,,14518,,BAO_0000218,,2107.0,CHEMBL627575,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in liver,Autocuration
,In vivo,Lung,,,0,,,U,22224,13257,1,,14519,,BAO_0000218,,2048.0,CHEMBL627576,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in lung,Autocuration
,In vivo,Muscle tissue,,,0,,,U,22224,13257,1,,14520,,BAO_0000218,,2385.0,CHEMBL627577,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in muscle,Autocuration
,In vivo,Prostate gland,,,0,,,U,22224,13257,1,,14521,,BAO_0000218,,2367.0,CHEMBL627578,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d),Autocuration
,In vivo,Prostate gland,,,0,,,U,22224,13257,1,,14522,,BAO_0000218,,2367.0,CHEMBL627579,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/biood,Autocuration
,In vivo,Muscle tissue,,,0,,,U,22224,13257,1,,14523,,BAO_0000218,,2385.0,CHEMBL627580,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/muscle,Autocuration
,In vivo,Prostate gland,,,0,,,U,22224,13257,1,,14524,,BAO_0000218,,2367.0,CHEMBL627581,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v),Autocuration
,In vivo,,,,0,,,U,22224,13257,1,,14525,,BAO_0000218,,,CHEMBL627582,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/blood,Autocuration
,In vivo,Muscle tissue,,,0,,,U,22224,13257,1,,14526,,BAO_0000218,,2385.0,CHEMBL627583,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/muscle,Autocuration
,In vivo,Spleen,,,0,,,U,22224,13257,1,,14527,,BAO_0000218,,2106.0,CHEMBL627584,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in spleen,Autocuration
,In vivo,Prostate gland,,,0,,,U,22224,13257,1,,14528,,BAO_0000218,,2367.0,CHEMBL627585,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/biood,Autocuration
,In vivo,Muscle tissue,,,0,,,U,22224,13257,1,,14529,,BAO_0000218,,2385.0,CHEMBL627586,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/muscle,Autocuration
,In vivo,,,,1,,,N,50597,15413,1,10116.0,14530,,BAO_0000218,Rattus norvegicus,,CHEMBL627587,A,,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 200 nmol of WAY 100635,Intermediate
,In vivo,,,,1,,,N,50597,15413,1,10116.0,14531,,BAO_0000218,Rattus norvegicus,,CHEMBL627588,A,,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,Intermediate
,In vivo,,,,1,,,N,50597,15413,1,10116.0,14532,,BAO_0000218,Rattus norvegicus,,CHEMBL628250,A,,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 200 nmol of WAY 100635,Intermediate
,In vivo,,,,1,,,N,50597,15413,1,10116.0,14533,,BAO_0000218,Rattus norvegicus,,CHEMBL628251,A,,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,Intermediate
,In vivo,Hippocampus,,,1,,,N,50597,15413,1,10116.0,14534,,BAO_0000218,Rattus norvegicus,10000000.0,CHEMBL628252,A,,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 200 nmol of WAY 100635,Intermediate
,In vivo,Hippocampus,,,1,,,N,50597,15413,1,10116.0,14535,,BAO_0000218,Rattus norvegicus,10000000.0,CHEMBL628253,A,,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,Intermediate
,In vivo,Hypothalamus,,,1,,,N,50597,15413,1,10116.0,14536,,BAO_0000218,Rattus norvegicus,1898.0,CHEMBL628254,A,,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 200 nmol of WAY 100635,Intermediate
,In vivo,Hypothalamus,,,1,,,N,50597,15413,1,10116.0,14537,,BAO_0000218,Rattus norvegicus,1898.0,CHEMBL877493,A,,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,Intermediate
,In vivo,,,,1,,,N,50597,15413,1,10116.0,14538,,BAO_0000218,Rattus norvegicus,,CHEMBL628255,A,,Biodistribution of the Radiolabeled FCWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,Intermediate
,In vivo,,,,1,,,N,50597,15413,1,10116.0,14539,,BAO_0000218,Rattus norvegicus,,CHEMBL628256,A,,Biodistribution of the Radiolabeled FCWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,Intermediate
,In vivo,Hippocampus,,,1,,,N,50597,15413,1,10116.0,14540,,BAO_0000218,Rattus norvegicus,10000000.0,CHEMBL628257,A,,Biodistribution of the Radiolabeled FCWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,Intermediate
,In vivo,Hypothalamus,,,1,,,N,50597,15413,1,10116.0,14541,,BAO_0000218,Rattus norvegicus,1898.0,CHEMBL628258,A,,Biodistribution of the Radiolabeled FCWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,Intermediate
,In vivo,,,,1,,,N,50597,15413,1,10116.0,14542,,BAO_0000218,Rattus norvegicus,,CHEMBL628259,A,,Biodistribution of the Radiolabeled MeFBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,Intermediate
,In vivo,,,,1,,,N,50597,15413,1,10116.0,14543,,BAO_0000218,Rattus norvegicus,,CHEMBL628429,A,,Biodistribution of the Radiolabeled MeFBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,Intermediate
,In vivo,Hippocampus,,,1,,,N,50597,15413,1,10116.0,14544,,BAO_0000218,Rattus norvegicus,10000000.0,CHEMBL626862,A,,Biodistribution of the Radiolabeled MeFBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,Intermediate
,In vivo,Hypothalamus,,,1,,,N,50597,15413,1,10116.0,14545,,BAO_0000218,Rattus norvegicus,1898.0,CHEMBL626863,A,,Biodistribution of the Radiolabeled MeFBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635; Not determined,Intermediate
,In vivo,Cerebellum,,,1,,,N,50597,15413,1,10116.0,14546,,BAO_0000218,Rattus norvegicus,2037.0,CHEMBL625886,A,,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum,Intermediate
,In vivo,Cerebellum,,,1,,,N,50597,15413,1,10116.0,14547,,BAO_0000218,Rattus norvegicus,2037.0,CHEMBL625887,A,,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum co-injected with 50 nM of WAY 100635.,Intermediate
,In vivo,,,,1,,,N,50597,15413,1,10116.0,14548,,BAO_0000218,Rattus norvegicus,,CHEMBL625888,A,,Biodistribution of the [11C]-radiolabeled compound in rat cortex,Intermediate
,In vivo,,,,1,,,N,50597,15413,1,10116.0,14549,,BAO_0000218,Rattus norvegicus,,CHEMBL625889,A,,Biodistribution of the [11C]-radiolabeled compound in rat cortex co-injected with 50 nM of WAY 100635.,Intermediate
,In vivo,Hippocampus,,,1,,,N,50597,15413,1,10116.0,14550,,BAO_0000218,Rattus norvegicus,10000000.0,CHEMBL625890,A,,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus,Intermediate
,In vivo,Hippocampus,,,1,,,N,50597,15413,1,10116.0,14551,,BAO_0000218,Rattus norvegicus,10000000.0,CHEMBL625891,A,,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus co-injected with 50 nM of WAY 100635.,Intermediate
,In vivo,Hypothalamus,,,1,,,N,50597,15413,1,10116.0,14552,,BAO_0000218,Rattus norvegicus,1898.0,CHEMBL625892,A,,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus,Intermediate
,In vivo,Hypothalamus,,,1,,,N,50597,15413,1,10116.0,14553,,BAO_0000218,Rattus norvegicus,1898.0,CHEMBL625893,A,,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus co-injected with 50 nM of WAY 100635.,Intermediate
,In vivo,Cerebellum,,,1,,,N,50597,15413,1,10116.0,14554,,BAO_0000218,Rattus norvegicus,2037.0,CHEMBL625894,A,,Biodistribution of the [18F]-radiolabeled compound in rat cerebellum,Intermediate
,In vivo,,,,1,,,N,50597,15413,1,10116.0,14555,,BAO_0000218,Rattus norvegicus,,CHEMBL625895,A,,Biodistribution of the [18F]-radiolabeled compound in rat cortex,Intermediate
,,,,,0,,,U,22224,12404,1,,14556,,BAO_0000019,,,CHEMBL625896,A,,Reaction rate parameter value for phosphate with transfer with respect to ATP,Autocuration
,,,,,0,,,U,22224,568,1,,14557,,BAO_0000019,,,CHEMBL625897,A,,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 8.5(Apparent inhibition constant)",Autocuration
,,,,,0,,,U,22224,568,1,,14558,,BAO_0000019,,,CHEMBL625898,A,,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",Autocuration
,,,,,0,,,U,22224,568,1,,14559,,BAO_0000019,,,CHEMBL625899,A,,"Tested for hydrolysis in presence of phenylboronic acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",Autocuration
,,,,,0,,,U,22224,12404,1,,14560,,BAO_0000019,,,CHEMBL626124,A,,Reaction rate parameter value for phosphate with transfer with respect to ATP,Autocuration
,,,,,1,,,N,50212,7624,1,562.0,14561,,BAO_0000218,Escherichia coli,,CHEMBL628500,A,,Ability to inhibit Escherichia coli adenylate kinase II activity expressed as half maximal velocity,Intermediate
,,,,,1,,,N,50597,7624,1,10116.0,14562,,BAO_0000218,Rattus norvegicus,,CHEMBL857856,A,,"Ability to inhibit rat adenylate kinase II, activity expressed as half-maximal velocity",Intermediate
,,,,,1,,,N,50597,7624,1,10116.0,14563,,BAO_0000218,Rattus norvegicus,,CHEMBL628501,A,,"Ability to inhibit rat adenylate kinase III, activity expressed as half-maximal velocity",Intermediate
,,,,,0,,,U,22224,4643,1,,14564,,BAO_0000019,,,CHEMBL628502,A,,"Compound was evaluated for the Michaelis-Menten constant, Km in a generic protein phosphatase stopped assay system",Autocuration
,,,,,0,,,U,22224,11532,1,,14565,,BAO_0000019,,,CHEMBL628503,A,,Kinetic parameter KM (nM) for the MAO-B catalyzed oxidation of the compound.,Autocuration
,,,,,0,,,U,22224,11018,1,,14566,,BAO_0000019,,,CHEMBL628504,A,,Kinetic parameter KM at pH 7.4 and 37 degree Centigrade,Autocuration
,,,,,0,,,U,22224,2276,1,,14567,,BAO_0000019,,,CHEMBL628505,A,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",Autocuration
,,,,,0,,,U,22224,2276,1,,14568,,BAO_0000019,,,CHEMBL874452,A,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as KM",Autocuration
,,,,,0,,,U,22224,2276,1,,14569,,BAO_0000019,,,CHEMBL628506,A,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as KM; Not determined",Autocuration
,,,,,0,,,U,22224,2276,1,,14570,,BAO_0000019,,,CHEMBL628507,A,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",Autocuration
,,,,,0,,,U,22224,2276,1,,14571,,BAO_0000019,,,CHEMBL628508,A,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as KM",Autocuration
,,,,,0,,,U,22224,8949,1,,14572,,BAO_0000019,,,CHEMBL628509,A,,Michaelis constant (KM) was evaluated,Autocuration
,,,,,0,,,U,22224,12404,1,,14573,,BAO_0000019,,,CHEMBL628510,A,,Reaction rate parameter value for phosphate with transfer with respect to ATP,Autocuration
,,,,,0,,,U,22224,7625,1,,14574,,BAO_0000019,,,CHEMBL628511,B,,Substrate concentration for half maximal velocity was reported for rat hexokinase I,Autocuration
,,,,,0,,,U,22224,7625,1,,14575,,BAO_0000019,,,CHEMBL628512,B,,Substrate concentration for half maximal velocity was reported for rat hexokinase II,Autocuration
,,,,,0,,,U,22224,7625,1,,14576,,BAO_0000019,,,CHEMBL628513,B,,Substrate concentration for half maximal velocity was reported for rat hexokinase III,Autocuration
,,,,,0,,,U,22224,7625,1,,14577,,BAO_0000019,,,CHEMBL628514,B,,Substrate concentration for half maximal velocity was reported for yeast hexokinase,Autocuration
,,,,,0,,,U,22224,12908,1,,14578,,BAO_0000019,,,CHEMBL628515,A,,Pseudo-first-order rate constant for alkylation of NBP in 50% aqueous acetone at 66 degrees celsius with 50 uM and 25 uM of NBP.,Autocuration
,,,,,0,,,U,22224,10368,1,,14579,,BAO_0000019,,,CHEMBL628516,A,,Rate constant for alkylation of 4-(4-nitrobenzyl)pyridine,Autocuration
,,,,,0,,,U,22224,13108,1,,14580,,BAO_0000019,,,CHEMBL628517,A,,Bimolecular rate constant (KOH) at 25 degree C (m = 0.5),Autocuration
,,,,,0,,,U,22224,13108,1,,14581,,BAO_0000019,,,CHEMBL628518,A,,its bimolecular rate constant (KOH) at 25 degree C (m = 0.5),Autocuration
,,,,,0,,,U,22224,15217,1,,14582,,BAO_0000019,,,CHEMBL628519,A,,Acid dissociation constant evaluated towards Hematin mu-oxo dimer,Autocuration
,,,,,0,,,U,22224,15217,1,,14583,,BAO_0000019,,,CHEMBL628520,A,,Acid dissociation constant evaluated towards Hematin mu-oxo dimer; Not available,Autocuration
,,,,,0,,,U,22224,10933,1,,14584,,BAO_0000019,,,CHEMBL628521,A,,Binding constant was determined,Autocuration
,,,,,0,,,U,22224,2363,1,,14585,,BAO_0000019,,,CHEMBL630443,A,,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree Centigrade,Autocuration
,,,,,0,,,U,22224,2363,1,,14586,,BAO_0000019,,,CHEMBL630444,A,,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree centigrade; Not determined,Autocuration
,,,,,0,,,U,22224,2276,1,,14587,,BAO_0000019,,,CHEMBL857732,A,,Rate constant with triethylamine at 30 degree C in 0.1 M potassium chloride was expressed as Kamine,Autocuration
,,,,,0,,,U,22224,14915,1,,14588,,BAO_0000100,,,CHEMBL630445,P,,Octanol-water apparent distribution coefficient measured in TRIS buffer at a pH 7.4.,Autocuration
,,,,,0,,,U,22224,8847,1,,14589,,BAO_0000019,,,CHEMBL630446,A,,Catalytic rate constant of the compound,Autocuration
,,,,,0,,,U,22224,15357,1,,14590,,BAO_0000019,,,CHEMBL630447,B,,inactivation rate constant calculated from experimental IC50 value for dipeptidyl peptidase IV inhibition,Autocuration
,,,,,0,,,U,22224,2869,1,,14591,,BAO_0000019,,,CHEMBL630448,A,,Catalytic constant expressed as Kinetic behavior of enzyme (PicK/6-His),Autocuration
,,,,,0,,,U,22224,3484,1,,14592,,BAO_0000019,,,CHEMBL630449,A,,Catalytic rate constant against phospholipase A2 was determined,Autocuration
,,,,,0,,,U,22224,1373,1,,14593,,BAO_0000019,,,CHEMBL630450,A,,"Compound was evaluated for catalytic constant, Kcat",Autocuration
,,,,,0,,,U,22224,8142,1,,14594,,BAO_0000019,,,CHEMBL630451,A,,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant (kcat) which is a first-order rate constant was determined,Autocuration
,,,,,0,,,U,22224,14131,1,,14595,,BAO_0000019,,,CHEMBL630452,A,,Kcat calculated from 0.693/T1/2,Autocuration
,,,,,0,,,U,22224,17269,1,,14596,,BAO_0000019,,,CHEMBL630453,A,,Kcat was determined,Autocuration
,,,,,0,,,U,22224,3485,1,,14597,,BAO_0000019,,,CHEMBL630454,A,,Kcat against class A PCI beta-lactamase catalyzed lactone hydrolysis,Autocuration
,,,,,0,,,U,22224,3485,1,,14598,,BAO_0000019,,,CHEMBL630455,A,,Kcat against class A TEM beta-lactamase catalyzed lactone hydrolysis,Autocuration
,,,,,0,,,U,22224,3485,1,,14599,,BAO_0000019,,,CHEMBL631487,A,,Kcat against class C P99 beta-lactamase catalyzed lactone hydrolysis,Autocuration
,,,,,0,,,U,22224,5962,1,,14600,,BAO_0000019,,,CHEMBL631488,A,,Kcat value was determined,Autocuration
,,,,,0,,,U,22224,3133,1,,14601,,BAO_0000019,,,CHEMBL876440,A,,Kinetic constant for the hydrolysis by the catalyst CPA was evaluated,Autocuration
,,,,,0,,,U,22224,3133,1,,14602,,BAO_0000019,,,CHEMBL631489,A,,Kinetic constant for the hydrolysis by the catalyst McAbIIF9D8 was evaluated,Autocuration
,,,,,0,,,U,22224,2276,1,,14603,,BAO_0000019,,,CHEMBL857742,A,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",Autocuration
,,,,,0,,,U,22224,2276,1,,14604,,BAO_0000019,,,CHEMBL631490,A,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat",Autocuration
,,,,,0,,,U,22224,2276,1,,14605,,BAO_0000019,,,CHEMBL631491,A,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat; Not determined",Autocuration
,,,,,0,,,U,22224,2276,1,,14606,,BAO_0000019,,,CHEMBL631492,A,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",Autocuration
,,,,,0,,,U,22224,2276,1,,14607,,BAO_0000019,,,CHEMBL631493,A,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat",Autocuration
,,,,,0,,,U,22224,4892,1,,14608,,BAO_0000019,,,CHEMBL631494,A,,Kinetic parameter for rate of conversion to PABA was determined,Autocuration
,,,,,0,,,U,22224,3133,1,,14609,,BAO_0000019,,,CHEMBL631495,A,,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,Autocuration
,,Feces,,,1,,,N,50597,11488,1,10116.0,14610,,BAO_0000218,Rattus norvegicus,1988.0,CHEMBL631496,A,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",Intermediate
,,Urine,,,1,,,N,50597,11488,1,10116.0,14611,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL631497,A,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",Intermediate
,,Urine,,,1,,,N,50597,11488,1,10116.0,14612,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL631498,A,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",Intermediate
,,Urine,,,1,,,N,50597,11488,1,10116.0,14613,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL629776,A,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",Intermediate
,,Urine,,,1,,,N,50597,11488,1,10116.0,14614,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL629777,A,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",Intermediate
,,Urine,,,1,,,N,50597,11488,1,10116.0,14615,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL629778,A,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",Intermediate
,,,,,1,,,N,50597,11488,1,10116.0,14616,,BAO_0000218,Rattus norvegicus,,CHEMBL630456,A,,Cumulative dose excreted after intraduodenal administration at 0-0.5 hours in rats,Intermediate
,,,,,1,,,N,50597,11488,1,10116.0,14617,,BAO_0000218,Rattus norvegicus,,CHEMBL630457,A,,Cumulative dose excreted after intraduodenal administration at 0.5-1.0 hours in rats,Intermediate
,,,,,1,,,N,50597,11488,1,10116.0,14618,,BAO_0000218,Rattus norvegicus,,CHEMBL630458,A,,Cumulative dose excreted after intraduodenal administration at 1.0-1.5 hours in rats,Intermediate
,,,,,1,,,N,50597,11488,1,10116.0,14619,,BAO_0000218,Rattus norvegicus,,CHEMBL630459,A,,Cumulative dose excreted after intraduodenal administration at 1.5-2.0 hours in rats,Intermediate
,,,,,1,,,N,50597,11488,1,10116.0,14620,,BAO_0000218,Rattus norvegicus,,CHEMBL630460,A,,Cumulative dose excreted after intraduodenal administration at 2-3 hours in rats,Intermediate
,,,,,1,,,N,50597,11488,1,10116.0,14621,,BAO_0000218,Rattus norvegicus,,CHEMBL876550,A,,Cumulative dose excreted after intraduodenal administration at 3-4 hours in rats,Intermediate
,,,,,1,,,N,50597,11488,1,10116.0,14622,,BAO_0000218,Rattus norvegicus,,CHEMBL630461,A,,Cumulative dose excreted after intraduodenal administration at 4-6 hours in rats,Intermediate
,,,,,1,,,N,50597,11488,1,10116.0,14623,,BAO_0000218,Rattus norvegicus,,CHEMBL630462,A,,Cumulative dose excreted after intraduodenal administration at 6-8 hours in rats,Intermediate
,,,,,1,,,N,50597,11488,1,10116.0,14624,,BAO_0000218,Rattus norvegicus,,CHEMBL630463,A,,Cumulative dose excreted after intraduodenal administration at 8-24 hours in rats,Intermediate
,,,,,1,,,N,50597,11488,1,10116.0,14625,,BAO_0000218,Rattus norvegicus,,CHEMBL630464,A,,Cumulative dose excreted after intravenous administration at 0-0.5 hours in rats,Intermediate
,,,,,1,,,N,50597,11488,1,10116.0,14626,,BAO_0000218,Rattus norvegicus,,CHEMBL630465,A,,Cumulative dose excreted after intravenous administration at 0.5-1 hours in rats,Intermediate
,,,,,1,,,N,50597,11488,1,10116.0,14627,,BAO_0000218,Rattus norvegicus,,CHEMBL630466,A,,Cumulative dose excreted after intravenous administration at 1.0-1.5 hours in rats,Intermediate
,,,,,1,,,N,50597,11488,1,10116.0,14628,,BAO_0000218,Rattus norvegicus,,CHEMBL630467,A,,Cumulative dose excreted after intravenous administration at 1.5-2 hours in rats,Intermediate
,,,,,1,,,N,50597,11488,1,10116.0,14629,,BAO_0000218,Rattus norvegicus,,CHEMBL630633,A,,Cumulative dose excreted after intravenous administration at 2-3 hours in rats,Intermediate
,,,,,1,,,N,50597,11488,1,10116.0,14630,,BAO_0000218,Rattus norvegicus,,CHEMBL630634,A,,Cumulative dose excreted after intravenous administration at 3-4 hours in rats,Intermediate
,,,,,1,,,N,50597,11488,1,10116.0,14631,,BAO_0000218,Rattus norvegicus,,CHEMBL630635,A,,Cumulative dose excreted after intravenous administration at 4-6 hours in rats,Intermediate
,,,,,1,,,N,50597,11488,1,10116.0,14632,,BAO_0000218,Rattus norvegicus,,CHEMBL630636,A,,Cumulative dose excreted after intravenous administration at 6-8 hours in rats,Intermediate
,,,,,1,,,N,50597,11488,1,10116.0,14633,,BAO_0000218,Rattus norvegicus,,CHEMBL630637,A,,Cumulative dose excreted after intravenous administration at 8-24 hours in rats,Intermediate
,,Feces,,,1,,,N,50592,7132,1,9986.0,14634,,BAO_0000218,Oryctolagus cuniculus,1988.0,CHEMBL630638,A,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",Intermediate
,,Feces,,,1,,,N,50592,7132,1,9986.0,14635,,BAO_0000218,Oryctolagus cuniculus,1988.0,CHEMBL630639,A,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",Intermediate
,,Feces,,,1,,,N,50592,7132,1,9986.0,14636,,BAO_0000218,Oryctolagus cuniculus,1988.0,CHEMBL630640,A,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",Intermediate
,,Feces,,,1,,,N,50592,7132,1,9986.0,14637,,BAO_0000218,Oryctolagus cuniculus,1988.0,CHEMBL876551,A,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",Intermediate
,,Urine,,,1,,,N,50592,7132,1,9986.0,14638,,BAO_0000218,Oryctolagus cuniculus,1088.0,CHEMBL630641,A,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated (total)",Intermediate
,,Urine,,,1,,,N,50592,7132,1,9986.0,14639,,BAO_0000218,Oryctolagus cuniculus,1088.0,CHEMBL630642,A,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",Intermediate
,,Urine,,,1,,,N,50592,7132,1,9986.0,14640,,BAO_0000218,Oryctolagus cuniculus,1088.0,CHEMBL630643,A,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",Intermediate
,,Urine,,,1,,,N,50592,7132,1,9986.0,14641,,BAO_0000218,Oryctolagus cuniculus,1088.0,CHEMBL630644,A,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",Intermediate
,,Urine,,,1,,,N,50592,7132,1,9986.0,14642,,BAO_0000218,Oryctolagus cuniculus,1088.0,CHEMBL630645,A,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",Intermediate
,,Feces,,,1,,,N,50592,7132,1,9986.0,14643,,BAO_0000218,Oryctolagus cuniculus,1988.0,CHEMBL625599,A,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",Intermediate
,,Feces,,,1,,,N,50592,7132,1,9986.0,14644,,BAO_0000218,Oryctolagus cuniculus,1988.0,CHEMBL625600,A,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",Intermediate
,,Feces,,,1,,,N,50592,7132,1,9986.0,14645,,BAO_0000218,Oryctolagus cuniculus,1988.0,CHEMBL625601,A,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",Intermediate
,,Feces,,,1,,,N,50592,7132,1,9986.0,14646,,BAO_0000218,Oryctolagus cuniculus,1988.0,CHEMBL625602,A,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",Intermediate
,,Urine,,,1,,,N,50592,7132,1,9986.0,14647,,BAO_0000218,Oryctolagus cuniculus,1088.0,CHEMBL627470,A,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated (total)",Intermediate
,,Urine,,,1,,,N,50592,7132,1,9986.0,14648,,BAO_0000218,Oryctolagus cuniculus,1088.0,CHEMBL627471,A,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",Intermediate
,,Urine,,,1,,,N,50592,7132,1,9986.0,14649,,BAO_0000218,Oryctolagus cuniculus,1088.0,CHEMBL627472,A,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",Intermediate
,,Urine,,,1,,,N,50592,7132,1,9986.0,14650,,BAO_0000218,Oryctolagus cuniculus,1088.0,CHEMBL627473,A,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",Intermediate
,,Urine,,,1,,,N,50592,7132,1,9986.0,14651,,BAO_0000218,Oryctolagus cuniculus,1088.0,CHEMBL627474,A,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",Intermediate
,In vivo,Blood,,,1,,,N,50597,13925,1,10116.0,14652,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL627475,A,,Biodistribution in rat blood post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate
,In vivo,Blood,,,1,,,N,50597,13925,1,10116.0,14653,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL627476,A,,Biodistribution in rat blood post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate
,,Urine,,,1,,,N,50588,12582,1,9615.0,14654,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL627477,A,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50588,12582,1,9615.0,14655,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL627478,A,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50588,12582,1,9615.0,14656,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL627479,A,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50588,12582,1,9615.0,14657,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL627480,A,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50588,12582,1,9615.0,14658,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL627481,A,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50588,12582,1,9615.0,14659,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL627482,A,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50588,12582,1,9615.0,14660,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL627483,A,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50588,12582,1,9615.0,14661,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL875636,A,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50588,12582,1,9615.0,14662,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL625764,A,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50588,12582,1,9615.0,14663,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL625765,A,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50588,12582,1,9615.0,14664,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL625766,A,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 102 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50588,12582,1,9615.0,14665,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL625767,A,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50588,12582,1,9615.0,14666,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL625768,A,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50588,12582,1,9615.0,14667,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL625769,A,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 34.1 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50588,12582,1,9615.0,14668,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL625770,A,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 50.8 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50588,12582,1,9615.0,14669,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL625771,A,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 68.1 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50588,12582,1,9615.0,14670,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL625772,A,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.060 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50588,12582,1,9615.0,14671,,BAO_0000218,Canis lupus familiaris,1088.0,CHEMBL625773,A,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14672,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL625774,A,,Total electrolytic excretion of sodium in urine of rats after intravenous administration of 7.94 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14673,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL625775,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 0 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14674,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL625776,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.01 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14675,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL625777,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.13 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14676,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL625778,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 10.1 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14677,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL625779,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 102 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14678,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL625780,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 105 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14679,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL625781,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 11.3 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14680,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL875637,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 113 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14681,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL626473,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 19.5 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14682,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL626474,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 195 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14683,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL626475,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 21.7 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14684,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL626476,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 217 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14685,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL634397,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 23.9 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14686,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL626477,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 239 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14687,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL631069,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 24.9 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14688,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL631070,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 249 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14689,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL631071,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 25.9 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14690,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL631072,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 259 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14691,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL631073,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 26.5 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14692,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL631074,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 265 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14693,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL631075,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14694,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL631725,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27.9 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14695,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL631726,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 270 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14696,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL631727,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 279 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14697,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL631728,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.2 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14698,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL631729,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.9 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14699,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL631730,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 282 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14700,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL631731,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 289 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14701,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL631910,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.40 uM/Kg of drug,Intermediate
,In vivo,Hippocampus,,,1,,,N,50597,15413,1,10116.0,14702,,BAO_0000218,Rattus norvegicus,10000000.0,CHEMBL631911,A,,Biodistribution of the [18F]-radiolabeled compound in rat hippocampus,Intermediate
,In vivo,Hypothalamus,,,1,,,N,50597,15413,1,10116.0,14703,,BAO_0000218,Rattus norvegicus,1898.0,CHEMBL631912,A,,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus,Intermediate
,In vivo,Hypothalamus,,,1,,,N,50597,15413,1,10116.0,14704,,BAO_0000218,Rattus norvegicus,1898.0,CHEMBL631913,A,,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus; Not determined,Intermediate
,In vivo,Blood,,,1,,,N,50597,12017,1,10116.0,14705,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL631914,A,,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Blood,,,1,,,N,50597,12017,1,10116.0,14706,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL631915,A,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Blood,,,1,,,N,50597,12017,1,10116.0,14707,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL875778,A,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate
,In vivo,Blood,,,1,,,N,50597,12017,1,10116.0,14708,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL631916,A,,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Blood,,,1,,,N,50597,12017,1,10116.0,14709,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL631917,A,,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Blood,,,1,,,N,50597,12017,1,10116.0,14710,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL631918,A,,Biodistribution in blood of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Blood,,,1,,,N,50597,12017,1,10116.0,14711,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL631919,A,,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Blood,,,1,,,N,50597,12017,1,10116.0,14712,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL631920,A,,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate
,In vivo,Blood,,,1,,,N,50597,12017,1,10116.0,14713,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL631921,A,,Biodistribution in blood of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Blood,,,1,,,N,50597,12017,1,10116.0,14714,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL631922,A,,Biodistribution in blood of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Blood,,,1,,,N,50597,12017,1,10116.0,14715,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL631923,A,,Biodistribution in blood of immature femalee rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate
,In vivo,,,,1,,,N,50597,12017,1,10116.0,14716,,BAO_0000218,Rattus norvegicus,,CHEMBL631924,A,,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,,,,1,,,N,50597,12017,1,10116.0,14717,,BAO_0000218,Rattus norvegicus,,CHEMBL630234,A,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,,,,1,,,N,50597,12017,1,10116.0,14718,,BAO_0000218,Rattus norvegicus,,CHEMBL630235,A,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate
,In vivo,,,,1,,,N,50597,12017,1,10116.0,14719,,BAO_0000218,Rattus norvegicus,,CHEMBL630236,A,,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,,,,1,,,N,50597,12017,1,10116.0,14720,,BAO_0000218,Rattus norvegicus,,CHEMBL630237,A,,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,,,,1,,,N,50597,12017,1,10116.0,14721,,BAO_0000218,Rattus norvegicus,,CHEMBL630238,A,,Biodistribution in fat of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,,,,1,,,N,50597,12017,1,10116.0,14722,,BAO_0000218,Rattus norvegicus,,CHEMBL630239,A,,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,,,,1,,,N,50597,12017,1,10116.0,14723,,BAO_0000218,Rattus norvegicus,,CHEMBL630303,A,,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate
,In vivo,,,,1,,,N,50597,12017,1,10116.0,14724,,BAO_0000218,Rattus norvegicus,,CHEMBL630304,A,,Biodistribution in fat of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,,,,1,,,N,50597,12017,1,10116.0,14725,,BAO_0000218,Rattus norvegicus,,CHEMBL630305,A,,Biodistribution in fat of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Kidney,,,1,,,N,50597,12017,1,10116.0,14726,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL630306,A,,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Kidney,,,1,,,N,50597,12017,1,10116.0,14727,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL630307,A,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Kidney,,,1,,,N,50597,12017,1,10116.0,14728,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL630308,A,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate
,In vivo,Kidney,,,1,,,N,50597,12017,1,10116.0,14729,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL630309,A,,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Kidney,,,1,,,N,50597,12017,1,10116.0,14730,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL629309,A,,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Kidney,,,1,,,N,50597,12017,1,10116.0,14731,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL629993,A,,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Kidney,,,1,,,N,50597,12017,1,10116.0,14732,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL629994,A,,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Kidney,,,1,,,N,50597,12017,1,10116.0,14733,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL629995,A,,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate
,In vivo,Kidney,,,1,,,N,50597,12017,1,10116.0,14734,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL631993,A,,Biodistribution in kidney of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Kidney,,,1,,,N,50597,12017,1,10116.0,14735,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL631994,A,,Biodistribution in kidney of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Kidney,,,1,,,N,50597,12017,1,10116.0,14736,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL631995,A,,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Liver,,,1,,,N,50597,12017,1,10116.0,14737,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL631996,A,,Biodistribution in liver of Iimmature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate
,In vivo,Liver,,,1,,,N,50597,12017,1,10116.0,14738,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL631997,A,,Biodistribution in liver of Iimmature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Liver,,,1,,,N,50597,12017,1,10116.0,14739,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL631998,A,,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Liver,,,1,,,N,50597,12017,1,10116.0,14740,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL631999,A,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Liver,,,1,,,N,50597,12017,1,10116.0,14741,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL632000,A,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate
,In vivo,Liver,,,1,,,N,50597,12017,1,10116.0,14742,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL632001,A,,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Liver,,,1,,,N,50597,12017,1,10116.0,14743,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL874424,A,,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Liver,,,1,,,N,50597,12017,1,10116.0,14744,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL632002,A,,Biodistribution in liver of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Liver,,,1,,,N,50597,12017,1,10116.0,14745,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL632003,A,,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,,,,,0,,,U,22224,3133,1,,14746,,BAO_0000019,,,CHEMBL632004,A,,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,Autocuration
,,,,,0,,,U,22224,2742,1,,14747,,BAO_0000019,,,CHEMBL632005,A,,Compound was tested for amidase rate in the presence of N62C fully characterised enzyme,Autocuration
,,,,,0,,,U,22224,2742,1,,14748,,BAO_0000019,,,CHEMBL632006,A,,Compound was tested for amidase rate in the presence of N62C screen enzyme,Autocuration
,,,,,0,,,U,22224,2742,1,,14749,,BAO_0000019,,,CHEMBL632007,A,,Compound was tested for amidase rate in the presence of S166C fully characterised enzyme,Autocuration
,,,,,0,,,U,22224,2742,1,,14750,,BAO_0000019,,,CHEMBL632008,A,,Compound was tested for amidase rate in the presence of S166C screen enzyme,Autocuration
,,,,,0,,,U,22224,2742,1,,14751,,BAO_0000019,,,CHEMBL632009,A,,Compound was tested for esterase rate in the presence of N62C fully characterised enzyme,Autocuration
,,,,,0,,,U,22224,2742,1,,14752,,BAO_0000019,,,CHEMBL632010,A,,Compound was tested for esterase rate in the presence of N62C screen enzyme,Autocuration
,,,,,0,,,U,22224,2742,1,,14753,,BAO_0000019,,,CHEMBL857750,A,,Compound was tested for esterase rate in the presence of S166C fully characterised enzyme,Autocuration
,,,,,0,,,U,22224,2742,1,,14754,,BAO_0000019,,,CHEMBL632011,A,,Compound was tested for esterase rate in the presence of S166C screen enzyme,Autocuration
,,,,,0,,,U,22224,2276,1,,14755,,BAO_0000019,,,CHEMBL632012,A,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",Autocuration
,,,,,0,,,U,22224,2276,1,,14756,,BAO_0000019,,,CHEMBL632013,A,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",Autocuration
,,,,,0,,,U,22224,2276,1,,14757,,BAO_0000019,,,CHEMBL632014,A,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat/KM",Autocuration
,,,,,0,,,U,22224,2276,1,,14758,,BAO_0000019,,,CHEMBL629622,A,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",Autocuration
,,,,,0,,,U,22224,2276,1,,14759,,BAO_0000019,,,CHEMBL629623,A,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",Autocuration
,,,,,0,,,U,22224,2276,1,,14760,,BAO_0000019,,,CHEMBL629624,A,,"Rate constant at 30 degree C in phosphate buffer pH 7.1, 0.5 % acetonitrile was expressed as Kcat/KM",Autocuration
,,,,,0,,,U,22224,17269,1,,14761,,BAO_0000019,,,CHEMBL629625,A,,Ratio of Kcat to that of Km was determined,Autocuration
,,,,,0,,,U,22224,2276,1,,14762,,BAO_0000019,,,CHEMBL629626,A,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",Autocuration
,,,,,0,,,U,22224,2276,1,,14763,,BAO_0000019,,,CHEMBL629627,A,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",Autocuration
,,,,,0,,,U,22224,15917,1,,14764,,BAO_0000019,,,CHEMBL629628,A,,"Compound was evaluated for constant, Kd",Autocuration
,,,,,0,,,U,22224,10933,1,,14765,,BAO_0000019,,,CHEMBL629629,A,,Deacylation rate constant(Kd fast) was determined by proflavin displacement assay,Autocuration
,,,,,0,,,U,22224,10933,1,,14766,,BAO_0000019,,,CHEMBL629630,A,,Deacylation rate constant(Kd slow) was determined by proflavin displacement assay,Autocuration
,,,,,0,,,U,22224,14293,1,,14767,,BAO_0000019,,,CHEMBL856030,A,,Dissociation Constant of compound determined,Autocuration
,,,,,0,,,U,22224,6698,1,,14768,,BAO_0000019,,,CHEMBL629631,B,,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined,Autocuration
,,,,,0,,,U,22224,6698,1,,14769,,BAO_0000019,,,CHEMBL629632,B,,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined; No data,Autocuration
,,,,,0,,,U,22224,4318,1,,14770,,BAO_0000100,,,CHEMBL629633,P,,Dissociation constant of compound with Fructose was determined,Autocuration
,,,,,0,,,U,22224,4318,1,,14771,,BAO_0000100,,,CHEMBL629634,P,,Dissociation constant of compound with Fructose was determined; Not determined,Autocuration
,,,,,0,,,U,22224,4318,1,,14772,,BAO_0000100,,,CHEMBL629635,P,,Dissociation constant of compound with Lactulose was determined,Autocuration
,,,,,0,,,U,22224,4318,1,,14773,,BAO_0000100,,,CHEMBL629636,P,,Dissociation constant of compound with Lactulose was determined; Not determined,Autocuration
,,,,,0,,,U,22224,14959,1,,14774,,BAO_0000100,,,CHEMBL629637,P,,Dissociation constant of the Compound,Autocuration
,,,,,0,,,U,22224,5913,1,,14775,,BAO_0000100,,,CHEMBL629638,P,,Dissociation constant by non-linear regression analysis,Autocuration
,,,,,0,,,U,22224,14218,1,,14776,,BAO_0000100,,,CHEMBL629639,P,,Dissociation constant was determined,Autocuration
,,,,,0,,,U,22224,10689,1,,14777,,BAO_0000100,,,CHEMBL629640,P,,Dissociation constant of the compound; value ranges from 0.81-1.2 nM,Autocuration
,,,,,0,,,U,22224,13925,1,,14778,,BAO_0000100,,,CHEMBL629641,P,,Dissociation constant was determined,Autocuration
,,,,,0,,,U,22224,16359,1,,14779,,BAO_0000100,,,CHEMBL631344,P,,Dissociation constant was determined,Autocuration
,,Muscle tissue,,,1,,,N,50597,10944,1,10116.0,14780,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL631345,A,,Equilibrium dissociation constant based on membrane concentration in rat smooth muscle,Intermediate
,,,,,0,,,U,22224,11080,1,,14781,,BAO_0000019,,,CHEMBL631346,A,,The dissociation constant determined by fluorescence displacement assay,Autocuration
,,,,,0,,,U,22224,17805,1,,14782,,BAO_0000019,,,CHEMBL631524,A,,kd value surface plasmon resonance (SPR) method,Autocuration
,,Muscle tissue,,,1,,,N,50597,10944,1,10116.0,14783,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL631525,A,,Equilibrium dissociation constant based on aqueous concentration in rat smooth muscle,Intermediate
,,,,,0,,,U,22224,16645,1,,14784,,BAO_0000019,,,CHEMBL631526,F,,First dissociation constant of the binding of compound to V30M TTR,Autocuration
,,,,,0,,,U,22224,16645,1,,14785,,BAO_0000019,,,CHEMBL631527,F,,Second dissociation constant of the binding of compound to V30M TTR,Autocuration
,,,,,0,,,U,22224,7793,1,,14786,,BAO_0000019,,,CHEMBL631528,A,,"Compound was evaluated for equilibrium constant, Ke",Autocuration
,,Hypothalamus,,,0,,,U,22224,12199,1,,14787,,BAO_0000019,,1898.0,CHEMBL631529,A,,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus,Autocuration
,,Hypothalamus,,,0,,,U,22224,12199,1,,14788,,BAO_0000019,,1898.0,CHEMBL631530,A,,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus; inactive,Autocuration
,,,,,0,,,U,22224,9680,1,,14789,,BAO_0000019,,,CHEMBL631531,A,,Keff is the effective biomolecular rate constant on VX for reactivation at pH 7.8 at 25 degree Centigrade,Autocuration
,,,,,0,,,U,22224,9680,1,,14790,,BAO_0000019,,,CHEMBL631532,A,,Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,Autocuration
,,,,,0,,,U,22224,9680,1,,14791,,BAO_0000019,,,CHEMBL631533,A,,Keff is the effective biomolecular rate constant on sarin for reactivation at pH 7.8 at 25 degree Centigrade,Autocuration
,,,,,1,,,N,50594,13758,1,10090.0,14792,,BAO_0000218,Mus musculus,,CHEMBL876552,A,,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,Intermediate
,,,,,1,,,N,50594,13758,1,10090.0,14793,,BAO_0000218,Mus musculus,,CHEMBL631534,A,,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,Intermediate
,,,,,1,,,N,50594,13758,1,10090.0,14794,,BAO_0000218,Mus musculus,,CHEMBL631535,A,,In vitro biotransformation of compound in mice brain homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,Intermediate
,,,,,1,,,N,50594,13758,1,10090.0,14795,,BAO_0000218,Mus musculus,,CHEMBL631536,A,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,Intermediate
,,,,,1,,,N,50594,13758,1,10090.0,14796,,BAO_0000218,Mus musculus,,CHEMBL631537,A,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-hypoxanthine(ara-H) analyte,Intermediate
,,,,,1,,,N,50594,13758,1,10090.0,14797,,BAO_0000218,Mus musculus,,CHEMBL631538,A,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,Intermediate
,,,,,1,,,N,50594,13758,1,10090.0,14798,,BAO_0000218,Mus musculus,,CHEMBL631539,A,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-H) analyte,Intermediate
,,,,,1,,,N,50594,13758,1,10090.0,14799,,BAO_0000218,Mus musculus,,CHEMBL631540,A,,In vitro biotransformation of compound in mice serum 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,Intermediate
,,,,,1,,,N,50597,14393,1,10116.0,14800,,BAO_0000218,Rattus norvegicus,,CHEMBL625637,A,,Pharmacokinetic Parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,Intermediate
,,,,,1,,,N,50597,14393,1,10116.0,14801,,BAO_0000218,Rattus norvegicus,,CHEMBL625638,A,,Pharmacokinetic parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,Intermediate
,,,,,1,,,N,50597,15078,1,10116.0,14802,,BAO_0000218,Rattus norvegicus,,CHEMBL625639,A,,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",Intermediate
,In vivo,Brain,,,1,,,N,50597,13925,1,10116.0,14803,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL625640,A,,Biodistribution in rat brain post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate
,In vivo,Brain,,,1,,,N,50597,13925,1,10116.0,14804,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL625641,A,,Biodistribution in rat brain post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate
,In vivo,Heart,,,1,,,N,50597,13925,1,10116.0,14805,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL625642,A,,Biodistribution in rat heart post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate
,In vivo,Heart,,,1,,,N,50597,13925,1,10116.0,14806,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL625643,A,,Biodistribution in rat heart post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate
,In vivo,Kidney,,,1,,,N,50597,13925,1,10116.0,14807,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL625644,A,,Biodistribution in rat kidney post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate
,In vivo,Kidney,,,1,,,N,50597,13925,1,10116.0,14808,,BAO_0000218,Rattus norvegicus,2113.0,CHEMBL625645,A,,Biodistribution in rat kidney post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate
,In vivo,Liver,,,1,,,N,50597,13925,1,10116.0,14809,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL625646,A,,Biodistribution in rat liver post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate
,In vivo,Liver,,,1,,,N,50597,13925,1,10116.0,14810,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL625647,A,,Biodistribution in rat liver post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate
,In vivo,Lung,,,1,,,N,50597,13925,1,10116.0,14811,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL625648,A,,Biodistribution in rat lung post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate
,In vivo,Lung,,,1,,,N,50597,13925,1,10116.0,14812,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL625649,A,,Biodistribution in rat lung post intravenous injection for 60 min of [99mTc]-TRODAT ligand expressed as percent dose per organ,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,13925,1,10116.0,14813,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL625650,A,,Biodistribution in rat muscle post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,13925,1,10116.0,14814,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL625651,A,,Biodistribution in rat muscle post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate
,In vivo,Zone of skin,,,1,,,N,50597,13925,1,10116.0,14815,,BAO_0000218,Rattus norvegicus,14.0,CHEMBL625652,A,,Biodistribution in rat skin post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate
,In vivo,Zone of skin,,,1,,,N,50597,13925,1,10116.0,14816,,BAO_0000218,Rattus norvegicus,14.0,CHEMBL625653,A,,Biodistribution in rat skin post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate
,In vivo,Spleen,,,1,,,N,50597,13925,1,10116.0,14817,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL625654,A,,Biodistribution in rat spleen post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate
,In vivo,Spleen,,,1,,,N,50597,13925,1,10116.0,14818,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL625655,A,,Biodistribution in rat spleen post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate
,In vivo,Blood,,,1,,,N,50597,9712,1,10116.0,14819,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL625656,A,,Biodistribution of Compound in rat blood after 15 minutes of administration,Intermediate
,In vivo,Blood,,,1,,,N,50597,9712,1,10116.0,14820,,BAO_0000218,Rattus norvegicus,178.0,CHEMBL625657,A,,Biodistribution of Compound in rat blood after 2 minutes of administration,Intermediate
,In vivo,Brain,,,1,,,N,50597,9712,1,10116.0,14821,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL625658,A,,Biodistribution of Compound in rat brain after 15 minutes of administration,Intermediate
,In vivo,Brain,,,1,,,N,50597,9712,1,10116.0,14822,,BAO_0000218,Rattus norvegicus,955.0,CHEMBL625659,A,,Biodistribution of Compound in rat brain after 2 minutes of administration,Intermediate
,In vivo,Heart,,,1,,,N,50597,9712,1,10116.0,14823,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL625660,A,,Biodistribution of Compound in rat heart after 15 minutes of administration,Intermediate
,In vivo,Heart,,,1,,,N,50597,9712,1,10116.0,14824,,BAO_0000218,Rattus norvegicus,948.0,CHEMBL625661,A,,Biodistribution of Compound in rat heart after 2 minutes of administration,Intermediate
,In vivo,Liver,,,1,,,N,50597,9712,1,10116.0,14825,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL625662,A,,Biodistribution of Compound in rat liver after 15 minutes of administration,Intermediate
,In vivo,Liver,,,1,,,N,50597,9712,1,10116.0,14826,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL625663,A,,Biodistribution of Compound in rat liver after 2 minutes of administration,Intermediate
,In vivo,Lung,,,1,,,N,50597,9712,1,10116.0,14827,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL875621,A,,Biodistribution of Compound in rat lung after 15 minutes of administration,Intermediate
,In vivo,Lung,,,1,,,N,50597,9712,1,10116.0,14828,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL628382,A,,Biodistribution of Compound in rat lung after 2 minutes of administration,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,9712,1,10116.0,14829,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL628383,A,,Biodistribution of Compound in rat muscle after 15 minutes of administration,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,9712,1,10116.0,14830,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL628384,A,,Biodistribution of Compound in rat muscle after 2 minutes of administration,Intermediate
,,,,,1,,,N,50597,13925,1,10116.0,14831,,BAO_0000218,Rattus norvegicus,,CHEMBL628385,A,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 2 mins,Intermediate
,,,,,1,,,N,50597,13925,1,10116.0,14832,,BAO_0000218,Rattus norvegicus,,CHEMBL875753,A,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 30 mins,Intermediate
,,,,,1,,,N,50597,13925,1,10116.0,14833,,BAO_0000218,Rattus norvegicus,,CHEMBL628386,A,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 60 mins,Intermediate
,,,,,1,,,N,50597,6941,1,10116.0,14834,,BAO_0000218,Rattus norvegicus,,CHEMBL628387,A,,Organ distribution in rat blood 2 minutes after intravenous injection,Intermediate
,,,,,1,,,N,50597,6941,1,10116.0,14835,,BAO_0000218,Rattus norvegicus,,CHEMBL628388,A,,Organ distribution in rat blood 2 hr after intravenous injection,Intermediate
,,,,,1,,,N,50597,6941,1,10116.0,14836,,BAO_0000218,Rattus norvegicus,,CHEMBL628389,A,,Organ distribution in rat blood 30 minutes after intravenous injection,Intermediate
,,,,,1,,,N,50597,6941,1,10116.0,14837,,BAO_0000218,Rattus norvegicus,,CHEMBL632756,A,,Organ distribution in rat blood 30 min after intravenous injection,Intermediate
,,,,,1,,,N,50597,6941,1,10116.0,14838,,BAO_0000218,Rattus norvegicus,,CHEMBL628390,A,,Organ distribution in rat brain 2 minutes after intravenous injection,Intermediate
,,,,,1,,,N,50597,6941,1,10116.0,14839,,BAO_0000218,Rattus norvegicus,,CHEMBL631811,A,,Organ distribution in rat brain 2 hr after intravenous injection,Intermediate
,,,,,1,,,N,50597,6941,1,10116.0,14840,,BAO_0000218,Rattus norvegicus,,CHEMBL631812,A,,Organ distribution in rat brain 30 minutes after intravenous injection,Intermediate
,,,,,1,,,N,50597,6941,1,10116.0,14841,,BAO_0000218,Rattus norvegicus,,CHEMBL631813,A,,Organ distribution in rat heart 2 minutes after intravenous injection,Intermediate
,,,,,1,,,N,50597,6941,1,10116.0,14842,,BAO_0000218,Rattus norvegicus,,CHEMBL631814,A,,Organ distribution in rat heart 2 hr after intravenous injection,Intermediate
,,,,,1,,,N,50597,6941,1,10116.0,14843,,BAO_0000218,Rattus norvegicus,,CHEMBL631815,A,,Organ distribution in rat heart 30 minutes after intravenous injection,Intermediate
,,,,,1,,,N,50597,6941,1,10116.0,14844,,BAO_0000218,Rattus norvegicus,,CHEMBL631816,A,,Organ distribution in rat kidney 2 minutes after intravenous injection,Intermediate
,,,,,1,,,N,50597,6941,1,10116.0,14845,,BAO_0000218,Rattus norvegicus,,CHEMBL875758,A,,Organ distribution in rat kidney 2 hr after intravenous injection,Intermediate
,,,,,1,,,N,50597,6941,1,10116.0,14846,,BAO_0000218,Rattus norvegicus,,CHEMBL631817,A,,Organ distribution in rat kidney 30 minutes after intravenous injection,Intermediate
,,Liver,,,1,,,N,50597,6941,1,10116.0,14847,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL631818,A,,Organ distribution in rat liver 2 minutes after intravenous injection,Intermediate
,,Liver,,,1,,,N,50597,6941,1,10116.0,14848,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL631819,A,,Organ distribution in rat liver 2 hr after intravenous injection,Intermediate
,,Liver,,,1,,,N,50597,6941,1,10116.0,14849,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL631820,A,,Organ distribution in rat liver 30 minutes after intravenous injection,Intermediate
,,,,,1,,,N,50597,6941,1,10116.0,14850,,BAO_0000218,Rattus norvegicus,,CHEMBL631821,A,,Organ distribution in rat lung 2 minutes after intravenous injection,Intermediate
,,,,,1,,,N,50597,6941,1,10116.0,14851,,BAO_0000218,Rattus norvegicus,,CHEMBL631822,A,,Organ distribution in rat lung 2 hr after intravenous injection,Intermediate
,,,,,1,,,N,50597,6941,1,10116.0,14852,,BAO_0000218,Rattus norvegicus,,CHEMBL631823,A,,Organ distribution in rat lung 30 minutes after intravenous injection,Intermediate
,,Muscle tissue,,,1,,,N,50597,6941,1,10116.0,14853,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL631824,A,,Organ distribution in rat muscle 2 minutes after intravenous injection,Intermediate
,,Muscle tissue,,,1,,,N,50597,6941,1,10116.0,14854,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL631825,A,,Organ distribution in rat muscle 2 hr after intravenous injection,Intermediate
,,Muscle tissue,,,1,,,N,50597,6941,1,10116.0,14855,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL631826,A,,Organ distribution in rat muscle 30 minutes after intravenous injection,Intermediate
,In vivo,,,,1,,,N,50594,14439,1,10090.0,14856,,BAO_0000218,Mus musculus,,CHEMBL631827,A,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Blood (B),Intermediate
,In vivo,,,,1,,,N,50594,14439,1,10090.0,14857,,BAO_0000218,Mus musculus,,CHEMBL631828,A,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Heart (H),Intermediate
,In vivo,,,,1,,,N,50594,14439,1,10090.0,14858,,BAO_0000218,Mus musculus,,CHEMBL631829,A,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Lung (L),Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14859,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL875759,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.76 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14860,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL631830,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 30.20 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14861,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL631831,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 302 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14862,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL631832,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 31.6 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14863,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL631833,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 316 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14864,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL631834,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 32.4 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14865,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL631835,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 324 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14866,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL631836,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.0 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14867,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL631837,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.1 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14868,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL631838,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.8 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14869,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL631839,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 341 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14870,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL631840,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 348 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14871,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL631841,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 37.6 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14872,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL631842,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 58.4 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14873,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL631843,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 65.2 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14874,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL631844,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.6 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14875,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL631845,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.8 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14876,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL631846,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 74.8 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14877,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL875760,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 77.5 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14878,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL632199,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 79.4 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14879,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL631847,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 80.9 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14880,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL631848,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 83.8 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14881,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL628707,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.5 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14882,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL628708,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.7 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14883,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL628709,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.7 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14884,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL628710,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.9 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14885,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL628711,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 9.06 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14886,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL628712,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 90.6 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14887,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL628713,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 94.9 uM/Kg of drug,Intermediate
,,Urine,,,1,,,N,50597,12582,1,10116.0,14888,,BAO_0000218,Rattus norvegicus,1088.0,CHEMBL628714,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 97.1 uM/Kg of drug,Intermediate
,,,,,1,,,N,50597,7415,1,10116.0,14889,,BAO_0000218,Rattus norvegicus,,CHEMBL628715,A,,"excretion rate in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour Rate of biliary excretion; 0.06-0.15%/h",Intermediate
,,,,,0,,,U,22224,7313,1,,14890,,BAO_0000019,,,CHEMBL629179,A,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 3.75-120 uM,Autocuration
,,,,,0,,,U,22224,7313,1,,14891,,BAO_0000019,,,CHEMBL629180,A,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 30 uM,Autocuration
,,,,,0,,,U,22224,7313,1,,14892,,BAO_0000019,,,CHEMBL875108,A,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 7.5-120 uM,Autocuration
,,Adrenal cortex,,,0,,,U,22224,7570,1,,14893,,BAO_0000019,,1235.0,CHEMBL629181,A,,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,Autocuration
,,Adrenal cortex,,,0,,,U,22224,7570,1,,14894,,BAO_0000019,,1235.0,CHEMBL629182,A,,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,Autocuration
,,,,,0,,,U,22224,7570,1,,14895,,BAO_0000019,,,CHEMBL629183,A,,Percent lipid extracted at 0.5 hr from liver plasma using CHCl3/CH3OH.,Autocuration
,,,,,0,,,U,22224,7570,1,,14896,,BAO_0000019,,,CHEMBL629184,A,,Percent lipid extracted at 0.5 hr from liver using CHCl3/CH3OH.,Autocuration
,,Adrenal cortex,,,0,,,U,22224,7570,1,,14897,,BAO_0000019,,1235.0,CHEMBL629185,A,,Percent lipid extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,Autocuration
,,Adrenal cortex,,,0,,,U,22224,7570,1,,14898,,BAO_0000019,,1235.0,CHEMBL629186,A,,Percent lipid extracted at 24 hours from adrenal cortex liver using CHCl3/CH3OH.,Autocuration
,,,,,0,,,U,22224,7570,1,,14899,,BAO_0000019,,,CHEMBL629187,A,,Percent lipid extracted at 24 hours from liverliver using CHCl3/CH3OH.,Autocuration
,,,,,0,,,U,22224,7570,1,,14900,,BAO_0000019,,,CHEMBL629887,A,,Percent lipid extracted at 24 hours from plasma using CHCl3/CH3OH.,Autocuration
,,,,,0,,,U,22224,7570,1,,14901,,BAO_0000019,,,CHEMBL629888,A,,Percent lipid extracted at 24 hours from plasmaliver using CHCl3/CH3OH.,Autocuration
,,,,,0,,,U,22224,7570,1,,14902,,BAO_0000019,,,CHEMBL629889,A,,Percent lipid extracted at 24 hr from liver using CHCl3/CH3OH.,Autocuration
,,Adrenal cortex,,,0,,,U,22224,7570,1,,14903,,BAO_0000019,,1235.0,CHEMBL629890,A,,Percent parent compound extracted at 0.5 hr from adrenal cortex using CHCl3/CH3OH.,Autocuration
,,,,,0,,,U,22224,7570,1,,14904,,BAO_0000019,,,CHEMBL629891,A,,Percent parent compound extracted at 0.5 hr from liver using CHCl3/CH3OH.,Autocuration
,,,,,0,,,U,22224,7570,1,,14905,,BAO_0000019,,,CHEMBL629892,A,,Percent parent compound extracted at 0.5 hr from plasma using CHCl3/CH3OH.,Autocuration
,,Adrenal cortex,,,0,,,U,22224,7570,1,,14906,,BAO_0000019,,1235.0,CHEMBL629893,A,,Percent parent compound extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,Autocuration
,,,,,0,,,U,22224,7570,1,,14907,,BAO_0000019,,,CHEMBL629894,A,,Percent parent compound extracted at 24 hours from liver using CHCl3/CH3OH.,Autocuration
,,,,,0,,,U,22224,7570,1,,14908,,BAO_0000019,,,CHEMBL629895,A,,Percent parent compound extracted at 24 hours from plasma using CHCl3/CH3OH.,Autocuration
,In vivo,,,,0,,,U,22224,14122,1,9615.0,14909,,BAO_0000218,Canis lupus familiaris,,CHEMBL875109,A,,"+Ratio of intravenous to oral integrated area under the concentration vs time curve, for compound in dog plasma",Autocuration
,In vivo,,,,0,,,U,22224,16449,1,9541.0,14910,,BAO_0000218,Macaca fascicularis,,CHEMBL629896,A,,Absolute bioavailability in male cynomolgus monkeys,Autocuration
,In vivo,,,,0,,,U,22224,16449,1,10116.0,14911,,BAO_0000218,Rattus norvegicus,,CHEMBL629897,A,,Absolute bioavailability in maleSprague-Dawley rats,Autocuration
,In vivo,Liver,,,1,,,N,50597,12017,1,10116.0,14912,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL629898,A,,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate
,In vivo,Liver,,,1,,,N,50597,12017,1,10116.0,14913,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL630057,A,,Biodistribution in liver of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Liver,,,1,,,N,50597,12017,1,10116.0,14914,,BAO_0000218,Rattus norvegicus,2107.0,CHEMBL630058,A,,Biodistribution in liver of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Lung,,,1,,,N,50597,12017,1,10116.0,14915,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL630059,A,,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Lung,,,1,,,N,50597,12017,1,10116.0,14916,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL630060,A,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Lung,,,1,,,N,50597,12017,1,10116.0,14917,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL630061,A,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate
,In vivo,Lung,,,1,,,N,50597,12017,1,10116.0,14918,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL630062,A,,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Lung,,,1,,,N,50597,12017,1,10116.0,14919,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL630063,A,,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Lung,,,1,,,N,50597,12017,1,10116.0,14920,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL630064,A,,Biodistribution in lungs of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Lung,,,1,,,N,50597,12017,1,10116.0,14921,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL630065,A,,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Lung,,,1,,,N,50597,12017,1,10116.0,14922,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL630066,A,,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate
,In vivo,Lung,,,1,,,N,50597,12017,1,10116.0,14923,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL630067,A,,Biodistribution in lungs of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Lung,,,1,,,N,50597,12017,1,10116.0,14924,,BAO_0000218,Rattus norvegicus,2048.0,CHEMBL630068,A,,Biodistribution in lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,12017,1,10116.0,14925,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL631113,A,,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,12017,1,10116.0,14926,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL631114,A,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,12017,1,10116.0,14927,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL631115,A,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,12017,1,10116.0,14928,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL631116,A,,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,12017,1,10116.0,14929,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL630528,A,,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,12017,1,10116.0,14930,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL630529,A,,Biodistribution in muscle of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,12017,1,10116.0,14931,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL630530,A,,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,12017,1,10116.0,14932,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL630531,A,,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,12017,1,10116.0,14933,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL630532,A,,Biodistribution in muscle of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Muscle tissue,,,1,,,N,50597,12017,1,10116.0,14934,,BAO_0000218,Rattus norvegicus,2385.0,CHEMBL630533,A,,Biodistribution in muscle of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Blood,,,1,,,N,50594,15045,1,10090.0,14935,,BAO_0000218,Mus musculus,178.0,CHEMBL630534,A,,Biodistribution in normal mice blood after 120 hr,Intermediate
,In vivo,Blood,,,1,,,N,50594,15045,1,10090.0,14936,,BAO_0000218,Mus musculus,178.0,CHEMBL630535,A,,Biodistribution in normal mice blood after 24 hr,Intermediate
,In vivo,Blood,,,1,,,N,50594,15045,1,10090.0,14937,,BAO_0000218,Mus musculus,178.0,CHEMBL630536,A,,Biodistribution in normal mice blood after 4 hr,Intermediate
,In vivo,Bone,,,1,,,N,50594,15045,1,10090.0,14938,,BAO_0000218,Mus musculus,10000001.0,CHEMBL630537,A,,Biodistribution in normal mice bone after 120 hr,Intermediate
,In vivo,Bone,,,1,,,N,50594,15045,1,10090.0,14939,,BAO_0000218,Mus musculus,10000001.0,CHEMBL630538,A,,Biodistribution in normal mice bone after 24 hr,Intermediate
,In vivo,Bone,,,1,,,N,50594,15045,1,10090.0,14940,,BAO_0000218,Mus musculus,10000001.0,CHEMBL630539,A,,Biodistribution in normal mice bone after 4 hr,Intermediate
,In vivo,Heart,,,1,,,N,50594,15045,1,10090.0,14941,,BAO_0000218,Mus musculus,948.0,CHEMBL630540,A,,Biodistribution in normal mice heart after 120 hr,Intermediate
,In vivo,Heart,,,1,,,N,50594,15045,1,10090.0,14942,,BAO_0000218,Mus musculus,948.0,CHEMBL630541,A,,Biodistribution in normal mice heart after 24 hr,Intermediate
,In vivo,Heart,,,1,,,N,50594,15045,1,10090.0,14943,,BAO_0000218,Mus musculus,948.0,CHEMBL630542,A,,Biodistribution in normal mice heart after 4 hr,Intermediate
,In vivo,Kidney,,,1,,,N,50594,15045,1,10090.0,14944,,BAO_0000218,Mus musculus,2113.0,CHEMBL630543,A,,Biodistribution in normal mice kidney after 120 hr,Intermediate
,In vivo,Kidney,,,1,,,N,50594,15045,1,10090.0,14945,,BAO_0000218,Mus musculus,2113.0,CHEMBL630544,A,,Biodistribution in normal mice kidney after 24 hr,Intermediate
,In vivo,Kidney,,,1,,,N,50594,15045,1,10090.0,14946,,BAO_0000218,Mus musculus,2113.0,CHEMBL630545,A,,Biodistribution in normal mice kidney after 4 hr,Intermediate
,In vivo,Liver,,,1,,,N,50594,15045,1,10090.0,14947,,BAO_0000218,Mus musculus,2107.0,CHEMBL630546,A,,Biodistribution in normal mice liver after 120 hr,Intermediate
,In vivo,Liver,,,1,,,N,50594,15045,1,10090.0,14948,,BAO_0000218,Mus musculus,2107.0,CHEMBL630547,A,,Biodistribution in normal mice liver after 24 hr,Intermediate
,In vivo,Liver,,,1,,,N,50594,15045,1,10090.0,14949,,BAO_0000218,Mus musculus,2107.0,CHEMBL630548,A,,Biodistribution in normal mice liver after 4 hr,Intermediate
,In vivo,Spleen,,,1,,,N,50594,15045,1,10090.0,14950,,BAO_0000218,Mus musculus,2106.0,CHEMBL630549,A,,Biodistribution in normal mice spleen after 120 hr,Intermediate
,In vivo,Spleen,,,1,,,N,50594,15045,1,10090.0,14951,,BAO_0000218,Mus musculus,2106.0,CHEMBL630550,A,,Biodistribution in normal mice spleen after 24 hr,Intermediate
,In vivo,Spleen,,,1,,,N,50594,15045,1,10090.0,14952,,BAO_0000218,Mus musculus,2106.0,CHEMBL876426,A,,Biodistribution in normal mice spleen after 4 hr,Intermediate
,In vivo,Spleen,,,1,,,N,50597,12017,1,10116.0,14953,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL630551,A,,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Spleen,,,1,,,N,50597,12017,1,10116.0,14954,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL630552,A,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Spleen,,,1,,,N,50597,12017,1,10116.0,14955,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL630553,A,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate
,In vivo,Spleen,,,1,,,N,50597,12017,1,10116.0,14956,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL630554,A,,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Spleen,,,1,,,N,50597,12017,1,10116.0,14957,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL630555,A,,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Spleen,,,1,,,N,50597,12017,1,10116.0,14958,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL630556,A,,Biodistribution in spleen of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Spleen,,,1,,,N,50597,12017,1,10116.0,14959,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL630557,A,,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Spleen,,,1,,,N,50597,12017,1,10116.0,14960,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL630558,A,,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate
,In vivo,Spleen,,,1,,,N,50597,12017,1,10116.0,14961,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL630559,A,,Biodistribution in spleen of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Spleen,,,1,,,N,50597,12017,1,10116.0,14962,,BAO_0000218,Rattus norvegicus,2106.0,CHEMBL630560,A,,Biodistribution in spleen of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,In vivo,Thyroid gland,,,1,,,N,50597,12017,1,10116.0,14963,,BAO_0000218,Rattus norvegicus,2046.0,CHEMBL876427,A,,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate
,,,,,1,,,N,50597,14941,1,10116.0,14964,,BAO_0000218,Rattus norvegicus,,CHEMBL630561,A,,The Kel values in female wistar rats.,Intermediate
,,,,,0,,,U,22224,4646,1,,14965,,BAO_0000019,,,CHEMBL630562,A,,The equilibrium constant pair at a pH of 7.0 and temperature of 25 degree Centigrade,Autocuration
,,,,,0,,,U,22224,8847,1,,14966,,BAO_0000019,,,CHEMBL630563,A,,Hydrolysis rate constant of the compound,Autocuration
,,,,,0,,,U,22229,11778,1,,14967,,BAO_0000100,,,CHEMBL629673,P,,Headecane/water partition coefficient expressed as the equilibrium ratio of the molar concentration in n-hexadecane to that in the buffer,Autocuration
,,,,,0,,,U,22224,2363,1,,14968,,BAO_0000019,,,CHEMBL629674,A,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0, T=66 degree Centigrade",Autocuration
,,,,,0,,,U,22224,2363,1,,14969,,BAO_0000019,,,CHEMBL629675,A,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree Centigrade",Autocuration
,,,,,0,,,U,22224,2363,1,,14970,,BAO_0000019,,,CHEMBL629676,A,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; No data",Autocuration
,,,,,0,,,U,22224,2363,1,,14971,,BAO_0000019,,,CHEMBL629677,A,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; Not determined",Autocuration
,,,,,0,,,U,22224,8371,1,,14972,,BAO_0000019,,,CHEMBL629678,A,,Apparent inactivation rate constant was evaluated,Autocuration
,,,,,0,,,U,22224,14883,1,,14973,,BAO_0000019,,,CHEMBL629679,A,,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 25 degree Centigrade.,Autocuration
,,,,,0,,,U,22224,14883,1,,14974,,BAO_0000019,,,CHEMBL629680,A,,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 37 degree Centigrade,Autocuration
,,,,,0,,,U,22224,4643,1,,14975,,BAO_0000019,,,CHEMBL629681,A,,Compound was evaluated for the Ki value for peptide alcohol for competitive inhibition in the presence of Mn2+ ions at pH 7.5,Autocuration
,,,,,0,,,U,22224,3519,1,,14976,,BAO_0000019,,,CHEMBL629682,A,,Compound was tested for the inhibition of antibody-catalyzed hydrolysis.,Autocuration
,,,,,0,,,U,22224,10600,1,,14977,,BAO_0000019,,,CHEMBL629683,A,,DBH (dopamine beta-hydroxylase) activity expressed as Ki value determined by degree to which compound inhibited conversion of tyramine to octopamine,Autocuration
,,,,,0,,,U,22224,8501,1,,14978,,BAO_0000019,,,CHEMBL629684,F,,Dissociation constant against constrictor response to the compound blocked competitively by phentolamine for alpha-mediated events,Autocuration
,,,,,0,,,U,22224,8505,1,,14979,,BAO_0000100,,,CHEMBL629685,P,,Dissociation constant was determined,Autocuration
,,,,,0,,,U,22224,9778,1,,14980,,BAO_0000100,,,CHEMBL629686,P,,Dissociation constant was determined,Autocuration
,,,,,0,,,U,22224,9778,1,,14981,,BAO_0000100,,,CHEMBL872932,P,,Dissociation constant at pH 7.4,Autocuration
,,,,,0,,,U,22224,9778,1,,14982,,BAO_0000100,,,CHEMBL629687,P,,Dissociation constant in presence of 1 mM dithiothreitol,Autocuration
,,,,,0,,,U,22224,13007,1,,14983,,BAO_0000019,,,CHEMBL872931,A,,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,Autocuration
,,,,,0,,,U,22224,13007,1,,14984,,BAO_0000019,,,CHEMBL628151,A,,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,Autocuration
,,,,,0,,,U,22224,13007,1,,14985,,BAO_0000019,,,CHEMBL628152,A,,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,Autocuration
,,,,,0,,,U,22224,13007,1,,14986,,BAO_0000019,,,CHEMBL628153,A,,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,Autocuration
,,,,,0,,,U,22224,11482,1,,14987,,BAO_0000019,,,CHEMBL628154,A,,Kinetic constant for aromatization of androstenedione,Autocuration
,,,,,0,,,U,22224,11482,1,,14988,,BAO_0000019,,,CHEMBL628155,A,,Kinetic constant for aromatization of testosterone,Autocuration
,,,,,0,,,U,22224,2303,1,,14989,,BAO_0000019,,,CHEMBL628156,A,,Kinetic parameter for hydrolysis of 1 by Antibody 2D10 after addition of compound 12,Autocuration
,,,,,0,,,U,22224,11964,1,,14990,,BAO_0000019,,,CHEMBL628157,A,,Local inhibition constant was determined,Autocuration
,,,,,1,,,N,50347,3140,1,4932.0,14991,,BAO_0000218,Saccharomyces cerevisiae,,CHEMBL857533,A,,Rate of inactivation of sterol methyl transferase from Saccharomyces cerevisiae using mechanism based inhibitor,Intermediate
,,,,,0,,,U,22224,10650,1,,14992,,BAO_0000100,,,CHEMBL628158,P,,Dissociation constant value of the compound,Autocuration
,,Cornea,,,0,,,U,22224,4667,1,,14993,,BAO_0000019,,964.0,CHEMBL628159,A,,In vitro permeability through cornea without epithelium,Autocuration
,,Cornea,,,0,,,U,22224,4667,1,,14994,,BAO_0000019,,964.0,CHEMBL875616,A,,In vitro permeability through intact cornea,Autocuration
,,Cornea,,,1,,,N,50592,9199,1,9986.0,14995,,BAO_0000218,Oryctolagus cuniculus,964.0,CHEMBL628160,A,,Evaluated for first order rate constant (Kin) for transcorneal penetration in anesthetized rabbits,Intermediate
,,,,,0,,,U,22224,11966,1,,14996,,BAO_0000019,,,CHEMBL628161,A,,Rate of enzyme inactivation for the compound was determined,Autocuration
,,Cornea,,,0,,,U,22224,4667,1,,14997,,BAO_0000019,,964.0,CHEMBL628162,A,,In vitro permeability through cornea without epithelium,Autocuration
,,Cornea,,,0,,,U,22224,4667,1,,14998,,BAO_0000019,,964.0,CHEMBL628163,A,,In vitro permeability through intact cornea,Autocuration
,,,,,0,,,U,22224,8354,1,,14999,,BAO_0000019,,,CHEMBL628164,A,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0300 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration
,,,,,0,,,U,22224,8354,1,,15000,,BAO_0000019,,,CHEMBL628165,A,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0384 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration
,,,,,0,,,U,22224,8354,1,,15001,,BAO_0000019,,,CHEMBL628166,A,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0395 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration
,,,,,0,,,U,22224,8354,1,,15002,,BAO_0000019,,,CHEMBL628167,A,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0500 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration
,,,,,0,,,U,22224,8354,1,,15003,,BAO_0000019,,,CHEMBL628168,A,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.050 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration
,,,,,0,,,U,22224,8354,1,,15004,,BAO_0000019,,,CHEMBL628169,A,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0767 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration
,,,,,0,,,U,22224,8354,1,,15005,,BAO_0000019,,,CHEMBL628170,A,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0790 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration
,,,,,0,,,U,22224,8354,1,,15006,,BAO_0000019,,,CHEMBL628171,A,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0800 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration
,,,,,0,,,U,22224,8354,1,,15007,,BAO_0000019,,,CHEMBL627434,A,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.100 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration
,,,,,0,,,U,22224,8354,1,,15008,,BAO_0000019,,,CHEMBL627435,A,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.200 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration
,,,,,0,,,U,22224,8354,1,,15009,,BAO_0000019,,,CHEMBL628110,A,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.300 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration
,,,,,0,,,U,22224,8354,1,,15010,,BAO_0000019,,,CHEMBL628111,A,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.384 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration
,,,,,0,,,U,22224,8354,1,,15011,,BAO_0000019,,,CHEMBL628112,A,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.395 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration
,,,,,0,,,U,22224,8354,1,,15012,,BAO_0000019,,,CHEMBL628260,A,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration
,,,,,0,,,U,22224,8354,1,,15013,,BAO_0000019,,,CHEMBL628261,A,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration
,In vivo,,,,1,,,N,50594,14439,1,10090.0,15014,,BAO_0000218,Mus musculus,,CHEMBL628262,A,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Muscle (M),Intermediate
,In vivo,,,,1,,,N,50587,14439,1,9606.0,15015,,BAO_0000218,Homo sapiens,,CHEMBL628263,A,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Tumor (T) cells,Intermediate
,In vivo,,,,1,,,N,50594,14439,1,10090.0,15016,,BAO_0000218,Mus musculus,,CHEMBL628264,A,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Blood (B),Intermediate
,In vivo,,,,1,,,N,50594,14439,1,10090.0,15017,,BAO_0000218,Mus musculus,,CHEMBL628265,A,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Heart (H),Intermediate
,In vivo,,,,1,,,N,50594,14439,1,10090.0,15018,,BAO_0000218,Mus musculus,,CHEMBL628266,A,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Lung (L),Intermediate
,In vivo,,,,1,,,N,50594,14439,1,10090.0,15019,,BAO_0000218,Mus musculus,,CHEMBL628267,A,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Muscle (M),Intermediate
,In vivo,,,,1,,,N,50594,14439,1,10090.0,15020,,BAO_0000218,Mus musculus,,CHEMBL628268,A,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Tumor (T) cells,Intermediate
,In vivo,,,,1,,,N,50594,14439,1,10090.0,15021,,BAO_0000218,Mus musculus,,CHEMBL628269,A,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Blood (B),Intermediate
,In vivo,,,,1,,,N,50594,14439,1,10090.0,15022,,BAO_0000218,Mus musculus,,CHEMBL628270,A,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Heart (H),Intermediate
,In vivo,,,,1,,,N,50594,14439,1,10090.0,15023,,BAO_0000218,Mus musculus,,CHEMBL628271,A,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Lung (L),Intermediate
,In vivo,,,,1,,,N,50594,14439,1,10090.0,15024,,BAO_0000218,Mus musculus,,CHEMBL628272,A,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Muscle (M),Intermediate
